<SEC-DOCUMENT>0000927066-23-000104.txt : 20230508
<SEC-HEADER>0000927066-23-000104.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508170328
ACCESSION NUMBER:		0000927066-23-000104
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		82
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		23898744

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dva-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5,d:a1113957fba14778a95e5a7387238c82--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20230331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dva-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18xLTEtMS0xLTU5ODk4NQ_30906576-8d41-43b5-86e7-99b284e5871d">false</ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18yLTEtMS0xLTU5ODk4NQ_bd96d244-78c6-4491-9304-fccf5c8db70e">2023</ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18zLTEtMS0xLTU5ODk4NQ_d2cf1d36-35c8-4a93-851f-d12da770bfca">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N180LTEtMS0xLTU5ODk4NQ_1fb39a1b-0b06-4293-afae-735e9e9167f2">0000927066</ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N181LTEtMS0xLTU5ODk4NQ_889d0f0e-d4dc-4182-aaa4-67afccf612f1">12/31</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMS0yLTEtMS01OTg5ODU_a400d795-b980-474d-887d-329c38ae3d6e">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMi0yLTEtMS01OTg5ODU_7cbdf07b-9cde-4a50-b386-cfaf3a8479e0">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMy0yLTEtMS01OTg5ODU_9a39558b-8053-44b0-9459-91084cbd25b3">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNC0yLTEtMS01OTg5ODU_198878fa-42e2-41fd-8d1e-8505ff70cdb1">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNS0yLTEtMS01OTg5ODU_c442d33e-2bd4-4b8e-a216-6fe10e6a1e63">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNi0yLTEtMS03MTE5Mzc_f4c67f3d-a8e1-4ef0-b123-1a805b2a1ecf">90,650</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNi0yLTEtMS01OTg5ODU_3f579fff-547f-4c17-a53a-a7b0dee253d5">90,411</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80OS9mcmFnOmEyMjk5NjFmMDE5MzRlMzM5NWU0NGE1MmVmOTc0ZDEyL3RleHRyZWdpb246YTIyOTk2MWYwMTkzNGUzMzk1ZTQ0YTUyZWY5NzRkMTJfMzY_ef92970e-4d55-436d-9503-43f6dc78e5d2">not</ix:nonFraction><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5">http://fasb.org/us-gaap/2022#InterestAndDebtExpense</ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dva:CorporateIntegrityAgreementPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81OC9mcmFnOjExMjkyNjBkNjc5MzQ4N2JhZDJiYzI2MDU4NDllZDRjL3RleHRyZWdpb246MTEyOTI2MGQ2NzkzNDg3YmFkMmJjMjYwNTg0OWVkNGNfMjE3_eba5fcc5-20c3-4dbd-924b-b7e5a605d0f5">five years</ix:nonNumeric><ix:nonNumeric contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401" name="dva:RegulatoryAndCommercialMilestonesBeginningDate" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3MzU1_707788c9-729d-4b75-995e-20490a6eca8d">2024-01-01</ix:nonNumeric><ix:nonNumeric contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401" name="dva:RegulatoryAndCommercialMilestonesEndingDate" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3MzYz_1d057f54-8d4d-4ec3-b381-d959b696686f">2028-12-31</ix:nonNumeric><ix:nonNumeric contextRef="ibb64289566f34b759fe950fa1ae62823_D20230428-20230428" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3NzQ4_7460863d-624b-4484-98b7-910d260398d3">five years</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dva-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bc6acfc3254044911840db1912bb40_I20230505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9371851bf60946538246702a8ff6a696_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id10db692f34a4aad9a81d68a86468a88_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37fcf42001e43c795ed70694ccbfda3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f89c44809d7411ba9977e1269611500_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb96decbd5ff48ecbcf4ff701f865932_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5878fb3ce344989a3a50ed0fbd3d5c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae59202d18bb409ea44ff98f022007a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i510e587c5c7d43579eff92128d1feffe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d636acdefa14579a4055e30a18c2ea1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbcdfa0ff4549d8b4c3b8d5daf4ccb3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de0a77acc61440791bc64a61b53a9b8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4ab925c36b4946a9f265610af5c18b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87376613e9424279b6a5359fa39d039d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3461f689329041ac8cfa8e508d1cde1a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca924f1ecfc49c69630f7b1f711fc6b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f3006d566c4ef08a32c52c2e496eec_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id541c72e0cbf46bfb9a30e55268d305f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie60f56cdc6a54c9fa3d7371a7e301cae_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic119590b905b456ea28d952ba0ebba06_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b64c02b45c8429281f3cad0048fd5a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29cc4e5470a24e859cdd1e50d0578b3a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12c3e24420bd492ca1237403f848d3ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1013614d759840f6b8be015cc3fec9fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb86b3a098944b288b2c33833a89c53f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7fdd7915974832a1894f287fbf74d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b52b3eff79543e5aac806c75366b585_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e5eb5a52daa4593b04658664913519d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ca7b69def744ed1951191362496db5a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c65854bb094f5391c31be7458fbc46_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib352cd5ae86642f9b567f560e60aa612_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987691c3f208415a9e66921b89163e85_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736bf7e4b947486db010c69b98f797e4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id011923f6bef4bbeb4834a6883fd2f71_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d427c61e12494a9abcd31dabc719a5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0056bc5a97b440586b4432e43698c40_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i607a0441599c46398e2c421e5264a57d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1091f89c58124befbd0b2e279e7bd5b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf31608c04e04edd937b2b95514487b7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i924864e1995e4749a67469d38a0bd5eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c073a8ecff340d59dd625febdf0c88d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80166e629e549cf924c2644ec659ac8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i716d73cc3cb1416fa1be96a2530344da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94201913127b40309f173dba20dd161d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51fc1a1f1e2a4010893b526540e40610_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebdd5494e2e4158a83cdce6c45ab4a5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i575a2fbf0f754d31b03e7240b518b771_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id30740c932b843f3a92ff50f65a092df_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8de7abdf687142db96dbc1fc809e6fa0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefb5c62e8a584a25b642428ebeb54320_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81154e11a8604522914cf349e50404c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c80ef7e66ba4116b2a34b46479e1285_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c6adb0ddf6453aa8f739edc4c66791_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id51aad86feab47bfaa419694af81fd6f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4872f694e94741ad47978f27eb53ff_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb309d7ddf66423d8e01bc5bd81b6dbc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05abc10dff1c4497a2d0e5f6502b16a5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127075439443455492ab04c3c885a932_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819376c882e444d183ee1f39d65e27b0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a8bf0e6f1bc434e833f7644ec2930a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cb19b8caaef4726a92cbe29d6bf4bbf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83decc5ca955447b80861e67476e8c7f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i168a2cc625074281a784a717f9630a3b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ebec9ed12d4a7b914fb6a4d2803206_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76335814a9534b91a6933754d6ee880a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd540dd8932e46899710b99d728179e5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida9b8b6291464081b6d6d46abed3ff45_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8680e140680144f3b9565b2256e74132_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b2480a61fd485aa01e45ea32bad4a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i871145753f01486ebf685b738fce5959_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2057b25571d24d71b857b3e76d1bedf2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4719531412846d6a89583a6b2671ae7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a4724707ff4691ad93ad034dc2a2ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669e1068f034489a9989b759ab694a1b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d323ea48e843f2b86a68ff4beda64c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfb12c8e4c1b49beabe60ce0a500841a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c237a00597482b8cfeabc140184f16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5169176a56184e19a1d27cfa20139011_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica637bc0d87441efa9e4e45677990b7b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a7f3900fa4a40d883391d98a93f7b4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dva:segment</xbrli:measure></xbrli:unit><xbrli:context id="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i055d4c5e34fe4929931b589f587c0980_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7198d297bdbd4b59b53e63fef3467ee5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d592dfa62de45988c9d46b6d5b78881_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic71000b0b41248f6bcafcb915b93a223_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e1c944e685419abccf81e69b562a8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b1ae9717e3b49f0a0d0440253c6b938_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ebb307dc0b4487ba3d84d58c6c92d94_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd9ed34d6454f8abc969538f9cfe069_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aef3a0c4afb46c6a2d663bf6a8df708_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iea574cb23af34671b3007a1894b492a2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07c0f702252454e8659bb3afea6d865_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3088bbf478db44e4b5510c92e9e067e7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id20d8e4a0d5946c0bde607ba39e21075_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cdf2cf3734745dab39d9af19b881af8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i751eb7e2aba74631a5d35b56d603cd36_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i633c8deded1e4748a5ea3a5e79109ccd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i889d0be36d854ef0ac45dccf0c11123b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7df1686fc84aad9568e0474639a756_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a9bca6cbb340b49899150f84ae8847_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ffe4e826bca45929bab4478c1fc082b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24848738473b434ab56999f3662f285e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2191bc56fe124cba99e0476a60dc454b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i680d044b226c493c92a0d22937dd96da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i918d80ef2d0d471b9ec39e92120325bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b4fc0c1fe9e48f688e101428dafafd4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if822c0b60f1343e596dc95916fa9ff3c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd27b8f4d024843b9742ab7f8244ea4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">dva:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-21</xbrli:startDate><xbrli:endDate>2023-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">dva:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-21</xbrli:startDate><xbrli:endDate>2023-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-22</xbrli:startDate><xbrli:endDate>2019-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54adb3547d1b4238b88fd5e40fb8c84c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-05-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02a973488e20476fb47615a3f807fa05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaee3aa16cbfd44e2990ae90b171f5177_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2eff4db03344e16b162f4f02fc9a3ee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7c88296b2e04e0db089b890c001d849_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibafc68641e624afe9be140dc2f3a0305_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id299644831124bbb8821f8f5c4c9630b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9de0c5885b59490495ce7284b4d660cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8a058875e44febb4f2f422c3462dea_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7db854d9b914c0b9a64e428f1c82c9e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f35fdf8c6145ccbf5f634642c80724_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2983185f3e94a5fa5decfdf5bfb04fc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i909208b4b7f844719f7ac20ac839d43b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd476b66dd8f482d92e7bc8eea43966e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980c082ed2474373bd9567687f6e1049_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie720dbf8a8414299bf7ee67eb13867c2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07abf49a236e4f8194d87f88f8b4b431_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1acf2afce18e45c098496603eec3a1e2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7bf666f9c43437ab5aa6ee983cffdd7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fcc5081c0343a9a1c14dd4e8eb166c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cdccc91fa064c2b8622899fe4990f76_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594302e643444e72a196b7a7758e44c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cf2d70aa9324948a2cc832ba7bd6142_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a53a270c4e04f138e74b1e7cfe51819_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d4c1594069844e69f63a91f84862402_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6608bb6cb94997a8b0a4397ff14ad0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f4a76215494ab98201d3f4c7c27890_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8145bc790f464c6097f88871f5552d27_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a8ea352a2743ed93515924f01db624_I20230401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0788ec757ea94bf4a9145a7a7ed57852_D20230421-20230421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-21</xbrli:startDate><xbrli:endDate>2023-04-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3966a9b63d8a4d6bbeaa5dd9fd9ff21a_I20230421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc23cd3becc842dfa58d5e0e248e0c6a_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3dd1537dba44f5900ed9f64c91677b_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b6c4f2fa614fecaa2c78eec44d5f17_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe1c2673f7634b01be99ea30dec31d8b_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f284922a3174384b3458e6319e9275c_D20230428-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb64289566f34b759fe950fa1ae62823_D20230428-20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-28</xbrli:startDate><xbrli:endDate>2023-04-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia1113957fba14778a95e5a7387238c82_1"></div><div style="min-height:9pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgx_d7758478-9bc9-44a3-9569-539560a33483">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YTk4YjUyY2E5OTBlNDI5YTkwNzg1ZjNlMTAzYTc5OGUvdGFibGVyYW5nZTphOThiNTJjYTk5MGU0MjlhOTA3ODVmM2UxMDNhNzk4ZV8wLTAtMS0xLTU5ODk4NQ_8f31ba53-bc55-455d-a22d-dcb7e7988981">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xMzA_76046771-dd2e-45e2-ac94-045cecd0f0cc">March&#160;31, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YzExNjExYzUwODQ2NGI4OTk5NDIxYTVlNTZjYjRlYTIvdGFibGVyYW5nZTpjMTE2MTFjNTA4NDY0Yjg5OTk0MjFhNWU1NmNiNGVhMl8wLTAtMS0xLTU5ODk4NQ_6936b076-e99c-489f-b0bf-18e6b6f19f16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgy_48f21ab9-2c97-417c-a997-14a5442d3b46">1-14106</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><img src="dva-20230331_g1.jpg" alt="logoa33.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgz_0573966b-70a5-43d3-b02f-e46173f3b22e">DAVITA INC.</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MWJlOWE4OWE0NTZmNDBlMzgwODQ1ZTQ0NGI5OTVhZmQvdGFibGVyYW5nZToxYmU5YTg5YTQ1NmY0MGUzODA4NDVlNDQ0Yjk5NWFmZF8wLTAtMS0xLTU5ODk4NQ_fb287964-d20d-49f6-8d76-58929f541a82">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MWJlOWE4OWE0NTZmNDBlMzgwODQ1ZTQ0NGI5OTVhZmQvdGFibGVyYW5nZToxYmU5YTg5YTQ1NmY0MGUzODA4NDVlNDQ0Yjk5NWFmZF8wLTItMS0xLTU5ODk4NQ_ba9dddb7-da60-463a-b65f-61f336ad9ffd">51-0354549</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State&#160;of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:18.103%"><tr><td style="width:1.0%"></td><td style="width:42.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18wLTAtMS0xLTU5ODk4NQ_6849fed7-bf6b-441a-979f-74c3d1274c4f">2000 16th Street</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTAtMS0xLTU5ODk4NQ_33984e5e-65b9-4370-92a5-b56eb753ea79">Denver,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTEtMS0xLTU5ODk4NQ_393e4b3d-9fa1-40af-9d41-7ee91060e795">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTItMS0xLTU5ODk4NQ_ef5f4c74-d170-4627-8a58-74f78133117a">80202</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telephone number (<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc2_350cabd3-ca9e-491f-af71-b34e28110732">720</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc3_fbf80282-32c5-4491-8bfe-49c858db0612">631-2100</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol(s):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTAtMS0xLTU5ODk4NQ_f475b947-3dc9-4b6d-8bb7-6b95ed3fadd4">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTItMS0xLTU5ODk4NQ_9000ca04-f8cc-4b4f-872e-775f8f399852">DVA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTQtMS0xLTU5ODk4NQ_6e574b42-0a25-461c-ac04-2c860694c22c">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:135.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc4_e535ac2f-36d9-40e2-a90c-eef467f37b1d">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744; </span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc5_40766985-e0f5-4d6f-adf6-917895861f49">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.873%"><tr><td style="width:1.0%"></td><td style="width:31.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml8wLTAtMS0xLTU5ODk4NQ_e1c783d6-1040-430c-9ec5-f13a0a0d5579">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml8yLTMtMS0xLTU5ODk4NQ_5c37b328-2993-49ea-94fc-5df449909349">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml80LTEtMS0xLTU5ODk4NQ_80a7240f-c270-4130-ac4f-dafa29a380f4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgw_1992feee-613b-4542-82d1-298da9e75288">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of May&#160;5, 2023, the number of shares of the registrant&#8217;s common stock outstanding was approximately <ix:nonFraction unitRef="shares" contextRef="i22bc6acfc3254044911840db1912bb40_I20230505" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODY1_a5449207-3234-4da7-961b-f1117529c0c6">90.7</ix:nonFraction> million shares.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_10">Condensed Consolidated Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_13">Consolidated Statements of Income for the three months ended March 31, 2023 and</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_13">March 31, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_16">Consolidated Statements of Comprehensive Income for the three months ended</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_16">&#160;March 31, 2023 and March 31, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_19">Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_25">Consolidated Statements of Cash Flow for the three months ended March 31, 2023 and</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_25">&#160;March 31, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_28">Consolidated Statements of Equity for the three months ended March 31, 2023 and</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_28">&#160;March 31, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_82">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_121">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_121">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_127">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_133">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_136">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_139">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_142">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_142">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia1113957fba14778a95e5a7387238c82_145">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia1113957fba14778a95e5a7387238c82_145">39</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note: Items 3, 4 and 5 of Part II are omitted because they are not applicable.&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="ia1113957fba14778a95e5a7387238c82_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMi0xLTEtMS01OTg5ODU_3fa03466-e9dd-4057-bfd5-deba90357879">2,760,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMi0zLTEtMS01OTg5ODU_384d1e22-5c3b-4813-a9e0-ca3641744dd9">2,716,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMy0xLTEtMS01OTg5ODU_828c136c-4ef3-4583-b2d1-187c61f03d2a">112,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMy0zLTEtMS01OTg5ODU_ee496f91-73e3-4afc-94f8-8f0249792818">101,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNC0xLTEtMS01OTg5ODU_6b258bcf-db23-4bd4-9d18-5ff5401973d5">2,872,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNC0zLTEtMS01OTg5ODU_88212bfd-d1cb-49c8-a6c6-b306d7403ae7">2,817,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNi0xLTEtMS01OTg5ODU_b2e84c2c-deea-4d56-a931-63742d7292a7">2,058,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNi0zLTEtMS01OTg5ODU_ea28bff5-eede-46a7-84bc-0038d55de43e">2,018,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNy0xLTEtMS01OTg5ODU_90867fe5-9bdc-456a-854a-572a5b4b6e14">331,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNy0zLTEtMS01OTg5ODU_18d97999-5a4a-4d5d-acc3-173675c0ecb2">294,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOC0xLTEtMS01OTg5ODU_08f7835c-e464-4827-8b74-d917dc866b4c">178,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOC0zLTEtMS01OTg5ODU_c6569282-c942-4fd1-8ef1-811688095353">172,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOS0xLTEtMS01OTg5ODU_6ad00ec1-bd93-4cd4-9852-8b360c44ea36">6,820</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOS0zLTEtMS01OTg5ODU_937cee91-c5d9-43f2-9cb4-eadcbe9a0cba">7,046</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTItMS0xLTEtNTk4OTg1_80f642fc-2d78-4f35-b40a-250cdb4a3578">2,561,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTItMy0xLTEtNTk4OTg1_85655b03-9fb4-4fcb-8109-bc68a9c26633">2,479,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTMtMS0xLTEtNTk4OTg1_b0d175c0-a7f3-4e3d-9690-671c4a84d140">311,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTMtMy0xLTEtNTk4OTg1_5a7ba2ca-f697-4d18-b131-3d66fba70290">338,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTQtMS0xLTEtNTk4OTg1_f15620cc-0918-4077-96bb-87d4aa01bba1">100,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTQtMy0xLTEtNTk4OTg1_62453d3d-5a5a-429a-8253-ee0542f04574">73,791</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTYtMS0xLTEtNTk4OTg1_d669662b-b535-4564-a449-68f00da1d6f3">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTYtMy0xLTEtNTk4OTg1_f17fd82a-9ecd-4a5f-a8c6-aab87d4b648e">1,786</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTctMS0xLTEtNTk4OTg1_0b050668-6d2e-4172-abe5-56936c267735">214,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTctMy0xLTEtNTk4OTg1_9987ad9a-e995-43c7-a2ad-3c81901afec5">262,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTgtMS0xLTEtNTk4OTg1_e9d2020f-160a-4203-8293-7f080ee0248d">43,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTgtMy0xLTEtNTk4OTg1_51a69c3d-7346-4807-9195-0883d908b126">57,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjEtMS0xLTEtNTk4OTg1_ba730741-4faf-4712-b2c4-c3851c5cb76e">170,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjEtMy0xLTEtNTk4OTg1_c818008d-c283-4239-bd62-ab39249912f7">205,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjItMS0xLTEtNTk4OTg1_fc07cdc8-927c-4e24-b112-84270091e1d8">55,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjItMy0xLTEtNTk4OTg1_a958a782-c3b9-45b4-be0b-85cc2068ae80">43,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjMtMS0xLTEtNTk4OTg1_bbf4b0a5-0184-46e1-8e75-c4636722bb7b">115,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjMtMy0xLTEtNTk4OTg1_79974fc3-2a56-4071-9928-7d1dcbaa57b7">162,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjctMS0xLTEtNTk4OTg1_f6aa773e-1189-4d1b-aa38-e596d6a84675">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjctMy0xLTEtNTk4OTg1_2651fa94-aafd-4f51-9796-324a431d0d55">1.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjktMS0xLTEtNTk4OTg1_0b8a76f3-3bd0-487e-a6f0-25cd1b4976ac">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjktMy0xLTEtNTk4OTg1_9cf396df-8680-4ae3-a118-2bc4f9489ec1">1.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzItMS0xLTEtNTk4OTg1_92d0d129-a6c6-413d-81b2-52ef41886e25">90,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzItMy0xLTEtNTk4OTg1_16cbecc8-5494-415d-b662-8c34476dd58f">96,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzMtMS0xLTEtNTk4OTg1_1f8aad4c-6ff8-453e-b9ce-a77c3b8ee8ec">92,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzMtMy0xLTEtNTk4OTg1_ddd308b6-e57e-41b0-b763-5dc719676dd7">100,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:72.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.731%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.734%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMi0xLTEtMS01OTg5ODU_ba730741-4faf-4712-b2c4-c3851c5cb76e">170,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMi0zLTEtMS01OTg5ODU_c818008d-c283-4239-bd62-ab39249912f7">205,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (losses) gains on interest rate cap agreements:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNS0xLTEtMS01OTg5ODU_442d6029-9d63-4b87-a178-04fdc007eb58">3,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNS0zLTEtMS01OTg5ODU_2b1d8eb4-0a73-4288-9689-914827c8e781">41,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications of net realized (gains) losses into net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNi0xLTEtMS01OTg5ODU_4fbfb323-1e14-49b8-aee1-94adbad47114">15,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNi0zLTEtMS01OTg5ODU_a8948232-360d-4a3e-8dd4-0f7554771d23">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains on foreign currency translation:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNy0xLTEtMS01OTg5ODU_369f65ed-3661-442b-af83-64273dcb6d67">33,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNy0zLTEtMS01OTg5ODU_475413f5-8abd-4a00-b995-5aa2a3acb3c1">62,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOC0xLTEtMS01OTg5ODU_daf1423b-768d-43ec-b79b-f14482de0409">14,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOC0zLTEtMS01OTg5ODU_b135fd13-267b-45e4-94dd-cb282a017235">104,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOS0xLTEtMS01OTg5ODU_2e060014-c396-419e-a228-d4449eb91867">184,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOS0zLTEtMS01OTg5ODU_5be56f84-6f17-4061-a27b-2fd77e877b38">310,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTAtMS0xLTEtNTk4OTg1_f272ac16-74f0-4bc8-8d12-d14f01584c5b">55,121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTAtMy0xLTEtNTk4OTg1_d1cf6c65-2acb-452f-b896-220dd0ddcda5">43,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTEtMS0xLTEtNTk4OTg1_56e7728c-91f9-4fa2-802b-c1400075e00c">129,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTEtMy0xLTEtNTk4OTg1_e788172d-58c0-4fbf-975b-a65a3b2a59d0">266,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_19"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMi0xLTEtMS01OTg5ODU_d4de1b76-c388-4298-a75a-24d6d305f58a">317,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMi0zLTEtMS01OTg5ODU_2b7af28c-3f79-483d-8346-07b9bc03e422">244,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMy0xLTEtMS01OTg5ODU_175d31db-ff6c-4b8f-8b7b-101b96a601af">94,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMy0zLTEtMS01OTg5ODU_074f248c-7852-4abf-9e47-00727acbff09">94,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNC0xLTEtMS01OTg5ODU_22b260f5-cd5a-4d40-acb2-02b2f07b4046">49,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNC0zLTEtMS01OTg5ODU_4e595628-618b-43bc-8eb0-6817fc336c21">77,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNS0xLTEtMS01OTg5ODU_0d8a96b7-8129-4123-8978-ef2197929e43">2,057,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNS0zLTEtMS01OTg5ODU_735a6516-df05-4e7d-95c6-a1b371670540">2,132,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNi0xLTEtMS01OTg5ODU_96f8d670-2efb-4977-a41b-1ab6a3dc4f85">106,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNi0zLTEtMS01OTg5ODU_adddd102-3c48-40b0-b011-f979a1368381">109,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNy0xLTEtMS01OTg5ODU_862ac6bf-8254-43b4-b0e8-cc17e179abc6">324,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNy0zLTEtMS01OTg5ODU_8990edf6-172c-4ef9-b856-2c71fa2e6431">413,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOC0xLTEtMS01OTg5ODU_9d51f0b9-9af2-452b-8de2-75e89aa8ed08">89,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOC0zLTEtMS01OTg5ODU_82423afc-8ea1-4588-87d7-b79dc99e8645">78,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOS0xLTEtMS01OTg5ODU_74799f00-2d35-492b-80bc-5b2bc266e811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOS0zLTEtMS01OTg5ODU_55abb1ed-a3ca-4977-8e66-26b7128ca4ef">4,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTAtMS0xLTEtNTk4OTg1_0a224087-4540-447e-9b60-ab5fb5bc31c3">3,039,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTAtMy0xLTEtNTk4OTg1_c774e529-0e9c-4a19-9f10-2421ec1393d0">3,155,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTNmNGFhNTM2MjY5NGExMWI2NTg1ZjViZjcxNWMwZjBfNjM_44b067bd-98b9-488d-bcfb-f5f01d41daa6">5,395,966</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTNmNGFhNTM2MjY5NGExMWI2NTg1ZjViZjcxNWMwZjBfNzA_79e4df7a-8176-4be7-9fbc-172cf8cb6592">5,265,372</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMS0xLTEtNTk4OTg1_33c260bc-4cd5-4011-9d76-12704dfa1c1c">3,216,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMy0xLTEtNTk4OTg1_14c7ed95-4b50-4195-8f6b-adafecb9c7b2">3,256,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTItMS0xLTEtNTk4OTg1_5800248a-a01e-4c79-8a96-fca9860a18f8">2,617,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTItMy0xLTEtNTk4OTg1_df60e49f-ba86-4b3e-95fa-6b9113871009">2,666,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246N2ZmYzFlNjRlMDBiNDk2YWFjZGQ3NTFlMDM0YWUwODlfNTg_0faecde1-ae9b-4042-a29c-2ca8106805ab">40,945</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246N2ZmYzFlNjRlMDBiNDk2YWFjZGQ3NTFlMDM0YWUwODlfNjU_500ae4ae-829e-44c6-847e-deef20f0e08a">49,772</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMS0xLTEtNTk4OTg1_5fc1d314-0b44-4c1a-8131-0c0931d3f2eb">186,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMy0xLTEtNTk4OTg1_382e16e6-305d-4433-8551-5f066c890ad5">182,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTQtMS0xLTEtNTk4OTg1_51120588-dc88-46ba-99c0-cec3d3eac9d4">241,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTQtMy0xLTEtNTk4OTg1_80adbc24-2155-4eb0-87b9-026410f9f0e8">231,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTUtMS0xLTEtNTk4OTg1_1b1a0f7e-9088-47cd-af20-c4804f60aa62">44,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTUtMy0xLTEtNTk4OTg1_f0619720-299e-4972-add5-4d0c9c02a1b3">44,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTYtMS0xLTEtNTk4OTg1_d936296e-4afe-4169-a987-0238cf684404">291,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTYtMy0xLTEtNTk4OTg1_fe1b1a89-e8a5-42a4-9b88-2a76f45770a0">315,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTctMS0xLTEtNTk4OTg1_1ffdf122-6c61-43ee-9005-dcbb7a3b953e">7,090,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTctMy0xLTEtNTk4OTg1_a5f240dd-350a-4461-b843-826dcc5eda4e">7,076,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTgtMS0xLTEtNTk4OTg1_b86bcfa0-3dad-4c22-ae58-8e54c2af2851">16,727,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTgtMy0xLTEtNTk4OTg1_28084c17-62c7-416a-b067-5f05589a1308">16,928,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjAtMS0xLTEtNTk4OTg1_598aa6c6-a605-4899-8f7c-43045b659ed6">447,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjAtMy0xLTEtNTk4OTg1_26c3229b-09cd-460a-9a3c-a2d66e709be2">479,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjEtMS0xLTEtNTk4OTg1_8a3f46e2-0d26-447f-a268-17918e6a7abd">796,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjEtMy0xLTEtNTk4OTg1_6754fa81-2504-4a60-ab98-b1c4b5401614">802,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjItMS0xLTEtNTk4OTg1_edda8b73-e382-4263-9315-ee80dad99991">618,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjItMy0xLTEtNTk4OTg1_b1ded387-9023-4909-8656-8452adb0d9ec">692,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjMtMS0xLTEtNTk4OTg1_6f0af2e7-c4ac-4f3c-9d77-4b1685ce8d6d">394,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjMtMy0xLTEtNTk4OTg1_c5119bae-6c0e-4e33-93c9-7046075dd95d">395,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjQtMS0xLTEtNTk4OTg1_84d89b85-6e74-4136-aed5-0637dd07261d">242,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjQtMy0xLTEtNTk4OTg1_7314e56f-6927-430a-a61d-4989d1ea5b26">231,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjUtMS0xLTEtNTk4OTg1_5a1907da-252b-4354-9d17-d10013b8f016">64,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjUtMy0xLTEtNTk4OTg1_06062662-e8e8-4c9a-b0d7-8ed2204355f5">18,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjYtMS0xLTEtNTk4OTg1_a1ae2ce5-30d6-45f8-afb4-f5b17bb32c8a">2,565,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjYtMy0xLTEtNTk4OTg1_665cc2b2-8c59-4a28-b2b7-0ef31f3dab98">2,619,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjctMS0xLTEtNTk4OTg1_34e526ba-61fd-456f-b79a-096b52667a4a">2,455,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjctMy0xLTEtNTk4OTg1_357a49a5-f1ae-4015-af4f-b8db4a5b2522">2,503,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjgtMS0xLTEtNTk4OTg1_fb347adf-ea3b-4259-bf1e-0cb3122e11ae">8,417,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjgtMy0xLTEtNTk4OTg1_d4cbec37-a98a-4f53-993e-3e8d7e8d9f30">8,692,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjktMS0xLTEtNTk4OTg1_d3e6fd6b-2a93-4ff6-a68c-bec68583786c">100,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjktMy0xLTEtNTk4OTg1_b8c7cae4-b9dc-436a-989d-3e857fb201be">105,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzAtMS0xLTEtNTk4OTg1_46736403-9989-42e5-8a69-cfcf97d48d0b">771,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzAtMy0xLTEtNTk4OTg1_e945a819-c946-4f64-9a73-626780a675cc">782,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzEtMS0xLTEtNTk4OTg1_7c985872-abf3-4428-b871-63c4acd9af7e">14,309,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzEtMy0xLTEtNTk4OTg1_9dc7cafd-1162-49d1-aee4-137c9d5672c5">14,703,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzMtMS0xLTEtNTk4OTg1_538f62d9-fde6-4e7e-8eb5-78b0c5bf2846">1,398,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzMtMy0xLTEtNTk4OTg1_cb3ecbce-a2a6-4ebb-94df-d5d952948b64">1,348,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfMjE_0c6275de-778d-4486-adb5-cfda19f88866">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfMzU_55d0f0c7-afde-46ac-ade5-fde9c8eeca7d">5,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfNTc_71faf43a-e25b-4eee-838e-e693e3ffd4d1">none</ix:nonFraction> issued)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMS0xLTEtNTk4OTg1_0ffbac19-47d7-4317-a334-c65b61863e15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMy0xLTEtNTk4OTg1_57d24ec6-e63b-4f73-91c0-2f5e006b14e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMTg_59352851-ed4b-4345-8fef-1e792f64992b">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMzI_ab7d5aa5-759f-4346-a116-f332d4376781">450,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfNTQ_5af54960-f8d1-43a6-8245-295177586b45">90,650</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMTIw_f3daae59-319a-462b-8a6f-33219228a1ef">90,411</ix:nonFraction> shares issued</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMS0xLTEtNTk4OTg1_a33feaa3-591c-408c-9b1f-f1ee918b0539">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMy0xLTEtNTk4OTg1_52712a09-690b-44e3-be67-d99fb0e5fc99">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzctMS0xLTEtNTk4OTg1_12e32374-a6a5-4f22-8a50-df273982e89d">590,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzctMy0xLTEtNTk4OTg1_ae8dfec8-52ff-4b8d-97b7-1acb7047f46a">606,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzgtMS0xLTEtNTk4OTg1_711845c9-fa66-4c2f-864c-4a161460ab58">290,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzgtMy0xLTEtNTk4OTg1_15bbdc47-42d3-4a47-9044-a1c8ccd3f9a2">174,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDAtMS0xLTEtNTk4OTg1_74ec5c12-c5ee-4397-985f-2211f0d30a1d">54,906</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDAtMy0xLTEtNTk4OTg1_5553485b-a3d8-45af-9a75-be9a13d19fcf">69,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDEtMS0xLTEtNTk4OTg1_c73c1e72-bba9-4c37-bf80-e083c5f4dc54">825,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDEtMy0xLTEtNTk4OTg1_113eef0a-4515-4d39-a408-c7ee1573fce5">712,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests not subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDItMS0xLTEtNTk4OTg1_c574c38d-3ee7-4a39-9eab-e984af25426e">194,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDItMy0xLTEtNTk4OTg1_f73d716b-33ee-4cac-b87c-f1ccce679d0a">163,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDMtMS0xLTEtNTk4OTg1_d4e52fe1-4a48-4be0-84a3-833b6902e537">1,019,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDMtMy0xLTEtNTk4OTg1_bf0a9edd-29e4-4554-b8cc-ac7c9d2711d0">875,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDQtMS0xLTEtNTk4OTg1_8c85d6ca-9ffd-43e6-84af-70be62b2ab14">16,727,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDQtMy0xLTEtNTk4OTg1_986797a1-f4b3-41a1-826d-469794fe4cfa">16,928,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMy0xLTEtMS01OTg5ODU_0964aa91-5ded-490f-b4ed-a1fb022b76fb">170,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMy0zLTEtMS01OTg5ODU_11765e71-7398-470d-b867-5c026bd3d140">205,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNS0xLTEtMS01OTg5ODU_6e8ea53e-ef07-4141-a887-7125f22ab312">178,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNS0zLTEtMS01OTg5ODU_8c490a9f-47ce-4f63-a652-3cbcf4986641">172,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOC0xLTEtMS01OTg5ODU_a53719ac-173d-4fbc-9a67-074606ab9fb2">25,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOC0zLTEtMS01OTg5ODU_ffed8da2-5ec8-417e-8241-7e4c4e914d21">24,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOS0xLTEtMS01OTg5ODU_2f0348b4-4a38-4900-b698-de554b59bc9b">3,621</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOS0zLTEtMS01OTg5ODU_d2f92785-9ea3-44fe-9e0c-67f1b1cd5de5">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment loss, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTAtMS0xLTEtNTk4OTg1_12ed301d-7b28-4fe9-a957-c42f5df54a2b">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTAtMy0xLTEtNTk4OTg1_a7334f7b-2479-499f-b16e-7dfad510f11b">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTItMS0xLTEtNTk4OTg1_12fcf930-8833-4d73-8ea6-381af517abac">5,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTItMy0xLTEtNTk4OTg1_fe0c402c-1785-4c02-8514-3a877e89f98d">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTQtMS0xLTEtNTk4OTg1_e0416221-bbf1-4686-b5b6-cc2344201f43">81,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTQtMy0xLTEtNTk4OTg1_6f35ba91-ec17-4441-b86a-53a6bd3f6af8">66,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTUtMS0xLTEtNTk4OTg1_fa46bd7f-5a1e-480b-a8c7-b1206fbc8853">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTUtMy0xLTEtNTk4OTg1_59958c3d-aed9-4ae1-9b83-57e9ba8a8101">849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables and prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTYtMS0xLTEtNTk4OTg1_35def917-ac7a-44d0-955b-46abb39d8e9d">66,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTYtMy0xLTEtNTk4OTg1_e3aa9f8a-3634-4b2b-8735-060c70afa251">17,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTctMS0xLTEtNTk4OTg1_9ed78d1c-97ee-41f8-a68c-d8d63246e01f">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTctMy0xLTEtNTk4OTg1_ac45e9fb-70c1-41a5-bb10-19e1602ab926">3,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTgtMS0xLTEtNTk4OTg1_98a901ba-f3d9-4d62-bfdf-9c319e5c29ee">20,535</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTgtMy0xLTEtNTk4OTg1_e4f75c3f-86f6-43c9-bee0-666a292cbdca">21,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTktMS0xLTEtNTk4OTg1_e1127442-a0b3-4b0b-af29-26cc37eacac9">74,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTktMy0xLTEtNTk4OTg1_1e089303-3cbc-44a5-9f77-5524134b7b99">95,927</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjAtMS0xLTEtNTk4OTg1_a6bec4c5-ae56-46a3-906b-5c782a0a02ae">6,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjAtMy0xLTEtNTk4OTg1_e1cac19e-3269-4a57-ac3a-27871ae44876">26,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjEtMS0xLTEtNTk4OTg1_7f7d0a0f-3c17-4a60-9486-6467f159a157">39,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjEtMy0xLTEtNTk4OTg1_12424722-ec6f-4eb6-ac47-cb819b932414">52,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjItMS0xLTEtNTk4OTg1_2d05c86c-74ea-4c82-b30b-dea804ae8734">5,516</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjItMy0xLTEtNTk4OTg1_0faed132-ebb8-4ad8-a93b-baf678fb647e">11,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjMtMS0xLTEtNTk4OTg1_9b13edf6-8745-4a98-b92e-98dfae0e2385">462,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjMtMy0xLTEtNTk4OTg1_9c77b170-e2b0-4812-aeb6-fc06856e7f8d">322,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjUtMS0xLTEtNTk4OTg1_93354d07-61ea-4c19-bcdd-3c52dcbecbc0">147,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjUtMy0xLTEtNTk4OTg1_5229e746-5981-4aee-a590-41b217f1d5d8">123,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjYtMS0xLTEtNTk4OTg1_2ad45c18-16f3-45c2-ae32-4169ed7506b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjYtMy0xLTEtNTk4OTg1_44b79c81-9787-45e9-8b6f-c6ccc2b37441">5,166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from asset and business sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjctMS0xLTEtNTk4OTg1_45ed4aca-f94c-4e3e-89a2-0887f27c6d5e">13,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjctMy0xLTEtNTk4OTg1_8c563d90-3118-4945-8cd8-8b9818fdd690">11,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjgtMS0xLTEtNTk4OTg1_27becd3f-48b2-489c-9186-959b59fc174b">25,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjgtMy0xLTEtNTk4OTg1_f17dc3b6-7dc9-49b7-bd90-5b488552fa0c">5,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjktMS0xLTEtNTk4OTg1_8666e8fb-0e59-42d6-88bb-13f52b572214">4,643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjktMy0xLTEtNTk4OTg1_3f226f85-ca64-4c3c-bc44-1ed730d8b98b">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzAtMS0xLTEtNTk4OTg1_36c94951-496e-491c-9796-13a866de5a66">50,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzAtMy0xLTEtNTk4OTg1_fab1852e-c014-4a47-b916-a76f41a60214">5,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzEtMS0xLTEtNTk4OTg1_de658a53-9273-4772-878c-19e52dca99b2">3,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzEtMy0xLTEtNTk4OTg1_3d62d2e4-6b76-466d-a008-7faf71883b52">3,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzMtMS0xLTEtNTk4OTg1_61196ffb-cedc-4f3c-9346-1868df4649f3">7,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzMtMy0xLTEtNTk4OTg1_eb8c9b80-1b00-4104-b274-ae2a1bf0bd1e">2,962</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions from equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzQtMS0xLTEtNTk4OTg1_abd75638-bd17-459a-b29a-4d107dd51b6e">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzQtMy0xLTEtNTk4OTg1_500cd352-4a7a-4741-8290-f12a1cfc4087">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzUtMS0xLTEtNTk4OTg1_82247d7b-df80-46ff-9b91-90a784dac760">116,544</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzUtMy0xLTEtNTk4OTg1_9b49f316-f53e-4a74-9b45-b40a3895a1bc">118,366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzctMS0xLTEtNTk4OTg1_24bd38e7-cf54-4e4e-b25a-698a2369826f">611,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzctMy0xLTEtNTk4OTg1_24545b85-6b0b-4504-95a0-e86a1c950c95">354,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzgtMS0xLTEtNTk4OTg1_e43b4465-2b49-4379-bec0-d4b8e70bba72">880,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzgtMy0xLTEtNTk4OTg1_2cf321c8-987a-41a1-83cf-4b5253dfc57e">398,990</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzktMS0xLTEtNTk4OTg1_2c9c6c3a-bd0b-4c6a-8b0a-ea4caaf9bf3a">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzktMy0xLTEtNTk4OTg1_0811ac73-0400-44d2-8c5d-3bb9feaac308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDAtMS0xLTEtNTk4OTg1_f168bdb2-7559-4a3e-b5e4-95212fd255cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDAtMy0xLTEtNTk4OTg1_ca8f0ddf-fc26-4931-94a4-d90ad4092d85">236,232</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDEtMS0xLTEtNTk4OTg1_1e4ea9cf-eb32-4cad-8660-2143fcef9826">54,837</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDEtMy0xLTEtNTk4OTg1_06995dd6-4a8e-4a18-8fb8-a6eb9b993416">65,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net payments related to stock purchases and awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDItMS0xLTEtNTk4OTg1_3580a6bb-17f9-4c35-aa15-4b4e1de9fba5">7,902</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDItMy0xLTEtNTk4OTg1_3fb15f01-e6e7-4ad2-abe6-e77aa5a23980">501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDMtMS0xLTEtNTk4OTg1_522b21e6-958e-4b0c-a88b-b267add5a081">4,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDMtMy0xLTEtNTk4OTg1_b5a5b7ea-cdcb-4ebf-8802-763aefa57df1">4,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of additional noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDQtMS0xLTEtNTk4OTg1_0b681603-99ff-4706-b192-8b3ed72b660c">50,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDQtMy0xLTEtNTk4OTg1_ed05b9fa-dc75-47de-82fb-92120266ba37">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDUtMS0xLTEtNTk4OTg1_c6e09039-7d9c-4dda-99b0-004cd3deea46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDUtMy0xLTEtNTk4OTg1_dc91d6e1-fa0a-4fbe-8e82-55ff44623bbc">3,283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDYtMS0xLTEtNTk4OTg1_7938a415-2a83-4ea2-8fee-8de1b0df58e7">275,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDYtMy0xLTEtNTk4OTg1_02f7b998-ccae-4d05-b073-815b4659ce74">341,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDctMS0xLTEtNTk4OTg1_24c45ef4-9040-497b-b191-947e64db7e09">2,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDctMy0xLTEtNTk4OTg1_0cf8e489-a210-4eeb-8c83-7491d168694b">3,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDgtMS0xLTEtNTk4OTg1_1346fada-eaa7-4125-ba69-bc238f7e4578">72,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDgtMy0xLTEtNTk4OTg1_9a9d58ce-9040-4f51-a9f8-ada1e0873213">134,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDktMS0xLTEtNTk4OTg1_9f23df61-d3cf-44da-be72-eeec93070640">338,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37fcf42001e43c795ed70694ccbfda3_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDktMy0xLTEtNTk4OTg1_f48d00d5-7c17-4c2b-915c-0dcbc47d7eb2">554,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNTAtMS0xLTEtNTk4OTg1_76565deb-a4a3-4bb0-b57c-cb21abc05729">411,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f89c44809d7411ba9977e1269611500_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNTAtMy0xLTEtNTk4OTg1_fc9f5a55-a06c-43f1-8c0c-359155dfd676">420,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb96decbd5ff48ecbcf4ff701f865932_I20221231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xLTEtMS01OTg5ODU_75e4f8ee-108c-46f2-bfbe-23dca92199db">1,348,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0zLTEtMS01OTg5ODU_973eafd5-4e89-49a0-aec9-42d8fd1a7911">90,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS01LTEtMS01OTg5ODU_8cdb1a7d-b4be-4fb6-8b60-8c904bb92964">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5878fb3ce344989a3a50ed0fbd3d5c1_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS03LTEtMS01OTg5ODU_f861cd99-fa7f-4794-adab-447f61e7859a">606,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae59202d18bb409ea44ff98f022007a5_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS05LTEtMS01OTg5ODU_c614c038-3e0d-47c3-9a25-7c8f981415e9">174,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i510e587c5c7d43579eff92128d1feffe_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xMS0xLTEtNTk4OTg1_0af1f3bf-912d-4423-a634-441aa6d8fdd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i510e587c5c7d43579eff92128d1feffe_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xMy0xLTEtNTk4OTg1_1f3ac51d-04d6-4376-8dbc-5a2af8d5b733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d636acdefa14579a4055e30a18c2ea1_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xNS0xLTEtNTk4OTg1_8ebc165b-bd19-4e5b-8974-7c0ea4852d35">69,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbcdfa0ff4549d8b4c3b8d5daf4ccb3_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xNy0xLTEtNTk4OTg1_85abe8f0-1624-40aa-a683-b828ad02143b">712,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de0a77acc61440791bc64a61b53a9b8_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xOS0xLTEtNTk4OTg1_1657cec8-ca7d-4158-abbe-e0e6cb2d7afc">163,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xLTEtMS01OTg5ODU_0eb16f97-3fe4-4e9e-8e19-e94d36cff7c7">36,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf4ab925c36b4946a9f265610af5c18b_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy05LTEtMS01OTg5ODU_8a480b61-e633-48f2-a810-212aff912b94">115,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xNy0xLTEtNTk4OTg1_3a8044e1-695a-4bcd-872b-0f9e274d9aca">115,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xOS0xLTEtNTk4OTg1_a29935c4-bedd-43d9-aa25-1fb069484c2e">18,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3461f689329041ac8cfa8e508d1cde1a_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfOS0xNS0xLTEtNTk4OTg1_96bc6df9-9be3-4ed0-b455-7ef76f2055c7">14,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfOS0xNy0xLTEtNTk4OTg1_e7885851-5839-4415-aa85-701bfef7196c">14,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtMy0xLTEtNTk4OTg1_5401f3dd-c8ac-4bae-9a33-e54b2154d99b">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtNS0xLTEtNTk4OTg1_6f1970fd-c000-4f23-a8a8-bc2f37cabfe4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtNy0xLTEtNTk4OTg1_fc871454-575d-451f-bd32-6a9031601aca">9,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtMTctMS0xLTU5ODk4NQ_db32a0f0-66f1-4a4f-bf14-05f0085ca7ae">9,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTItNy0xLTEtNTk4OTg1_3ef4e6fc-1ceb-4f52-9b70-3162f31f35ef">24,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTItMTctMS0xLTU5ODk4NQ_4ed6883d-1101-4bec-a327-4b08775e12e9">24,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTQtMS0xLTEtNTk4OTg1_c05c3c11-f9e8-48d6-82ea-6118363d8c7c">35,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTQtMTktMS0xLTU5ODk4NQ_99e01cef-706c-4d92-bbbc-635378f1e4d3">19,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTUtMS0xLTEtNTk4OTg1_93f5431d-8054-4355-9d64-df35f9ec1f43">3,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTUtMTktMS0xLTU5ODk4NQ_b5308202-591d-4c42-a088-cf736a4d900d">977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtNy0xLTEtNTk4OTg1_83025aad-986f-40e1-b614-ed9d5402140b">13,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtMTctMS0xLTU5ODk4NQ_492a4cce-505c-481c-8176-6fccd9050332">13,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtMTktMS0xLTU5ODk4NQ_45a53919-7286-4f31-baa6-58ba870852bd">30,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtMS0xLTEtNTk4OTg1_3b583f44-11c7-49b2-bc1c-e3356c47c7de">45,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtNy0xLTEtNTk4OTg1_c31d6c6e-9252-446b-af07-3548605dfc65">45,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtMTctMS0xLTU5ODk4NQ_e429563a-460a-4f28-83e2-b86bcaf5adea">45,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca924f1ecfc49c69630f7b1f711fc6b_I20230331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMS0xLTEtNTk4OTg1_9c0239cc-42a0-410e-8cce-07e116943ef8">1,398,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f3006d566c4ef08a32c52c2e496eec_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMy0xLTEtNTk4OTg1_d63756a7-1023-4029-8eb7-900d21b93f46">90,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31f3006d566c4ef08a32c52c2e496eec_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtNS0xLTEtNTk4OTg1_04927413-95a0-4f30-9270-3aadd5e4d61d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id541c72e0cbf46bfb9a30e55268d305f_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtNy0xLTEtNTk4OTg1_99c50a59-f399-4080-84e5-08de172fb3ec">590,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60f56cdc6a54c9fa3d7371a7e301cae_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtOS0xLTEtNTk4OTg1_5c016cfd-c098-444d-90c2-c950f1be3246">290,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTEtMS0xLTU5ODk4NQ_41e953e8-5c42-412f-964f-2a5be7777099">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTMtMS0xLTU5ODk4NQ_bcd4352b-1ea9-4496-96f3-abe35b9f9f16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic119590b905b456ea28d952ba0ebba06_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTUtMS0xLTU5ODk4NQ_964ae440-e0f0-4e77-84cd-35bbc2f82854">54,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b64c02b45c8429281f3cad0048fd5a8_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTctMS0xLTU5ODk4NQ_979e6386-e022-43e8-afc5-0d1ddc9dbda5">825,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29cc4e5470a24e859cdd1e50d0578b3a_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTktMS0xLTU5ODk4NQ_495897d0-ef3e-4bbf-a5d3-ddae31b0c92b">194,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xLTEtMS01OTg5ODU_5dd15ff7-453f-4a85-982f-6beae2bcb471">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0zLTEtMS01OTg5ODU_daf031f2-8aed-4a7c-8de4-cb0d70049fb6">97,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS01LTEtMS01OTg5ODU_55aebaca-8bd3-48c4-a807-ce9d0622e460">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12c3e24420bd492ca1237403f848d3ea_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS03LTEtMS01OTg5ODU_d0f6b214-7f59-474a-9cef-07697e30806b">540,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1013614d759840f6b8be015cc3fec9fc_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS05LTEtMS01OTg5ODU_174cc51e-95fb-4686-a0fc-42c1740a6098">354,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xMS0xLTEtNTk4OTg1_688b92b4-ff3d-4ca7-af9f-c8352c1ec81d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xMy0xLTEtNTk4OTg1_3ec4c832-c5dd-4e5c-bfc1-0163c57c232a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb86b3a098944b288b2c33833a89c53f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xNS0xLTEtNTk4OTg1_3c12de4d-d6a4-4282-998d-914525264635">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7fdd7915974832a1894f287fbf74d5_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xNy0xLTEtNTk4OTg1_04abfb62-4ec1-453b-86fb-ecc8d03d7d14">755,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b52b3eff79543e5aac806c75366b585_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xOS0xLTEtNTk4OTg1_d7731232-e7bd-4aa8-a632-19822fbdead7">180,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xLTEtMS01OTg5ODU_272e330e-122f-43cf-8e49-e9c2aa0b07dd">28,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5eb5a52daa4593b04658664913519d_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy05LTEtMS01OTg5ODU_529cb430-6be1-4b13-8025-19b783360399">162,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xNy0xLTEtNTk4OTg1_b2d24089-ad20-4aa4-9473-e2c227cf6155">162,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xOS0xLTEtNTk4OTg1_29d04e22-6849-4746-b471-91838b46d45d">15,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93c65854bb094f5391c31be7458fbc46_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfOS0xNS0xLTEtNjQ5MTY3_a2f81fe6-cc36-4139-91d5-6fee6c9cb269">104,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfOS0xNy0xLTEtNTk4OTg1_9dfeca21-e89e-4e11-bfa1-13523b012cca">104,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib352cd5ae86642f9b567f560e60aa612_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtMy0xLTEtNjQ5MTY3_effa9b9c-babc-4eac-bdd5-cf493827fe83">53</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtNy0xLTEtNTk4OTg1_6f5da130-f2c3-4068-84a3-0d5ca408ba02">3,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtMTctMS0xLTU5ODk4NQ_24965180-0837-4b85-a5a3-9942d39e6d56">3,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTItNy0xLTEtNjQ5MTY3_675b1fc2-0a40-4b33-a287-08409270ccdc">24,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTItMTctMS0xLTY0OTE2Nw_e24b3df9-f97e-4716-9f1f-f85cb50c38f9">24,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTQtMS0xLTEtNTk4OTg1_50a99086-2cb4-4a5e-ada8-574e51bca09b">42,881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTQtMTktMS0xLTU5ODk4NQ_58ca138f-9a40-4248-b5bf-37143ad5baff">22,571</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTUtMS0xLTEtNTk4OTg1_d5c4966c-db6f-4dda-983c-bcbcccb6657e">3,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTUtMTktMS0xLTU5ODk4NQ_8d615ccd-8041-44ba-92b1-bdf67a815459">1,732</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtMS0xLTEtNjQ5MTY3_68884746-f244-4a50-a902-cffe7211241a">2,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtNy0xLTEtNTk4OTg1_dddcab34-5f89-45ea-a15c-b160b7ee0a17">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtMTctMS0xLTU5ODk4NQ_4ba9c3a8-6a56-4efc-877c-0318c60e0158">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctMS0xLTEtNTk4OTg1_0146bdf5-4bee-4175-b2e4-a3c01e5fd6d9">822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctNy0xLTEtNTk4OTg1_7a6220bd-b075-4103-957a-c1aec203c4d3">1,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctMTctMS0xLTU5ODk4NQ_097ab30e-c9a2-495d-81d4-92cc05fc3f82">1,774</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtMS0xLTEtNjEyMDUx_402ba0a1-3bf6-4ab4-831b-54c147396698">34,835</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtNy0xLTEtNjQ5MTY3_aadd8894-fe6a-47e7-8c71-cab8c76e1094">34,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtMTctMS0xLTY0OTE2Nw_36c7490c-ca02-489e-88b3-6589505c9096">34,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTktMS0xLTEtNjQ5MTY3_6c510611-fced-4181-9c5a-399ece45a256">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331" decimals="-3" name="dva:NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTktMTktMS0xLTY0OTE2Nw_a075b3a7-c3b1-4e8c-b573-0f30e6d085cc">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTEtMS0xLTY0OTE2Nw_403b8af9-a134-4a00-b4ae-7398634bf9ed">2,104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTMtMS0xLTY0OTE2Nw_bcfc3e7a-62bf-452a-84cb-182dfe01740a">233,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTctMS0xLTY0OTE2Nw_ec169c33-0b6d-4e0e-9b97-bef0b7d7e2d4">233,318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736bf7e4b947486db010c69b98f797e4_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMS0xLTEtNTk4OTg1_2beffc08-0b8a-4c5d-8b7f-468a6b5a4b93">1,390,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMy0xLTEtNTk4OTg1_e8cdfbca-1c91-42fe-9a02-cd5a1c714bc6">97,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtNS0xLTEtNTk4OTg1_78e04cc0-a954-4c5e-a890-a18106636ac5">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id011923f6bef4bbeb4834a6883fd2f71_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtNy0xLTEtNTk4OTg1_d845f5ef-974f-4104-900c-a8382fbdf82a">595,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46d427c61e12494a9abcd31dabc719a5_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtOS0xLTEtNTk4OTg1_65636024-648e-4783-988a-34820077a654">516,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie0056bc5a97b440586b4432e43698c40_I20220331" decimals="-3" sign="-" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTEtMS0xLTU5ODk4NQ_90ed68f2-24d9-474d-9d22-00d1f917e88b">2,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0056bc5a97b440586b4432e43698c40_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTMtMS0xLTU5ODk4NQ_45cab272-82c0-4f8d-be2b-f19307581e27">233,318</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i607a0441599c46398e2c421e5264a57d_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTUtMS0xLTU5ODk4NQ_18387e9c-a332-43c2-89de-d2a3a9586e7d">34,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1091f89c58124befbd0b2e279e7bd5b8_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTctMS0xLTU5ODk4NQ_a2725dd3-e251-4698-842a-8d308c784a77">843,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf31608c04e04edd937b2b95514487b7_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTktMS0xLTU5ODk4NQ_1c6e8444-52b8-4d16-af10-4eadb954a01c">174,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_31"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in this Quarterly Report on Form 10-Q, "the Company", "we", "us", "our" and similar terms refer to DaVita Inc. and its consolidated subsidiaries.</span></div><div id="ia1113957fba14778a95e5a7387238c82_34"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNC9mcmFnOmFiOTJkNmQ5OTkwODQ1ZDg4ZTAyZDBjNzEwZTVhMDNlL3RleHRyZWdpb246YWI5MmQ2ZDk5OTA4NDVkODhlMDJkMGM3MTBlNWEwM2VfMTU5Mg_070d92e7-544f-4d4e-b682-30fc1566a535" continuedAt="ib104504a21ca42b2b2d2e8f87e6bbf71" escape="true"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNC9mcmFnOmFiOTJkNmQ5OTkwODQ1ZDg4ZTAyZDBjNzEwZTVhMDNlL3RleHRyZWdpb246YWI5MmQ2ZDk5OTA4NDVkODhlMDJkMGM3MTBlNWEwM2VfMTU5Nw_e8300871-1046-4799-bfa8-545e4c804577" continuedAt="idf21031faa3748a68f3f232d6c22c83a" escape="true">Condensed consolidated interim financial statements</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib104504a21ca42b2b2d2e8f87e6bbf71"><ix:continuation id="idf21031faa3748a68f3f232d6c22c83a">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</ix:continuation></ix:continuation></span></div><div id="ia1113957fba14778a95e5a7387238c82_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjc0Mw_cd3ed0f3-b34e-4469-95b8-bf63a1d41c1b" continuedAt="i295fe58ab3fe4bfea3bf45db250ce30b" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="i295fe58ab3fe4bfea3bf45db250ce30b" continuedAt="i8e49cad3f69a4185b36c99af724dfa6c"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjczNw_6633b58c-54d9-446e-b4ef-ea850a5bf9e8" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i924864e1995e4749a67469d38a0bd5eb_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy0xLTEtMS01OTg5ODU_fe7c825f-5ec7-4900-a1c6-f8cdac6e7f73">1,482,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy01LTEtMS01OTg5ODU_c4c71893-b20a-4ab6-9a7c-56255368da4b">1,482,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c073a8ecff340d59dd625febdf0c88d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy03LTEtMS01OTg5ODU_7874e190-d62a-4cee-a703-82d7b2760325">1,464,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy0xMS0xLTEtNTk4OTg1_4b3ab67f-c959-4e38-90ce-345da7950a0e">1,464,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib80166e629e549cf924c2644ec659ac8_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC0xLTEtMS01OTg5ODU_230beee0-740c-4194-baad-223794893cc3">205,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC01LTEtMS01OTg5ODU_9ff0a6ac-23a0-4e7a-8d5a-82e98d7c0579">205,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i716d73cc3cb1416fa1be96a2530344da_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC03LTEtMS01OTg5ODU_1d09f019-7b71-43f8-99a4-8de863bc43a7">189,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94201913127b40309f173dba20dd161d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC0xMS0xLTEtNTk4OTg1_71ddbfb2-ed34-4a1b-81e3-a094ce3a2d4e">189,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51fc1a1f1e2a4010893b526540e40610_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0xLTEtMS01OTg5ODU_3703972e-107c-4b95-a5c8-71bc7d8ebb11">82,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebdd5494e2e4158a83cdce6c45ab4a5_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0zLTEtMS01OTg5ODU_1364c263-de3d-40a4-8082-b2a82c4279b8">121,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i575a2fbf0f754d31b03e7240b518b771_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS01LTEtMS01OTg5ODU_eb743c44-aee6-49b9-aac2-5968827291c9">203,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id30740c932b843f3a92ff50f65a092df_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS03LTEtMS01OTg5ODU_423d214f-8646-4c82-b77d-6c8d022d9001">80,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de7abdf687142db96dbc1fc809e6fa0_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS05LTEtMS01OTg5ODU_1ece4130-25d1-4f8e-8de4-1d1177a4313d">116,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefb5c62e8a584a25b642428ebeb54320_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0xMS0xLTEtNTk4OTg1_2217308e-9825-467e-8dca-da4cc5fb6cff">197,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81154e11a8604522914cf349e50404c3_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0xLTEtMS01OTg5ODU_b7acd163-3fdb-49bb-8526-602de126a5fe">835,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0zLTEtMS01OTg5ODU_6a050139-4043-43a5-add2-ad8c41952368">54,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi01LTEtMS01OTg5ODU_cdfb01d7-a025-4f20-abe8-2bb197d241f1">889,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c80ef7e66ba4116b2a34b46479e1285_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi03LTEtMS01OTg5ODU_4dfbc8e0-511b-436d-b3a8-6673073d4969">834,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi05LTEtMS01OTg5ODU_7b15d94c-83aa-466c-893e-35ea463b0535">52,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0xMS0xLTEtNTk4OTg1_4c9b72f8-8cad-4f64-9d24-aa7d2a12f815">887,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5c6adb0ddf6453aa8f739edc4c66791_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC0zLTEtMS01OTg5ODU_ef85141f-0576-4f9c-ae32-a3f09a1b57f6">93,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC01LTEtMS01OTg5ODU_66eb30d5-998c-439a-afa5-10944984e275">93,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id51aad86feab47bfaa419694af81fd6f_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC05LTEtMS01OTg5ODU_dcb7aa6d-a4ee-4374-a634-2601bfca9081">83,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC0xMS0xLTEtNTk4OTg1_2268c2d6-4716-4743-bb8f-c9f2269a3502">83,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4872f694e94741ad47978f27eb53ff_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS0zLTEtMS01OTg5ODU_f3e64f8b-97a1-47cf-b740-b2372a3148a6">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS01LTEtMS01OTg5ODU_4452cbbb-2be2-4169-a632-72e43bcf9083">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb309d7ddf66423d8e01bc5bd81b6dbc_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS05LTEtMS01OTg5ODU_7fb813b0-aa29-4480-b850-7b84ca5f9a5a">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94201913127b40309f173dba20dd161d_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS0xMS0xLTEtNTk4OTg1_93cd0bda-4ef2-423e-8806-5dbf3428f031">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtMy0xLTEtNTk4OTg1_25e702fb-50fe-4f75-8f18-f634f327a4c4">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtNS0xLTEtNTk4OTg1_37058556-c8ef-4da7-b8e7-5aa2ec0f3982">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtOS0xLTEtNTk4OTg1_32d57803-46e9-4eef-ba74-53bd8ca9372b">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtMTEtMS0xLTU5ODk4NQ_4ce48973-8597-48ca-8594-9391e4c9bcad">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05abc10dff1c4497a2d0e5f6502b16a5_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMS0xLTEtNTk4OTg1_047882b3-cb76-4fa3-b5b3-a4bde6038842">6,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127075439443455492ab04c3c885a932_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMy0xLTEtNTk4OTg1_6eb8143c-13a2-47f1-a649-c498f7eb454b">12,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819376c882e444d183ee1f39d65e27b0_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtNS0xLTEtNTk4OTg1_c3ecddc2-7f59-4d0b-a068-abda917d7e3d">19,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a8bf0e6f1bc434e833f7644ec2930a6_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtNy0xLTEtNTk4OTg1_ece575d5-d402-438b-9590-34492477709d">5,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cb19b8caaef4726a92cbe29d6bf4bbf_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtOS0xLTEtNTk4OTg1_9e8fb413-f299-47a9-be35-543f7ec2c02a">9,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83decc5ca955447b80861e67476e8c7f_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMTEtMS0xLTU5ODk4NQ_30298290-5225-45c7-b1c4-ee0bcb4fbab8">15,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i168a2cc625074281a784a717f9630a3b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMS0xLTEtNTk4OTg1_db8532b3-4e58-4621-b01e-090883ea5e30">22,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86ebec9ed12d4a7b914fb6a4d2803206_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMy0xLTEtNTk4OTg1_f1373eeb-87f5-4b79-8070-e0f0ed1f7598">1,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76335814a9534b91a6933754d6ee880a_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItNS0xLTEtNTk4OTg1_1f800feb-6dfc-4e79-b681-2f44bffc290f">23,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd540dd8932e46899710b99d728179e5_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItNy0xLTEtNTk4OTg1_9e10ae8c-ea82-434b-9395-2d971e1bf307">22,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ida9b8b6291464081b6d6d46abed3ff45_D20220101-20220331" xsi:nil="true" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItOS0xLTEtNTk4OTg1_96387c46-d6cf-44a5-84fc-28ef1fdefcfb"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8680e140680144f3b9565b2256e74132_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMTEtMS0xLTU5ODk4NQ_332f8955-c309-4f40-8115-f562d360afda">22,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMS0xLTEtNTk4OTg1_752a25ac-326f-4a5b-9474-d2d6ef1cb745">2,590,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMy0xLTEtNTk4OTg1_deabb999-4de8-4b53-90b9-95adf2996a58">282,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtNS0xLTEtNTk4OTg1_cd384467-e756-4f87-b068-c89041b665f8">2,872,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtNy0xLTEtNTk4OTg1_de66ac3c-1867-4fbd-98f4-29b064230969">2,552,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtOS0xLTEtNTk4OTg1_12e0d5b6-6550-4d09-9d5c-41c79d065cc8">264,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMTEtMS0xLTU5ODk4NQ_b2a04dc2-d2a7-4bd3-ae06-5b22eed4c2c1">2,817,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjc0NQ_e6fc18af-103d-41fc-bdce-65caddb40cd2" continuedAt="ie9431cdccbc947c481e056d393ca4b78" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><ix:continuation id="i8e49cad3f69a4185b36c99af724dfa6c"><ix:continuation id="ie9431cdccbc947c481e056d393ca4b78"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's integrated kidney care (IKC) revenues include revenues earned under risk-based arrangements, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span></ix:continuation></ix:continuation></div><div id="ia1113957fba14778a95e5a7387238c82_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODc4_7620559c-2fc5-405c-9ad1-5b36b162cb80" continuedAt="i6368946ad49a4eca8f8ed4cc7561dade" escape="true">Earnings per share</ix:nonNumeric></span></div><ix:continuation id="i6368946ad49a4eca8f8ed4cc7561dade"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODg5_4b7b07fb-b44b-4d41-9dc6-7721101e74c1" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODgx_6020f65e-1dd4-4432-9b12-0a8269b2789a" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"></td><td style="width:68.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNC0xLTEtMS01OTg5ODU_c12dd4b9-6b67-4f76-a7a9-8fcf59b1ef1f">115,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNC0zLTEtMS01OTg5ODU_bbeafba1-4eb3-4372-b21b-b4279933d8b3">162,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNy0xLTEtMS01OTg5ODU_a3eebe34-378a-45c7-9f55-035c6c59f027">90,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNy0zLTEtMS01OTg5ODU_27bd346e-9a00-40f1-92d4-043549138954">96,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOC0xLTEtMS01OTg5ODU_3365ce0a-a196-449f-bbc6-d8b3aafaaeae">1,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOC0zLTEtMS01OTg5ODU_ddf60d4a-b939-4389-8987-971443f0a2de">4,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOS0xLTEtMS01OTg5ODU_a59efa4c-f0b3-4368-860e-c61a629eb339">92,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOS0zLTEtMS01OTg5ODU_a02c9d85-a99a-49fb-82dc-abd4ca9c2b5d">100,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTMtMS0xLTEtNTk4OTg1_f6aa773e-1189-4d1b-aa38-e596d6a84675">1.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTMtMy0xLTEtNTk4OTg1_2651fa94-aafd-4f51-9796-324a431d0d55">1.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTctMS0xLTEtNTk4OTg1_0b8a76f3-3bd0-487e-a6f0-25cd1b4976ac">1.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTctMy0xLTEtNTk4OTg1_9cf396df-8680-4ae3-a118-2bc4f9489ec1">1.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTktMS0xLTEtNTk4OTg1_386f01a8-5909-46f1-a453-3bf15cd509ef">1,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTktMy0xLTEtNTk4OTg1_d6813e86-9c7d-468a-9932-c2437c017120">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI2_79c6570f-1fdb-41e9-ba90-c195af049049" continuedAt="i254e10509088488ba3612269297a4372" escape="true">Short-term and long-term investments</ix:nonNumeric></span></div><ix:continuation id="i254e10509088488ba3612269297a4372" continuedAt="i9ef728ea236f462cb162d0aade3e864d"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI3_9d3b8594-1773-4e93-9b68-52df5efffc5e" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0xLTEtMS01OTg5ODU_353e1ff0-5441-4c15-84b5-9df8ae4e6c07">58,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0zLTEtMS01OTg5ODU_cddaeb6b-9bc4-47ea-80cf-b4f958d0a55e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi01LTEtMS01OTg5ODU_e6ec9ae5-15c2-4d0f-8bfe-e728580044e0">58,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi03LTEtMS01OTg5ODU_d1b23c75-bb82-4edb-a37f-1f9bb1a795a5">82,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi05LTEtMS01OTg5ODU_bb8d549c-966c-4fba-af5b-cf9729cfde1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0xMS0xLTEtNTk4OTg1_94ef8e88-45ef-4e3b-a32d-098417c8ace1">82,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871145753f01486ebf685b738fce5959_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0xLTEtMS01OTg5ODU_65b43176-5c78-48bb-b205-fde54e67872d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871145753f01486ebf685b738fce5959_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0zLTEtMS01OTg5ODU_0f4dc040-18c5-484f-be3b-51068a2e895e">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871145753f01486ebf685b738fce5959_I20230331" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy01LTEtMS01OTg5ODU_a50a566f-5719-49d9-b7f3-92693eb55c2e">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy03LTEtMS01OTg5ODU_b6ad6895-a547-4ca9-b70f-619507900ec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy05LTEtMS01OTg5ODU_082c0c5a-2e2e-440d-8572-6abed55f4d8f">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0xMS0xLTEtNTk4OTg1_47f6a233-2bff-40d3-a4b6-1b49367d9347">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0xLTEtMS01OTg5ODU_eed41a61-bafa-409a-bc97-45654af39c52">58,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0zLTEtMS01OTg5ODU_abcc6453-9570-45dc-9d68-432df3d9464b">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC01LTEtMS01OTg5ODU_92ddd3d4-6f1c-4aea-95c1-86349a02fc77">94,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC03LTEtMS01OTg5ODU_2ff3a43d-24a4-43fd-827a-fcc93b3668dd">82,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC05LTEtMS01OTg5ODU_09f569ee-4f5c-452d-982d-1c296cc28b28">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0xMS0xLTEtNTk4OTg1_d1d7a9c8-6f93-435f-bcb7-ef2b56adbf93">122,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0xLTEtMS01OTg5ODU_52259eb1-c5aa-47d1-abe1-dce46b772bc7">43,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4719531412846d6a89583a6b2671ae7_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0zLTEtMS01OTg5ODU_37f62060-c56a-44dd-9090-b76b862a913f">6,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS01LTEtMS01OTg5ODU_4ced5f08-db69-4e57-a3c6-cb1c9caae679">49,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS03LTEtMS01OTg5ODU_b452de38-e7b6-42c5-ba84-4ba133a85618">67,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a4724707ff4691ad93ad034dc2a2ae_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS05LTEtMS01OTg5ODU_613b288d-da33-4ce9-b3eb-311fe564e3b5">9,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0xMS0xLTEtNTk4OTg1_8dee98c2-7b3e-4a13-b279-8bd583bb61ad">77,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0xLTEtMS01OTg5ODU_faf06e87-c44c-4ffa-aa68-b8fa45fdb21b">15,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669e1068f034489a9989b759ab694a1b_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFVNINoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0zLTEtMS01OTg5ODU_7365cd17-1f50-4bd4-bc8b-dbf34e553424">29,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi01LTEtMS01OTg5ODU_9bd4a6c7-2800-4051-93a3-31b57f56948a">44,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi03LTEtMS01OTg5ODU_daea1bb4-63bb-4e8f-8124-5ce64b58dc8c">15,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d323ea48e843f2b86a68ff4beda64c_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFVNINoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi05LTEtMS01OTg5ODU_bcca010c-79c5-41d4-b47b-b6b5ae29d84f">29,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0xMS0xLTEtNTk4OTg1_e893fcc3-6ba8-49af-8a66-2772c6f6ea87">44,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0xLTEtMS01OTg5ODU_c2bd4c81-2be6-47cd-9e96-8bc145ca66ba">58,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0zLTEtMS01OTg5ODU_74847739-0b75-4f9a-897a-27226f78e771">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy01LTEtMS01OTg5ODU_6f6aac06-2e22-4a2d-b112-0f446fed78a6">94,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy03LTEtMS01OTg5ODU_36ec7e1b-5ae7-4063-90d5-7b3a702e70af">82,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy05LTEtMS01OTg5ODU_83eaaba4-2709-440f-b311-e1db5d60f80b">39,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0xMS0xLTEtNTk4OTg1_dd431a4b-42be-4697-8084-7e3cf4d2459c">122,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI4_d38e8426-17ce-4e8c-847a-7a1f15e35f3f" continuedAt="i49ccb02c3b9840ecb448adc7d1b04a2d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time </span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i9ef728ea236f462cb162d0aade3e864d"><ix:continuation id="i49ccb02c3b9840ecb448adc7d1b04a2d"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div></ix:continuation></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_46"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjgxNg_6b22450d-aa68-4e6f-9a9d-c8432fd03628" continuedAt="id7ea0f3e9d3f496794b50b4c4c74d812" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="id7ea0f3e9d3f496794b50b4c4c74d812" continuedAt="i829a78a85acb44729f94d92f87dc2225"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjgxNA_d3156f2c-6c06-4434-9def-2d438427038f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"></td><td style="width:39.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfb12c8e4c1b49beabe60ce0a500841a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS0xLTEtMS01OTg5ODU_5f73f810-ebb2-4a62-bf19-c38cc068b65f">6,400,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c237a00597482b8cfeabc140184f16_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS0zLTEtMS01OTg5ODU_a43448c7-a867-4bfc-b464-dc8312dcf8c8">646,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37fcf42001e43c795ed70694ccbfda3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS01LTEtMS01OTg5ODU_08cb9125-46e0-44d3-ba55-c5c800458c46">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi0xLTEtMS01OTg5ODU_a92e299c-4570-4351-b6b0-13e1fde5a6a1">16,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi0zLTEtMS01OTg5ODU_b752d676-63f2-4470-8da5-384e0c520001">32,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi01LTEtMS01OTg5ODU_6aabf4c8-5c39-4ee0-a597-fba51d7f4233">49,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy0xLTEtMS01OTg5ODU_c358baf6-04df-4484-b2d3-8e573ad71555">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy0zLTEtMS01OTg5ODU_3f4a180b-f31a-42fe-a36a-9275b9646ff8">3,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy01LTEtMS01OTg5ODU_3e4333fc-6c3f-407a-b2e4-432e3e36c356">3,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC0xLTEtMS01OTg5ODU_b5ec7a1c-8a2b-4ae5-915a-d5e999f9ae20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC0zLTEtMS01OTg5ODU_9c77dcf0-11af-4244-b2c4-e048a094478d">15,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC01LTEtMS01OTg5ODU_dedd61d8-7592-4800-a9f2-1caede5c2a8f">15,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS0xLTEtMS01OTg5ODU_ee04e463-d372-4e1f-b854-3d5d402ee577">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS0zLTEtMS01OTg5ODU_0251269f-1119-4f07-b3ae-d9f6998987b8">659,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS01LTEtMS01OTg5ODU_46996806-38a8-483f-8ca6-b3150d53222b">7,076,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC0xLTEtMS01OTg5ODU_373bfe63-4861-47f2-ae00-d3698af07598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC0zLTEtMS01OTg5ODU_532fa89e-4485-468f-9833-1df7a3ba8478">13,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC01LTEtMS01OTg5ODU_00b7b520-0a16-49b2-b8aa-d82e7281614c">13,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS0xLTEtMS01OTg5ODU_1d36fb3d-25ef-4739-9344-62e1e6cf75c4">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS0zLTEtMS01OTg5ODU_4a0915c7-7ff4-4b10-8c27-6e2f08ba1590">673,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS01LTEtMS01OTg5ODU_4047906a-7176-4683-93cc-92f9cd244576">7,090,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItMS0xLTEtNTk4OTg1_553fc4ab-8995-474c-85f9-faacd3f8ad74">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItMy0xLTEtNTk4OTg1_adea51c3-ea51-4bfd-8e80-3d731b219861">794,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItNS0xLTEtNTk4OTg1_f8444d82-a06e-4e8f-a413-ea341ed3ba1d">7,211,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtMS0xLTEtNTk4OTg1_6281b63f-2028-47b6-8d06-8b1e46926cf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtMy0xLTEtNTk4OTg1_b5f81d2f-ba1f-4f06-859a-dc97343475fb">120,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtNS0xLTEtNTk4OTg1_29487cf1-1304-4ba9-8e14-bc9c23e00286">120,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtMS0xLTEtNTk4OTg1_142a1039-ca53-4012-a0bb-c46a8cc9aa77">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtMy0xLTEtNTk4OTg1_2c832dcd-2c24-48d0-8ad2-41dd1f751ab7">673,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtNS0xLTEtNTk4OTg1_f44636aa-c610-4828-a59b-43eea0cf7e05">7,090,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfNTQ5NzU1ODE0NDM4Nw_3a93f571-e13b-4509-b779-95f93d1814cd">not</ix:nonFraction> recognize any goodwill impairment charges during the three months ended March 31, 2023 and 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations continue to be impacted by the effects of the coronavirus (COVID-19) pandemic. While the Company does not currently expect a material adverse impact to its business as a result of the ongoing COVID-19 pandemic, there can be no assurance that the magnitude of the cumulative impacts of the COVID-19 pandemic, including certain conditions and developments in the U.S. and global economies, labor market conditions, inflation and monetary policies that may have been intensified by the pandemic, will not have a material adverse impact on one or more of the Company's businesses.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i829a78a85acb44729f94d92f87dc2225">Developments, events, changes in operating performance and other changes in key circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2023. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2022 10-K, <ix:nonFraction unitRef="segment" contextRef="i0a7f3900fa4a40d883391d98a93f7b4b_D20230101-20230331" decimals="0" name="us-gaap:NumberOfOperatingSegments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjY4Ng_055c96b3-f823-4bf0-bbae-056b36687302">none</ix:nonFraction> of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2023.</ix:continuation>&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_52"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg5Mg_7300c43a-5b7a-493b-a916-cce008eb1773" continuedAt="i70db34a7dc044935860de58136d307c4" escape="true">Long-term debt</ix:nonNumeric></span></div><ix:continuation id="i70db34a7dc044935860de58136d307c4" continuedAt="i32522416ebdb40e6aefd53831c2252ec"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg5Mw_5a1ab909-7eef-4098-93ed-7491a7f4c52f" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy0xLTEtMS01OTg5ODU_2c263feb-16e4-41ed-a66b-55c8144996e8">1,444,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i055d4c5e34fe4929931b589f587c0980_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy0zLTEtMS01OTg5ODU_a9d8727d-b63d-486b-97a2-383242570651">1,498,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy01LTEtMS01OTg5ODU_c3331276-b6a8-4185-8633-747b18bae023">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7198d297bdbd4b59b53e63fef3467ee5_D20230101-20230331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy03LTEtMS01OTg5ODU_861a3e40-cbba-4b7d-b9ec-96e4bdd3dba3">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy05LTEtMS01OTg5ODU_fdc49f55-7d84-4cb8-b086-9be2dcf19b8f">1,433,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC0xLTEtMS01OTg5ODU_e59a676e-85fb-4240-8c9a-7bcecbe06e0c">2,624,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d592dfa62de45988c9d46b6d5b78881_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC0zLTEtMS01OTg5ODU_1b1d5385-889e-4dd2-a672-f68d44cce26f">2,660,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC01LTEtMS01OTg5ODU_41a19ef5-7143-40dd-9ee0-eb89d35e48e8">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC03LTEtMS01OTg5ODU_1895e14c-20e6-4c94-8929-9931e1e7c623">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC05LTEtMS01OTg5ODU_a03dd028-57de-4ab7-8e65-50d2496cc7b7">2,584,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS0xLTEtMS01OTg5ODU_9ffb17c2-a379-4afa-8032-1ea816ae1954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e1c944e685419abccf81e69b562a8d_I20221231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS0zLTEtMS01OTg5ODU_a9b515a2-4e22-4898-b254-3299017aac5f">165,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b1ae9717e3b49f0a0d0440253c6b938_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS01LTEtMS01OTg5ODU_4351c971-935c-4e5e-9783-fc9fff8d9b5c">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ebb307dc0b4487ba3d84d58c6c92d94_D20230101-20230331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS03LTEtMS01OTg5ODU_b707292b-7d39-4899-ac4f-5ba54c8e48f4">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331" decimals="-3" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS05LTEtMS01OTg5ODU_574b8072-6c8a-4885-8b5b-9c98fe80d7a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd9ed34d6454f8abc969538f9cfe069_I20230331" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy0xLTEtMS01OTg5ODU_fe68ed96-add5-49f0-ac1e-747680f43def">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aef3a0c4afb46c6a2d663bf6a8df708_I20221231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy0zLTEtMS01OTg5ODU_9d0acf48-c329-4df9-867b-d5172ccf7285">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy01LTEtMS01OTg5ODU_523b4df0-f5a9-4ddf-9269-e934adea1802">6/1/2030</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy03LTEtMS01OTg5ODU_d0749068-61a4-49ac-91cb-7bb0a5a7367b">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd9ed34d6454f8abc969538f9cfe069_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy05LTEtMS01OTg5ODU_ff96dd02-c958-4239-a0b3-22926b9d4fab">2,344,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea574cb23af34671b3007a1894b492a2_I20230331" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC0xLTEtMS01OTg5ODU_9f763c79-1fc0-4d04-b72f-dfab18b54403">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id07c0f702252454e8659bb3afea6d865_I20221231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC0zLTEtMS01OTg5ODU_51c7b6f5-784d-487a-9a0b-d232ee747dd5">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC01LTEtMS01OTg5ODU_01404d5f-75cc-4f31-907f-3839a1ec427e">2/15/2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC03LTEtMS01OTg5ODU_4b09b6f6-96f9-4702-987d-649f68752444">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea574cb23af34671b3007a1894b492a2_I20230331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC05LTEtMS01OTg5ODU_506b0a6b-8cf4-45e0-bdf2-2f81f1098c39">1,183,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS0xLTEtMS01OTg5ODU_f03beb7f-c8c0-471c-ac02-433c021300cd">117,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id20d8e4a0d5946c0bde607ba39e21075_I20221231" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS0zLTEtMS01OTg5ODU_96a2008e-6337-4725-96ee-f081b7c891e8">120,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0cdf2cf3734745dab39d9af19b881af8_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS01LTEtMS01OTg5ODU_e8a0b587-9cd3-4fea-86c6-0eb5132a7925">2023-2036</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS03LTEtMS01OTg5ODU_98a03291-1e50-4321-bc52-e758810e9e5d">6.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayableFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS05LTEtMS01OTg5ODU_d44717fd-7731-49e8-a5a6-fcb4b84fbf8f">117,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i751eb7e2aba74631a5d35b56d603cd36_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtMS0xLTEtNTk4OTg1_610c4c74-7b65-4718-b802-0f4c3701b690">264,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i633c8deded1e4748a5ea3a5e79109ccd_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtMy0xLTEtNTk4OTg1_d3179cd5-dbf8-47ba-9814-61bd336ba85d">273,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i889d0be36d854ef0ac45dccf0c11123b_D20230101-20230331" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtNS0xLTEtNTk4OTg1_9083e5d4-81e2-467b-8ce0-f80545930c04">2024-2039</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i751eb7e2aba74631a5d35b56d603cd36_I20230331" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtNy0xLTEtNTk4OTg1_a0772a8b-e722-43a3-92db-d27d68b7dc57">4.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTEtMS0xLTEtNTk4OTg1_49edcade-36f7-4422-b39f-814e2a95ce71">8,701,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTEtMy0xLTEtNTk4OTg1_dc7a7c4c-b85b-402b-b9b5-97a78a81a474">8,968,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="dva:DiscountPremiumAndDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTItMS0xLTEtNTk4OTg1_71098fa0-db83-420d-87af-e3fb38a7175d">41,529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="dva:DiscountPremiumAndDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTItMy0xLTEtNTk4OTg1_339cd4b7-24ef-44af-8f8d-782a6cd24fc2">44,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTMtMS0xLTEtNTk4OTg1_dfa5e0a3-f1e9-4072-a3aa-4b08bda6a74a">8,659,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTMtMy0xLTEtNTk4OTg1_91e56c1b-2ab1-4ef7-a335-93282d3c4266">8,924,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTQtMS0xLTEtNTk4OTg1_5c1f984b-8a43-4b0e-9c14-68aadd748251">242,193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTQtMy0xLTEtNTk4OTg1_53c52afe-3b82-4448-b67e-cf00b3d9d707">231,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTUtMS0xLTEtNTk4OTg1_a81c6e5a-e417-4d36-a3dd-108f7837dc0b">8,417,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTUtMy0xLTEtNTk4OTg1_f7c6727c-2f0b-4b27-93e6-d36e75574dcc">8,692,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Term Loan A, Term Loan B-1 and the revolving line of credit have each been amended subsequent to March 31, 2023. See Note 14 for more information on these amendments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of March&#160;31, 2023.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March&#160;31, 2023, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="iee7df1686fc84aad9568e0474639a756_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfOTUy_98393f7f-1cd0-4d45-ad67-cd65c8c6eac0">3,254</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="iee7df1686fc84aad9568e0474639a756_I20230331" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfOTg3_23b543fc-847a-4a41-8788-be440cfafb34">16,797</ix:nonFraction>, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i48a9bca6cbb340b49899150f84ae8847_I20230331" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTA5NA_d56fd142-03b1-499c-a8d8-6c7d3fd487fa">35,024</ix:nonFraction> and increased by a debt premium of $<ix:nonFraction unitRef="usd" contextRef="i48a9bca6cbb340b49899150f84ae8847_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTEzMg_2101c2e9-6208-4dd1-89a1-66d81e541205">13,546</ix:nonFraction>. As of December&#160;31, 2022, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="i7ffe4e826bca45929bab4478c1fc082b_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTI0Ng_06d1c5c3-a36f-4db5-afd6-05cb650dbc16">3,497</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i7ffe4e826bca45929bab4478c1fc082b_I20221231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTI4MQ_0d2adb4e-c817-4cd6-935a-5f30a95ed253">18,816</ix:nonFraction>, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i24848738473b434ab56999f3662f285e_I20221231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTM4Mw_08956d04-3813-4265-9d8e-daf24c415d25">36,203</ix:nonFraction> and increased by a debt premium of $<ix:nonFraction unitRef="usd" contextRef="i24848738473b434ab56999f3662f285e_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTQyMQ_0008c3af-11a0-433f-a9a9-76c143ff05ad">14,018</ix:nonFraction>.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first three months of 2023, the Company made regularly scheduled and other principal payments under its senior secured credit facilities totaling </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTU3Nw_ee82cd5d-ebaf-4219-84cd-07d6d1b6538b">54,011</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Term Loan A and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTU5OQ_df7ff595-5b63-4fba-a4ea-fe66a2c68e49">36,472</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company's 2019 interest rate cap agreements described below had the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $<ix:nonFraction unitRef="usd" contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331" decimals="-3" name="dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwMjYyNQ_84e1c861-b5c9-4a5b-bd7d-4d55207f977f">568,786</ix:nonFraction> outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. <ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg0ODI5MDcxOTA0NA_83117bb9-2b69-4d58-b320-bec2c63dc4ec" escape="true">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i32522416ebdb40e6aefd53831c2252ec"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzkxNg_ce7043dd-f9f3-40e0-99aa-789d292cb201" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2023 and December&#160;31, 2022, which are classified in other long-term assets on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:17.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5">Debt expense (offset)</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2191bc56fe124cba99e0476a60dc454b_I20230331" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xLTEtMS01OTg5ODU_ebc2bef9-f251-479f-9ae1-75247cd2182c">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i680d044b226c493c92a0d22937dd96da_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0zLTEtMS01OTg5ODU_5d747c93-9e3f-407d-83ff-9e87450cd0e7">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331" name="us-gaap:DerivativeInceptionDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi01LTEtMS01OTg5ODU_c21bc8f6-98bd-4391-a45c-8113cb32ac8b">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331" name="us-gaap:DerivativeMaturityDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi03LTEtMS01OTg5ODU_01571da2-755c-4a82-adc4-a86a665967a1">6/30/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi05LTEtMS01OTg5ODU_400d317c-7cee-47cd-bfe8-0bf3cc3a94d0">20,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xMS0xLTEtNTk4OTg1_f47e8ea8-5b0d-4e16-8b07-0910c50eaeb0">4,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918d80ef2d0d471b9ec39e92120325bd_I20230331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xMy0xLTEtNTk4OTg1_2fc8be62-9058-4f5f-89c0-724b7cf3d315">112,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4fc0c1fe9e48f688e101428dafafd4_I20221231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xNS0xLTEtNTk4OTg1_914e921c-aa3c-4c63-b5ca-168c99bfe628">139,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the LIBOR cap from the Company's 2019 interest rate cap agreements, the Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2023 was <ix:nonFraction unitRef="number" contextRef="iee7df1686fc84aad9568e0474639a756_I20230331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzA3Nw_39ae6e1e-243d-4d96-911b-ad1fcb910f3e">4.60</ix:nonFraction>%, based on the current margins in effect for its senior secured credit facilities as of March&#160;31, 2023, as detailed in the table above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was <ix:nonFraction unitRef="number" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5Nw_d4e7d99a-522d-4653-9d1d-b56237319c65">4.55</ix:nonFraction>% for the three months ended March&#160;31, 2023 and <ix:nonFraction unitRef="number" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzMyNQ_57d14ac7-07cc-4c3a-b13a-1b90129de0d5">4.53</ix:nonFraction>% as of March&#160;31, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company&#8217;s interest rates were fixed and economically fixed on approximately <ix:nonFraction unitRef="number" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="4" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzQxOQ_bbfb1a73-12b3-44f4-bdd5-3fb0c748c2e4">53</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="4" name="dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzQyNg_40de8865-e7cc-44c7-a670-5cdec094a7d5">93</ix:nonFraction>% of its total debt, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had an undrawn $<ix:nonFraction unitRef="usd" contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNDc3OA_1bc58756-3382-44fc-ab3b-c0581d7b9f54">1,000,000</ix:nonFraction> revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding under the facility, of which there were <ix:nonFraction unitRef="usd" contextRef="if822c0b60f1343e596dc95916fa9ff3c_I20230331" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNDk5OA_0d5da24f-b3b1-4fbe-9435-c7419074788b">none</ix:nonFraction> as of March&#160;31, 2023. The Company also had letters of credit of approximately $<ix:nonFraction unitRef="usd" contextRef="i4bd27b8f4d024843b9742ab7f8244ea4_I20230331" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNTA2OQ_55aecf66-c5cd-4cf6-b557-f0700d8df5a5">151,358</ix:nonFraction> outstanding under a separate bilateral secured letter of credit facility as of March&#160;31, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Company amended its senior secured credit facilities and entered into several forward interest rate cap agreements that become effective <ix:nonNumeric contextRef="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421" name="dva:DerivativeEffectiveDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg0ODI5MDcxOTEwOQ_419b03d8-f996-4d44-842e-9a9b332f3b2e">June&#160;28, 2024</ix:nonNumeric> and <ix:nonNumeric contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421" name="dva:DerivativeEffectiveDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfNjA0NzMxMzk3NDY4Nw_f6720574-3cc1-4a90-9dd4-b19b112f89d5">June&#160;30, 2024</ix:nonNumeric>. For additional information see Note 14.</span></div></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_55"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQ4NTg_3996f2e1-493c-4b32-9b44-e8b0ae596ac6" continuedAt="i6cf5a00170274170b8eaaa6723b7f61d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span></ix:nonNumeric></div><ix:continuation id="i6cf5a00170274170b8eaaa6723b7f61d" continuedAt="i17948286c9f344cabc7849ccfd77bbbf"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2023 and December&#160;31, 2022, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i17948286c9f344cabc7849ccfd77bbbf" continuedAt="i017896fbfdfc4599b448cdec36d03a39"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government conducted a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. After its investigation, the government and the named states declined to intervene in the matter, and on April 5, 2023, the U.S. District Court, Northern District of Texas, entered an order unsealing the complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Grenon v. DaVita Rx, LLC et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The complaint has not been served on the Company. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired <ix:nonNumeric contextRef="ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022" name="dva:CorporateIntegrityAgreementExpirationDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfNjM5Mw_c48e5207-2974-44f8-8dab-773a413fd336">October 22, 2019</ix:nonNumeric>. In November 2022, the Company learned that, on April 1, 2022, the U.S. Attorney&#8217;s Office for the District of New Jersey notified the U.S. District Court for the District of New Jersey of its decision not to elect to intervene in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and filed a Stipulation of Dismissal. On April 13, 2022, the U.S. District Court for the District of New Jersey dismissed the case without prejudice. On October 12, 2022, the U.S. Attorney&#8217;s Office for the Eastern District of Pennsylvania notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Bayne v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The court then unsealed an amended complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. In January 2023, the private party relator served the Company with the amended complaint. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 District of Columbia Office of Attorney General Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In January 2023, the Office of the Attorney General for the District of Columbia issued a CID to the Company in connection with an antitrust investigation into the American Kidney Fund (AKF). The CID covers the period from January 1, 2016 to the present. The CID requests information on a number of topics, including but not limited to the Company&#8217;s communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i017896fbfdfc4599b448cdec36d03a39" continuedAt="i91afff3a17434b1bbbccbaede7eddfdc"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#8217;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i91afff3a17434b1bbbccbaede7eddfdc"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resolved Matters</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covered the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. In February 2023, the Department of Justice notified the Company that it had closed its investigation. </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div></ix:continuation><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQ4NTc_8e9e4d7c-803d-4549-82cb-b9830a0bc8ac" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i54adb3547d1b4238b88fd5e40fb8c84c_I20230331" decimals="-3" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQwMjg_cd83d5f4-d311-4370-a40b-014f10b2a041">10,099</ix:nonFraction>.</span></div></ix:nonNumeric><div id="ia1113957fba14778a95e5a7387238c82_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTU1OQ_6328f5e5-3ba3-464f-805b-532ad670cd75" continuedAt="id7525ff7d2554631bbb4ceec15724b62" escape="true">Shareholders' equity</ix:nonNumeric></span></div><ix:continuation id="id7525ff7d2554631bbb4ceec15724b62"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTA2_6632973d-7f0a-4ee1-9331-592404071715">1,322</ix:nonFraction> stock-settled restricted and performance stock units with an aggregate grant-date fair value of $<ix:nonFraction unitRef="usd" contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331" decimals="-3" name="dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTkx_0b6fbcdd-86ea-47a0-aabb-171d729d6d64">101,467</ix:nonFraction> and a weighted-average expected life of approximately <ix:nonNumeric contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMjQ4_ccb1754f-03e9-41cc-8fff-3d1a801e8d1d">3.4</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had $<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfNDI4_13c1e2d3-9aa0-4a85-9161-d55e6e4dd429">204,451</ix:nonFraction> in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of <ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfNjY1_6fd1770d-2c6e-4b43-b68f-4db62d3e880e">1.4</ix:nonNumeric> years.</span></div></ix:continuation><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTU2MQ_58c32727-2201-42c7-905a-547428cd61ea" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="shares" contextRef="i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfODE0_3f3ebbba-055c-46c4-90bb-0c8c89ac9011">not</ix:nonFraction> repurchased any shares subsequent to December 31, 2022.</span></div></ix:nonNumeric><div id="ia1113957fba14778a95e5a7387238c82_64"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RleHRyZWdpb246ZjNkMWY2NDE2NWYwNGNjM2E3MjdjMWVhYWM1YTM5YjlfMjUw_a3a94e14-ffb2-4117-9310-ba366407e449" continuedAt="i6a81f96f35e140b69db676a890e7cc5c" escape="true">Accumulated other comprehensive loss</ix:nonNumeric></span></div><ix:continuation id="i6a81f96f35e140b69db676a890e7cc5c"><div style="margin-top:6pt"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RleHRyZWdpb246ZjNkMWY2NDE2NWYwNGNjM2E3MjdjMWVhYWM1YTM5YjlfMjUy_9206a879-74b7-4796-8b84-dbe683b66c2a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.606%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02a973488e20476fb47615a3f807fa05_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0xLTEtMS01OTg5ODU_063b88ce-6d28-48ff-bf0a-787577356967">98,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaee3aa16cbfd44e2990ae90b171f5177_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0zLTEtMS01OTg5ODU_2e86d510-83a2-4565-b30f-c602f7945f34">167,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2eff4db03344e16b162f4f02fc9a3ee_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi01LTEtMS01OTg5ODU_c9e25ac4-d793-4985-8bf1-b4421739d94a">69,186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7c88296b2e04e0db089b890c001d849_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi03LTEtMS01OTg5ODU_dccb865d-f455-4473-8153-29a37430869f">1,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibafc68641e624afe9be140dc2f3a0305_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi05LTEtMS01OTg5ODU_2cc58e95-dcce-4964-8331-1d628801381a">138,069</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id299644831124bbb8821f8f5c4c9630b_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0xMS0xLTEtNTk4OTg1_48990589-289a-4701-93ae-c9fab67a07be">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0xLTEtMS01OTg5ODU_cd441300-9600-4269-a50c-13e506f0486b">4,716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0zLTEtMS01OTg5ODU_415f2125-dd00-4f26-bd1b-0b105ab87592">33,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy01LTEtMS01OTg5ODU_8ef2fedb-71fd-4349-bca0-e9270e6c7928">28,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy03LTEtMS01OTg5ODU_d86930e2-4aab-48e7-a7b2-5e2e8f73fd7a">54,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy05LTEtMS01OTg5ODU_d9e058f0-4e28-4c5d-83ad-1b71ae6a5838">62,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0xMS0xLTEtNTk4OTg1_d63af9f3-8234-4ee8-9e80-4516d4f20e11">117,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0xLTEtMS01OTg5ODU_6544763a-6d02-4967-8f00-5b1cf65656f6">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0zLTEtMS01OTg5ODU_5e659736-5e1e-431d-b59b-2d37b19cff19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC01LTEtMS01OTg5ODU_5a9ec472-30ed-4ba0-bb6c-a59c6199452e">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC03LTEtMS01OTg5ODU_6d120bd8-7384-409d-9bf5-562db29c7998">13,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC05LTEtMS01OTg5ODU_726da2ac-c365-4307-9b13-38f8e64ddf61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0xMS0xLTEtNTk4OTg1_80d7ae1c-889e-47f9-9324-1b196a9a182a">13,674</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0xLTEtMS01OTg5ODU_86b15f7f-b99e-445f-ad56-4ebd7806702e">3,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0zLTEtMS01OTg5ODU_5f793022-56e1-4a2b-9e0c-69edbe5ea543">33,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS01LTEtMS01OTg5ODU_0f3e9f91-d2f4-40be-9bd5-9444e1183b62">30,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS03LTEtMS01OTg5ODU_04975989-f0c4-4856-aa12-bec01bef785b">41,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS05LTEtMS01OTg5ODU_d02e7115-e6ea-45ca-82c8-4421247e49e5">62,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0xMS0xLTEtNTk4OTg1_25facb6a-e86b-4e85-98b0-548b16f71a1e">103,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0xLTEtMS01OTg5ODU_1b78d859-035e-4963-9946-5a0e11521044">20,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0zLTEtMS01OTg5ODU_7722004a-eccb-4ab7-8769-2c979538a9b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi01LTEtMS01OTg5ODU_3ec984ae-2881-4668-959d-87e056ae818f">20,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi03LTEtMS01OTg5ODU_c4d29985-9cbe-4761-8ea3-a4a0329ce270">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi05LTEtMS01OTg5ODU_da744c93-bb64-4232-a430-aa52c5c96909">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0xMS0xLTEtNTk4OTg1_13ccd0b7-0ac6-4ec0-8eea-23c7374b0183">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0xLTEtMS01OTg5ODU_8a7ec589-1616-411b-af60-7591735effe2">5,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0zLTEtMS01OTg5ODU_2b51742d-129d-402d-90f2-089685101015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy01LTEtMS01OTg5ODU_c0ec2a35-5707-496f-86a1-0e73e8cfe353">5,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy03LTEtMS01OTg5ODU_36d67e90-18e6-4452-9b29-0035865e6ab5">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy05LTEtMS01OTg5ODU_32a2934f-1e24-4b20-8504-0f08606c6b1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0xMS0xLTEtNTk4OTg1_e68cdf53-6bc6-4694-be49-269a8d13c23f">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0xLTEtMS01OTg5ODU_47a052f4-ac01-4099-926d-4ef318751e90">15,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0zLTEtMS01OTg5ODU_a6ca5fee-ec19-4fdd-acb2-5adca8cf6c6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC01LTEtMS01OTg5ODU_cdf8900e-47d2-4abb-8cc9-1002674b6acc">15,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC03LTEtMS01OTg5ODU_5ffd7f20-b535-49f6-b150-a42d61178351">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC05LTEtMS01OTg5ODU_afb708e9-0b9a-4a4f-8679-09f58dfd662d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0xMS0xLTEtNTk4OTg1_7e72eac0-939f-47f9-ac2f-b03054626b02">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de0c5885b59490495ce7284b4d660cf_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0xLTEtMS01OTg5ODU_1b5cc39a-b11e-4198-9dab-2caac4aa6f93">79,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd8a058875e44febb4f2f422c3462dea_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0zLTEtMS01OTg5ODU_b426740e-9469-4eea-98e3-459394923a57">134,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7db854d9b914c0b9a64e428f1c82c9e_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS01LTEtMS01OTg5ODU_39e843f3-2897-4329-8693-cca6983c4d9f">54,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f35fdf8c6145ccbf5f634642c80724_I20220331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS03LTEtMS01OTg5ODU_b3c31526-e6a9-4559-8edb-352d3a980e90">40,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2983185f3e94a5fa5decfdf5bfb04fc_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS05LTEtMS01OTg5ODU_e3709b69-7d9f-4ca4-91cd-abf313a1fef2">75,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i909208b4b7f844719f7ac20ac839d43b_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0xMS0xLTEtNTk4OTg1_96ff525b-47cf-4479-914c-2f2252ee82f7">34,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.</span></div></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_70"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfNDc0_918e76b0-658d-479c-9cea-b7f8e2cf2372" continuedAt="i1038a3e2124147fd826ddb5cd1a5b094" escape="true">Variable interest entities (VIEs)</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1038a3e2124147fd826ddb5cd1a5b094">At March&#160;31, 2023, these condensed consolidated financial statements include total assets of VIEs of $<ix:nonFraction unitRef="usd" contextRef="ibd476b66dd8f482d92e7bc8eea43966e_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfMTQ1_94a6d3f9-16e9-49cc-9f51-1e4fba15f46f">308,455</ix:nonFraction> and total liabilities and noncontrolling interests of VIEs to third parties of $<ix:nonFraction unitRef="usd" contextRef="ibd476b66dd8f482d92e7bc8eea43966e_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfMjQw_aa9b24a1-d871-47ef-9dc5-5b66d3f48643">178,382</ix:nonFraction>. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2022 10-K.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_73"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM3MA_56c88b73-654e-4c57-93c5-b2155b679f8a" continuedAt="ibfe03d511fdf47cdaf7c1b1654fc01ff" escape="true">Fair values of financial instruments</ix:nonNumeric></span></div><ix:continuation id="ibfe03d511fdf47cdaf7c1b1654fc01ff" continuedAt="i678781d670d74ff28a9aaae8e8f38195"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM4Mw_c1e51097-c253-4798-816e-eec71446c372" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2023:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi0xLTEtMS01OTg5ODU_281d308d-e46e-46bd-bfcb-a0ea2275f1a8">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980c082ed2474373bd9567687f6e1049_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi0zLTEtMS01OTg5ODU_cd5dd7bb-1c88-4d0b-8087-a3f047e6051b">36,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi01LTEtMS01OTg5ODU_277acfc8-a20f-42f0-8aa2-a0fbe81664f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi03LTEtMS01OTg5ODU_965dc0dd-4adc-4888-834a-442c8fd60f95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1acf2afce18e45c098496603eec3a1e2_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy0xLTEtMS01OTg5ODU_c7b7cb11-3d5c-47a1-8bf9-e43905c02148">112,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7bf666f9c43437ab5aa6ee983cffdd7_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy0zLTEtMS01OTg5ODU_045764dc-3115-458a-a5ca-dc78f588e326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fcc5081c0343a9a1c14dd4e8eb166c_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy01LTEtMS01OTg5ODU_dc46a59d-e0a4-47ed-9a4a-8b5d6b515521">112,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdccc91fa064c2b8622899fe4990f76_I20230331" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy03LTEtMS01OTg5ODU_d8e0893e-981c-4296-bb56-df970b25c40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS0xLTEtMS01OTg5ODU_0c1a5715-adc3-4d5a-9cb0-0d9e045d23e8">25,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980c082ed2474373bd9567687f6e1049_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS0zLTEtMS01OTg5ODU_c97f5928-533b-4b1c-ab9a-a6721c9d3e28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS01LTEtMS01OTg5ODU_22127622-631d-44dd-9a02-f0d3a977065c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS03LTEtMS01OTg5ODU_33cd6c5d-d8d3-4605-93e1-aa0e0a9530fd">25,098</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy0xLTEtMS01OTg5ODU_f235c4a2-bbae-41c7-8644-35eae5f22ab3">1,398,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980c082ed2474373bd9567687f6e1049_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy0zLTEtMS01OTg5ODU_93c4a62b-d5a1-414c-9ee9-acbe7ab54561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy01LTEtMS01OTg5ODU_a10533f6-99ad-4e41-b4e6-ab47f85af24a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy03LTEtMS01OTg5ODU_6261ce93-ed1c-4af3-bb1d-53640ca8c3c1">1,398,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a reconciliation of changes in noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2023, see the consolidated statement of equity.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM4MA_591e074c-0aca-4143-be0f-ccd4dd5086b9" escape="true">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported.</ix:nonNumeric> See Note 6 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i594302e643444e72a196b7a7758e44c3_D20230101-20230331" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTIxMw_93e35a0c-0397-4aac-8795-1adfe8a4dac3">59,351</ix:nonFraction> if certain performance targets or quality margins are met over the next <ix:nonNumeric contextRef="i1cf2d70aa9324948a2cc832ba7bd6142_D20230101-20230331" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTI4OQ_513c8da8-52a1-4f0a-b6d7-86f3d0bfb094">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i9a53a270c4e04f138e74b1e7cfe51819_D20230101-20230331" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTI5Ng_2260732e-a43e-442e-baa1-b2a6ff7ded9d">five years</ix:nonNumeric>. The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2023, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $<ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfMzQ1Ng_3c8a6de3-c978-4bed-b51b-d7f53c8b4f27">175,000</ix:nonFraction>. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2022 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i678781d670d74ff28a9aaae8e8f38195"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2023 at their approximate fair values due to the short-term nature of their settlements.</span></div></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_76"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3NA_24aa97b6-01d4-4275-a93a-f422149c3430" continuedAt="ib38c78cea5ba47c4bfe3063c06b24b99" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="ib38c78cea5ba47c4bfe3063c06b24b99" continuedAt="ic59faf88bee249eca4da709860c5afb0"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. IKC business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. IKC business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2022 10-K for further description of how the Company determines and measures results for its operating segments.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="ic59faf88bee249eca4da709860c5afb0" continuedAt="i8fcc6f770cd3438da0ef55088b64d009"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3OA_783bb8b1-a5a3-404e-8991-18e74ee4801e" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNS0xLTEtMS01OTg5ODU_a167b8cc-7afd-4886-ba2d-b6c7ae993928">2,583,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNS0zLTEtMS01OTg5ODU_bedbd1ea-9ea5-42fc-ae4b-49d01872f43a">2,546,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNi0xLTEtMS01OTg5ODU_70c8bf7a-723c-4312-aaba-9115159caec8">22,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNi0zLTEtMS01OTg5ODU_6fc57123-1842-42af-b3e8-69b1cf23eedd">22,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfOS0xLTEtMS01OTg5ODU_356db94b-31f1-4e0a-bfa2-e3b075d0a71a">2,605,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfOS0zLTEtMS01OTg5ODU_70556a35-c9b6-49fa-84f1-f09263d481f4">2,569,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTEtMS0xLTEtNTk4OTg1_f7096d5c-bde1-4ec6-93af-2195424a095d">6,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTEtMy0xLTEtNTk4OTg1_1959fdda-172c-4337-8730-e6ce406c8310">5,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTItMS0xLTEtNTk4OTg1_e599d542-4db5-441b-a73e-54f9f4bfa562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTItMy0xLTEtNTk4OTg1_7f3076e0-74ad-438b-bc81-5ab30110b3df">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTMtMS0xLTEtNTk4OTg1_7f63181f-4bbe-4bef-af7b-bf4744d708db">2,612,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTMtMy0xLTEtNTk4OTg1_00e4ee48-f57e-45e3-ad72-7c7bd9cd963a">2,575,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTUtMS0xLTEtNTk4OTg1_d7733ae0-5e6b-4ce5-bb56-1222df979f1b">176,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTUtMy0xLTEtNTk4OTg1_5de1bae2-2dcb-4760-9a5c-14292e918c45">169,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTYtMS0xLTEtNTk4OTg1_4442d4b0-01b3-4596-affe-9a4184d21a02">106,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTYtMy0xLTEtNTk4OTg1_22975769-5edf-471f-9852-b09d153fbe8d">95,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6608bb6cb94997a8b0a4397ff14ad0_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTctMS0xLTEtNTk4OTg1_2b7b16e7-7be8-435f-845d-0753e9becd3f">1,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f4a76215494ab98201d3f4c7c27890_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTctMy0xLTEtNTk4OTg1_2dff8b7f-d326-4f19-bc74-6d38e656dd8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTgtMS0xLTEtNTk4OTg1_15183bb5-d3fe-422d-9691-314c797eb040">283,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTgtMy0xLTEtNTk4OTg1_dd8b905f-9749-4fcd-8cac-a65e113b0e38">264,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTktMS0xLTEtNTk4OTg1_984c3c0b-e5b0-4a92-a675-c8d42c9e2576">2,896,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8145bc790f464c6097f88871f5552d27_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTktMy0xLTEtNTk4OTg1_430f189d-a7f5-4351-859b-627a12b01ad1">2,839,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76335814a9534b91a6933754d6ee880a_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjAtMS0xLTEtNTk4OTg1_d82ddccd-49e4-4144-8386-1c9e74d181b3">23,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8680e140680144f3b9565b2256e74132_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjAtMy0xLTEtNTk4OTg1_26e32b19-17a0-48d6-9abe-c8096eb0515d">22,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjEtMS0xLTEtNTk4OTg1_47c05d52-0b86-49ac-9544-e1fe02894076">2,872,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjEtMy0xLTEtNTk4OTg1_75ee6ab0-dfcc-4001-a474-4ca33d6c3097">2,817,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjMtMS0xLTEtNTk4OTg1_eb6518db-a690-4fcf-8813-45dfb79c2b24">361,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjMtMy0xLTEtNTk4OTg1_bf76c374-ac1a-4215-8f23-a99b4b480b27">406,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjQtMS0xLTEtNTk4OTg1_1198ceb5-4ecc-4a0b-b8c8-e1e793913d81">24,865</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjQtMy0xLTEtNTk4OTg1_032a29d5-4332-4d43-b242-7b5a12f267eb">32,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjUtMS0xLTEtNTk4OTg1_25bdf997-7848-40b5-8e56-48f1945d8dc7">336,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8145bc790f464c6097f88871f5552d27_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjUtMy0xLTEtNTk4OTg1_66da7aed-f824-4c99-8383-3860e24584b7">374,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income before income<br/>&#160;taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjctMS0xLTEtNTk4OTg1_b4de4c1c-bd4a-481f-95c2-779bd6dd7d8e">24,588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjctMy0xLTEtNTk4OTg1_127dcaa5-e636-483f-a1c3-15b0fff9b1f3">35,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjgtMS0xLTEtNTk4OTg1_72550dfb-97b8-4a62-8d8f-e35748ba669a">311,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjgtMy0xLTEtNTk4OTg1_3ea48883-013c-4f50-9461-89f3ce52717b">338,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjktMS0xLTEtNTk4OTg1_9bc28b00-4561-4fdd-bc5b-cc0fc953148c">100,774</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjktMy0xLTEtNTk4OTg1_62453d3d-5a5a-429a-8253-ee0542f04574">73,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzEtMS0xLTEtNTk4OTg1_d669662b-b535-4564-a449-68f00da1d6f3">3,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzEtMy0xLTEtNTk4OTg1_f17fd82a-9ecd-4a5f-a8c6-aab87d4b648e">1,786</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzItMS0xLTEtNTk4OTg1_13c34971-e02a-4b7d-b964-1f9bc4bf881a">214,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzItMy0xLTEtNTk4OTg1_0948ad32-5e62-4456-bf0b-9c7148746eef">262,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" xsi:nil="true" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3OQ_196486c4-e9d3-46b1-9d9e-c7d15378af5f" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i8fcc6f770cd3438da0ef55088b64d009"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ4MA_2836e034-2e58-41a6-a56b-9c65337e0e1e" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.065%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMi0xLTEtMS01OTg5ODU_1c081c98-9f2a-439a-b7b0-1f05fcd34ff3">166,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMi0zLTEtMS01OTg5ODU_7a724b66-3e9e-46bd-8704-4221e5e069c1">162,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMy0xLTEtMS01OTg5ODU_7a96c084-378f-43fd-b1c0-4dec1e0b5a50">11,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMy0zLTEtMS01OTg5ODU_9279d679-477c-4f70-85ae-5541808daf15">10,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfNC0xLTEtMS01OTg5ODU_92f84b97-cf17-4912-8d6f-506346ff21eb">178,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfNC0zLTEtMS01OTg5ODU_29e4648f-031d-41d7-bbb2-84c8c9530523">172,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3NQ_646cf866-07c7-4835-bd95-00e8676d0a74" continuedAt="i841b3ff977ee4ccebc91aa33f01a1f28" escape="true">Expenditures for property and equipment by reportable segment were as follows:</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="i841b3ff977ee4ccebc91aa33f01a1f28"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.065%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMi0xLTEtMS01OTg5ODU_bf708a18-159d-44df-bddd-5eb83408e723">130,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMi0zLTEtMS01OTg5ODU_583e4a90-311a-48b3-9e98-7bc07338e734">107,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMy0xLTEtMS01OTg5ODU_e50db122-79d5-4824-8a15-d39adaae0161">16,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMy0zLTEtMS01OTg5ODU_30e6bd6d-7dde-47e2-a161-5c3603cf4eca">15,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfNC0xLTEtMS01OTg5ODU_11300a95-b00c-422e-8c7b-ebc8a7c55605">147,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfNC0zLTEtMS01OTg5ODU_127abb88-a8ee-4bc9-9d11-e61a7a11b4e4">123,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ4Ng_1db79051-27d0-4901-af1e-fe9173944804" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"></td><td style="width:61.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMS0xLTEtMS01OTg5ODU_be5dd787-b4d3-4931-97db-dd41003b2efb">14,789,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMS0zLTEtMS01OTg5ODU_9117a315-3c2a-4125-95d8-5322b521eaf6">15,084,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMi0xLTEtMS01OTg5ODU_733b3278-80ce-4372-9de2-e6673ac95836">1,938,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMi0zLTEtMS01OTg5ODU_c34dc26d-1c02-4588-8e80-564c4acf694a">1,843,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9371851bf60946538246702a8ff6a696_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMy0xLTEtMS01OTg5ODU_9f9762d0-3739-4edc-b5e8-a5cc455912e5">16,727,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMy0zLTEtMS01OTg5ODU_443663e8-6b96-4985-b0ed-c289bfaa6b03">16,928,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_79"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83OS9mcmFnOjI2MzA1Y2Q1ODI2NTQ4MGZhOGEzMjFjZmMxY2MxYWEwL3RleHRyZWdpb246MjYzMDVjZDU4MjY1NDgwZmE4YTMyMWNmYzFjYzFhYTBfMjA1MQ_cdf92344-e060-4739-a33b-4b791ca8e7d8" continuedAt="i4f73d4c451b2498f8aaa0b93e9be4528" escape="true">New accounting standards</ix:nonNumeric></span></div><ix:continuation id="i4f73d4c451b2498f8aaa0b93e9be4528"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (ASU) No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company could elect to apply the amendments prospectively through December 31, 2022. In December 2022, the FASB issued ASU No. 2022-06,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which extended the election date to December 31, 2024. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have <ix:nonFraction unitRef="usd" contextRef="i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701" decimals="-3" name="dva:ChangeInAccountingPrincipleImpactAbilityToBorrow" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83OS9mcmFnOjI2MzA1Y2Q1ODI2NTQ4MGZhOGEzMjFjZmMxY2MxYWEwL3RleHRyZWdpb246MjYzMDVjZDU4MjY1NDgwZmE4YTMyMWNmYzFjYzFhYTBfMTUzOTMxNjI3OTk3NTU_7ee6f39e-dafa-4010-857c-549620b8b9cf">no</ix:nonFraction> impact on the Company's ability to borrow. The Company does not expect application of this ASU to have a material impact on its consolidated financial statements.</span></div></ix:continuation><div id="ia1113957fba14778a95e5a7387238c82_1270"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xNTM5MzE2Mjc5MTA5Ng_775a73a5-3cd0-44bc-bfdb-58949042ab89" continuedAt="i79af5f815b254f30baec17e2c5d2dbee" escape="true">Subsequent events</ix:nonNumeric></span></div><ix:continuation id="i79af5f815b254f30baec17e2c5d2dbee" continuedAt="i42f79008efc84af4be3af6f56af012d1"><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Launch of Mozarc Medical</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401" name="dva:BusinessAgreementDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTU5OTg3_4abb4c8c-0b88-40af-8218-52027d0a5bbe">May&#160;25, 2022</ix:nonNumeric>, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (Mozarc Medical) via a deconsolidating partial interest sale from Medtronic to the Company, which closed effective <ix:nonNumeric contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401" name="dva:BusinessAgreementEffectiveClosingDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODQw_15a75f34-8d18-4295-9d59-8bc30153af56">April&#160;1, 2023</ix:nonNumeric>. At the closing, the Company made a cash payment to Medtronic of $<ix:nonFraction unitRef="usd" contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNDE2_9a442891-bc23-4cd8-9575-27872347e145">44,651</ix:nonFraction>, subject to certain customary post-closing adjustments, and contributed certain other non-cash assets to Mozarc Medical. Additionally, at close, the Company and Medtronic each contributed $<ix:nonFraction unitRef="usd" contextRef="i06a8ea352a2743ed93515924f01db624_I20230401" decimals="-3" name="dva:AdditionalCashCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNjIz_1787ff2c-5129-4c13-b03d-7c50244aa68d">224,415</ix:nonFraction> in cash to launch Mozarc Medical. Pursuant to its agreement with Medtronic, the Company has also agreed to pay Medtronic additional consideration of up to $<ix:nonFraction unitRef="usd" contextRef="i06a8ea352a2743ed93515924f01db624_I20230401" decimals="-3" name="us-gaap:OtherCommitmentDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNzM2_7d761497-f791-4109-a49e-35fa521c2035">300,000</ix:nonFraction> if certain regulatory and commercial milestones are achieved between 2024 and 2028.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward Interest Rate Cap Agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i0788ec757ea94bf4a9145a7a7ed57852_D20230421-20230421" name="us-gaap:DerivativeInceptionDates" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NDg3_bac543f8-f3a5-4456-92ef-63b67f418bf6">April&#160;21, 2023</ix:nonNumeric>, the Company entered into several forward interest rate cap agreements with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i3966a9b63d8a4d6bbeaa5dd9fd9ff21a_I20230421" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA3ODg5_5c070845-68ea-4a7d-b940-71582cc2e58b">1,000,000</ix:nonFraction> that have the economic effect of capping the Company's exposure to Secured Overnight Financing Rate (SOFR) variable interest rate changes on specific portions of the Company's floating rate debt (2023 cap agreements). These </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i42f79008efc84af4be3af6f56af012d1"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 cap agreements are designated as cash flow hedges and, as a result, changes in their fair values will be reported in other comprehensive income. These 2023 cap agreements do not contain credit-risk contingent features, and become effective on <ix:nonNumeric contextRef="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421" name="dva:DerivativeEffectiveDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NDMw_419b03d8-f996-4d44-842e-9a9b332f3b2e">June&#160;28, 2024</ix:nonNumeric> and <ix:nonNumeric contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421" name="dva:DerivativeEffectiveDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xODY5MTY5NzY4NDQ5MQ_f6720574-3cc1-4a90-9dd4-b19b112f89d5">June&#160;30, 2024</ix:nonNumeric> and expire on <ix:nonNumeric contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421" name="us-gaap:DerivativeMaturityDates" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV81NDk3NTU4MTUxMzYy_b65fb505-defe-4765-a026-86b2bf6d9cd2">December&#160;31, 2025</ix:nonNumeric>. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second and Third Amendments to Credit Agreement</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="icc23cd3becc842dfa58d5e0e248e0c6a_D20230403-20230403" name="us-gaap:DebtInstrumentIssuanceDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NTA2_dca09de8-2811-4c52-bdc9-3bd1feb4de22">April&#160;3, 2023</ix:nonNumeric>, the Company entered into the Second Amendment (the Second Amendment) to the Credit Agreement. The Second Amendment modifies the Credit Agreement to, among other things, transition the interest pricing on Term Loan B-1 from <ix:nonNumeric contextRef="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODYz_1895e14c-20e6-4c94-8929-9931e1e7c623">LIBOR+1.75%</ix:nonNumeric> to a forward-looking term rate based on SOFR (Term SOFR) +<ix:nonFraction unitRef="number" contextRef="i2b3dd1537dba44f5900ed9f64c91677b_D20230403-20230403" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODg0_e6f7e0d9-7550-4d3a-8398-6eeaa3d01a92">1.75</ix:nonFraction>% and an additional credit spread adjustment (CSA), as well as to update the successor interest rate provisions in the Credit Agreement with respect to Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" name="us-gaap:DebtInstrumentIssuanceDate1" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xODY5MTY5NzY4NDUyOA_4081e7db-ea59-4ec0-a352-ab45fa800bbd">April&#160;28, 2023</ix:nonNumeric> (&#8220;Effective Date&#8221;), the Company entered into the Third Amendment (the Third Amendment) to the Credit Agreement. The Third Amendment modifies the Credit Agreement to, among other things, refinance its Term Loan A and revolving line of credit with a secured Term Loan A-1 facility in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i16b6c4f2fa614fecaa2c78eec44d5f17_I20230428" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV85ODk1NjA0NjYxNDEw_7ffb5ea3-dc34-4be6-baeb-136933bc7ef9">1,250,000</ix:nonFraction> and a secured revolving line of credit in the aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="ibe1c2673f7634b01be99ea30dec31d8b_I20230428" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV85ODk1NjA0NjYxNjE2_3941546c-76d8-4d17-8820-66720477dc6c">1,500,000</ix:nonFraction>. The facilities bear interest at a rate equal to one-month Term SOFR plus an interest rate percentage (initially <ix:nonFraction unitRef="number" contextRef="i1f284922a3174384b3458e6319e9275c_D20230428-20230428" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTM2_5e5bcb08-423b-4cba-b16a-934846627dc5">2.00</ix:nonFraction>%) and an additional CSA. The Credit Agreement, as amended, continues to include customary affirmative and negative covenants and events of default for financings of this type.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A-1 facility amortizes on a <ix:nonNumeric contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTky_f3a9a687-9b1d-4e75-ae70-3b2c65a70cc6">quarterly</ix:nonNumeric> basis beginning <ix:nonNumeric contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" name="dva:DebtInstrumentPeriodicPaymentStartDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xMDk5NTExNjQyNTQ3_684ad259-b600-427a-9dc7-a25d445e3095">September&#160;30, 2023</ix:nonNumeric> at a rate of (i) <ix:nonFraction unitRef="number" contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" decimals="3" name="dva:DebtInstrumentPeriodicPaymentInterestRateYearOne" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTk0_f88d72da-963e-4c65-88a3-b4d4dd49ce1f">2.5</ix:nonFraction>% per annum during the first year following the Effective Date of the Third Amendment, (ii) <ix:nonFraction unitRef="number" contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" decimals="3" name="dva:DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDAz_3d17f774-1ae7-4d77-a32d-2e59d916a8cf">5.0</ix:nonFraction>% per annum during the second, third and fourth years following the Effective Date of the Third Amendment and (iii) <ix:nonFraction unitRef="number" contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" decimals="3" name="dva:DebtInstrumentPeriodicPaymentInterestRateYearFive" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDEy_7ee0fc47-cbdc-4339-a9e9-e848ec047b40">7.5</ix:nonFraction>% per annum during the fifth year following the Effective Date of the Third Amendment, with the balance due on <ix:nonNumeric contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428" name="dva:DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDM5_6045144f-3c58-4b77-818c-ae0d6b3327a2">April&#160;28, 2028</ix:nonNumeric>. The new secured revolving line of credit has a five-year term.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="ia1113957fba14778a95e5a7387238c82_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-looking statements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements could include, among other things, DaVita's response to and the expected future impacts of the coronavirus (COVID-19), including statements about our balance sheet and liquidity, our expenses and expense offsets, revenues, billings and collections, availability or cost of supplies, treatment volumes, mix expectation, such as the percentage or number of patients under commercial insurance, the availability, acceptance, impact, administration and efficacy of COVID-19 vaccines, treatments and therapies, the continuing impact on the U.S. and global economies, labor market conditions, and overall impact on our patients and teammates, as well as other statements regarding our future operations, financial condition and prospects, expenses, strategic initiatives, government and commercial payment rates, expectations related to value-based care, integrated kidney care and Medicare Advantage (MA) plan enrollment, and our ongoing stock repurchase program. All statements in this report, other than statements of historical fact, are forward-looking statements. Without limiting the foregoing, statements including the words "expect," "intend," "will," &#8220;could,&#8221; "plan," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on DaVita's current expectations and are based solely on information available as of the date of this report. DaVita undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things:</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the continuing impact of the COVID-19 pandemic, current macroeconomic and marketplace conditions, and global events, many of which are interrelated and which relate to, among other things, the impact of the COVID-19 pandemic on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition and results of operations; the government&#8217;s response to the ongoing pandemic; the pandemic's impact on the U.S. and global economies, labor market conditions, interest rates, inflation and evolving monetary policies; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; the continuing impact of the pandemic on our revenues and non-acquired growth due to lower treatment volumes; COVID-19's impact on the chronic kidney disease (CKD) population and our patient population including on the mortality of these patients; any potential negative impact on our commercial mix or the number of our patients covered by commercial insurance plans; continued increased COVID-19-related costs; our ability to successfully implement cost savings initiatives; supply chain challenges and disruptions; and elevated teammate turnover and training costs and higher salary and wage expense. including, among other things, increased contract wages, driven in part by persisting labor market conditions and a high demand for our clinical personnel, any of which may also have the effect of heightening many of the other risks and uncertainties discussed below, and in many cases, the impact of the pandemic and the aforementioned global economic conditions on our business may persist even after the pandemic subsides; </span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates; a reduction in the number or percentage of our patients under such plans, including, without limitation, as a result of restrictions or prohibitions on the use and/or availability of charitable premium assistance, which may result in the loss of revenues or patients, as a result of our making incorrect assumptions about how our patients will respond to any change in financial assistance from charitable organizations; or as a result of payors' implementing restrictive plan designs, including, without limitation, actions taken in response to the U.S. Supreme Court&#8217;s decision in Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. (Marietta); how and whether regulators and legislators will respond to the Marietta decision including, without limitation, whether they will issue regulatory guidance or adopt new legislation; how courts will interpret other anti-discriminatory provisions that may apply to restrictive plan designs; whether there could be other potential negative impacts of the Marietta decision; and the timing of each of these items;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof or related litigation result in a reduction in coverage or reimbursement rates for our services, a reduction in the number of patients enrolled in or that select higher-paying commercial plans, including for example MA plans; or other material impacts to our business or operations; or our making incorrect assumptions about how our patients will respond to any such developments;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">risks arising from potential changes in laws, regulations or requirements applicable to us, such as potential and proposed federal and/or state legislation, regulation, ballot, executive action or other initiatives, including, without limitation, those related to healthcare and/or labor matters;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to attract, retain and motivate teammates and our ability to manage operating cost increases or productivity decreases whether due to union organizing activities, legislative or other changes, demand for labor, volatility and uncertainty in the labor market, the current challenging and highly competitive labor market conditions, or other reasons;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">U.S. and global economic and marketplace conditions, interest rates, inflation, unemployment, labor market conditions, and evolving monetary policies, and our ability to respond to these challenging conditions, including among other things our ability to successfully identify cost savings opportunities and to implement cost savings initiatives such as ongoing initiatives that increase our use of third-party service providers to perform certain activities, initiatives that relate to clinic optimization and capacity utilization improvement, and procurement opportunities, among other things;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to successfully implement our strategies with respect to integrated kidney care and value-based care initiatives and home based dialysis in the desired time frame and in a complex, dynamic and highly regulated environment, including, among other things, maintaining our existing business; meeting growth expectations; recovering our investments; entering into agreements with payors, third party vendors and others on terms that are competitive and, as appropriate, prove actuarially sound; structuring operations, agreements and arrangements to comply with evolving rules and regulations; finding, training and retaining appropriate staff; and further developing our integrated care and other capabilities to provide competitive programs at scale; </span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">a reduction in government payment rates under the Medicare End Stage Renal Disease program, state Medicaid or other government-based programs and the impact of the MA benchmark structure;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">noncompliance by us or our business associates with any privacy or security laws or any security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">legal and compliance risks, such as our continued compliance with complex, and at times, evolving government regulations and requirements;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the Affordable Care Act, the exchanges and many other core aspects of the current healthcare marketplace, as well as the composition of the U.S. Supreme Court and the current presidential administration and congressional majority;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">changes in pharmaceutical practice patterns, reimbursement and payment policies and processes, or pharmaceutical pricing, including with respect to hypoxia inducible factors, among other things;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to develop and maintain relationships with physicians and hospitals, changing affiliation models for physicians, and the emergence of new models of care or other initiatives introduced by the government or private sector that, among other things, may erode our patient base and impact reimbursement rates;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to complete acquisitions, mergers, dispositions, joint ventures or other strategic transactions that we might announce or be considering, on terms favorable to us or at all, or to successfully integrate any acquired businesses, or to successfully operate any acquired businesses, joint ventures or other strategic transactions, or to successfully expand our operations and services in markets outside the United States, or to businesses or products outside of dialysis services;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">continued increased competition from dialysis providers and others, and other potential marketplace changes, including without limitation increased investment in and availability of funding to new entrants in the dialysis and pre-dialysis marketplace;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the variability of our cash flows, including without limitation any extended billing or collections cycles; the risk that we may not be able to generate or access sufficient cash in the future to service our indebtedness or to fund our other liquidity needs; and the risk that we may not be able to refinance our indebtedness as it becomes due, on terms favorable to us or at all;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">factors that may impact our ability to repurchase stock under our stock repurchase program and the timing of any such stock repurchases, as well as our use of a considerable amount of available funds to repurchase stock;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">risks arising from the use of accounting estimates, judgments and interpretations in our financial statements;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">impairment of our goodwill, investments or other assets;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our aspirations, goals and disclosures related to environmental, social and governance (ESG) matters, including, among other things, evolving regulatory requirements affecting ESG standards, measurements and reporting requirements; the availability of suppliers that can meet our sustainability standards; and our ability to recruit, develop and retain diverse talent in our labor markets; and</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the other risk factors, trends and uncertainties set forth in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K), and the risks and uncertainties discussed in any subsequent reports that we file or furnish with the Securities and Exchange Commission (SEC) from time to time. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following should be read in conjunction with our condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_88"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal business is to provide dialysis and related lab services to patients in the United States, which we refer to as our U.S. dialysis business. We also operate our U.S. integrated kidney care (IKC) business, our U.S. other ancillary services, and our international operations, which we collectively refer to as our ancillary services, as well as our corporate administrative support. Our U.S. dialysis business is a leading provider of kidney dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Economic and Marketplace Conditions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developments in general economic and market conditions could have a material adverse impact on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition, results of operations, cash flows and/or liquidity. Many of these external factors and conditions are interrelated, including, among other things, the continuing impact of COVID-19 on the mortality rates of our patients and other ESRD or CKD patients, supply chain challenges, inflation, rising interest rates, labor market conditions and wage pressure. Certain of these impacts could be further intensified by concurrent global events such as the ongoing conflict between Russia and Ukraine, which has continued to drive sociopolitical and economic uncertainty in Europe and across the globe.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational and Financial Impacts</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we saw an increase in treatment volume compared to the prior quarter due primarily to a higher patient census. However, we continue to experience a negative impact on revenue and treatment volume on a full year over full year basis due to the cumulative negative impact of COVID-19 on the mortality rates of our patients, which has in turn had an adverse impact on our patient census over time. As the pandemic continues to subside, we expect that the impact of COVID-19 will likely continue to negatively impact our revenue and non-acquired growth for a period of time due to the compounding impact of mortalities, among other things. New admission rates, future revenues and non-acquired growth could also continue to be negatively impacted over time to the extent that the CKD population experiences elevated mortality levels due to the pandemic. There remains significant uncertainty as to the ultimate impact of COVID-19 on our treatment volumes, in part due to, among other things, the indeterminate severity and duration of the pandemic and the complexity of factors that may drive new admissions and missed treatment rates over time. Depending on the ultimate severity and duration of the pandemic, the magnitude of these cumulative impacts could have a material adverse impact on our results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing global economic conditions, such as general labor, supply chain and inflationary pressures, combined with the impact of COVID-19, have also increased, and will continue to increase, our expenses, including, among others, staffing and labor costs. While we continued to experience elevated levels of compensation and training expenses during the first quarter, we have experienced improvement in labor costs, primarily due to decreased utilization of contract labor in the first quarter. We expect certain of these increased costs to continue, and the cumulative impact of these costs could be material. In addition, potential staffing shortages or disruptions, if material, could ultimately lead to the unplanned closures of certain centers or adversely impact clinical operations, and may otherwise have a material adverse impact on our ability to provide dialysis services or the cost of providing those services, among other things. In the first quarter, we also saw a continued elevated level of effort and cost needed to procure certain of our equipment and clinical supplies, including dialysis supplies.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The staffing and labor cost inflation described above, in addition to higher equipment and clinical supply costs, have put pressure on our existing cost structure, and as noted above, we expect that certain of those increased costs will persist as global supply chains continue to experience volatility and disruptions and as inflationary pressures and challenging labor market conditions continue. During the first quarter, we continued to implement cost savings opportunities to help mitigate these cost and volume pressures. These include, among other things, anticipated cost savings related to certain general and administrative cost efficiencies, such as ongoing initiatives that increase our use of third party service providers to perform certain activities, including, among others, finance and accounting functions as well as related information technology functions; initiatives relating to clinic optimization and initiatives for capacity utilization improvement; and procurement opportunities. We have incurred, and expect to continue to incur, charges in connection with the continued implementation of certain of these initiatives, and there can be no assurance that we will be able to successfully execute these initiatives or that they will achieve expectations or succeed in helping offset the impact of these challenging conditions. Any failure on our part to adjust our business and operations in this manner, to adjust to other marketplace developments or dynamics or to appropriately implement these initiatives in accordance with applicable legal, regulatory or compliance requirements could adversely impact our ability to provide dialysis services or the cost of providing those services, among other things, and ultimately could have a material adverse effect on our business, reputation, results of operations, financial condition and cash flows. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of the COVID-19 pandemic and the aforementioned general economic and marketplace conditions on the Company over time will depend on future developments that are highly uncertain and difficult to predict. We expect that these conditions will continue to impact our business in 2023.</span></div><div id="ia1113957fba14778a95e5a7387238c82_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below includes analysis of our financial condition and results of operations for the three months ended March&#160;31, 2023 compared to the three months ended December&#160;31, 2022, and the year to date periods for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022.</span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated results of operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our revenues, operating income and adjusted operating income by line of business. See the discussion of our results for each line of business following the tables. When multiple drivers are identified in the following discussion of results, they are listed in order of magnitude:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,917&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted operating income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted operating income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div id="ia1113957fba14778a95e5a7387238c82_94"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis results of operations </span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment volume:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,117,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,239,660&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,233)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Normalized non-acquired treatment growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Normalized non-acquired treatment growth reflects year over year growth in treatment volume, adjusted to exclude acquisitions and other similar transactions, and further adjusted to normalize for the number and mix of treatment days in a given quarter versus the prior year quarter.</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,117,427&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,109,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis treatment volume is directly correlated with our operating revenues and expenses. The decrease in our U.S. dialysis treatments for the first quarter of 2023 from the fourth quarter of 2022 was primarily driven by two fewer treatment days, partially offset by increased average treatments per day due to increased admits due to growth in our patient population.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in our U.S. dialysis treatments for the three months ended March&#160;31, 2023 from the three months ended March&#160;31, 2022 was primarily driven by increased average treatments per day due to decreased mortality in our patient population.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis average patient service revenue per treatment for the first quarter of 2023 compared to the fourth quarter of 2022 decreased, driven by a seasonal decline from co-insurance and deductibles, partially offset by an increase in the Medicare base rate in 2023, favorable changes due to the continued shift to MA plans and a seasonal increase in hospital inpatient dialysis treatments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis average patient service revenue per treatment for the three months ended March&#160;31, 2023 increased compared to the three months ended March&#160;31, 2022 primarily driven by a net increase in the Medicare rate due to base rate increase in 2023 partially offset by the reinstatement of 2% sequestration. The increase was also impacted by the continued shift to MA plans and increases in hospital inpatient dialysis revenues.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.60&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.26)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257.34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.61&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.73&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charges impacting operating income </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Closure costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the third quarter of 2022, we began a strategic review of our outpatient clinic capacity requirements and utilization, which have been impacted both by declines in our patient census in some markets due to the COVID-19 pandemic, as well as by our initiatives toward, and advances in, increasing the proportion of our home dialysis patients. This review has resulted in higher than normal charges for center capacity closures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we incurred charges for U.S. dialysis center closures of approximately $22.2 million, which increased our patient care costs by $12.6 million, our general and administrative expenses by $4.8 million and our depreciation and amortization expense by $4.8 million. By comparison, during the fourth quarter of 2022, U.S. dialysis center closures were approximately $35.3 million, which increased our patient care costs by $6.0 million, our general and administrative expenses by $5.3 million and our depreciation and amortization expense by $24.0 million. During the first quarter of 2022, U.S. dialysis center closures were approximately $4.5 million, which increased our patient care costs by $2.9 million, our general and administrative expenses by $1.4 million and our depreciation and amortization expense by $0.2 million. These capacity closures costs included net losses on assets retired, lease costs, asset impairments and accelerated depreciation and amortization.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to optimize our U.S. dialysis center footprint through center mergers and/or closures and expect our center closure rates to remain at elevated levels over the next several quarters.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Severance costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the fourth quarter of 2022, we committed to a plan to increase efficiencies and cost savings in certain general and administrative support functions. As a result of this plan, we recognized expenses related to termination and other benefit commitments in our U.S. dialysis business of $16.9 million and $17.0 million during first quarter of 2023 and the fourth quarter of 2022, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient care costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> U.S. dialysis patient care costs per treatment for the first quarter of 2023 decreased from the fourth quarter of 2022 primarily due to decreases in pharmaceutical costs, health benefit expenses, contract wages and insurance expense. These decreases were partially offset by increases in compensation expenses and fixed other direct operating expenses in our dialysis centers due to fewer number of treatments in the first quarter of 2023. In addition, our patient costs per treatment were negatively impacted by increases in center closure costs, as described above, and costs related to management meetings.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment for the three months ended March&#160;31, 2023 increased from the three months ended March&#160;31, 2022 primarily due to increased compensation expenses including increased wage rates and headcount. Other drivers of the increase include increases in other direct operating expenses associated with our dialysis centers as well as center closure costs, as described above, and travel costs, including management meetings. These increases were partially offset by decreased pharmaceutical costs, contract wages and health benefit expenses.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses in the first quarter of 2023 decreased from the fourth quarter of 2022 primarily due to decreased professional fees, a refund received related to 2022 advocacy costs, seasonal decreases in other costs, including IT costs and other purchased services as well as health benefit expenses. These decreases were partially offset by increased long-term incentive compensation expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses for the three months ended March&#160;31, 2023 increased from the three months ended March&#160;31, 2022 primarily due to increases in compensation expenses including increased wage rates and severance costs, as described above. Other drivers of this change include increased costs related to travel and management meetings, center closure costs, as described above, and higher IT-related costs. These increases were partially offset by a refund received related to 2022 advocacy costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis depreciation and amortization expenses for the quarter ended March&#160;31, 2023 decreased compared to the quarter ended December&#160;31, 2022 primarily due to less accelerated depreciation related to center closures, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis depreciation and amortization expenses for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 increased primarily due to accelerated depreciation related to expected center closures, as described above, as well as a full quarter of depreciation from the rollout of our new clinical system in May 2022, partially offset by operating fewer centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity investment income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income decreased for the first quarter of 2023 compared to the fourth quarter of 2022 due to a decline in profitability at certain nonconsolidated dialysis partnerships.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income remained relatively flat for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.970%"><tr><td style="width:1.0%"></td><td style="width:31.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.970%"><tr><td style="width:1.0%"></td><td style="width:31.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income for the first quarter of 2023 compared to the fourth quarter of 2023 and for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022, was impacted by center closure and severance costs, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income for the first quarter of 2023 increased from the fourth quarter of 2022 primarily due to decreased pharmaceutical costs, health benefit expenses, contract wages, professional fees, a refund received related to 2022 advocacy costs and seasonal decreases in other general administrative costs, as described above. Operating income and adjusted operating income were negatively impacted by decreased dialysis treatments, as described above. Other impacts include increased compensation expenses, costs related to management meetings and long-term incentive compensation expense.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income for the three months ended March&#160;31, 2023 decreased from the three months ended March&#160;31, 2022 primarily due to increases in compensation expenses and travel costs including management meetings as well as other direct operating expenses associated with our dialysis centers and IT-related costs. Operating income and adjusted operating income were positively impacted by increases in dialysis treatments and our average patient service revenue per treatment, as described above, as well as decreases in pharmaceutical costs, contract wages, and a refund received related to 2022 advocacy costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_97"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other&#8212;Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other operations include ancillary services that are primarily aligned with our core business of providing dialysis services to our network of patients. As of March&#160;31, 2023, these consisted principally of our U.S. IKC business, certain U.S. other ancillary businesses (including our clinical research programs, transplant software business, and venture investment group), and our international operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These ancillary services generated revenues of approximately $284 million in the first quarter of 2023, representing approximately 10% of our consolidated revenues. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, DaVita IKC provided integrated care and disease management services to approximately 67,000 patients in risk-based integrated care arrangements and to an additional 15,000 patients in other integrated care arrangements. We also expect to add additional service offerings to our business and pursue additional strategic initiatives in the future as circumstances warrant, which could include, among other things, healthcare services not related to dialysis.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the risks related to IKC and our ancillary services, see the discussion in the risk factors in Part I, Item 1A Risk Factors of our 2022 10-K under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The U.S. integrated kidney care, U.S. other ancillary services and international operations that we operate or invest in now or in the future..." </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "If we are not able to successfully implement our strategy with respect to our integrated kidney care and value-based care initiatives..."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, our international dialysis operations provided dialysis and administrative services through a total of 351 outpatient dialysis centers located in 11 countries outside of the United States. </span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services results of operations</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating (loss) income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services adjusted operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income (loss) and adjusted operating income for the three months ended March&#160;31, 2023 and December&#160;31, 2022 includes foreign currency losses embedded in equity method income recognized from our APAC JV of approximately $(0.7) million and $(5.0) million, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating (loss) income by reportable segment, see &#8220;Reconciliations of Non-GAAP measures&#8221; section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating (loss) income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. IKC</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. other ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services adjusted operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income and adjusted operating income for the three months ended March&#160;31, 2023 and March&#160;31, 2022 includes foreign currency (losses) gains embedded in equity method income recognized from our Asia Pacific joint venture (APAC JV) of approximately $(0.7) million and $0.3 million, respectively.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating (loss) income by reportable segment, see &#8220;Reconciliations of Non-GAAP measures&#8221; section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC revenues for the first quarter of 2023 decreased compared to the fourth quarter of 2022 due to a net decrease in shared savings, partially offset by an increase in revenues from our special needs plans. Other U.S. ancillary revenues for the first quarter of 2023 remained flat compared to the fourth quarter of 2022. International revenues for the first quarter of 2023 increased compared to the fourth quarter of 2022 due to a rate increase in one country and acquisition-related growth.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC revenues for the three months ended March&#160;31, 2023 increased compared to the three months ended March&#160;31, 2022 due to an increase in shared savings. Other U.S. ancillary services revenues for the three months ended March&#160;31, 2023 increased compared to the three months ended March&#160;31, 2022 due to increased revenues in our clinical research programs. Our international revenues for the three months ended March&#160;31, 2023 increased from the three months ended March&#160;31, 2022 due to acquisition-related growth as well as rate increases.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charges impacting operating income - severance and other costs</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2022, similar to U.S. dialysis, we committed to a plan to increase efficiencies and cost savings in certain general and administrative support functions and other overhead costs. As a result of this plan, we recognized expenses related to termination and other benefit commitments in our IKC business of $0.4 million and $0.5 million during the first quarter of 2023 and the fourth quarter of 2022, respectively. We recognized these expenses and other charges in our international operations of $7.5 million during the fourth quarter of 2022.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating loss and adjusted operating loss</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC operating loss and adjusted operating loss for the first quarter of 2023 compared to the fourth quarter of 2022 increased due to a net decrease in shared savings, partially offset by an increase in revenues from our special needs plans. Other U.S. ancillary services operating loss and adjusted operating loss for the first quarter of 2023 increased compared to the fourth quarter of 2022, driven by an increase in expenses related to our clinical research programs. International operating results and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjusted operating income for the first quarter of 2023 increased from the fourth quarter of 2022 primarily due to an acquisition-related expense recognized in fourth quarter 2022, as well as increases in equity income resulting from fluctuations in foreign currency at our APAC JV and increases in revenue, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC operating loss and adjusted operating loss for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 remained flat, primarily due to increased shared savings, offset by continued investments in our integrated care support functions. Other U.S. ancillary services operating loss and adjusted operating loss for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 remained flat. International operating income and adjusted operating income for the three months ended March&#160;31, 2023 increased compared to the three months ended March&#160;31, 2022 primarily driven by acquisition-related growth and revenue increases, as well as rate increases.</span></div><div id="ia1113957fba14778a95e5a7387238c82_100"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support expenses for the quarter ended March&#160;31, 2023 compared to the quarter ended December&#160;31, 2022 decreased primarily due to decreases in legal fees, partially offset by an increase in long-term incentive compensation. Corporate administrative support expenses for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 decreased primarily due to decreased legal fees.</span></div><div id="ia1113957fba14778a95e5a7387238c82_103"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate-level charges</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q1 2023 vs. Q4 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing<br/>&#160;operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;operations attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate attributable to DaVita Inc., see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate attributable to DaVita Inc., see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense for the first quarter of 2023 compared to the fourth quarter of 2022 was relatively flat primarily due to an increase in our weighted average effective interest rate, offset by a decrease in our weighted average outstanding credit facility balance. Debt expense for the three months ended March&#160;31, 2023 compared to the three months ended March&#160;31, 2022 increased due to an increase in our weighted average effective interest rate.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our overall weighted average effective interest rate for the three months ended March&#160;31, 2023 was 4.55% compared to 4.49% for the three months ended December&#160;31, 2022. See Note 6 to the condensed consolidated financial statements for further information on the components of our debt.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (loss), net</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income for the first quarter of 2023 compared to other loss for the fourth quarter of 2022, was primarily driven by a decrease in losses on investments. Other income for the three months ended March 31, 2023 compared to other loss for the three months ended March 31, 2022 was driven by an increase in interest income, partially offset by increased losses on investments.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effective income tax rate</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate and the effective income tax rate attributable to DaVita Inc. decreased for the first quarter of 2023 compared to the fourth quarter of 2022 primarily due to expenses recognized in the fourth quarter related to finalized tax returns, international tax accruals and higher non-deductible advocacy spend.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the three months ended March&#160;31, 2023 decreased compared to the three months ended March&#160;31, 2022 primarily due to an increase in the portion of our earnings attributable to non-controlling interests and a decrease in forecasted non-deductible advocacy spend in 2023, partially offset by a reduction in recognized tax benefits from stock-based compensation and tax credits. The effective income tax rate attributable to DaVita Inc. for the three months ended March&#160;31, 2023 increased from the three months ended March&#160;31, 2022 primarily due to a reduction in recognized tax benefits from stock-based compensation and tax credits, partially offset by a decrease in forecasted non-deductible advocacy spend in 2023.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net income attributable to noncontrolling interests for the first quarter of 2023 from the fourth quarter of 2022 was due to reduced earnings at certain U.S. dialysis partnerships. The increase in net income attributable to noncontrolling interests for the three months ended March&#160;31, 2023 from the three months ended March&#160;31, 2022 was due to increased profitability at certain U.S. dialysis partnerships.</span></div><div id="ia1113957fba14778a95e5a7387238c82_106"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated accounts receivable balances at March&#160;31, 2023 and December&#160;31, 2022 were $2.058 billion and $2.132 billion, respectively, representing approximately 65 and 68 days of revenue outstanding (DSO), respectively. Consolidated DSO decreased primarily due to release of billing holds and improved collections from certain payers. Our DSO calculation is based on the current quarter&#8217;s average revenues per day. There were no significant changes from the fourth quarter of 2022 to the first quarter of 2023 in the carrying amount of accounts receivable outstanding over one year old.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_109"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the summary of our major sources and uses of cash, cash equivalents and restricted cash:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q1 2023 vs. YTD Q1 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash items in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other working capital changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine maintenance/information technology/other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and relocations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt payments, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(342)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our free cash flow, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated cash flows</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated cash flows from operating activities during the three months ended March&#160;31, 2023 increased compared to the three months ended March&#160;31, 2022 primarily due to a decrease in total DSO, which decreased approximately three days for the three months ended March 31, 2023 compared to an increase of four days for the three months ended March 31, 2022 as well as by changes in other working capital items partially offset by an increase in interest payments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow during the three months ended March&#160;31, 2023 increased from the three months ended March&#160;31, 2022 primarily due to a increase in net cash provided by operating activities partially offset by an increase in capital expenditures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uses of cash during the period included net debt payments which consisted of the repayment of $165 million on our revolving line of credit and regularly scheduled and other principal payments under our senior secured credit facilities totaling approximately $54 million on Term Loan A and $36 million on Term Loan B-1, as well as additional required payments under other debt arrangements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By comparison, the same period in 2022 included draws on our revolving line of credit and subsequent repayment in full as of quarter end. Other net debt payments during the three months ended March 31, 2022 primarily consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $22 million on Term </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loan A and $7 million on Term Loan B-1, as well as additional required payments under other debt agreements. For the three months ended March&#160;31, 2022 we also used cash to repurchase 2,103,905 shares of our common stock.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis center footprint</span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the footprint of our dialysis operations by number of dialysis centers owned or operated:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:53.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired centers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed centers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in non-owned managed or administered centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sold and closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,809&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers which we manage or provide administrative services to but in which we own a noncontrolling equity interest or which are wholly-owned by third parties, including our APAC JV centers. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were sold and/or closed for which the majority of patients were not retained.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were closed for which the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available liquidity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had an undrawn $1.0 billion revolving line of credit under our senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were none as of March&#160;31, 2023. We separately had approximately $151 million in letters of credit outstanding under a separate bilateral secured letter of credit facility.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 to the condensed consolidated financial statements for components of our long-term debt and their interest rates, as well as Note 14 concerning amendments to our senior secured credit facilities entered into subsequent to March&#160;31, 2023. We may from time to time seek to obtain funds or refinance existing debt through additional debt financings or other capital alternatives.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and certain economic and marketplace conditions, including inflationary and labor pressures, have driven increased pressure on our cash flows. As of the date of this report, we have not experienced a material deterioration in our liquidity position as a result of COVID-19 or those global economic and market conditions. The ultimate impact of the pandemic and those economic and market conditions will depend on future developments that are highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our senior secured credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings, which are subject to general, economic, financial, competitive, regulatory and other factors that are beyond our control, as described in Item 1A Risk Factors of our 2022 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div id="ia1113957fba14778a95e5a7387238c82_112"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliations of Non-GAAP measures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide reconciliations of adjusted operating income (loss) to operating income (loss) as presented on a U.S. generally accepted accounting principles (GAAP) basis for our U.S. dialysis reportable segment as well as for our U.S. IKC business, our U.S. other ancillary services, our international business, and for our total ancillary services which combines them and is disclosed as our other segments category, in addition to our corporate administrative support. These non-GAAP or &#8220;adjusted&#8221; measures are presented because management believes these measures are useful adjuncts to, but not alternatives for, our GAAP results. Note that the non-GAAP measures presented for prior periods below have been conformed to the method or calculation of non-GAAP measures presented for the current period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, management uses adjusted operating income (loss) to compare and evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe this non-GAAP measure is also useful to investors and analysts in evaluating our performance over time and relative to competitors, as well as in analyzing the underlying trends in our business. We also believe this presentation enhances a user's understanding of our normal operating income by excluding certain items which we do not believe are indicative of our ordinary results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our effective income tax rate on income attributable to DaVita Inc. excludes noncontrolling owners' income, which primarily relates to non-tax paying entities. We believe this adjusted effective income tax rate is useful to management, investors and analysts in evaluating our performance and establishing expectations for income taxes incurred on our ordinary results attributable to DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, our free cash flow represents net cash provided by operating activities less distributions to noncontrolling interests and all capital expenditures (including development capital expenditures, routine maintenance and information technology), plus contributions from noncontrolling interests and proceeds from the sale of self-developed properties. Management uses this measure to assess our ability to fund acquisitions and meet our debt service obligations and we believe this measure is equally useful to investors and analysts as an adjunct to cash flows from operating activities and other measures under GAAP.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important to bear in mind that these non-GAAP &#8220;adjusted&#8221; measures are not measures of financial performance under GAAP and should not be considered in isolation from, nor as substitutes for, their most comparable GAAP measures.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended December 31, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:68.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, <br/>2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling owners' income primarily attributable to non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Income tax attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate on income from continuing operations attributable to<br/>&#160;DaVita Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net cash provided by operating activities to free cash flow:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for routine maintenance and information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for development and relocations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div id="ia1113957fba14778a95e5a7387238c82_115"></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-balance sheet arrangements and aggregate contractual obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt obligations and operating lease liabilities reflected on our balance sheet, we have commitments associated with letters of credit, as well as certain working capital funding obligations associated with our equity investments in nonconsolidated dialysis ventures that we manage and some that we manage which are wholly-owned by third parties. For additional information see Note 7 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities. These obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods as outlined in each specific put provision. For additional information on these obligations and how we measure and report them, see Note 11 to the condensed consolidated financial statements included in this report and Notes 17 and 24 to the consolidated financial statements included in our 2022 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on the maturities and other terms of our long term debt, see Note 6 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have outstanding letters of credit in the aggregate amount of approximately $151 million under a bilateral secured letter of credit facility separate from our senior secured credit facilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we have outstanding purchase agreements with various suppliers to purchase set amounts of dialysis equipment, parts, pharmaceuticals, and supplies. If we fail to meet the minimum purchase commitments under these contracts during any year, we are required to pay the difference to the supplier, as described further in Note 17 to the Company's consolidated financial statements included in the 2022 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, on May 25, 2022, we entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (Mozarc Medical). The transaction closed effective April 1, 2023. For additional information see Note 14.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_118"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of new accounting standards in Note 13 to the condensed consolidated financial statements.</span></div><div id="ia1113957fba14778a95e5a7387238c82_121"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></div><div id="ia1113957fba14778a95e5a7387238c82_124"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate and foreign currency sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no material change in the nature of the Company's interest rate risks or foreign currency exchange risks from those described in Part II Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide information about our financial instruments that are sensitive to changes in interest rates as of March&#160;31, 2023. For further information on the components of the Company's long-term debt and their interest rates, see Note 6 to the condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q at Part I Item 1. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.133%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expected maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average interest rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents the fair value of the Company&#8217;s long-term debt excluding financing leases. See Note 6 to the condensed consolidated financial statements for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled principal payments for all debt that bears a variable rate by its terms, including all of Term Loan B-1 and Term Loan A, have been included on the variable rate line of the schedule of expected maturities above. Additionally, the principal amounts of Term Loan B-1 and Term Loan A have been included in the calculation of the average variable interest rate presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, principal amounts of $2,624 million for Term Loan B-1 and $876 million of Term Loan A (the capped debt) are subject to LIBOR caps of 2.00% through June&#160;30, 2024. As of March&#160;31, 2023, applicable LIBOR rates were above this 2.00%, making the interest rates on this capped debt &#8220;economically fixed", unless or until applicable LIBOR rates were to fall back below 2.00% during the remaining term of the caps. As a result, as of March&#160;31, 2023, total fixed and economically fixed debt was $8,089 million, with an average interest rate of 4.28%, while total variable rate debt not subject to caps was $612 million with an average rate of 7.74%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 for further details on the Company&#8217;s interest rate cap agreements.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.204%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contract maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Receive variable</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR&#160;above 2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Company amended its senior secured credit facilities and entered into several forward interest rate cap agreements that become effective beginning June 28, 2024. For additional information see Note 14.</span></div><div id="ia1113957fba14778a95e5a7387238c82_127"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934 (Exchange Act) as amended is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms, and that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer (CEO) and Chief Financial Officer (CFO) as appropriate to allow for timely decisions regarding required disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of the Company&#8217;s CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures in accordance with the Exchange Act requirements as of March&#160;31, 2023. Based upon that evaluation, the CEO and CFO concluded that the Company&#8217;s disclosure controls and procedures were effective as required by the Exchange Act as of such date for our Exchange Act reports, including this report. Management recognizes that these controls and procedures can </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the Company's internal control over financial reporting that was identified during the evaluation that occurred during the fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_130"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="ia1113957fba14778a95e5a7387238c82_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Part II, Item 1 is incorporated herein by reference to the information set forth under the caption &#8220;Commitments and contingencies&#8221; in Note 7 to the condensed consolidated financial statements included in this report. </span></div><div id="ia1113957fba14778a95e5a7387238c82_136"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K (2022 10-K) for the year ended December 31, 2022 filed with Securities and Exchange Commission. You should carefully consider the risks included in our 2022 10-K, together with all the other information in this Quarterly Report on Form 10-Q, including the forward-looking statements in Part I, Item 2 of this Quarterly Report on Form 10-Q under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div id="ia1113957fba14778a95e5a7387238c82_139"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any shares from January 1, 2023 through March&#160;31, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May&#160;8, 2023, we had approximately $1.596 billion available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, we remain subject to share repurchase limitations including under our current senior secured credit facilities. </span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items 3, 4 and 5 are not applicable</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_142"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-formssarawardagreeme.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Appreciation Rights Agreement (DaVita Inc. 2020 Incentive Award Plan).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-formpsuawardagreemen.htm">10.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Performance-Based Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103-formrsuawardagreemen.htm">10.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Restricted Stock Unit Agreement (DaVita Inc. 2020 Incentive Award Plan).</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104-secondamendmenttocre.htm">10.4</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment, dated as of April 3, 2023, to that certain Credit Agreement, dated as of August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/927066/000092706623000096/ex101-thirdamendmenttocred.htm">10.5</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amendment, dated as of April 28, 2023, to that certain Credit Agreement, dated as of August 12, 2019, by and among DaVita Inc., certain subsidiary guarantors party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.(1)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33123ex31110xq.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated May&#160;8, 2023, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33123ex31210xq.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated May&#160;8, 2023, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33123ex32110xq.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated May&#160;8, 2023, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-33123ex32210xq.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated May&#160;8, 2023, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation, Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed or furnished herewith.</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:2.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed on May 1, 2023 as an exhibit to the Company's Current Report on Form 8-K.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ia1113957fba14778a95e5a7387238c82_145"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:56.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVITA INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN D. WINSTEL</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John D. Winstel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Accounting Officer*</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May&#160;8, 2023</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr.&#160;Winstel has signed both on behalf of the Registrant as a duly authorized officer and as the Registrant&#8217;s principal accounting officer.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-formssarawardagreeme.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i291b9f658b094bd996cb0ed19fd07ff4_1"></div><div style="min-height:67.68pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-top:3.95pt;padding-left:203.35pt;padding-right:203.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:121.27pt;padding-right:121.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Stock Appreciation Rights Agreement under the DaVita Inc. 2020 Incentive Award Plan</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:24.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Stock Appreciation Rights Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(this &#8220;Agreement&#8221;) is dated as of the Grant Date indicated below by and between DaVita Inc., a Delaware corporation (the &#8220;Company&#8221;), and the Grantee indicated below pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DaVita Inc. 2020 Incentive Award Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Plan&#8221;).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.762%"><div style="margin-top:4.6pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Primary Terms</font></div><div style="margin-top:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;Grantee&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Address&#58; </font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Address_1&#187;<br>&#171;City&#187;, &#171;State&#187; &#171;Zip&#187;<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Grant Date&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Base Shares&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;SSAR_Award&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Base Price per Share&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$&#171;Base_Price&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;SSAR_Vesting_1&#187;<br>&#171;SSAR_Vesting_2&#187;<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Expiration_Date&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020 Incentive Award Plan</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan ID#&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;2020&#93;</font></td></tr></table></div></div><div style="display:inline-block;max-width:0.475%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.763%"></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement includes this cover page and the following Exhibits, which are expressly incorporated by reference in their entirety herein&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; General Terms and Conditions</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Events Causing Full Vesting of Awards</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:20.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee hereby expressly acknowledges and agrees that he&#47;she&#47;they is an employee at will and may be terminated by the Company or its applicable Affiliate at any time, with or without cause. By accepting this Award, Grantee hereby acknowledges he&#47;she&#47;they has a copy of the Plan, and accepts and agrees to the terms and provisions of this Agreement and the Plan. Capitalized terms that are used but not defined in this Agreement shall have the meanings set forth in the Plan.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:28.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF, the Company and the Grantee have accepted this Agreement effective as of the Grant Date.</font></div><div style="margin-bottom:0.05pt;margin-top:0.5pt"><font><br></font></div><div style="padding-left:11.15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.634%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">DaVita Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 6.3pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">Grantee*</font></td></tr></table></div><div style="padding-left:20.55pt"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%"> </font><img alt="image_2a.jpg" src="image_2a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:15.4pt;padding-right:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:134%">*If permitted by the Company, this Agreement may be accepted electronically by the Grantee pursuant to the Company&#8217;s third-party stock plan administrator&#8217;s procedures.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i291b9f658b094bd996cb0ed19fd07ff4_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:203.25pt;padding-right:203.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:145.72pt;padding-right:145.72pt;text-align:center;text-indent:-0.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%">Stock Appreciation Rights Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%"> &#8211; General Terms and Conditions</font></div><div style="margin-top:8.2pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For valuable consideration, the receipt of which is acknowledged, the parties hereto agree as follows&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Grant of Stock Appreciation Rights Award</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company hereby grants to Grantee an award of stock appreciation rights (&#8220;Award&#8221;) covering the number of Base Shares of Common Stock indicated on the front page, pursuant to which the Grantee shall be eligible to receive a number of shares (&#8220;Gain Shares&#8221;) of Common Stock with an aggregate value equal to (1) the number of Base Shares indicated on the front page, times (2) the difference between the Fair Market Value of one share of Common Stock on the last trading day prior to exercise of the Stock Appreciation Rights and the Base Price specified on the front page, subject to Grantee&#8217;s fulfillment of the vesting and other conditions set forth in this Agreement.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Term of Stock Appreciation Rights Award</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:16.1pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt">This Award shall be effective for the period (&#8220;Term&#8221;) from the Grant Date shown above through the Expiration Date specified on the front page.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:16.1pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt">In the case of the termination of Grantee's employment with the Company or any of its subsidiaries or affiliates for any reason, whether voluntary or involuntary (&#8220;Severance&#8221;), the date upon which the Award shall terminate shall be determined based on the following&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:82pt;padding-right:16.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.63pt">If Grantee dies while employed by the Company or during the three (3) month period immediately subsequent to his&#47;her&#47;their Severance, the Award shall terminate one (1) year from the date of the Severance.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:82pt;padding-right:15.8pt;text-align:justify;text-indent:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.83pt">If Grantee was disabled (as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto) at the time of his&#47;her&#47;their Severance, the Award shall terminate one (1) year following the Severance.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:82pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.53pt">If the Grantee satisfies the requirements for Rule of 65 vesting (as described in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto) at the time of his&#47;her&#47;their Severance and such Severance is not for Cause (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto), the Award shall terminate on the Expiration Date.</font></div><div><font><br></font></div><div style="padding-left:82pt;padding-right:16.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.13pt">In all other cases, the Award shall terminate three (3) months following the Severance.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:82pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.18pt">Notwithstanding the foregoing, the Award shall terminate no later than the Expiration Date, regardless of whether or not Grantee remains in the employ of the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16.2pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt">If Grantee is transferred between the Company and an Affiliate thereof, or vice versa, or between Affiliates, Severance shall not be deemed to have occurred.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Exercisability</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.95pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.45pt">The Base Shares subject to this Award shall become exercisable (&#8220;vest&#8221;) on the dates indicated under the Vesting Schedule indicated on the front page such that this Award shall be fully exercisable on the last date listed on the table on the front page&#59; provided, however, that such vesting shall cease at the</font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">time of Grantee's Severance&#59; provided, further, that, if the Grantee is an &#8220;officer&#8221; under Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), at the time of death or Severance, then</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) the Award shall continue to vest on the dates indicated in the Vesting Schedule if the Grantee satisfies the requirements of Rule of 65 vesting (as set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) at the time of his&#47;her&#47;their Severance and his&#47;her&#47;their Severance is other than for Cause or (ii) the entire Award shall vest immediately upon the Grantee&#8217;s Severance due to death or disability (as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto). The specific provisions regarding circumstances in which vesting would occur upon death, disability or Rule of 65 are set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.75pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.83pt">These installments shall be cumulative, so that this Award may be exercised as to any or all of the Base Shares covered by an installment at any time or times after the installment becomes vested and until this Award terminates.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.45pt">Notwithstanding the foregoing, in the event of a Change of Control, the entire Award may vest immediately in accordance with the terms of the Plan. The specific provisions regarding circumstances in which full vesting would occur upon or following a Change in Control under this Agreement are set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:16.05pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.83pt">Except as otherwise provided for herein, Grantee's Severance shall not accelerate the number of Base Shares with respect to which an Award may be exercised.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Method of Exercising</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Award may be exercised by Grantee upon delivery of the following documents to the Company at its principal executive offices, or as otherwise required in accordance with a broker-assisted cashless exercise program&#58;</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:16.2pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.45pt">Written notice, in the form of a completed exercise election form, specifying the number of Base Shares with respect to which the Award is being exercised&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:75.3pt;text-align:justify;text-indent:-29pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.18pt">Such agreements or undertakings that are required by the Committee pursuant to the Plan&#59;</font></div><div style="margin-top:0.1pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:16.05pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.45pt">Provision for the payment of any taxes (including withholding taxes), which may be required by the Company, as described in Section 5.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:23.8pt;text-align:justify;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Taxes</font></div><div style="margin-top:5.7pt;padding-left:10.1pt;padding-right:15.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.7pt">Grantee is ultimately liable and responsible for all taxes under all applicable federal, state, local or other laws or regulations (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Tax Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) owed in connection with the Award, regardless of any action the Company or any of its Affiliates takes with respect to any tax withholding obligations that arise in connection with the Award. Neither the Company nor any of its Affiliates makes any representation or undertaking regarding the treatment of any tax withholding in connection with the grant, vesting or exercise of the Award or the subsequent sale of the Gain Shares issuable pursuant to the Award. The Company and its Affiliates do not commit and are under no obligation to structure the Award to reduce or eliminate Grantee&#8217;s tax liability.</font></div><div><font><br></font></div><div style="margin-top:9.15pt;padding-left:10.1pt;padding-right:15.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.08pt">As a condition precedent to the delivery to the Grantee of any Gain Shares upon exercise of the Award, the Grantee shall satisfy the Required Tax Payments by the Company withholding from the Gain Shares otherwise to be delivered to the Grantee pursuant to the Award a whole number of Shares having a Fair Market Value, determined as of the date the obligation to withhold or pay taxes first arises in connection with the Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), equal to the Required Tax Payments, with the number of Shares withheld rounded up to the nearest whole Share to satisfy the Required Tax Payments. Notwithstanding the foregoing, the Company (or, in the case of a Grantee subject to Section 16 of the Exchange Act, the Committee) may, in its sole discretion, establish alternative methods for the Grantee to satisfy the Required Tax Payments, which may include, without limitation, a cash payment, proceeds from the sale of the Gain Shares otherwise issuable to Grantee, or delivery (either actual delivery or by attestation procedures established by the Company) to the Company of previously owned whole Shares, in each case, having an aggregate value, determined as of the Tax Date, equal to the amount necessary to satisfy the Required Tax Payments.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-top:10.4pt;padding-left:46pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:9.8pt;text-decoration:underline">Settlement of Award</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon exercise of the Award, in whole or in part, the Company shall&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt">provide for the registration in book-entry form for Grantee&#8217;s benefit of the Gain Shares (rounded down to the nearest whole number, and which may be reduced by any Gain Shares required to be withheld or sold on behalf of Grantee to satisfy tax withholding requirements)&#59; or</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt">deliver to Grantee a stock certificate representing the Gain Shares (rounded down to the nearest whole number, and which may be reduced by any Gain Shares required to be withheld or sold on behalf of Grantee to satisfy tax withholding requirements).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Clawback Provision</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provision in this Agreement to the contrary, Grantee shall be subject to the Company&#8217;s Compensation Clawback Policy or other clawback policy adopted by the Company, each as may be amended from time to time (the &#8220;Clawback Policy&#8221;). The provisions of this Section 7 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Assignments</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.45pt">Subject to Section 8(b) below, this Award shall be exercisable only by Grantee during Grantee's lifetime. In the event of Grantee&#8217;s death while still employed by the Company or during the three</font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.18pt">month period immediately subsequent to his&#47;her&#47;their Severance, this Award may be exercised by any of Grantee&#8217;s executor, heirs or administrator to whom this Award may have been assigned or transferred.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.83pt">The rights of Grantee under this Award may not be assigned or transferred except by will or by the laws of descent and distribution.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.35pt;text-indent:-13.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">No Rights as a Stockholder</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.05pt;text-indent:33.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee shall have no rights as a stockholder of any Base Shares or Gain Shares unless and until the Gain Shares are issued to Grantee upon the exercise of the Award.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:51.9pt;text-indent:-19.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Interpretation of Award</font></div><div style="padding-left:51.9pt;text-align:right"><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:16.1pt;text-align:justify;text-indent:39.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.7pt">This Award is granted under the provisions of the Plan and shall be interpreted in a manner consistent with it.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:74.5pt;text-align:justify;text-indent:-25.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.63pt">Any provision in this Award inconsistent with the Plan shall be superseded and governed by</font></div><div style="margin-top:0.1pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:39.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.7pt">For all purposes under this Award, employment by the Company shall include employment by the Company or any Affiliate thereof.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:36.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.83pt">This Award shall be subject to the terms of any written employment agreement between the Grantee and the Company or any Affiliate thereof to the extent permissible under the Plan.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:51.9pt;text-indent:-19.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Restrictions on Transfer of Shares</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee acknowledges that any Gain Shares issued upon exercise of this Award may be subject to such transfer restrictions that prohibit any transfer, pledge, sale or disposition of the Gain Shares as the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:16pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company may deem necessary to comply with all applicable state and federal securities laws and regulations.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:49.1pt;text-indent:-16.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:2.85pt;text-decoration:underline">Amendments</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company may amend the provisions of this Agreement at any time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, an amendment that would adversely affect the Grantee&#8217;s rights under this Agreement in a material manner shall be subject to the written consent of the Grantee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:51.9pt;text-indent:-19.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.65pt;text-decoration:underline">&#91;Non-Competition&#47;&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;text-decoration:underline;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Non-Solicitation&#47;Non-Disclosure</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee acknowledges and recognizes the highly competitive nature of the business of the Company and the unique access to the Company&#8217;s confidential business, personnel, and customer and patient information, including trade secret information, that Grantee receives solely as a result of Grantee&#8217;s employment with the Company, and  accordingly  agrees  that  while  Grantee  is  an  Employee, and  for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;NonCompete_Term&#187; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following termination of such relationship for any reason (whether voluntary or involuntary) (the &#8220;Restricted Period&#8221;), Grantee shall not, as an employee, independent contractor, consultant, or in any other capacity, prepare to provide or provide any of the same or similar services that Grantee performed during his&#47;her&#47;their employment with or service to the Company for any other individual, partnership, limited liability company, corporation, independent practice association, management services organization, or any other entity (collectively, &#8220;Person&#8221;) anywhere in the Restricted Territory that competes in any way with the area of business of the Company, or any of its subsidiaries or affiliates, in which Grantee worked and&#47;or performed services during the last five years of Grantee&#8217;s employment with the Company. For purposes of the above, preparing to provide any of the same or similar services includes, but is not limited to, planning with any Person on how best to compete with the Company or any of its subsidiaries or affiliates, or discussing the Company&#8217;s, or any    of    its    subsidiaries&#8217;     or    affiliates&#8217;     business    plans     or    strategies     with     any   Person.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee further agrees that during the Restricted Period, Grantee shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise engage in, act for, or act on behalf of any Person (other than the Company and its subsidiaries and affiliates) engaged in any activity that Grantee was responsible for during the last five years of Grantee&#8217;s employment with or engagement by the Company in the Restricted Territory where such activity is competitive with the    activities    carried    on    by    the    Company    or    any    of    its    subsidiaries    or    affiliates.</font></div><div><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee acknowledges that during the Restricted Period, Grantee may be exposed to confidential information and&#47;or trade secrets relating to business areas of the Company or any of its subsidiaries or affiliates that are different from and in addition to the areas in which Grantee primarily works for the Company (the &#8220;Additional Protected Areas of Business&#8221;). As a result, Grantee agrees he&#47;she&#47;they shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise act for, act on behalf, or provide the same or similar services to, any Person that engages in the Additional Protected Areas of Business.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, nothing in this Section 13(a) prohibits Grantee from passively owning not in excess of 2% in the aggregate of any company&#8217;s stock or other ownership interests that are publicly traded&#160;&#160;&#160;&#160;on&#160;&#160;&#160;&#160;any&#160;&#160;&#160;&#160;national&#160;&#160;&#160;&#160;or&#160;&#160;&#160;&#160;regional&#160;&#160;&#160;&#160;stock&#160;&#160;&#160;&#160;exchange.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Section 13(a), &#8220;Restricted Territory&#8221; means the territory or territories or other geographic areas in which the Company does business and as to which Grantee provided services or had a material presence or influence, and&#47;or about which Grantee learned confidential information and&#47;or trade secrets. Grantee acknowledges and agrees that, given Grantee&#8217;s role at the Company, the geographical limitations and duration of this covenant not to compete are reasonable and appropriate, it being understood that the business of the Company can be, and is, practiced throughout the United States, and that the restrictions set forth herein will not impose any undue hardship on Grantee.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To be included based on teammate jurisdiction and status.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the provisions of this Section 13(a) conflict with any other agreement signed by Grantee relating to non-competition, the provisions that are most protective of the Company&#8217;s, and any of its subsidiaries&#8217; or affiliates&#8217;, interests shall govern.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Section 13(a) (Non-competition) and the rights and obligations of Company hereunder may be assigned by Company and shall inure to the benefit of and shall be enforceable by any such assignee, as well as any of Company&#8217;s successors in interest. This Section 13(a) (Non-competition) and the rights and obligations of Grantee hereunder may not be assigned by Grantee, but are binding upon Grantee's heirs, administrators, executors, and personal representatives.&#93;</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Solicitation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Grantee agrees that during the term of his&#47;her&#47;their employment and&#47;or service to the Company or any of its subsidiaries or affiliates and for the one-year period following the termination of his&#47;her&#47;their employment and&#47;or service for any reason (whether voluntary or involuntary), Grantee shall not (i) solicit any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work for any Person&#59; (ii) hire any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work (as an employee or an independent contractor) for any Person&#59; or (iii) take any action that may reasonably result in any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company going to work (as an employee or an independent contractor) for any Person.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Disclosure.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In addition, Grantee agrees not to disclose or use for his&#47;her&#47;their own benefit or purposes or for the benefit or purposes of any Person other than the Company and any of its subsidiaries or affiliates, any trade secrets, information, data, or other confidential information relating to customers, development, programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, financing methods, plans, or the business and affairs of the Company or any of its subsidiaries or affiliates (&#8220;Information&#8221;)&#59; provided, however, the foregoing shall not apply to (i) Information which is not unique to the Company or any of its subsidiaries or affiliates&#59; (ii) Information which is generally known to the industry or the public other than as a result of Grantee&#8217;s breach of this covenant&#59; or (iii) disclosure that is required by any applicable law, rule or regulation. If Grantee receives such a request to produce Information in his&#47;her&#47;their possession, Grantee shall provide the Company reasonable advance notice, in writing, prior to producing said Information, so as to give the Company reasonable time to object to Grantee producing said Information. Grantee also agrees that Grantee will not become employed by or enter into service with any Person other than the Company and any of its subsidiaries or affiliates in which Grantee will be obligated to disclose or use any Information, or where such disclosure would be inevitable because of the nature of the position. Grantee shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (1) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (2) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Disclosures to attorneys, made under seal, or pursuant to court order are also protected in certain circumstances under 18 U.S.C. &#167; 1833.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing contained in this Agreement prohibits or limits Grantee&#8217;s ability to file a charge or complaint with any federal, state or local governmental agency or commission, including but not limited to the U.S. Securities and Exchange Commission.  This Agreement also does not prohibit or limit Grantee&#8217;s ability to communicate with any federal, state or local governmental agency or commission (including but not limited to the U.S. Securities and Exchange Commission), or to otherwise participate in any investigation or proceeding that may be conducted by such an agency or commission (including but not limited to the U.S. Securities and Exchange Commission), including providing documents or other information. Moreover, nothing in this agreement prevents Grantee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Grantee has reason to believe is unlawful.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee agrees that any breach of Section &#91;13(a),&#93; 13(b), or 13(c) will result in immediate and irreparable harm to the Company and its affiliates for which damages alone are an inadequate remedy and cannot readily be calculated. Accordingly, the Grantee agrees that the Company and its affiliates shall be entitled to temporary, preliminary and permanent injunctive relief to prevent any </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">such actual or threatened breach, without posting a bond or other security or limiting other available remedies.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> This Agreement and the Award shall terminate effective on the date on which Grantee enters into any activity in breach of Section &#91;13(a),&#93; 13(b), or 13(c). This Agreement and the Award shall also terminate if at any time during Grantee&#8217;s employment with the Company or any of its subsidiaries or affiliates or within one (1) year after the termination of such employment for any reason (whether voluntary or involuntary), Grantee (i) is convicted of a felony&#59; (ii) has been adjudicated by a court of competent jurisdiction of having committed an act of fraud or dishonesty resulting or intending to result directly or indirectly in personal enrichment at the expense of the Company or any of its subsidiaries or affiliates&#59; or (iii) is excluded from participating in any federal health care program. In any of the aforementioned cases, in addition to injunctive relief as forth above, the Company may seek an order requiring Grantee to repay the Company any value, gain or other consideration received or realized by Grantee as a result of this Award or any Shares received pursuant to the Award. The provisions of this Section 13(f) are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.  Notwithstanding the foregoing and any other language in this Agreement, for the avoidance of doubt, this Section 13(f) does not supersede or preclude the application or enforceability of Section 7 or the Clawback Policy.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Grantee acknowledges and agrees that Grantee has carefully read and fully understands all of the provisions of this Section 13 and that Grantee has been advised to and&#47;or has obtained representation by counsel in connection with Grantee&#8217;s execution of this Agreement.</font></div><div style="margin-top:9.95pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Plan or this Agreement to the contrary, this Section 13 shall be construed and regulated under and by the laws of the state where Grantee resides. The parties agree that any and all actions or proceedings to enforce Section 13 shall be brought in the state or federal court where Grantee resides.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:51.9pt;text-indent:-19.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Compliance with Policies.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.65pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is understood and agreed upon that at all times Grantee will act in full compliance with the Company&#8217;s policies and procedures as may be in effect from time to time, including without limitation, the Company&#8217;s Code of Conduct, Joint Venture Arrangements Policy, Medical Director Agreements Compliance Handbook, Acceptance of Gifts Policy and&#47;or credentialing process (collectively, the &#8220;Policies&#8221;). If Grantee&#8217;s conduct, whether related to the Award granted under this Agreement or otherwise, materially violates the requirements of the Policies, as determined by the Committee (with respect to a Grantee that is an &#8220;officer&#8221; under Section 16 of the Exchange Act) or the Company&#8217;s Chief Executive Officer, Chief Compliance Officer or Chief Legal Officer (with respect to a Grantee that is not an &#8220;officer&#8221; under Section 16 of the Exchange Act), then the Company may require Grantee to forfeit any unvested portion of the Award granted under this Agreement and be subject to immediate disciplinary action, up to and including termination. The provisions of this Section 14 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies or any laws or regulations. If at any time Grantee has questions or concerns about the provisions in this Section 14, or suspects any improper conduct related to the Policies, Grantee should immediately contact his&#47;her&#47;their supervisor or Team Quest. Grantee also may anonymously and confidentially call the Company&#8217;s Compliance Hotline.</font></div><div><font><br></font></div><div style="margin-top:10.45pt;padding-left:51.9pt;text-indent:-19.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.6pt;text-decoration:underline">Compliance with Law</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Shares shall be issued and delivered for a Gain Share unless and until all applicable registration requirements of the Securities Act of 1933, as amended, all applicable listing requirements of any national securities exchange on which the Common Stock is then listed, and all other requirements of law or of any regulatory bodies having jurisdiction over such issuance and delivery, shall have been complied with. In particular, the Committee may require certain investment (or other) representations and undertakings in connection with the issuance of securities in connection with the Plan and this Award in order to comply with applicable law.</font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Agreement is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. Furthermore, if any provision of this Agreement is determined to be illegal under any applicable law, such provision shall be null and void to the extent necessary to comply with applicable law, but the other provisions of this Agreement shall remain in full force and effect.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:22.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:25.7pt;text-decoration:underline">Electronic Delivery and Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee will not be able to initiate any stock transactions related to this Award until Grantee has accepted the terms of this Agreement. The Company may, in its sole discretion, decide to deliver any documents related to this Award or future awards made under the Plan by electronic means or request Grantee&#8217;s consent to participate in the Plan by electronic means. Grantee hereby consents to receive such documents by electronic delivery and, if requested, agrees to participate in the Plan through any online or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i291b9f658b094bd996cb0ed19fd07ff4_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:108.4pt;padding-right:108.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:132.35pt;padding-right:132.35pt;text-align:center;text-indent:27.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%">Stock Appreciation Rights Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%"> &#8211; Events Causing Full Vesting Awards</font></div><div style="margin-top:2.2pt;padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Exhibit, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean&#58; (i) a material breach by Grantee of his&#47;her&#47;their duties and responsibilities which do not differ in any material respect from the duties and responsibilities of Grantee during the ninety (90) days immediately prior to a Change of Control (other than as a result of incapacity due to physical or mental illness) which is demonstrably willful and deliberate on Grantee&#8217;s part, which is committed in bad faith or without reasonable belief that such breach is in the best interests of the Company and which is not remedied in a reasonable period of time after receipt of written notice from the Company specifying such breach&#59; (ii) willful misconduct or gross negligence which results in material harm to the Company&#59; (iii) the conviction of Grantee of, or a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">by Grantee to, a felony or other crime involving fraud or dishonesty&#59; or (iv) willful violation of Company policies which results in material harm to the Company.</font></div><div style="margin-top:10.1pt;padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control Vesting</font></div><div style="margin-top:10pt;padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a Change of Control, this Award shall automatically vest in its entirety upon the earlier of the following two events&#58; (i) immediately prior to the effective date of a Change of Control if the successor in such Change of Control (the &#8220;Acquiror&#8221;) fails to effectively assume, convert or replace this Award, or</font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) if the Award is effectively assumed in a Change of Control, as of the date of termination of Grantee&#8217;s employment if such termination occurs within twenty-four (24) months following such Change of Control by the Company (or the Acquiror) (a) other than for &#8220;Cause&#8221; (defined above) or (b) if applicable, by Grantee in accordance with the termination for &#8220;Good Reason&#8221; provisions of Grantee&#8217;s employment agreement, if any.</font></div><div><font><br></font></div><div style="margin-top:8.75pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be effectively assumed in the Change of Control, the award received in exchange for the Award in connection with a Change of Control&#58; (i) must be of the same type as the Award&#59; (ii) must have a value intended to preserve the value of the Award&#59; (iii) must relate to publicly traded equity securities of the Company (or the Acquiror or another entity that is affiliated with the Company or the Acquiror)&#59; and (iv) must have other terms and conditions that are not less favorable to the Grantee than the terms and conditions of the Award (including the provisions that would apply in the event of a subsequent Change of Control). Without limiting the generality of the foregoing, the replaced Award may take the form of a continuation of the Award if the requirements of the preceding sentence are satisfied. The determination of whether the conditions for effectively assuming the Award have been satisfied shall be made by the Board, as constituted immediately before the Change of Control, in its sole discretion.</font></div><div><font><br></font></div><div style="margin-top:10.2pt;padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule of 65 Vesting</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that (i) the Grantee has remained continuously employed with the Company for at least one year from the Grant Date, (ii) the Grantee has satisfied the Rule of 65 (as defined below) at the time of his&#47;her&#47;their termination of employment and such termination of employment is not for Cause, and (iii) the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such termination of employment, then the Award shall vest and become exercisable in accordance with its normal vesting schedule set forth on the cover page of the Agreement&#59; provided, however, that if following the Grantee&#8217;s termination of employment under this paragraph, there is a Change of Control and the Award is not effectively assumed, converted or replaced, then the Award shall vest and become exercisable upon such Change of Control. If the Grantee satisfies the requirements of the preceding sentence but the Grantee&#8217;s termination of employment occurs prior to the first anniversary of the Grant Date, then the portion of the Award eligible</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i291b9f658b094bd996cb0ed19fd07ff4_13"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:20.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">for vesting shall be prorated based on the number of full months from the Grant Date to the Grantee&#8217;s termination of employment divided by 12.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:20.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Rule of 65&#8221; shall mean that the sum of the Grantee&#8217;s age and years of service equals or exceeds 65, with a minimum age of 55 and a minimum of five years of continuous service.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Death or Disability</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of the Grantee&#8217;s death or Disability while employed by the Company and the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such death or Disability, the Award shall vest and become exercisable upon such death or Disability.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Disability&#8221; shall mean that the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months.</font></div><div style="margin-top:3.95pt;padding-left:216.8pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102-formpsuawardagreemen.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib0511faccdcf4520ae290885ecdff83b_1"></div><div style="min-height:67.68pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.2</font></div><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:203.35pt;padding-right:203.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:97.2pt;padding-right:97.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance-Based Restricted Stock Unit Agreement under the DaVita Inc. 2020 Incentive Award Plan</font></div><div style="margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:10pt;padding-right:17.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance-Based Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(this &#8220;Agreement&#8221;) is dated as of the Grant Date indicated below by and between DaVita Inc., a Delaware corporation (the &#8220;Company&#8221;), and the Grantee indicated below pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DaVita Inc. 2020 Incentive Award Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Plan&#8221;).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.762%"><div style="margin-top:4.6pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Primary Terms</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;Grantee&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Address&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Address_1&#187;<br>&#171;City&#187;, &#171;State&#187; &#171;Zip&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Grant Date&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance Conditions&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As indicated on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance Period&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As indicated on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Conditions&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As indicated on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Vesting_Date&#187;  </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Target Number of Units&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;PSU_Award&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020 Incentive Award Plan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan ID#&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;2020&#93;</font></td></tr></table></div></div><div style="display:inline-block;max-width:0.475%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.763%"></div></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement includes this cover page and the following Exhibits, which are expressly incorporated by reference in their entirety herein&#58;</font></div><div><font><br></font></div><div style="padding-left:46pt;padding-right:230.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; General Terms and Conditions </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; Performance and Vesting Conditions</font></div><div style="margin-top:0.05pt;padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8211; Calculation of Relative Total Shareholder Return</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:20.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee hereby expressly acknowledges and agrees that he&#47;she&#47;they is an employee at will and may be terminated by the Company or its applicable Affiliate at any time, with or without cause. By accepting this Award, Grantee hereby acknowledges he&#47;she&#47;they has a copy of the Plan, and accepts and agrees to the terms and provisions of this Agreement and the Plan. Capitalized terms that are used but not defined in this Agreement shall have the meanings set forth in the Plan.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:28.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:134%">IN WITNESS WHEREOF, the Company and the Grantee have accepted this Agreement effective as of the Grant Date.</font></div><div style="padding-right:28.15pt"><font><br></font></div><div style="margin-top:0.45pt;padding-left:11.15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.634%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-0.18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DaVita Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 6.3pt;text-align:left;text-indent:-0.18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee*</font></td></tr></table></div><div style="padding-left:20.55pt"><img alt="image_1.jpg" src="image_1.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%"> </font><img alt="image_2.jpg" src="image_2.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:15.4pt;padding-right:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:134%">*If permitted by the Company, this Agreement may be accepted electronically by the Grantee pursuant to the Company&#8217;s third-party stock plan administrator&#8217;s procedures.</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ib0511faccdcf4520ae290885ecdff83b_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:203.35pt;padding-right:203.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:121.37pt;padding-right:121.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%">Performance-Based Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%"> &#8211; General Terms and Conditions</font></div><div style="margin-top:2.2pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For valuable consideration, the receipt of which is acknowledged, the parties hereto agree as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Grant of Performance Stock Units. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company hereby grants to Grantee this award (the &#8220;Award&#8221;) of the target number of performance-based restricted stock units indicated on the front page (&#8220;Performance Stock Units&#8221;) under the Plan, subject to adjustment, forfeiture and the other terms and conditions set forth below and in the Plan. This Award represents Grantee&#8217;s right to receive shares of common stock of the Company (&#8220;Common Stock&#8221;), subject to Grantee&#8217;s fulfillment of the performance, vesting and other conditions set forth in this Agreement.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Performance and Vesting Conditions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The number of Performance Stock Units that may be earned by and for which shares of Common Stock (&#8220;Shares&#8221;) become issuable to Grantee (the &#8220;Earned Units&#8221;) shall be based upon the achievement of the performance criteria as reviewed and approved by the Committee (and the independent directors of the Board, as applicable) and reflected in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;Performance Goals&#8221;) over the performance period or periods reflected in</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;Performance Period&#8221;) and the remaining terms of this Agreement (the &#8220;Vesting Conditions&#8221;). The determination by the Committee with respect to the achievement of the Performance Goals shall be made as soon as administratively practicable following the end of the applicable Performance Period after all necessary Company information is available.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.55pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Conversion of Performance Stock Units and Stock Issuance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the Committee determines that some or all of the Performance Goals and the Vesting Conditions have been achieved, then as of the Vesting Date or as soon as administratively practicable thereafter (but in any event no later than 60 days following the applicable Vesting Date or the vesting event, subject to Section 12 below and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the Company shall issue the number of Shares issuable to Grantee (the &#8220;Shares&#8221;), for the Earned Units determined pursuant to the Committee&#8217;s determination of the level of achievement of the Performance Goals, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Termination of Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or pursuant to the terms of any written employment agreement between the Grantee and the Company or an Affiliate thereof in effect on the Grant Date, Performance Stock Units will cease vesting upon the date Grantee&#8217;s employment with the Company or any Affiliate is terminated for any reason. Upon the date that Grantee ceases being an Employee for any reason other than as expressly contemplated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or pursuant to the terms of any written employment agreement between the Grantee and the Company or an Affiliate thereof in effect on the Grant Date, Grantee will forfeit his&#47;her&#47;their right to any unvested Performance Stock Units.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Rights to Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee shall not have any rights to the Shares subject to the Award, including without limitation, voting rights and rights to dividends, unless and until the Shares shall have been issued by the Company and held of record by or for the benefit of Grantee. The Performance Stock Units shall include a right to Dividend Equivalents equal to the value of any dividends paid on the Common Stock for which the dividend record date occurs between the Grant Date and the date the Performance Stock Units are settled or forfeited. Subject to vesting, each Dividend Equivalent entitles Grantee to receive the equivalent cash value of any such dividends paid on the number of Shares underlying the Performance Stock Units that are outstanding during such period. Dividend Equivalents will be accrued (without interest) and will be subject to the same conditions as the Performance Stock Units to which they are attributable, including, without limitation, the vesting conditions and the provisions governing the time and form of settlement of the Performance Stock Units.</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ib0511faccdcf4520ae290885ecdff83b_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9.55pt;padding-left:30.75pt;text-align:justify;text-indent:-20.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:114%;padding-left:12.55pt">Taxes</font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:13.85pt">Generally. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee is ultimately liable and responsible for all taxes under all applicable federal, state, local or other laws or regulations (the &#8220;Required Tax Payments&#8221;) owed in connection with the Award, regardless of any action the Company or any of its Affiliates takes with respect to any tax withholding obligations that arise in connection with the Award. Neither the Company nor any of its Affiliates makes any representation or undertaking regarding the treatment of any tax withholding in connection with the grant or vesting of the Award or the subsequent sale of Shares issuable pursuant to the Award. The Company and its Affiliates do not commit and are under no obligation to structure the Award to reduce or eliminate Grantee&#8217;s tax liability.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:13.23pt">Payment of Withholding Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As a condition precedent to the delivery to the Grantee of any Shares upon vesting of the Award, the Grantee shall satisfy the Required Tax Payments by the Company withholding from the Shares otherwise to be delivered to the Grantee pursuant to the Award a whole number of Shares having a Fair Market Value, determined as of the date the obligation to withhold or pay taxes first arises in connection with the Award (the &#8220;Tax Date&#8221;), equal to the Required Tax Payments, with the number of Shares withheld rounded up to the nearest whole Share to satisfy the Required Tax Payments. Notwithstanding the foregoing, the Company (or, in the case of a Grantee subject to Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), the Committee) may, in its sole discretion, establish alternative methods for the Grantee to satisfy the Required Tax Payments, which may include, without limitation, a cash payment, proceeds from the sale of Shares otherwise issuable to Grantee, or delivery (either actual delivery or by attestation procedures established by the Company) to the Company of previously owned whole Shares, in each case, having an aggregate value, determined as of the Tax Date, equal to the amount necessary to satisfy the Required Tax Payments.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:16.05pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Assignment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee&#8217;s interest in this Award may not be assigned or alienated, whether voluntarily or involuntarily.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Clawback Provision. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provision in this Agreement to the contrary, Grantee shall be subject to the Company&#8217;s Compensation Clawback Policy or other clawback policy adopted by the Company, each as may be amended from time to time (the &#8220;Clawback Policy&#8221;). The provisions of this Section 8 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Amendments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company may amend the provisions of this Agreement at any time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, an amendment that would adversely affect the Grantee&#8217;s rights under this Agreement in a material manner shall be subject to the written consent of the Grantee.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Change of Control of the Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a Change of Control, the number of Earned Units that are assigned to each Performance Goal issuable shall be determined as specified in the Relative Total Shareholder Return Performance Condition, as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event the Performance Period has not concluded as of the date of such Change of Control. For the avoidance of doubt, in the event the Performance Period has concluded on or prior to the date of the Change of Control, then the Earned Units shall vest and be determined based on the achievement of the applicable Performance Goal during the completed Performance Period.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:32.55pt;text-align:justify;text-indent:-22.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.85pt">&#91;Non-Competition&#47;&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-Solicitation&#47;Non-Disclosure</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee acknowledges and recognizes the highly competitive nature of the business of the Company and the unique access to the Company&#8217;s confidential business, personnel, and customer and patient information, including trade secret information, that Grantee receives solely as a result of Grantee&#8217;s employment with the Company, and accordingly agrees that while Grantee is an Employee, and for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;NonCompete_Term&#187; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following termination of such relationship for any reason (whether voluntary or involuntary) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Grantee shall not, as an employee, independent contractor, consultant, or in any other capacity, prepare to provide or provide any of the same or similar services that Grantee performed during his&#47;her&#47;their employment with or service to the Company for any other individual, partnership, limited liability company, corporation, independent practice association, </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To be included based on teammate jurisdiction and status. </font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">management services organization, or any other entity (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) anywhere in the Restricted Territory that competes in any way with the area of business of the Company, or any of its subsidiaries or affiliates, in which Grantee worked and&#47;or performed services during the last five years of Grantee&#8217;s employment with the Company. For purposes of the above, preparing to provide any of the same or similar services includes, but is not limited to, planning with any Person on how best to compete with the Company or any of its subsidiaries or affiliates, or discussing the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217; business plans or strategies with any Person.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee further agrees that during the Restricted Period, Grantee shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise engage in, act for, or act on behalf of any Person (other than the Company and its subsidiaries and affiliates) engaged in any activity that Grantee was responsible for during the last five years of Grantee&#8217;s employment with or engagement by the Company in the Restricted Territory where such activity is competitive with the activities carried on by the Company or any of its subsidiaries or affiliates.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee acknowledges that during the Restricted Period, Grantee may be exposed to confidential information and&#47;or trade secrets relating to business areas of the Company or any of its subsidiaries or affiliates that are different from and in addition to the areas in which Grantee primarily works for the Company (the &#8220;Additional Protected Areas of Business&#8221;). As a result, Grantee agrees he&#47;she&#47;they shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise act for, act on behalf, or provide the same or similar services to, any Person that engages in the Additional Protected Areas of Business.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, nothing in this Section 11(a) prohibits Grantee from passively owning not in excess of 2% in the aggregate of any company&#8217;s stock or other ownership interests that are publicly traded on any national or regional stock exchange.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Section 11(a), &#8220;Restricted Territory&#8221; means the territory or territories or other geographic areas in which the Company does business and as to which Grantee provided services or had a material presence or influence, and&#47;or about which Grantee learned confidential information and&#47;or trade secrets. Grantee acknowledges and agrees that, given Grantee&#8217;s role at the Company, the geographical limitations and duration of this covenant not to compete are reasonable and appropriate, it being understood that the business of the Company can be, and is, practiced throughout the United States, and that the restrictions set forth herein will not impose any undue hardship on Grantee.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the provisions of this Section 11(a) conflict with any other agreement signed by Grantee relating to non-competition, the provisions that are most protective of the Company&#8217;s, and any of its subsidiaries&#8217; or affiliates&#8217;, interests shall govern.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Section 11(a) (Non-competition) and the rights and obligations of Company hereunder may be assigned by Company and shall inure to the benefit of and shall be enforceable by any such assignee, as well as any of Company&#8217;s successors in interest. This Section 11(a) (Non-competition) and the rights and obligations of Grantee hereunder may not be assigned by Grantee, but are binding upon Grantee's heirs, administrators, executors, and personal representatives.&#93;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee agrees that during the term of his&#47;her&#47;their employment and&#47;or service to the Company or any of its subsidiaries or affiliates and for the one-year period following the termination of his&#47;her&#47;their employment and&#47;or service for any reason (whether voluntary or involuntary), Grantee shall not (i) solicit any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work for any Person&#59; (ii) hire any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work (as an employee or an independent contractor) for any Person&#59; or (iii) take any action that may reasonably result in any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company going to work (as an employee or an independent contractor) for any Person.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt;text-decoration:underline">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In addition, Grantee agrees not to disclose or use for his&#47;her&#47;their own benefit or purposes or for the benefit or purposes of any Person other than the Company and any of its subsidiaries or affiliates, any trade secrets, information, data, or other confidential information relating to customers, development, programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, financing methods, plans, or the business and affairs of the Company or any of its subsidiaries or affiliates (&#8220;Information&#8221;)&#59; provided, however, the foregoing shall not apply to (i) Information which is not unique to the Company or any of its subsidiaries or affiliates&#59; (ii) Information which is generally known to the industry or the public other than as a result of Grantee&#8217;s breach of this covenant&#59; or (iii) disclosure that is required by any applicable law, rule or regulation. If Grantee receives such a request to produce Information in his&#47;her&#47;their possession, Grantee shall provide the Company reasonable advance notice, in writing, prior to producing said Information, so as to give the Company reasonable time to object to Grantee producing said Information. Grantee also agrees that Grantee will not become employed by or enter into service with any Person other than the Company and any of its subsidiaries or affiliates in which Grantee will be obligated to disclose or use any Information, or where such disclosure would be inevitable because of the nature of the position. Grantee shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (1) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or investigating a suspected violation of law&#59; or (2) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Disclosures to attorneys, made under seal, or pursuant to court order are also protected in certain circumstances under 18 U.S.C. &#167; 1833.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Protected Rights.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Nothing contained in this Agreement prohibits or limits Grantee&#8217;s ability to file a charge or complaint with any federal, state or local governmental agency or commission, including but not limited to the U.S. Securities and Exchange Commission.  This Agreement also does not prohibit or limit Grantee&#8217;s ability to communicate with any federal, state or local governmental agency or commission (including but not limited to the U.S. Securities and Exchange Commission), or to otherwise participate in any investigation or proceeding that may be conducted by such an agency or commission (including but not limited to the U.S. Securities and Exchange Commission), including providing documents or other information. Moreover, nothing in this agreement prevents Grantee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Grantee has reason to believe is unlawful.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee agrees that any breach of Section &#91;11(a),&#93; 11(b), or 11(c) will result in immediate and irreparable harm to the Company and its affiliates for which damages alone are an inadequate remedy and cannot readily be calculated. Accordingly, the Grantee agrees that the Company and its affiliates shall be entitled to temporary, preliminary and permanent injunctive relief to prevent any such actual or threatened breach, without posting a bond or other security or limiting other available remedies.</font></div><div style="padding-left:45.95pt;padding-right:15.8pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.07pt;text-decoration:underline">Termination of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement and the Award shall terminate effective on the date on which Grantee enters into any activity in breach of Section &#91;11(a),&#93; 11(b), or 11(c). This Agreement and the Award shall also terminate if at any time during Grantee&#8217;s employment with the Company or any of its subsidiaries or affiliates or within one (1) year after the termination of such employment for any reason (whether voluntary or involuntary), Grantee (i) is convicted of a felony&#59; (ii) has been adjudicated by a court of competent jurisdiction of having committed an act of fraud or dishonesty resulting or intending to result directly or indirectly in personal enrichment at the expense of the Company or any of its subsidiaries or affiliates&#59; or (iii) is excluded from participating in any federal health care program. In any of the aforementioned cases, in addition to injunctive relief as forth above, the Company may seek an order requiring Grantee to repay the Company any value, gain or other consideration received or realized by Grantee as a result of this Award or any Shares received pursuant to the Award. The provisions of this Section 11(f) are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.   Notwithstanding the foregoing and any other language in this Agreement, for the avoidance of doubt, this Section 11(f) does not supersede or preclude the application or enforceability of Section 8 or the Clawback Policy.</font></div><div style="padding-left:45.95pt;padding-right:15.8pt"><font><br></font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Grantee acknowledges and agrees that Grantee has carefully read and fully understands all of the provisions of this Section 11 and that Grantee has been advised to and&#47;or has obtained representation by counsel in connection with Grantee&#8217;s execution of this Agreement.</font></div><div style="padding-left:45.95pt;padding-right:15.8pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Plan or this Agreement to the contrary, this Section 11 shall be construed and regulated under and by the laws of the state where Grantee resides. The parties agree that any and all actions or proceedings to enforce Section 11 shall be brought in the state or federal court where Grantee resides.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Section 409A of the Code. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement and the Award are intended to be exempt from or meet the requirements of Section 409A of the Code, as applicable, and shall be interpreted and construed consistent with that intent and each settlement hereunder shall be considered a separate payment for purposes of Section 409A of the Code. Notwithstanding any other provisions of this Agreement, to the extent that the right to any issuance of Shares or payment to Grantee hereunder provides for non-qualified deferred compensation within the meaning of Section 409A(d)(1) of the Code that is subject to Section 409A of the Code, the issuance or payment shall be made in accordance with the following&#58;</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If Grantee is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of Grantee&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A(a)(2)(A)(i) of the Code (the &#8220;Separation Date&#8221;), then no such issuance of Shares or payment shall be made during the period beginning on the Separation Date and ending on the date that is six months following the Separation Date or, if earlier, on the date of Grantee&#8217;s death, if the earlier making of such issuance of Shares or payment would result in tax penalties being imposed on Grantee under Section 409A of the Code. The amount of any issuance of Shares or payment that would otherwise be made during this period shall instead be made on the first business day following the date that is six months following the Separation Date or, if earlier, the date of Grantee&#8217;s death.  If the Grantee is subject to an employment or other agreement that specifies  a time and form of payment that differs from the time and form of payment set forth in Exhibit B, then this Award shall be settled in accordance with such employment or other agreement to the extent required to comply with Section 409A of the Code in a manner permissible under the Plan.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Compliance with Policies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is understood and agreed upon that at all times Grantee will act in full compliance with the Company&#8217;s policies and procedures as may be in effect from time to time, including without limitation, the Company&#8217;s Code of Conduct, Joint Venture Arrangements Policy,</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ib0511faccdcf4520ae290885ecdff83b_13"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Medical Director Agreements Compliance Handbook, Acceptance of Gifts Policy and&#47;or credentialing process (collectively, the &#8220;Policies&#8221;). If Grantee&#8217;s conduct, whether related to the Award granted under this Agreement or otherwise, materially violates the requirements of the Policies, as determined by the Committee (with respect to a Grantee that is an &#8220;officer&#8221; under Section 16 of the Exchange Act) or the Company&#8217;s Chief Executive Officer, Chief Compliance Officer or Chief Legal Officer (with respect to a Grantee that is not an &#8220;officer&#8221; under Section 16 of the Exchange Act), then the Company may require Grantee to forfeit any unvested portion of the Award granted under this Agreement and be subject to immediate disciplinary action, up to and including termination. The provisions of this Section 13 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies or any laws or regulations. If at any time Grantee has questions or concerns about the provisions in this Section 13, or suspects any improper conduct related to the Policies, Grantee should immediately contact his&#47;her&#47;their supervisor or Team Quest. Grantee also may anonymously and confidentially call the Company&#8217;s Compliance Hotline.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Compliance with Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Shares shall be issued and delivered pursuant to this Award unless and until all applicable registration requirements of the Securities Act of 1933, as amended, all applicable listing requirements of any national securities exchange on which the Common Stock is then listed, and all other requirements of law or of any regulatory bodies having jurisdiction over such issuance and delivery, shall have been complied with. In particular, the Committee may require certain investment (or other) representations and undertakings in connection with the issuance of securities in connection with the Plan and this Award in order to comply with applicable law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Agreement is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. Furthermore, if any provision of this Agreement is determined to be illegal under any applicable law, such provision shall be null and void to the extent necessary to comply with applicable law, but the other provisions of this Agreement shall remain in full force and effect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:28pt;text-align:justify;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:4.3pt">Interpretation of Award.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.8pt">This Award is granted under the provisions of the Plan and shall be interpreted in a manner consistent with it.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:16.3pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.18pt">Any provision in this Award inconsistent with the Plan shall be superseded and governed by the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.95pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.8pt">For all purposes under this Award, employment by the Company shall include employment by the Company or any Affiliate thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;padding-left:31.18pt">This Award shall be subject to the terms of any written employment agreement between the Grantee and the Company or any Affiliate thereof to the extent permissible under the Plan.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Electronic Delivery and Execution. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee will not be able to initiate any stock transactions related to this Award until Grantee has accepted the terms of this Agreement. The Company may, in its sole discretion, decide to deliver any documents related to this Award or future awards made under the Plan by electronic means or request Grantee&#8217;s consent to participate in the Plan by electronic means. Grantee hereby consents to receive such documents by electronic delivery and, if requested, agrees to participate in the Plan through any online or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><div id="ib0511faccdcf4520ae290885ecdff83b_16"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:203.35pt;padding-right:203.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:121.37pt;padding-right:121.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Performance-Based Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> &#8211; Performance and Vesting Conditions</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Shares issuable under this Agreement will be determined based on the level of performance achieved on specified Performance Goals. Except as set forth in this Exhibit B or the terms of any written employment agreement between the Grantee and the Company or an Affiliate thereof in effect on the Grant Date, vesting in the right to receive the number of shares so determined shall be contingent on Grantee&#8217;s continued employment by the Company on the Vesting Date (which, for the avoidance of doubt, shall be the date on which the Award is earned).</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Exhibit, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean&#58; (i) a material breach by Grantee of his&#47;her&#47;their duties and responsibilities which do not differ in any material respect from the duties and responsibilities of Grantee during the ninety (90) days immediately prior to a Change of Control (other than as a result of incapacity due to physical or mental illness) which is demonstrably willful and deliberate on Grantee&#8217;s part, which is committed in bad faith or without reasonable belief that such breach is in the best interests of the Company and which is not remedied in a reasonable period of time after receipt of written notice from the Company specifying such breach&#59; (ii) willful misconduct or gross negligence which results in material harm to the Company&#59; (iii) the conviction of Grantee of, or a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">by Grantee to, a felony or other crime involving fraud or dishonesty&#59; or (iv) willful violation of Company policies which results in material harm to the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change of Control Vesting</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a Change of Control, this Award shall automatically vest in its entirety upon the earlier of the following two events&#58; (i) immediately prior to the effective date of a Change of Control if the successor in such Change of Control (the &#8220;Acquiror&#8221;) fails to effectively assume, convert or replace this Award, or</font></div><div style="padding-left:10pt;padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) if the Award is effectively assumed in a Change of Control, as of the date of termination of Grantee&#8217;s employment if such termination occurs within twenty-four (24) months following such Change of Control by the Company (or the Acquiror) (a) other than for &#8220;Cause&#8221; (defined above) or (b) if applicable, by Grantee in accordance with the termination for &#8220;Good Reason&#8221; provisions of Grantee&#8217;s employment agreement, if any&#59; provided, however, that if the Award constitutes nonqualified deferred compensation within the meaning of Section 409A of the Code, then in the case of clause (i), if the Award is not effectively assumed, converted or replaced and the Change of Control was not a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code or to the extent distribution would not be permissible under Section 409A of the Code without adverse tax consequences, then the vested Award shall be settled upon the normal Vesting Date or, if earlier and to the extent permitted by Section 409A of the Code, Grantee&#8217;s termination of employment, provided that the Grantee would not satisfy the age and service requirements for Rule of 65 Vesting during the term of the Award, and in the case of clause (ii), if the Change of Control was not a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code and the Grantee would satisfy the age and service requirements for Rule of 65 Vesting during the term of this Award, then the vested Award shall be settled, to the extent required by Section 409A of the Code, upon the Vesting Date, in accordance with the Rule of 65 provisions. In the event of such accelerated vesting due to a Change of Control, the number of Shares issuable for the portion of Condition Target PSUs assigned to the Performance Conditions described in Section A. with respect to any Performance Period that had not concluded on or prior to the date of such Change of Control shall be determined as specified in the Relative Total Shareholder Return Performance Condition described in Section B. below.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be effectively assumed in the Change of Control, the award received in exchange for the Award in connection with a Change of Control&#58; (i) must be of the same type as the Award&#59; (ii) must have a value intended to preserve the value of the Award&#59; (iii) must relate to publicly traded equity securities of the Company (or the Acquiror or another entity that is affiliated with the Company or the Acquiror)&#59; and (iv) must have other terms and conditions that are not less favorable to the Grantee than the terms and conditions of the Award (including the provisions that would apply in the event of a subsequent Change of Control but excluding the Performance Conditions). Without limiting the generality of the foregoing, the replaced Award may take the form of a continuation of the Award if the requirements of the preceding sentence are satisfied. The determination of whether the conditions for effectively assuming the Award </font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16.15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">have been satisfied shall be made by the Board, as constituted immediately before the Change of Control, in its sole discretion.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule of 65 Vesting</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that (i) the Grantee has remained continuously employed with the Company for at least one year from the Grant Date, (ii) the Grantee has satisfied the Rule of 65 (as defined below) at the time of his&#47;her&#47;their termination of employment and such termination of employment is not for Cause, and (iii) the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such termination of employment, then the Award shall vest and shall be settled on its normal Vesting Date&#59; provided, however, that if following the Grantee&#8217;s termination of employment under this paragraph, there is a Change of Control and the Award is not effectively assumed, converted or replaced and the Change of Control is a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code, then the vested Award shall be settled upon such Change of Control to the extent permitted without adverse tax consequences by Section 409A of the Code, with the number of Shares issuable as determined above under Change of Control Vesting. If the Grantee satisfies the requirements of the preceding sentence but the Grantee&#8217;s termination of employment occurs prior to the first anniversary of the Grant Date, then the number of Condition Target PSUs eligible for vesting shall be prorated based on the number of full months from the Grant Date to the Grantee&#8217;s termination of employment divided by 12.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule of 65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that the sum of the Grantee&#8217;s age and years of service equals or exceeds 65, with a minimum age of 55 and a minimum of five years of continuous service.</font></div><div><font><br></font></div><div style="padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Death or Disability</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of the Grantee&#8217;s death or Disability while employed by the Company and the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such death or Disability, the Condition Target PSUs shall vest and be settled within 60 days following such death or Disability (or, if later and to the extent permitted under Section 409A of the Code, within 60 days following the conclusion of the Performance Period applicable to the underlying Performance Goals)&#59; provided, however, that if the Grantee&#8217;s death or Disability occurs following the conclusion of the Performance Period, the Award shall vest based on the achievement of the applicable Performance Goal during such completed Performance Period.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, determined in accordance with Section 409A of the Code.</font></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify"><font><br></font></div><div style="padding-left:12.97pt;padding-right:12.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">&#91;Performance Conditions Intentionally Omitted&#93;</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div><font><br></font></div><div style="height:69.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex103-formrsuawardagreemen.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id192d4c7005d4363948b771587e7126f_1"></div><div style="min-height:67.68pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div></div><div style="margin-top:3.95pt;padding-left:203.35pt;padding-right:203.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:145.05pt;padding-right:145.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restricted Stock Unit Agreement under the DaVita Inc. 2020 Incentive Award Plan</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:17.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(this &#8220;Agreement&#8221;) is dated as of the Grant Date indicated below by and between DaVita Inc., a Delaware corporation (the &#8220;Company&#8221;), and the Grantee indicated below pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DaVita Inc. 2020 Incentive Award Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Plan&#8221;).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.762%"><div style="margin-top:4.6pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Primary Terms</font></div><div><font><br></font></div><div style="margin-top:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grantee&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;Grantee&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Address&#58; </font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Address_1&#187;<br>&#171;City&#187;, &#171;State&#187; &#171;Zip&#187;<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;Grant Date&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Number of Units&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;RSU_Award&#187;</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#171;RSU_Vesting_1&#187;<br>&#171;RSU_Vesting_2&#187;<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><br></font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan Name&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2020 Incentive Award Plan</font></td></tr><tr><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Plan ID#&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;2020&#93;</font></td></tr></table></div></div><div style="display:inline-block;max-width:0.475%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.763%"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:18.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement includes this cover page and the following Exhibits, which are expressly incorporated by reference in their entirety herein&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; General Terms and Conditions</font></div><div style="padding-left:46pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Events Causing Full Vesting of Awards</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:20.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee hereby expressly acknowledges and agrees that he&#47;she&#47;they is an employee at will and may be terminated by the Company or its applicable Affiliate at any time, with or without cause. By accepting this Award, Grantee hereby acknowledges he&#47;she&#47;they has a copy of the Plan, and accepts and agrees to the terms and provisions of this Agreement and the Plan. Capitalized terms that are used but not defined in this Agreement shall have the meanings set forth in the Plan.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:28.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:133%">IN WITNESS WHEREOF, the Company and the Grantee have accepted this Agreement effective as of the Grant Date.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.45pt;padding-left:11.15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.634%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11pt;text-align:left;text-indent:-0.18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DaVita Inc.</font></td><td colspan="3" style="padding:2px 1pt 2px 6.3pt;text-align:left;text-indent:-0.18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee*</font></td></tr></table></div><div style="padding-left:20.55pt"><img alt="image_11a.jpg" src="image_11a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:80%"> </font><img alt="image_21a.jpg" src="image_21a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:205px"></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:15.4pt;padding-right:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:134%">*If permitted by the Company, this Agreement may be accepted electronically by the Grantee pursuant to the Company&#8217;s third-party stock plan administrator&#8217;s procedures.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id192d4c7005d4363948b771587e7126f_7"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:216.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:142.85pt;padding-right:147.8pt;text-indent:23.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%">Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:209%"> &#8211; General Terms and Conditions</font></div><div style="margin-top:8.2pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For valuable consideration, the receipt of which is acknowledged, the parties hereto agree as follows&#58;</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Grant of Restricted Stock Units. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company hereby grants to Grantee this award (the &#8220;Award&#8221;) of the number of restricted stock units indicated on the front page (&#8220;Restricted Stock Units&#8221;) under the Plan, subject to adjustment, forfeiture and the other terms and conditions set forth below and in the Plan. This Award represents Grantee&#8217;s right to receive shares of common stock of the Company (&#8220;Common Stock&#8221;), subject to Grantee&#8217;s fulfillment of the vesting and other conditions set forth in this Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:117%;padding-left:17.75pt">Vesting Conditions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">The Restricted Stock Units shall vest in accordance with the Vesting Schedule specified on the front page.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Conversion of Restricted Stock Units and Stock Issuance. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">One share of Common Stock (each, a &#8220;Share&#8221;) will become issuable to Grantee for each Restricted Stock Unit that vests pursuant to this Agreement, subject to any reduction in the number of Shares pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below, with such Shares to be distributed to the Grantee within 60 days following the applicable vesting date or vesting event, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below and Exhibit B. The number of Shares issuable to Grantee, after any reduction pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be rounded down to the nearest whole number of Shares.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Termination of Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> B or pursuant to the terms of any written employment agreement between the Grantee and the Company or an Affiliate thereof in effect on the Grant Date, Restricted Stock Units will cease vesting upon the date Grantee&#8217;s employment with the Company or any Affiliate is terminated for any reason. Upon the date that Grantee ceases being an Employee for any reason other than as expressly contemplated in Exhibit B or pursuant to the terms of any written employment agreement between the Grantee and the Company or an Affiliate thereof in effect on the Grant Date, Grantee will forfeit his&#47;her&#47;their right to any unvested Restricted Stock Units.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Rights to Shares. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee shall not have any rights to the Shares subject to the Award, including without limitation, voting rights and rights to dividends, unless and until the Shares shall have been issued by the Company and held of record by or for the benefit of Grantee. The Restricted Stock Units shall include a right to Dividend Equivalents equal to the value of any dividends paid on the Common Stock for which the dividend record date occurs between the Grant Date and the date the Restricted Stock Units are settled or forfeited. Subject to vesting, each Dividend Equivalent entitles Grantee to receive the equivalent cash value of any such dividends paid on the number of Shares underlying the Restricted Stock Units that are outstanding during such period. Dividend Equivalents will be accrued (without interest) and will be subject to the same conditions as the Restricted Stock Units to which they are attributable, including, without limitation, the vesting conditions and the provisions governing the time and form of settlement of the Restricted Stock Units.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:32.55pt;text-align:justify;text-indent:-22.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:14.35pt">Taxes</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:46pt;padding-right:15.8pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.8pt">Generally. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee is ultimately liable and responsible for all taxes under all applicable federal, state, local or other laws or regulations (the &#8220;Required Tax Payments&#8221;) owed in connection with the Award, regardless of any action the Company or any of its Affiliates takes with respect to any tax withholding obligations that arise in connection with the Award. Neither the Company nor any of its Affiliates makes any representation or undertaking regarding the treatment of any tax withholding in connection with the grant or vesting of the Award or the subsequent sale of Shares issuable pursuant to the Award. The Company and its Affiliates do not commit and are under no obligation to structure the Award to reduce or eliminate Grantee&#8217;s tax liability.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:46pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:5.18pt">Payment of Withholding Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As a condition precedent to the delivery to the Grantee of any Shares upon vesting of the Award, the Grantee shall satisfy the Required Tax Payments by the Company withholding from the Shares otherwise to be delivered to the Grantee pursuant to the Award a whole number of Shares having a Fair Market Value, determined as of the date the obligation to withhold or pay taxes first arises in connection with the Award (the &#8220;Tax Date&#8221;), </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:46pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">equal to the Required Tax Payments, with the number of Shares withheld rounded up to the nearest whole Share to satisfy the Required Tax Payments. Notwithstanding the foregoing, the Company (or, in the case of a Grantee subject to Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), the Committee) may, in its sole discretion, establish alternative methods for the Grantee to satisfy the Required Tax Payments, which may include, without limitation, a cash payment, proceeds from the sale of Shares otherwise issuable to Grantee, or delivery (either actual delivery or by attestation procedures established by the Company) to the Company of previously owned whole Shares, in each case, having an aggregate value, determined as of the Tax Date, equal to the amount necessary to satisfy the Required Tax Payments.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Assignment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee&#8217;s interest in this Award may not be assigned or alienated, whether voluntarily or involuntarily.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Clawback Provision. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding any other provision in this Agreement to the contrary, Grantee shall be subject to the Company&#8217;s Compensation Clawback Policy or other clawback policy adopted by the Company, each as may be amended from time to time (the &#8220;Clawback Policy&#8221;). The provisions of this Section 8 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:17.75pt">Amendments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Company may amend the provisions of this Agreement at any time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, an amendment that would adversely affect the Grantee&#8217;s rights under this Agreement in a material manner shall be subject to the written consent of the Grantee.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Change of Control of the Company. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a Change of Control, the entire Award may vest immediately in accordance with the terms of the Plan. The specific provisions regarding circumstances in which full vesting would occur upon or following a Change of Control under this Agreement are set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:32.55pt;text-indent:-22.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.85pt">&#91;Non-Competition&#47;&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:700;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Non-Solicitation&#47;Non-Disclosure</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee acknowledges and recognizes the highly competitive nature of the business of the Company and the unique access to the Company&#8217;s confidential business, personnel, and customer and patient information, including trade secret information, that Grantee receives solely as a result of Grantee&#8217;s employment with the Company, and accordingly agrees that while Grantee is an Employee and for the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#171;NonCompete_Term&#187; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">period following termination of such relationship for any reason (whether voluntary or involuntary) (the &#8220;Restricted Period&#8221;), Grantee shall not, as an employee, independent contractor, consultant, or in any other capacity, prepare to provide or provide any of the same or similar services that Grantee performed during his&#47;her&#47;their employment with or service to the Company for any other individual, partnership, limited liability company, corporation, independent practice association, management services organization, or any other entity (collectively, &#8220;Person&#8221;) anywhere in the Restricted Territory that competes in any way with the area of business of the Company, or any of its subsidiaries or affiliates, in which Grantee worked and&#47;or performed services during the last five years of Grantee&#8217;s employment with the Company. For purposes of the above, preparing to provide any of the same or similar services includes, but is not limited to, planning with any Person on how best to compete with the Company or any of its subsidiaries or affiliates, or discussing the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217; business plans or strategies with any Person.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee further agrees that during the Restricted Period, Grantee shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise engage in, act for, or act on behalf of any Person (other than the Company and its subsidiaries and affiliates) engaged in any activity that Grantee was responsible for during the last five years of Grantee&#8217;s employment with or engagement by the Company in the Restricted Territory where such activity is competitive with the activities carried on by the Company or any of its subsidiaries or affiliates.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee acknowledges that during the Restricted Period, Grantee may be exposed to confidential information and&#47;or trade secrets relating to business areas of the Company or any of its subsidiaries or affiliates that are different from and in addition to the areas in which Grantee primarily works for the </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> To be included based on teammate jurisdiction and status. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company (the &#8220;Additional Protected Areas of Business&#8221;). As a result, Grantee agrees he&#47;she&#47;they shall not own, manage, control, operate, invest in, acquire an interest in, or otherwise act for, act on behalf, or provide the same or similar services to, any Person that engages in the Additional Protected Areas of Business.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:16.1pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, nothing in this Section 11(a) prohibits Grantee from passively owning not in excess of 2% in the aggregate of any company&#8217;s stock or other ownership interests that are publicly traded on any national or regional stock exchange.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Section 11(a), &#8220;Restricted Territory&#8221; means the territory or territories or other geographic areas in which the Company does business and as to which Grantee provided services or had a material presence or influence, and&#47;or about which Grantee learned confidential information and&#47;or trade secrets. Grantee acknowledges and agrees that, given Grantee&#8217;s role at the Company, the geographical limitations and duration of this covenant not to compete are reasonable and appropriate, it being understood that the business of the Company can be, and is, practiced throughout the United States, and that the restrictions set forth herein will not impose any undue hardship on Grantee.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To the extent that the provisions of this Section 11(a) conflict with any other agreement signed by Grantee relating to non-competition, the provisions that are most protective of the Company&#8217;s, and any of its subsidiaries&#8217; or affiliates&#8217;, interests shall govern.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Section 11(a) (Non-competition) and the rights and obligations of Company hereunder may be assigned by Company and shall inure to the benefit of and shall be enforceable by any such assignee, as well as any of Company&#8217;s successors in interest. This Section 11(a) (Non-competition) and the rights and obligations of Grantee hereunder may not be assigned by Grantee, but are binding upon Grantee's heirs, administrators, executors, and personal representatives.&#93;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.23pt;text-decoration:underline">Non-Solicitation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> Grantee agrees that during the term of his&#47;her&#47;their employment and&#47;or service to the Company or any of its subsidiaries or affiliates and for the one-year period following the termination of his&#47;her&#47;their employment and&#47;or service for any reason (whether voluntary or involuntary), Grantee shall not (i) solicit any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work for any Person&#59; (ii) hire any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company to work (as an employee or an independent contractor) for any Person&#59; or (iii) take any action that may reasonably result in any of the Company&#8217;s, or any of its subsidiaries&#8217; or affiliates&#8217;, employees with whom Grantee worked on more than a de minimis basis or whom Grantee directly or indirectly supervised while with the Company going to work (as an employee or an independent contractor) for any Person.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt;text-decoration:underline">Non-Disclosure.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> In addition, Grantee agrees not to disclose or use for his&#47;her&#47;their own benefit or purposes or for the benefit or purposes of any Person other than the Company and any of its subsidiaries or affiliates, any trade secrets, information, data, or other confidential information relating to customers, development, programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, financing methods, plans, or the business and affairs of the Company or any of its subsidiaries or affiliates (&#8220;Information&#8221;)&#59; provided, however, the foregoing shall not apply to (i) Information which is not unique to the Company or any of its subsidiaries or affiliates&#59; (ii) Information which is generally known to the industry or the public other than as a result of Grantee&#8217;s breach of this covenant&#59; or (iii) disclosure that is required by any applicable law, rule or regulation. If Grantee receives such a request to produce Information in his&#47;her&#47;their possession, Grantee shall provide the Company reasonable advance notice, in writing, prior to producing said Information, so as to give the Company reasonable time to object to Grantee producing said Information. Grantee also agrees that Grantee will not become employed by or enter into service with any Person other than the Company and any of its subsidiaries or affiliates in which Grantee will be obligated to disclose or use any Information, or where such disclosure would be inevitable because of the nature of the position. Grantee shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that&#58; (1) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and (b) solely for the purpose of reporting or investigating a suspected </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">violation of law&#59; or (2) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. Disclosures to attorneys, made under seal, or pursuant to court order are also protected in certain circumstances under 18 U.S.C. &#167; 1833.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Protected Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Nothing contained in this Agreement prohibits or limits Grantee&#8217;s ability to file a charge or complaint with any federal, state or local governmental agency or commission, including but not limited to the U.S. Securities and Exchange Commission.  This Agreement also does not prohibit or limit Grantee&#8217;s ability to communicate with any federal, state or local governmental agency or commission (including but not limited to the U.S. Securities and Exchange Commission), or to otherwise participate in any investigation or proceeding that may be conducted by such an agency or commission (including but not limited to the U.S. Securities and Exchange Commission), including providing documents or other information. Moreover, nothing in this agreement prevents Grantee from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Grantee has reason to believe is unlawful.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.85pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Grantee agrees that any breach of Section &#91;11(a),&#93; 11(b), or 11(c) will result in immediate and irreparable harm to the Company and its affiliates for which damages alone are an inadequate remedy and cannot readily be calculated. Accordingly, the Grantee agrees that the Company and its affiliates shall be entitled to temporary, preliminary and permanent injunctive relief to prevent any such actual or threatened breach, without posting a bond or other security or limiting other available remedies.</font></div><div style="padding-left:45.95pt;padding-right:15.75pt"><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.07pt;text-decoration:underline">Termination of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Agreement and the Award shall terminate effective on the date on which Grantee enters into any activity in breach of Section &#91;11(a),&#93; 11(b), or 11(c). This Agreement and the Award shall also terminate if at any time during Grantee&#8217;s employment with the Company or any of its subsidiaries or affiliates or within one (1) year after the termination of such employment for any reason (whether voluntary or involuntary), Grantee (i) is convicted of a felony&#59; (ii) has been adjudicated by a court of competent jurisdiction of having committed an act of fraud or dishonesty resulting or intending to result directly or indirectly in personal enrichment at the expense of the Company or any of its subsidiaries or affiliates&#59; or (iii) is excluded from participating in any federal health care program. In any of the aforementioned cases, in addition to injunctive relief as forth above, the Company may seek an order requiring Grantee to repay the Company any value, gain or other consideration received or realized by Grantee as a result of this Award or any Shares received pursuant to the Award. The provisions of this Section 11(f) are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies (as defined herein below), or any laws or regulations.  Notwithstanding the foregoing and any other language in this Agreement, for the avoidance of doubt, this Section 11(f) does not supersede or preclude the application or enforceability of Section 8 or the Clawback Policy.</font></div><div style="margin-top:3.7pt;padding-left:45.95pt;padding-right:16pt"><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Advice of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Grantee acknowledges and agrees that Grantee has carefully read and fully understands all of the provisions of this Section 11 and that Grantee has been advised to and&#47;or has obtained representation by counsel in connection with Grantee&#8217;s execution of this Agreement.</font></div><div style="margin-top:3.7pt;padding-left:45.95pt;padding-right:16pt"><font><br></font></div><div style="margin-top:3.7pt;padding-left:10pt;padding-right:16pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:13.23pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Plan or this Agreement to the contrary, this Section 11 shall be construed and regulated under and by the laws of the state where Grantee resides. The parties agree that any and all actions or proceedings to enforce Section 11 shall be brought in the state or federal court where Grantee resides.</font></div><div style="margin-top:3.7pt;padding-left:45.95pt;padding-right:16pt;text-align:justify"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Section 409A of the Code. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Agreement and the Award are intended to be exempt from or meet the requirements of Section 409A of the Code, as applicable, and shall be interpreted and construed consistent with that intent and each settlement hereunder shall be considered a separate payment for purposes of Section 409A of the Code. Notwithstanding any other provisions of this Agreement, to the extent that the right to any issuance of Shares or payment to Grantee hereunder provides for non-qualified deferred compensation within the meaning of Section 409A(d)(1) of the Code that is subject to Section 409A of the Code, the issuance or payment shall be made in accordance with the following&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If Grantee is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of Grantee&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A(a)(2)(A)(i) of the Code </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(the &#8220;Separation Date&#8221;), then no such issuance of Shares or payment shall be made during the period beginning on the Separation Date and ending on the date that is six months following the Separation Date or, if earlier, on the date of Grantee&#8217;s death, if the earlier making of such issuance of Shares or payment would result in tax penalties being imposed on Grantee under Section 409A of the Code. The amount of any issuance of Shares or payment that would otherwise be made during this period shall instead be made on the first business day following the date that is six months following the Separation Date or, if earlier, the date of Grantee&#8217;s death. If the Grantee is subject to an employment or other agreement that specifies a time and form of payment that differs from the time and form of payment set forth in Exhibit B, then this Award shall be settled in accordance with such employment or other agreement to the extent required to comply with Section 409A of the Code in a manner permissible under the Plan.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Compliance with Policies. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">It is understood and agreed upon that at all times Grantee will act in full compliance with the Company&#8217;s policies and procedures as may be in effect from time to time, including without limitation, the Company&#8217;s Code of Conduct, Joint Venture Arrangements Policy, Medical Director Agreements Compliance Handbook, Acceptance of Gifts Policy and&#47;or credentialing process (collectively, the &#8220;Policies&#8221;). If Grantee&#8217;s conduct, whether related to the Award granted under this Agreement or otherwise, materially violates the requirements of the Policies, as determined by the Committee (with respect to a Grantee that is an &#8220;officer&#8221; under Section 16 of the Exchange Act) or the Company&#8217;s Chief Executive Officer, Chief Compliance Officer or Chief Legal Officer (with respect to a Grantee that is not an &#8220;officer&#8221; under Section 16 of the Exchange Act), then the Company may require Grantee to forfeit any unvested portion of the Award granted under this Agreement and be subject to immediate disciplinary action, up to and including termination. The provisions of this Section 13 are in addition to and not in lieu of any other remedies available to the Company in the event Grantee violates the Policies or any laws or regulations. If at any time Grantee has questions or concerns about the provisions in this Section 13, or suspects any improper conduct related to the Policies, Grantee should immediately contact his&#47;her&#47;their supervisor or Team Quest. Grantee also may anonymously and confidentially call the Company&#8217;s Compliance Hotline.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Compliance with Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Shares shall be issued and delivered pursuant to this Award unless and until all applicable registration requirements of the Securities Act of 1933, as amended, all applicable listing requirements of any national securities exchange on which the Common Stock is then listed, and all other requirements of law or of any regulatory bodies having jurisdiction over such issuance and delivery, shall have been complied with. In particular, the Committee may require certain investment (or other) representations and undertakings in connection with the issuance of securities in connection with the Plan and this Award in order to comply with applicable law.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If any provision of this Agreement is determined to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted by applicable law, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. Furthermore, if any provision of this Agreement is determined to be illegal under any applicable law, such provision shall be null and void to the extent necessary to comply with applicable law, but the other provisions of this Agreement shall remain in full force and effect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:32.55pt;text-align:justify;text-indent:-22.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.85pt">Interpretation of Award.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:15.85pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.8pt">This Award is granted under the provisions of the Plan and shall be interpreted in a manner consistent with it.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16.1pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.18pt">Any provision in this Award inconsistent with the Plan shall be superseded and governed by the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:10pt;padding-right:15.7pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.8pt">For all purposes under this Award, employment by the Company shall include employment by the Company or any Affiliate thereof.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:16.2pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:31.18pt">This Award shall be subject to the terms of any written employment agreement between the Grantee and the Company or any Affiliate thereof to the extent permissible under the Plan.</font></div><div><font><br></font></div><div style="padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.25pt">Electronic Delivery and Execution. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grantee will not be able to initiate any stock transactions related to this Award until Grantee has accepted the terms of this Agreement. The Company may, in its </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:10pt;padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">sole discretion, decide to deliver any documents related to this Award or future awards made under the Plan by electronic means or request Grantee&#8217;s consent to participate in the Plan by electronic means. Grantee hereby consents to receive such documents by electronic delivery and, if requested, agrees to participate in the Plan through any online or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id192d4c7005d4363948b771587e7126f_10"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.95pt;padding-left:108.4pt;padding-right:108.4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">DaVita Inc.</font></div><div style="padding-left:132.35pt;padding-right:132.35pt;text-align:center;text-indent:39.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:172%">Restricted Stock Unit Agreement </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:172%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:172%"> &#8211; Events Causing Full Vesting Awards</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Change of Control Vesting</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:16pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of a Change of Control, this Award shall automatically vest in its entirety upon the earlier of the following two events&#58; (i) immediately prior to the effective date of a Change of Control if the successor in such Change of Control (the &#8220;Acquiror&#8221;) fails to effectively assume, convert or replace this Award, or</font></div><div style="padding-left:10pt;padding-right:15.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii) if the Award is effectively assumed in a Change of Control, as of the date of termination of Grantee&#8217;s employment if such termination occurs within twenty-four (24) months following such Change of Control by the Company (or the Acquiror) (a) other than for &#8220;Cause&#8221; (defined below) or (b) if applicable, by Grantee in accordance with the termination for &#8220;Good Reason&#8221; provisions of Grantee&#8217;s employment agreement, if any&#59; provided, however, that if the Award constitutes nonqualified deferred compensation within the meaning of Section 409A of the Code, then in the case of clause (i), if the Award is not effectively assumed, converted or replaced and the Change of Control was not a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code or to the extent distribution would not be permissible under Section 409A of the Code without adverse tax consequences, then the vested Award shall be settled in accordance with the Award&#8217;s normal Vesting Schedule or, if earlier and to the extent permitted by Section 409A of the Code, Grantee&#8217;s termination of employment, provided that the Grantee would not satisfy the age and service requirements for Rule of 65 Vesting during the duration of the Vesting Schedule, and in the case of clause (ii), if the Change of Control was not a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code and the Grantee would satisfy the age and service requirements for Rule of 65 Vesting during the duration of the Vesting Schedule, then the vested Award shall be settled in accordance with the normal Vesting Schedule, in accordance with the Rule of 65 provisions.</font></div><div><font><br></font></div><div style="margin-top:10.25pt;padding-left:10pt;padding-right:15.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">To be effectively assumed in the Change of Control, the award received in exchange for the Award in connection with a Change of Control&#58; (i) must be of the same type as the Award&#59; (ii) must have a value intended to preserve the value of the Award&#59; (iii) must relate to publicly traded equity securities of the Company (or the Acquiror or another entity that is affiliated with the Company or the Acquiror)&#59; and (iv) must have other terms and conditions that are not less favorable to the Grantee than the terms and conditions of the Award (including the provisions that would apply in the event of a subsequent Change of Control). Without limiting the generality of the foregoing, the replaced Award may take the form of a continuation of the Award if the requirements of the preceding sentence are satisfied. The determination of whether the conditions for effectively assuming the Award have been satisfied shall be made by the Board, as constituted immediately before the Change of Control, in its sole discretion.</font></div><div><font><br></font></div><div style="margin-top:10.2pt;padding-left:10pt;padding-right:15.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this Exhibit, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean&#58; (i) a material breach by Grantee of his&#47;her&#47;their duties and responsibilities which do not differ in any material respect from the duties and responsibilities of Grantee during the ninety (90) days immediately prior to a Change of Control (other than as a result of incapacity due to physical or mental illness) which is demonstrably willful and deliberate on Grantee&#8217;s part, which is committed in bad faith or without reasonable belief that such breach is in the best interests of the Company and which is not remedied in a reasonable period of time after receipt of written notice from the Company specifying such breach&#59; (ii) willful misconduct or gross negligence which results in material harm to the Company&#59; (iii) the conviction of Grantee of, or a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">by Grantee to, a felony or other crime involving fraud or dishonesty&#59; or (iv) willful violation of Company policies which results in material harm to the Company.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id192d4c7005d4363948b771587e7126f_13"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3.7pt;padding-left:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rule of 65 Vesting</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:10pt;padding-right:15.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that (i) the Grantee has remained continuously employed with the Company for at least one year from the Grant Date, (ii) the Grantee has satisfied the Rule of 65 (as defined below) at the time of his&#47;her&#47;their termination of employment and such termination of employment is not for Cause, and (iii) the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such termination of employment, then the Award shall vest and shall be settled in accordance with the normal Vesting Schedule set forth on the cover page of the Agreement&#59; provided, however, that if following the Grantee&#8217;s termination of employment under this paragraph, there is a Change of Control and the Award is not effectively assumed, converted or replaced and the Change of Control is a &#8220;change in control event&#8221; within the meaning of Section 409A of the Code, then the vested Award shall be settled upon such Change of Control to the extent permitted without adverse tax consequences by Section 409A of the Code. If the Grantee satisfies the requirements of the preceding sentence but the Grantee&#8217;s termination of employment occurs prior to the first anniversary of the Grant Date, then the number of Shares eligible for vesting shall be prorated based on the number of full months from the Grant Date to the Grantee&#8217;s termination of employment divided by 12.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:16.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Rule of 65&#8221; shall mean that the sum of the Grantee&#8217;s age and years of service equals or exceeds 65, with a minimum age of 55 and a minimum of five years of continuous service.</font></div><div><font><br></font></div><div style="padding-left:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Death or Disability</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:10pt;padding-right:15.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event of the Grantee&#8217;s death or Disability while employed by the Company and the Grantee is an &#8220;officer&#8221; under Section 16 of the Exchange Act at the time of such death or Disability, the Award shall vest and be settled within 60 days following such death or Disability.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:10pt;padding-right:27.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Disability&#8221; shall mean that the Grantee is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, determined in accordance with Section 409A of the Code.</font></div><div style="margin-top:3.95pt;padding-left:216.8pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ex104-secondamendmenttocre.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i66fa5437d00449c287748a0afadd48cb_3469"></div><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.4</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECOND AMENDMENT dated as of April 3, 2023 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), to the Credit Agreement (as defined below) among DaVita Inc., as Borrower (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Wells Fargo Bank, National Association, as Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.&#160;&#160;&#160;&#160;The Borrower, the Lenders party thereto from time to time, the other parties thereto and Wells Fargo Bank, National Association, as Administrative Agent (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), Collateral Agent and Swingline Lender, are party to that certain Credit Agreement dated as of August 12, 2019 (as amended by that certain First Amendment, dated as of February 13, 2020, and as may be further amended, supplemented or otherwise modified from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">B.&#160;&#160;&#160;&#160;Pursuant to Section 2.16(b) of the Credit Agreement, if at any time the Administrative Agent determines (which determination shall be made by notice to the Borrower and conclusive absent manifest error) that (i) the circumstances set forth in Section 2.16(a)(i) of the Credit Agreement have arisen and such circumstances are unlikely to be temporary or (ii) the circumstances set forth in Section 2.16(a)(i) of the Credit Agreement have not arisen but either (w) the supervisor for the administrator of the LIBOR Screen Rate has made a public statement that the administrator of the LIBOR Screen Rate is insolvent (and there is no successor administrator that will continue publication of the LIBOR Screen Rate), (x) the administrator of the LIBOR Screen Rate has made a public statement identifying a specific date after which the LIBOR Screen Rate will permanently or indefinitely cease to be published by it (and there is no successor administrator that will continue publication of the LIBOR Screen Rate), (y) the supervisor for the administrator of the LIBOR Screen Rate has made a public statement identifying a specific date after which the LIBOR Screen Rate will permanently or indefinitely cease to be published or (z) the supervisor for the administrator of the LIBOR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which the LIBOR Screen Rate may no longer be used for determining interest rates for loans, then the Administrative Agent and the Borrower shall endeavor to establish an alternate rate of interest to the LIBOR Screen Rate that gives due consideration to the then prevailing market convention for determining a rate of interest for syndicated loans in the United States at such time and to similarly situated borrowers, and shall enter into an amendment to the Credit Agreement to reflect such alternate rate of interest and such other related changes to the Credit Agreement as may be applicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.&#160;&#160;&#160;&#160;Pursuant to Section 2.16(b) of the Credit Agreement, notwithstanding anything to the contrary in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> of the Credit Agreement, such amendment shall become effective without any further action or consent of any other party to the Credit Agreement so long as the Administrative Agent shall not have received, within five (5) Business Days of the date notice of such alternate rate of interest is provided to the Lenders (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Objection Deadline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), a written notice from the Required Lenders of any Class stating that such Required Lenders object to such amendment</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">D.&#160;&#160;&#160;&#160;In order to effect the foregoing, the Borrower and the Administrative Agent desire to amend the Credit Agreement to replace the LIBOR Screen Rate for Dollars with respect to Tranche B-1 Term Loans with an alternate rate of interest, together with certain related changes that are applicable, subject to the terms and conditions set forth herein.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">AGREEMENTS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Borrower and the Administrative Agent hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.37pt">Amendment</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Capitalized terms used herein (including in the recitals hereto) and not otherwise defined herein shall have the meanings assigned to such terms in the Credit Agreement.  The rules of construction specified in Section&#160;1.3 of the Credit Agreement also apply to this Amendment.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.02.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt;text-decoration:underline">Amendment of Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Effective as of the Second Amendment Effective Date&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">the Credit Agreement is hereby amended to delete the stricken text (indicated textually in the same manner as the following example&#58; </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:line-through">stricken text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and to add the double-underlined text (indicated textually in the same manner as the following example&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">double-underlined text</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) as set forth in the Credit Agreement attached as Annex A hereto&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Exhibit H of the Credit Agreement is hereby amended and restated in its entirety in the form attached as Annex B hereto&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Exhibit P of the Credit Agreement is hereby amended and restated in its entirety in the form attached as Annex C hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1.03.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:30.36pt;text-decoration:underline">Amendment Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The effectiveness of this Amendment is subject to the satisfaction of the following conditions precedent (the first date of such satisfaction, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Second Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">The Administrative Agent (or its counsel) shall have received from (i)&#160;the Borrower, and (ii)&#160;the Administrative Agent, either (x) counterparts of this Amendment signed on behalf of such parties or (y) written evidence satisfactory to the Administrative Agent (which may include facsimile or other electronic transmissions of signed signature pages) that such parties have signed counterparts of this Amendment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Administrative Agent shall have not received, by the Objection Deadline, a written notice from the Required Lenders of any Class stating that such Required Lenders object to such amendment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Administrative Agent shall notify the Borrower and the Lenders of the Second Amendment Effective Date and such notice shall be conclusive and binding.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.38pt">Miscellaneous</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.01.&#160;&#160;&#160;&#160;Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  (a) To induce the other parties hereto to enter into this Amendment, the Borrower represents and warrants to each of the Lenders and the Administrative Agent that, as of the Second Amendment Effective Date and after giving effect to the transactions and amendments to occur on the Second Amendment Effective Date, this Amendment has been duly authorized, executed and delivered by the Borrower and constitutes, and the Credit Agreement, as amended hereby on the Second Amendment Effective Date will constitute, its legal, valid and binding obligation, enforceable against each of the Loan Parties in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The representations and warranties of the Borrower set forth in the Loan Documents are, after giving effect to this Amendment on such date, true and correct in all material respects (except that any representation and warranty that is qualified as to &#8220;materiality&#8221; or &#8220;Material Adverse Effect&#8221; shall be true and correct in all respects) on and as of the Second Amendment Effective Date with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date (in which case such representations and warranties were true and correct in all material respects as of such earlier date).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">After giving effect to this Amendment, no Default or Event of Default has occurred and is continuing on the Second Amendment Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.02&#160;&#160;&#160;&#160;Effect of Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  This Amendment shall not constitute a novation of the Credit Agreement or any of the other Loan Documents.  Except as expressly set forth herein, this Amendment (i) shall not by implication or otherwise limit, impair, constitute a waiver of, or otherwise affect the rights and remedies of, the Lenders, the Issuing Lender or the Agents under the Credit Agreement or any other Loan Document, and (ii) shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document. Except as expressly </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">set forth herein, each and every term, condition, obligation, covenant and agreement contained in the Credit Agreement or any other Loan Document is hereby ratified and re-affirmed in all respects and shall continue in full force and effect.  Nothing herein shall be deemed to establish a precedent for purposes of interpreting the provisions of the Credit Agreement or entitle any Loan Party to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document in similar or different circumstances.  This Amendment shall apply to and be effective only with respect to the provisions of the Credit Agreement and the other Loan Documents specifically referred to herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">On and after the Second Amendment Effective Date each reference in the Credit Agreement to &#8220;this Agreement&#8221;, &#8220;hereunder&#8221;, &#8220;hereof&#8221;, &#8220;herein&#8221; or words of like import, and each reference to the Credit Agreement, &#8220;thereunder&#8221;, &#8220;thereof&#8221;, &#8220;therein&#8221; or words of like import in any other Loan Document, shall be deemed a reference to the Credit Agreement, as amended hereby on the Second Amendment Effective Date.  This Amendment shall constitute a &#8220;Loan Document&#8221; for all purposes of the Credit Agreement and the other Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">SECTION 2.03.&#160;&#160;&#160;&#160;Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The jurisdiction and waiver of right to trial by jury provisions in Section 11.12 of the Credit Agreement are incorporated herein by reference mutatis mutandis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.04.&#160;&#160;&#160;&#160;Costs and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Borrower agrees to reimburse the Administrative Agent for its reasonable out of pocket expenses in connection with this Amendment and the transactions contemplated hereby, including the reasonable fees, charges and disbursements of Cahill Gordon &#38; Reindel </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:100%">llp</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, counsel for the Administrative Agent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.05.&#160;&#160;&#160;&#160;Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.  The Administrative Agent may also require that any such documents and signatures delivered by facsimile, .pdf or other electronic means be confirmed by a manually signed original thereof&#59; provided that the failure to request or deliver the same shall not limit the effectiveness of any document or signature delivered by facsimile, .pdf or other electronic means. Any signature to this Amendment may be delivered by facsimile, .pdf, electronic mail or any electronic signature complying with the U.S. federal ESIGN Act of 2000 or the New York Electronic Signature and Records Act or other transmission method any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes to the fullest extent permitted by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.06.&#160;&#160;&#160;&#160;Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 2.07.&#160;&#160;&#160;&#160;Eurodollar Rate Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any other provision herein or in any other Loan Document, to the extent any Tranche B-1 Term Loan bearing interest at the Eurodollar Rate is outstanding on the Second Amendment Effective Date, this Amendment shall not apply to such Tranche B-1 Term Loan in only such a manner such that such Tranche B-1 Term Loan shall continue to bear interest at the Eurodollar Rate until the end of the then-current Interest Period applicable to such Tranche B-1 Term Loan and the provisions of the Credit Agreement applicable thereto shall continue and remain in effect (notwithstanding the consummation of this Amendment and the occurrence of the Second Amendment Effective Date) until the end of the current Interest Period or payment period applicable to such Eurodollar Loan, after which such provisions shall have no further force or effect (and, for the avoidance of doubt, after which the Credit Agreement, as amended by this Amendment, shall apply with full force and effect in all other regards)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> that, for the avoidance of doubt, at any time from and after the Second Amendment Effective Date, the Borrower shall not be permitted to request a borrowing of, </font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">conversion to, or continuation of, any Eurodollar Loan that is a Tranche B-1 Term Loan that is outstanding on the Second Amendment Effective Date.</font></div><div><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_3474"></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their officers as of the date first above written.</font></div><div style="margin-top:17pt;padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.212%"><tr><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DAVITA INC.</font></td></tr><tr style="height:6pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Joel Ackerman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Joel Ackerman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:17pt;padding-left:216pt;text-align:right"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:17pt;padding-left:216pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.212%"><tr><td style="width:1.0%"></td><td style="width:9.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.049%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent</font></td></tr><tr style="height:6pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kirk Tesch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kirk Tesch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Managing Director</font></td></tr></table></div><div id="i66fa5437d00449c287748a0afadd48cb_3479"></div><div style="margin-top:17pt;padding-left:216pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:33.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Annex A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Credit Agreement</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;See attached&#93;</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_1"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.2pt;padding-right:18.65pt;text-align:right"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Annex A</font></div><div><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.25pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:190.05pt;padding-right:190.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">CREDIT AGREEMENT</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:71.97pt;padding-right:71.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Dated as of August 12, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%;text-decoration:line-through">2019</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%;text-decoration:underline">2019,</font></div><div style="padding-left:121.65pt;padding-right:121.65pt;text-align:center;text-indent:-0.15pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">as amended by the First Amendment, dated as of February 13, 2020</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%;text-decoration:underline">and as amended by the Second Amendment, dated as of April 3, 2023</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:190.05pt;padding-right:190.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">among</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:218.35pt;padding-right:218.35pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">DaVita Inc., as Borrower,</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:190.1pt;padding-right:190.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">The Guarantors Party Hereto, The Lenders Party Hereto, and</font></div><div style="padding-left:168.52pt;padding-right:168.52pt;text-align:center;text-indent:-0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Wells Fargo Bank, National Association, as Administrative Agent, Collateral Agent and Swingline lender,</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:157.62pt;padding-right:157.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A. and</font></div><div style="padding-left:207.87pt;padding-right:207.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">MUFG Bank, Ltd., as</font></div><div style="padding-left:190.07pt;padding-right:190.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Co-Syndication Agents,</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:190.05pt;padding-right:190.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Bank of America, N.A., Barclays Bank PLC,</font></div><div style="padding-left:170.42pt;padding-right:170.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Credit Suisse Loan Funding LLC Goldman Sachs Bank USA,</font></div><div style="padding-left:157.62pt;padding-right:157.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Morgan Stanley Senior Funding, Inc., and SunTrust Bank,</font></div><div style="padding-left:71.97pt;padding-right:71.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:114%">as</font></div><div style="padding-left:190.07pt;padding-right:190.07pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Co-Documentation Agents</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:190pt;padding-right:190pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:114%">Wells Fargo Securities, LLC,</font></div><div style="padding-left:157.62pt;padding-right:157.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A.,</font></div><div style="padding-left:199.55pt;padding-right:199.55pt;text-align:center;text-indent:-0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">MUFG Bank, Ltd., Bank of America, N.A., Barclays Bank PLC,</font></div><div style="padding-left:170.45pt;padding-right:170.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA,</font></div><div style="padding-left:157.62pt;padding-right:157.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Morgan Stanley Senior Funding, Inc., and SunTrust Robinson Humphrey, Inc.,</font></div><div style="padding-left:71.97pt;padding-right:71.97pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">as</font></div><div style="padding-left:157.62pt;padding-right:157.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">Joint Lead Arrangers and Joint Bookrunners</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:173.45pt;padding-right:173.45pt;text-align:center;text-indent:-0.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">The Bank of Nova Scotia, and Sumitomo Mitsui Banking Corporation as</font></div><div style="padding-left:71.85pt;padding-right:71.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:113%">Senior Managing Agents</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:71.85pt;padding-right:71.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">BBVA USA,</font></div><div style="padding-left:170.42pt;padding-right:170.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Capital One, National Association, Citizens Bank, N.A.,</font></div><div style="padding-left:190pt;padding-right:190pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:114%">Fifth Third Bank,</font></div><div style="padding-left:170.5pt;padding-right:170.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">HSBC Bank USA, National Association, The Huntington National Bank,</font></div><div style="padding-left:182.87pt;padding-right:182.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">PNC Bank, National Association, Regions Bank,</font></div><div style="padding-left:201.82pt;padding-right:201.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Santander Bank, N.A., and</font></div><div style="padding-left:190.05pt;padding-right:190.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:114%">TD Bank, N.A.</font></div><div style="padding-left:209.92pt;padding-right:209.92pt;text-align:center;text-indent:26.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">as</font></div><div style="padding-left:207.77pt;padding-right:207.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Managing Agents</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_4"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TABLE OF CONTENTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-right:7.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 1 DEFINITIONS&#160;&#160;&#160;&#160;1</font></div><div style="margin-top:11.95pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.01.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Defined Terms&#160;&#160;&#160;&#160;1</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.02.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Classification of Loans&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">49</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">53</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.03.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Terms Generally&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">49</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">53</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.04.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Accounting Terms&#59; GAAP&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">49</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">54</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.05.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Resolution of Drafting Ambiguities&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">50</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">54</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.06.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Exchange Rates&#59; Currency Equivalents.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">50</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">54</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.07.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Additional Alternative Currencies.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">50</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">54</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.08.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Change of Currency.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">51</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">55</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.09.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:31.85pt">Certain Conditions, Calculations and Tests.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">51</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">56</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SECTION 1.010.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:26.35pt">Divisions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">53</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">57</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2 AMOUNT AND TERMS OF COMMITMENTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">53</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">57</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Term Commitments&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">53</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">57</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Procedure for Term Loan Borrowing&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">53</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">58</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Repayment of Term Loans.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">54</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">58</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Revolving Commitments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">54</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">59</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Procedure for Revolving Loan Borrowing&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">55</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">59</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Swingline Commitment.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">56</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">60</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Procedure for Swingline Borrowing&#59; Refunding of Swingline Loans.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">56</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">60</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Commitment Fees, etc.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">58</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">62</font></div><div style="padding-left:77pt;padding-right:8.35pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Termination or Reduction of Revolving Commitments and Tranche A Term Commitments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">59</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">63</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:16.75pt">Optional Prepayments&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:line-through">59</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;text-decoration:underline">64</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Mandatory Prepayments and Commitment Reductions.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">60</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">65</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Conversion and Continuation Options.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">63</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">68</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Limitations on Eurodollar </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">or Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Tranches&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">64</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">68</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Interest Rates and Payment Dates.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">64</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">68</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Computation of Interest and Fees.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">64</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">69</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Inability to Determine Interest Rate&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">65</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">69</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Pro Rata Treatment and Payments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">66</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">73</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Requirements of Law.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">68</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">74</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Taxes&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">69</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">76</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Indemnity&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">71</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">78</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Change of Lending Office&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">79</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Replacement of Lenders&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">72</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">79</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Repayment of Loans&#59; Evidence of Debt.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">79</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Increase in Commitments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">73</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">80</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Extensions of Term Loans and Revolving Commitments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">76</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">83</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Defaulting Lenders&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">79</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">86</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Refinancing Amendments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">80</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">87</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 3 LETTERS OF CREDIT&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">81</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">88</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">LC Commitment.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">81</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">88</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.742%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_7"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:7.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Notice of Issuance, Amendment, Renewal, Extension&#59; Certain Conditions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">82</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">89</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Fees and Other Charges&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">90</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Participations&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">90</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Reimbursement&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">83</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">90</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Obligations Absolute&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">84</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">91</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Disbursement Procedures&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">85</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">92</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Interim Interest&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">85</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">92</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Replacement of the Issuing Lender&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">85</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">92</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Cash Collateralization&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">85</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">92</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Provisions Related to Extended Revolving Commitments&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">86</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">93</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 4 REPRESENTATIONS AND WARRANTIES&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">86</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">93</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Organization&#59; Power&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">86</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">93</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Capital Stock&#59; Subsidiaries&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">94</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Authorization&#59; No Conflicts&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">94</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">No Approvals&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">94</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Enforceability&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">87</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">94</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Litigation&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">94</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Financial Statements&#59; Projections.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">95</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Properties&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">95</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Intellectual Property&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">95</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">No Material Misstatements&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">88</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">95</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Margin Stock&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">96</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Investment Company Act&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">96</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Solvency&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">96</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Employee Benefit Plans.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">89</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">96</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Environmental Laws.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">90</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">97</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Taxes&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">91</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">97</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Government Reimbursement Programs&#59; Medicare&#47;Medicaid&#47;Tricare.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">91</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">98</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Agreements&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">99</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Use of Proceeds&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">100</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Labor Matters&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">100</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">&#91;Reserved&#93;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">100</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Security Documents&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">100</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Anti-Terrorism Law&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">93</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">100</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Beneficial Ownership Certification&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">101</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 5 CONDITIONS PRECEDENT&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">101</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Conditions to Initial Credit Extension&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">94</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">101</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Conditions to All Credit Extensions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">97</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">104</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 6 AFFIRMATIVE COVENANTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">98</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">104</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Reporting Requirements&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">98</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">105</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Compliance with Laws, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">100</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">107</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Payment of Taxes, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">100</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">107</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Compliance with Environmental Laws&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">101</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">107</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Insurance.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">101</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">108</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Preservation of Corporate Existence, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">101</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">108</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:3.898%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt;padding-left:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- ii-</font></div></td></tr></table></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_10"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:7.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Visitation Rights&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">101</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">108</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Keeping of Books&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">102</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">109</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Maintenance of Properties, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">102</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">109</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Transactions with Affiliates&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">102</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">109</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Use of Proceeds&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">109</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Additional Collateral&#59; Additional Guarantors.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">109</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Security Interests&#59; Further Assurances&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">103</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">110</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Ratings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">104</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">111</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Designation of Subsidiaries&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">104</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">111</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Post-Closing Actions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">105</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">111</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 7 NEGATIVE COVENANTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">105</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">111</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Liens, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">105</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">112</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Debt&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">107</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">114</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Change in Nature of Business&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">117</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Mergers, Etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">110</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">117</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Sales, Etc., of Assets&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">111</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">118</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Investments in Other Persons&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">114</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">121</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Restricted Payments&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">117</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">124</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Fiscal Year&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">118</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">125</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Prepayments of Other Debt&#59; Modifications of Constitutive Documents and</font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Other Documents, etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">119</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">125</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Negative Pledge&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">119</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">126</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Payment Restrictions Affecting Restricted Subsidiaries&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">120</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">127</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">&#91;Reserved&#93;.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">121</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">128</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">&#91;Reserved&#93;&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">121</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">128</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Anti-Terrorism Law&#59; Anti-Money Laundering.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">121</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">128</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Embargoed Person&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">121</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">128</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Financial Covenant&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">122</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">128</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 8 EVENTS OF DEFAULT&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">122</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">129</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Events of Default&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">122</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">129</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Application of Proceeds&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">125</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">132</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 9 THE AGENTS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">126</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">133</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Appointment and Authority&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">126</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">133</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Rights as a Lender&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">126</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">133</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Exculpatory Provisions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">126</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">133</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Reliance by Agent&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">127</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">134</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Delegation of Duties&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">127</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">134</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Resignation of Agent&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">135</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Non-Reliance on Agent and Other Lenders&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">135</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">No Other Duties, etc&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">135</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:22.25pt">Withholding Tax&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">128</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">135</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Certain ERISA Matters.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">129</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">136</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_13"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:7.95pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Page</font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 10 GUARANTEE&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">137</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">The Guarantee&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">137</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Obligations Unconditional&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">130</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">137</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Reinstatement&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">131</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">138</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Subrogation&#59; Subordination&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Remedies&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Instrument for the Payment of Money&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Continuing Guarantee&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">General Limitation on Guaranteed Obligations&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Release of Guarantors&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">132</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">139</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Keepwell&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">133</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">140</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 11 MISCELLANEOUS&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">133</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">140</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Amendments and Waivers&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">133</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">140</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Notices.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">135</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">142</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">No Waiver&#59; Cumulative Remedies&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">137</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">144</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Survival&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">137</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">144</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Expenses&#59; Indemnity&#59; Damage Waiver.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">138</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">145</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Successors and Assigns&#59; Participations and Assignments.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">139</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">146</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Adjustments&#59; Set-off.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">143</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">150</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Counterparts&#59; Integration&#59; Effectiveness&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">143</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">150</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.75pt">Severability&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">151</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">WAIVER OF JURY TRIAL&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">151</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">GOVERNING LAW&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">151</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Submission to Jurisdiction&#59; Waivers&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">144</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">151</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Acknowledgments&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">145</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">152</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Releases of Guarantees and Liens.&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">145</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">152</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Confidentiality&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">145</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">152</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Headings&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">146</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">153</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">USA PATRIOT Act&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">146</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">153</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Interest Rate Limitation&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">146</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">153</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Third Party Beneficiary&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">146</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">153</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Acknowledgment and Consent to Bail-In of EEA Financial Institutions&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">154</font></div><div style="padding-left:77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:11.25pt">Acknowledgment Regarding Any Supported QFCs&#160;&#160;&#160;&#160;</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:line-through">147</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">154</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_16"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SCHEDULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:56.84pt">Commitments</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:53.18pt">Specified LC Sublimits</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:49.52pt">Guarantors</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:48.9pt">Unrestricted Subsidiaries</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">1.1&#160;&#160;&#160;&#160;Existing Letters of Credit</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.2&#160;&#160;&#160;&#160;Subsidiaries</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">4.4&#160;&#160;&#160;&#160;Consents, Authorizations, Filings and Notices</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">6.16&#160;&#160;&#160;&#160;Post-Closing Actions</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.1(c)&#160;&#160;&#160;&#160;Existing Liens</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">7.2(b)&#160;&#160;&#160;&#160;Existing Debt</font></div><div style="padding-left:5pt;padding-right:362.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">7.6&#160;&#160;&#160;&#160;Investments </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">EXHIBITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#58;</font></div><div style="margin-top:0.1pt;padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">&#91;Reserved&#93;</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:53.17pt">Form of Compliance Certificate</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:53.17pt">Form of Solvency Certificate</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">D</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">&#91;Reserved&#93;</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:53.79pt">Form of Assignment and Assumption</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">F</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:54.39pt">&#91;Reserved&#93;</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">Form of Prepayment Option Notice</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">Form of Borrowing Request</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:56.84pt">&#91;Reserved&#93;</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:56.22pt">Form of Exemption Certificate</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">&#91;Reserved&#93;</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:53.79pt">Form of Joinder Agreement</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:50.72pt">Form of Intercompany Note</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">N-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:43.4pt">Form of Revolving Loan Note</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">N-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:43.4pt">Form of Tranche A Term Loan Note </font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">N-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:43.4pt">Form of Tranche B-1 Term Loan Note </font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">N-4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:43.4pt">Form of Swingline Note</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%;padding-left:52.56pt">Form of LC Request</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:54.39pt">Form of Interest Election Request</font></div><div style="padding-left:65.45pt;text-indent:-60.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Q</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:52.56pt">Form of First Lien Intercreditor Agreement</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_19"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This CREDIT AGREEMENT, dated as of August 12, 2019 (as may be amended, restated, supplemented or otherwise modified from time to time, this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), among DaVita Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the Guarantors (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) party hereto, the several banks and other financial institutions or entities from time to time lenders under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Bank of America, N.A. , Barclays Bank PLC, Credit Suisse Loan Funding LLC, Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc. and SunTrust Bank, as co-documentation agents (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), Credit Agricole Corporate and Investment Bank, JPMorgan Chase Bank, N.A. and MUFG Bank, Ltd., as co-syndication agents (in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and Wells Fargo Bank, National Association, as administrative agent, collateral agent and swingline lender.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:179.27pt;padding-right:179.27pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">WITNESSETH&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower, the guarantors party thereto, the lenders party thereto from time to time and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, are party to that certain credit agreement, dated as of June 24, 2014, (as amended on March 29, 2018, November 21, 2018 and May 6, 2019, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Borrower intends to redeem any and all of its outstanding 5.750% senior notes due 2022&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:11.3pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, in connection with the consummation of the Transactions (as defined below), the Borrower has requested the Lenders to extend credit in the form of (a) Tranche A Term Loans on or after the Closing Date, in an aggregate principal amount of $1,750,000,000, (b) Tranche B Term Loans on the Closing Date in an aggregate principal amount of $2,750,000,000 and (c) Dollar Revolving Commitments in an aggregate principal amount of $700,000,000 and (d) Alternative Currency Revolving Commitments in an aggregate principal amount of $300,000,000&#59; and</font></div><div style="padding-right:11.3pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:11.3pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the proceeds of the Loans are to be used in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; NOW, THEREFORE, the Lenders are willing to extend such credit to Borrower and the Issuing Lender is willing to issue letters of credit for the account of Borrower on the terms and subject to the conditions set forth herein. Accordingly, the parties hereto agree as follows&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:200.75pt;padding-right:200.75pt;text-align:center;text-indent:-9pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">DEFINITIONS</font></div><div style="padding-left:4.5pt;text-indent:67.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:22.25pt">Defined Terms. As used in this Agreement, the terms listed in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 1.1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">shall have the respective meanings set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2022 Senior Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the 5.750% Senior Notes due 2022 issued pursuant to the 2022 Senior Notes Indenture, including, without limitation, $1,250,000,000 aggregate principal amount of such 5.750% Senior Notes due 2022 outstanding as of the Closing Date and such additional 5.750% Senior Notes due 2022 as may be issued from time to time thereafter.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2022 Senior Notes Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the guarantees of the 2022 Senior Notes pursuant to the 2022 Senior Notes Indenture by the guarantors party to the 2022 Senior Notes Indenture from time to time.</font></div><div style="height:13.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_22"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2022 Senior Notes Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the indenture dated as of August 28, 2012 by and among the Borrower, the guarantors party thereto from time to time and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to which the 2022 Senior Notes were and may be issued, as heretofore amended and supplemented and as the same may be further amended or supplemented from time to time.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2024 Senior Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the 5.125% Senior Notes due 2024 issued pursuant to the 2024 Senior Notes Indenture, including, without limitation, $1,750,000,000 aggregate principal amount of such 5.125% Senior Notes due 2024 Notes outstanding as of the Closing Date and such additional 5.125% Senior Notes due 2024 as may be issued from time to time thereafter.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2024 Senior Notes Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the guarantees of the 2024 Senior Notes pursuant to the 2024 Senior Notes Indenture by the guarantors party to the 2024 Senior Notes Indenture from time to time.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2024 Senior Notes Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the indenture dated as of June 13, 2014 by and among the Borrower, the guarantors party thereto from time to time and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to which the 2024 Senior Notes were issued, and may hereafter be issued, as heretofore amended and supplemented and as the same may be further amended or supplemented from time to time.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2025 Senior Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the 5.000% Senior Notes due 2025 issued pursuant to the 2025 Senior Notes Indenture, including, without limitation, $1,500,000,000 aggregate principal amount of such 5.000% Senior Notes due 2025 outstanding as of the Closing Date and such additional 5.000% Senior Notes due 2025 as may be issued from time to time thereafter.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2025 Senior Notes Guarantees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the guarantees of the 2025 Senior Notes pursuant to the 2025 Senior Notes Indenture by the guarantors party to the 2025 Senior Notes Indenture from time to time.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2025 Senior Notes Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the indenture dated as of April 17, 2015 by and among the Borrower, the guarantors party thereto from time to time and The Bank of New York Mellon Trust Company, N.A., as trustee, pursuant to which the 2025 Senior Notes were issued and may hereafter be issued, as heretofore amended and supplemented and as the same may be further amended or supplemented from time to time.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any day, a rate per annum (rounded upwards, if necessary, to the next 1&#47;100 of 1%) equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#189; of 1% and (c) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i) with respect to Tranche A Term Loans and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Eurodollar Rate applicable on such day (or, if such date is not a Business Day, the immediately preceding Business Day) if a Eurodollar Loan with an Interest Period of one month were being made on such day </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 1%</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> and (ii) with respect to Tranche B-1 Term Loans, Adjusted Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">for a one-month tenor in effect on such day plus 1%</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes hereof&#58; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the rate of interest per annum publicly announced from time to time by the Person serving as Administrative Agent as its prime rate in effect at its principal office in New York City (the Prime Rate not being intended to be the lowest rate of interest charged by the Person serving as Administrative Agent in connection with extensions of credit to debtors). Any change in the ABR due to a change in the Prime Rate or the Federal Funds Effective Rate shall be effective as of the opening of business on the effective day of such change in the Prime Rate or the Federal Funds Effective Rate, respectively&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the ABR shall at no time be less than 0.0% per annum.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_25"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Loans the rate of interest applicable to which is based upon the ABR. ABR Loans shall be denominated in Dollars.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Acquisition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any period commencing on the date that a Material Acquisition is consummated through and including the last day of the fourth full fiscal quarter following the date on which such acquisition is consummated&#59; provided that there shall be at least one full fiscal quarter between any two Acquisition Periods.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Refinancing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, any bank, financial institution or other institutional lender or investor (other than any such bank, financial institution or other institutional lender or investor that is a Lender at such time) that agrees to provide any portion of Credit Agreement Refinancing Debt pursuant to a Refinancing Amendment in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that each Additional Refinancing Lender shall be subject to the approval of (i) the Administrative Agent, such approval not to be unreasonably withheld or delayed, to the extent that each such Additional Refinancing Lender is not then an existing Lender, an Affiliate of a then existing Lender or an Approved Fund, (ii) in the case of any Other Revolving Commitments, the Issuing Lender and the Swingline Lender and (iii) the Borrower.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;text-indent:74.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Adjusted Term SOFR&#8221; means, for purposes of any calculation, the rate per annum equal to (a) Term SOFR for such calculation plus (b) the Term SOFR Adjustment&#59; provided that if Adjusted</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR as so determined shall ever be less than 0.00% per annum, then Adjusted Term SOFR shall be deemed to be 0.00% per annum.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;text-indent:74.75pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustment Date&#8221; shall have the meaning given to such term in the definition of &#8220;Pricing Grid.&#8221;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:24.45pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Wells Fargo Bank, National Association, together with its affiliates, as the arranger of the Commitments and as the administrative agent for the Lenders under this Agreement and the other Loan Documents, together with any of its successors.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:22.15pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Questionnaire</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an Administrative Questionnaire in a form supplied by the Administrative Agent.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Person, any other Person that, directly or indirectly, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, &#8220;control&#8221; of a Person shall mean the power, directly or indirectly, to direct or cause the direction of the management and policies of such Person, whether by contract or otherwise.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Syndication Agents, the Documentation Agents, the Collateral Agent and the Administrative Agent.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Exposure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Lender at any time, an amount equal to the sum of (i) the aggregate then unpaid principal amount of such Lender&#8217;s Term Loans and (ii) the amount of such Lender&#8217;s Revolving Commitment then in effect or, if the Revolving Commitments have been terminated, the amount of such Lender&#8217;s Revolving Extensions of Credit then outstanding.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Exposure Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Lender at any time, the ratio (expressed as a percentage) of such Lender&#8217;s Aggregate Exposure at such time to the Aggregate Exposure of all Lenders at such time.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the preamble hereto.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_28"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each of Dollars, Euro and Sterling and each other currency that is approved in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, with respect to any amount denominated in Dollars, (i) if the applicable Alternative Currency is other than Dollars, the equivalent amount thereof in such Alternative Currency as determined by the Administrative Agent at such time on the basis of the Spot Rate (determined in respect of the most recent Revaluation Date) for the purchase of such Alternative Currency with Dollars or (ii) if the applicable Alternative Currency is Dollars, such amount.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency LC Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, an amount equal to the sum of (a) the aggregate then undrawn and unexpired amount of the then outstanding Alternative Currency Letters of Credit and (b) the aggregate amount of all LC Disbursements in respect of Alternative Currency Letters of Credit that have not then been reimbursed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Alternative Currency LC Obligations of any Lender at any time shall be its Alternative Currency Revolving Percentage of the total Alternative Currency LC Obligations at such time.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Letter of Credit issued under the Alternative Currency Revolving Facility.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Lender, the obligation of such Lender, if any, to make Alternative Currency Revolving Loans and participate in Swingline Loans and Alternative Currency Letters of Credit in an aggregate principal and&#47;or face amount not to exceed the amount set forth opposite such Lender&#8217;s name on Schedule I, in an Increase Joinder or in the Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.05pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Alternative Currency Revolving Lender at any time, an amount equal to the sum of (a) the aggregate principal amount of all Alternative Currency Revolving Loans held by such Lender then outstanding, (b) such Lender&#8217;s Alternative Currency Revolving Percentage of the LC Obligations then outstanding and (c) such Lender&#8217;s Alternative Currency Revolving Percentage of the aggregate principal amount of Swingline Loans then outstanding.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Alternative Currency Revolving Commitments and the Alternative Currency Revolving Loans made thereunder.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Lender that has an Alternative Currency Revolving Commitment or holds Alternative Currency Revolving Loans.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Alternative Currency Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Alternative Currency Revolving Lender at any time, the percentage which such Lender&#8217;s Alternative Currency Revolving Commitment then constitutes of the Total Alternative Currency Revolving Commitments or, at any time after the Alternative Currency Revolving Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender&#8217;s Alternative Currency Revolving Loans then outstanding constitutes of the aggregate principal amount of the Alternative Currency Revolving Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the event that the Alternative Currency Revolving Loans are paid in full prior to the reduction to zero of the Total Alternative Currency Revolving Extensions of Credit, the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_31"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:13.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternative Currency Revolving Percentages shall be the Alternative Currency Revolving Percentages in effect immediately prior to such payment in full.</font></div><div style="padding-right:13.4pt;text-align:justify"><font><br></font></div><div style="margin-top:2.5pt;padding-left:4.5pt;padding-right:12.45pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Anti-Terrorism Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Section 4.23(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Applicable Margin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean, for each Type of Loan, the rate per annum set forth under the relevant column heading below&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:43.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.867%"><tr><td style="width:1.0%"></td><td style="width:50.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.281%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:28.05pt;padding-right:28.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR Loans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.32pt;padding-right:1.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:87%">Eurodollar Loans</font></div></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1.1pt;padding-left:6.52pt;padding-right:6.52pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%;text-decoration:underline">or Term SOFR</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.52pt;padding-right:6.52pt;text-align:center"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%;text-decoration:underline">Loans</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">Revolving Loans and Swingline Loans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:28.05pt;padding-right:28.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.50%</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.45pt;padding-right:6.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">1.50%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">Tranche A Term Loans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:28.05pt;padding-right:28.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.50%</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.45pt;padding-right:6.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">1.50%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Tranche B-1 Term Loans</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:28.05pt;padding-right:28.05pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">0.75%</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.45pt;padding-right:6.45pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">1.75%</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on and after the first Adjustment Date occurring after the completion of the Fiscal Quarter of the Borrower ending December 31, 2019, the Applicable Margin in respect of all Loans (other than the Tranche B-1 Term Loans) will be determined pursuant to the Pricing Grid.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Applicable Participants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) with respect to any Alternative Currency Letter of Credit, the Alternative Currency Revolving Lenders and (ii) with respect to any Dollar Letters of Credit, the Dollar Revolving Lenders.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Application</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an application, in such form as the Issuing Lender may specify from time to time, requesting the Issuing Lender to open a Letter of Credit.</font></div><div style="padding-right:9pt"><font><br></font></div><div style="margin-top:2.5pt;padding-left:77pt;padding-right:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Section 11.6(b)</font></div><div style="padding-right:23.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Asset Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Disposition of property (including sales and issuances of Capital Stock of any Restricted Subsidiary (other than sales and issuances that do not decrease the percentage ownership of the Borrower and its Restricted Subsidiaries in each class of Capital Stock of such Restricted Subsidiary)) or series of related Dispositions of property (excluding any such Disposition permitted by clauses (a) &#8211; (e), (g), (h), (i), (j), (l) &#8211; (t) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) that yields Net Cash Proceeds to any Restricted Company (valued at the initial principal amount thereof in the case of non-cash proceeds consisting of notes or other debt securities and valued at fair market value in the case of other non-cash proceeds) in excess of $50,000,000 (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the issuance and sale of the Borrower&#8217;s stock by the Borrower shall not be deemed an &#8220;Asset Sale&#8221;).</font></div><div style="padding-right:23.75pt"><font><br></font></div><div style="margin-top:2.2pt;padding-left:77pt;padding-right:12.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Section 11.6(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">. </font></div><div style="padding-right:12.25pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignment and Assumption</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an Assignment and Assumption, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Attributable Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, on any date, in respect of any Financing Lease of any Person, the capitalized amount thereof that would appear on a balance sheet as debt of such Person prepared as of such date in accordance with GAAP.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Alternative Currency Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Alternative Currency Revolving Lender at any time, an amount equal to (a) such Lender&#8217;s Alternative Currency Revolving Commitment then in effect minus (b) such Lender&#8217;s Alternative Currency Revolving</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_34"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Extensions of Credit then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in calculating any Lender&#8217;s Alternative Currency Revolving Extensions of Credit for the purpose of determining such Lender&#8217;s Available Alternative Currency Revolving Commitment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the aggregate principal amount of Swingline Loans then outstanding shall be deemed to be zero.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), an amount equal to (a) Cumulative Consolidated Net Income </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the aggregate sum of (i) Investments made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(k)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) the amount of purchases, redemptions, acquisitions, dividends and distributions made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7(d)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iii) the amount of payments, prepayments, redemptions or acquisitions of Debt pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.9(a)(ii)(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in each case during the period from and including the Business Day immediately following the Closing Date through and including the Available Amount Reference Date (without taking into account the intended usage of the Available Amount on such Available Amount Reference Date). For the avoidance of doubt, if the Available Amount is a negative amount, it shall not reduce availability hereunder under any other exception or provision not based on the Available Amount.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Dollar Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Dollar Revolving Lender at any time, an amount equal to (a) such Lender&#8217;s Dollar Revolving Commitment then in effect minus (b) such Lender&#8217;s Dollar Revolving Extensions of Credit then outstanding.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Available Dollar Revolving Commitment and the Available Alternative Currency Revolving Commitment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:27.4pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Available Tenor&#8221; means, as of any date of determination and with respect to any then-current Benchmark for Dollars, as applicable, (a) if such Benchmark is a term rate, any tenor for such Benchmark (or component thereof) that is or may be used for determining the length of an interest period pursuant to this Agreement or (b) otherwise, any payment period for interest calculated with reference to such Benchmark (or component thereof) that is or may be used for determining any frequency of making payments of interest calculated with reference to such Benchmark, in each case, as of such date and not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to Section 2.16(B)(b)(iv).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bail-In Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any EEA Member Country implementing Article 55 of Directive 2014&#47;59&#47;EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Bankruptcy Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, such Person has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, custodian, assignee for the benefit of creditors or similar Person charged with the reorganization or liquidation of its business appointed for it, or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such proceeding or appointment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Bankruptcy Event shall not result solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority or instrumentality thereof if such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_37"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark&#8221; means, initially, the Term SOFR Reference Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:8.7pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Replacement&#8221; means, with respect to any Benchmark Transition Event for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any then-current Benchmark, the sum of&#58; (a) the alternate benchmark rate that has been selected by the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrative Agent and the Borrower as the replacement for such Benchmark giving due consideration</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">to (i) any selection or recommendation of a replacement benchmark rate or the mechanism for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">determining such a rate by the Relevant Governmental Body or (ii) any evolving or then-prevailing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">market convention for determining a benchmark rate as a replacement for such Benchmark for syndicated</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">credit facilities denominated in Dollars at such time and (b) the related Benchmark Replacement</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment&#59; provided that, if such Benchmark Replacement as so determined would be less than 0.00%</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">per annum, such Benchmark Replacement will be deemed to be 0.00% per annum for the purposes of this</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement and the other Loan Documents.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:13.9pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Replacement Adjustment&#8221; means, with respect to any replacement of any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">then-current Benchmark with an Unadjusted Benchmark Replacement for any applicable Available</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tenor, the spread adjustment, or method for calculating or determining such spread adjustment, (which</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">may be a positive or negative value or zero) that has been selected by the Administrative Agent and the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower giving due consideration to (a) any selection or recommendation of a spread adjustment, or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">method for calculating or determining such spread adjustment, for the replacement of such Benchmark</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">with the applicable Unadjusted Benchmark Replacement by the Relevant Governmental Body or (b) any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">evolving or then-prevailing market convention for determining a spread adjustment, or method for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">calculating or determining such spread adjustment, for the replacement of such Benchmark with the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable Unadjusted Benchmark Replacement for syndicated credit facilities denominated in Dollars.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Replacement Date&#8221; means the earliest to occur of the following events with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">respect to the then-current Benchmark for Dollars&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:15.4pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">in the case of clause (a) or (b) of the definition of &#8220;Benchmark Transition Event,&#8221; the later of (i) the date of the public statement or publication of information referenced therein and (ii) the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to provide all Available Tenors of such Benchmark (or such component thereof)&#59; or</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:8.2pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">in the case of clause (c) of the definition of &#8220;Benchmark Transition Event,&#8221; the first date on which such Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be non-representative&#59; provided that such non-representativeness will be determined by reference to the most recent statement or publication referenced in such clause (c) and even if any Available Tenor of such Benchmark (or such component thereof) continues to be provided on such date.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">For the avoidance of doubt, the &#8220;Benchmark Replacement Date&#8221; will be deemed to have</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">occurred in the case of clause (a) or (b) with respect to any Benchmark upon the occurrence of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable event or events set forth therein with respect to all then-current Available Tenors of such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark (or the published component used in the calculation thereof).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Transition Event&#8221; means, with respect to the then-current Benchmark for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars, the occurrence of one or more of the following events with respect to such Benchmark&#58;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_40"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:17.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">a public statement or publication of information by or on behalf of the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administrator of such Benchmark (or the published component used in the calculation thereof)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">announcing that such administrator has ceased or will cease to provide all Available Tenors of such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark (or such component thereof), permanently or indefinitely&#59; provided that, at the time of such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">statement or publication, there is no successor administrator that will continue to provide any Available</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tenor of such Benchmark (or such component thereof)&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:13.15pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">a public statement or publication of information by the regulatory supervisor for </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the administrator of such Benchmark (or the published component used in the calculation thereof), the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board, the Federal Reserve Bank of New York, the central bank for Dollars, an insolvency official with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">jurisdiction over the administrator for such Benchmark (or such component), a resolution authority with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">similar insolvency or resolution authority over the administrator for such Benchmark (or such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">component), which states that the administrator of such Benchmark (or such component) has ceased or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or indefinitely&#59; provided that, at the time of such statement or publication, there is no successor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administrator that will continue to provide any Available Tenor of such Benchmark (or such component</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">thereof)&#59; or</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:13.15pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">a public statement or publication of information by the regulatory supervisor for </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the administrator of such Benchmark (or the published component used in the calculation thereof)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">announcing that all Available Tenors of such Benchmark (or such component thereof) are not, or as of a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">specified future date will not be, representative.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">For the avoidance of doubt, a &#8220;Benchmark Transition Event&#8221; will be deemed to have</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">occurred with respect to any Benchmark if a public statement or publication of information set forth</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">above has occurred with respect to each then-current Available Tenor of such Benchmark (or the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">published component used in the calculation thereof).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:8.05pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Transition Start Date&#8221; means, with respect to any Benchmark for Dollars, in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the case of a Benchmark Transition Event, the earlier of (a) the applicable Benchmark Replacement Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">and (b) if such Benchmark Transition Event is a public statement or publication of information of a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> prospective event, the 90</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">day prior to the expected date of such event as of such public statement or </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">publication of information (or if the expected date of such prospective event is fewer than 90 days after</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such statement or publication, the date of such statement or publication).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Benchmark Unavailability Period&#8221; means, with respect to any then-current Benchmark for Dollars, the period (if any) (x) beginning at the time that a Benchmark Replacement Date with respect to such Benchmark pursuant to clauses (a) or (b) of that definition has occurred if, at such time, no Benchmark Replacement has replaced such Benchmark for all purposes hereunder and under any Loan Document in accordance with Section 2.16(B)(b)(i) and (v) ending at the time that a Benchmark Replacement has replaced such Benchmark for all purposes hereunder and under any Loan Document in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">accordance with Section 2.16(B)(b)(i).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a certification regarding beneficial ownership as required by the Beneficial Ownership Regulation.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means 31 C.F.R. &#167; 1010.230.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefit Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of (a) an &#8220;employee benefit plan&#8221; (as defined in ERISA) that is subject to Title I of ERISA, (b) a &#8220;plan&#8221; as defined in and subject to Section 4975 of the Code or (c)</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_43"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">any Person whose assets include (for purposes of ERISA Section 3(42) or otherwise for purposes of Title I of ERISA or Section 4975 of the Code) the assets of any such &#8220;employee benefit plan&#8221; or &#8220;plan&#8221;.</font></div><div style="padding-right:10.8pt"><font><br></font></div><div style="margin-top:2.5pt;padding-left:77pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Benefitted Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Section 11.7(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean the Board of Governors of the Federal Reserve System of the United</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:91%">States (or any successor).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, (i) in the case of any corporation, the board of directors of such Person, (ii) in the case of any limited liability company, the board of managers of such Person, (iii) in the case of any partnership, the Board of Directors of the general partner of such Person and (iv) in any other case, the functional equivalent of the foregoing.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="padding-right:14.15pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the preamble hereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrowing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Business Day specified by the Borrower as a date on which the Borrower requests the relevant Lenders to make Loans hereunder.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:67.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Borrowing Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean a Borrowing Request substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit H</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Business Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) with respect to Obligations denominated in Dollars, a day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law to close and (ii) with respect to Obligations denominated in an Alternative Currency (other than Dollars), a day on which banks are open for general business in London and, in each case,</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">if such day relates to any interest rate settings as to a Eurodollar Loan denominated in Dollars, any fundings, disbursements, settlements and payments in Dollars in respect of any such Eurodollar Loan, or any other dealings in Dollars to be carried out pursuant to this Agreement in respect of any such Eurodollar Loan, means any such day on which dealings in deposits in Dollars are conducted by and between banks in the London interbank eurodollar market&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">if such day relates to any interest rate settings as to a </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan denominated in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Euro</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any fundings, disbursements, settlements and payments in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Euro</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in respect of any such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan, or any other dealings in </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Euro</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to be carried out pursuant to this Agreement in respect of any such </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan, means any such day except a day on which the Securities Industry and Financial Markets</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Association recommends that the fixed income departments of its members be closed for the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">entire day for purposes of trading in United States government securities&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41pt;padding-right:15.6pt;text-indent:36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">if such day relates to any interest rate settings as to a Eurodollar Loan denominated in Euro, any fundings, disbursements, settlements and payments in Euro in respect</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">of any such Eurodollar Loan, or any other dealings in Euro to be carried out pursuant to this</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement in respect of any such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eurodollar Loan, means (i) a TARGET Day and (ii) a day on which banks are open for general business in London&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;if such day relates to any interest rate settings as to a Eurodollar Loan denominated in Sterling, means any such day on which dealings in deposits in Sterling are conducted by and between banks in the London or other applicable offshore interbank market for Sterling&#59; and</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_46"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:17.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">d</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#160;&#160;&#160;&#160;if such day relates to any fundings, disbursements, settlements and payments in Sterling in respect of a Eurodollar Loan denominated in Sterling, or any other dealings in Sterling to be carried out pursuant to this Agreement in respect of any such Eurodollar Loan (other than any interest rate settings), means any such day on which banks are open for foreign exchange business in London.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, all equipment, fixed assets and Real Property or improvements of such Person, or replacements or substitutions therefor or additions thereto that, in accordance with GAAP, have been or should be reflected as additions to property, plant or equipment on the balance sheet of such Person.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Expenditures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person for any period, all expenditures made directly or indirectly by such Person during such period for Capital Assets related to acquiring, maintaining, replacing or repairing existing property or assets (including any Dialysis Facility) of such Person (whether paid in cash or other consideration or accrued as a liability), but, for the avoidance of doubt, excluding any Investments permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For purposes of this definition, the purchase price of equipment or other fixed assets that are purchased simultaneously with the trade-in of existing assets or with insurance proceeds shall be included in Capital Expenditures only to the extent of the amount by which such purchase price exceeds the credit granted by the seller of such assets for the assets being traded in at such time or the amount of such insurance proceeds, as the case may be.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Capital Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any and all shares, interests, participations or other equivalents (however designated) of capital stock of a corporation, any and all equivalent ownership interests in a Person (other than a corporation) and any and all warrants, rights or options to purchase any of the foregoing.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Captive Insurance Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, any Subsidiary that is regulated as an insurance company by a state health, financing, insurance or human services agency in the United States.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) securities with maturities of one year or less from the date of acquisition, or floating rate securities with longer maturities but rate resets within a year, issued, fully guaranteed or insured by the United States of America (or any agency or instrumentality thereof), or any foreign government or supranational organization, rated AAA by S&#38;P and Aaa by Moody&#8217;s, (b) securities with maturities of one year or less from the date of acquisition issued, fully guaranteed by any State of the United States of America or any political subdivision thereof either (i) rated at least AA- or SP1 by S&#38;P or Aa3 or MIG1 by Moody&#8217;s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two named rating agencies cease publishing ratings of investments or (ii) fully collateralized by securities described in clause (a) and&#47;or cash, (c) certificates of deposit, time deposits, overnight bank deposits, bankers&#8217; acceptances and repurchase agreements issued by a Qualified Issuer or fully insured or guaranteed by the United States of America (or any agency or instrumentality thereof) to the extent the same are backed by the full faith and credit of the United States of America having maturities of one year or less from the date of acquisition, (d) commercial paper or corporate bonds of an issuer rated at least A-2 by S&#38;P or P-2 by Moody&#8217;s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two named rating agencies cease publishing ratings of investments, and having maturities of 270 days or less from the date of acquisition, (e) money market accounts or funds, mutual funds, or funds exempt from SEC registration, a substantial portion of the assets of which constitute Cash Equivalents described in clauses (a) through (d) above, with, issued by or managed by Qualified Issuers, (f) money market accounts or funds, mutual funds, or funds exempt from SEC registration, a substantial portion of the assets of which constitute Cash Equivalents described in clauses (a) through (d) above, which money market accounts or funds have net assets of not less than</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_49"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$500,000,000 and have the highest rating available of either S&#38;P or Moody&#8217;s, or carrying an equivalent rating by a nationally recognized rating agency if both of the two named rating agencies cease publishing ratings of investments and (g) money market accounts or funds rated at least AA by S&#38;P and at least Aa by Moody&#8217;s.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Flow from Operating Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the net cash provided by operating activities of the Borrower and its Restricted Subsidiaries, determined on a Consolidated basis in accordance with GAAP, as set forth on the financial statements delivered by the Borrower pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any agreement to provide cash management services, including treasury, depository, overdraft, purchasing card, travel and entertainment card, credit or debit card, electronic funds transfer and other cash management arrangements.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.25pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cash Management Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Person that, at the time it enters into a Cash Management Agreement (or with respect to Cash Management Agreements existing on the Closing Date, on the Closing Date), is the Administrative Agent, a Lender or an Affiliate of the Administrative Agent or a Lender, in its capacity as a party to such Cash Management Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">CERCLA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended, 42 U.S.C. &#167; 9601 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., and all implementing regulations.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt;padding-right:23.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.18(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall mean at any time&#58;</font></div><div style="margin-top:0.15pt;padding-left:41pt;padding-right:12.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any &#8220;person&#8221; or &#8220;group&#8221; (each as used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act) other than a Permitted Holder (i) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of Voting Interests in the Borrower (including through securities convertible into or exchangeable for such Voting Interests) representing 35% or more of the combined voting power of all of the Voting Interests in the Borrower (on a fully diluted basis) or (ii) otherwise has the ability, directly or indirectly, to elect a majority of the Board of Directors of the Borrower&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">during any period of two consecutive years, individuals who at the beginning of such period constituted the Board of Directors of the Borrower (together with any new directors whose election to such Board of Directors or whose nomination for election was approved by a vote of a majority of the members of the Board of Directors of the Borrower, which members comprising such majority were either directors at the beginning of such period or were elected or nominated by such directors) have ceased for any reason to constitute a majority of the Board of Directors of the Borrower&#59; or</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">the occurrence of a Specified Change of Control&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that notwithstanding the foregoing the occurrence of a reorganization that results in all the Capital Stock of the Borrower being held by a Parent Entity shall not result in a Change of Control, so long as the shareholders of the Parent Entity immediately after such reorganization are substantially the same as the shareholders of the Borrower (with substantially equivalent ownership percentages) immediately preceding such reorganization.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_52"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:8.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; when used in reference to any Loan or borrowing, refers to whether such Loan, or the Loans comprising such borrowing, are Dollar Revolving Loans, Alternative Currency Revolving Loans, Tranche A Term Loans, Tranche B-1 Term Loans, Incremental Term Loans, Extended Term Loans, Other Revolving Loans or Other Term Loans&#59; when used in reference to any Commitment, refers to whether such Commitment is a Tranche A Term Commitment, Tranche B-1 Term Commitment, Dollar Revolving Commitment, Alternative Currency Revolving Commitment, Incremental Term Loan Commitment, Increased Revolving Commitment, Extended Revolving Commitment, Other Term Loan Commitment or Other Revolving Commitment&#59; and, when used in reference to any Lender, refers to whether such Lender has a Loan or Commitment with respect to a particular Class.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Closing Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the date on which the conditions precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall have been satisfied or waived.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Internal Revenue Code of 1986, as amended from time to time. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Collateral as defined in the Security Agreement and all other property of the Loan Parties, now owned or hereafter acquired, or in which a Loan Party otherwise has rights, title or interest, upon which a Lien is purported to be created by any Security Document.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Collateral Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Wells Fargo Bank, National Association, in its capacity as collateral agent for the Secured Parties and the Issuing Lender, and its successors.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Lender, the sum of the Tranche A Term Commitment, the Tranche B-1 Term Commitment and the Revolving Commitment of such Lender and any Commitment extended by such Lender as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment Fee Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean 0.25% per annum&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on and after the first Adjustment Date occurring after the completion of the Fiscal Quarter of the Borrower ending December 31, 2019, the Commitment Fee Rate will be determined pursuant to the Pricing Grid.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commodity Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Commodity Exchange Act (7 U.S.C. &#167; 1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.), as amended from time to time, and any successor statute.</font></div><div style="padding-right:12.45pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a certificate duly executed by a Responsible Officer substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conduit Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any special purpose corporation organized and administered by any Lender for the purpose of making Loans otherwise required to be made by such Lender and designated by such Lender in a written instrument&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the designation by any Lender of a Conduit Lender shall not relieve the designating Lender of any of its obligations to fund a Loan under this Agreement if, for any reason, its Conduit Lender fails to fund any such Loan, and the designating Lender (and not the Conduit Lender) shall have the sole right and responsibility to deliver all consents and waivers required or requested under this Agreement with respect to its Conduit Lender, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no Conduit Lender shall (a) be entitled to receive any greater amount pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> than the designating Lender would have been entitled to receive in respect of the extensions of credit made by such Conduit Lender or (b) be deemed to have any Commitment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Healthcare Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_55"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential Information Memorandum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Confidential Information Memorandum dated July 2019, and furnished to certain Lenders.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conforming Changes&#8221; means, with respect to the use or administration of an initial</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark or the use, administration, adoption or implementation of any Benchmark Replacement, any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">technical, administrative or operational changes (including changes to the definition of &#8220;ABR&#8221;, the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period&#8221; or any similar or analogous definition (or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the addition of a concept of &#8220;interest period&#8221;), timing and frequency of determining rates and making</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicability and length of lookback periods, the applicability of Section 2.20 and other technical,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administrative or operational matters) that the Administrative Agent reasonably decides may be</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">appropriate to reflect the adoption and implementation of any such rate or to permit the use and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administration thereof by the Administrative Agent in a manner substantially consistent with market</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">practice (or, if the Administrative Agent reasonably decides that adoption of any portion of such market</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">practice is not administratively feasible or if the Administrative Agent reasonably determines that no</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">market practice for the administration of any such rate exists, in such other manner of administration as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the Administrative Agent reasonably decides is reasonably necessary in connection with the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administration of this Agreement and the other Loan Documents).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Consolidated&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">consolidated</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean the consolidation of accounts in accordance with GAAP.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:10.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated EBITDA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean with respect to any Person for any period, the amount equal to the sum of (a) the Consolidated Net Income of such Person and its Restricted Subsidiaries for such period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the sum of each of the following expenses that have been deducted in the determination of the Consolidated Net Income of such Person and its Restricted Subsidiaries for such period&#58; (i) the Consolidated Interest Expense of such Person and its Restricted Subsidiaries for such period and any cash charges for refinancing any of the Obligations, (ii) all income tax expense (whether federal, state, local, foreign or otherwise) of such Person and its Restricted Subsidiaries for such period, (iii) all depreciation expense of such Person and its Restricted Subsidiaries for such period, (iv) all amortization expense of such Person and its Restricted Subsidiaries for such period, (v) cash fees, expenses, charges, debt extinguishment costs and other costs incurred in connection with the Transactions, (vi) all non-cash charges, write-downs, expenses, losses or items otherwise deducted in determining the Consolidated Net Income of such Person and its Restricted Subsidiaries for such period (excluding any non-cash charge that results in an accrual of a reserve for cash charges in any future period or amortization of a prepaid cash expense that was paid in a prior period not included in the calculation)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that for any period, the amount of non-cash charges arising from the write-off of current assets shall not be included in this subclause (vi), (vii) consolidated expenses for valuation adjustments or impairment charges, (viii) all expenses and charges relating to non-controlling interests and equity income in Restricted Subsidiaries, (ix) all extraordinary losses subtracted in determining the Consolidated Net Income of such Person and its Restricted Subsidiaries for such period, (x) any losses of a Person (other than a Restricted Subsidiary) in which the Borrower or any of its Restricted Subsidiaries has an ownership interest that is accounted for using the equity method, (xi) cash fees, expenses, charges, debt extinguishment costs and other costs incurred in connection with any Investments permitted by Section 7.6(e), (f), (j) or (i) and any sale, lease transfer or other disposition of assets permitted by Section 7.5(f), (g), (h), (i), (j), (k) or (m), (xii) cash expenses attributable to the early extinguishment or conversion of Debt (including deferred financing expenses written off and premiums paid) and (xiii) unusual or nonrecurring losses or charges for such period </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (c) all extraordinary gains added in determining the Consolidated Net Income of such Person and its Restricted Subsidiaries for such period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (d) the aggregate amount of all non-cash items increasing Consolidated Net Income (other than the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_58"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">accrual of revenue or recording of receivables in the ordinary course of business)for such period, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">minus</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(e) unusual or nonrecurring gains for such period.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the context otherwise requires, each reference to &#8220;Consolidated EBITDA&#8221; in this Agreement shall be deemed to refer to the Consolidated EBITDA of the Borrower and the Restricted Subsidiaries.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Consolidated EBITDA shall be calculated on a Pro Forma Basis to give effect to Specified Transactions that have been made at any time on or after the first day of the Measurement Period thereof but prior to or contemporaneously with the event for which the calculation is made (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) as if each such Specified Transaction had been consummated on the day prior to the first day of such period. Notwithstanding anything to the contrary contained in this paragraph, when calculating the Leverage Ratio for purposes of (i) the Pricing Grid, (ii) the ECF Percentages and (iii) determining actual compliance (and not compliance on a Pro Forma Basis) with any covenant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) any Specified Transactions that occurred subsequent to the end of the applicable Measurement Period shall not be given </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro forma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> effect and (B) such calculations shall be based on the financial statements delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, for the relevant Measurement Period.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:12.1pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Interest Expense</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person for any period, the gross interest expense accrued on all Debt of such Person and its Restricted Subsidiaries during such period, determined on a Consolidated basis and in accordance with GAAP for such period, including, without limitation, (a) in the case of the Borrower, all fees paid or payable pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) commissions, discounts and other fees and charges paid or payable in connection with letters of credit (including, without limitation, the Letters of Credit), (c) all amortization of original issue discount in respect of all Debt of such Person and its Restricted Subsidiaries, (d) all dividends on Redeemable Preferred Interests, to the extent paid or payable in cash, (e) commissions, discounts, yield and other fees and charges incurred in connection with any Permitted Receivables Financing which are payable to any Person other than the Borrower or a Guarantor, (f) imputed interest on Financing Lease Obligations of the Borrower and its Restricted Subsidiaries for such period (but excluding, for the avoidance of doubt, any lease, rental or other expense in connection with a Non-Financing Lease Obligation) and (g) cash contributions to any employee stock ownership plan or similar trust to the extent such contributions are used by such plan or trust to pay interest or fees to any Person (other than such Person and its Restricted Subsidiaries) in connection with Debt incurred by such plan or trust, minus interest income of the Borrower and its Restricted Subsidiaries received upon cash and Cash Equivalents during such period.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of this definition, interest on a Financing Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by the Borrower to be the rate of interest implicit in such Financing Lease Obligation in accordance with GAAP (or, if not implicit, as otherwise determined in accordance with GAAP).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any period, the consolidated net income (or net loss) of the Restricted Companies, determined on a Consolidated basis in accordance with GAAP&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that there shall be excluded (a) the income (or deficit) of any Person accrued prior to the date it becomes a Restricted Subsidiary of the Borrower or is merged into or consolidated with the Borrower or any of its Restricted Subsidiaries (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such income (or deficit) may be included in pro forma calculations as otherwise provided in this Agreement), (b) the income (or deficit) of any Person (other than a Restricted Subsidiary of the Borrower) in which the Borrower or any of its Restricted Subsidiaries has an ownership interest, except to the extent that any such income is actually received by the Borrower or such Restricted Subsidiary in the form of dividends or similar distributions and (c) solely for purposes of calculating the Cumulative Consolidated Net Income, the undistributed earnings of any Restricted</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_61"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subsidiary of the Borrower to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary is not at the time permitted by the terms of any Contractual Obligation (other than under any Loan Document) or Requirement of Law applicable to such Restricted Subsidiary.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Consolidated Tangible Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, the consolidated assets of such Person and its Restricted Subsidiaries as determined in accordance with GAAP (and if applicable as appearing within the Required Financial Information) minus goodwill and other amortizable intangible assets.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Constitutive Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, the certificate of incorporation or registration (including, if applicable, certificate of change of name), articles of incorporation or association, memorandum of association, charter, bylaws, certificate of limited partnership, partnership agreement, trust agreement, joint venture agreement, certificate of formation, articles of organization, limited liability company operating or members agreement, joint venture agreement or one or more similar agreements, instruments or documents constituting the organizational or governing documents of such Person.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Contingent Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, any obligation or arrangement of such Person to guarantee or intended to guarantee any Debt, (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) of any other Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in any manner, whether directly or indirectly, including, without limitation, (a) the direct or indirect guarantee, endorsement (other than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the primary obligations of a primary obligor, (b) the obligation to make take-or-pay or similar payments, if required, regardless of non-performance by any other party or parties to an agreement or (c) any obligation of such Person, whether or not contingent, (i) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (ii) to advance or supply funds (A) for the purchase or payment of any such primary obligation or (B) to maintain working capital, equity capital, net worth or other balance sheet condition or any income statement condition of the primary obligor or otherwise to maintain the solvency of the primary obligor, (iii) to purchase, lease or otherwise acquire property, assets, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (iv) otherwise to assure or hold harmless the holder of such primary obligation against loss in respect thereof. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such Contingent Obligation is made (or, if less, the maximum amount of such primary obligation for which such Person may be liable pursuant to the terms of the agreement, instrument or other document evidencing such Contingent Obligation) or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder), as determined by such Person in good faith.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Contractual Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise, and the terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have meanings correlative thereto.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_64"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Controlled Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Subsidiary of the Borrower that is a &#8220;controlled foreign corporation&#8221; within the meaning of Section 957 of the Code.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:80.85pt;padding-right:80.85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Conversion</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned thereto in the First Amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Converted Tranche B-1 Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; has the meaning assigned thereto in the First</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Agreement Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) Permitted First Priority Refinancing Debt, (b) Permitted Second Priority Refinancing Debt, (c) Permitted Unsecured Refinancing Debt or (d) other Debt incurred pursuant to a Refinancing Amendment, in each case, issued, incurred or otherwise obtained (including by means of the extension or renewal of existing Debt) in exchange for, or to extend, renew, replace, repurchase, retire or refinance, in whole or part, existing Term Loans or existing Revolving Loans (or unused Revolving Commitments), or any then-existing Credit Agreement Refinancing Debt (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Debt has a maturity no earlier than, and a Weighted Average Life to Maturity equal to or greater than, the Refinanced Debt, (ii) such Debt shall not have a greater principal amount than the principal amount of the Refinanced Debt plus accrued interest, fees, premiums (if any) and penalties thereon and reasonable fees and expenses associated with the refinancing, (iii) the terms and conditions of such Debt (except as otherwise provided in clause (ii) above and with respect to pricing, premiums and optional prepayment or redemption terms) are substantially identical to, or (taken as a whole) are no more materially favorable, taken as a whole, to the lenders or holders providing such Debt in the good faith determination of the Borrower than, those applicable to the Refinanced Debt being refinanced (except for covenants or other provisions applicable only to periods after the Latest Maturity Date at the time of incurrence of such Debt), (iv) such Debt is not at any time guaranteed by any Subsidiaries other than Subsidiaries that are Guarantors, (v) such Debt does not have scheduled amortization payments of principal or payments of principal and is not subject to mandatory redemption, repurchase, prepayment, sinking fund obligations or prepayments at the option of the holders thereof (except customary asset sale or change of control provisions that provide for the prior repayment in full of the Loans and all other Obligations), in each case prior to the Latest Maturity Date at the time such Debt is incurred, (vi) to the extent secured, the security agreements relating to such Debt are substantially the same as or more favorable to the Loan Parties than the Security Documents (with such differences as are reasonably satisfactory to the Administrative Agent) and (vii) such Refinanced Debt shall be repaid, repurchased, retired, defeased or satisfied and discharged, and all accrued interest, fees, premiums (if any) and penalties in connection therewith shall be paid, on the date such Credit Agreement Refinancing Debt is issued, incurred or obtained.</font></div><div style="margin-top:10.65pt;padding-left:5pt;padding-right:12.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as the context may require, (i) the making of a Loan by a Lender or (ii) the issuance of any Letter of Credit, or the amendment, extension or renewal of any existing Letter of Credit, by the Issuing Lender.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Administrative Agent, the Issuing Lender, the Swingline Lender or any other Lender.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Cumulative Consolidated Net Income</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as of any date, 50% of the cumulative Consolidated Net Income (or, if such Cumulative Consolidated Net Income shall be a loss, 100% of such loss) of the Restricted Companies since the fiscal quarter ending June 30, 2017 to the end of the last fiscal period (taken as one accounting period) for which financial statements have been provided to the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> prior to such date.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person (without duplication), (a) all indebtedness of such Person for borrowed money, (b) all Obligations of such Person for the deferred purchase price of</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_67"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">property or services (other than current trade payables or other accrued liabilities incurred in the ordinary course of such Person&#8217;s business), (c) all obligations of such Person evidenced by notes, bonds, debentures or other similar instruments, or upon which interest payments are customarily made, (d) all obligations of such Person created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all Attributable Indebtedness of such Person, (f) all obligations, contingent or otherwise, of such Person under acceptance, letter of credit or similar facilities (excluding reimbursement obligations thereunder to the extent issued in relation to trade payables and that are discharged within 30 days after they become due), (g) the amount of all obligations of such Person with respect to the redemption, repayment or other repurchase of any Redeemable Preferred Interest, valued at the greater of its voluntary or involuntary liquidation preference </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> accrued and unpaid dividends, (h) for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.1(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> only, all net obligations of such Person in respect of Swap Agreements, take-or-pay agreements or other similar arrangements, (i) all obligations of such Person under any synthetic lease, tax retention operating lease, off-balance sheet loan or similar off-balance sheet financing if the transaction giving rise to such obligation is considered indebtedness for borrowed money for tax purposes but is classified as an operating lease in accordance with GAAP, (j) all Contingent Obligations of such Person, and (k) all indebtedness and other payment obligations referred to in clauses (a) through (i) above of another Person secured by (or for which the holder of such indebtedness or other payment obligations has an existing right, contingent or otherwise, to be secured by) any Lien on property (including, without limitation, accounts and contract rights) owned by such Person, even though such Person has not assumed or become liable for the payment of such indebtedness or other payment obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that for the purposes of this subclause (k) the amount thereof shall be equal to the lesser of (i) the amount of such indebtedness or other payment obligations and (ii) the fair market value of the property subject to such Lien&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, for the avoidance of doubt and without any implication to the contrary, Non-Financing Lease Obligations shall not constitute Debt for purposes of this Agreement. The Debt of any Person shall include the Debt of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity, except to the extent the terms of such Debt expressly provide that such Person is not liable therefor. To the extent not otherwise included, Debt shall include the amount of any Permitted Receivables Financing. For the avoidance of doubt, and without any implication to the contrary, no Intercompany Receivables or any transactions giving rise thereto shall constitute Debt.</font></div><div style="margin-top:10.35pt;padding-left:5pt;padding-right:8.05pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Event of Default, whether or not any requirement for the giving of notice, the lapse of time, or both, has been satisfied.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Defaulting Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Lender that (a) has failed, within two Business Days of the date required to be funded or paid, to (i) fund any portion of its Loans, (ii) fund any portion of its participations in Letters of Credit or Swingline Loans or (iii) pay over to any Credit Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, or, in the case of clause (iii) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender&#8217;s good faith dispute concerning the amount of costs and expenses claimed by the Administrative Agent to be reimbursed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender&#8217;s good faith determination that a condition precedent (specifically identified and including the particular default, if any) to funding a loan under this Agreement cannot be satisfied) or</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_70"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">generally under other agreements in which it commits to extend credit, (c) has failed, within three Business Days after request by a Credit Party, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations (and is financially able to meet such obligations) to fund prospective Loans and participations in then outstanding Letters of Credit and Swingline Loans under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon such Credit Party&#8217;s receipt of such certification in form and substance satisfactory to it and the Administrative Agent&#59; or (d) has, or has a direct or indirect parent company that has, in any such case (i) become the subject of a Bankruptcy Event, or (ii) become the subject of a Bail-In Action.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Denver Headquarters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that certain Real Property owned by the Borrower and located at 2000 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Street, Denver, Colorado.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Denver Headquarters II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that certain Real Property owned by the Borrower and located at 2001 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Street, Denver, Colorado.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Non-Cash Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the fair market value of non-cash consideration as determined by the Borrower in good faith received by the Borrower or any of its Restricted Subsidiaries in connection with a lease, sale, transfer or other disposition of any assets pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that is designated as Designated Non-Cash Consideration pursuant to a certificate of a Responsible Officer of the Borrower, setting forth the basis of such valuation.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Designated Prepayment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dialysis Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disposition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any property, any sale, lease, sale and leaseback, assignment, conveyance, transfer or other disposition thereof. The terms &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dispose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disposed of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have correlative meanings.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disqualified Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean those Persons who are competitors of the Borrower and who are identified in writing to the Administrative Agent for further distribution to the Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to any competitor identified in writing to the Administrative Agent after the Closing Date, if the Required Lenders instruct the Administrative Agent to object to such competitor within 60 days after receipt of such identification by the Borrower, such competitor shall not be a &#8220;Disqualified Lender&#8221; hereunder.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Division</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">DMG Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the sale of the Capital Stock of DaVita Medical Holdings, LLC, certain other Subsidiaries and affiliates of the Borrower and other transactions pursuant to that certain Equity Purchase Agreement dated as of December 5, 2017, as amended by that certain First Amendment to the Equity Purchase Agreement, dated as of September 20, 2018 and that certain Second Amendment to the Equity Purchase Agreement, dated as of December 11, 2018, by and among the Borrower, Collaborative Care Holdings, LLC, and solely with respect to Section 9.13 and Section 9.18 thereof, UnitedHealth Group Incorporated.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Documentation Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in the preamble hereto.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_73"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Equivalent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, (a) with respect to any amount denominated in Dollars, such amount, and (b) with respect to any amount denominated in any Alternative Currency (other than Dollars), the equivalent amount thereof in Dollars as determined by the Administrative Agent at such time on the basis of the Spot Rate (determined in respect of the most recent Revaluation Date) for the purchase of Dollars with such Alternative Currency.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollars</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">$</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean lawful currency of the United States.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar LC Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, an amount equal to the sum of (a) the aggregate then undrawn and unexpired amount of the then outstanding Dollar Letters of Credit and (b) the aggregate amount of all LC Disbursements in respect of Dollar Letters of Credit that have not then been reimbursed pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Dollar LC Obligations of any Dollar Revolving Lender at any time shall be its Dollar Revolving Percentage of the total Dollar LC Obligations at such time.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Letter of Credit issued under the Dollar Revolving Facility.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Lender, the obligation of such Lender, if any, to make Dollar Revolving Loans and to participate in Dollar Letters of Credit hereunder in an aggregate principal and&#47;or face amount not to exceed the amount set forth opposite such Lender&#8217;s name on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an Increase Joinder or in the Assignment and Assumption pursuant to which such Lender became a party hereto, as the same may be changed from time to time pursuant to the terms hereof.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Dollar Revolving Lender at any time, an amount equal to the sum of (a) aggregate principal amount of all Dollar Revolving Loans held by such Lender then outstanding and (b) such Lender&#8217;s Dollar Revolving Percentage of the LC Obligations then outstanding.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Dollar Revolving Commitments and the Dollar Revolving Loans made thereunder.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Lender that has a Dollar Revolving Commitment or holds Dollar Revolving Loans.</font></div><div style="text-indent:76.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Dollar Revolving Lender at any time, the percentage which such Lender&#8217;s Dollar Revolving Commitment then constitutes of the Total Dollar Revolving Commitments or, at any time after the Dollar Revolving Commitments shall have expired or terminated, the percentage which the aggregate principal amount of such Lender&#8217;s Dollar Revolving Loans then outstanding constitutes of the aggregate principal amount of the Dollar Revolving Loans then outstanding&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the event that the Dollar Revolving Loans are paid in full prior to the reduction to zero of the Total Dollar Revolving Extensions of Credit, the Dollar Revolving Percentages shall be the Dollar Revolving Percentages in effect immediately prior to such payment in full.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Person that is organized under the laws of, or whose property is located in, a jurisdiction within the United States.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_76"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Subsidiary of the Borrower organized under the laws of any jurisdiction within the United States.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Domestic Wholly Owned Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Domestic Subsidiary of the Borrower all of the Capital Stock of which (other than directors&#8217; qualifying shares required by law) is owned by Borrower directly and&#47;or through other Domestic Wholly Owned Subsidiaries.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ECF Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) with respect to any Fiscal Year at the end of which the Leverage Ratio is greater than 4.00 to 1.00, 25%&#59; and (ii) with respect to any Fiscal Year at the end of which the Leverage Ratio is less than or equal to 4.00 to 1.00, 0%.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Financial Institution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a Subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Member Country</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EEA Resolution Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="margin-top:2.45pt;padding-left:77pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Embargoed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning assigned to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Section 7.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">EMU Legislation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean the legislative measures of the European Council for the</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:91%">introduction of, changeover to or operation of a single or unified European currency.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean ambient air, indoor air, surface water, groundwater, drinking water, soil, land surface and subsurface strata, and natural resources such as wetlands, flora and fauna.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any outstanding action, suit, demand, demand letter, claim, notice of noncompliance or violation, notice of liability or potential liability, investigation, proceeding, consent order or consent agreement, abatement order or other order or directive (conditional or otherwise) relating in any way to any Environmental Law, any Environmental Permit or any Hazardous Materials or arising from alleged injury or threat to health, safety, natural resources or the environment, including, (a) by any Governmental Authority for enforcement, cleanup, removal, response, remedial or other actions or damages and (b) by any applicable Governmental Authority or any other third party for damages, contribution, indemnification, cost recovery, compensation or injunctive relief.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Requirement of Law relating to (a) the generation, use, handling, transportation, treatment, storage, disposal or Release of Hazardous Materials, (b) pollution or the protection of the Environment or health or safety or (c) occupational safety and health, industrial hygiene, land use or the protection of human, plant or animal health or welfare, including, without limitation, CERCLA, in each case as amended from time to time, and including the regulations promulgated and the rulings issued from time to time thereunder.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), of any</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_79"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><img alt="image_74.jpg" src="image_74.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Restricted Company directly or indirectly resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage or treatment of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the Release or threatened Release of any Hazardous Materials or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Environmental Permit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any permit, approval, identification number, license or other authorization required under any Environmental Law.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time, and the rules and regulations promulgated thereunder.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Person that for purposes of Title IV of ERISA is a member of the controlled group of any Loan Party, or under common control with any Loan Party, within the meaning of Section 414 of the Code.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ERISA Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) (i) the occurrence of a reportable event, within the meaning of Section 4043 of ERISA or the regulations issued thereunder, with respect to any Plan unless the 30-day notice requirement with respect to such event has been waived under such regulations or (ii) Section 4043(b) of ERISA applies to a contributing sponsor, as defined in Section 4001(a)(13) of ERISA, of a Plan, and an event described in paragraph (9), (10), (11), (12) or (13) of Section 4043(c) of ERISA could reasonably be expected to occur with respect to such Plan within the following 30 days&#59; (b) with respect to any Plan, the failure to satisfy the minimum funding standard under Section 412 of the Code or Section 302 of ERISA, whether or not waived, or the failure to make any required contribution to a Multiemployer Plan&#59; (c) the application for a minimum funding waiver with respect to a Plan&#59; (d) the provision by the administrator of any Plan of a notice of intent to terminate such Plan pursuant to Section 4041(a)(2) of ERISA (including any such notice with respect to a plan amendment referred to in Section 4041(e) of ERISA)&#59; (e) the cessation of operations at a facility of any Loan Party or any ERISA Affiliate in the circumstances described in Section 4062(e) of ERISA&#59; (f) the partial or complete withdrawal by any Loan Party or any ERISA Affiliate from a Plan or Multiemployer Plan&#59; (g) the conditions for imposition of a lien under Section 303(k) of ERISA shall have been met with respect to any Plan&#59; (h) the institution by the PBGC of proceedings to terminate a Plan pursuant to Section 4042 of ERISA, or the occurrence of any event or condition described in Section 4042 of ERISA, that constitutes grounds for the termination of, or the appointment of a trustee to administer, a Plan&#59; or (i) the occurrence of a nonexempt prohibited transaction (within the meaning of Section 4975 of the Code or Section 406 of ERISA) with respect to a Plan.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EU Bail-In Legislation Schedule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor Person), as in effect from time to time.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Euro</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8364;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the lawful currency of the Participating Member States introduced in accordance with the EMU Legislation.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurodollar Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> (other than Tranche B-1 Term Loans)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the rate of interest applicable to which is based upon the Eurodollar Rate. Eurodollar Loans may be denominated in Dollars or an Alternative Currency (other than Dollars).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurodollar Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any Interest Period with respect to a Eurodollar Loan of any currency, the LIBOR Screen Rate as of approximately 11&#58;00 a.m., London time, two Business Days prior to the commencement of such Interest Period, for deposits in such currency for such Interest Period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if a LIBOR Screen Rate shall not be available at the applicable time for the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_82"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">applicable Interest Period, then the Eurodollar Rate for such currency and Interest Period shall be the Interpolated Rate&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Eurodollar Rate shall at no time be less than 0.0% per annum.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Eurodollar Tranche</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, Eurodollar Loans under a particular Facility the then current Interest Periods with respect to all of which begin on the same date and end on the same later date (whether or not such Loans shall originally have been made on the same day).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Cash Flow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any Fiscal Year of the Borrower, the excess, if any, of (a) Cash Flow from Operating Activities </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">over</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the sum, without duplication, of (i) the aggregate amount (A) actually paid by the Borrower and its Restricted Subsidiaries during such Fiscal Year and (B) expected as of the last day of such Fiscal Year to be paid in the first Fiscal Quarter following such Fiscal Year, on account of Capital Expenditures or any other expenditures for Capital Assets (excluding the principal amount of Debt incurred in connection with such expenditures and any such expenditures financed with the proceeds of any Reinvestment Deferred Amount)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (I) any amount deducted on account of such committed expenditure pursuant to clause (B) shall not be deducted in the calculation of Excess Cash Flow for the following Fiscal Year to the extent such amount is actually paid in the first Fiscal Quarter of the following Fiscal Year, and (II) to the extent any such committed amount is not actually paid in the first Fiscal Quarter of the following Fiscal Year, such unspent amount shall not be deducted in the calculation of Excess Cash Flow for the preceding Fiscal Year, (ii) the aggregate amount of all prepayments of Revolving Loans and Swingline Loans during such Fiscal Year to the extent of accompanying permanent optional reductions of the Revolving Commitments and all optional prepayments of the Term Loans during such Fiscal Year, (iii) the aggregate amount of all regularly scheduled principal payments of Funded Debt (including the Term Loans) of the Borrower and its Restricted Subsidiaries made during such Fiscal Year (other than in respect of any revolving credit facility to the extent there is not an equivalent permanent reduction in commitments thereunder), (iv) the aggregate amount actually paid during such Fiscal Year, or expected to be paid in the first Fiscal Quarter of the following Fiscal Year pursuant to letters of intent or acquisition agreements, on Investments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> pursuant to this clause (iv) without giving effect to any part of an Investment that was permitted by utilizing the Available Amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (I) any amount deducted on account of such letter of intent or acquisition agreement shall not be deducted in the calculation of Excess Cash Flow for the following Fiscal Year to the extent such amount is actually paid in the first Fiscal Quarter of the following Fiscal Year and (II) to the extent any such committed amount is not actually paid in the first Fiscal Quarter of the following Fiscal Year, such unspent amount shall not be deducted in the calculation of Excess Cash Flow for the preceding Fiscal Year and (v) the aggregate amount of distributions for such Fiscal Year on account of non-controlling interests in Restricted Subsidiaries.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Excess Cash Flow Application Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time, and the regulations promulgated and the rulings issued thereunder.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a Subsidiary that (i) is prohibited (A) by applicable law from guaranteeing the Guaranteed Obligations, or which would require governmental (including regulatory) consent, approval, license or authorization to provide a guarantee unless, such consent, approval, license or authorization has been received, in each case so long as the Administrative Agent shall have received a certification from a Responsible Officer of the Borrower as to the existence of such</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_85"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:11.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">prohibition or consent, approval, license or authorization requirement or (B) by any Contractual Obligation in existence on the Closing Date or the date of acquisition of such Subsidiary (but not entered into in contemplation thereof) and only for so long as any such Contractual Obligation exists (ii) is a Special Purpose Receivables Subsidiary, (iii) is an Immaterial Subsidiary, (iv) is not a Wholly Owned Subsidiary on the Closing Date or on the date such Subsidiary is formed or acquired, in each case for so long as such Subsidiary remains a non-Wholly Owned Subsidiary, or is a New Development JV (and upon issuance of equity to the applicable joint venture partner, for so long as such New Development JV remains a non-Wholly Owned Subsidiary), (v) is a Captive Insurance Subsidiary, (vi) is an Unrestricted Subsidiary, or (vii) is a Foreign Subsidiary or a Domestic Subsidiary of a Foreign Subsidiary that is a Controlled Foreign Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the term &#8220;Excluded Subsidiary&#8221; shall not include any Subsidiary that is an issuer, borrower or guarantor in respect of the 2022 Senior Notes, 2024 Senior Notes, the 2025 Senior Notes, any Permitted Other Debt or any Credit Agreement Refinancing Debt.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excluded Swap Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Guarantor, any Swap Obligation if, and to the extent that, all or a portion of the guaranty of such Guarantor of, or the grant by such Guarantor of a security interest to secure, such Swap Obligation (or any Guarantee thereof) is or becomes illegal under the Commodity Exchange Act or any rule, regulation or order of the Commodity Futures Trading Commission (or the application or official interpretation of any thereof) by virtue of such Guarantor&#8217;s failure for any reason to constitute an &#8220;eligible contract participant&#8221; as defined in the Commodity Exchange Act (determined after giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and any other &#8220;keepwell, support or other agreement&#8221; for the benefit of such Guarantor and any and all guarantees of such Guarantor&#8217;s Swap Obligations by other Loan Parties) at the time the guaranty of such Guarantor, or a grant by such Guarantor of a security interest, becomes effective with respect to such Swap Obligation. If a Swap Obligation arises under a master agreement governing more than one swap, such exclusion shall apply only to the portion of such Swap Obligation that is attributable to swaps for which such Guarantee or security interest is or becomes excluded in accordance with the first sentence of this definition.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean, with respect to the Administrative Agent or any Lender,</font></div><div style="padding-left:5pt;padding-right:7.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) Taxes imposed on (or measured by) such Administrative Agent&#8217;s or Lender&#8217;s net income and franchise Taxes (imposed on such Administrative Agent or Lender in lieu of net income Taxes) by any jurisdiction as a result of such Administrative Agent or Lender being organized or having its principal office or, in the case of any Lender, having its applicable lending office in such jurisdiction or as a result of any other present or former connection between such Administrative Agent or Lender and the jurisdiction imposing such Taxes (other than a connection arising solely from such Administrative Agent or Lender having executed, delivered, enforced, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, or engaged in any other transaction pursuant to, any Loan Document), (ii) branch profits Taxes (or any similar Taxes) imposed on such Administrative Agent or Lender by any jurisdiction described in clause (i), (iii) in the case of a Lender, any Taxes that are attributable to such Lender&#8217;s failure to comply with the requirements of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iv) in the case of a Lender, any United States federal withholding Taxes imposed on amounts payable to such Lender pursuant to a Requirement of Law in effect at the time such Lender becomes a party to this Agreement (or designates a new lending office), except to the extent that such Lender&#8217;s assignor (if any) was entitled, immediately before the designation of a new lending office (or assignment), to receive additional amounts from any Loan Party with respect to such Taxes pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this subclause (iv) shall not apply to any Tax imposed on a Lender in connection with an interest or participation in any Loan or other obligation that such Lender was required to acquire pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (v) any Taxes imposed under FATCA, and (vi) any U.S. federal backup withholding Tax imposed pursuant to Section 3406 of the Code.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.23(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_88"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in the recitals</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each bank which issued Existing Letters of Credit.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Existing Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all letters of credit outstanding on the Closing Date, as more fully described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Extended Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Extending Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">.</font></div><div style="margin-top:0.1pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each of (a) the Tranche A Term Commitments and the Tranche A Term Loans made thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (b) the Tranche B-1 Term Commitments and the Tranche B-1 Term Loans made thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (c) the Revolving Facility, (d) the Extended Term Loans, if any, and (e) the Extended Revolving Commitments, if any, as the case may be.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FATCA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations thereunder or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code as of the date of this Agreement (or any such amended or successor version described above), and any intergovernmental agreements between a non-U.S. jurisdiction and the United States (and any related Requirements of Law) implementing the foregoing.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Funds Effective Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for any day, the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average of the quotations for the day of such transactions received by the Administrative Agent from three federal funds brokers of recognized standing selected by it.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Federal Way Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Real Property adjacent, appurtenant or proximate to, or constituting an expansion upon, the Real Property located at 32275 32nd Ave S., Federal Way, WA 98001.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fee Payment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) the third Business Day following the last day of each March, June, September and December and (b) the last day of the Revolving Commitment Period.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Lease Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, at the time any determination thereof is to be made, the amount of the liability in respect of a Financing Lease.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_91"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Financing Leases</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all leases that have been or are required to be recorded as a financing or capital leases (and, for the avoidance of doubt, not an operating lease) for financial reporting purposes in accordance with GAAP.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">FIRREA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Financial Institutions Reform, Recovery and Enforcement Act of 1989, as amended.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the First Amendment to this Agreement dated as of February 13, 2020, among the Borrower, the other Loan Parties thereto, the Tranche B-1 Term Lenders party thereto and the Administrative Agent.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">First Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; has the meaning assigned thereto in the First Amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.05pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Lien Intercreditor Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an intercreditor agreement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit Q</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto (in such form or with immaterial changes thereto which the Administrative Agent is hereby authorized to enter into) together with any material changes thereto requested by Borrower in light of prevailing market conditions, which material changes shall be posted to the Lenders not less than five (5) Business Days before execution thereof and, if the Required Lenders shall not have objected to such changes within five (5) Business Days after posting, then the Required Lenders shall be deemed to have agreed that the Administrative Agent&#8217;s entry into such intercreditor agreement (with such changes) is reasonable and to have consented to such intercreditor agreement (with such changes) and to the Administrative Agent&#8217;s execution thereof.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.55pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fiscal Quarter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to the Borrower or any of its Restricted Subsidiaries, the period commencing January 1 in any Fiscal Year and ending on the next succeeding March 31, the period commencing April 1 in any Fiscal Year and ending on the next succeeding June 30, the period commencing July 1 in any Fiscal Year and ending on the next succeeding September 30 or the period commencing October 1 in any Fiscal Year and ending on the next succeeding December 31, as the context may require, or, if any such Restricted Subsidiary was not in existence on the first day of any such period, the period commencing on the date on which such Restricted Subsidiary is incorporated, organized, formed or otherwise created and ending on the last day of such period.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fiscal Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to the Borrower or any of its Restricted Subsidiaries, the period commencing on January 1 in any calendar year and ending on the next succeeding December 31 or, if any such Restricted Subsidiary was not in existence on January 1 in any calendar year, the period commencing on the date on which such Restricted Subsidiary is incorporated, organized, formed or otherwise created and ending on the next succeeding December 31.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.1pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Foreign Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means each employee benefit plan (within the meaning of Section 3(3) of ERISA, whether or not subject to ERISA) that is not subject to US law and is maintained or contributed to by any Loan Party.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Foreign Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean any Subsidiary of the Borrower that is not a Domestic Subsidiary.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funded Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; of any Person shall mean all Debt as set forth on the balance sheet of such Person determined on a Consolidated basis in accordance with GAAP, including, without limitation,</font></div><div style="padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) the aggregate amount of Government Reimbursement Program Costs (exclusive of, with respect to the determination of Funded Debt in any period, the portion of Government Reimbursement Program Costs paid in such period), (ii) in the case of the Borrower, the Loans, (iii) any Receivables Transaction</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_94"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amount, (iv) all obligations of such Person to purchase, redeem, retire, defease or otherwise make any payment in respect of any preferred Capital Stock in such Person or any other Person and (v) all Attributable Indebtedness of such Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the term &#8220;Funded Debt&#8221; shall not include (i) any Contingent Obligations of such Person (if and to the extent such Contingent Obligations would otherwise be included in such term on any date of determination) that are incurred solely to support any obligations, Debt or Government Reimbursement Program Costs of the Borrower or one or more Restricted Subsidiaries of the Borrower to the extent such Contingent Obligations are otherwise expressly permitted to be incurred under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) obligations in respect of Non-Financing Lease Obligations.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Funding Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any currency, the office of the Administrative Agent specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or such other office as may be specified from time to time by the Administrative Agent as its funding office by written notice to the Borrower and the Lenders.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean generally accepted accounting principles in the United States as in effect from time to time applied on a consistent basis, subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Government Reimbursement Program Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any payable of the Borrower and its Restricted Subsidiaries, the sum of&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.8pt;text-indent:39.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.83pt">all amounts (including punitive and other similar amounts) agreed to be paid in settlement or payable as a result of a final, non-appealable judgment, award or similar order relating to participation in Medical Reimbursement Programs&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.25pt;text-indent:36.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.88pt">all final, non-appealable fines, penalties, forfeitures or other amounts rendered pursuant to criminal indictments or other criminal proceedings relating to participation in Medical Reimbursement Programs&#59; and</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:19.95pt;text-indent:33.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.93pt">the amount of final, non-appealable recovery, damages, awards, penalties, forfeitures or similar amounts rendered in any litigation, suit, arbitration, investigation or other legal or administrative proceeding of any kind relating to participation in Medical Reimbursement Programs&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that the amount of any &#8220;Government Reimbursement Program Costs&#8221; shall be reduced by any amounts held with respect to such costs for the benefit of the Borrowers and its Restricted Subsidiaries in an escrow, fiduciary or trust account or otherwise.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Government Reimbursement Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 4.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative functions of or pertaining to government (including any supranational authority such as the European Union or the European Central Bank), any securities exchange and any self-regulatory organization (including the National Association of Insurance Commissioners).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Governmental Authorization</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any authorization, approval, consent, franchise, license, covenant, order, ruling, permit, certification, exemption, notice, declaration or similar right, undertaking or other action of, to or by, or any filing, qualification or registration with, any Governmental Authority.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_97"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guaranteed Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:22.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Subsidiary of the Borrower listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto (which </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule III</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> lists all Subsidiaries of the Borrower as of the Closing Date, other than Excluded Subsidiaries) and each other Subsidiary of the Borrower that becomes a Guarantor pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Hazardous Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) petroleum or petroleum products, by-products or breakdown products, radioactive materials, asbestos, asbestos-containing materials, polychlorinated biphenyls and radon gas and (b) any other chemicals, materials, substances, wastes (including medical and human waste), constituents, pollutants or contaminants subject to regulation or which can give rise to liability under any Environmental Law.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.17(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Immaterial Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as of any date of determination, any Subsidiary that did not, as of the last day of the fiscal quarter of the Borrower ended immediately prior to such date of determination, have gross unconsolidated revenues in excess of $100,000,000 during the four consecutive fiscal quarters ending as of such date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that as of the last day of the fiscal quarter of the Borrower ended immediately prior to such date of determination, the gross unconsolidated revenues during the four consecutive fiscal quarters ending on such prior date of all Domestic Subsidiaries (other than any Subsidiary described under clauses (i), (iv) or (vi) of the definition of &#8220;Excluded Subsidiary&#8221;, any Special Purpose Receivables Subsidiary or Captive Insurance Subsidiary) that are &#8220;Immaterial Subsidiaries&#8221; (after giving effect to any designations made pursuant to the immediately following proviso) shall not exceed fifteen percent (15.0%) of the gross unconsolidated revenues during such period of the Borrower and its consolidated Domestic Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, the Borrower shall have the right to designate in writing to the Administrative Agent additional Domestic Subsidiaries as excluded from the definition of &#8220;Immaterial Subsidiaries&#8221; (and to either remove or re-make such designation in writing so long as &#8220;Immaterial Subsidiaries&#8221; would comply with the immediately preceding proviso after giving effect to such removal or re-designation).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Impacted Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to a LIBOR Screen Rate, an Interest Period which shall not be available at the applicable time.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Increase Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.24(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Increase Joinder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.24(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">.</font></div><div style="margin-top:0.1pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Increased Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.24(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:79.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Incremental Term A Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.24(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Incremental Term B Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.24(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Incremental Term Loan Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.24(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_100"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt"><img alt="image_74.jpg" src="image_74.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Incremental Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.24(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 11.5(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">.</font></div><div style="margin-top:0.1pt;padding-left:5pt;padding-right:18.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, all rights, priorities and privileges relating to intellectual property, whether arising under United States, multinational or foreign laws or otherwise, including copyrights, copyright licenses, patents, patent licenses, trademarks, trademark licenses, trade names, service marks, domain names, trade secrets, proprietary information, technology, know-how and processes, and all rights to sue at law or in equity for any infringement or other impairment thereof, including the right to receive all proceeds and damages therefrom.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Intercompany Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean a promissory note substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intercompany Receivables</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any debits or credits by and among the Borrower and its Subsidiaries arising in connection with any centralized purchasing, payment or other cash management or treasury services, in each case, in the ordinary course of business.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Intercreditor Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the First Lien Intercreditor Agreement and the Junior Lien Intercreditor Agreement, collectively, in each case to the extent in effect.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Election Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an Interest Election Request, substantially in the form of Exhibit P.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Interest Payment Date&#8221; shall mean (a) as to any ABR Loan (other than any Swingline Loan), the last day of each March, June, September and December to occur while such Loan is outstanding and the final Maturity Date of the Facility under which such Loan was made, (b) as to any Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">having an Interest Period of three months or less, the last day of such Interest Period and the Maturity Date of the Facility under which such Loan was made, (c) as to any Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">having an Interest Period longer than three months, each day that is three months, or a whole multiple thereof, after the first day of such Interest Period, the last day of such Interest Period and the Maturity Date of the Facility under which such Loan was made, (d) as to any Loan (other than any Revolving Loan that is an ABR Loan and any Swingline Loan), the date of any repayment or prepayment made in respect thereof and (e) as to any Swingline Loan, the day that such Loan is required to be repaid.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:77pt"><img alt="image_68a.jpg" src="image_68a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:4px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">, as to any Eurodollar</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt;text-decoration:underline">as to any Eurodollar Loan, (a) initially, the period commencing on the borrowing or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">conversion date, as the case may be, with respect to such Eurodollar Loan and ending</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(x) one week</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">thereafter or (y) one, two</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, three or six or (if available to all Lenders under the relevant Facility) twelve</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">months thereafter, as selected by the Borrower in its notice of borrowing or notice of conversion, as the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">case may be, given with respect thereto&#59; and (b) thereafter, each period commencing on the last day of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the next preceding Interest Period applicable to such Eurodollar Loan and ending one, two, three or six or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(if available to all Lenders under the relevant Facility) or twelve months thereafter, as selected by the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Borrower by irrevocable notice to the Administrative Agent not later than 11&#58;00 A.M., Local Time, on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the date that is three Business Days prior to the last day of the then current Interest Period with respect</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">thereto&#59;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_103"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.1pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.58pt;text-decoration:underline">as to any Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan, (a) initially, the period commencing on the borrowing or conversion date, as the case may be, with respect to such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan and ending </font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">(x) one</font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#00c000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">week thereafter or (y) one, two</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">one</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, three or six</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or (if available to all Lenders under the relevant Facility)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">twelve</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">months thereafter, as selected by the Borrower in its notice of borrowing or notice of conversion, as the case may be, given with respect thereto&#59; and (b) thereafter, each period commencing on the last day of the next preceding Interest Period applicable to such </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">Eurodollar</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loan and ending one, </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">two,</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">three or six </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">or (if available to all Lenders under the relevant Facility) or twelve</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">months thereafter, as selected by the Borrower by irrevocable notice to the Administrative Agent not later than 11&#58;00 A.M., Local Time, on the date that is three Business Days prior to the last day of the then current Interest Period with respect thereto&#59;</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that all of the foregoing provisions relating to Interest Periods are subject to the</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">following&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41pt;padding-right:8.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">if any Interest Period would otherwise end on a day that is not a Business Day, such Interest Period shall be extended to the next succeeding Business Day unless the result of such extension would be to carry such Interest Period into another calendar month in which event such Interest Period shall end on the immediately preceding Business Day&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:25.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower may not select an Interest Period under a particular Facility that would extend beyond the Maturity Date of such Facility&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:11.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any Interest Period that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of a calendar month.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interpolated Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, for any Interest Period, the rate per annum (rounded to the same number of decimal places as the LIBOR Screen Rates) determined by the Administrative Agent (which determination shall be conclusive and binding absent manifest error) to be equal to the rate that results from interpolating on a linear basis between&#58; (a) the LIBOR Screen Rate for the longest period (for which the LIBOR Screen Rate is available) that is shorter than the Impacted Interest Period and (b) the LIBOR Screen Rate for the shortest period (for which the LIBOR Screen Rate is available) that exceeds the Impacted Interest Period, in each case, as of 11&#58;00 a.m., London Time, two Business Days prior to the commencement of such Interest Period. When determining the rate for a period which is less than the shortest period for which the LIBOR Screen Rate is available, the LIBOR Screen Rate for purposes of clause (a) above shall be deemed to be the overnight screen rate where &#8220;overnight screen rate&#8221; means the overnight rate determined by the Administrative Agent from such service as the Administrative Agent may select.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, any loan or advance for borrowed money to such Person, any purchase or other acquisition of Capital Stock or Debt of, or the property and assets comprising a division or business unit or all or a substantial part of the business of, such Person, any capital contribution to such Person or any other investment in such Person, including, without limitation, any acquisition by way of a merger or consolidation (or similar transaction) and any arrangement pursuant to which the investor incurs Debt of the types referred to in clause (j) or (k) of the definition of &#8220;Debt&#8221; set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in respect of such Person, but excluding advances or extensions of credit to customers and receivables arising in the ordinary course of business. For the avoidance of doubt, without any implication to the contrary, no Intercompany Receivables or any transactions giving rise thereto shall constitute Investments. For purposes of covenant compliance, the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_106"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any of (i) the institutions set forth on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto or in each case, any affiliate thereof, in its capacity as issuer of any Letter of Credit, (ii) any other Lender reasonably satisfactory to the Administrative Agent that from time to time agrees in writing to issue Letters of Credit hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any Extension or Extensions of Revolving Commitments is or are effected in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then on the occurrence of the Revolving Termination Date and on each later date which is or was at any time a Maturity Date with respect to Revolving Commitments (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender&#47;Swingline Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), each Issuing Lender at such time shall have the right to resign as an Issuing Lender on, or on any date within twenty (20) Business Days after, the respective Issuing Lender&#47;Swingline Termination Date, in each case upon not less than ten (10) days&#8217; prior written notice thereof to the Borrower and the Administrative Agent and, in the event of any such resignation and upon the effectiveness thereof, the respective entity so resigning shall retain all of its rights hereunder and under the other Loan Documents as an Issuing Lender with respect to all Letters of Credit theretofore issued by it (which Letters of Credit shall remain outstanding in accordance with the terms hereof until their respective expirations) but shall not be required to issue any further Letters of Credit hereunder, and (iii) solely with respect to the Existing Letters of Credit, each Existing Issuing Bank. If at any time and for any reason (including as a result of resignations as contemplated by the proviso to the preceding sentence), each Issuing Lender has resigned in such capacity in accordance with the preceding sentence, then no Person shall be an Issuing Lender hereunder obligated to issue Letters of Credit unless and until (and only for so long as) a Lender (or affiliate of a Lender) reasonably satisfactory to the Administrative Agent and the Borrower agrees to act as Issuing Lender hereunder.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Issuing Lender&#47;Swingline Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the definition of &#8220;Issuing Lender.&#8221;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Joinder Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean a joinder agreement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">L</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Junior Lien Intercreditor Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an intercreditor agreement by and among the Collateral Agent and the collateral agents or other representatives for the holders of Debt secured by Liens on the Collateral that are intended to rank junior to the Liens securing the Obligations and that are otherwise Liens permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, providing that all proceeds of Collateral shall first be applied to repay the Obligations in full prior to being applied to any obligations under the Debt secured by such junior Liens (subject to customary exceptions and current payments) and that until the termination of the Commitments and the repayment in full (or cash collateralization of outstanding Letters of Credit) of all Obligations (other than contingent obligations not then due and payable), the Collateral Agent shall have the sole right to exercise remedies against the Collateral (subject to customary exceptions and the expiration of any standstill periods) and otherwise in form and substance reasonably satisfactory to the Collateral Agent.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Latest Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, the latest Maturity Date applicable to any Loan or Commitment hereunder at such time, including the latest maturity date of any Refinancing Term Loan, any Refinancing Term Commitment, any Extended Term Loan, any Extended Revolving Commitment, any Incremental Term Loans, any Increased Revolving Commitments or any Other Revolving Commitments, in each case as extended in accordance with this Agreement from time to time.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean $325,000,000, which amount shall be allocated among the Issuing Lenders in the respective amounts set forth beside each Issuing Lender in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">LC Disbursement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean a payment by the Issuing Lender pursuant to a Letter of</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Credit.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_109"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><img alt="image_74.jpg" src="image_74.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LC Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate Alternative Currency LC Obligations and Dollar LC Obligations.</font></div><div style="margin-top:2.5pt;padding-left:77pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">LC Request</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean an LC Request, substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Exhibit O</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall have the meaning given to such term in the preamble hereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">provided</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:91%">that unless the context otherwise requires, each reference herein to the Lenders shall be deemed to</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">include any Conduit Lender.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lending Office</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Lender, the office or offices of such Lender described as such in such Lender&#8217;s Administrative Questionnaire, or such other office or offices as a Lender may from time to time notify the Borrower and the Administrative Agent.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Letter of Credit Facility Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, the ratio of (a) (i) all Funded Debt of the Borrower and its Restricted Subsidiaries, including Debt in respect of Specified Letters of Credit outstanding as of such date (assuming that the maximum amount of each such Specified Letter of Credit is fully drawn) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) to the extent not otherwise included in subclause (a)(i) of this definition, the face amount of all Letters of Credit issued for the account of the Borrower or any of its Restricted Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (iii) up to the lesser of (x) all unrestricted cash and Cash Equivalents of the Borrower and its Restricted Subsidiaries on a Consolidated basis and (y) $750,000,000 to (b) Consolidated EBITDA of the Borrower and its Restricted Subsidiaries for the most recently completed Measurement Period prior to such date.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Leverage Ratio shall be calculated on a Pro Forma Basis to give effect to any Debt incurred, assumed or permanently repaid or extinguished after the relevant Measurement Period but prior to or contemporaneously with the Reference Date as if such incurrence, assumption, repayment or extinguishment had been effected on the last day of such period. Notwithstanding anything to the contrary contained in this paragraph, when calculating the Leverage Ratio for purposes of (i) the Pricing Grid, (ii) the ECF Percentage and (iii) determining actual compliance (and not compliance on a Pro Forma Basis) with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) any Debt incurred, assumed or permanently repaid or extinguished subsequent to the end of the applicable Measurement Period shall not be given </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro forma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> effect and (B) such calculations shall be based on the financial statements delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, for the relevant Measurement Period.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LIBOR Screen Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the London interbank offered rate administered by the ICE Benchmark Administration Limited (or any other Person that takes over the administration of such rate) for the applicable currency for a period equal in length to such Interest Period as displayed on pages LIBOR01 or LIBOR02 of the Reuters screen or, in the event such rate does not appear on either of such Reuters pages, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, unless otherwise specified in any amendment to this Agreement entered into in accordance with Section 2.16</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">A</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b), in the event that an alternate rate with respect to the LIBOR Screen Rate is implemented, then all references herein to the &#8220;LIBOR Screen Rate&#8221; shall be deemed references to such alternate rate.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_112"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:15.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lien</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any mortgage, deed of trust, pledge, hypothecation, assignment, deposit arrangement, encumbrance, lien (statutory or other), charge or other security interest or any preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including any conditional sale or other title retention agreement and any Financing Lease having substantially the same economic effect as any of the foregoing)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in no event shall a Non-Financing Lease Obligation be deemed to constitute a Lien.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Condition Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any acquisition of, or similar third-party Investment (including the assumption or incurrence of Debt) by one or more of the Borrower and its Restricted Subsidiaries in, any assets, business or Person permitted by this Agreement the consummation of which is not conditioned on the availability of, or on obtaining, financing.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Limited Condition Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any (a) Limited Condition Acquisition or (b) redemption, repurchase, defeasance, satisfaction, discharge or repayment of Debt requiring irrevocable advance notice or any irrevocable offer to purchase, repurchase, defease, satisfy, discharge or repay Debt that is not subject to obtaining financing.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any loan made by any Lender pursuant to this Agreement (including pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean this Agreement, the Intercreditor Agreements, the Security Documents, the Notes and including the First Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Borrower and the Guarantors.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Local Time</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the local time in (i) London with respect to Obligations denominated in an Alternative Currency and (ii) New York City, otherwise.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Majority Facility Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Facility, the holders of more than 50% of the aggregate unpaid principal amount of the Term Loans, Extended Term Loans or the Total Revolving Extensions of Credit, as the case may be, outstanding under such Facility (or, in the case of the Dollar Revolving Facility or the Alternative Currency Revolving Facility, prior to any termination, respectively, of the Dollar Revolving Commitments or the Alternative Currency Revolving Commitments, the holders of more than 50% of the Total Dollar Revolving Commitments or Total Alternative Currency Revolving Commitments, respectively).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Mandatory Prepayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Margin Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean &#8220;margin stock&#8221; as defined in Regulation U of the Board, as the same may be amended or supplemented from time to time.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Acquisition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an acquisition or a series of related acquisitions of any Person, property, business or assets for which the aggregate consideration payable by Borrower or a Restricted Subsidiary is not less than $750,000,000.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Adverse Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a material adverse effect on (a) the business, property, operations, or financial condition of the Borrower and its Restricted Subsidiaries taken as a whole, (b) the validity or enforceability of this Agreement or any of the other Loan Documents or the rights or remedies of the Administrative Agent, the Collateral Agent or the Lenders hereunder or</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_115"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">thereunder or (c) the Collateral or the Liens in favor of the Collateral Agent (for its benefit and for the benefit of the other Secured Parties) on the Collateral or on the priority of such Liens.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (i) with respect to the Tranche A Term Loans that have not been extended pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Tranche A Term Loan Maturity Date, (ii) with respect to the Tranche B-1 Term Loans that have not been extended pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Tranche B-1 Term Loan Maturity Date, (iii) with respect to the Revolving Commitments that have not been extended pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Revolving Termination Date and (iv) with respect to any Class of Extended Term Loans or Extended Revolving Commitments, the final maturity date as specified in the applicable Extension Offer accepted by the respective Lender or Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if any such day is not a Business Day, the applicable Maturity Date shall be the Business Day immediately succeeding such day.</font></div><div><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Measurement Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, the most recently completed four consecutive Fiscal Quarters ended prior to such date for which financial information is</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(or is required to be) available.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Medicaid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that means-tested entitlement program under Title XIX of the Social Security Act that provides federal grants to states for medical assistance based on specific eligibility criteria (Social Security Act of 1965, Title XIX, P.L. 89-97, as amended&#59; 42 U.S.C. &#167; 1396 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.).</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Medical Reimbursement Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Medicare, Medicaid and Tricare programs and any other health care program operated by or financed in whole or in part by any federal, state or local government.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Medicare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that government-sponsored entitlement program under Title XVIII of the Social Security Act that provides for a health insurance system for eligible elderly and disabled individuals (Social Security Act of 1965, Title XVIII, P.L. 89-97, as amended&#59; 42 U.S.C. &#167; 1395 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Minimum Extension Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.25(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Minority Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 7.6(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Moody&#8217;s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall mean Moody&#8217;s Investors Service, Inc.</font></div><div style="margin-top:0.15pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Multiemployer Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a multiemployer plan as defined in Section 4001(a)(3) of ERISA to which any Restricted Company or any ERISA Affiliate is required to contribute or was required to contribute during the preceding five (5) plan years.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Net Cash Proceeds</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) in connection with any Asset Sale or any Recovery Event, the proceeds thereof in the form of cash and Cash Equivalents (including any such proceeds received by way of deferred payment of principal pursuant to a note or installment receivable or purchase price adjustment receivable or otherwise, but only as and when received) of such Asset Sale or Recovery Event, net of attorneys&#8217; fees, accountants&#8217; fees, investment banking fees, amounts required to be applied to the repayment of Debt secured by a Lien expressly permitted hereunder on any asset that is the subject of such Asset Sale or Recovery Event (other than any Lien pursuant to a Security Document) and other customary fees and expenses actually incurred (or estimated by the Borrower in good faith) in connection</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_118"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:11.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">therewith, and net of (i) taxes paid or reasonably estimated to be payable as a result thereof (after taking into account any available tax credits or deductions and any tax sharing arrangements), (ii) amounts reserved in accordance with GAAP against liabilities relating to breaches of representations and warranties and indemnification obligations, liabilities related to environmental matters or other liabilities associated with the property and liabilities relating to assets subject to such sale, lease, transfer or other disposition that are not assumed by the purchaser in such Asset Sale and (iii) in the case of any Asset Sale by a Restricted Subsidiary, the amount of any payments or distributions required to be made in respect of such transaction to owners of Capital Stock in such Restricted Subsidiary other than the Borrower or any other Restricted Subsidiary and (b) in connection with any issuance or sale of Capital Stock or any incurrence of Debt, the cash proceeds received from such issuance or incurrence, net of attorneys&#8217; fees, investment banking fees, accountants&#8217; fees, underwriting discounts and commissions and other customary fees and expenses actually incurred in connection therewith.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">New Development JV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an entity, which may initially be a Wholly Owned Subsidiary, formed or held for the purpose of establishing and operating a dialysis center with a joint venture partner&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, such joint venture partner shall acquire, or has acquired, an interest in such entity (and such entity shall become, or became, a non-Wholly Owned Subsidiary) prior to the generation of any revenues.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="margin-top:2.35pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">NMTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean a new market tax credit as defined in Section 45D of the Code. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">NMTC Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; shall mean any credit, loan or finance agreement and any other</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:91%">document, agreement or instrument governing or otherwise relating to any NMTC Indebtedness.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NMTC Indebtedness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Debt incurred by a NMTC Subsidiary, including in the form of an intercompany loan from the Borrower or another Restricted Subsidiary in connection with an NMTC financing, the proceeds of which such NMTC Subsidiary will substantially concurrently use to acquire Real Property, renovate Real Property or construct improvements on Real Property, in each case after the Closing Date (any such acquisition, renovation or construction, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NMTC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NMTC Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any fixed assets which are acquired, renovated or improved with the proceeds of NMTC Indebtedness and any related capital contributions.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NMTC Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Domestic Subsidiary that receives an intercompany loan in the form of NMTC Indebtedness or any related capital contributions.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Excluded Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all Taxes imposed on or with respect to any payment made by or on account of any obligation of any Loan Party under any Loan Document other than (i) Excluded Taxes and (ii) Other Taxes.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Financing Lease Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a lease obligation that is not required to be accounted for as a financing or capital lease for financial reporting purposes in accordance with GAAP. For the avoidance of doubt, an operating lease shall be considered a Non-Financing Lease Obligation.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Guarantor Domestic Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Domestic Subsidiary of the Borrower that is not a Guarantor.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Non-Guarantor Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean a Subsidiary of the Borrower that is not a Guarantor.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_121"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:16.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, each promissory note in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit N-1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">N-2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">N-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">N-4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as applicable, evidencing Loans.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">NPL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the National Priorities List under CERCLA.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) obligations of the Borrower and the other Loan Parties from time to time arising under or in respect of the due and punctual payment of (i) the principal of and premium, if any, and interest (including premium and interest accruing during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) on the Loans, when and as due, whether at maturity, by acceleration, upon one or more dates set for prepayment or otherwise, (ii) each payment required to be made by the Borrower and the other Loan Parties under this Agreement in respect of any Letter of Credit, when and as due, including payments in respect of Reimbursement Obligations, interest thereon and obligations to provide cash collateral (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and (iii) all other monetary obligations, including fees, costs, expenses and indemnities, whether primary, secondary, direct, contingent, fixed or otherwise (including monetary obligations incurred during the pendency of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding), of the Borrower and the other Loan Parties under this Agreement and the other Loan Documents, and (b) the due and punctual performance of all covenants, agreements, obligations and liabilities of the Borrower and the other Loan Parties under or pursuant to this Agreement and the other Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that Obligations shall exclude any Excluded Swap Obligations.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:77pt;padding-right:52.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 4.23(b)(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">OID</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.24(b)(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Original Tranche B Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; has the meaning assigned thereto in the First Amendment.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more Classes of revolving credit commitments hereunder that result from a Refinancing Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more Classes of Revolving Loans that result from a Refinancing Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all present or future stamp or documentary Taxes or any other excise or property Taxes, charges or similar levies arising from any payment made hereunder or under any other Loan Document or from the execution, delivery or enforcement of, or otherwise with respect to, this Agreement or any other Loan Document.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Term Loan Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more Classes of term loan commitments hereunder that result from a Refinancing Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Other Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more Classes of Term Loans that result from a Refinancing Amendment.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_124"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Lender, any Person as to which such Lender is, directly or indirectly, a Subsidiary.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Parent Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, for purposes of the provisos to the definition of &#8220;Change of Control,&#8221; a newly created entity having, at the time of consummation of a reorganization transaction permitted by such provisos, no assets with a fair market value in excess of $1.0 million (other than Capital Stock of the Borrower and its Subsidiaries) and no liabilities with a fair market value in excess of $1.0 million, in each case that would be reflected on an unconsolidated balance sheet of such entity at such time.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:77pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 11.6(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 11.6(c)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">.</font></div><div style="margin-top:0.1pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Participating Member State</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean each state so described in any EMU Legislation.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:55.9pt;padding-right:55.9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.23(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PBGC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any successor thereto).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Perfection Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a certificate in the form of Exhibit 7 to the Security Agreement or any other form approved by the Collateral Agent, as the same shall be supplemented from time to time.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:11.6pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted First Priority Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any secured Debt (including any Registered Equivalent Notes) incurred by the Borrower in the form of one or more series of senior secured notes&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Debt otherwise constitutes Credit Agreement Refinancing Debt, (ii) such Debt is secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis (but without regard to the control of remedies) with the Obligations and is not secured by any property or assets of the Borrower or any Subsidiary other than the Collateral, and (iii) a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Debt is the initial Permitted First Priority Refinancing Debt incurred by the Borrower, then the Borrower, the Guarantors, the Administrative Agent and the Senior Representative for such Debt shall have executed and delivered a First Lien Intercreditor Agreement. Permitted First Priority Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:31.25pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Holder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Berkshire Hathaway Inc. or any of its Affiliates (but excluding, for the avoidance of doubt, any portfolio company thereof, the holdings of which shall be considered independently of any Permitted Holder).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Liens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the following types of Liens (excluding any such Lien imposed pursuant to Section 430(k) of the Code or by ERISA or any such Lien relating to or imposed in connection with any Environmental Action)&#58; (a) Liens for taxes, assessments and governmental charges or levies to the extent not otherwise required to be paid under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; (b) Liens imposed by law, such as materialmen&#8217;s, mechanics&#8217;, carriers&#8217;, landlords&#8217;, workmen&#8217;s and repairmen&#8217;s Liens and other similar Liens arising in the ordinary course of business securing obligations (other than Debt for borrowed money) (i) that are not overdue for a period of more than 60 days or (ii) the amount, applicability or validity of which are being contested in good faith and with respect to which the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_127"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Borrower or any of its Restricted Subsidiaries, as the case may be, has established reserves in accordance with GAAP&#59; (c) pledges or deposits to secure obligations incurred in the ordinary course of business under workers&#8217; compensation laws, unemployment insurance or similar social security legislation (other than in respect of employee benefit plans subject to ERISA) or to secure public, regulatory or statutory obligations&#59; (d) Liens, pledges and deposits securing the performance of, or payment in respect of, bids, tenders, leases, contracts (other than for the repayment of borrowed money), surety and appeal bonds, letters of credit, and other obligations of a similar nature incurred in the ordinary course of business&#59; (e) any interest or title of a lessor or sublessor and any restriction or encumbrance to which the interest or title of such lessor or sublessor may be subject that is incurred in the ordinary course of business and, either individually or when aggregated with all other Permitted Liens in effect on any date of determination, could not be reasonably expected to have a Material Adverse Effect&#59; (f) Liens in favor of customs and revenue authorities arising as a matter of law or pursuant to a bond to secure payment of customs duties in connection with the importation of goods&#59; (g) Liens arising out of judgments or awards that do not constitute an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and in respect of which the Borrower or any of its Restricted Subsidiaries subject thereto shall be prosecuting an appeal or proceedings for review in good faith and, pending such appeal or proceedings, shall have secured within 60 days after the entry thereof a subsisting stay of execution and shall be maintaining reserves, in accordance with GAAP, with respect to any such judgment or award&#59; (h) unperfected Liens of suppliers and vendors to secure the purchase price of the property or assets sold&#59; (i) protective UCC filings by lessors under operating leases&#59;</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:106%">(j) any easements, rights of way, restrictions, defects, encroachments and other encumbrances on title to Real Property which either individually or when aggregated with all other Permitted Liens, would not be reasonably expected to have a Material Adverse Effect&#59; and (k) bankers&#8217; Liens, rights of setoff and other similar Liens with respect to cash and Cash Equivalents.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.25pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Other Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Debt of the Borrower or any other Loan Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that immediately after giving pro forma effect thereto and to the use of the proceeds thereof, (i) no Event of Default shall be continuing or result therefrom, (ii) if such Debt is unsecured, the Borrower and the Restricted Subsidiaries will be in compliance on a Pro Forma Basis (as of the date of such incurrence), after giving effect to any such incurrence, with a Leverage Ratio that is no greater than 4.50&#58;1.00, (iii) if such Debt is secured by a Lien on the Collateral that is junior to the Lien on the Collateral securing the Obligations, the Borrower and the Restricted Subsidiaries will be in compliance on a Pro Forma Basis (as of the date of such incurrence), after giving effect to any such incurrence, with a Leverage Ratio that is no greater than 4.25&#58;1.00, (iv) if such Debt is secured by a Lien on the Collateral that is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">with the Lien securing the Obligations, such Debt shall not exceed the sum of (x) the Shared Incremental Amount and (y) an additional amount such that the Senior Secured Leverage Ratio, on a Pro Forma Basis (as of the date of such incurrence), after giving effect to such incurrence, is no greater than 3.50&#58;1.00, (v) such Debt does not mature prior to the date that is ninety-one (91) days after the Latest Maturity Date at the time such Debt is incurred or the maturity date of such Debt can be extended subject to any customary conditions to a date that is ninety-one (91) days after the Latest Maturity Date at the time such Debt is incurred, (vi) such Debt shall be in the form of debt securities or junior lien or unsecured credit facility, (vii) if such Debt is secured by a Lien on the Collateral, (x) such Debt is secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or junior basis (but without regard to the control of remedies) with the Obligations and is not secured by any property or assets of the Borrower or any Restricted Subsidiary other than the Collateral and (y) such Debt is subject to an Intercreditor Agreement, (viii) such Debt shall not be guaranteed by any Restricted Subsidiaries that are not Guarantors hereunder and (ix) such Debt shall have terms and conditions (other than pricing, rate floors, discounts, fees, premiums and optional prepayment or redemption provisions) that in the good faith determination of the Borrower are not materially less favorable (when taken as a whole) to the Borrower than the terms and conditions of the Loan Documents (when taken as a whole).</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_130"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all documents and agreements evidencing, relating to or otherwise governing a Permitted Receivables Financing.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Receivables Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more transactions pursuant to which (i) Receivables Assets or interests therein are sold to or financed by one or more Special Purpose Receivables Subsidiaries, and (ii) such Special Purpose Receivables Subsidiaries finance their acquisition of such Receivables Assets or interests therein, or the financing thereof, by selling or borrowing against such Receivables Assets&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) recourse to Borrower or any Restricted Subsidiary (other than the Special Purpose Receivables Subsidiaries) and any obligations or agreements of Borrower or any Restricted Subsidiary (other than the Special Purpose Receivables Subsidiaries) in connection with such transactions shall be limited to the extent customary for similar transactions in the applicable jurisdictions (including, to the extent applicable, in a manner consistent with the delivery of a &#8220;true sale&#8221;&#47;&#8221;absolute transfer&#8221; opinion with respect to any transfer by Borrower or any Restricted Subsidiary (other than a Special Purpose Receivables Subsidiary), and (B) the sum of (x) the aggregate Receivables Transaction Amount outstanding at any time pursuant to clause (a) of the definition of &#8220;Receivables Transaction Amount&#8221; and (y) the aggregate Receivables Transaction Amount since the Closing Date pursuant to clause (b) of the definition of &#8220;Receivables Transaction Amount&#8221; shall not exceed $500,000,000.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Refinancing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Debt, any modification, refinancing, refunding, renewal or extension of such Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (a) the principal amount (or accreted value, if applicable) thereof does not exceed the principal amount (or accreted value, if applicable) of the Debt so modified, refinanced, refunded, renewed or extended except by an amount equal to unpaid accrued interest and premium thereon plus other amounts paid, and fees and expenses incurred, in connection with such modification, refinancing, refunding, renewal or extension and by an amount equal to any existing commitments unutilized thereunder&#59; (b) the Debt resulting from such modification, refinancing, refunding, renewal or extension has a final maturity date equal to or later than the final maturity date of the Debt being modified, refinanced, refunded, renewed or extended&#59; (c) immediately after giving effect thereto, no Default shall have occurred and be continuing&#59; (d) if the Debt being modified, refinanced, refunded, renewed or extended is subordinated in right of payment to the Obligations, the Debt resulting from such modification, refinancing, refunding, renewal or extension is subordinated in right of payment to the Obligations on terms at least as favorable to the Lenders as those contained in the documentation governing the Debt being modified, refinanced, refunded, renewed or extended&#59; and (e) no Person that is not an obligor under the Debt being modified, refinanced, refunded, renewed or extended shall be an obligor under such modification, refinancing, refunding, renewal or extension.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Second Priority Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean secured Debt (including any Registered Equivalent Notes) incurred by the Borrower in the form of one or more series of second lien (or other junior lien) secured notes or second lien (or other junior lien) secured loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such Debt otherwise constitutes Credit Agreement Refinancing Debt, (ii) such Debt is secured by the Collateral on a second priority (or other junior priority) basis to the liens securing the Obligations and the obligations in respect of any Permitted First Priority Refinancing Debt and is not secured by any property or assets of the Borrower or any Subsidiary other than the Collateral and (iii) a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a Junior Lien Intercreditor Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Debt is the initial Permitted Second Priority Refinancing Debt incurred by the Borrower, then the Borrower, the Guarantors, the Administrative Agent and the Senior Representative for such Debt shall have executed and delivered a Junior Lien Intercreditor Agreement. Permitted Second Priority Refinancing Debt will include any Registered Equivalent Notes issued in exchange therefor.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_133"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:30.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Unsecured Refinancing Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean unsecured Debt (including any Registered Equivalent Notes) which constitutes Credit Agreement Refinancing Debt, incurred by the Borrower in the form of one or more series of senior unsecured notes or loans.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated association, joint venture, Governmental Authority or other entity of whatever nature.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean at a particular time, any employee benefit plan that is covered by Title IV of ERISA or Section 412 of the Code and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated at such time, would under Section 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in Section 3(5) of ERISA, other than any Multiemployer Plan.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:51.42pt;padding-right:51.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Post-Increase Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.24(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Pre-Increase Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.24(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:79.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Prepayment Option Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pricing Grid</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the table set forth below.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For all Loans (other than Tranche B-1 Term Loans) and the Commitment Fee Rate&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:39.96pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.691%"><tr><td style="width:1.0%"></td><td style="width:28.831%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.841%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">Leverage Ratio</font></div></td><td colspan="3" style="border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt;text-indent:-11.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicable Margin for Eurodollar Loans</font></div></td><td colspan="3" style="border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.65pt;padding-right:0.7pt;text-indent:-7.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Applicable Margin for ABR Loans</font></div></td><td colspan="3" style="border-right:0.75pt solid #010101;border-top:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:21.3pt;padding-right:17.1pt;text-indent:-9.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Commitment Fee Rate</font></div></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:4.57pt;padding-right:4.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#8805;4.25 to 1.0</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">2.00%</font></div></td><td colspan="3" style="padding:2px 1pt 2px 34.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">1.00%</font></td><td colspan="3" style="border-right:0.75pt solid #010101;padding:2px 1pt 2px 27.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.35%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:4.57pt;padding-right:4.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#60;4.25 to 1.0 but &#8805;3.50 to 1.0</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">1.75%</font></div></td><td colspan="3" style="padding:2px 1pt 2px 34.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.75%</font></td><td colspan="3" style="border-right:0.75pt solid #010101;padding:2px 1pt 2px 27.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.30%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:4.57pt;padding-right:4.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#60;3.50 to 1.0 but &#8805;2.75 to 1.0</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">1.50%</font></div></td><td colspan="3" style="padding:2px 1pt 2px 34.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.50%</font></td><td colspan="3" style="border-right:0.75pt solid #010101;padding:2px 1pt 2px 27.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.25%</font></td></tr><tr><td colspan="3" style="border-left:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:4.57pt;padding-right:4.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#60;2.75 to 1.0 but &#8805;2.00 to 1.0</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">1.25%</font></div></td><td colspan="3" style="padding:2px 1pt 2px 34.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.25%</font></td><td colspan="3" style="border-right:0.75pt solid #010101;padding:2px 1pt 2px 27.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.20%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #010101;border-left:0.75pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:4.52pt;padding-right:4.52pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">&#60;2.00 to 1.0</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.1pt;padding-left:40.22pt;padding-right:40.22pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">1.00%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #010101;padding:2px 1pt 2px 34.45pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.00%</font></td><td colspan="3" style="border-bottom:0.5pt solid #010101;border-right:0.75pt solid #010101;padding:2px 1pt 2px 27.6pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">0.15%</font></td></tr></table></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the purposes of the Pricing Grid, changes in the Applicable Margin resulting from changes in the Leverage Ratio shall become effective on the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjustment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is (x) in the case of calculation of the Leverage Ratio as of the last day of the first three Fiscal Quarters of any Fiscal Year, one Business Day after the date on which financial statements are delivered to the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (y) in the case of calculation of the Leverage Ratio as of the last day of any Fiscal Year, one Business Day after the date on which the annual financial statements are delivered to Lenders setting forth such financial information and accompanied by such certifications as are required with respect to annual financial information pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Such Applicable Margin shall remain in effect until the next change to be effected pursuant to this paragraph. If any financial statements referred to above are not delivered within the time periods specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then, until the date that is one Business Day after the date on which such financial statements are delivered, the highest rate set forth in each column of the Pricing Grid shall apply. In addition, at all times while an Event of Default shall have occurred and be continuing, the highest rate set forth in each column of the Pricing Grid shall apply. Each determination of the Leverage Ratio pursuant to the Pricing Grid shall be made in a manner consistent with the determination thereof pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_136"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the definition of &#8220;Contingent Obligation&#8221; set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">primary obligor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the definition of &#8220;Contingent Obligation&#8221; set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prime Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the definition of &#8220;ABR. </font></div><div style="padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pro Forma Basis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean on a pro forma basis in accordance with GAAP and Regulation S-X&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that notwithstanding the provisions of Regulation S-X, pro forma adjustments may include operating expense reductions for such period resulting from the transaction which is being given pro forma effect which are identified and factually supported in a certificate in which a Responsible Officer of the Borrower certifies that such reductions are reasonably expected to be sustainable and have been realized or the steps necessary for such realization have been taken or are reasonably expected to be taken within twelve months following any such transaction.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">PTE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a prohibited transaction class exemption issued by the U.S. Department of Labor, as any such exemption may be amended from time to time.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified ECP Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, each Loan Party with total assets exceeding $10,000,000 or that qualifies at such time as an &#8220;eligible contract participant&#8221; under the Commodity Exchange Act and can cause another person to qualify as an &#8220;eligible contract participant&#8221; at such time under Section 1a(18)(A)(v)(II) of the Commodity Exchange Act.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Issuer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any commercial bank that has a combined capital and surplus in excess of $500,000,000.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Real Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, all right, title and interest (including any leasehold, mineral or other estate) in and to any and all parcels of or interests in real property owned, leased or operated by any Person, whether by lease, license or other means, together with, in each case, all easements, hereditaments and appurtenances relating thereto, all improvements and appurtenant fixtures and equipment, all general intangibles and contract rights and other property and rights incidental to the ownership, lease or operation thereof.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:12.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a right to receive payment arising from a sale or lease of goods or the performance of services by the Borrower or any of its Restricted Subsidiaries pursuant to an arrangement with another Person pursuant to which such other Person is obligated to pay for goods or services under terms that permit the purchase of such goods and services on credit and all proceeds thereof and rights (contractual or otherwise) and collateral related thereto and shall include, in any event, any items of property that would be classified as an account receivable of the Borrower or any of its Restricted Subsidiaries or an &#8220;account,&#8221; &#8220;chattel paper,&#8221; &#8220;payment intangible&#8221; or &#8220;instrument&#8221; under the Uniform Commercial Code as in effect in the State of New York and any &#8220;supporting obligations&#8221; or &#8220;proceeds&#8221; as so defined of any such items.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Receivables Transaction Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) in the case of any Receivables Assets securitization, the amount of obligations outstanding under the legal documents entered into as part of such Receivables Assets securitization on any date of determination that would be characterized as principal if such Receivables Assets securitization were structured as a secured lending transaction rather than as a purchase and (b) in the case of any sale or factoring of Receivables Assets (but excluding any transaction included under clause (a) hereof), the cash purchase price paid by the buyer in connection with its purchase of Receivables Assets (including any bills of exchange) less the amount of collections</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_139"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">received in respect of such Receivables Assets and paid to such buyer, excluding any amounts applied to purchase fees or discount or in the nature of interest, in each case as determined in good faith and in a consistent and commercially reasonable manner by the Borrower.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Recovery Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any settlement of or payment in respect of any property or casualty insurance claim or any condemnation proceeding relating to any asset of any Restricted Company.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Redeemable Preferred Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person, any Capital Stock of such Person that, by its terms or by the terms of any security into which it is convertible, exercisable or exchangeable, is, or upon the happening of an event or the passage of time or both would be, required to be redeemed or repurchased (including at the option of the holder thereof) by such Person or any of its Subsidiaries, in whole or in part, earlier than six months after the Latest Maturity Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (i) any Capital Stock that would constitute a Redeemable Preferred Interest solely because the holders thereof have the right to require the issuer to repurchase such a Redeemable Preferred Interest upon the occurrence of a change of control shall not be so treated if the terms thereof</font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) do not trigger any rights upon any circumstance constituting a change of control under such Redeemable Preferred Interest that would not constitute a Change of Control under this Agreement and</font></div><div style="padding-left:5pt;padding-right:11.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) do not permit either any repurchase by such Person or any rights of the holder of such Capital Stock to assert any claim in respect of such failure to purchase as long as any Event of Default exists hereunder and (ii) any Capital Stock in any Subsidiary or Minority Investment that the Borrower or any Restricted Subsidiary may be required to repurchase from any joint venture partner or other investor in such Subsidiary or Minority Investment shall not constitute Redeemable Preferred Interest.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Debt</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the definition of &#8220;Credit Agreement Refinancing Debt&#8221;.</font></div><div style="padding-right:9pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1.</font></div><div style="padding-left:4.5pt;padding-right:9pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the repayment in full and the termination of any commitment to make extensions of credit under the Existing Credit Agreement, to the extent not already repaid (or terminated) in connection with the DMG Sale.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing (Additional)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (A) the consummation of a tender offer for the 2022 Senior Notes or (B) in the absence of the consummation of a tender offer, the Borrower having unconditionally called all 2022 Senior Notes for redemption pursuant to the terms of the indenture governing the 2022 Senior Notes.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean an amendment to this Agreement executed by each of (a) the Borrower, (b) the Administrative Agent, (c) each Additional Refinancing Lender and (d) each Lender that agrees to provide any portion of Refinancing Term Loans, Other Revolving Commitments or Other Revolving Loans incurred pursuant thereto, in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Series</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all Refinancing Term Loans or Refinancing Term Commitments that are established pursuant to the same Refinancing Amendment (or any subsequent Refinancing Amendment to the extent such Refinancing Amendment expressly provides that the Refinancing Term Loans or Refinancing Term Commitments provided for therein are intended to be a part of any previously established Refinancing Series) and that provide for the same effective yield and amortization schedule.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_142"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Term Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more term loan commitments hereunder that fund Refinancing Term Loans of the applicable Refinancing Series hereunder pursuant to a Refinancing Amendment.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinancing Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean one or more term loans hereunder that result from a Refinancing Amendment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Refunded Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:58.42pt;padding-right:58.42pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6(b)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.1pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Registered Equivalent Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any notes originally issued in an offering pursuant to Rule 144A under the Securities Act or other private placement transaction under the Securities Act of 1933, substantially identical notes (having the same guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered with the SEC.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.2pt;text-align:justify;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reimbursement Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the obligation of the Borrower to reimburse the Issuing Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for amounts drawn under Letters of Credit.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reinvestment Deferred Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Reinvestment Event, the aggregate Net Cash Proceeds received by any Restricted Company in connection therewith that are not applied to prepay the Term Loans the Revolving Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as a result of the delivery of a Reinvestment Notice.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reinvestment Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Asset Sale or Recovery Event in respect of which the Borrower has delivered a Reinvestment Notice.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reinvestment Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a written notice executed by a Responsible Officer stating that no Event of Default has occurred and is continuing and that the Borrower (directly or indirectly through a Restricted Subsidiary) intends and expects to use all or a specified portion of the Net Cash Proceeds of an Asset Sale or Recovery Event to acquire or repair assets useful in its business, in any acquisitions and other similar Investments not prohibited under this Agreement, and in capital expenditures.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reinvestment Prepayment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Reinvestment Event, the Reinvestment Deferred Amount relating thereto less any amount expended prior to the relevant Reinvestment Prepayment Date to acquire or repair assets useful in the Borrower&#8217;s business.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reinvestment Prepayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Reinvestment Event, the earliest of (a) the date occurring on the second anniversary of such Reinvestment Event, (b) if the Borrower shall not have entered into a binding commitment to reinvest the Net Cash Proceeds received in connection with such Reinvestment Event, the date occurring 540 days after such Reinvestment Event and (c) the date on which the Borrower shall have determined not to acquire or repair assets useful in the Borrower&#8217;s business with all or any portion of the relevant Reinvestment Deferred Amount.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Related Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any specified Person, such Person&#8217;s Affiliates and the respective directors, officers, employees, agents and advisors of such Person and such Person&#8217;s Affiliates.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_145"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:12.45pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any release, spill, emission, discharge, deposit, disposal, leaking, pumping, pouring, dumping, emptying, injecting or leaching into the Environment, or into, from or through any structure or facility.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Relevant Governmental Body&#8221; means, with respect to a Benchmark Replacement in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">respect of Obligations, interest, fees, commissions or other amounts denominated in, or calculated with</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">respect to, Dollars, the Board or the Federal Reserve Bank of New York, or a committee officially</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">endorsed or convened by the Board or the Federal Reserve Bank of New York, or any successor thereto.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:13.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Repricing Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the prepayment, refinancing, substitution or replacement of all or a portion of the Tranche B-1 Term Loans with the incurrence by any Restricted Company of any debt financing having an effective interest cost or weighted average yield (with the comparative determinations to be made by the Administrative Agent consistent with generally accepted financial practices, after giving effect to, among other factors, margin, interest rate floors, upfront or similar fees or original issue discount shared with all providers of such financing, but excluding the effect of any arrangement, structuring, syndication or other fees payable in connection therewith that are not shared with all providers of such financing, and without taking into account any fluctuations in the Eurodollar Rate (other than due to the definition thereof)) that is less than the effective interest cost or weighted average yield (as determined by the Administrative Agent on the same basis) of such Tranche B-1 Term Loans so repaid, refinanced, substituted or replaced, including without limitation, as may be effected through any amendment to this Agreement relating to the interest rate for, or weighted average yield of, such Tranche B-1 Term Loans.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Financial Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, the Consolidated financial statements of the Borrower and its Restricted Subsidiaries most recently delivered to the Administrative Agent and the Lenders on or prior to such date pursuant to, and satisfying all of the requirements of, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and accompanied by the certificates and other information required to be delivered therewith.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Required Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean, at any time, the holders of more than 50% of the sum of</font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) the aggregate unpaid principal amount of the Term Loans then outstanding and (ii) the Total Revolving Commitments then in effect or, if the Revolving Commitments have been terminated, the Total Revolving Extensions of Credit then outstanding.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Requirement of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Person, any law, treaty, rule or regulation, official administrative pronouncement or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Responsible Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Loan Party, the chief executive officer, the president, the chief financial officer, the principal accounting officer or the treasurer (or the equivalent of any of the foregoing) or any other officer, partner or member (or Person performing similar functions) of such Loan Party responsible for overseeing the administration of, or reviewing compliance with, all or any portion of this Agreement or any of the other Loan Documents.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Companies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the Borrower and the Restricted Subsidiaries, and &#8220;Restricted Company&#8221; means any of the foregoing.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_148"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Restricted Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; means any Subsidiary of the Borrower other than an Unrestricted Subsidiary.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revaluation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) with respect to Alternative Currency Revolving Loans, each of the following&#58; (i) each Borrowing Date of a Eurodollar Loan denominated in an Alternative Currency, (ii) each date of a continuation of a Eurodollar Loan denominated in an Alternative Currency pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iii) the date of any partial reduction of the Alternative Currency Revolving Commitments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(f)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iv) after a Default has occurred and is continuing, such additional dates as the Administrative Agent shall determine or the Required Lenders shall require&#59; and (b) with respect to an Alternative Currency Letter of Credit, each of the following&#58; (i) each date of issuance of an Alternative Currency Letter of Credit, (ii) each date of an amendment of any Alternative Currency Letter of Credit having the effect of increasing the amount thereof, (iii) each date of any payment by an Issuing Lender under any Alternative Currency Letter of Credit and (iv) such additional dates as the Administrative Agent or an Issuing Lender shall reasonably determine or the Required Lenders shall require.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Revolving Lender, collectively, the Dollar Revolving Commitment and the Alternative Currency Revolving Commitment of such Revolving Lender.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Commitment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the period from and including the Closing Date to but excluding the Business Day preceding the latest Maturity Date applicable to the Revolving Facility.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Dollar Revolving Extensions of Credit and the Alternative Currency Revolving Extensions of Credit.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Dollar Revolving Facility and the Alternative Currency Revolving Facility.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Dollar Revolving Lenders and Alternative Currency Revolving Lenders.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Dollar Revolving Loans and Alternative Currency Revolving Loans.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Revolving Lender, collectively, the Dollar Revolving Percentage and the Alternative Currency Revolving Percentage of such Revolving Lender.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Revolving Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean August 12, 2024.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">S&#38;P</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean S&#38;P Global Ratings, or any successor to the rating agency business</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">thereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sale and Leaseback Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; with respect to any Person shall mean an arrangement to sell or transfer any property, real or personal, used or useful in such Person&#8217;s business, whether now owned or hereafter acquired, and thereafter rent or lease such property or other property which it intends to use for substantially the same purpose or purposes as the property being sold or transferred.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Securities and Exchange Commission, any successor thereto and any analogous Governmental Authority.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_151"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Cash Management Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Cash Management Agreement that is entered into by and between the Borrower or any Restricted Subsidiary and any Cash Management Bank.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) the Obligations and (b) the due and punctual payment and performance of all obligations of the Borrower or any Restricted Subsidiary under or in respect of each Specified Swap Agreement and each Secured Cash Management Agreement and each Specified Letter of Credit, in each case, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against any Loan Party or any Affiliate thereof of any proceeding under any bankruptcy, insolvency, receivership or other similar proceeding naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Secured Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Administrative Agent, the Collateral Agent, each other Agent, the Lenders, each Issuing Lender, each Swingline Lender, each Cash Management Bank, each party to a Specified Swap Agreement (other than any Restricted Company) and each issuing lender of a Specified Letter of Credit, if, in the case of any Person not already a party to this Agreement, such Person executes and delivers to the Administrative Agent a letter agreement in form and substance acceptable to the Administrative Agent pursuant to which such Person (i) appoints the Collateral Agent as its agent under the applicable Loan Documents and (ii) agrees to be bound by the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as if it were a Lender and as if the fair market value of its Secured Obligations constituted Loans hereunder.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Security Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean that certain Security Agreement, dated as of the Closing Date, by and among the Loan Parties and the Collateral Agent.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:26.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Security Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Security Agreement and all other security documents hereafter delivered to the Collateral Agent granting a Lien on any property of any Person to secure the Secured Obligations.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Senior Representative</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any series of Permitted First Priority Refinancing Debt, Permitted Second Priority Refinancing Debt, Permitted Other Debt or any Debt incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the trustee, administrative agent, collateral agent, security agent or similar agent under the indenture or agreement pursuant to which such Debt is issued, incurred or otherwise obtained, as the case may be, and each of their successors in such capacities.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Senior Secured Leverage Ratio</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean, at any date of determination, the ratio of</font></div><div style="padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a) (i) all Funded Debt of the Borrower and its Restricted Subsidiaries that is secured by a Lien on any asset or property of the Borrower or any Restricted Subsidiary (other than any Lien that is junior to the Lien securing the Obligations pursuant to the Junior Lien Intercreditor Agreement), including Debt in respect of Specified Letters of Credit outstanding as of such date (assuming that the maximum amount of each such Specified Letter of Credit is fully drawn) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) to the extent not otherwise included in subclause (a)(i) of this definition, the face amount of all Letters of Credit issued for the account of the Borrower or any of its Restricted Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (iii) up to the lesser of (x) all unrestricted cash and Cash Equivalents of the Borrower and its Restricted Subsidiaries on a Consolidated basis and (y) $750,000,000 to (b) Consolidated EBITDA of the Borrower and its Restricted Subsidiaries for the most recently completed Measurement Period prior to such date.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:30.6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Senior Secured Leverage Ratio shall be calculated on a Pro Forma Basis to give effect to any Debt incurred, assumed or permanently repaid or extinguished after the relevant</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_154"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Measurement Period but prior to or contemporaneously with the Reference Date as if such incurrence, assumption, repayment or extinguishment had been effected on the last day of such period.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Shared Incremental Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (x) $1,500,000,000 minus (y) the aggregate outstanding principal amount of all Increased Revolving Commitments, Incremental Term Loans and&#47;or Permitted Other Debt, in each case, incurred or issued in reliance on the Shared Incremental Amount.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR&#8221; means a rate equal to the secured overnight financing rate as administered by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the SOFR Administrator.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;SOFR Administrator&#8221; means the Federal Reserve Bank of New York (or a successor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administrator of the secured overnight financing rate).</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:8.7pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Solvent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, when used with respect to any Person, that, as of any date of determination, (a) the amount of the &#8220;present fair saleable value&#8221; of the assets of such Person will, as of such date, exceed the amount of all &#8220;liabilities of such Person, contingent or otherwise,&#8221; as of such date, as such quoted terms are determined in accordance with applicable federal and state laws governing determinations of the insolvency of debtors, (b) the present fair saleable value of the assets of such Person will, as of such date, be greater than the amount that will be required to pay the liability of such Person on its debts as such debts become absolute and matured, (c) such Person will not have, as of such date, an unreasonably small amount of capital with which to conduct its business, and (d) such Person will be able to pay its debts as they mature. For purposes of this definition, (i) &#8220;debt&#8221; shall mean liability on a &#8220;claim,&#8221; and (ii) &#8220;claim&#8221; shall mean any (x) right to payment, whether or not such a right is reduced to judgment, liquidated, unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured or unsecured or (y) right to an equitable remedy for breach of performance if such breach gives rise to a right to payment, whether or not such right to an equitable remedy is reduced to judgment, fixed, contingent, matured or unmatured, disputed, undisputed, secured or unsecured&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, customary due to&#47;due from intercompany arrangements which do not create a contractual repayment requirement shall not be treated as a debt or liability for purposes of the determination of solvency.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Special Purpose Licensed Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Person in a related business of the Borrower and its Restricted Subsidiaries that (i) the Borrower and its Restricted Subsidiaries are prohibited from engaging in directly under applicable law, including provisions of state law (a) prohibiting the ownership of healthcare facilities by public companies, (b) prohibiting the corporate practice of medicine or (c) otherwise restricting the ability of the Borrower or one of its Restricted Subsidiaries to acquire directly a required license to operate a healthcare facility, and (ii) has entered into a transaction or series of transactions with the Borrower or any of its Restricted Subsidiaries under which&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:46.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower or any of its Restricted Subsidiaries provides management, administrative or consulting services to the Special Purpose Licensed Entity,</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:18.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the owners of the Special Purpose Licensed Entity are prohibited from transferring any of their interests in the Special Purpose Licensed Entity without the consent of the Borrower or one of its Restricted Subsidiaries, and</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:29.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the Borrower or one of its Restricted Subsidiaries has the right to require the owners of the Special Purpose Licensed Entity to transfer all of their interests in the Special Purpose Licensed Entity to a Person designated by the Borrower or one of its Restricted Subsidiaries.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_157"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Special Purpose Receivables Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a direct or indirect Restricted Subsidiary of the Borrower established in connection with a Permitted Receivables Financing for the acquisition of Receivables Assets or interests therein, and which is organized in a manner intended to reduce the likelihood that it would be substantively consolidated with the Borrower or any of the Restricted Subsidiaries (other than Special Purpose Receivables Subsidiaries) in the event the Borrower or any such Restricted Subsidiary becomes subject to a proceeding under the U.S. Bankruptcy Code (or other insolvency law).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Alternative Currency LC Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Issuing Lender, the amount set forth beside each Issuing Lender on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto with respect to Alternative Currency Letters of Credit or in each case such other amount as is specified in the agreement pursuant to which such Person becomes an Issuing Lender hereunder.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a &#8220;Change of Control&#8221; (or any other defined term having a similar purpose) as defined in the 2022 Senior Notes Indenture, 2024 Senior Notes Indenture or the 2025 Senior Notes Indenture.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.75pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Dollar LC Sublimit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Issuing Lender, the amount set forth beside such Issuing Lender on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule II</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto with respect to Dollar Letters of Credit or in each case such other amount as is specified in the agreement pursuant to which such Person becomes an Issuing Lender hereunder.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any letter of credit issued by any Lender (at the time of the issuance of such letter of credit) or affiliate thereof for the account of the Borrower or any Restricted Subsidiary, which the Borrower designates as a &#8220;Specified Letter of Credit&#8221; by notice in writing to the Administrative Agent.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Loan Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Loan Party that is not an &#8220;eligible contract participant&#8221; under the Commodity Exchange Act (determined prior to giving effect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Swap Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any Swap Agreement entered into by the Borrower or any Restricted Subsidiary and the Administrative Agent or any Lender (at the time of the execution of such Swap Agreement or with respect to Swap Agreements existing on the Closing Date, on the Closing Date) or affiliate of the Administrative Agent or any Lender in respect of interest rates or currency exchange rates.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Specified Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean (a) the acquisition of any Restricted Subsidiary permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> , (b) the consummation of any Asset Sale, (c) the incurrence, assumption, permanent repayment or extinguishment of any Debt, and (d) the designation of an Unrestricted Subsidiary.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:12.35pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Spot Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; for a currency shall mean the rate determined by the Administrative Agent to be the rate quoted by the Person acting in such capacity as the spot rate for the purchase by such Person of such currency with another currency through its principal foreign exchange trading office at approximately 11&#58;00 a.m. on the date two Business Days prior to the date as of which the foreign exchange computation is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Administrative Agent may obtain such spot rate from another financial institution designated by the Administrative Agent if the Person acting in such capacity does not have as of the date of determination a spot buying rate for any such currency.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:54.72pt;padding-right:54.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sterling</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; and &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#163;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the lawful currency of the United Kingdom.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_160"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to any Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">parent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) at any date, any corporation, limited liability company, partnership, association or other business entity (a) (i) of which securities or other ownership interests representing more than 50% of the voting power of all Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of the Board of Directors thereof are, as of such date, owned, Controlled or held by the parent and&#47;or one or more subsidiaries of the parent and (ii) that is, as of such date, otherwise Controlled by the parent and&#47;or one or more subsidiaries of the parent&#59; or (b) designated as a &#8220;Subsidiary&#8221; by the Borrower by written notice to the Administrative Agent and (i) of which securities or other ownership interests representing more than 50% of the voting power of all Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of the Board of Directors thereof are, as of such date, owned, Controlled or held by the parent and&#47;or one or more subsidiaries of the parent, (ii) that is, as of such date, otherwise Controlled by the parent and&#47;or one or more subsidiaries of the parent or (iii) the accounts of which would be consolidated with those of the parent in the parent&#8217;s Consolidated financial statements&#59; provided, however, that entities shall not be deemed Subsidiaries so long as the assets of each such entity do not exceed $25,000 (unless the Borrower shall elect to include such entity as a Guarantor). Unless the context requires otherwise, &#8220;Subsidiary&#8221; refers to a Subsidiary of the Borrower.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.05pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any agreement with respect to any swap, forward, future or derivative transaction or option or similar agreement involving, or settled by reference to, one or more rates, currencies, commodities, equity or debt instruments or securities, or economic, financial or pricing indices or measures of economic, financial or pricing risk or value or any similar transaction or any combination of these transactions&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no phantom stock or similar plan providing for payments only on account of services provided by current or former directors, officers, employees or consultants of the Borrower or any of its Restricted Subsidiaries shall be a &#8220;Swap Agreement.&#8221;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swap Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean with respect to any Guarantor any obligation to pay or perform under any agreement, contract or transaction that constitutes a &#8220;swap&#8221; within the meaning of Section 1a(47) of the Commodity Exchange Act.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the obligation of the Swingline Lender to make Swingline Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in an aggregate principal amount at any one time outstanding not to exceed $100,000,000.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean Wells Fargo Bank, N.A., in its capacity as the lender of Swingline Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if any Extension or Extensions of Alternative Currency Revolving Commitments is or are effected in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then on the occurrence of each Issuing Lender&#47;Swingline Termination Date, the Swingline Lender at such time shall have the right to resign as Swingline Lender on, or on any date within twenty (20) Business Days after, the respective Issuing Lender&#47;Swingline Termination Date, in each case upon not less than ten (10) days&#8217; prior written notice thereof to the Borrower and the Administrative Agent and, in the event of any such resignation and upon the effectiveness thereof, the Borrower shall repay any outstanding Swingline Loans made by the respective entity so resigning and such entity shall not be required to make any further Swingline Loans hereunder. If at any time and for any reason (including as a result of resignations as contemplated by the proviso to the preceding sentence), the Swingline Lender has resigned in such capacity in accordance with the preceding sentence, then no Person shall be the Swingline Lender hereunder or obligated to make Swingline Loans unless and until (and only for so long as) a Lender (or affiliate of a Lender) reasonably satisfactory to the Administrative Agent and the Borrower agrees to act as the Swingline Lender hereunder.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_163"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Swingline Participation Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Syndication Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in the preamble hereto.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">TARGET Day</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any day on which the Trans-European Automated Real-time Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative, such other payment system (if any) determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euro.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean all present or future taxes, levies, imposts, duties, deductions, withholdings, assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.4pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, the Tranche A Term Lenders and the Tranche B-1 Term Lenders.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall mean, collectively, the Tranche A Term Loans and the Tranche B-1 Term Loans.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:77pt;padding-right:88.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Ticking Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.8(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">&#8220;Term SOFR&#8221; means, with respect to the Tranche B-1 Term Loans,</font></div><div style="margin-top:0.15pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">for any calculation with respect to a Term SOFR Loan, the Term SOFR</font></div><div style="padding-left:41pt;padding-right:8.65pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Rate for a tenor comparable to the applicable Interest Period on the day (such day, the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Periodic Term SOFR Determination Day&#8221;) that is two (2) Business Days prior to the first day of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such Interest Period, as such rate is published by the Term SOFR Administrator&#59; provided,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however, that if as of 5&#58;00 p.m. (Eastern time) on any Periodic Term SOFR Determination Day</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the Term SOFR Reference Rate for the applicable tenor has not been published by the Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such tenor as published by the Term SOFR Administrator on the first preceding Business Day for</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">which such Term SOFR Reference Rate for such tenor was published by the Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Administrator so long as such first preceding Business Day is not more than three (3) Business</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Days prior to such Periodic Term SOFR Determination Day, and</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">for any calculation with respect to an ABR Loan on any day, the Term SOFR</font></div><div style="padding-left:41pt;padding-right:10.2pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Reference Rate for a tenor of one month on the day (such day, the &#8220;ABR Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Determination Day&#8221;) that is two (2) Business Days prior to such day, as such rate is published by</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the Term SOFR Administrator&#59; provided, however, that if as of 5&#58;00 p.m. (Eastern time) on any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ABR Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">has not been published by the Term SOFR Administrator and a Benchmark Replacement Date</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Reference Rate for such tenor as published by the Term SOFR Administrator on the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first preceding Business Day for which such Term SOFR Reference Rate for such tenor was</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">published by the Term SOFR Administrator so long as such first preceding Business Day is not</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">more than three (3) Business Days prior to such ABR Term SOFR Determination Day.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_166"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Adjustment&#8221; means a percentage equal to (i) with respect to an Interest</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Period of one month, 0.11448%, (ii) with respect to an Interest Period of three months, 0.26161% or (iii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">with respect to an Interest Period of six months, 0.42826%.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Administrator&#8221; means CME Group Benchmark Administration Limited</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(CBA) (or a successor administrator of the Term SOFR Reference Rate selected by the Administrative</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent in its reasonable discretion).</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Loan&#8221; means any Loan that bears interest at a rate based on Adjusted Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR other than pursuant to clause (c) of the definition of &#8220;ABR&#8221;. Term SOFR Loans shall be</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">denominated in Dollars.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Reference Rate&#8221; means the forward-looking term rate based on SOFR.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#8220;Term SOFR Tranche&#8221; shall mean, collectively, Term SOFR Loans under a particular</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Facility the then current Interest Periods with respect to all of which begin on the same date and end on</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the same later date (whether or not such Loans shall originally have been made on the same day).</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Alternative Currency Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Alternative Currency Revolving Commitments then in effect. The original amount of the Total Alternative Currency Revolving Commitments is the Alternative Currency Equivalent of $300,000,000.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Alternative Currency Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Alternative Currency Revolving Extensions of Credit of the Alternative Currency Revolving Lenders outstanding at such time.</font></div><div><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Dollar Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Dollar Revolving Commitments then in effect. The original amount of the Total Dollar Revolving Commitments is $700,000,000.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:27.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Dollar Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Dollar Revolving Extensions of Credit of the Dollar Revolving Lenders outstanding at such time.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:23.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Revolving Commitments then in effect.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Total Revolving Extensions of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any time, the aggregate amount of the Revolving Extensions of Credit of the Revolving Lenders outstanding at such time.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:14.15pt;text-indent:74.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Lender, the obligation of such Lender, if any, to make a Tranche A Term Loan to the Borrower in a principal amount not to exceed the amount set forth opposite such Lender&#8217;s name on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule I</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The original aggregate amount of the Tranche A Term Commitments is $1,750,000,000.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Commitment Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the earlier to occur of (x) September 26, 2019 and (y) the date on which the Tranche A Term Commitment is reduced to zero.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Tranche A Term Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221; shall have the meaning given to such term in the definition of</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8220;Facility.&#8221;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_169"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:14.15pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean each Lender that has a Tranche A Term Commitment or that holds a Tranche A Term Loan.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Tranche A Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%;text-decoration:underline">Tranche A Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:225%">&#8221; shall mean August 12, 2024.</font></div><div style="margin-top:0.1pt;padding-left:5pt;padding-right:9.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Tranche A Term Lender at any time, the percentage which such Lender&#8217;s Tranche A Term Commitment then constitutes of the aggregate Tranche A Term Commitments (or, at any time after the Closing Date, the percentage which the aggregate principal amount of such Lender&#8217;s Tranche A Term Loans then outstanding constitutes of the aggregate principal amount of the Tranche A Term Loans then outstanding).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, with respect to each Term Lender, its obligation to make a Tranche B-1 Term Loan to the Borrower pursuant to the First Amendment (including pursuant to a Conversion of Original Tranche B Term Loans of such Term Lender) in an aggregate amount not to exceed the amount set forth on such Lender&#8217;s signature page to the First Amendment under the caption &#8220;Tranche B-1 Term Commitment&#8221; or in the Assignment and Assumption pursuant to which such Term Lender becomes a party hereto, as applicable, as such amount may be adjusted from time to time in accordance with this Agreement. On the First Amendment Effective Date the initial aggregate amount of the Tranche B-1 Term Commitments is $2,743,125,000.00.</font></div><div style="padding-right:15.9pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;padding-right:15.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Facility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned thereto in the First Amendment. </font></div><div><font><br></font></div><div style="padding-left:4.5pt;padding-right:15.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned thereto in the First Amendment. </font></div><div><font><br></font></div><div style="padding-left:4.5pt;padding-right:15.9pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a Tranche B-1 Term Loan constituting a Replacement Term Loan made pursuant to, and as defined in, the First Amendment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Loan Maturity Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean August 12, 2026.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B-1 Term Percentage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Tranche B-1 Term Lender at any time, the percentage which such Lender&#8217;s Tranche B-1 Term Commitment then constitutes of the aggregate Tranche B-1 Term Commitments (or, at any time after the First Amendment Effective Date, the percentage which the aggregate principal amount of such Lender&#8217;s Tranche B-1 Term Loans then outstanding constitutes of the aggregate principal amount of the Tranche B-1 Term Loans then outstanding).</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transaction Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Loan Documents.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, collectively, (a) the execution, delivery and performance of the Loan Documents and the initial borrowings hereunder&#59; (b) the Refinancing and (c) the payment of all fees and expenses owing in connection with the foregoing.</font></div><div style="padding-right:9.85pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transferred Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tricare</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the managed health care program that is established by the Department of Defense under Title 10, Subtitle A, Part II, Chapter 55 (10 U.S.C. &#167;1071 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.) for members of the military, certain military retirees, and their dependents.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Type</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Loan, its nature as an ABR Loan</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_172"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">UCC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Uniform Commercial Code as in effect from time to time (except as otherwise specified) in any applicable state or jurisdiction.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">United States</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the United States of America.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unrestricted Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means (a) as of the Closing Date, each Subsidiary of the Borrower listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule IV</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) any Subsidiary of an Unrestricted Subsidiary and (c) any Subsidiary of the Borrower designated by the board of directors of the Borrower as an Unrestricted Subsidiary pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> subsequent to the Closing Date (and continuing until such time that such designation may be thereafter revoked by the Borrower).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Voting Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean shares of Capital Stock issued by a corporation, or equivalent Capital Stock of any other Person, the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of such Person, even if the right so to vote has been suspended by the happening of such a contingency.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Weighted Average Life to Maturity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, when applied to any Debt at any date, the number of years obtained by dividing&#58; (a) the sum of the products obtained by multiplying (i) the amount of each then remaining installment, sinking fund, serial maturity or other required payments of principal, including payment at final maturity, in respect thereof, by (ii) the number of years (calculated to the nearest one-twelfth) that will elapse between such date and the making of such payment&#59; by (b) the then outstanding principal amount of such Debt.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Wholly Owned Subsidiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, as to any Person, any other Person all of the Capital Stock of which (other than directors&#8217; qualifying shares required by law) is owned by such Person directly and&#47;or through other Wholly Owned Subsidiaries.</font></div><div><font><br></font></div><div style="padding-left:4.5pt;padding-right:32.55pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Withdrawal Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning specified in Section 4201 of ERISA. </font></div><div><font><br></font></div><div style="padding-left:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Write-Down and Conversion Powers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Classification of Loans. For purposes of this Agreement, Loans may be</font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">classified and referred to by Class (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., a &#8220;Revolving Loan&#8221;) or by Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., a &#8220;Eurodollar Loan&#8221;) or by Class and Type (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">e.g</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., a &#8220;Eurodollar Revolving Loan&#8221;).</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Terms Generally. The definitions of terms herein shall apply equally to the</font></div><div style="padding-left:5pt;padding-right:10.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; shall be deemed to be followed by the phrase &#8220;without limitation.&#8221; The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall.&#8221; Unless the context requires otherwise (a) any definition of or reference to any Loan Document, agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, amended and restated, supplemented or otherwise modified (subject to any restrictions on such amendments, supplements or modifications set forth herein), (b) any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns, (c) the words &#8220;herein,&#8221; &#8220;hereof&#8221; and &#8220;hereunder,&#8221; and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all references herein to Sections, Exhibits and Schedules shall be construed to refer to Sections of, and Exhibits and Schedules to, this Agreement,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_175"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">unless otherwise indicated, (e) any reference to any law or regulation herein shall refer to such law or regulation as amended, modified or supplemented from time to time and (f) the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Accounting Terms&#59; GAAP. Except as otherwise expressly provided herein (including, without limitation and other than as provided below, with respect to Financing Leases and Financing Lease Obligations), GAAP shall refer to generally accepted accounting principles in the United States as in effect from time to time applied on a consistent basis and all terms of an accounting or financial nature shall be construed in accordance with GAAP, as in effect from time to time&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Borrower notifies the Administrative Agent that the Borrower requests an amendment to any provision hereof to eliminate the effect of any change in GAAP occurring after the Closing Date or in the application thereof on such provision (or if the Administrative Agent notifies the Borrower that the Required Lenders request an amendment to any provision hereof for such purpose), regardless of whether any such notice is given before or after such change in GAAP or in the application thereof, then such provision shall be interpreted on the basis of GAAP as in effect and applied immediately before such change shall have become effective until such notice shall have been withdrawn or such provision amended in accordance herewith&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall provide to the Administrative Agent and the Lenders a written reconciliation, between calculations of the affected item in amounts required to be reported under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including in any Compliance Certificate) before and after giving effect to such change in GAAP.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:4.5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For the avoidance of doubt, Persons that are not Restricted Subsidiaries shall not be included in any calculation relevant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Resolution of Drafting Ambiguities. Each Loan Party acknowledges and agrees that it was represented by counsel in connection with the execution and delivery of the Loan Documents to which it is a party, that it and its counsel reviewed and participated in the preparation and negotiation hereof and thereof and that any rule of construction to the effect that ambiguities are to be resolved against the drafting party shall not be employed in the interpretation hereof or thereof.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Exchange Rates&#59; Currency Equivalents.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Administrative Agent shall determine the Spot Rates as of each Revaluation Date to be used for calculating Dollar Equivalent amounts of Alternative Currency Revolving Loans or Alternative Currency Letters of Credit, as applicable, outstanding. Such Spot Rates shall become effective as of such Revaluation Date and shall be the Spot Rates employed in converting any amounts between the applicable currencies until the next Revaluation Date to occur. Except for purposes of financial statements delivered by Loan Parties hereunder or calculating financial covenants hereunder or except as otherwise provided herein, the applicable amount of any currency (other than Dollars) for purposes of the Loan Documents shall be such Dollar Equivalent amount as so determined by the Administrative Agent.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Wherever in this Agreement in connection with an Alternative Currency Revolving Loan, an Alternative Currency Letter of Credit, or a conversion, continuation or prepayment of an Alternative Currency Revolving Loan, an amount, such as a required minimum or multiple amount, is expressed in Dollars, but such Alternative Currency Revolving Loan or Alternative Currency Letter of Credit, as applicable, is denominated in an Alternative Currency, such amount shall be the relevant Alternative Currency Equivalent of such Dollar amount (rounded to the nearest unit of such Alternative Currency, with 0.5 of a unit being rounded upward), as determined by the Administrative Agent.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_178"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Additional Alternative Currencies.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower may from time to time request that Alternative Currency Revolving Loans be made and&#47;or Alternative Currency Letters of Credit be issued in a currency other than those specifically listed in the definition of &#8220;Alternative Currency&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the case of Alternative Currency Revolving Loans, such requested currency is a lawful currency (other than Dollars) that is readily available and convertible into Dollars, and, in the case of Alternative Currency Letters of Credit, such requested currency is a lawful currency (other than Dollars) and the Issuing Lender is willing to issue an Alternative Currency Letter of Credit in such currency. In the case of any such request with respect to (x) the making of Alternative Currency Revolving Loans, such request shall be subject to the approval of the Administrative Agent and the Alternative Currency Revolving Lenders, and (y) to the issuance of Alternative Currency Letters of Credit, such request shall be subject to the approval of the Administrative Agent and the Issuing Lender thereunder and, if the requested currency for such Alternative Currency Letter of Credit is not freely transferable and convertible into Dollars, the Administrative Agent and the Issuing Lender thereunder shall agree on the currency conversion between such requested currency and Dollars.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Any such request shall be made to the Administrative Agent not later than 11&#58;00 a.m., Local Time, 20 Business Days prior to the date of the desired extension of credit (or, in the case of any such request pertaining to Alternative Currency Letters of Credit, the Issuing Lender, in its or their sole discretion). In the case of any such request pertaining to Alternative Currency Revolving Loans, the Administrative Agent shall promptly notify each Alternative Currency Revolving Lender of any request pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and in the case of any such request pertaining to Alternative Currency Letters of Credit, the Administrative Agent shall promptly notify the Issuing Lender thereof. Each Alternative Currency Revolving Lender (in the case of any such request pertaining to Alternative Currency Revolving Loans) or Issuing Lender (in the case of a request pertaining to Alternative Currency Letters of Credit) shall notify the Administrative Agent, not later than 11&#58;00 a.m., Local Time, ten Business Days after receipt of such request whether it consents, in its sole discretion, to the making of Alternative Currency Revolving Loans or the issuance of Alternative Currency Letters of Credit , as the case may be, denominated in such currency.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Any failure by an Alternative Currency Revolving Lender or Issuing Lender, asthe case may be, to respond to such request within the time period specified in the preceding sentence shall be deemed to be a refusal by such Alternative Currency Revolving Lender or Issuing Lender, as the case may be, to permit Alternative Currency Revolving Loans to be made or Alternative Currency Letters of Credit to be issued in such requested currency. If the Administrative Agent and all the Alternative Currency Revolving Lenders consent to making Alternative Currency Revolving Loans in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Alternative Currency Revolving Loans&#59; and if the Administrative Agent and an Issuing Lender consent to the issuance of Alternative Currency Letters of Credit in such requested currency, the Administrative Agent shall so notify the Borrower and such currency shall thereupon be deemed for all purposes to be an Alternative Currency hereunder for purposes of any Letter of Credit issuances by such consenting Issuing Lender. If the Administrative Agent shall fail to obtain consent to any request for an additional currency under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall promptly so notify the Borrower.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Change of Currency.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Each obligation of the Borrower to make a payment denominated in the national</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">currency unit of any member state of the European Union that adopts the Euro as its lawful currency after the Closing Date shall be redenominated into Euro at the time of such adoption (in accordance with the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_181"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:9.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EMU Legislation). If, in relation to the currency of any such member state, the basis of accrual of interest expressed in this Agreement in respect of that currency shall be inconsistent with any convention or practice in the London interbank market for the basis of accrual of interest in respect of the Euro, such expressed basis shall be replaced by such convention or practice with effect from the date on which such member state adopts the Euro as its lawful currency&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if any Alternative Currency Revolving Loans in the currency of such member state is outstanding immediately prior to such date, such replacement shall take effect, with respect to such Alternative Currency Revolving Loans, at the end of the then current Interest Period.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Each provision of this Agreement shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect the adoption of the Euro by any member state of the European Union and any relevant market conventions or practices relating to the Euro.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each provision of this Agreement also shall be subject to such reasonable changes of construction as the Administrative Agent may from time to time specify to be appropriate to reflect a change in currency of any other country and any relevant market conventions or practices relating to the change in currency.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Certain Conditions, Calculations and Tests.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;padding-right:43.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">In connection with any action being taken solely in connection with a Limited Condition Transaction, for purposes of&#58;</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.13pt">determining compliance with any provision of this Agreement which requires the calculation of Consolidated EBITDA (including, without limitation, tests measured as a percentage of Consolidated EBITDA), the Leverage Ratio, the Senior Secured Leverage Ratio, or any financial ratio (other than for purposes of any Applicable Margin)&#59; or</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.08pt">testing availability under baskets set forth in this Agreement (including, without limitation, baskets measured as a percentage of Consolidated Tangible Assets)&#59; in each case, at the option of the Borrower (the Borrower&#8217;s election to exercise such option in connection with any Limited Condition Transaction, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LCT Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the date of determination of whether any such action is permitted hereunder shall be deemed to be (i) in the case of a Limited Condition Acquisition, the date the definitive agreements for such Limited Condition Acquisition are entered into, (ii) in the case of any redemption or repayment of Debt requiring irrevocable advance notice or any irrevocable offer to purchase Debt that is not subject to obtaining financing, the date of such irrevocable advance notice or irrevocable offer and (iii) in the case of any Restricted Payment, the date of the declaration, irrevocable advance notice or irrevocable offer of such Restricted Payment (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">LCT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Test Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and if, after giving pro forma effect to the Limited Condition Acquisition and the other transactions to be entered into in connection therewith (including any incurrence of Debt and the use of proceeds thereof) as if they had occurred at the beginning of the most recent Measurement Period ended prior to the LCT Test Date, the Borrower could have taken such action on the relevant LCT Test Date in compliance with such test, ratio or basket, such test, ratio or basket shall be deemed to have been complied with. If the Borrower has made an LCT Election and any of the tests, ratios or baskets for which compliance was determined or tested as of the LCT Test Date are exceeded as a result of fluctuations in any such test, ratio or basket, including due to fluctuations in Consolidated EBITDA or Consolidated Tangible Assets of the Borrower and its Restricted Subsidiaries, at or prior to the consummation of the relevant transaction or action, such tests, baskets or ratios will be deemed not to have been exceeded as a result of such fluctuations solely for purposes of determining whether the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_184"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">relevant transaction or action is permitted to be consummated or taken&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such ratios or baskets improve as a result of such fluctuations, such improved ratios and&#47;or baskets may be utilized. If the Borrower has made an LCT Election for any Limited Condition Transaction, then in connection with any subsequent calculation of any test, ratio or basket availability with respect to the incurrence of Debt or Liens, or the making of Investments, Restricted Payments, mergers, the conveyance, lease or other transfer of all or substantially all of the assets of the Borrower, the prepayment, redemption, purchase, defeasance or other satisfaction of Debt on or following the relevant LCT Test Date and prior to the earlier of the date on which such Limited Condition Transaction is consummated or, in the case of a Limited Condition Acquisition, the definitive agreement for such Limited Condition Acquisition is terminated or expires without consummation of such Limited Condition Acquisition, any such test, ratio or basket shall be tested by calculating the availability under such test, ratio or basket on a Pro Forma Basis assuming such Limited Condition Transaction and other transactions in connection therewith have been consummated (including any incurrence of Debt and any associated Lien and the use of proceeds thereof).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:11.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In connection with any action being taken in connection with a Limited Condition Transaction, for purposes of determining compliance with any provision of this Agreement which requires that no Event of Default or Default, as applicable, has occurred, is continuing or would result from any such action, as applicable, such condition shall, at the option of the Borrower, be deemed satisfied, so long as no Event of Default or Default, as applicable, exists on the date the definitive agreements for such Limited Condition Transaction are entered into. If the Borrower has exercised its option under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and any Event of Default or Default occurs following the date the definitive agreements for the applicable Limited Condition Transaction were entered into and prior to the consummation of such Limited Condition Transaction, any such Event of Default or Default shall be deemed to not have occurred or be continuing for purposes of determining whether any action being taken in connection with such Limited Condition Transaction is permitted hereunder.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Notwithstanding anything to the contrary herein, with respect to any amounts incurred or transactions entered into (or consummated) in reliance on a provision of this Agreement that does not require compliance with a financial ratio or test (including, without limitation, any Leverage Ratio and&#47;or Senior Secured Leverage Ratio) (any such amounts, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Fixed Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) substantially concurrently with any amounts incurred or transactions entered into (or consummated) in reliance on a provision of this Agreement that requires compliance with any such financial ratio or test (any such amounts, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incurrence Based Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), it is understood and agreed that the Fixed Amounts (and any cash proceeds thereof) shall be disregarded in the calculation of the financial ratio or test applicable to the Incurrence Based Amounts in connection with such substantially concurrent incurrence.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt;text-decoration:underline">Divisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Division</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#58; (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Capital Stock at such time.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">1.11</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt;text-decoration:underline">Rates. The Administrative Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, (a) the continuation of, administration of, submission of, calculation of or any other matter related to the Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR or any other Benchmark, or any component definition thereof or rates referred to in the definition thereof, or with respect to any alternative, successor or replacement rate thereto (including any Benchmark Replacement), including whether the composition or characteristics of any such alternative,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_187"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:10.05pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">successor or replacement rate (including any Benchmark Replacement), as it may or may not be adjusted pursuant to Section 2.16, will be similar to, or produce the same value or economic equivalence of, or have the same volume or liquidity as, the Term SOFR Reference Rate, Adjusted Term SOFR, Term SOFR or any other Benchmark prior to its discontinuance or unavailability, or (b) the effect, implementation or composition of any Conforming Changes. The Administrative Agent and its Affiliates or other related entities may engage in transactions that affect the calculation of a Benchmark, any alternative, successor or replacement rate (including any Benchmark Replacement) or any relevant adjustments thereto and such transactions may be adverse to the Borrower. The Administrative Agent may select information sources or services in its reasonable discretion to ascertain any Benchmark, any component definition thereof or rates referred to in the definition thereof, in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrower, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:179.25pt;padding-right:179.25pt;text-align:center"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SECTION 2</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:52.25pt;padding-right:52.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AMOUNT AND TERMS OF COMMITMENTS</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Term Commitments. Subject to the terms and conditions hereof, (a) each Tranche A Term Lender, subject to the satisfaction of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, severally agrees to make a term loan denominated in Dollars (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower on or after the Closing Date until the Tranche A Term Commitment Expiration Date in one drawing in an amount not to exceed the amount of the Tranche A Term Commitment of such Lender and (b) each Tranche B Term Lender severally agrees to make a term loan denominated in Dollars (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower on the Closing Date in an amount not to exceed the amount of the Tranche B Term Commitment of such Lender. The </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Tranche A</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term Loans may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrower and notified to the Administrative Agent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">The Tranche B-1 Term Loans may from time to time be Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Loans or ABR Loans, as determined by the Borrower and notified to the Administrative Agent in</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">accordance with Sections 2.2 and 2.12.</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amounts borrowed under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and repaid may not be reborrowed.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Procedure for Term Loan Borrowing. The Borrower shall give the Administrative Agent irrevocable notice in the form of a Borrowing Request (which notice must be received by the Administrative Agent prior to 1&#58;00 P.M., New York City time, (a) three Business Days prior to the requested Borrowing Date in the case of any Tranche B</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">-1</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term Loans or Tranche A Term Loans that will be </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, respectively</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or (b) one Business Day prior to the requested Borrowing Date in the case of any Tranche B</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">-1</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term Loans or Tranche A Term Loans that will be ABR Loans) requesting that the Term Lenders make the Term Loans on such Borrowing Date, and specifying the amount to be borrowed under each Class. Upon receipt of such notice the Administrative Agent shall promptly notify each Term Lender thereof. Not later than 12&#58;00 Noon, New York City time, on the Closing Date or such Borrowing Date, as applicable, each Term Lender shall make available to the Administrative Agent at the Funding Office an amount in immediately available funds equal to the Term Loan to be made by such Term Lender. The Administrative Agent shall credit the account of the Borrower on the books of such office of the Administrative Agent with the aggregate of the amounts made available to the Administrative Agent by the Term Lenders in immediately available funds.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Repayment of Term Loans.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_190"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">From and after the borrowing of the Tranche A Term Loans, the Tranche A</font></div><div style="padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term Loan of each Tranche A Term Lender shall mature in 19 consecutive quarterly installments and on the Tranche A Term Loan Maturity Date, in an amount equal to such Lender&#8217;s Tranche A Term Percentage multiplied by the amount set forth below opposite such installment&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:76.66pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.226%"><tr><td style="width:1.0%"></td><td style="width:60.874%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%;text-decoration:underline">Installment Due Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.35pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%;text-decoration:underline">Principal Amount</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">December 31, 2019</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$10,937,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">March 31, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$10,937,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">June 30, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$10,937,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">September 30, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$10,937,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">December 31, 2020</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">March 31, 2021</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">June 30, 2021</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">September 30, 2021</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">December 31, 2021</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">March 31, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">June 30, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">September 30, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$21,875,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">December 31, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$32,812,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">March 31, 2023</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$32,812,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">June 30, 2023</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$32,812,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">September 30, 2023</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$32,812,500</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">December 31, 2023</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$43,750,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">March 31, 2024</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$43,750,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">June 30, 2024</font></div></td><td colspan="3" style="padding:2px 1pt 2px 66.75pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:105%">$43,750,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Tranche A Term Loan Maturity Date</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:7.15pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">$1,268,750,000</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Tranche B-1 Term Loan of each Tranche B-1 Term Lender shall mature (i) in quarterly installments on the last day of each March, June, September and December (commencing on March 31, 2020), each in an amount equal to such Lender&#8217;s Tranche B-1 Term Percentage multiplied by 0.25% of the aggregate principal amount of the Tranche B-1 Term Loans outstanding on the First Amendment Effective Date immediately after funding the Tranche B-1 Term Facility, until the Tranche B-1 Term Loan Maturity Date and (ii) on the Tranche B-1 Term Loan Maturity Date in an amount equal to all remaining outstanding Tranche B-1 Term Loans of such Tranche B-1 Term Lender.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Revolving Commitments.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subject to the terms and conditions hereof, (1) each Dollar Revolving Lender severally agrees to make revolving credit loans in Dollars (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dollar Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower from time to time during the Revolving Commitment Period in an aggregate principal amount at any one time outstanding which, when added to such Lender&#8217;s Dollar Revolving Percentage of the LC Obligations then outstanding, does not exceed the amount of such Lender&#8217;s Dollar Revolving Commitment and (2) each Alternative Currency Revolving Lender severally agrees to make revolving credit loans in one or more Alternative Currencies (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Alternative Currency Revolving Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower from time to time during the Revolving Commitment Period in an aggregate principal amount at any one time outstanding which, when added to such Lender&#8217;s Alternative Currency Revolving Percentage of the sum of (i) the LC Obligations then outstanding and (ii) the aggregate principal amount of the Swingline Loans then outstanding, does not exceed the amount of such Lender&#8217;s Alternative Currency Revolving Commitment. During the Revolving Commitment Period the Borrower may use the Revolving Commitments by borrowing, prepaying the Revolving Loans in whole or in part, and reborrowing, all in accordance with the terms and conditions hereof. The Dollar Revolving Loans and</font></div><div id="i66fa5437d00449c287748a0afadd48cb_193"></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Alternative Currency Revolving Loans denominated in Dollars may from time to time be Eurodollar Loans or ABR Loans, as determined by the Borrower and notified to the Administrative </font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agent in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Alternative Currency Revolving Loans denominated in an Alternative Currency other than Dollars shall be Eurodollar Loans.</font></div><div style="padding-right:12.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower shall repay all outstanding Revolving Loans on applicable Maturity Date. </font></div><div style="padding-left:4.5pt;padding-right:12.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Procedure for Revolving Loan Borrowing. The Borrower may borrow under the Revolving Commitments during the Revolving Commitment Period on any Business Day&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall give the Administrative Agent irrevocable notice in the form of a Borrowing Request (which notice must be received by the Administrative Agent prior to 2&#58;00 P.M., New York City time, (a)(i) three Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans denominated in Dollars or (ii) four Business Days prior to the requested Borrowing Date, in the case of Eurodollar Loans denominated in Alternative Currencies (other than Dollars), or (b) one Business Day prior to the requested Borrowing Date, in the case of ABR Loans) (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such notice of a borrowing of ABR Loans under the Alternative Currency Revolving Facility to finance payments required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may be given not later than 1&#58;00 P.M., New York City time, on the date of the proposed borrowing), specifying (i) the amount of Revolving Loans to be borrowed, (ii) the requested Borrowing Date, (iii) the Revolving Facility pursuant to which such Loan is to be made, (iv) the currency of the Revolving Loans to be borrowed, (v) if the Revolving Loans to be borrowed are denominated in Dollars, the Type of Revolving Loans to be borrowed and (vi) in the case of Eurodollar Loans, the respective amounts of each such Type of Loan and the respective lengths of the initial Interest Period therefor. Each borrowing under the Dollar Revolving Commitments and each borrowing under the Alternative Currency Revolving Commitments denominated in Dollars shall be in an amount equal to (x) in the case of ABR Loans, $1,000,000 or a whole multiple thereof (or, if the then aggregate Available Revolving Commitments are less than $1,000,000, such lesser amount) and (y) in the case of Eurodollar Loans, $5,000,000 or a whole multiple of $1,000,000 in excess thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Swingline Lender may request, on behalf of the Borrower, borrowings denominated in Dollars under the Alternative Currency Revolving Commitments that are ABR Loans in other amounts pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each borrowing under the Alternative Currency Revolving Commitments (other than a borrowing denominated in Dollars) shall be in an amount equal to the Alternative Currency Equivalent of $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Upon receipt of any such notice from the Borrower, the Administrative Agent shall promptly notify each Revolving Lender thereof. Each Revolving Lender will make the amount of its </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> share of each borrowing available to the Administrative Agent for the account of the Borrower at the Funding Office for the applicable currency prior to 12&#58;00 Noon, New York City time, on the Borrowing Date requested by the Borrower in funds immediately available to the Administrative Agent. Such borrowing will then be made available to the Borrower by the Administrative Agent crediting the account of the Borrower on the books of such office with the aggregate of the amounts made available to the Administrative Agent by the Revolving Lenders and in like funds as received by the Administrative Agent.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Swingline Commitment.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Subject to the terms and conditions hereof, the Swingline Lender agrees to make</font></div><div style="padding-left:4.5pt;padding-right:11.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">a portion of the credit otherwise available to the Borrower under the Alternative Currency Revolving Commitments from time to time after the Closing Date and during the Revolving Commitment Period by making swing line loans denominated in Dollars (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the aggregate principal amount of Swingline Loans outstanding at any time shall not exceed the Swingline Commitment then in effect and (ii) the Borrower shall not request, and the Swingline Lender shall not make, any Swingline Loan if, after giving effect to the making of such Swingline Loan, the</font></div><div id="i66fa5437d00449c287748a0afadd48cb_196"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.055%"><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.415%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.055%"></div><div style="display:inline-block;max-width:0.415%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.060%"></div></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_199"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">aggregate amount of the Available Alternative Currency Revolving Commitments would be less than zero. During the Revolving Commitment Period, the Borrower may use the Swingline Commitment by borrowing, repaying and reborrowing, all in accordance with the terms and conditions hereof. Swingline Loans shall be ABR Loans only.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Borrower shall repay to the Swingline Lender the then unpaid principal amount of each Swingline Loan on the earlier of the applicable Maturity Date in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.7(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the first date after such Swingline Loan is made that is the 15th or last day of a calendar month and is at least two Business Days after such Swingline Loan is made&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on each date that an Alternative Currency Revolving Loan denominated in Dollars is borrowed, the Borrower shall repay all Swingline Loans then outstanding.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Procedure for Swingline Borrowing&#59; Refunding of Swingline Loans.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">To request a Swingline Loan, the Borrower shall notify the Administrative Agent of such request by telephone (confirmed by telecopy of a Borrowing Request), not later than 2&#58;00 P.M., New York City time, on the day (which shall be a Business Day during the Revolving Commitment Period) of a proposed Swingline Loan. Each such notice shall be irrevocable and shall specify the requested date (which shall be a Business Day) and amount of the requested Swingline Loan. The Administrative Agent will promptly advise the Swingline Lender of any such notice received from the Borrower. The Swingline Lender shall make each Swingline Loan available to the Borrower by means of a credit to the general deposit account of the Borrower with the Swingline Lender (or, in the case of a Swingline Loan made to finance the reimbursement of an LC Disbursement as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, by remittance to the Issuing Lender) by 4&#58;00 P.M., New York City time, on the requested date of such Swingline Loan. Each borrowing under the Swingline Commitment shall be in an amount equal to $500,000 or a whole multiple of $100,000 in excess thereof.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Swingline Lender, at any time and from time to time in its sole and absolute discretion may, on behalf of the Borrower (which hereby irrevocably directs the Swingline Lender to act on its behalf), on one Business Day&#8217;s notice given by the Swingline Lender no later than 2&#58;00 P.M., New York City time, request each Alternative Currency Revolving Lender to make, and each Alternative Currency Revolving Lender hereby agrees to make, an Alternative Currency Revolving Loan denominated in Dollars, in an amount equal to such Alternative Currency Revolving Lender&#8217;s Alternative Currency Revolving Percentage of the aggregate amount of the Swingline Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding the foregoing, no Alternative Currency Revolving Lender shall be obligated to make any Alternative Currency Revolving Loan if after giving effect to the making of such Alternative Currency Revolving Loan the outstanding amount of Alternative Currency Revolving Extensions of Credit of such Lender exceed such Lender&#8217;s Alternative Currency Revolving Commitment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refunded Swingline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) outstanding on the date of such notice, to repay the Swingline Lender. Each Alternative Currency Revolving Lender shall make the amount of such Alternative Currency Revolving Loan available to the Administrative Agent at the Funding Office for Dollar-denominated payments in immediately available funds, not later than 10&#58;00 A.M., New York City time, one Business Day after the date of such notice. The proceeds of such Alternative Currency Revolving Loans shall be immediately made available by the Administrative Agent to the Swingline Lender for application by the Swingline Lender to the repayment of the Refunded Swingline Loans. The Borrower irrevocably authorizes the Swingline Lender to charge the Borrower&#8217;s accounts with the Administrative Agent (up to the amount available in each such account) in order to immediately pay the amount of such Refunded Swingline Loans to the extent amounts received from the Alternative Currency Revolving Lenders are not sufficient to repay in full such Refunded Swingline Loans.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_202"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">If prior to the time an Alternative Currency Revolving Loan denominated in Dollars would have otherwise been made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, one of the events described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall have occurred and be continuing with respect to the Borrower or if for any other reason, as determined by the Swingline Lender in its sole discretion, Alternative Currency Revolving Loans may not be made as contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, each Alternative Currency Revolving Lender shall, on the date such Alternative Currency Revolving Loan was to have been made pursuant to the notice referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, purchase for cash an undivided participating interest in the then outstanding Swingline Loans by paying to the Swingline Lender an amount (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Swingline Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) equal to (i) such Alternative Currency Revolving Lender&#8217;s Alternative Currency Revolving Percentage </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">times</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the sum of the aggregate principal amount of Swingline Loans then outstanding that were to have been repaid with such Alternative Currency Revolving Loans.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Whenever, at any time after the Swingline Lender has received from any Alternative Currency Revolving Lender such Lender&#8217;s Swingline Participation Amount, the Swingline Lender receives any payment on account of the Swingline Loans, the Swingline Lender will distribute to such Lender its Swingline Participation Amount (appropriately adjusted, in the case of interest payments, to reflect the period of time during which such Lender&#8217;s participating interest was outstanding and funded and, in the case of principal and interest payments, to reflect such Lender&#8217;s </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> portion of such payment if such payment is not sufficient to pay the principal of and interest on all Swingline Loans then due)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in the event that such payment received by the Swingline Lender is required to be returned, such Alternative Currency Revolving Lender will return to the Swingline Lender any portion thereof previously distributed to it by the Swingline Lender.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each Alternative Currency Revolving Lender&#8217;s obligation to make the Loans referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and to purchase participating interests pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be absolute and unconditional and shall not be affected by any circumstance, including (i) any setoff, counterclaim, recoupment, defense or other right that such Alternative Currency Revolving Lender or the Borrower may have against the Swingline Lender, the Borrower or any other Person for any reason whatsoever&#59; (ii) the occurrence or continuance of a Default or the failure to satisfy any of the other conditions specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; (iii) any adverse change in the financial condition of the Borrower&#59; (iv) any breach of this Agreement or any other Loan Document by the Borrower, any other Loan Party or any other Alternative Currency Revolving Lender&#59; or (v) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">If the Maturity Date shall have occurred in respect of any tranche of Alternative Currency Revolving Commitments at a time when another tranche or tranches of Alternative Currency Revolving Commitments is or are in effect with a longer Maturity Date, then on the earliest occurring Maturity Date all then outstanding Swingline Loans shall be repaid in full (and there shall be no adjustment to the participations in such Swingline Loans as a result of the occurrence of such Maturity Date)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if on the occurrence of such earliest Maturity Date (after giving effect to any repayments of Alternative Currency Revolving Loans and any reallocation of Letter of Credit participations as contemplated in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), there shall exist sufficient unutilized Extended Revolving Commitments that are the Alternative Currency Revolving Commitments so that the respective outstanding Swingline Loans could be incurred pursuant to such Extended Revolving Commitments which will remain in effect after the occurrence of such Maturity Date, then there shall be an automatic adjustment on such date of the Swingline Participation Amounts of each Alternative Currency Revolving Lender that is an Extending Revolving Lender and such outstanding Swingline Loans shall be deemed to have been incurred solely pursuant to the relevant Extended Revolving Commitments, and such Swingline Loans shall not be so required to be repaid in full on such earliest Maturity Date.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Commitment Fees, etc.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_205"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower agrees to pay to the Administrative Agent for the account of each Revolving Lender a commitment fee for the period from and including the Closing Date to the last day of the Revolving Commitment Period, computed at the Commitment Fee Rate on the average daily amount of the Available Dollar Revolving Commitment and&#47;or Available Alternative Currency Revolving Commitment, as applicable, of such Lender during the period for which payment is made, payable quarterly in arrears on each Fee Payment Date, commencing on the first such date to occur after the Closing Date and on the Maturity Date for the Revolving Facility.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Borrower agrees to pay to the Administrative Agent the fees in the amounts and on the dates previously agreed to in writing by the Borrower and the Administrative Agent.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower will pay to the Administrative Agent for the account of each Applicable Participant in accordance with its Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, a fee for each Letter of Credit with respect to which it is an Applicable Participant equal to the product of (i) the Dollar Equivalent of the daily maximum amount then available to be drawn on such Letters of Credit and (ii) a per annum rate equal to the Applicable Margin then in effect with respect to Eurodollar Loans under the Revolving Facility, payable quarterly in arrears on each Fee Payment Date after the issuance date. In addition, the Borrower shall pay to the Issuing Lender for its own account a fronting fee of 0.125% per annum on the undrawn and unexpired amount of each Letter of Credit, payable quarterly in arrears on each Fee Payment Date after the issuance date.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In addition to the foregoing fees, the Borrower shall pay or reimburse the Issuing Lender for such normal and customary costs and expenses (including issuance fees) as are incurred or charged by the Issuing Lender in issuing, negotiating, effecting payment under, amending or otherwise administering any Letter of Credit.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower agrees to pay on the Closing Date (w) to each Tranche A Term Lender party to this Agreement on the Closing Date, as fee compensation for the funding of such Tranche A Term Lender&#8217;s Tranche A Term Loan, a funding fee in an amount agreed between such Tranche A Term Lender and the Borrower, (x) to each Tranche B Term Lender party to this Agreement on the Closing Date, as fee compensation for the funding of such Tranche B Term Lender&#8217;s Tranche B Term Loan, a funding fee in an amount equal to 0.25% of the stated principal amount of such Tranche B Term Lender&#8217;s Tranche B Term Loan funded on the Closing Date, (y) to each Dollar Revolving Lender party to this Agreement on the Closing Date, as compensation for the Dollar Revolving Commitment of such Dollar Revolving Lender, a commitment fee in the amount agreed between such Dollar Revolving Lender and the Borrower and (z) to each Alternative Currency Revolving Lender party to this Agreement on the Closing Date, as compensation for the Alternative Currency Revolving Commitment of such Alternative Currency Revolving Lender, a commitment fee in the amount agreed between such Alternative Currency Revolving Lender and the Borrower.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">All fees payable hereunder (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) shall be paid on the dates due, in immediately available funds, to the Administrative Agent (or to the Issuing Lender, in the case of fees payable to it) for distribution, in the case of facility fees and participation fees, to the Lenders. Fees paid shall not be refundable under any circumstances.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Borrower agrees to pay to the Administrative Agent for the account of each Tranche A Term Lender a ticking fee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Ticking Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in dollars at a rate per annum equal to the then applicable Commitment Fee Rate on the undrawn portion of the Tranche A Term Commitments, payable quarterly in arrears on the last Business Day of each fiscal quarter of each year and on the Tranche A Term Commitment Expiration Date, commencing on the first such date to occur after the Closing Date,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_208"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">calculated based upon the actual number of days elapsed over a 360-day year, accruing beginning on the Closing Date to but excluding the Tranche A Term Commitment Expiration Date. The Ticking Fee shall be distributed to the Tranche A Term Lenders pro rata in accordance with the amount of each such Tranche A Term Lender&#8217;s Tranche A Term Commitment.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:31.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Termination or Reduction of Revolving Commitments and Tranche A Term Commitments.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="margin-top:0.3pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_211"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.042%"><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.436%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.042%"></div><div style="display:inline-block;max-width:0.436%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.044%"></div></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower shall have the right, upon not less than three Business Days&#8217; notice to the Administrative Agent, to terminate, or from time to time to reduce the amount of, the Revolving Commitments under one or more Revolving Facilities&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such termination or reduction of Revolving Commitments shall be permitted if, after giving effect thereto and to any prepayments of the Revolving Loans and Swingline Loans made on the effective date thereof, (i) the Total Alternative Currency Revolving Extensions of Credit would exceed the Total Alternative Currency Revolving Commitments, (ii) the Total Dollar Revolving Extensions of Credit would exceed the Total Dollar Revolving Commitments or (iii) the Total Revolving Extensions of Credit would exceed the Total Revolving Commitments. Any such reduction shall be in an amount equal to (i) with respect to the Alternative Currency Revolving Commitments, $1,000,000, a whole multiple thereof, or the remaining aggregate amount of the Alternative Currency Revolving Commitments, and shall reduce permanently the Alternative Currency Revolving Commitments then in effect and (ii) with respect to the Dollar Revolving Commitments, $1,000,000, a whole multiple thereof, or the remaining aggregate amount of the Dollar Revolving Commitments, and shall reduce permanently the Dollar Revolving Commitments then in effect. The Revolving Commitment (other than any Extended Revolving Commitment) of each Revolving Lender shall automatically and permanently terminate on the Revolving Termination Date. On the respective Maturity Date applicable thereto, the Extended Revolving Commitment of each Extended Revolving Commitment shall automatically and permanently terminate.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Borrower shall have the right, upon not less than three Business Days&#8217; notice to the Administrative Agent, to terminate, or from time to time to reduce the amount of, the Tranche A Term Commitments under the Tranche A Term Facility. Any such reduction shall be in an amount equal to $1,000,000, a whole multiple thereof, or the remaining aggregate amount of the Tranche A Term Commitments, and shall reduce permanently the Tranche A Term Commitments then in effect. The Tranche A Term Commitments of each Tranche A Term Lender shall automatically and permanently terminate on the Tranche A Term Commitment Expiration Date.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Optional Prepayments. The Borrower may at any time and from time to time prepay the Loans, in whole or in part, without premium (except as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or penalty, upon notice delivered to the Administrative Agent no later than 2&#58;00 P.M., New York City time, (i) three Business Days prior thereto, in the case of Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">denominated in Dollars and (ii) four Business Days prior thereto in the case of Eurodollar Loans denominated in Alternative Currencies (other than Dollars), and no later than 2&#58;00 P.M., New York City time, one Business Day prior thereto, in the case of ABR Loans, which notice shall specify the date and amount of prepayment, the installment or installments of the respective Classes of the Loans to be repaid and whether the prepayment is of Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">, Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or ABR Loans (it being understood that the Borrower may elect to prepay one Class of Term Loans without prepaying another)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in the case of Swingline Loans notice may be given no later than 2&#58;00 P.M. New York City time on the date of prepayment&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided, further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if a Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is prepaid on any day other than the last day of the Interest Period applicable thereto, the Borrower shall also pay any amounts owing pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with (except in the case of</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_214"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revolving Loans that are ABR Loans and Swingline Loans) accrued interest to such date on the amount prepaid. Partial prepayments of a Class of Term Loans shall be in an aggregate principal amount of $1,000,000 or a whole multiple thereof. Partial prepayments of Revolving Loans denominated in an Alternative Currency (other than Dollars) shall be in an aggregate principal amount of the Alternative Currency Equivalent of $1,000,000 or a whole multiple thereof. Partial prepayments of Revolving Loans denominated in Dollars shall be in an aggregate principal amount of $1,000,000 or a whole multiple thereof. Partial prepayments of Swingline Loans shall be in an aggregate principal amount of $100,000 or a whole multiple thereof. Notwithstanding anything to the contrary contained in this Agreement, the Borrower may rescind any notice of optional prepayment if such prepayment would have resulted from a refinancing of all or a portion of the applicable Facility, which refinancing shall not be consummated or shall otherwise be delayed. Voluntary prepayments of any Class of Term Loans permitted hereunder shall be applied to the remaining scheduled installments of principal thereof (or to any anticipated mandatory prepayments under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> specific in writing by the Borrower) in a manner determined at the discretion of the Borrower and specified in the notice of prepayment and the Borrower may elect to apply voluntary prepayments of Term Loans to one or more Class or Classes of Term Loans selected by the Borrower. In the event that the Borrower does not specify the order in which to apply prepayments to reduce scheduled installments of principal or as between Classes of Term Loans, the Borrower shall be deemed to have elected that such proceeds be applied to reduce the scheduled installments of principal in direct order of maturity on a pro rata basis among the Classes of Term Loans.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Mandatory Prepayments and Commitment Reductions.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">If any Redeemable Preferred Interests or Debt shall be issued or incurred by any Restricted Company (excluding any Debt or Redeemable Preferred Interests incurred in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (other than Credit Agreement Refinancing Debt) or Capital Stock issued in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), an amount equal to 100% of the Net Cash Proceeds thereof shall be applied within five Business Days of such issuance or incurrence toward the prepayment of the Term Loans and the Revolving Loans as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If on any date any Restricted Company shall receive Net Cash Proceeds from any Asset Sale or Recovery Event and such Net Cash Proceeds are not prohibited under any Requirements of Law to be distributed or otherwise transferred without the consent or approval of a Governmental Authority then, to the extent a Reinvestment Notice shall not have been delivered in respect thereof, an amount equal to such Net Cash Proceeds shall be applied within ten Business Days after the date that all post-closing adjustments associated therewith have been completed toward the prepayment of the Term Loans and the Revolving Loans as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, notwithstanding the foregoing, on each Reinvestment Prepayment Date, an amount equal to the Reinvestment Prepayment Amount with respect to the relevant Reinvestment Event shall be applied toward the prepayment of the Term Loans and the Revolving Loans as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">If, for any Fiscal Year of the Borrower commencing with the Fiscal Year ending December 31, 2020, there shall be Excess Cash Flow, the Borrower shall, on the relevant Excess Cash Flow Application Date, apply toward the prepayment of the Term Loans and the reduction of the Revolving Commitments as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) the ECF Percentage of such Excess Cash Flow, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (B) the sum of (i) all voluntary prepayments of Term Loans (and Revolving Loans to the extent the applicable Revolving Commitments are permanently reduced by the amount of such payments) and any other prepayments of Permitted Other Debt, Permitted Refinancings and&#47;or other Debt secured by Liens on the Collateral on a pari passu basis or senior basis to the Liens on the Collateral made during such Fiscal Year, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the amount of cash consideration paid by the Borrower and its Restricted Subsidiaries in connection with Investments permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each such prepayment and commitment reduction shall be made on a date (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Excess Cash Flow Application Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) no later than</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_217"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ten Business Days after the earlier of (i) the date on which the financial statements of the Borrower referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, for the Fiscal Year with respect to which such prepayment is made, are required to be delivered to the Administrative Agent (for distribution to the Agents and the Lenders) and (ii) the date such financial statements are actually delivered&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that a prepayment of Term Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall only be required in the amount (if any) by which such payment amount for the applicable Fiscal Year exceeds $25,000,000.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Amounts to be applied in connection with prepayments made pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be applied, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the prepayment of the Term Loans in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to reduce the Swingline Loans and then Revolving Loans without a permanent reduction of the Revolving Commitments. The application of any prepayment pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be made, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to ABR Loans and, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> and Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each prepayment of the Loans under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (except in the case of Revolving Loans that are ABR Loans and Swingline Loans) shall be accompanied by accrued interest to the date of such prepayment on the amount prepaid.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding anything to the contrary in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, with respect to the amount of any mandatory prepayment described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that is allocated to Tranche B-1 Term Loans (such amount, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Prepayment Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), at any time when Tranche A Term Loans remain outstanding, the Borrower will give the Administrative Agent notice in writing of such mandatory prepayment at least three (3) Business Days prior to the date of such prepayment (each a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Mandatory Prepayment Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). As promptly as practicable after receiving such notice from the Borrower, the Administrative Agent will send to each Tranche B-1 Term Lender a notice, which shall be in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prepayment Option Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and shall include the relevant Term Loans of such Lender by an amount equal to the portion of the Designated Prepayment Amount indicated in such Lender&#8217;s Prepayment Option Notice as being applicable to such Lender&#8217;s Tranche B-1 Term Loans. On the Mandatory Prepayment Date, (i) the Borrower shall pay to the relevant Tranche B-1 Term Lenders the aggregate amount necessary to prepay that portion of the outstanding relevant Term Loans as described above in respect of which such Lenders have accepted prepayment (it being understood that a failure to respond to a Prepayment Option Notice no later than 5&#58;00 p.m. one Business Day after the date of such Lender&#8217;s receipt of notice from the Administrative Agent regarding such prepayment shall be deemed an acceptance of the prepayment referenced therein) and (ii) the Borrower shall pay to the Tranche A Term Lenders an amount equal to the portion of the Designated Prepayment Amount not accepted by the relevant Lenders, and such amount shall be applied to the prepayment of the Tranche A Term Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if after the application of amounts pursuant to clause (ii), any portion of the Designated Prepayment Amount not accepted by the Tranche B-1 Term Lenders shall remain, such amount shall be used to prepay the Tranche B-1 Term Loans on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">Revolving Loan Prepayments.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:14.1pt;text-indent:75.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.83pt">In the event of the termination of all the Alternative Currency Revolving Commitments, the Borrower shall, on the date of such termination, repay or prepay all its outstanding Alternative Currency Revolving Loans and all outstanding Swingline Loans and replace all outstanding Alternative Currency Letters of Credit or cash collateralize all outstanding Alternative Currency Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event of the termination of all the Dollar Revolving Commitments, the Borrower shall, on the date of such termination, repay or prepay all its outstanding Dollar Revolving Loans and replace all outstanding Dollar Letters of Credit or cash collateralize all outstanding Dollar Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_220"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:13.95pt;text-indent:72.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.88pt">In the event of any partial reduction of the Alternative Currency Revolving Commitments, then (x) at or prior to the effective date of such reduction, the Administrative Agent shall notify the Borrower and the Alternative Currency Revolving Lenders of the sum of the Alternative Currency Revolving Extensions of Credit after giving effect thereto and (y) if the sum of the Alternative Currency Revolving Extensions of Credit would exceed the aggregate amount of Alternative Currency Revolving Commitments after giving effect to such reduction, then the Borrower shall, on the date of such reduction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Swingline Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Alternative Currency Revolving Loans and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, replace outstanding Alternative Currency Letters of Credit or cash collateralize outstanding Alternative Currency Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount sufficient to eliminate such excess. In the event of any partial reduction of the Dollar Revolving Commitments, then (x) at or prior to the effective date of such reduction, the Administrative Agent shall notify the Borrower and the Dollar Revolving Lenders of the sum of the Dollar Revolving Extensions of Credit after giving effect thereto and (y) if the sum of the Dollar Revolving Extensions of Credit would exceed the aggregate amount of Dollar Revolving Commitments after giving effect to such reduction, then the Borrower shall, on the date of such reduction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Dollar Revolving Loans and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, replace outstanding Dollar Letters of Credit or cash collateralize outstanding Dollar Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount sufficient to eliminate such excess.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.35pt;text-indent:69.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.93pt">In the event that the sum of all Alternative Currency Revolving Lenders&#8217; Alternative Currency Revolving Extensions of Credit exceeds the Alternative Currency Revolving Commitments then in effect (including, without limitation, as a result of any Revaluation Date or as a result of currency fluctuations), the Borrower shall, without notice or demand, immediately </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Swingline Loans, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Alternative Currency Revolving Loans, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, replace outstanding Alternative Currency Letters of Credit or cash collateralize outstanding Alternative Currency Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount sufficient to eliminate such excess. In the event that the sum of all Dollar Revolving Lenders&#8217; Dollar Revolving Extensions of Credit exceeds the Dollar Revolving Commitments then in effect, the Borrower shall, without notice or demand, immediately </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">first</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, repay or prepay Dollar Revolving Loans, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, replace outstanding Dollar Letters of Credit or cash collateralize outstanding Dollar Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount sufficient to eliminate such excess.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.35pt;text-indent:70.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.73pt">In the event that the aggregate LC Obligations exceed the LC Commitment then in effect, the Borrower shall, without notice or demand, immediately replace outstanding Letters of Credit or cash collateralize outstanding Letters of Credit in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount sufficient to eliminate such excess.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#91;Reserved&#93;.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In the event that, on or prior to the date that is six months after the Closing Date, the Borrower (x) prepays, refinances, substitutes or replaces any Tranche B-1 Term Loan pursuant to a Repricing Transaction (including, for avoidance of doubt, any prepayment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that constitutes a Repricing Transaction), or (y) effects any amendment of this Agreement resulting in a Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Tranche B-1 Term Lenders, (I) in the case of clause (x), a prepayment premium of 1.00% of the aggregate principal amount of the Tranche B-1 Term Loan so prepaid, refinanced, substituted or replaced and (II) in the case of clause (y), a fee equal to 1.00% of the aggregate principal amount of the applicable Tranche B-1 Term Loan outstanding immediately prior to such amendment. Such amounts shall be due and payable on the date of effectiveness of such Repricing Transaction.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_223"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.13pt">In the event that, on or prior to the date that is six months after the First Amendment Effective Date, the Borrower (x) prepays, refinances, substitutes or replaces any Tranche B-1 Term Loan pursuant to a Repricing Transaction (including, for avoidance of doubt, any prepayment made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that constitutes a Repricing Transaction), or (y) effects any amendment of this Agreement resulting in a Repricing Transaction, the Borrower shall pay to the Administrative Agent, for the ratable account of each of the applicable Tranche B-1 Term Lenders, (I) in the case of clause (x), a prepayment premium of 1.00% of the aggregate principal amount of the Tranche B-1 Term Loan so prepaid, refinanced, substituted or replaced and (II) in the case of clause (y), a fee equal to 1.00% of the aggregate principal amount of the applicable Tranche B-1 Term Loan outstanding immediately prior to such amendment. Such amounts shall be due and payable on the date of effectiveness of such Repricing Transaction.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Conversion and Continuation Options.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower may elect from time to time to convert Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">denominated in Dollars to ABR Loans by giving the Administrative Agent prior irrevocable notice of such election pursuant to an Interest Election Request no later than 2&#58;00 P.M., Local Time, on the Business Day preceding the proposed conversion date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such conversion of Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may only be made on the last day of an Interest Period with respect thereto. The Borrower may elect from time to time to convert ABR Loans denominated in Dollars to Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">by giving the Administrative Agent prior irrevocable notice of such election no later than 2&#58;00 P.M., Local Time, on the third Business Day preceding the proposed conversion date (which notice shall specify the length of the initial Interest Period therefor)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no ABR Loan under a particular Facility may be converted into a Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">when any Event of Default has occurred and is continuing and the Administrative Agent or the Majority Facility Lenders in respect of such Facility have determined by written notice in its or their sole discretion not to permit such conversions. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof. No Revolving Loan may be converted into or continued as a Revolving Loan denominated in a different currency, but instead must be prepaid in the original currency of such Revolving Loan and reborrowed in the other currency.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Any Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may be continued as such upon the expiration of the then current Interest Period with respect thereto by the Borrower giving irrevocable notice to the Administrative Agent pursuant to an Interest Election Request, in accordance with the applicable provisions of the definition of the term &#8220;Interest Period&#8221; set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, of the length of the next Interest Period to be applicable to such Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower may not elect to continue a Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">under a particular Facility as such when any Event of Default has occurred and is continuing and the Administrative Agent has or the Majority Facility Lenders in respect of such Facility have determined by written notice in its or their sole discretion not to permit such continuations, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if the Borrower shall fail to give any required notice as described above in this paragraph or if such continuation is not permitted pursuant to the preceding proviso (i) if such Loans are denominated in Dollars, such shall be automatically converted to ABR Loans on the last day of such then expiring Interest Period and (ii) if such Loans are denominated in an Alternative Currency (other than Dollars), such Loans shall be automatically continued as Eurodollar Loans with an Interest Period of one month. Upon receipt of any such notice the Administrative Agent shall promptly notify each relevant Lender thereof.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Limitations on Eurodollar </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Tranches. Notwithstanding anything to the contrary in this Agreement, all borrowings, conversions and continuations of Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and all selections of Interest Periods shall be in such amounts and be made pursuant to such elections so that (a) after giving effect thereto, the aggregate principal amount of the Eurodollar</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_226"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">comprising each Eurodollar Tranche </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Tranche</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be equal to (i) with respect to Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">denominated in Dollars, $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (ii) with respect to Eurodollar Loans denominated in an Alternative Currency (other than Dollars), the Alternative Currency Equivalent of $5,000,000 or a whole multiple of $1,000,000 in excess thereof and (b) no more than fifteen Eurodollar Tranches</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Tranches (taken collectively)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall be outstanding at any one time.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Interest Rates and Payment Dates.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each Eurodollar Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to the Eurodollar Rate determined for such day plus the Applicable Margin.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Each Term SOFR Loan shall bear interest for each day during each Interest Period with respect thereto at a rate per annum equal to Adjusted Term SOFR determined for such day</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus the Applicable Margin.</font></div><div style="padding-right:14.15pt"><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_229"></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:line-through">(b)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each ABR Loan shall bear interest at a rate per annum equal to the ABR plus the Applicable Margin</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:line-through">(c)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Upon the occurrence and during the continuance of an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if all or a portion of the principal amount of any Loan or Reimbursement Obligation or any interest payable on any Loan or Reimbursement Obligation or any commitment fee or other amount payable hereunder shall not be paid when due (whether at the stated maturity, by acceleration or otherwise), such overdue amount shall bear interest at a rate per annum equal to the greater of (i) the rate then applicable to such Loans under the relevant Facility </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 2% (or, in the case of any such other amounts that do not relate to a particular Facility, the rate then applicable to ABR Loans under the Revolving Facility </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 2%) and (ii) the actual rate applicable to such amount </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> 2%, from the date of such non-payment until such amount is paid in full (after as well as before judgment).</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:line-through">(d)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Interest shall be payable in arrears on each Interest Payment Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that interest accruing pursuant to paragraph (</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">c</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">d</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be payable from time to time on demand.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Computation of Interest and Fees.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Interest and fees payable pursuant hereto shall be calculated on the basis of a 360-day year for the actual days elapsed, except that, with respect to ABR Loans the rate of interest on which is calculated on the basis of the Prime Rate, the interest thereon shall be calculated on the basis of a 365- (or 366-, as the case may be) day year for the actual days elapsed or, in the case of interest in respect of Loans denominated in Alternative Currencies as to which market practice differs from the foregoing, in accordance with such market practice. The Administrative Agent shall as soon as practicable notify the Borrower and the relevant Lenders of each determination of a Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any change in the interest rate on a Loan resulting from a change in the ABR</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Adjusted Term SOFR</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall become effective as of the opening of business on the day on which such change becomes effective. The Administrative Agent shall as soon as practicable notify the Borrower and the relevant Lenders of the effective date and the amount of each such change in interest rate.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Each determination of an interest rate by the Administrative Agent pursuant to any provision of this Agreement shall be conclusive and binding on the Borrower and the Lenders in the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_232"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">absence of manifest error. The Administrative Agent shall, at the request of the Borrower, deliver to the Borrower a statement showing the quotations used by the Administrative Agent in determining any interest rate pursuant to Section 2.14(a) </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Inability to Determine Interest Rate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:23.1pt;text-indent:-18.15pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(A)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.89pt;text-decoration:underline">With respect to the Tranche A Loans and Revolving Loans&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If prior to the first day of any Interest Period&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">the Administrative Agent shall have determined (which determination shall be conclusive and binding upon the Borrower) that, by reason of circumstances affecting the relevant market, adequate and reasonable means do not exist for ascertaining the Eurodollar Rate for such Interest Period, or</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">the Administrative Agent shall have received notice from the Majority Facility Lenders in respect of the relevant Facility that the Eurodollar Rate determined or to be determined for such Interest Period will not adequately and fairly reflect the cost to such Lenders (as conclusively certified by such Lenders) of making or maintaining their affected Loans during such Interest Period,</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Administrative Agent shall give telecopy or telephonic notice thereof to the Borrower and the relevant Lenders as soon as practicable thereafter. If such notice is given (and until such notice is withdrawn), (w) any Eurodollar Loans denominated in Dollars under the relevant Facility requested to be made on the first day of such Interest Period shall be made as ABR Loans, (x) any Loans denominated in Dollars under the relevant Facility that were to have been converted on the first day of such Interest Period to Eurodollar Loans shall be continued as ABR Loans, (y) any outstanding Eurodollar Loans denominated in Dollars under the relevant Facility shall be converted, on the last day of the then-current Interest Period, to ABR Loans and (z) any outstanding Eurodollar Loans denominated in an Alternative Currency (other than Dollars) shall be continued with an interest applicable thereto equal to the sum of (I) the Applicable Margin for such Eurodollar Loans and (II) the rate for each day during such Interest Period reasonably determined by the Administrative Agent to be the cost of funds of representative participating members in the interbank eurodollar market selected by the Administrative Agent (which may include Lenders) for maintaining loans similar to the relevant Loans (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any change in the rate determined pursuant to this clause (II) shall be effective as of the opening of business on the effective day of any change in the relevant component of such rate). Until such notice has been withdrawn by the Administrative Agent, no further Eurodollar Loans denominated in Dollars under the relevant Facility shall be made or continued as such, nor shall the Borrower have the right to convert Loans denominated in Dollars under the relevant Facility to Eurodollar Loans.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If at any time the Administrative Agent determines (which determination shall be made by notice to the Borrower and conclusive absent manifest error) that (i) the circumstances set forth in clause (a)(i) have arisen and such circumstances are unlikely to be temporary or (ii) the circumstances set forth in clause (a)(i) have not arisen but either (w) the supervisor for the administrator of the LIBOR Screen Rate has made a public statement that the administrator of the LIBOR Screen Rate is insolvent (and there is no successor administrator that will continue publication of the LIBOR Screen Rate), (x) the administrator of the LIBOR Screen Rate has made a public statement identifying a specific date after which the LIBOR Screen Rate will permanently or indefinitely cease to be published by it (and there is no successor administrator that will continue publication of the LIBOR Screen Rate), (y) the supervisor for the administrator of the LIBOR Screen Rate has made a public statement identifying a specific date after which the LIBOR Screen Rate will permanently or indefinitely cease to be published or (z) the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_235"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:12.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">supervisor for the administrator of the LIBOR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which the LIBOR Screen Rate may no longer be used for determining interest rates for loans, then the Administrative Agent and the Borrower shall endeavor to establish an alternate rate of interest to the LIBOR Screen Rate that gives due consideration to the then prevailing market convention for determining a rate of interest for syndicated loans in the United States at such time and to similarly situated borrowers, and shall enter into an amendment to this Agreement to reflect such alternate rate of interest and such other related changes to this Agreement as may be applicable (but for the avoidance of doubt, such related changes shall not include a reduction of the Applicable Margin)&#59; provided that, if such alternate rate of interest as so determined would be less than zero, such rate shall be deemed to be zero for the purposes of this Agreement. Notwithstanding anything to the contrary in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, such amendment shall become effective without any further action or consent of any other party to this Agreement so long as the Administrative Agent shall not have received, within five (5) Business Days of the date notice of such alternate rate of interest is provided to the Lenders, a written notice from the Required Lenders of any Class stating that such Required Lenders object to such amendment. Until an alternate rate of interest shall be determined in accordance with this clause (b) (but, in the case of the circumstances described in clause (ii) of the first sentence of this Section 2.16</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b), only to the extent the LIBOR Screen Rate for the applicable currency and such Interest Period is not available or published at such time on a current basis), (x) any Interest Election Request that requests the conversion of any Revolving Loan to, or continuation of any Revolving Loan as, a Eurodollar Loan shall be ineffective, (y) if any Borrowing Request requests a Eurodollar Revolving Loan, such borrowing shall be made as an ABR Revolving Loan and (z) any request by the Borrower for a Eurodollar Loan shall be ineffective.</font></div><div><font><br></font></div><div style="padding-left:22.5pt;text-indent:-17.55pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(B)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:2.9pt;text-decoration:underline">With respect to Tranche B-1 Term Loans&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(a)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.86pt;text-decoration:underline">Circumstances Affecting Term SOFR Loans. Subject to clause (b) below, in connection with any Term SOFR Loan, a request therefor, a conversion to or a continuation thereof or otherwise, if</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">for any reason (i) the Administrative Agent shall determine (which determination shall be conclusive and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">binding absent manifest error) that if Term SOFR is utilized in any calculations hereunder or under any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">other Loan Document with respect to any Obligations, interest, fees, commissions or other amounts,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">reasonable and adequate means do not exist for ascertaining Term SOFR for the applicable Interest</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Period with respect to a proposed Term SOFR Loan on or prior to the first day of such Interest Period or (ii) the Required Lenders shall determine (which determination shall be conclusive and binding absent</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">manifest error) that if Adjusted Term SOFR is utilized in any calculations hereunder or under any other</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan Document with respect to any Obligations, interest, fees, commissions or other amounts, Adjusted</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR does not adequately and fairly reflect the cost to such Lenders of making or maintaining</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such Loans during the applicable Interest Period and the Required Lenders have provided notice of such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">determination to the Administrative Agent, then, in each case, the Administrative Agent shall promptly</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">give notice thereof to the Borrower. Upon notice thereof by the Administrative Agent to the Borrower,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any obligation of the Lenders to make Term SOFR Loans and any right of the Borrower to convert any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Loan to or continue any Loan as a Term SOFR Loan shall be suspended (to the extent of the affected</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Interest Periods) until the Administrative Agent (with respect to clause (ii), at the instruction of the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Required Lenders) revokes such notice. Upon receipt of such notice, (A) the Borrower may revoke any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pending request for a borrowing of, conversion to or continuation of Term SOFR Loans (to the extent of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the affected Interest Periods) or, failing that, the Borrower will be deemed to have converted any such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">request into a request for a borrowing of or conversion to ABR Loans denominated in Dollars in the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">amount specified therein and (B) any outstanding affected Term SOFR Loans will be deemed to have</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">been converted into ABR Loans at the end of the applicable Interest Period. Upon any such prepayment</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or conversion, the Borrower shall also pay accrued interest on the amount so prepaid or converted,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">together with any additional amounts required pursuant to Section 2.20.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_238"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt;text-decoration:underline">Benchmark Replacement Setting.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.11pt;text-decoration:underline">Benchmark Replacement. Notwithstanding anything to the contrary herein or in any other Loan Document, upon the occurrence of a Benchmark Transition Event with respect to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any Benchmark, the Administrative Agent and the Borrower may amend this Agreement to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">replace such Benchmark with a Benchmark Replacement. Any such amendment with respect to</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> a Benchmark Transition Event will become effective at 5&#58;00 p.m. on the fifth (5</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">th</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) Business Day </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">after the Administrative Agent has posted such proposed amendment to all affected Lenders and</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the Borrower so long as the Administrative Agent has not received, by such time, written notice</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">of objection to such amendment from Lenders comprising the Required Lenders. No</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">replacement of a Benchmark with a Benchmark Replacement pursuant to this Section</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.16(B)(b)(i) will occur prior to the applicable Benchmark Transition Start Date.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.2pt;text-decoration:underline">Benchmark Replacement Conforming Changes. In connection with the use, administration, adoption or implementation of a Benchmark Replacement, the Administrative</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent will have the right to make Conforming Changes from time to time and, notwithstanding</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">anything to the contrary herein or in any other Loan Document, any amendments implementing</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">such Conforming Changes will become effective without any further action or consent of any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">other party to this Agreement or any other Loan Document.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(iii)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.29pt;text-decoration:underline">Notices&#59; Standards for Decisions and Determinations. The Administrative Agent will promptly notify the Borrower and the Lenders of (A) the implementation of any Benchmark</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement and (B) the effectiveness of any Conforming Changes in connection with the use,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">administration, adoption or implementation of a Benchmark Replacement. The Administrative</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent will promptly notify the Borrower of the removal or reinstatement of any tenor of a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark pursuant to Section 2.16(B)(b)(iv). Any determination, decision or election that may</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">be made by the Administrative Agent or, if applicable, any Lender (or group of Lenders)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pursuant to this Section 2.16(B)(b)(iv), including any determination with respect to a tenor, rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">decision to take or refrain from taking any action or any selection, will be conclusive and binding</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">absent manifest error and may be made in its or their sole discretion and without consent from</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">any other party to this Agreement or any other Loan Document, except, in each case, as expressly</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">required pursuant to this Section 2.16(B)(b).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(iv)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.86pt;text-decoration:underline">Unavailability of Tenor of Benchmark. Notwithstanding anything to the contrary herein or in any other Loan Document, at any time (including in connection with the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">implementation of a Benchmark Replacement), (A) if any then-current Benchmark is a term rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(including the Term SOFR Reference Rate) and either (1) any tenor for such Benchmark is not</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">displayed on a screen or other information service that publishes such rate from time to time as</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">selected by the Administrative Agent in its reasonable discretion or (2) the regulatory supervisor</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">for the administrator of such Benchmark has provided a public statement or publication of</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">information announcing that any tenor for such Benchmark is not or will not be representative,</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; (or any similar or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">analogous definition) for any Benchmark settings at or after such time to remove such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">unavailable or non-representative tenor and (B) if a tenor that was removed pursuant to clause (A) above either (1) is subsequently displayed on a screen or information service for a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark (including a Benchmark Replacement) or (2) is not, or is no longer, subject to an</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">announcement that it is not or will not be representative for a Benchmark (including a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Period&#8221; (or any similar or analogous definition) for all Benchmark settings at or after such time</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">to reinstate such previously removed tenor.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_241"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%;text-decoration:underline">(v)</font><img alt="image_74.jpg" src="image_74.jpg" style="height:18px;margin-bottom:5pt;vertical-align:text-bottom;width:1px"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.77pt;text-decoration:underline">Benchmark Unavailability Period. Upon the Borrower&#8217;s receipt of notice of the commencement of a Benchmark Unavailability Period with respect to a given Benchmark, (A)</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">the Borrower may revoke any pending request for a borrowing of, conversion to or continuation</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">of Term SOFR Loans to be made, converted or continued during any Benchmark Unavailability</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Period and, failing that, in the case of any request for any affected Term SOFR Loans, if</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable, the Borrower will be deemed to have converted any such request into a request for a</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">borrowing of or conversion to ABR Loans in the amount specified therein. During a Benchmark</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Unavailability Period with respect to any Benchmark or at any time that a tenor for any then-current Benchmark is not an Available Tenor, the component of the ABR based upon the</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">then-current Benchmark that is the subject of such Benchmark Unavailability Period or such</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">tenor for such Benchmark, as applicable, will not be used in any determination of ABR.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Pro Rata Treatment and Payments.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each borrowing by the Borrower from the Lenders hereunder, each payment by the Borrower on account of any commitment fee and any reduction of the Commitments of the Lenders shall be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> according to the respective Tranche A Term Percentages, Tranche B-1 Term Percentages, Dollar Revolving Percentages or Alternative Currency Revolving Percentages, as the case may be, of the relevant Lenders in the Class subject to reduction.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Each payment (including each prepayment) by the Borrower on account of principal of and interest on the Term Loans shall be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> according to the respective outstanding principal amounts of the Term Loans then held by the Term Lenders (except (i) as otherwise provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) that an optional prepayment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> need only be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> according to the respective outstanding principal amounts of the Term Loans of the applicable Class being prepaid then held by the Term Lenders, (iii) any prepayment of Term Loans with the Net Cash Proceeds of Credit Agreement Refinancing Debt shall be applied solely to each applicable Class of Refinanced Debt and (iv) any prepayment of Term Loans with the Net Cash Proceeds of Debt pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may be applied to a Class or Classes of Term Loans as directed by the Borrower). The amount of each principal prepayment of the Term Loans shall be applied to reduce the then remaining installments of the Tranche A Term Loans and Tranche B-1 Term Loans, as the case may be, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> based upon the respective then remaining principal amounts thereof. Amounts prepaid on account of the Term Loans may not be reborrowed. Notwithstanding any other provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a Lender may, at its option, and if agreed by the Borrower, in connection with any prepayment of Term Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, exchange such Lender&#8217;s portion of the Term Loan to be repaid for Debt of the Borrower, in lieu of such Lender&#8217;s pro rata portion of such prepayment (and any such Term Loans so exchanged shall be deemed repaid for all purposes under the Loan Documents).</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each payment (including each prepayment) by the Borrower on account of principal of and interest on the Revolving Loans shall be made </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> according to the respective outstanding principal amounts of the Revolving Loans then held by the relevant Revolving Lenders.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">All payments (including prepayments) to be made by the Borrower hereunder, whether on account of principal, interest, fees or otherwise, shall be made without setoff or counterclaim and shall be made prior to 1&#58;00 P.M., New York City time, on the due date thereof to the Administrative Agent, for the account of the Lenders, at the Funding Office for the applicable currency, in the currency in which the applicable Loan was made and in immediately available funds. The Administrative Agent shall distribute such payments to the Lenders promptly upon receipt in like funds as received. If any payment hereunder (other than payments on the Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) becomes due and payable on a day other than a Business Day, such payment shall be extended to the next succeeding Business Day. If any payment on a Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">becomes due and payable on a</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_244"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:11.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">day other than a Business Day, the maturity thereof shall be extended to the next succeeding Business Day unless the result of such extension would be to extend such payment into another calendar month, in which event such payment shall be made on the immediately preceding Business Day. In the case of any extension of any payment of principal pursuant to the preceding two sentences, interest thereon shall be payable at the then applicable rate during such extension.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Unless the Administrative Agent shall have been notified in writing by any Lender prior to a borrowing that such Lender will not make the amount that would constitute its share of such borrowing available to the Administrative Agent, the Administrative Agent may assume that such Lender is making such amount available to the Administrative Agent, and the Administrative Agent may, in reliance upon such assumption, make available to the Borrower a corresponding amount. If such amount is not made available to the Administrative Agent by the required time on the Borrowing Date therefor, such Lender shall pay to the Administrative Agent, on demand, such amount with interest thereon, at a rate equal to the greater of (i) the Federal Funds Effective Rate and (ii) a rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation, for the period until such Lender makes such amount immediately available to the Administrative Agent. A certificate of the Administrative Agent submitted to any Lender with respect to any amounts owing under this paragraph shall be conclusive in the absence of manifest error. If such Lender&#8217;s share of such borrowing is not made available to the Administrative Agent by such Lender within three Business Days after such Borrowing Date, the Administrative Agent shall also be entitled to recover such amount with interest thereon at the rate per annum applicable to (i) with respect to borrowings under the Dollar Revolving Facility, ABR Loans under the Dollar Revolving Facility or (ii) with respect to borrowings under the Alternative Currency Revolving Facility, Eurodollar Loans under the Alternative Currency Revolving Facility, in each case, on demand, from the Borrower.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">Unless the Administrative Agent shall have been notified in writing by the Borrower prior to the date of any payment due to be made by the Borrower hereunder that the Borrower will not make such payment to the Administrative Agent, the Administrative Agent may assume that the Borrower is making such payment, and the Administrative Agent may, but shall not be required to, in reliance upon such assumption, make available to the Lenders their respective </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shares of a corresponding amount. If such payment is not made to the Administrative Agent by the Borrower within three Business Days after such due date, the Administrative Agent shall be entitled to recover, on demand, from each Lender to which any amount which was made available pursuant to the preceding sentence, such amount with interest thereon at the rate per annum equal to the daily average Federal Funds Effective Rate. Nothing herein shall be deemed to limit the rights of the Administrative Agent or any Lender against the Borrower.</font></div><div style="margin-top:0.55pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If any Lender shall fail to make any payment required to be made by it pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then the Administrative Agent may, in its discretion and notwithstanding any contrary provision hereof, (i) apply any amounts thereafter received by the Administrative Agent for the account of such Lender for the benefit of the Administrative Agent, the Swingline Lender or the Issuing Lender to satisfy such Lender&#8217;s obligations to it under such Section until all such unsatisfied obligations are fully paid, and&#47;or (ii) until such failure to make payment has been cured, hold any such amounts in a segregated account as cash collateral for, and application to, any future funding obligations of such Lender under any such Section, in the case of each of clauses (i) and (ii) above, in any order as determined by the Administrative Agent in its discretion.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Requirements of Law.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">If the adoption of or any change in any Requirement of Law or in the interpretation or application thereof or compliance by any Lender or Issuing Lender with any request or</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_247"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">directive (whether or not having the force of law) from any central bank or other Governmental Authority made subsequent to the Closing Date&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">shall subject any Lender or Issuing Lender to any Taxes of any kind whatsoever with respect to this Agreement, any Letter of Credit, any Application or any Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">made by it, or change the basis of taxation of payments to such Lender or Issuing Lender in respect thereof (except for Excluded Taxes, Non-Excluded Taxes and Other Taxes)&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">shall impose, modify or hold applicable any reserve, special deposit, compulsory loan or similar requirement against assets held by, deposits or other liabilities in or for the account of, advances, loans or other extensions of credit by, or any other acquisition of funds by, any office of such Lender or Issuing Lender that is not otherwise included in the determination of the Eurodollar Rate</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Adjusted Term SOFR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">shall impose on such Lender or Issuing Lender any other condition&#59; and the result of any of the foregoing is to increase the cost to such Lender or Issuing Lender, by an amount that such Lender or Issuing Lender deems to be material, of making, converting into, continuing or maintaining Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or issuing or participating in Letters of Credit, or to reduce any amount receivable hereunder in respect thereof, then, in any such case, the Borrower shall promptly pay such Lender or Issuing Lender, upon its demand, any additional amounts necessary to compensate such Lender or Issuing Lender for such increased cost or reduced amount receivable. If any Lender or Issuing Lender becomes entitled to claim any additional amounts pursuant to this paragraph, it shall promptly notify the Borrower (with a copy to the Administrative Agent) of the event by reason of which it has become so entitled.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If any Lender or Issuing Lender shall have determined that the adoption of or any change in any Requirement of Law regarding capital adequacy or liquidity or in the interpretation or application thereof or compliance by such Lender or Issuing Lender or any corporation Controlling such Lender or Issuing Lender with any request or directive regarding capital adequacy (whether or not having the force of law) from any Governmental Authority made subsequent to the Closing Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a &#8220;Change in Law,&#8221; regardless of the date enacted, adopted or issued) shall have the effect of reducing the rate of return on such Lender&#8217;s or Issuing Lender&#8217;s or such corporation&#8217;s capital as a consequence of its obligations hereunder or under or in respect of any Letter of Credit to a level below that which such Lender or Issuing Lender or such corporation could have achieved but for such Change in Law (taking into consideration such Lender&#8217;s or Issuing Lender&#8217;s or such corporation&#8217;s policies with respect to capital adequacy and liquidity) by an amount deemed by such Lender or Issuing Lender to be material, then from time to time, after submission by such Lender or Issuing Lender to the Borrower (with a copy to the Administrative Agent) of a written request therefor, the Borrower shall pay to such Lender or Issuing Lender such additional amount or amounts as will compensate such Lender or such corporation for such reduction.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each request by a Lender or Issuing Lender for the payment of an additional amount under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be accompanied by a certificate showing in reasonable detail the method of calculation and the allocation (which shall be reasonable) thereof. Such certificate as to any</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_250"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">additional amounts payable pursuant to this Section submitted by any Lender or Issuing Lender to the Borrower (with a copy to the Administrative Agent) shall be conclusive in the absence of manifest error. Notwithstanding anything to the contrary in this Section, the Borrower shall not be required to compensate a Lender or Issuing Lender pursuant to this Section for any amounts incurred more than six months prior to the date that such Lender or Issuing Lender notifies the Borrower of such Lender&#8217;s or Issuing Lender&#8217;s intention to claim compensation therefor&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the change in law giving rise to such claim have a retroactive effect, then such six-month period shall be extended to include the period of such retroactive effect. The obligations of the Borrower pursuant to this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If at any time any Lender shall have determined that the making or continuance of any Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">has been made unlawful by any law or governmental rule, regulation or order, or any Governmental Authority has imposed material restrictions on the authority of a Lender to purchase or sell, or to take deposits of, Dollars in the </font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through">London</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interbank market, then such Lender shall promptly give notice (by telephone promptly confirmed in writing) to the Borrower and to the Administrative Agent of such determination (which notice the Administrative Agent shall promptly transmit to each of the other Lenders). Thereafter the Borrower shall either (x) if the affected Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is then being made initially or pursuant to a conversion, cancel such borrowing by giving the Administrative Agent telephonic notice (confirmed in writing) on the same date that the Borrower was notified by the affected Lender or the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (y) if the affected Eurodollar Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is then outstanding, upon at least three Business Days&#8217; written notice to the Administrative Agent, require the affected Lender to convert such Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">into a ABR Loan, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if more than one Lender is affected at any time, then all affected Lenders must be treated the same pursuant to this Section </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.18(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Taxes.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">All payments made by any Loan Party under this Agreement or any other Loan Document shall be made free and clear of, and without deduction or withholding for or on account of, any Taxes. If any Taxes are required to be withheld or deducted by any applicable withholding agent from any amounts payable (which shall include withholdings or deductions applicable to additional sums payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) to the Administrative Agent or any Lender under any Loan Document, (1) to the extent such withholding or deduction is on account of Non-Excluded Taxes or Other Taxes, the amounts so payable to the Administrative Agent or such Lender shall be increased to the extent necessary to yield to the applicable Lender (or, in the case of payments made to the Administrative Agent for its own account, the Administrative Agent), after all withholding or deduction on account of all Non-Excluded Taxes and Other Taxes have been made, interest or any such other amounts payable hereunder at the rates or in the amounts specified in this Agreement, (2) the applicable withholding agent will make such withholdings or deductions, and (3) the applicable withholding agent shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In addition, the Borrower shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower and the Guarantors shall indemnify the Administrative Agent, or the affected Lender, as applicable, within 10 days after demand therefor, for the full amount of any Non-Excluded Taxes or Other Taxes (including Non-Excluded Taxes or Other Taxes imposed or asserted on or attributable to amounts payable under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) paid or payable by the Administrative</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_253"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Agent or such Lender, as the case may be, and any penalties, interest and reasonable expenses arising therefrom or with respect thereto, whether or not such Non-Excluded Taxes or Other Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to the Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">As soon as practicable after any payment of any Taxes by any Loan Party to a Governmental Authority pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Any Lender that is entitled to an exemption from or reduction of withholding Tax under the law of the jurisdiction in which the Borrower is located, or any treaty to which such jurisdiction is a party, with respect to payments under this Agreement shall deliver to the Borrower (with a copy to the Administrative Agent), at the time or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation prescribed by applicable law as will permit such payments to be made without withholding or at a reduced rate of withholding. Without limiting the generality of the foregoing&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">each Lender that is a &#8220;United States person&#8221; as defined in Section 7701(a)(30) of the Code shall deliver to the Borrower (with a copy to the Administrative Agent) two duly executed original copies of Internal Revenue Service Form W-9 or any successor form, and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">each Lender that is not a &#8220;United States person&#8221; as defined in Section 7701(a)(30) of the Code (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Non-U.S. Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall deliver to the Borrower and the Administrative Agent two duly executed original copies of whichever of the following is applicable&#58; (i) U.S. Internal Revenue Service Form W-8BEN or W-8BEN-E claiming eligibility for benefits of an income tax treaty to which the United States is a party, (ii) U.S. Internal Revenue Service Form W-8ECI, (iii) in the case of a Non-U.S. Lender claiming exemption from U.S. federal withholding Tax under Section 871(h) or 881(c) of the Code with respect to payments of &#8220;portfolio interest,&#8221; a statement substantially in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (any such certificate, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Tax Compliance Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and U.S. Internal Revenue Service Form W-8BEN or W-8BEN-E, (iv) to the extent a Non-U.S. Lender is not the beneficial owner (for example, where the Non-U.S. Lender is a partnership or a participating Lender), U.S. Internal Revenue Service Form W-8IMY of the Lender, accompanied by U.S. Internal Revenue Service Form W-8ECI, W-8BEN, W-8BEN-E, W-8IMY, W-9, a U.S. Tax Compliance Certificate, and&#47;or any other required information from each beneficial owner, as applicable (provided that, if the Non-U.S. Lender is a partnership for U.S. federal income Tax purposes (and not a participating Lender), and one or more direct or indirect partners are claiming the portfolio interest exemption, the U.S. Tax Compliance Certificate may be provided by such Non-U.S. Lender on behalf of such direct or indirect partner(s)), or (v) any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in United States Federal withholding Tax duly completed together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower to determine the withholding or deduction required to be made, or, in each case, any subsequent versions thereof or successors thereto, properly completed and duly executed by such Non-U.S. Lender claiming complete exemption from, or a reduced rate of, U.S. federal withholding Tax on any payments by the Borrower under this Agreement and the other Loan Documents. Such documentation shall be delivered by each Lender on or before the date it becomes a party to this Agreement. In addition, each Lender shall deliver updated</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_256"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:113pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">documentation promptly upon the obsolescence, expiration, invalidity or inaccuracy of any documentation previously delivered by such Lender. Each Lender shall promptly notify the Borrower at any time it determines that it is no longer legally eligible to provide any previously delivered documentation to the Borrower (or any other form of certification adopted by the U.S. taxing authorities for such purpose).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">Notwithstanding any other provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a Lender shall not be required to deliver any documentation pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Lender is not legally able to deliver. Each Lender hereby authorizes the Administrative Agent to deliver to the Borrower and to any successor Administrative Agent any documentation provided by the Lender to the Administrative Agent pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">If the Administrative Agent or any Lender determines, in its sole discretion, that it has received a refund of any Non-Excluded Taxes or Other Taxes as to which it has been indemnified by any Loan Party or with respect to which any Loan Party has paid additional amounts pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, it shall pay over such refund to the Borrower (but only to the extent of indemnity payments made, or additional amounts paid, by any Loan Party under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the Non-Excluded Taxes or Other Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses (including Taxes) of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. Notwithstanding anything to the contrary, in no event will any Lender be required to pay any amount to the Borrower the payment of which would place such Lender in a less favorable net after-tax position than such Lender would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the additional amounts giving rise to such refund of any Non-Excluded Taxes or Other Taxes had never been paid. This paragraph shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes which it deems confidential) to the Borrower or any other Person.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The agreements in this Section shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the term &#8220;Lender&#8221; shall include any Issuing Lender and any Swingline Lender.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Indemnity. The Borrower agrees to indemnify each Lender for, and to hold each Lender harmless from, any loss or expense that such Lender may sustain or incur as a consequence of (a) default by the Borrower in making a borrowing of, conversion into or continuation of Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">after the Borrower has given a notice requesting the same in accordance with the provisions of this Agreement, (b) default by the Borrower in making any prepayment of or conversion from Eurodollar Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> or Term SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">after the Borrower has given a notice thereof in accordance with the provisions of this Agreement or (c) the making of a prepayment of Eurodollar Loans </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">SOFR Loans</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">on a day that is not the last day of an Interest Period with respect thereto. Such indemnification may include an amount equal to the excess, if any, of (i) the amount of interest that would have accrued on the amount so prepaid, or not so borrowed, converted or continued, for the period from the date of such prepayment or of such failure to borrow, convert or continue to the last day of such Interest Period (or, in the case of a failure to borrow, convert or continue, the Interest Period that would have commenced on the date of such failure) in each case at the applicable rate of interest for such Loans</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_259"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provided for herein (excluding, however, the Applicable Margin included therein, if any) minus (ii) the amount of interest (as reasonably determined by such Lender) that would have accrued to such Lender on such amount by placing such amount on deposit for a comparable period with leading banks in the </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">applicable</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">interbank</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:line-through"> eurodollar</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">market. A certificate as to any amounts payable pursuant to this Section submitted to the Borrower by any Lender shall be conclusive in the absence of manifest error. This covenant shall survive the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Change of Lending Office. Each Lender agrees that, upon the occurrence of any event giving rise to the operation of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Lender, it will, if requested by the Borrower, use reasonable efforts (subject to overall policy considerations of such Lender) to designate another lending office for any Loans affected by such event with the object of avoiding the consequences of such event&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such designation is made on terms that, in the sole judgment of such Lender, cause such Lender and its lending office(s) to suffer no economic, legal or regulatory disadvantage, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that nothing in this Section shall affect or postpone any of the obligations of the Borrower or the rights of any Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Replacement of Lenders. The Borrower shall be permitted to replace any Lender that (a) requests reimbursement for amounts owing pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (b) is a Defaulting Lender or (c) is replaced pursuant to the third paragraph of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with a replacement financial institution&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) such replacement does not conflict with any Requirement of Law, (ii) no Event of Default shall have occurred and be continuing at the time of such replacement, (iii) if applicable, prior to any such replacement, such Lender shall not have taken appropriate action under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> so as to eliminate the continued need for payment of amounts owing pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (iv) the replacement financial institution shall purchase, at par, all Loans and other amounts owing to such replaced Lender on or prior to the date of replacement, (v) the Borrower shall be liable to such replaced Lender under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if any Eurodollar Loan </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">or Term SOFR Loan</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">owing to such replaced Lender shall be purchased other than on the last day of the Interest Period relating thereto, (vi) the replacement financial institution, if not already a Lender, shall be reasonably satisfactory to the Administrative Agent, (vii) the replaced Lender shall be obligated to make such replacement in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall be obligated to pay the registration and processing fee referred to therein) and by its execution of this Agreement each Lender hereby authorizes the Administrative Agent to act as its agent in executing any documents to replace such Lender in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (viii) until such time as such replacement shall be consummated, the Borrower shall pay all additional amounts (if any) required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, as the case may be, and (ix) any such replacement shall not be deemed to be a waiver of any rights that the Borrower, the Administrative Agent or any other Lender shall have against the replaced Lender. Notwithstanding the foregoing, this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may only be utilized with respect to a replaced Lender in respect of any amendment to this Agreement after the Closing Date and prior to the date that is six months after the Closing Date that constitutes a Repricing Transaction pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if such replaced Tranche B-1 Term Lender is paid a fee equal to 1.0% of the principal amount of such Tranche B-1 Term Lender&#8217;s Tranche B-1 Term Loans being replaced and repaid.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Repayment of Loans&#59; Evidence of Debt.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower hereby unconditionally promises to pay (i) to the Administrative Agent for the account of each Lender the then unpaid principal amount of each Revolving Loan on the Revolving Termination Date (or with respect to any Revolving Loans outstanding with respect to an Extended Revolving Commitment, the Maturity Date applicable thereto), (ii) to the Administrative Agent for the account of each Lender the Term Loans in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, to the extent specified in the respective Extension Offer, amortization payments with respect to Extended Term</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_262"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loans for periods prior to the Tranche A Term Loan Maturity Date and the Tranche B-1 Term Loan Maturity Date, as applicable, may be reduced (but not increased) and amortization payments required with respect to Extended Term Loans for periods after the Tranche A Term Loan Maturity Date and the Tranche B-1 Term Loan Maturity Date, as applicable, shall be as specified in the respective Extension Offer and (iii) to the Swingline Lender the then unpaid principal amount of each Swingline Loan in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Each Lender shall maintain in accordance with its usual practice an account or accounts evidencing the indebtedness of the Borrower to such Lender resulting from each Loan made by such Lender, including the amounts of principal and interest payable and paid to such Lender from time to time hereunder.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Administrative Agent shall maintain accounts in which it shall record (i) the amount of each Loan made hereunder, the Facility, Type and currency thereof and the Interest Period applicable thereto, (ii) the amount of any principal or interest due and payable or to become due and payable from the Borrower to each Lender hereunder and (iii) the amount of any sum received by the Administrative Agent hereunder for the account of the Lenders and each Lender&#8217;s share thereof.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The entries made in the accounts maintained pursuant to paragraph (b) or (c) of this Section shall be </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">prima facie</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> evidence of the existence and amounts of the obligations recorded therein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the failure of any Lender or the Administrative Agent to maintain such accounts or any error therein shall not in any manner affect the obligation of the Borrower to repay the Loans in accordance with the terms of this Agreement.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Any Lender may request that Loans made by it be evidenced by a promissory note. In such event, the Borrower shall prepare, execute and deliver to such Lender a promissory note payable to the order of such Lender (or, if requested by such Lender, to such Lender and its registered assigns) and in a form approved by the Administrative Agent. Thereafter, the Loans evidenced by such promissory note and interest thereon shall at all times (including after assignment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) be represented by one or more promissory notes in such form payable to the order of the payee named therein (or, if such promissory note is a registered note, to such payee and its registered assigns).</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Increase in Commitments.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Borrower may at any time or from time to time on one or more occasions request (x) prior to the Revolving Termination Date, an increase to the existing Revolving Commitments under one or more of the Revolving Facilities (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increased Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and&#47;or (y) the establishment of one or more new term loan Commitments (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in an amount not less than $100,000,000 individually and in an amount not to exceed the sum of (A) the Shared Incremental Amount, (B) the amount of any optional prepayment of any Loan including any Loan under any Increased Revolving Commitment or Incremental Term Loan Commitment other than, in each case, incurred pursuant to clause (C) below in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (accompanied, to the extent such prepayments are of Loans under any Revolving Facility and&#47;or any Increased Revolving Commitments, by a commitment reduction in the like amount under such Revolving Facility and&#47;or Increased Revolving Commitment) and&#47;or the amount of any permanent reduction of any Revolving Commitment or Increased Revolving Commitment so long as, in the case of any such optional prepayment, such prepayment was not funded with the proceeds of a contemporaneous refinancing with new long-term Debt </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">less</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the aggregate principal amount of all Increased Revolving Commitments or Incremental Term Loan Commitments incurred or issued in reliance on clause (B) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (C) an amount of Incremental Term Loans or Increased Revolving Commitments such that the Senior Secured Leverage Ratio is no more than 3.50 to 1.00 as of the last day of the most recently ended period</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_265"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of four fiscal quarters of the Borrower for which financial statements are internally available, determined on the applicable date on which the new or increased Commitments shall become effective (each such date, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), after giving effect to any such incurrence on a Pro Forma Basis, and, in each case, with respect to any Increased Revolving Commitments, assuming a borrowing of the maximum amount of Loans available thereunder, and excluding the cash proceeds of any such Incremental Term Loans or Increased Revolving Commitments (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (I), for the avoidance of doubt, any Incremental Term Loans or Increased Revolving Commitments incurred or issued pursuant to clause (C) on any Increase Effective Date on which the Senior Secured Leverage Ratio test in this clause (C) is met shall remain authorized pursuant to clause (C) if such Senior Secured Leverage Ratio test is not met as of any subsequent date and (II) each Increased Revolving Commitment or Incremental Term Loan Commitment under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be incurred under clause (C) if clause (C) is available at the time of such incurrence up to the maximum amount available, and any additional amounts incurred at any time that clause (C) is unavailable shall be incurred under clauses (A) and&#47;or (B) and any simultaneous incurrence under clauses (A) and&#47;or (B) shall not be given pro forma effect for purposes of determining the Senior Secured Leverage Ratio with respect to any incurrence under clause (C)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">the condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be satisfied&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, unless otherwise agreed by the Borrower, to the extent the proceeds of any Incremental Term Loans or Increased Revolving Commitments are being used to finance a Limited Condition Acquisition, this clause (a)(i) shall be subject to customary &#8220;SunGard&#8221; or other applicable &#8220;certain funds&#8221; conditionality limitations and &#8220;specified representations&#8221; provisions&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">no Default shall have occurred and be continuing or would result from the borrowings to be made on the Increase Effective Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, unless otherwise agreed by the Borrower, to the extent the proceeds of any Incremental Term Loans or Increased Revolving Commitments are being used to finance a Limited Condition Acquisition (I) this clause (a)(ii) shall be subject to customary &#8220;SunGard&#8221; or other applicable &#8220;certain funds&#8221; conditionality limitations and &#8220;specified representations&#8221; provisions, in which case it shall only be a condition that no Default under clause (a), (b) or (g) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall have occurred and be continuing or would result therefrom and (II) such Default may be tested in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">after giving pro forma effect to the borrowings to be made on the Increase Effective Date and to any change in Consolidated EBITDA and any increase in Debt resulting from the consummation of any acquisition permitted by this Agreement concurrently with such borrowings as of the date of the most recent financial statements delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in any subsequent delivery of financial information by the Borrower to the Administrative Agent prior to such time, the Borrower shall be in compliance with each of the covenants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">no existing Lender will be required to participate in any such increased or new Commitments without its consent&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-34.45pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.63pt">the Borrower shall make any payments required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in connection with any adjustment of Revolving Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">the Borrower shall deliver or cause to be delivered any legal opinions or other documents reasonably requested by the Administrative Agent in connection with any such transaction.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_268"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:32.855%"><div style="margin-top:0.55pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.717%;min-width:0.217%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:32.855%"><div style="padding-left:5pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_271"></div></div><div style="display:inline-block;max-width:0.717%;min-width:0.217%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:32.856%"></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:40.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b) The terms and provisions of Loans made pursuant to the new Commitments shall be as follows&#58; </font></div><div style="padding-left:1.13pt;text-indent:-0.36pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-32.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">terms and provisions of Loans made pursuant to Incremental Term Loan Commitments shall be, except as otherwise set forth herein or in the Increase Joinder, identical to (i) the Tranche B-1 Term Loans (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term B Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) or (ii) the Tranche A Term Loans (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term A Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, and together with any Incremental Term B Loans, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Incremental Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (it being understood that Incremental Term Loans may be part of an existing Class of Term Loans)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all Incremental Term A Loans shall not exceed (A) $750,000,000 plus (B) an amount equal to the excess, if any, of (x) the amount of Tranche A Term Loans outstanding on the Closing Date less (y) the amount of Tranche A Term Loans outstanding on the applicable Increase Effective Date&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">any Loans made pursuant to Incremental Term Loan Commitments shall rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in right of payment and of security with the Term Loans&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">all terms and provisions (including Maturity Date) of Revolving Loans made pursuant to new Commitments shall be identical to the existing Revolving Loans&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in connection with any such new Commitments for additional Revolving Loans, the Borrower may pay to the Lenders providing such Commitments a fee in an amount not to exceed the highest upfront fee paid to Revolving Lenders of the applicable Revolving Facility on the Closing Date&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">the weighted average life to maturity of all (x) Incremental Term B Loans shall be no shorter than the weighted average life to maturity of the existing Tranche B-1 Term Loans and (y) Incremental Term A Loans shall be no shorter than the weighted average life to maturity of the existing Tranche A Term Loans&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-34.45pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.63pt">the maturity date of (x) all Incremental Term B Loans shall not be earlier than the latest Maturity Date with respect to the Tranche B-1 Term Loans as then in effect and (y) all Incremental Term A Loans shall not be earlier than the latest Maturity Date with respect to the Tranche A Term Loans as then in effect&#59; and</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">the interest rate margins for (x) the new Incremental Term A Loans shall be determined by Borrower and the applicable new Lenders and (y) the new Incremental Term B Loans shall be determined by Borrower and the applicable new Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, prior to the date that is twelve months after the Closing Date, that the interest rate margins for the new Incremental Term B Loans, shall not be greater than the highest interest rate margins that may, under any circumstances, be payable with respect to any Tranche B-1 Term Loans plus 50 basis points (and the interest rate margins applicable to the Tranche B-1 Term Loans shall be increased to the extent necessary to achieve the foregoing)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in determining the interest rate margins applicable to the existing Tranche B-1 Term Loans, and the Incremental Term B Loans, as applicable, (x) original issue discount or upfront or similar fees (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OID</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) payable by the Borrower to the Lenders of the existing Tranche B-1 Term Loans or the Incremental Term B Loans in the primary syndication thereof shall be included (with OID being equated to interest based on an assumed four-year life to maturity), (y) customary arrangement or commitment fees payable to arrangers (or their respective affiliates) shall be excluded and (z) if the Incremental Term B Loans include an interest rate floor greater than the interest rate floor applicable to the Tranche B-1 Term Loans, such increased amount shall be equated to interest rate margins for purposes of determining whether an increase in the interest rate margins for the Tranche B-1 Term Loans shall be required, to the extent an increase in the interest rate floor in</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_274"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Tranche B-1 Term Loans would cause an increase in the interest rate margins, and in such case the interest rate floor (but not the Applicable Margin) applicable to the Tranche B-1 Term Loans shall be increased by such increased amount.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The increased or new Commitments shall be effected by a joinder agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Increase Joinder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) executed by Borrower, the Administrative Agent and each Lender making such increased or new Commitment, in form and substance satisfactory to each of them. The Increase Joinder may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the opinion of the Administrative Agent, to effect the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">To the extent the Commitments being increased on the relevant Increase Effective Date are Revolving Commitments, then each of the Revolving Lenders having a Revolving Commitment under the applicable Revolving Facility prior to such Increase Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Pre-Increase Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">shall assign to any Revolving Lender which is acquiring a new or additional Revolving Commitment under the applicable Revolving Facility on the Increase Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Post-Increase Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and such Post-Increase Revolving Lenders shall purchase from each Pre-Increase Revolving Lender, at the principal amount thereof, such interests in the Revolving Loans under the applicable Revolving Facility (which purchases shall be deemed prepayments of such Revolving Loans for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) and, in the case of Alternative Currency Revolving Commitments, participation interests in LC Obligations and Swingline Loans outstanding on such Increase Effective Date as shall be necessary in order that, after giving effect to all such assignments and purchases, such Revolving Loans under the applicable Revolving Facility and, in the case of Alternative Currency Revolving Commitments, participation interests in LC Obligations and Swingline Loans will be held by Pre-Increase Revolving Lenders and Post-Increase Revolving Lenders ratably in accordance with their Revolving Commitments under the applicable Revolving Facility after giving effect to such Increased Revolving Commitments under the applicable Revolving Facility.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">On any Increase Effective Date on which new Commitments for term loans under Incremental Term Loan Commitments are effective, subject to the satisfaction of the foregoing terms and conditions, each Lender of such new Commitment shall make a new Term Loan to the Borrower in an amount equal to its new Commitment.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Loans and Commitments established pursuant to this paragraph shall constitute Loans and Commitments under, and shall be entitled to all the benefits afforded by, this Agreement and the other Loan Documents, and shall, without limiting the foregoing, benefit equally and ratably from </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof and security interests created by the Security Documents. The Loan Parties shall take any actions reasonably required by the Administrative Agent to ensure and&#47;or demonstrate that the Lien and security interests granted by the Security Documents continue to be perfected under the UCC or otherwise after giving effect to the establishment of any such Class of Term Loans or any such new Commitments.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Extensions of Term Loans and Revolving Commitments.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding anything to the contrary in this Agreement, pursuant to one or more offers (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension Offer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) made from time to time by the Borrower to all Lenders of Term Loans with a like Maturity Date or Revolving Commitments with a like Maturity Date, in each case on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis (based on the aggregate outstanding principal amount of the respective Term Loans or Revolving Commitments with the same Maturity Date, as the case may be) and on the same terms to each such Lender, the Borrower may from time to time offer to extend the maturity date of any Term Loans and&#47;or Revolving Commitments under any Revolving Facility and otherwise modify the terms of such</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_277"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Term Loans and&#47;or such Revolving Commitments pursuant to the terms of the relevant Extension Offer (including, without limitation, by increasing the interest rate or fees payable in respect of such Term Loans and&#47;or such Revolving Commitments (and related outstandings) and&#47;or modifying the amortization schedule in respect of such Lender&#8217;s Term Loans) (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extension</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,&#8221; and each group of Term Loans or Revolving Commitments, as applicable, in each case as so extended, as well as the original Term Loans and the original Revolving Commitments (in each case not so extended), being a separate Class&#59; any Extended Term Loans shall constitute a separate Class of Term Loans from the Class of Term Loans from which they were converted, and any Extended Revolving Commitments shall constitute a separate Class of Revolving Commitments from the Class of Revolving Commitments from which they were converted), so long as the following terms are satisfied&#58; (i) no Default shall have occurred and be continuing at the time an Extension Offer is delivered to the Lenders, (ii) except as to interest rates, fees and final maturity, the Revolving Commitment under any Revolving Facility of any Revolving Lender (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) extended pursuant to an Extension (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Revolving</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the related outstandings, shall be a Revolving Commitment under such Revolving Facility (or related outstandings, as the case may be) with the same terms as the applicable original Revolving Commitments (and related outstandings)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) subject to the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.7(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to the extent dealing with Swingline Loans and Letters of Credit which mature or expire after a Maturity Date when there exist Extended Revolving Commitments with a longer Maturity Date, all Swingline Loans and Letters of Credit shall be participated in on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis by all Alternative Currency Revolving Lenders in accordance with their </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> share of the Alternative Currency Revolving Facility (and except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without giving effect to changes thereto on an earlier Maturity Date with respect to Swingline Loans and Letters of Credit theretofore incurred or issued) and all borrowings under the Alternative Currency Revolving Commitments and repayments thereunder shall be made on a pro rata basis (except for (A) payments of interest and fees at different rates on Extended Revolving Commitments (and related outstandings) and (B) repayments required upon the Maturity Date of the non-extending Alternative Currency Revolving Commitments) and (y) at no time shall there be Revolving Commitments hereunder (including Extended Revolving Commitments and any original Revolving Commitments) which have more than three different Maturity Dates, (iii) except as to interest rates, fees, amortization, final maturity date, premium, required prepayment dates and participation in prepayments (which shall, subject to immediately succeeding clauses (iv), (v) and (vi), be determined by the Borrower and set forth in the relevant Extension Offer), the Term Loans of any Term Lender (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extending Term Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) extended pursuant to any Extension (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Extended Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall have the same terms as the Class of Term Loans subject to such Extension Offer, (iv) the final maturity date of any Extended Term Loans shall be no earlier than the then Latest Maturity Date hereunder and the amortization schedule applicable to Term Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for periods prior to the Tranche A Term Loan Maturity Date or the Tranche B-1 Term Loan Maturity Date, as applicable, may not be increased, (v) the Weighted Average Life to Maturity of any Extended Term Loans shall be no shorter than the remaining Weighted Average Life to Maturity of the Term Loans extended thereby, (vi) any Extended Term Loans may participate on a pro rata basis or a less than pro rata basis (but not greater than a pro rata basis) in any voluntary or mandatory repayments or prepayments hereunder, in each case as specified in the respective Extension Offer, (vii) if the aggregate principal amount of applicable Term Loans (calculated on the face amount thereof) or applicable Revolving Commitments, as the case may be, in respect of which applicable Term Lenders or applicable Revolving Lenders, as the case may be, shall have accepted the relevant Extension Offer (as hereinafter provided) shall exceed the maximum aggregate principal amount of applicable Term Loans or applicable Revolving Commitments, as the case may be, offered to be extended by the Borrower pursuant to such Extension Offer, then the applicable Term Loans or applicable Revolving Loans, as the case may be, of the applicable Term Lenders or applicable Revolving Lenders, as the case may be, shall be extended ratably up to such maximum amount based on the respective principal amounts (but not to exceed actual holdings of record) with respect to which such Term Lenders or such Revolving Lenders, as the case may be, have accepted such Extension Offer (as hereinafter provided), (viii) all</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_280"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">documentation in respect of such Extension shall be consistent with the foregoing, and (ix) any applicable Minimum Extension Condition shall be satisfied unless waived by the Borrower. Following any such Extension Offer, the Administrative Agent shall notify the applicable Lenders thereof, each of whom shall, in its sole discretion, determine whether or not to accept such Extension Offer.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">With respect to all Extensions accepted by the relevant Lenders and consummated by the Borrower pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (i) such Extensions shall not constitute voluntary or mandatory payments or prepayments for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) no Extension Offer is required to be in any minimum amount or any minimum increment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower may at its election specify as a condition (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Extension Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to consummating any such Extension that a minimum amount (to be determined and specified in the relevant Extension Offer in the Borrower&#8217;s sole discretion and which may be waived by the Borrower) of Term Loans or Revolving Commitments (as applicable) of any or all applicable Classes be tendered. The Administrative Agent and the Lenders hereby consent to the Extensions and the other transactions contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including, for the avoidance of doubt, payment of any interest, fees or premium in respect of any Extended Term Loans and&#47;or Extended Revolving Commitments on such terms as may be set forth in the relevant Extension Offer) and hereby waive the requirements of any provision of this Agreement (including, without limitation, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or any other Loan Document that may otherwise prohibit any such Extension or any other transaction contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Lenders hereby irrevocably authorize the Administrative Agent and Collateral Agent to enter into amendments to this Agreement and the other Loan Documents with the Borrower as may be necessary in order to establish new Classes or sub-Classes in respect of Revolving Commitments or Term Loans so extended and such technical amendments as may be necessary or appropriate in the reasonable opinion of the Administrative Agent and the Borrower in connection with the establishment of such new Classes or sub-Classes, in each case on terms consistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding the foregoing, each of the Administrative Agent and the Collateral Agent shall have the right (but not the obligation) to seek the advice or concurrence of the Required Lenders with respect to any matter contemplated by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, if either the Administrative Agent or the Collateral Agent seeks such advice or concurrence, it shall be permitted to enter into such amendments with the Borrower in accordance with any instructions actually received by such Required Lenders and shall also be entitled to refrain from entering into such amendments with the Borrower unless and until it shall have received such advice or concurrence&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that whether or not there has been a request by the Administrative Agent or the Collateral Agent for any such advice or concurrence, all such amendments entered into with the Borrower by the Administrative Agent or the Collateral Agent hereunder shall be binding and conclusive on the Lenders.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In connection with any Extension, the Borrower shall provide the Administrative Agent at least ten (10) Business Days&#8217; (or such shorter period as may be agreed by the Administrative Agent) prior written notice thereof, and shall agree to such procedures, if any, as may be established by, or acceptable to, the Administrative Agent, in each case acting reasonably to accomplish the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, for the avoidance of doubt, no Lender shall have such Lender&#8217;s Commitment or Loans extended without the written consent of such Lender.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.26</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Defaulting Lenders. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender hereunder, then the following provisions shall apply for so long as such Lender is a Defaulting Lender&#58;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_283"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:46.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">fees shall cease to accrue on the Commitment of such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Commitments and the Total Revolving Extensions of Credit of such Defaulting Lender shall not be included in determining whether all Lenders, the Required Lenders, or the Majority Facility Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any waiver, amendment or modification of a type described in clause (i) or (ii) of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that would apply to the Commitments or Obligations owing to such Defaulting Lender shall require the consent of such Defaulting Lender with respect to the effectiveness of such waiver, amendment or modification with respect to the Commitments or Obligations owing to such Defaulting Lender&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:14.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">if any Swingline Loan or Letter of Credit is outstanding at the time such Lender becomes a Defaulting Lender then&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt;padding-right:10.45pt;text-indent:48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.63pt">unless a Default shall have occurred and be continuing, all or any part of the Swingline Participation Amount and LC Obligations of such Defaulting Lender shall be reallocated among the non-Defaulting Lenders in accordance with their respective Alternative Currency Revolving Percentages but only to the extent the sum of all non-Defaulting Lenders&#8217; Alternative Currency Revolving Extensions of Credit plus such Defaulting Lender&#8217;s Swingline Participation Amount and LC Obligations do not exceed the total of all non-Defaulting Lenders&#8217; Alternative Currency Revolving Commitments&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:77pt;padding-right:15.8pt;text-indent:44.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.73pt">if the reallocation described in clause (i) above cannot, or can only partially, be effected, the Borrower shall within one Business Day following notice by the Administrative Agent (x) first, prepay such Swingline Participation Amount and (y) second, cash collateralize for the benefit of the Issuing Lender only the Borrower&#8217;s obligations corresponding to such Defaulting Lender&#8217;s LC Obligations (after giving effect to any partial reallocation pursuant to clause (i) above) in accordance with the procedures set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for so long as such LC Obligations are outstanding&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:77pt;padding-right:11.55pt;text-indent:41.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.78pt">if the Borrower cash collateralizes any portion of such Defaulting Lender&#8217;s Alternative Currency Revolving Percentage of the LC Obligations pursuant to clause (ii) above, the Borrower shall not be required to pay any fees to such Defaulting Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Defaulting Lender&#8217;s Alternative Currency Revolving Percentage of the LC Obligations during the period such Defaulting Lender&#8217;s LC Obligations are cash collateralized&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77pt;padding-right:28.5pt;text-indent:42.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.53pt">if the LC Obligations of the non-Defaulting Lenders are reallocated pursuant to clause (i) above, then the fees payable to the Lenders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be adjusted in accordance with such non-Defaulting Lenders&#8217; Alternative Currency Revolving Percentages&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:77pt;padding-right:19.8pt;text-indent:45.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.48pt">if all or any portion of such Defaulting Lender&#8217;s LC Obligations is neither reallocated nor cash collateralized pursuant to clause (i) or (ii) above, then, without prejudice to any rights or remedies of the Issuing Lender or any other Lender hereunder, all letter of credit fees payable under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such Defaulting Lender&#8217;s LC Obligations shall be payable to the Issuing Lender until and to the extent that such LC Obligations are reallocated and&#47;or cash collateralized&#59; and</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_286"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:8.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">so long as such Lender is a Defaulting Lender, the Swingline Lender shall not be required to fund any Swingline Loan and the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless it is satisfied that the related exposure and the Defaulting Lender&#8217;s then outstanding LC Obligations will be 100% covered by the Alternative Currency Revolving Commitments of the non-Defaulting Lenders and&#47;or cash collateral will be provided by the Borrower in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.26(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and participating interests in any newly made Swingline Loan or any newly issued or increased Letter of Credit shall be allocated among non-Defaulting Alternative Currency Revolving Lenders in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.26(c)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (and such Defaulting Lender shall not participate therein).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.55pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If (i) a Bankruptcy Event with respect to a Parent of any Lender shall occur following the Closing Date and for so long as such event shall continue or (ii) the Swingline Lender or the Issuing Lender has a good faith belief that any Lender has defaulted in fulfilling its obligations under one or more other agreements in which such Lender commits to extend credit, the Swingline Lender shall not be required to fund any Swingline Loan and the Issuing Lender shall not be required to issue, amend or increase any Letter of Credit, unless the Swingline Lender or the Issuing Lender, as the case may be, shall have entered into arrangements with the Borrower or such Lender, satisfactory to the Swingline Lender or the Issuing Lender, as the case may be, to defease any risk to it in respect of such Lender hereunder.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.8pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that the Administrative Agent, the Borrower, the Swingline Lender and the Issuing Lender each agrees that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then the Swingline Participation Amount and LC Obligations of the Lenders shall be readjusted to reflect the inclusion of such Lender&#8217;s Alternative Currency Revolving Commitment and on such date such Lender shall purchase at par such of the Revolving Loans of the other Lenders (other than Swingline Loans) as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Revolving Percentage.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Refinancing Amendments.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">At any time after the Closing Date, the Borrower may obtain from any existing</font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Lender or any other Person reasonably satisfactory to the Borrower and, in the case of any Other Revolving Commitments, the Administrative Agent, the Swingline Lender and the Issuing Lender (any such existing Lender or other Person being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Additional Refinancing Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) Credit Agreement Refinancing Debt in respect of (a) all or any portion of the Term Loans then outstanding under this Agreement (which for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will be deemed to include any then outstanding Other Term Loans) or (b) all or any portion of the Revolving Commitments (including the corresponding portion of the Revolving Loans) under this Agreement (which for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause</font></div><div style="padding-left:5pt;padding-right:9.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">will be deemed to include any then outstanding Other Revolving Commitments (including the corresponding portion of the Other Revolving Loans)), in the form of (x) Other Term Loans or Other Term Loan Commitments in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (y) Other Revolving Loans or Other Revolving Commitments in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in each case pursuant to a Refinancing Amendment&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Credit Agreement Refinancing Debt (i) will rank </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or junior in right of payment and of security with the other Loans and Commitments hereunder, (ii) have such pricing, interest, fees, premiums and optional prepayment terms as may be agreed by the Borrower and the Additional Refinancing Lenders thereof, (iii) not be secured by any assets that do not constitute Collateral and (iv) except as permitted in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clause (ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, will otherwise be treated hereunder no more materially favorably taken as a whole, including with respect to covenants and events of default, in the good faith determination of the Borrower than the Refinanced Debt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the terms and conditions applicable to such Credit Agreement Refinancing Debt may provide for additional or different financial or other covenants or other provisions that are agreed by the Borrower and the applicable</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_289"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Additional Refinancing Lenders to the extent applicable only after the Latest Maturity Date as determined on the date such Credit Agreement Refinancing Debt is incurred or obtained.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The effectiveness of any Refinancing Amendment shall be subject to the satisfaction on the date thereof of each of the conditions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and, to the extent reasonably requested by the Administrative Agent, to receipt by the Administrative Agent of (i) customary legal opinions, board resolutions and officers&#8217; certificates consistent with those delivered on the Closing Date other than changes to such legal opinion resulting from a change in law, change in fact or change to counsel&#8217;s form of opinion reasonably satisfactory to the Administrative Agent and (ii) reaffirmation agreements and&#47;or such amendments to the Security Documents as may be reasonably requested by the Administrative Agent in order to ensure that such Credit Agreement Refinancing Debt is provided with the benefit of the applicable Loan Documents.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each issuance of Credit Agreement Refinancing Debt under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.27(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be in an aggregate principal amount that is (x) not less than $25,000,000 and (y) an integral multiple of $1,000,000 in excess thereof.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Each of the parties hereto hereby agrees that this Agreement and the other Loan Documents may be amended pursuant to a Refinancing Amendment, without the consent of any other Lenders, to the extent (but only to the extent) necessary to (i) reflect the existence and terms of the Credit Agreement Refinancing Debt incurred pursuant thereto and (ii) effect such other amendments to this Agreement and the other Loan Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.27</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and the Required Lenders hereby expressly authorize the Administrative Agent to enter into any such Refinancing Amendment.</font></div><div><font><br></font></div><div style="padding-left:177.85pt;padding-right:177.85pt;text-align:center;text-indent:25.9pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 3 </font></div><div style="padding-left:85pt;padding-right:85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LETTERS OF CREDIT</font></div><div style="padding-left:85pt;padding-right:85pt;text-align:center"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:22.25pt">LC Commitment.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;text-indent:76.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Subject to the terms and conditions hereof, the Issuing Lender, in reliance on the agreements of the other Applicable Participants set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, agrees to issue letters of credit (x) denominated in Dollars, in the case of Dollar Letters of Credit or (y) denominated in Dollars or in any other Alternative Currency, in the case of Alternative Currency Letters of Credit (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letters of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), in each case for the account of the Borrower or a Restricted Subsidiary on any Business Day during the Revolving Commitment Period in such form as may be approved from time to time by the Issuing Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Issuing Lender shall have no obligation to issue any Letter of Credit if, after giving effect to such issuance, (i) the LC Obligations would exceed the LC Commitment or (ii) the aggregate amount of the Available Revolving Commitments would be less than zero. Each Letter of Credit shall expire no later than the first anniversary of its date of issuance or last renewal (unless otherwise agreed by the relevant Issuing Lender) and no Letter of Credit shall expire following the date that is five Business Days prior to the Revolving Termination Date (or with respect to any Letters of Credit outstanding with respect to an Extended Revolving Commitment, the Maturity Date applicable thereto) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Letter of Credit Facility Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), unless the relevant Issuing Lender has approved a later expiry date (which approval may be subject to such Letter of Credit being cash collateralized or otherwise backstopped pursuant to arrangements acceptable to such Issuing Lender) (it being understood that the participations of the Applicable Participants in any undrawn Letter of Credit shall in any event terminate on the Letter of Credit Facility Expiration Date).</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_292"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Issuing Lender shall not at any time be obligated to issue any Letter of Credit if such issuance would conflict with, or cause the Issuing Lender or any Applicable Participant to exceed any limits imposed by, any applicable Requirement of Law. In the event of any inconsistency between the terms and conditions of this Agreement and the terms and conditions of any Application or other agreement submitted by the Borrower to, or entered into by the Borrower with, the Issuing Lender relating to any Letter of Credit, the terms and conditions of this Agreement shall control.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">All Existing Letters of Credit shall be deemed to be issued hereunder and shall constitute Letters of Credit subject to the terms hereof.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Notwithstanding that a Letter of Credit issued or outstanding hereunder is in support of any obligations of, or is for the account of, a Restricted Subsidiary, the Borrower shall be obligated to reimburse the Issuing Lender hereunder for any and all drawings under such Letter of Credit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2&#160;&#160;&#160;&#160;Notice of Issuance, Amendment, Renewal, Extension&#59; Certain Conditions. To request the issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit), the Borrower shall hand deliver or telecopy (or transmit by electronic communication, if arrangements for doing so have been approved by the Issuing Lender) to the Issuing Lender and the Administrative Agent (reasonably in advance of the requested date of issuance, amendment, renewal or extension) a notice pursuant to an LC Request requesting the issuance of a Letter of Credit, or identifying the Letter of Credit to be amended, renewed or extended, and specifying the date of issuance, amendment, renewal or extension (which shall be a Business Day), the date on which such Letter of Credit is to expire (which shall comply with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), the amount of such Letter of Credit, whether such Letter of Credit is to be a Dollar Letter of Credit or an Alternative Currency Letter of Credit, the currency in which such Letter of Credit is to be denominated (which, in the case of a Dollar Letter of Credit, shall be in Dollars, and, in the case of an Alternative Currency Letter of Credit, shall be in Dollars or any other Alternative Currency), the name and address of the beneficiary thereof and such other information as shall be necessary to prepare, amend, renew or extend such Letter of Credit. If requested by the Issuing Lender, the Borrower also shall submit an Application on the Issuing Lender&#8217;s standard form in connection with any request for a Letter of Credit. A Dollar Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension, (i) the LC Obligations shall not exceed the LC Commitment, (ii) the Available Dollar Revolving Commitments would not be less than zero and (iii) the Dollar LC Obligations with respect to any Issuing Lender would not exceed the applicable Specified Dollar LC Sublimit of such Issuing Lender then in effect. An Alternative Currency Letter of Credit shall be issued, amended, renewed or extended only if (and upon issuance, amendment, renewal or extension of each Letter of Credit the Borrower shall be deemed to represent and warrant that), after giving effect to such issuance, amendment, renewal or extension, (i) the LC Obligations shall not exceed the LC Commitment,(ii) the Available Alternative Currency Revolving Commitments would not be less than zero and (iii) the Alternative Currency LC Obligations with respect to any Issuing Lender would not exceed the applicable Specified Alternative Currency LC Sublimit of such Issuing Lender then in effect Upon request of an Issuing Lender, the Administrative Agent will provide written confirmation to such Issuing Lender of (i) the amount available under the Alternative Currency LC Commitment or Dollar LC Commitment, as applicable, as of such date and (ii) the aggregate Total Alternative Currency Revolving Extensions of Credit or Total Dollar Revolving Extensions of Credit, as applicable, then outstanding.</font></div><div style="padding-left:4.5pt;padding-right:12.45pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:12.45pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3&#160;&#160;&#160;&#160;Fees and Other Charges. The Borrower shall pay the fees specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_295"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:31.233%"><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:3.149%;min-width:2.649%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:31.233%"></div><div style="display:inline-block;max-width:3.149%;min-width:2.649%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:31.236%"></div></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_298"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4&#160;&#160;&#160;&#160;Participations. By the issuance of a Letter of Credit (or an amendment to a Letter of Credit increasing the amount thereof) and without any further action on the part of the Issuing Lender or the Lenders, the Issuing Lender hereby grants to each Applicable Participant, and each Applicable Participant hereby acquires from the Issuing Lender, a participation in such Letter of Credit equal to such Lender&#8217;s Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, of the aggregate amount available to be drawn under such Letter of Credit. In consideration and in furtherance of the foregoing, (x) each Alternative Currency Revolving Lender hereby absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Lender, such Lender&#8217;s Alternative Currency Revolving Percentage of (i) each LC Disbursement in respect of any Alternative Currency Letter of Credit made by the Issuing Lender in Dollars and (ii) the Dollar Equivalent, using the Spot Rate on the date such payment is required, of each LC Disbursement in respect of any Alternative Currency Letter of Credit made by the Issuing Lender in an Alternative Currency other than Dollars and, in each case, not reimbursed by the Borrower on the date due as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or of any reimbursement payment required to be refunded to the Borrower for any reason and (y) each Dollar Revolving Lender hereby absolutely and unconditionally agrees to pay to the Administrative Agent, for the account of the Issuing Lender, such Lender&#8217;s Dollar Revolving Percentage of each LC Disbursement in respect of any Dollar Letter of Credit made by the Issuing Lender in Dollars and not reimbursed by the Borrower on the date due as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or of any reimbursement payment required to be refunded to the Borrower for any reason. Each Applicable Participant acknowledges and agrees that its obligation to acquire participations pursuant to this paragraph in respect of Letters of Credit is absolute and unconditional and shall not be affected by any circumstance whatsoever, including any amendment, renewal or extension of any Letter of Credit or the occurrence and continuance of a Default or reduction or termination of the Revolving Commitments, and that each such payment shall be made without any offset, abatement, withholding or reduction whatsoever.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.5&#160;&#160;&#160;&#160;Reimbursement. If the Issuing Lender shall make any LC Disbursement in respect of a Letter of Credit, the Borrower shall reimburse such LC Disbursement by paying to the Administrative Agent an amount equal to the Dollar Equivalent (for Letters of Credit denominated in Alternative Currencies, calculated using the Spot Rate when such payment is due), of such LC Disbursement, in Dollars, or at the option of the Borrower with respect to any Alternative Currency Letter of Credit, in the applicable Alternative Currency other than Dollars to the extent such LC Disbursement is made in such Alternative Currency, in each case, not later than 1&#58;00 P.M., New York City time, on the date that such LC Disbursement is made, if the Borrower shall have received notice of such LC Disbursement prior to 12&#58;00 noon, New York City time, on such date, or, if such notice has not been received by the Borrower prior to such time on such date, then not later than 1&#58;00 P.M., New York City time, on (i) the Business Day that the Borrower receives such notice, if such notice is received prior to 12&#58;00 noon, New York City time, on the day of receipt, or (ii) the Business Day immediately following the day that the Borrower receives such notice, if such notice is not received prior to such time on the day of receipt&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if such LC Disbursement is not less than $1,000,000, the Borrower may, subject to the conditions to borrowing set forth herein, request in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such payment be financed with a Revolving Loan of the same Class denominated in Dollars that is an ABR Loan or Swingline Loan in an amount equal to the Dollar Equivalent of such LC Disbursement and, to the extent so financed, the Borrower&#8217;s obligation to make such payment shall be discharged and replaced by the resulting Revolving Loan denominated in Dollars that is an ABR Loan or Swingline Loan. If the Borrower fails to make such payment when due, the Administrative Agent shall notify each Applicable Participant of the applicable LC Disbursement, the payment then due from the Borrower in respect thereof and such Lender&#8217;s Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, thereof. Promptly following receipt of such notice, each Applicable Participant shall pay to the Administrative Agent its Alternative Currency Revolving Percentage or Dollar Revolving Percentage, as applicable, of the Dollar Equivalent of the payment then due from the Borrower, in the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_301"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">same manner as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (without regard to minimum amounts) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to Loans made by such Applicable Participant (and such Sections shall apply, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment obligations of the Applicable Participants), and the Administrative Agent shall promptly pay to the Issuing Lender the amounts so received by it from the Applicable Participants. Promptly following receipt by the Administrative Agent of any payment from the Borrower pursuant to this paragraph, the Administrative Agent shall distribute such payment to the Issuing Lender or, to the extent that Applicable Participants have made payments pursuant to this paragraph to reimburse the Issuing Lender, then to such Applicable Participants and the Issuing Lender as their interests may appear. Any payment made by an Applicable Participant pursuant to this paragraph to reimburse the Issuing Lender for any LC Disbursement (other than the funding of ABR Revolving Loans or a Swingline Loan as contemplated above) shall not constitute a Loan and shall not relieve the Borrower of its obligation to reimburse such LC Disbursement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.6 &#160;&#160;&#160;&#160;Obligations Absolute. The Borrower&#8217;s obligation to reimburse LC Disbursements as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be absolute, unconditional and irrevocable, and shall be performed strictly in accordance with the terms of this Agreement under any and all circumstances whatsoever and irrespective of (i) any lack of validity or enforceability of any Letter of Credit or this Agreement, or any term or provision therein, (ii) any draft or other document presented under a Letter of Credit proving to be forged, fraudulent or invalid in any respect or any statement therein being untrue or inaccurate in any respect, (iii) payment by the Issuing Lender under a Letter of Credit against presentation of a draft or other document that does not comply with the terms of such Letter of Credit, or (iv) any other event or circumstance whatsoever, whether or not similar to any of the foregoing, that might, but for the provisions of this Section, constitute a legal or equitable discharge of, or provide a right of setoff against, the Borrower&#8217;s obligations hereunder. Neither the Administrative Agent, the Lenders nor the Issuing Lender, nor any of their Related Parties, shall have any liability or responsibility by reason of or in connection with the issuance or transfer of any Letter of Credit or any payment or failure to make any payment thereunder (irrespective of any of the circumstances referred to in the preceding sentence), or any error, omission, interruption, loss or delay in transmission or delivery of any draft, notice or other communication under or relating to any Letter of Credit (including any document required to make a drawing thereunder), any error in interpretation of technical terms or any consequence arising from causes beyond the control of the Issuing Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not be construed to excuse the Issuing Lender from liability to the Borrower to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by the Borrower to the extent permitted by applicable law) suffered by the Borrower that are caused by the Issuing Lender&#8217;s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof. The parties hereto expressly agree that, in the absence of gross negligence or willful misconduct on the part of the Issuing Lender (as finally determined by a court of competent jurisdiction), the Issuing Lender shall be deemed to have exercised care in each such determination. In furtherance of the foregoing and without limiting the generality thereof, the parties agree that, with respect to documents presented which appear on their face to be in substantial compliance with the terms of a Letter of Credit, the Issuing Lender may, in its sole discretion, either accept and make payment upon such documents without responsibility for further investigation, regardless of any notice or information to the contrary, or refuse to accept and make payment upon such documents if such documents are not in strict compliance with the terms of such Letter of Credit.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7&#160;&#160;&#160;&#160;Disbursement Procedures. The Issuing Lender shall, promptly following its receipt thereof, examine all documents purporting to represent a demand for payment under a Letter of Credit. The Issuing Lender shall promptly notify the Administrative Agent and the Borrower by telephone (confirmed by telecopy) of such demand for payment and whether the Issuing Lender has made or will make an LC Disbursement thereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any failure to give or delay in giving such</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_304"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">notice shall not relieve the Borrower of its obligation to reimburse the Issuing Lender and the Applicable Participants with respect to any such LC Disbursement.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Interim Interest. If the Issuing Lender shall make any LC Disbursement, then, unless the Borrower shall reimburse such LC Disbursement in full on the date such LC Disbursement is made, the unpaid amount thereof shall bear interest, for each day from and including the date such LC Disbursement is made to but excluding the date that the Borrower reimburses such LC Disbursement, at the rate per annum then applicable to Alternative Currency Revolving Loans denominated in the applicable Alternative Currency which are ABR Loans or Dollar Revolving Loans which are ABR Loans, as applicable&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, if the Borrower fails to reimburse such LC Disbursement when due pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.14(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall apply. Interest accrued pursuant to this Section shall be for the account of the Issuing Lender, except that interest accrued on and after the date of payment by any Applicable Participant pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to reimburse the Issuing Lender shall be for the account of such Applicable Participant to the extent of such payment.</font></div><div style="margin-top:0.55pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Replacement of the Issuing Lender. The Issuing Lender may be replaced at any time with another party eligible to become the Issuing Lender as provided herein, by written notice given by the Borrower (with the approval of the successor Issuing Lender and the Administrative Agent) to the replaced Issuing Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that prior to such replacement all Letters of Credit issued by the replaced Issuing Lender are terminated or cash collateralized on terms satisfactory to the replaced Issuing Lender. The Administrative Agent shall notify the Lenders of any such replacement of the Issuing Lender. At the time any such replacement shall become effective, the Borrower shall pay all unpaid fees accrued for the account of the replaced Issuing Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). From and after the effective date of any such replacement, (i) the successor Issuing Lender shall have all the rights and obligations of the Issuing Lender under this Agreement with respect to Letters of Credit to be issued thereafter and (ii) references herein to the term &#8220;Issuing Lender&#8221; shall be deemed to refer to such successor or to any previous Issuing Lender, or to such successor and all previous Issuing Lenders, as the context shall require. After the replacement of an Issuing Lender hereunder, the replaced Issuing Lender shall remain a party hereto and shall continue to have all the rights and obligations of an Issuing Lender under this Agreement with respect to Letters of Credit issued by it prior to such replacement, but shall not be required to issue additional Letters of Credit.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Cash Collateralization. (i) If any Event of Default shall occur and be continuing, on the Business Day that the Borrower receives notice from the Administrative Agent or the Required Lenders (or, if the maturity of the Loans has been accelerated, Lenders with LC Obligations representing greater than 50% of the total LC Obligations) demanding the deposit of cash collateral pursuant to this Section, or (ii) if required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.26(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, on the Business Day the Borrower receives the notice contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.26(c)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower shall deposit in an account with the Collateral Agent, in the name of the Collateral Agent and for the benefit of the Secured Parties, an amount in cash equal to 103 % of the Dollar Equivalent of the LC Obligations as of such date plus any accrued and unpaid interest thereon&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the obligation to deposit such cash collateral shall become effective immediately, and such deposit shall become immediately due and payable, without demand or other notice of any kind, upon the occurrence of any Event of Default with respect to the Borrower described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Such deposit shall be held by the Collateral Agent as collateral for the payment and performance of the obligations of the Borrower under this Agreement. The Collateral Agent shall have exclusive dominion and control, including the exclusive right of withdrawal, over such account. Other than any interest earned on the investment of such deposits, which investments shall be made at the option and sole discretion of the Collateral Agent and at the Borrower&#8217;s risk and expense, such deposits shall not bear interest. Interest or profits, if any, on such investments shall accumulate in such account. Moneys in such account shall be applied by the Collateral Agent to reimburse the Issuing Lender for LC Disbursements for which it has not been reimbursed and, to the extent not so applied, shall be held for</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_307"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the satisfaction of the reimbursement obligations of the Borrower for the LC Obligations at such time or, if the maturity of the Loans has been accelerated (but subject to the consent of Lenders with LC Obligations representing greater than 50% of the total LC Obligations), be applied to satisfy other obligations of the Borrower under this Agreement, and any surplus remaining shall be returned to the Borrower after all Events of Default triggering such deposit cease to exist. If the Borrower is required to provide an amount of cash collateral hereunder as a result of the occurrence of an Event of Default, such amount (to the extent not applied as aforesaid) shall be returned to the Borrower within three Business Days after all Events of Default have been cured or waived.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Provisions Related to Extended Revolving Commitments. If the Maturity Date in respect of any Class of Alternative Currency Revolving Commitments occurs prior to the expiration of any Alternative Currency Letter of Credit or any Class of Dollar Revolving Commitments occurs prior to the expiration of any Dollar Letter of Credit, then (i) if one or more other Classes of Revolving Commitments in respect of which the Maturity Date shall not have occurred are then in effect, such Letter of Credit shall automatically be deemed to have been issued (including for purposes of the obligations of the Revolving Lenders to purchase participations therein and to make Revolving Loans and payments in respect thereof pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) under (and ratably participated in by Lenders pursuant to) the Revolving Commitments in respect of such non-terminating Classes up to an aggregate amount not to exceed the aggregate principal amount of the unutilized Revolving Commitments thereunder at such time (it being understood that no partial face amount of any Letter of Credit may be so reallocated and no Letter of Credit denominated in an Alternative Currency may be reallocated to Revolving Commitments that do not permit borrowings in such currency) and (ii) to the extent not reallocated pursuant to immediately preceding clause (i), the Borrower shall cash collateralize any such Letter of Credit in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Except to the extent of reallocations of participations pursuant to clause (i) of the immediately preceding sentence, the occurrence of a Maturity Date with respect to a given Class of Revolving Commitments shall have no effect upon (and shall not diminish) the percentage participations of the Applicable Participants in any Letter of Credit issued before such Maturity Date.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:125.47pt;padding-right:125.47pt;text-align:center;text-indent:74.25pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 4</font></div><div style="padding-left:56.8pt;padding-right:56.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">REPRESENTATIONS AND WARRANTIES</font></div><div style="padding-left:56.8pt;padding-right:56.8pt;text-align:center"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Loan Party represents and warrants to the Administrative Agent, the Collateral Agent, the Issuing Lender and each of the Lenders that&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Organization&#59; Power. Each Loan Party (i) (x) is duly organized and validly existing and (y) in good standing (if such concept is applicable) under the laws of the jurisdiction of its organization, (ii) is duly qualified and in good standing as a foreign business enterprise (if such concept is applicable) in each other jurisdiction in which it owns or leases property or in which the conduct of its business requires it to so qualify or be licensed and (iii) has all requisite power and authority (including, without limitation, all material Governmental Authorizations) to own or lease and operate its properties and to carry on its business as now conducted and as proposed to be conducted, except in the case of the foregoing clauses (i)(y), (ii) and (iii), where the failure to be so qualified or licensed would not, individually or in the aggregate, result in a Material Adverse Effect.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Capital Stock&#59; Subsidiaries. As of the Closing Date, the Loan Parties do not have any direct or indirect Subsidiaries that are not Excluded Subsidiaries other than those specifically disclosed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (it being understood </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 4.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may also set forth Subsidiaries that are Excluded Subsidiaries). All of the outstanding Capital Stock of each such Subsidiary (A) (in the case of Subsidiaries that are corporations) has been validly issued, is fully paid and non-assessable and (B) to the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_310"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">extent owned by the Borrower or any other Loan Party, is free and clear of all Liens, except those created under the Security Documents or Liens permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Authorization&#59; No Conflicts. The execution, delivery and performance by each Loan Party of each Loan Document to which it is or is to be a party, and the consummation of the Transactions, are within such Loan Party&#8217;s corporate, partnership or limited liability company powers, as applicable, have been duly authorized by all necessary corporate, partnership or limited liability company action, as applicable, do not (i) contravene such Loan Party&#8217;s Constitutive Documents, (ii) violate any Requirements of Law, (iii) conflict with or result in the breach of, or constitute a default or require any payment to be made under, any material contract, loan agreement, indenture, mortgage, deed of trust, lease or other instrument binding on or affecting any Loan Party or any of its properties that would reasonably be likely to have a Material Adverse Effect or (iv) except for the Liens created under the Loan Documents, result in or require the creation or imposition of any Lien upon or with respect to any of the properties of any Loan Party. No Loan Party is in violation of any such Requirements of Law, the violation of which would be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">No Approvals. No Governmental Authorization, and no other authorization or approval or other action by, and no notice to or filing with, any Governmental Authority is required for (i) the due execution, delivery, recordation, filing or performance by any Loan Party of any Loan Document to which it is or is to be a party, or for the consummation of the Transactions, (ii) the grant by any Loan Party of the Liens granted by it pursuant to the Security Documents, (iii) the perfection or maintenance of the Liens created under the Security Documents on such of the Collateral located in the United States in which a Lien may be perfected by the filing of financing statements, the recordation of security agreements with the U.S. Patent and Trademark Office or the U.S. Copyright Office or the delivery of Collateral (including the first priority nature thereof) or (iv) the exercise by any Agent or any Lender of its rights under the Loan Documents or the remedies in respect of the Collateral pursuant to the Security Documents, except for (A) the authorizations, approvals, filings and actions described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 4.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto, all of which either (i) have been duly obtained and are in full force and effect or will be obtained and in full force and effect prior to the Closing Date or (ii) the failure to obtain could not reasonably be expected to result in a Material Adverse Effect, (B) filings, notices, recordings and other similar actions necessary for the creation or perfection of the Liens and security interests contemplated by the Loan Documents and (C) the actions required by laws generally with respect to the exercise by secured creditors of their rights and remedies.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Enforceability. This Agreement has been, and each other Loan Document when delivered hereunder will have been, duly executed and delivered by each Loan Party thereto. This Agreement is, and each other Loan Document when delivered hereunder will be, the legal, valid and binding obligation of each Loan Party thereto, enforceable against such Loan Party in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Litigation. There is no action, suit, investigation, litigation or proceeding affecting any Restricted Company, including any Environmental Action, pending or, to the knowledge of the Loan Parties, threatened by on behalf of or before any Governmental Authority or arbitrator (i) that would reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect or (ii) that challenges or that may affect the legality, validity or enforceability of any Loan Document or the consummation of the Transactions, except as disclosed prior to the Closing Date in the Borrower&#8217;s filings made with the SEC.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_313"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Financial Statements&#59; Projections.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Borrower has heretofore delivered to the Lenders the Consolidated balance sheets and related statements of income, stockholders&#8217; equity and cash flows of Borrower as of and for the Fiscal Year ended December 31, 2018, audited by and accompanied by the unqualified opinion of KPMG LLP, independent public accountants. Such financial statements and all financial statements delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> have been prepared in accordance with GAAP and present fairly in all material respects the financial condition and results of operations and cash flows of Borrower as of the dates and for the periods to which they relate except, in the case of interim financial statements, for the absence of footnotes and the same being subject to year-end audit adjustments.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Since December 31, 2018, there has been no event, change, circumstance or occurrence that, individually or in the aggregate, has had or could reasonably be expected to have a Material Adverse Effect (excluding the Borrower&#8217;s entering into the Loan Documents).</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The forecasts of financial performance of Borrower and its Subsidiaries furnished to the Lenders have been prepared in good faith by Borrower and based on assumptions believed by Borrower to reasonable.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Properties. Except to the extent the same would not be expected, individually or in the aggregate, to have a Material Adverse Effect, each Loan Party has good title to, or valid leasehold interests in, all its property material to its business, free and clear of all Liens except for Liens permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and minor irregularities or deficiencies in title that, individually and in the aggregate, do not interfere with its ability to conduct its business as currently conducted or to utilize such property for its intended purpose.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Intellectual Property. Except to the extent the same would not be expected, individually or in the aggregate, to have a Material Adverse Effect, (i) each Loan Party owns, or is licensed to use, all Intellectual Property necessary for the conduct of its business as currently conducted, (ii) to the knowledge of such Loan Party, no claim has been asserted and is pending by any Person challenging or questioning the use of any such Intellectual Property or the validity or effectiveness of any such Intellectual Property, nor does any Loan Party know of any valid basis for any such claim and (iii) to the knowledge of such Loan Party, the use of such Intellectual Property by each Loan Party does not infringe the rights of any Person.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">No Material Misstatements. Neither the Confidential Information Memorandum nor any other written information, exhibit or report furnished by any Loan Party to any Agent or any Lender in connection with the negotiation and syndication of the Loan Documents or pursuant to the terms of the Loan Documents taken as a whole in combination with the Borrower&#8217;s most recent Form 10-K, and each Form 10-Q and Form 8-K subsequent to such Form 10-K, in each case, filed or furnished with the SEC, contained, as of the date such information exhibit or report was so furnished, any untrue statement of a material fact or omitted to state a material fact necessary to make the statements made therein not misleading, except with respect to any projections or forecasts contained in such materials, the Loan Parties represent only that the same were prepared in good faith on the basis of assumptions believed to be reasonable, at the time made and at the time furnished, it being recognized by the Lenders that such projections and forecasts as they relate to future events are not to be viewed as fact and that actual results during the period or periods covered by such projections and forecasts may differ from such projections and forecasts.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Margin Stock. No Loan Party is engaged in the business of extending credit for the purpose of purchasing or carrying Margin Stock, and no proceeds of any Loan or drawings under any</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_316"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Letter of Credit will be used to purchase or carry any Margin Stock or to extend credit to others for the purpose of purchasing or carrying any Margin Stock, except for purchases of the Borrower&#8217;s Capital Stock permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Investment Company Act. No Restricted Company is an &#8220;investment company,&#8221; or is required to be registered as an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act of 1940, as amended.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Solvency. As of the Closing Date, and after giving effect to the incurrence of all indebtedness and obligations being incurred on the Closing Date in connection herewith, each Loan Party is, individually and together with its Subsidiaries, Solvent.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Employee Benefit Plans.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:29.05pt;text-indent:75.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.83pt">No ERISA Event has occurred or is reasonably expected to occur that would have or would reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.25pt;text-indent:72.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.88pt">Schedule B (Actuarial Information) to the most recent annual report (Form 5500 Series) for each Plan, copies of which have been filed with the Internal Revenue Service and furnished to the Lenders, is complete and accurate and fairly presents the funding status of such Plan, and since the date of such Schedule B there has been no material adverse change in such funding status.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-38.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.1pt;text-indent:70.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.73pt">Neither any Loan Party nor any ERISA Affiliate has been notified by the sponsor of a Multiemployer Plan that such Multiemployer Plan is insolvent or has been terminated, within the meaning of Title IV of ERISA or is in &#8220;endangered&#8221; or &#8220;critical&#8221; status, within the meaning of Section 432 of the Code or Section 305 of ERISA.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:27.8pt;text-align:justify;text-indent:73.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">Each Loan Party is in compliance with the presently applicable provisions of ERISA and the Code with respect to each Plan except as would not reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.3pt;text-indent:70.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.73pt">The present value of all accumulated benefit obligations of all underfunded Plans (based on the assumptions used for purposes of Accounting Standards Codification No. 715) did not, as of the date of the most recent financial statements reflecting such amounts, exceed the fair market value of the assets of all such underfunded Plans by an amount that could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-40.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.78pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:10.75pt;text-indent:64.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.83pt">Except to the extent the same would not be expected, individually or in the aggregate, to have a Material Adverse Effect, (a) each Loan Party is in compliance with the provisions of applicable law with respect to each Foreign Plan maintained or contributed to with respect to employees (or former employees) employed outside the United States or in Puerto Rico and (b) no Loan Party has incurred, or reasonably expects to incur, any obligation in connection with the termination of, or withdrawal from, any Foreign Plan maintained or contributed to with respect to employees (or former employees) employed outside the United States or in Puerto Rico.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Environmental Laws.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_319"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:8.4pt;text-indent:75.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.83pt">The operations and properties of each Loan Party comply with all applicable Environmental Laws and Environmental Permits, except where any such failure to comply would not be reasonably expected to have a Material Adverse Effect&#59; any past non-compliance with such Environmental Laws and Environmental Permits has been resolved without ongoing obligations or costs, except where any such failure to comply would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect&#59; no Environmental Action is pending or, to the Loan Parties&#8217; knowledge threatened, against any Loan Party&#59; and no circumstances exist that, in each case, could be reasonably likely to (A) form the basis of an Environmental Action against any Loan Party or any of properties currently owned or operated by any of them that could, individually or in the aggregate, have a Material Adverse Effect or (B) cause any such property owned by any Loan Party to be subject to any restrictions on ownership, occupancy, use or transferability under any Environmental Law that could, individually or in the aggregate, have a Material Adverse Effect.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.75pt;text-indent:72.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.88pt">To Borrower&#8217;s knowledge, none of the properties currently or formerly owned or operated by any Loan Party is listed or formally proposed for listing on the NPL or any analogous foreign, state or local list&#59; and except to the extent that any of the following would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (A) there are no and, to the Loan Parties&#8217; knowledge, never have been any underground or aboveground storage tanks or related piping or any surface impoundments, land disposal areas, septic tanks, pits, sumps or lagoons in which Hazardous Materials are being or have been treated, stored or disposed on any property currently owned or operated by any Loan Party or, to their knowledge, on any property formerly owned or operated by any Loan Party, (B) there is no asbestos or asbestos-containing material on or at any facility or property currently owned or operated by any Loan Party, and (C) there has been no Release of Hazardous Materials on, at, under or from any property currently or, to Borrower&#8217;s knowledge formerly owned or operated by any Loan Party.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:15.55pt;text-indent:69.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.93pt">(A) No Loan Party is undertaking, and has not completed, either individually or together with other potentially responsible parties, any investigation or remedial or response action relating to any actual or threatened Release of Hazardous Materials at any location&#59; and (B) all Hazardous Materials generated, used, treated, handled or stored at, or transported to or from, any property currently or formerly owned or operated by any Loan Party have been disposed of in a manner that could not reasonably be expected to result in liability to any Loan Party that, in the case of clauses (A) and (B), either individually or in the aggregate, would have a Material Adverse Effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Taxes. Each Loan Party has duly filed, has caused to be duly filed or has been included in all material tax returns (federal, state, local and foreign) required to be filed and has paid all material Taxes whether or not shown to be due on a tax return, together with applicable interest and penalties. Each Loan Party has made adequate provision in accordance with GAAP for all Taxes not yet due and payable, except as could not reasonably be expected to, individually or in the aggregate, result in a Material Adverse Effect. Each Loan Party is unaware of any proposed or pending tax assessments, deficiencies or audits that could be reasonably expected to, individually or in the aggregate, result in a Material Adverse Effect. No Loan Party has ever been a party to any understanding or arrangement constituting a &#8220;tax shelter&#8221; within the meaning of Section 6662(d)(2)(C)(iii) of the Code or within the meaning of Section 6111(c) or Section 6111(d) of the Code as in effect immediately prior to the enactment of the American Jobs Creation Act of 2004, or has ever &#8220;participated&#8221; in a &#8220;reportable transaction&#8221; within the meaning of Treasury Regulation Section 1.6011-4, except as could not be reasonably expected to, individually or in the aggregate, result in a Material Adverse Effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Government Reimbursement Programs&#59; Medicare&#47;Medicaid&#47;Tricare.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_322"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The dialysis facilities operated by each Restricted Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dialysis Facilities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) (i) are qualified for participation in the Medicare programs and the Medicaid programs and Tricare programs in which they participate (together with their respective intermediaries or carriers, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Government Reimbursement Programs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), (ii) are entitled to reimbursement under Government Reimbursement Programs for services rendered to qualified beneficiaries of Government Reimbursement Programs in which the Borrower and its Restricted Subsidiaries participate, and (iii) comply in all respects with the conditions of participation in all Government Reimbursement Programs in which they participate, except, in each case of clauses (i), (ii) and (iii), to the extent any such failure would not reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated net operating revenues for any (including any future) four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower, and except for the fact that Dialysis Facilities (i) newly developed by the Restricted Companies may from time to time be awaiting an initial Medicare certification and&#47;or initial Medicare or Medicaid provider number in accordance with normal business practice because of standard waiting times between the proper timely filing of the relevant documents therefor and the receipt of such certification and&#47;or provider number and (ii) acquired by Restricted Companies may from time to time be awaiting a Medicare certification and&#47;or Medicare or Medicaid provider number issued in the name of such Restricted Company in accordance with normal business practice because of standard waiting times between the proper timely filing of the relevant documents therefor and the receipt of such provider number. There is no pending or, to the Loan Parties&#8217; knowledge, threatened proceeding or investigation by any of the Government Reimbursement Programs with respect to (i) any Restricted Company&#8217;s qualification or right to participate in any Government Reimbursement Program in which it participates or has participated, (ii) the compliance or non-compliance by any Restricted Company with the terms or provisions of any Government Reimbursement Program in which it participates or has participated, or (iii) the right of any Restricted Company to receive or retain amounts received or due or to become due from any Government Reimbursement Program in which it participates or has participated, in each case of clauses (i), (ii) and (iii), which proceeding or investigation, together with all other such proceedings and investigations, would reasonably be expected to (x) have a Material Adverse Effect or (y) result in Consolidated net operating revenues for any (including any future) four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower, except as disclosed prior to the Closing Date in the Borrower&#8217;s filings made with the SEC.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">No Restricted Company nor any of their respective officers, directors, managers or partners on behalf of any Restricted Company has (A) committed any act that would cause any of them to incur a civil monetary penalty under or violated 42 U.S.C. &#167; 1320a-7a or &#167; 1320a-7b or knowingly or willfully violated any of the other federal statutes applicable to Government Reimbursement Programs or the regulations promulgated pursuant to such statutes or related state or local statutes or regulations, including but not limited to the following&#58; (i) knowingly and willfully making or causing to be made a false statement or representation of a material fact in any applications for any benefit or payment&#59; (ii) knowingly and willfully making or causing to be made any false statement or representation of a material fact for use in determining rights to any benefit or payment&#59; (iii) failing to disclose knowledge by a claimant of the occurrence of any event affecting the initial or continued right to any benefit or payment on its own behalf or on behalf of another, with intent to secure such benefit or payment fraudulently&#59; (iv) knowingly and willfully soliciting, receiving, offering or paying any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind or offering to pay such remuneration (a) in return for referring an individual to a Person for the furnishing or arranging for the furnishing of any item or service for which payment may be made in whole or in part by Medicare, Medicaid or other applicable government payers, or (b) in return for purchasing, leasing or ordering or arranging for or recommending the purchasing, leasing or ordering of any good, facility, service or item for which payment may be made in whole or in part by Medicare, Medicaid or other applicable</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_325"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:8.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">government payers, (B) knowingly and willfully presented or caused to be presented a claim for a medical or other item or service that was not provided as claimed, or was for a medical or other item or service and the Person knew or should have known the claim was false or fraudulent or (C) in violation of 42 U.S.C. &#167; 1395nn, presented or caused to be presented a claim to any individual, third party payor or other entity for a designated health service furnished pursuant to a referral by a physician if the physician (or an immediate family member) had a financial relationship with the Borrower or any of its Restricted Subsidiaries for which there was no permissible exception, except in the case of each of clauses (A), (B) and (C) as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect. Except as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect, neither the Borrower nor any of its Restricted Subsidiaries, nor any of their respective officers, directors, managers or partners, on behalf of the Borrower or any of its Restricted Subsidiaries, has violated the federal false claims act, 31 U.S.C. &#167;3729, including, but not limited to, by (i) knowingly and willfully presenting or causing to be presented to a government official a false claim for payment or approval, (ii) knowingly and willfully making, using or causing to be made or used, a false record or statement to get a false or fraudulent claim paid or approved by the government or (iii) conspiring to defraud the government by knowingly and willfully getting a false or fraudulent claim paid. With respect to this Section, knowledge of an individual director, officer, manager or partner of a Restricted Company or any of any of the events described in this Section shall not be imputed to a Restricted Company unless such knowledge was obtained or learned by the director, officer, manager or partner in his or her official capacity as a director, officer, manager or partner of a Restricted Company. Except as individually or in the aggregate could not reasonably be expected to have a Material Adverse Effect, the Borrower and each of its Restricted Subsidiaries is in compliance with the privacy and security rules promulgated under the Health Insurance Portability and Accountability Act of 1996 found at 45 C.F.R. parts 160-164 (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">HIPAA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the amendments to HIPAA made under the Health Information Technology for Economic and Clinical Health Act amendments to the American Recovery and Reinvestment Act of 2009. Except as would not be reasonably likely, individually or in the aggregate, to have a Material Adverse Effect, to the knowledge of the Borrower, neither the Borrower nor any of its Restricted Subsidiaries has violated 18 U.S.C. &#167; 1347 including, but not limited to, knowingly and willfully executing or attempting to execute a scheme or artifice by means of false or fraudulent pretenses (i) to defraud any health care benefit program, or (ii) to obtain any money or property owned by, or under the custody or control of, any health benefit program.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Agreements. No Loan Party is a party to any agreement or instrument or subject to any corporate or other constitutional restriction that has resulted or could reasonably be expected to result in a Material Adverse Effect. No Loan Party is in default in any manner under any provision of any agreement or instrument to which it is a party or by which it or any of its property is or may be bound, and no condition exists which, with the giving of notice or the lapse of time or both, would constitute such a default, in each case where such default could reasonably be expected to result in a Material Adverse Effect.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Use of Proceeds. Borrower will use the proceeds of (a) the Tranche A Term Loans and Tranche B-1 Term Loans (i) to finance the Refinancing, (ii) for general corporate purposes, including, without limitation, stock repurchases, acquisitions and investments, and (iii) to pay related fees, commissions and expenses and (b) the Revolving Loans and Swingline Loans on and after the Closing Date for working capital and general corporate purposes (including, without limitation, stock repurchases, acquisitions and investments).</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Labor Matters. There are no collective bargaining agreements or Multiemployer Plans covering the employees of any Restricted Company as of the Closing Date, and no Restricted Company has suffered any strikes, lockouts or slowdowns within the last five years that would reasonably be expected to have a Material Adverse Effect.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_328"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Security Documents. The Security Documents are effective to create in favor of the Collateral Agent, for the benefit of the Secured Parties, legal, valid and enforceable Liens on, and security interests in, the Collateral described therein except as such enforceability may be limited by a Bankruptcy Event and by general principles of equity, and (i) when all appropriate filings or recordings are made in the appropriate offices as may be required under applicable Requirements of Laws (which filings or recordings shall be made to the extent required by any Security Document) and (ii) upon the taking of possession or control by the Collateral Agent of such Collateral with respect to which a security interest may be perfected only by possession or control (which possession or control shall be given to the Collateral Agent to the extent required by any Security Document), the Liens created by such Security Documents will constitute fully perfected Liens on, and security interests in, all right, title and interest of the Loan Parties in such Collateral (other than such Collateral in which a security interest cannot be perfected under the UCC as in effect at the relevant time in the relevant jurisdiction or by filing with the United States Copyright Office), in each case subject to no Liens other than Liens permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.23</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Anti-Terrorism Law.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">No Loan Party and, to the knowledge of the Loan Parties, none of its Affiliates is in violation of any Requirement of Law relating to terrorism, corruption, bribery or money laundering (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Anti-Terrorism Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), including Executive Order No. 13224 on Terrorist Financing, effective September 24, 2001 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001, Public Law 107-56 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">No Loan Party and to the knowledge of the Loan Parties, no Affiliate of any Loan Party acting or benefiting in any capacity in connection with the Loans is any of the following&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">a Person owned or Controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, the Executive Order&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">a Person with which any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">a Person that commits, threatens or conspires to commit or supports &#8220;terrorism&#8221; as defined in the Executive Order&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">a Person that is named as a &#8220;specially designated national and blocked person&#8221; on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">OFAC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">No Loan Party, unless authorized by law, knowingly (i) conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Person described in paragraph (b) above, (ii) deals in, or otherwise engages in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order, or (iii) engages in or conspires to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">No part of the proceeds of the Loans will be used, directly or indirectly, by any Loan Party or any of its Subsidiaries (i) for any payments to any governmental official or employee,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_331"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:17.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of 1977, as amended or (ii) for the purpose of financing the activities of any Person that is the subject of U.S. sanctions administered by OFAC in violation of OFAC.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Beneficial Ownership Certification. As of the Closing Date, the information included in the Beneficial Ownership Certification provided to any Lender on or prior to the Closing Date is true and correct in all respects.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:171.2pt;padding-right:171.2pt;text-align:center;text-indent:39.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 5</font></div><div style="padding-left:85pt;padding-right:85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CONDITIONS PRECEDENT</font></div><div style="padding-left:85pt;padding-right:85pt;text-align:center"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:17.75pt">Conditions to Initial Credit Extension. The obligation of each Lender and, if applicable, the Issuing Lender to fund the initial Credit Extension requested to be made by it shall be subject to the prior or concurrent satisfaction of each of the conditions precedent set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> unless otherwise waived.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. There shall have been delivered to the Administrative Agent&#160;&#160;&#160;&#160;an executed counterpart of each of the Loan Documents.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Corporate Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">a certificate of the secretary or assistant secretary of each Loan Party dated the Closing Date, certifying (A) that attached thereto is a true and complete copy of each Constitutive Document of such Loan Party certified (to the extent applicable) as of a recent date by the Secretary of State of the state of its organization, (B) that attached thereto is a true and complete copy of resolutions duly adopted by the Board of Directors of such Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such Loan Party is a party and, in the case of the Borrower, the borrowings hereunder, and that such resolutions have not been modified, rescinded or amended and are in full force and effect and (C) as to the incumbency and specimen signature of each officer executing any Loan Document or any other document delivered in connection herewith on behalf of such Loan Party (together with a certificate of another officer as to the incumbency and specimen signature of the secretary or assistant secretary executing the certificate in this clause (i))&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">a certificate as to the good standing of each Loan Party (in so-called &#8220;long-form&#8221; if available) as of a recent date, from such Secretary of State (or other applicable Governmental Authority).</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Officers&#8217; Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a certificate, dated the Closing Date and signed by two Responsible Officers of the Borrower, confirming compliance with the conditions precedent set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Financings and Other Transactions, Etc.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">The Refinancing shall have been consummated or shall be consummated on the&#160;&#160;&#160;&#160;Closing Date, in each case in accordance with the terms hereof and the terms of the Transaction Documents, without the waiver or amendment of any such terms not approved by the Administrative Agent.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_334"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">All Liens in favor of the existing lenders under the Existing Credit Agreement shall simultaneously with the consummation of the Refinancing be unconditionally released&#59; and the Administrative Agent shall have received from any Person holding any Lien securing any such debt, such UCC termination statements, mortgage releases, releases of assignments of leases and rents, releases of security interests in Intellectual Property and other instruments, in each case in proper form for recording, as the Administrative Agent shall have reasonably requested to release and terminate of record the Liens securing such debt.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Opinions of Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received, on behalf of itself, the other Agents, the Lenders and the Issuing Lender, a favorable written opinion of (i) Sidley Austin, LLP, special counsel for the Loan Parties, (ii) Kathleen Waters, Chief Legal Officer of the Borrower, (iii) Bass, Berry &#38; Sims PLC, special Tennessee counsel for the Loan Parties, (iv) Cole, Scot &#38; Kissane, P.A., special Florida counsel for the Loan Parties, (v) Bailey Kennedy, LLP, special Nevada counsel for the Loan Parties and (vi) Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., special Massachusetts counsel for the Loan Parties, in each case (A) dated the Closing Date, (B) addressed to the Agents, the Issuing Lender and the Lenders and (C) in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt;text-decoration:underline">Solvency Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a solvency certificate in the form of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, dated the Closing Date and signed by the chief financial officer of the Borrower.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The arrangers, Administrative Agent and the Lenders shall have received all reasonable fees and other amounts due and payable on or prior to the Closing Date, including, to the extent invoiced, reimbursement or payment of all reasonable out-of-pocket expenses (including the invoiced legal fees and expenses of Cahill Gordon &#38; Reindel </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LLP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, special counsel to the Agents) required to be reimbursed or paid by the Borrower on or prior to the Closing Date hereunder or under any other Loan Document.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Personal Property Requirements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Collateral Agent shall have received&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">all certificates, agreements or instruments necessary to perfect the Collateral Agent&#8217;s security interest, for the benefit of the Secured Parties, in all Pledged Collateral (as defined in the Security Agreement), in each case, with the exception of those items permitted to be delivered after the Closing Date pursuant to the terms of the Security Agreement&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">UCC financing statements in appropriate form for filing under the UCC, filings or recordations with the United States Patent and Trademark Office and United States Copyright Office and such other documents under applicable Requirements of Law in each jurisdiction as may be necessary or appropriate or, in the opinion of the Collateral Agent, desirable to perfect the Liens created, or purported to be created, by the Security Documents and with respect to all UCC financing statements required to be filed pursuant to the Loan Documents&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">copies of UCC, United States Patent and Trademark Office and United States Copyright Office, tax and judgment lien searches, bankruptcy and pending lawsuit searches or equivalent reports or searches, each of a recent date listing all effective financing statements, lien notices or comparable documents that name any Loan Party as debtor and that are filed in those state and county jurisdictions in which any property of any Loan Party is located and the state and county jurisdictions in which any Loan Party is organized or maintains its principal place of business and such other searches that the Collateral Agent deems necessary or appropriate, none of which encumber the Collateral covered or intended to be covered by the Security Documents</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_337"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(other than Liens permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or any other Liens acceptable to the Collateral Agent)&#59;</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.63pt">evidence acceptable to the Collateral Agent of payment or arrangements for payment by the Loan Parties of all applicable recording taxes, fees, charges, costs and expenses required for the recording of the Security Documents&#59; and</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">a Perfection Certificate, duly executed and delivered by the Loan Parties, along with all attachments contemplated thereby.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.13pt;text-decoration:underline">USA Patriot Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Lenders shall have received, sufficiently in advance of the Closing Date, all documentation and other information required by bank regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation, the Patriot Act, including, without limitation, the information described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.13pt;text-decoration:underline">Beneficial Ownership Regulation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At least three days prior to the Closing Date, if the Borrower qualifies as a &#8220;legal entity customer&#8221; under the Beneficial Ownership Regulation and the Administrative Agent has provided the Borrower the name of each requesting Lender and its electronic delivery requirements at least 10 Business Days prior to the Closing Date, the Administrative Agent and each such Lender requesting a Beneficial Ownership Certification (which request shall be made through the Administrative Agent) shall have received such Beneficial Ownership Certification.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Master Intercompany Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Borrower shall have delivered to the Collateral Agent the Intercompany Note executed by and among the Borrower and each of its Restricted Subsidiaries, accompanied by instruments of transfer undated and endorsed in blank.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.13pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.63pt;text-decoration:underline">Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall receive a copy of, or a certificate as to coverage under (including endorsements thereto), the insurance policies required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and the applicable provisions of the Security Documents, each of which shall name the Collateral Agent, on behalf of the Secured Parties, as additional insured or loss payee, as applicable, in form and substance satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt;text-decoration:underline">Conditions to All Credit Extensions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The obligation of each Lender and each Issuing Lender to make any Credit Extension (including the initial Credit Extension) shall be subject to, and to the satisfaction of, each of the conditions precedent set forth below.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Administrative Agent shall have received a notice as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if Loans are being requested or, in the case of the issuance, amendment, extension or renewal of a Letter of Credit, the Issuing Lender and the Administrative Agent shall have received an Application or notice as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or, in the case of a Swingline Loan, the Swingline Lender and the Administrative Agent shall have received a notice as required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">No Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At the time of and immediately after giving effect to such Credit Extension and the application of the proceeds thereof, no Default shall have occurred and be continuing on such date.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each of the representations and warranties made by any Loan Party set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in any other Loan Document shall be true and correct in all material respects (except that any representation and warranty that is qualified as to &#8220;materiality&#8221; or</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_340"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Material Adverse Effect&#8221; shall be true and correct in all respects) on and as of the date of such Credit Extension with the same effect as though made on and as of such date, except to the extent such representations and warranties expressly relate to an earlier date.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In the case of an Alternative Currency Revolving Loan, there shall not have occurred any change in national or international financial, political or economic conditions or currency exchange rates or exchange controls which in the reasonable opinion of the Administrative Agent or the Required Lenders (in the case of any Loans to be denominated in an Alternative Currency) would make it impracticable for such extension of credit to be denominated in the relevant Alternative Currency.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">In the case of a Tranche A Term Loan in an amount greater than $500,000,000, the Refinancing (Additional) shall have been consummated or shall be consummated on the proposed date of such Credit Extension.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each notice of borrowing or an Application and the acceptance by the Borrower of the proceeds of such Credit Extension shall constitute a representation and warranty by the Borrower and each other Loan Party that on the date of such Credit Extension (both immediately before and after giving effect to such Credit Extension and the application of the proceeds thereof) the conditions contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 5.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> have been satisfied.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:168.67pt;padding-right:168.67pt;text-align:center;text-indent:44.25pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 6</font></div><div style="padding-left:85pt;padding-right:85pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AFFIRMATIVE COVENANTS</font></div><div style="padding-right:170pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Loan Party warrants, covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document and all other Obligations (excluding Contingent Obligations as to which no claim has been asserted) shall have been paid in full and all Letters of Credit have been canceled or have expired and all amounts drawn thereunder have been reimbursed in full or have been cash collateralized at 103% of the face amount thereof, unless the Required Lenders shall otherwise consent in writing, each Loan Party will, and will cause each of its Restricted Subsidiaries to&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Reporting Requirements. The Borrower will furnish to the Administrative Agent (for distribution to the Agents and Lenders)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">Default Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly after a Responsible Officer obtains actual knowledge of a Default or any event, development or occurrence reasonably likely to have a Material Adverse Effect continuing on the date of such statement, a written notice setting forth details of such Default or other event, development or occurrence and the action that the Borrower has taken and proposes to take with respect thereto.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Annual Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available and in any event within 90 days after the end of each Fiscal Year (or such earlier date on which Borrower is required to file Form 10-K under the Exchange Act), a copy of the annual audit report for such year for the Borrower and its Subsidiaries, including therein a Consolidated balance sheet of the Borrower and its Subsidiaries as of the end of such Fiscal Year and a Consolidated statement of income and a Consolidated statement of cash flows of the Borrower and its Subsidiaries for such Fiscal Year, in each case accompanied by an opinion of KPMG LLP or other independent public accountants of recognized national standing, which opinion shall be prepared in accordance with Generally Accepted Auditing Standards and shall not be subject to a &#8220;going concern&#8221; modification (other</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_343"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:10.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">than an emphasis of matter paragraph and except for any such modification pertaining to impending debt maturities of any Indebtedness occurring within 12 months of such audit or any breach or anticipated breach of any financial covenant under this Agreement or a modification relating to change in accounting principles or practices reflecting a change in GAAP required or approved by such independent public accountants)&#59; (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if the independent auditor provides an attestation and a report with respect to management&#8217;s report on internal control over financial reporting and its own evaluation of internal control over financial reporting, then such report may include a qualification or limitation due to the exclusion of any acquired business from such report to the extent such exclusion is permitted under rules or regulations promulgated by the SEC or the Public Company Accounting Oversight Board), together with, no later than five Business Days after the delivery of such annual audit report, a Compliance Certificate.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">Quarterly Financials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available and in any event within 45 days (or such earlier date on which the Borrower is required to file form 10-Q under the Exchange Act) after the end of each of the first three Fiscal Quarters of each Fiscal Year, a Consolidated balance sheet of the Borrower and its Subsidiaries as of the end of such quarter and a Consolidated statement of income for the period commencing at the end of the previous Fiscal Quarter and ending with the end of such Fiscal Quarter and a Consolidated statement of income and a Consolidated statement of cash flows of the Borrower and its Subsidiaries for the period commencing at the end of the previous Fiscal Year and ending with the end of such Fiscal Quarter, setting forth in each case in comparative form the corresponding figures for the corresponding date or period of the preceding Fiscal Year, all in reasonable detail and duly certified (subject to normal year-end audit adjustments) by a Responsible Officer of the Borrower as having been prepared in accordance with generally accepted accounting principles (except that such financial statements may not contain all required notes and may be subject to year-end audit adjustments) and having been subject to a SAS 100 or equivalent review by KPMG LLP or other independent public accountants of recognized national standing, together with, no later than five Business Days after the delivery of such quarterly financial statements, a Compliance Certificate&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:24.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Unrestricted Subsidiaries</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. At the time of delivery of the financial statements provided for in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, if there are any Unrestricted Subsidiaries as of the last day of any Fiscal Quarter or Fiscal Year, the Borrower shall deliver related consolidating financial statements reflecting the adjustments necessary to eliminate the accounts of Unrestricted Subsidiaries from such consolidated financial statements.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">Annual Forecasts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. As soon as available and in any event no later than 90 days after the end of each Fiscal Year, a reasonably detailed forecast for such Fiscal Year, in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:9.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt;text-decoration:underline">Litigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly after a Responsible Officer obtains actual knowledge of the commencement thereof, notice of all actions, suits, investigations, litigation and proceedings by on behalf of or before any Governmental Authority or arbitrator affecting any Restricted Company of the type described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt;text-decoration:underline">ERISA Events and ERISA Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. (A) Promptly and in any event within 10 days after any Loan Party or any ERISA Affiliate knows or has reason to know that any ERISA</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_346"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Event has occurred, a statement of the chief financial officer of the Borrower describing such ERISA Event and the action, if any, that such Loan Party or such ERISA Affiliate has taken and proposes to take with respect thereto and (B) on the date any records, documents or other information must be furnished to the PBGC with respect to any Plan pursuant to Section 4010 of ERISA, a copy of such records, documents and information.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt;text-decoration:underline">Plan Terminations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly and in any event within two Business Days after receipt thereof by any Loan Party or any ERISA Affiliate, copies of each notice from the PBGC stating its intention to terminate any Plan or to have a trustee appointed to administer any Plan.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt;text-decoration:underline">Plan Annual Reports</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly and in any event within 30 days after the filing thereof with the Internal Revenue Service, copies of each Schedule B (Actuarial Information) to the annual report (Form 5500 Series) with respect to each Plan.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt;text-decoration:underline">Multiemployer Plan Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly and in any event within five Business Days after receipt thereof by any Loan Party or any ERISA Affiliate from the sponsor of a Multiemployer Plan, copies of each notice concerning (A) the imposition of Withdrawal Liability by any such Multiemployer Plan, (B) the insolvency or termination, within the meaning of Title IV of ERISA, of any such Multiemployer Plan or (C) the amount of liability incurred, or that may be incurred, by such Loan Party or any ERISA Affiliate in connection with any event described in clause (A) or (B).</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt;text-decoration:underline">Environmental Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly after the assertion or occurrence thereof, notice of any Environmental Action against or of any noncompliance by any Restricted Company with any Environmental Law or Environmental Permit that could reasonably be expected to have a Material Adverse Effect.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt;text-decoration:underline">&#91;Reserved&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Regulatory Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Promptly provide notice that any Loan Party knows or has reason to know (A) that Dialysis Facilities have lost their qualification to participate in Government Reimbursement Programs as would have a Material Adverse Effect, (B) of an investigation described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.17(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that would have a Material Adverse Effect or (C) of any violation described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.17(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that would have a Material Adverse Effect.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:16.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt;text-decoration:underline">FinCEN</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Prompt notice of any change in the information provided in the Beneficial Ownership Certification that would result in a change to the list of beneficial owners identified in parts (c) or (d) of such certification.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:27.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt;text-decoration:underline">Other Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Such other information respecting the business, financial condition, operations or properties of any Restricted Company as any Agent or any Lender, through the Administrative Agent, may from time to time reasonably request.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Documents required to be delivered pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (to the extent any such documents are included in materials otherwise filed with the SEC) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower&#8217;s website&#59; or (ii) on which such documents are posted on the Borrower&#8217;s behalf on an Internet or intranet website or www.sec.gov, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent) and (iii) the Lenders shall be deemed to have received such information on the date such information is posted on the applicable website pursuant to clause (i) or (ii)</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_349"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">above. The Administrative Agent shall have no obligation to request the delivery of or maintain paper copies of the documents referred to above, and each Lender shall be solely responsible for timely accessing posted documents and maintaining its copies of such documents.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Compliance with Laws, Etc. Comply, and cause each of its Restricted Subsidiaries to comply, in all material respects, with all applicable Requirements of Law, such compliance to include, without limitation, compliance with (x) ERISA, the Racketeer Influenced and Corrupt Organizations Chapter of the Organized Crime Control Act of 1970 and all applicable laws and regulations under the federal Social Security Act and all other applicable federal and state healthcare laws, except to the extent that non-compliance could not be reasonably expected, individually or in the aggregate, to result in a Material Adverse Effect and (y) the Patriot Act and all other laws and regulations relating to money laundering and terrorist activities.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Payment of Taxes, Etc. Pay and discharge, and cause each of its Restricted Subsidiaries to pay and discharge, before the same shall become delinquent, (i) all Taxes imposed upon it or upon its property and (ii) all lawful claims that, if unpaid, might by law become a Lien upon its property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that neither the Borrower nor any of its Restricted Subsidiaries shall be required to pay or discharge any such Tax, assessment, charge or claim (A) the non-payment or non-discharge of which could not be reasonably expected, individually or in the aggregate, to result in a Material Adverse Effect or (B) that is being contested in good faith and (in the case of clause (i)) by proper proceedings and as to which appropriate reserves are being maintained in accordance with GAAP, unless and until any Lien resulting therefrom attaches to its property and becomes enforceable against its other creditors and subjects the property to a substantial risk of forfeiture.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Compliance with Environmental Laws. Except as could not reasonably be expected to result in a Material Adverse Effect, comply, and cause each of its Restricted Subsidiaries and all lessees and other Persons operating or occupying its properties to comply, with all applicable Environmental Laws and Environmental Permits&#59; obtain and renew and cause each of its Restricted Subsidiaries to obtain and renew all Environmental Permits necessary for its operations and properties that are the legal responsibility of the Borrower or such Restricted Subsidiary&#59; and conduct, and cause each of its Restricted Subsidiaries to conduct, any investigation, study, sampling and testing, and undertake any cleanup, removal, remedial or other action required under Environmental Laws to address the presence, or Release or threatened Release of Hazardous Materials at, on, under or from any of its properties, in accordance with the requirements of all applicable Environmental Laws&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that neither the Borrower nor any of its Restricted Subsidiaries shall be required to undertake any such cleanup, removal, remedial or other action to the extent that its obligation to do so is being contested in good faith and by proper proceedings and appropriate reserves are being maintained in accordance with GAAP requirements with respect to such circumstances.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Insurance.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Keep its insurable property adequately insured at all times by financially sound and reputable insurers&#59; maintain such other insurance, to such extent and against such risks as is customary with companies in the same or similar businesses operating in the same or similar locations, including insurance with respect to properties material to the business of the Restricted Companies against such casualties and contingencies and of such types and in such amounts with such deductibles as is customary in the case of similar businesses operating in the same or similar locations, except, in the case of Foreign Subsidiaries, to the extent that the failure to maintain such insurance with respect to one or more Foreign Subsidiaries could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_352"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Requirements of Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. All such insurance shall name the Collateral Agent as mortgagee (in the case of property insurance) or additional insured on behalf of the Secured Parties (in the case of liability insurance) or additional loss payee (in the case of property insurance), as applicable.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Preservation of Corporate Existence, Etc. Preserve and maintain, and cause each of its Restricted Subsidiaries to preserve and maintain, its existence, legal entity structure, legal name, corporate powers (or its equivalent) and material franchises except, in each case (other than with respect to the Borrower as to existence), to the extent that failure to do so could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect, or as otherwise permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Visitation Rights. At any reasonable time and from time to time, and, unless an Event of Default shall have occurred and be continuing, not more than two times during any calendar year and upon reasonable notice, permit any of the Agents or any of the Lenders, or any agents or representatives thereof (provided that only the Administrative Agent on behalf of the Agents and Lenders (or any Agent or Lender solely at such Agent&#8217;s or Lender&#8217;s expense if accompanying the Administrative Agent) may exercise rights under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), to examine and make copies of and abstracts from the records and books of account of, and visit the properties of, the Borrower and any of its Restricted Subsidiaries, and to discuss the affairs, finances and accounts of the Borrower and any of its Restricted Subsidiaries with any of their officers or directors and with their independent certified public accountants (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that representatives of the Borrower shall be entitled to notice of and to participate in any such discussion). Notwithstanding anything to the contrary in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, none of the Borrower or any Restricted Subsidiary will be required to disclose or permit the inspection or discussion of, any document, information or other matter (i) that constitutes non-financial trade secrets or non-financial proprietary information, (ii) in respect of which disclosure to any Agent or Lender (or their respective representatives or contractors) would be in breach of any confidentiality obligations, fiduciary duty or Law or (iii) that is subject to attorney client or similar privilege or constitutes attorney work product&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that in the event that the Borrower does not provide information in reliance on the exclusions in this sentence, it shall use its commercially reasonable efforts to communicate, to the extent permitted, the applicable information in a way that would not violate such restrictions. During the course of the above described visits, inspections and examinations and discussions, representatives of the Agents and the Lenders may encounter individually identifiable healthcare information as defined under the &#8220;Administrative Simplification&#8221; (including privacy and security) regulations promulgated pursuant to HIPAA or other confidential information relating to health care patients (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Confidential</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Healthcare Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Borrower or the Restricted Subsidiary maintaining such Confidential Healthcare Information shall, consistent with HIPAA&#8217;s &#8220;minimum necessary&#8221; provisions, permit such disclosures for their &#8220;healthcare operations&#8221; purposes. Unless otherwise required by the law, the Agents, the Lenders and their respective representatives shall not require or perform any act that would cause the Borrower or any of its Restricted Subsidiaries to violate any laws, regulations or ordinances intended to protect the privacy rights of healthcare patients, including, without limitation, HIPAA.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Keeping of Books. Keep, and cause each of its Restricted Subsidiaries to keep, proper books of record and account, in which full and correct entries in all material respects shall be made of all material financial transactions sufficient to permit the preparation of financial statements based thereon in accordance with GAAP.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Maintenance of Properties, Etc. (i) Maintain and preserve, and cause each of its Restricted Subsidiaries to maintain and preserve, absent events or circumstances leading to a Recovery Event, in all material respects, all of its properties that are material in the conduct of its business in good working order and condition, ordinary wear and tear</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_355"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">excepted, and (ii) maintain, renew and preserve, in all material respects, all of its Intellectual Property that are material in the conduct of its business.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Transactions with Affiliates. Conduct, and cause each of its Restricted Subsidiaries to conduct, all transactions (other than any transaction having a fair market value not in excess of $25,000,000 in a single transaction or series of related transactions) otherwise permitted under the Loan Documents with any of their Affiliates on terms that are fair and reasonable and no less favorable to the Borrower or such Restricted Subsidiary than it would obtain in a comparable arm&#8217;s-length transaction with a Person not an Affiliate (it being understood that the Transactions are deemed to be on such terms) except (a) transactions between or among the Borrower and the Restricted Subsidiaries, (b) any transaction permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (c) notional pooling cash management arrangements in the ordinary course of business and tax sharing arrangements upon customary terms and (d) employment and severance arrangements in the ordinary course of business and transactions pursuant to stock option plans and employee benefit plans and arrangements, and equity issuances, repurchases, redemptions, retirements or other acquisitions or retirements of Capital Stock by the Borrower or any of its Restricted Subsidiaries not prohibited under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_358"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:33.055%"><div style="margin-top:0.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.415%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.055%"></div><div style="display:inline-block;max-width:0.415%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:33.060%"></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.11</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Use of Proceeds. Use the proceeds of the Loans only for purposes set forth in </font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.19</font><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Additional Collateral&#59; Additional Guarantors.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Upon the formation (including without limitation, by Division) or acquisition of any new direct or indirect Domestic Subsidiary that is not an Excluded Subsidiary (or a direct or indirect Domestic Subsidiary ceasing to constitute an Excluded Subsidiary) after the Closing Date promptly, and in any event, within the later of (x) 45 days following the date of such Person becoming a Subsidiary (or ceasing to constitute an Excluded Subsidiary) or (y) 30 Business Days following the end of the Fiscal Quarter in which such Person becomes a Subsidiary that is not an Excluded Subsidiary (or ceases to constitute an Excluded Subsidiary) (or such later date as the Administrative Agent may agree, in its sole discretion) (A) to execute a Joinder Agreement or such comparable documentation to become a Guarantor and a joinder agreement to the applicable Security Agreement, substantially in the form annexed thereto and (B) to take all actions necessary or advisable in the opinion of the Administrative Agent or the Collateral Agent to cause the Lien created by the applicable Security Agreement to be duly perfected to the extent required by such agreement in accordance with all applicable Requirements of Law, including the filing of financing statements in such jurisdictions as may be reasonably requested by the Administrative Agent or the Collateral Agent.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Upon the formation (including without limitation, by Division) or acquisition of any new direct Subsidiary of a Loan Party after the Closing Date promptly, and in any event within the later of (x) 45 days following the date of such Person becoming a Subsidiary or (y) 30 Business Days following the end of the Fiscal Quarter in which such formation or acquisition occurs (or such later date as the Administrative Agent may agree, in its sole discretion), solely to the extent required by the Security Agreement, deliver to the Collateral Agent the certificates, if any, representing all of the Capital Stock of such Subsidiary, together with undated stock powers or other appropriate instruments of transfer executed and delivered in blank by a duly authorized officer of the holder(s) of such Capital Stock, and all intercompany notes owing from such Subsidiary to any Loan Party that together with undated instruments of transfer executed and delivered in blank by a duly authorized officer of such Loan Party&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the foregoing requirements shall not apply to the Capital Stock of any Immaterial Subsidiary and (ii) the Capital Stock of Controlled Foreign Subsidiaries required to be delivered shall be limited to (A) Voting Interests of any such Subsidiary representing 65% of the total voting power of all outstanding voting interests of such Subsidiary and (B) 100% of the Capital Stock not constituting</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_361"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Voting Interests of any such Subsidiary, except that any such Capital Stock constituting &#8220;stock entitled to vote&#8221; within the meaning of Treasury Regulation Section 1.956-2(c)(2) shall be treated as Voting Interests for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.12(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Security Interests&#59; Further Assurances.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:5pt;padding-right:9.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">Promptly, upon the reasonable request of the Administrative Agent, the Collateral Agent or any Lender, at the Borrower&#8217;s expense, execute, acknowledge and deliver, or cause the execution, acknowledgment and delivery of, and thereafter register, file or record, or cause to be registered, filed or recorded, in an appropriate governmental office, any document or instrument supplemental to or confirmatory of the Security Documents or otherwise deemed by the Administrative Agent or the Collateral Agent reasonably necessary or desirable for the continued validity, perfection and priority of the Liens on the Collateral covered thereby subject to no other Liens except as permitted hereunder or by the applicable Security Document, or obtain any consents or waivers as may be reasonably deemed necessary or appropriate in connection therewith.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:19pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Deliver or cause to be delivered to the Administrative Agent and the Collateral Agent from time to time such other documentation, consents, authorizations, approvals and orders in form and substance reasonably satisfactory to the Administrative Agent and the Collateral Agent as the Administrative Agent and the Collateral Agent shall reasonably deem necessary to perfect or maintain the Liens on the Collateral pursuant to the Security Documents.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">Upon the exercise by the Administrative Agent, the Collateral Agent or any Lender of any power, right, privilege or remedy pursuant to any Loan Document which requires any consent, approval, registration, qualification or authorization of any Governmental Authority execute and deliver all applications, certifications, instruments and other documents and papers that the Administrative Agent, the Collateral Agent or such Lender may reasonably require.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Ratings. Use commercially reasonable efforts to cause (x) S&#38;P and Moody&#8217;s to continue to issue ratings for the Facilities, (y) Moody&#8217;s to continue to issue a corporate family rating (or the equivalent thereof) and (z) S&#38;P to continue to issue a corporate credit rating (or the equivalent thereof) (it being understood, in each case, that such obligation shall not require the Borrower to maintain a specific rating).</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Designation of Subsidiaries. The Borrower may at any time designate any Restricted Subsidiary as an Unrestricted Subsidiary or any Unrestricted Subsidiary as a Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (a) immediately before and after such designation, no Event of Default shall have occurred and be continuing, (b) any Subsidiary of an Unrestricted Subsidiary will automatically be deemed to be an Unrestricted Subsidiary, (c) immediately after giving effect to such designation, the Borrower and the Restricted Subsidiaries shall be in compliance, on a Pro Forma Basis, with the covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (d) the Borrower shall not be designated as an Unrestricted Subsidiary, (e) immediately after giving effect to such designation, the Subsidiary is not party to any transaction or arrangement with the Borrower or any Restricted Subsidiary that would not be permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (f) each of (1) the Subsidiary to be so designated and (2) its Subsidiaries has not at the time of designation, and does not thereafter, create, incur, issue, assume, guarantee, or otherwise become directly or indirectly liable with respect to any Debt pursuant to which the lender has recourse to any of the assets of the Borrower or any Restricted Subsidiary except for Debt that could otherwise be incurred by the Borrower or such Restricted Subsidiary hereunder and, if such Debt is secured, the Liens securing such Debt are permitted to be incurred by the Borrower or such Restricted Subsidiary hereunder (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such Debt shall be deemed incurred hereunder by the Borrower or such Restricted Subsidiary, as the case may be) and (g) no Subsidiary may be designated as an Unrestricted Subsidiary if</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_364"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">it is a &#8220;Restricted Subsidiary&#8221; for the purpose of the 2022 Senior Notes, 2024 Senior Notes, 2025 Senior notes, any Permitted Other Debt or any Credit Agreement Refinancing Debt. The designation of any Subsidiary as an Unrestricted Subsidiary shall constitute an Investment by the applicable Restricted Companies therein at the date of designation in an amount equal to the net book value (or, in the case of any guarantee or similar Investment, the amount) of the Restricted Companies&#8217; Investments therein (and such designation shall only be permitted to the extent such Investment is permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). If any Person becomes a Restricted Subsidiary on any date after the Closing Date (including by redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary), the Debt, Liens and Investments of such Person outstanding on such date will be deemed to have been incurred by such Person on such date for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, respectively, but will not be considered the sale or issuance of Capital Stock for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Upon a re-designation of such Unrestricted Subsidiary as a Restricted Subsidiary, the Borrower shall be deemed to continue to have a permanent Investment in the re-designated Restricted Subsidiary in an amount (if positive) equal to (i) the Borrower&#8217;s &#8220;Investment&#8221; in such Person at the time of such re-designation, less (ii) the portion of the fair market value of the net assets of such Person attributable to the Borrower&#8217;s equity therein at the time of such re-designation.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Post-Closing Actions. To the extent not satisfied on the Closing Date and unless such requirement is waived or extended, in the reasonable discretion of the Administrative Agent, the Borrower shall, and shall cause each of its Restricted Subsidiaries to complete each of the actions described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by no later than the date set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 6.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to such action.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:177.85pt;padding-right:177.85pt;text-align:center;text-indent:35.15pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 7</font></div><div style="padding-left:89.62pt;padding-right:89.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NEGATIVE COVENANTS</font></div><div style="padding-right:179.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.55pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Loan Party covenants and agrees with each Lender that, so long as this Agreement shall remain in effect and until the Commitments have been terminated and the principal of and interest on each Loan, all fees and all other expenses or amounts payable under any Loan Document and all other Obligations (excluding Contingent Obligations as to which no claim has been asserted) have been paid in full and all Letters of Credit have been canceled or have expired and all amounts drawn thereunder have been reimbursed in full or have been cash collateralized at 103% of the face amount thereof, unless the Required Lenders shall otherwise consent in writing, no Loan Party will, nor will they cause or permit any Restricted Subsidiaries to&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Liens, Etc. Create, incur, assume or suffer to exist, or permit any of its Restricted Subsidiaries to create, incur, assume or suffer to exist, any Lien on or with respect to any of its properties of any character whether now owned or hereafter acquired or assign, or permit any of its Restricted Subsidiaries to assign, any accounts or other right to receive income, except&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Liens created under the Loan Documents&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Permitted Liens&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Liens existing on the Closing Date and described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 7.1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens upon or in an asset acquired or held by the Borrower or any of its Restricted Subsidiaries to secure the purchase price of such property or equipment or to secure Debt incurred solely for the purpose of financing the acquisition, construction or improvement of any such asset to be subject to such Liens, or Liens existing on any such property or equipment at</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_367"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:10.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the time of acquisition (other than any such Liens created in contemplation of such acquisition that do not secure the purchase price), or extensions, renewals or replacements of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that (i) such Liens shall be created not more than 180 days after the date of acquisition or completion of construction or improvement and (ii) no such Lien shall extend to or cover any asset other than the asset being acquired, constructed or improved and any attachments thereto and proceeds thereof, and no such extension, renewal or replacement shall extend to or cover any asset not theretofore subject to the Lien being extended, renewed or replaced&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of the Debt secured by Liens permitted by this clause (d) shall not exceed the amount permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> at any time outstanding&#59;</font></div><div><font><br></font></div><div style="padding-left:41pt;padding-right:9.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">Liens arising in connection with Financing Leases permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such Lien shall extend to or cover any assets other than the assets subject to such Financing Leases&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:19.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens arising in connection with Debt permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such Lien shall extend to or cover any assets other than the assets of the relevant borrowing entity&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the replacement, extension or renewal of any Lien permitted by clause (c) above upon or in the same property theretofore subject thereto or the replacement, extension or renewal (without increase in the amount (except by an amount equal to accrued and unpaid interest and premium thereon plus fees, original issue discount and expenses incurred in connection with such replacement, extension or renewal) or change in any direct or contingent obligor) of the Debt secured thereby&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:22.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens on assets of the Borrower or any of its Restricted Subsidiaries arising in connection with Sale and Leaseback Transactions permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:43.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">Liens on assets that are the subject of, or are customarily subject to Liens relating to, Permitted Receivables Financings&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">Liens existing on property at the time of its acquisition or existing on the property of any Person at the time such Person becomes a Restricted Subsidiary of the Borrower, in each case after the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) such Lien was not created in contemplation of such acquisition or such Person becoming a Restricted Subsidiary of the Borrower, (B) such Lien does not extend to or cover any other assets or property (other than the proceeds or products thereof and other than after-acquired property to the extent included in the grant of such Lien), and (C) the Debt secured thereby is permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:31.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">customary Liens and setoff rights securing obligations in respect of notional pooling cash management arrangements in the ordinary course of business&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:16.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">other Liens not otherwise permitted by the foregoing clauses of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> securing an aggregate principal amount at any time outstanding not to exceed $100,000,000&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:8.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt">Liens on the Collateral to secure Debt permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a (i) a First Lien Intercreditor Agreement if such Debt is secured by the Collateral on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis (but without regard to the control of remedies) with the Obligations, or (ii) a Junior Lien Intercreditor Agreement if such Debt is secured by the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_370"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Collateral on a second priority (or other junior priority) basis to the liens securing the Obligations&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens on the Collateral securing obligations in respect of Permitted First Priority Refinancing Debt or Permitted Second Priority Refinancing Debt and any Permitted Refinancing of any of the foregoing&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a (i) a First Lien Intercreditor Agreement if such Debt is secured by the Collateral on a</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> pari passu</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis (but without regard to the control of remedies) with the Obligations, or (ii) a Junior Lien Intercreditor Agreement if such Debt is secured by the Collateral on a second priority (or other junior priority) basis to the liens securing the Obligations&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens on the Collateral to secure Debt permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">pari passu </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">basis (but without regard to the control of remedies) with the Obligations&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Senior Representative acting on behalf of the holders of such Debt shall have become party to or otherwise subject to the provisions of a First Lien Intercreditor Agreement&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:14.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens on Collateral to secure Debt permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Debt constitutes a Secured Obligation&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Liens on NMTC Property securing the NMTC Indebtedness the proceeds of which are (or will be) used to acquire, renovate or improve such NMTC Property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such Liens are on property that is (or is required to be) Collateral then such Liens are subordinated to the Liens securing the Obligations pursuant to an intercreditor agreement in form and substance reasonably satisfactory to the Administrative Agent&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">Liens on the Capital Stock of an Unrestricted Subsidiary or Foreign Subsidiary (other than any Foreign Subsidiary whose Capital Stock constitute Collateral) to secure Debt of such Unrestricted Subsidiary or Foreign Subsidiary, as applicable, to the extent such pledge constitutes an Investment permitted under this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) a Lien securing an item of Debt need not be permitted solely by reference to one category of permitted Liens (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> but may be permitted in part under any combination thereof and (B) in the event that a Lien securing an item of Debt (or any portion thereof) meets the criteria of one or more of the categories of permitted Liens (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower may, in its sole discretion, classify or divide such Lien securing such item of Debt (or any portion thereof) in any manner that complies with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and will be entitled to only include the amount and type of such Lien or such item of Debt secured by such Lien (or any portion thereof) in one of the above clauses and such Lien securing such item of Debt (or portion thereof) will be treated as being incurred or existing pursuant to only such clause or clauses (or any portion thereof).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Debt. Create, incur, assume or suffer to exist, or permit any of its Restricted Subsidiaries to create, incur, assume or suffer to exist, any Debt, except&#58;</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Debt under the Loan Documents&#59;</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:14.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">(i) the 2022 Senior Notes and the 2022 Senior Notes Guarantees and, in each case, any Permitted Refinancing thereof&#59; provide that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $1,250,000,000, (ii) the 2024 Senior Notes and the 2024 Senior Notes Guarantees and, in each</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_373"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">case, any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(b)(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $1,750,000,000, (iii) the 2025 Senior Notes and the 2025 Senior Notes Guarantees and, and, in each case, any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed $1,500,000,000, and (iv) Debt existing on the Closing Date and described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 7.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto and any Permitted Refinancing thereof&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">Debt of the Borrower in respect of Swap Agreements (A) existing on the Closing Date and described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 7.2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto or (B) entered into from time to time after the Closing Date with counterparties that are Lenders at the time such Swap Agreement is entered into (or Affiliates of such Lender at such time)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in all cases under this clause (c), all such Swap Agreements shall be entered into for business, commercial or financial purposes in the ordinary course of business (including, without limitation, with respect to the term and purpose thereof)&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt of (A) the Borrower owing to any Restricted Subsidiary, and (B) any of the Restricted Subsidiaries owing to the Borrower or any other Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that with respect to any loan or advance by a Loan Party, (i) any such Debt shall be evidenced by an Intercompany Note and pledged by such Loan Party as Collateral pursuant to the Security Documents and (ii) if such loan or advance is to a Non-Guarantor Subsidiary, such loan or advance is permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:11.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">Debt incurred and secured by Liens expressly permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (or with respect to NMTC Indebtedness) and any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, when aggregated with the principal amount of all Debt outstanding at such time under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed the greater of $500,000,000 or 10.0% of the Consolidated Tangible Assets of the Borrower and its Restricted Subsidiaries&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:14.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">Attributable Indebtedness (including Financing Leases) incurred and any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate principal amount of all such Debt at any one time outstanding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, when aggregated with the principal amount of all Debt outstanding at such time under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall not exceed the greater of $500,000,000 or 10.0% of the Consolidated Tangible Assets of the Borrower and its Restricted Subsidiaries&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:11.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Contingent Obligations of (A) the Borrower guaranteeing any obligations of any Restricted Subsidiary and (B) any Restricted Subsidiary of the Borrower guaranteeing any obligations of the Borrower or any other Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that each such primary obligation is not otherwise prohibited under the terms of the Loan Documents&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that any guaranty of obligations of any Non-Guarantor Subsidiary by a Loan Party is permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:50.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">(i) Debt in an aggregate amount not to exceed $250,000,000 at any time outstanding and (ii) any Permitted Refinancing thereof&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:41.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business&#59;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_376"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:11.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">Debt comprised of indemnities given by the Borrower or any of its Restricted Subsidiaries, or guarantees or other similar undertakings by the Borrower or any of its Restricted Subsidiaries entered into in lieu thereof, in favor of the purchaser of property and assets of the Borrower and its Restricted Subsidiaries being sold, leased, transferred or otherwise disposed of in accordance with this Agreement and covering liabilities incurred by the Borrower or its applicable Restricted Subsidiary in respect of such property and assets prior to the date of consummation of the sale, lease, transfer or other disposition thereof, which indemnities, guarantees or undertakings are required under the terms of the documentation for such sale, lease, transfer or other disposition&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt comprised of liabilities or other obligations assumed or retained by the Borrower or any of its Restricted Subsidiaries from Restricted Subsidiaries of the Borrower that are, or all or substantially all of the property and assets of which are, sold, leased, transferred or otherwise disposed of pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such liabilities or other obligations were not created or incurred in contemplation of the related sale, lease, transfer or other disposition&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:19.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">secured and unsecured Debt of Non-Guarantor Subsidiaries (including Foreign Subsidiaries) in an aggregate amount not to exceed $1,000,000,000 at any time outstanding&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:14.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt">Debt comprised of guarantees given by the Borrower or any of its Restricted Subsidiaries in respect of any Special Purpose Licensed Entity which obligations, when aggregated with the aggregate amount of all Investments made under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, shall not exceed $150,000,000 at any time outstanding&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt under Cash Management Agreements and similar arrangements in each case in connection with cash management, financial services and deposit accounts in the ordinary course of business or Debt under notional pooling cash management arrangements or insurance premium financings in the ordinary course of business&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Debt in connection with Permitted Receivables Financings&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt of any Person that becomes a Restricted Subsidiary of the Borrower (or of any Person not previously a Restricted Subsidiary of the Borrower that is merged or consolidated with or into the Borrower or one of its Restricted Subsidiaries) after the Closing Date as a result of an Investment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or Debt of any Person that is assumed by the Borrower or any of its Restricted Subsidiaries in connection with an acquisition of assets by the Borrower or such Restricted Subsidiary in an Investment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) such Debt is not incurred in contemplation of such Investment and (B) the Borrower and the Restricted Subsidiaries will be in compliance on a Pro Forma Basis with the covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:16.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt incurred in the ordinary course of business with respect to performance bonds, surety bonds, completion bonds, guaranty bonds, appeal bonds or customs bonds, letters of credit, and other obligations of a similar nature required in the ordinary course of business or in connection with the enforcement of rights or claims of the Borrower or any of its Restricted Subsidiaries or in connection with judgments that do not result in a Default or to secure obligations under workers&#8217; compensation laws, unemployment insurance or similar social security legislation (other than in respect of employee benefit plans subject to ERISA), public, regulatory or statutory obligations or payment of customs duties in connection with the importation of goods.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_379"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">Permitted Other Debt and any Permitted Refinancing thereof&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:16.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.4pt">Debt (other than Debt for borrowed money) incurred by the Borrower or any of its Restricted Subsidiaries supported by any Specified Letter of Credit and any Permitted Refinancing thereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that on a Pro Forma Basis, on the date such Specified Letter of Credit is issued, after giving effect to any such incurrence (and assuming that the maximum amount of any such Specified Letters of Credit are fully drawn), the Senior Secured Leverage Ratio is no more than 3.50&#58;1.00&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Credit Agreement Refinancing Debt&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt incurred by the Borrower or any of its Restricted Subsidiaries in connection with any Investment permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, constituting indemnification obligations or obligations in respect of purchase price (including earnouts) or other similar adjustments&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:31.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Debt incurred by a Restricted Company under a letter of credit facility in an aggregate amount not to exceed $250,000,000 at any time outstanding&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:24.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.74pt">NMTC Indebtedness, so long as the Borrower and the Restricted Subsidiaries will be in compliance on a Pro Forma Basis with the covenant set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">all premiums (if any), interest (including post-petition interest), fees, expenses, charges and additional or contingent interest on obligations described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> above.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) Debt need not be permitted solely by reference to one category of permitted Debt (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> but may be permitted in part under any relevant combination thereof (and subject to compliance, where relevant, with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), (B) in the event that an item of Debt (or any portion thereof) meets the criteria of one or more of the categories of permitted Debt (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(w)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower may, in its sole discretion, classify or divide such item of Debt (or any portion thereof) in any manner that complies with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and will be entitled to only include the amount and type of such item of Debt (or any portion thereof) in one of the above clauses (or any portion thereof) and such item of Debt (or any portion thereof) shall be treated as having been incurred or existing pursuant to only such clause or clauses (or any portion thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that all Debt outstanding under this Agreement shall at all times be deemed to have been incurred pursuant to clause (a) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Change in Nature of Business. Engage, or permit any of its Restricted Subsidiaries to engage, to any material extent in any business other than healthcare services and any businesses incidental, complementary, ancillary or related thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a Special Purpose Receivables Subsidiary may engage in any Permitted Receivables Financing.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Mergers, Etc. Merge into or consolidate with any Person or permit any Person to merge into it, or permit any of its Restricted Subsidiaries to do so, except that&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:43.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any of the Restricted Subsidiaries may merge into or consolidate with the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower is the surviving corporation&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">any Restricted Subsidiary of the Borrower may merge into or consolidate with any other Restricted Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the case of any such merger or</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_382"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">consolidation involving a Wholly Owned Subsidiary, the Person formed by or surviving such merger or consolidation shall be a Wholly Owned Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, in the case of any such merger or consolidation to which a Guarantor is a party, the Person formed by such merger or consolidation shall be a Guarantor&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">in connection with any purchase or other acquisition of Capital Stock of, or property and assets of, any Person permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower may permit any other Person to merge into or consolidate with it (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the Borrower is the surviving entity or (ii) the surviving entity (x) is a Domestic Person and (y) simultaneously with such merger or consolidation agrees to be bound by the terms hereof and of the Loan Documents and assume the Borrower&#8217;s obligations hereunder and thereunder pursuant to an agreement or instrument satisfactory in form and substance to the Administrative Agent (and shall thereafter be the Borrower hereunder), and any of the Restricted Subsidiaries of the Borrower may merge into or consolidate with any other Person or permit any other Person to merge into or consolidate with it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Person with which such Restricted Subsidiary is merging or consolidating (i) shall be engaged in a business permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) shall take all actions required under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (iii) shall be a Guarantor if the merging Restricted Subsidiary was a Guarantor prior to such transaction&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:21.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">in connection with any sale, transfer or other disposition of all or substantially all of the Capital Stock of, or the property and assets of, any Person permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.5(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, any of the Restricted Subsidiaries of the Borrower may merge into or consolidate with any other Person or permit any other Person to merge into or consolidate with it&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that in each case, immediately after giving effect thereto, no event shall occur and be continuing that constitutes a Default.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Sales, Etc., of Assets. Sell, lease, transfer or otherwise dispose of, or permit any of its Restricted Subsidiaries to sell (including sales and issuances of Capital Stock of any Restricted Subsidiary (other than sales and issuances that do not decrease the percentage ownership of the Borrower and its Restricted Subsidiaries in each class of Capital Stock of such Restricted Subsidiary)), lease, transfer or otherwise dispose of, any assets, or grant any option or other right to purchase, lease or otherwise acquire any assets, except (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the issuance and sale of stock by the Borrower shall not be subject to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#58;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the Borrower and its Restricted Subsidiaries may sell or dispose of inventory or immaterial assets in the ordinary course of business&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">(A) the Borrower may sell, lease, transfer or otherwise dispose of any of its property or assets to any of the Restricted Subsidiaries, and (B) any of the Restricted Subsidiaries may sell, lease, transfer or otherwise dispose of any of its property or assets to the Borrower or any of the other Restricted Subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in each case (other than in connection with Intercompany Receivables), (x) if the transferor in such transaction is a Domestic Subsidiary and the transferee in such transaction is a Domestic Subsidiary, on a pro forma basis, the Borrower and its Restricted Subsidiaries would be in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (y) if the transferee in such transaction is a Foreign Subsidiary (or any other Non-Guarantor Subsidiary), such transaction is permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any Restricted Subsidiary of the Borrower that is no longer actively engaged in any business or activities and does not have property and assets with an aggregate book value in excess of $1,000,000 may be wound up, liquidated or dissolved so long as such winding up,</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_385"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">liquidation or dissolution is determined in good faith by management of the Borrower to be in the best interests of the Borrower and its Restricted Subsidiaries&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may sell, lease, transfer or otherwise dispose of any obsolete, damaged or worn out or surplus equipment or any other assets or property that is otherwise no longer useful in the conduct of their businesses&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:11.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the Borrower and its Restricted Subsidiaries may lease, sublease, license or sublicense Real Property or other assets to the extent required for their respective businesses and operations in the ordinary course so long as such lease, sublease, license or sublicense is not otherwise prohibited under the terms of the Loan Documents&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower and its Restricted Subsidiaries may sell, lease, transfer or otherwise dispose of property and assets not otherwise permitted to be sold, leased, transferred or disposed of pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> so long as the aggregate book value of all of the property and assets of the Borrower and its Restricted Subsidiaries sold, leased, transferred or otherwise disposed of pursuant to this clause (f) does not exceed $1,000,000,000 in the aggregate since the Closing Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:77pt;padding-right:19.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.74pt">the gross proceeds received from any such sale, lease, transfer or other disposition shall be at least equal to the fair market value of the property and assets so sold, leased, transferred or otherwise disposed of, determined at the time of such sale, lease, transfer or other disposition&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:76.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:16.85pt">with respect to any disposition under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that exceeds $25,000,000 (in the good faith determination of the Borrower) at least 75% of the value of the aggregate consideration received from any such sale, lease, transfer or other disposition shall be in cash or Cash Equivalents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that (i) up to one-third of such 75% may consist of notes or other obligations received by the Borrower or such Restricted Subsidiary that are due and payable or otherwise converted by the Borrower or such Restricted Subsidiary into cash within 365 days of receipt, which cash (to the extent received) shall constitute Net Cash Proceeds attributable to the original transaction&#59; (ii) any unsubordinated Debt of the Borrower or any of its Restricted Subsidiaries (as shown on the Borrower&#8217;s or such Restricted Subsidiary&#8217;s most recent balance sheet) that is assumed by the transferee of any such assets shall constitute cash for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, so long as the Borrower and all of its Restricted Subsidiaries are fully and unconditionally released therefrom&#59; and (iii) any Designated Non-Cash Consideration received by the Borrower or any of its Restricted Subsidiaries, having an aggregate fair market value, taken together with all other Designated Non-Cash Consideration received pursuant to this clause (B) after the Closing Date not to exceed $100,000,000 at the time of receipt of such Designated Non-Cash Consideration shall be deemed to be cash for purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> (it being understood that the fair market value of each item of Designated Non-Cash Consideration is measured at the time of receipt without giving effect to subsequent changes in value)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that if such Designated Non-Cash Consideration is sold for, or otherwise converted into, cash, such cash shall constitute Net Cash Proceeds attributable to the original transaction&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:77pt;padding-right:10.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.35pt">immediately before and immediately after giving pro forma effect to any such sale, lease, transfer or other disposition, no Event of Default shall have occurred and be continuing&#59; and</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_388"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:77pt;padding-right:21.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.74pt">if and to the extent that the Net Cash Proceeds of any transaction effected pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not have been reinvested (pursuant to a Reinvestment Notice), such Net Cash Proceeds shall be applied to prepay Loans to the extent, and in accordance with, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:11.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may exchange assets and properties with another Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that&#58;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt;padding-right:42.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.74pt">the assets or properties received by the Borrower or its Restricted Subsidiaries shall be used in a business permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as conducted immediately prior to such transaction, or in an incidental or related business&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:77pt;padding-right:26.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.35pt">the total consideration received by the Borrower or such Restricted Subsidiary for such assets or property shall have been determined by the Borrower or such Restricted Subsidiary to be not less than the fair market value of the assets or property exchanged&#59; and</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:77pt;padding-right:10.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.35pt">immediately before and immediately after giving pro forma effect to any such exchange, no Default shall have occurred and be continuing.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may enter into Sale and Leaseback Transactions (i) with respect to the Denver Headquarters, Denver Headquarters II or Federal Way Property and (ii) with respect to any other property&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the aggregate value of property sold or transferred under this subclause (ii) shall not exceed $225,000,000 since the Closing Date&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">the Borrower and its Restricted Subsidiaries may purchase, sell or otherwise transfer (including by capital contribution) Receivables Assets pursuant to Permitted Receivables Financings&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">the Borrower and its Restricted Subsidiaries may sell, lease, transfer or otherwise dispose of assets or property (i) in anticipation of any Investment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.6(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (including as a result of discussion with antitrust regulators in connection with such Investment) or (ii) as reasonably expected to be required pursuant to any consent decree or similar order or agreement, which decree, order or agreement is issued or entered into prior to the consummation of such Investment and in connection therewith by the Antitrust Division of the U.S. Department of Justice, the Bureau of Competition of the U.S. Federal Trade Commission and&#47;or any similar state or foreign regulatory agency or body&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:9.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">within 545 days of the acquisition by the Borrower or any Restricted Subsidiary of any Real Property after the Closing Date the Borrower or such Restricted Subsidiary may sell or otherwise transfer such Real Property in connection with a Sale and Leaseback Transaction so long as the Borrower shall be in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> after giving effect to such Sale and Leaseback Transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Net Cash Proceeds from such transaction are applied in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (other than any Net Cash Proceeds from a transaction permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:16.05pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">the Borrower and its Restricted Subsidiaries may issue additional Capital Stock to directors, management or employees and physicians under contract with the Borrower or any of its Restricted Subsidiaries in an amount not in excess of $50,000,000 in the aggregate in any twelve month period (with any unused amounts in any such twelve month period being carried</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_391"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:10.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">over to the immediately succeeding twelve month period), and in connection with option plans of Restricted Subsidiaries pursuant to which options are granted at a strike price of fair market value (as determined in good faith of the Borrower or the applicable Restricted Subsidiary) together with any subsequent exercise of such options&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:38.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt">the Borrower and its Restricted Subsidiaries may enter into any transfer or disposition of property or assets constituting an Investment pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may trade, sell or dispose of Cash Equivalents&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may transfer or dispose of Investments and&#47;or issue Capital Stock to the extent required by, or made pursuant to, customary buy&#47;sell arrangements between the parties to any joint venture or shareholders of any non-Wholly Owned Subsidiaries set forth in the shareholder agreements, joint venture agreements, organization documents or binding agreements relating to such joint venture or non-Wholly-Owned Subsidiary&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may transfer or dispose of accounts receivable in the ordinary course of business in connection with the collection or compromise thereof&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the unwinding of any Swap Contract pursuant to its terms&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:13.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower and its Restricted Subsidiaries may surrender or waive contractual rights and leases and settle or waive contractual or litigation claims in the ordinary course of business&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.4pt">any sale of Capital Stock in, or Debt or other securities of, an Unrestricted Subsidiary (other than Unrestricted Subsidiaries the primary assets of which are cash and&#47;or Cash Equivalents) or a Restricted Subsidiary which owns an Unrestricted Subsidiary (so long as such Restricted Subsidiary owns no assets other than the Capital Stock of such an Unrestricted Subsidiary)&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:19.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">the Borrower and its Restricted Subsidiaries may sell or transfer property to an Unrestricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such transaction is permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Investments in Other Persons. Make or hold, or permit any of its Restricted</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Subsidiaries to make or hold, any Investment in any Person, except&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Investments by the Borrower and its Restricted Subsidiaries in Cash Equivalents&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Investments existing on the Closing Date and described on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereto&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:23.8pt">Investments by the Borrower in Swap Agreements permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section</font></div><div style="padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">7.2(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41pt;padding-right:23.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Investments in accounts receivable in the ordinary course of business or notes received in transactions permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.5(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the purchase or other acquisition of (1) Capital Stock of any Person that, upon the consummation thereof, will be more than 50% owned by the Borrower or one or more of its</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_394"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Wholly Owned Subsidiaries (including, without limitation, as a result of a merger or consolidation) or (2) all or substantially all the property and assets of a Person or consisting of a line of business or business unit of a Person&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, with respect to each purchase or other acquisition made pursuant to this clause (e)&#58;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:77pt;padding-right:21.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.74pt">the lines of business of the Person to be (or the property and assets of which are to be) so purchased or otherwise acquired shall be permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:77pt;padding-right:10.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.35pt">(1) immediately before and immediately after giving </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro forma</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> effect to any such purchase or other acquisition, no Default shall have occurred and be continuing and (2) immediately after giving effect to such purchase or other acquisition, the Borrower and its Restricted Subsidiaries shall be in compliance on a Pro Forma Basis with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt;padding-right:11.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.35pt">the aggregate amount of consideration paid or provided by the Borrower and its Restricted Subsidiaries after the Closing Date pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (under clause (i) below) for the purchase or acquisition for Persons that will be Foreign Subsidiaries, when taken together with any Investments made in Foreign Subsidiaries pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(h)(ii)(y)(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall not exceed (i) $2,000,000,000 or (ii) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), consideration in an unlimited amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the amount of all such cash payments exceeds the limitation set forth in clause (i) of this clause (C) during any period during which the Leverage Ratio test in clause (ii) of this clause (C) is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:149pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt;text-decoration:underline">Sections 6.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are complied with&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:14.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">Investments by the Borrower or any Restricted Subsidiary in 50% or less of the Capital Stock of another Person (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minority Investment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the aggregate outstanding amount of Minority Investments made by the Borrower and any Restricted Subsidiary shall not exceed $350,000,000 at any one time outstanding, (ii) the Borrower or any Restricted Subsidiary shall control or act as the managing general partner of such Person if such Person is a partnership and if the Borrower or any Restricted Subsidiary is the largest holder of Capital Stock of such Person, and (iii) immediately before and after giving effect thereto, no Default shall exist&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">loans or advances to officers, directors, managers, partners and employees of the Borrower or its Restricted Subsidiaries (i) in connection with such Person&#8217;s payment for Capital Stock of the Borrower or representing payment of the exercise price of options to purchase Capital Stock of the Borrower, (ii) for reasonable and customary business-related travel, entertainment, relocation and analogous ordinary business purposes, and (iii) for purposes not described in the foregoing </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">clauses (i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in an aggregate amount outstanding at the time made not to exceed $30,000,000&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:19.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Investments by (i) any Restricted Subsidiary of the Borrower in the Borrower and (ii) the Borrower or any of its Restricted Subsidiaries in any Restricted Subsidiary of the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (x) no Investment in any Non-Guarantor Domestic Subsidiary shall be made unless, after giving pro forma effect thereto, the Borrower and its Restricted Subsidiaries shall be in compliance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (y) no Investment in any Foreign Subsidiary shall</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_397"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">be made unless the aggregate amount of Investments by the Borrower and its Restricted Subsidiaries in Foreign Subsidiaries after the Closing Date pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(h)(ii)(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (under clause (A) below), when taken together with any Investments made in Foreign Subsidiaries pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(e)(C)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not exceed (A) $2,000,000,000 or (B) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (as of the date of such Investment (or, with respect to Investments in existence on the Closing Date, as of the Closing Date)), both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), an unlimited amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the amount of all such cash payments exceeds the limitation set forth in clause (x) of this clause (ii) during any period during which the Leverage Ratio test in clause (y)(B) of this clause (ii) is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">Investments of the Borrower or any of its Restricted Subsidiaries in any Special Purpose Licensed Entity which, when aggregated with the aggregate amount of all obligations guaranteed under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall not exceed $150,000,000 at any time&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">Investments arising as a result of Permitted Receivables Financings&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:8.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">Investments by the Borrower or any of its Restricted Subsidiaries (i) in an aggregate amount outstanding not to exceed the sum of (x) $250,000,000 plus (y) $750,000,000 minus the aggregate amount of purchases, redemptions, acquisitions, dividends and distributions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and payments, prepayments, redemptions or acquisitions of Debt pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.9(a)(ii)(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> since the Closing Date, (ii) in an aggregate amount not to exceed the Available Amount on the date of such Investment or (iii) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (as of the date of such Investment (or, with respect to Investments in existence on the Closing Date, as of the Closing Date)), both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), in an unlimited amount&#59; provided that if the amount of all such Investments exceeds the limitation set forth in clauses (i) and (ii) of this Section during any period during which the Leverage Ratio test in clause (iii) of this Section is met, such excess Investments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:28.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">guarantees by the Borrower of any operating lease (other than any Financing Lease Obligation) of any joint venture entered into in the ordinary course of business&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt">Investments by the Borrower or any Restricted Subsidiary in Unrestricted Subsidiaries after the Closing Date in an aggregate amount for all such Investments (less an amount equal to the book value of all Unrestricted Subsidiaries that, after the Closing Date, are redesignated by the Borrower to be Restricted Subsidiaries, calculated as of the date of such redesignation) not to exceed for all Unrestricted Subsidiaries, at the time such Investment is made and after giving effect to such Investment, shall not exceed (A) $250,000,000 or (B) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (as of the date of such Investment (or, with respect to Investments in existence on the Closing Date, as of the Closing Date)), both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), an unlimited amount&#59; and</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">(i) Investments by the Borrower or any Restricted Domestic Subsidiary in an NMTC Subsidiary in the form of NMTC Indebtedness and any related capital contribution and</font></div><div style="padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:114%">(ii) NMTC Investments by an NMTC Subsidiary in an aggregate amount not to exceed the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_400"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">portion of the related NMTC Indebtedness and any related capital contribution received by such NMTC Subsidiary.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (A) an Investment need not be permitted solely by reference to one category of permitted Investments (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> but may be permitted in part under any relevant combination thereof and (B) in the event that an Investment (or any portion thereof) meets the criteria of one or more of the categories of permitted Investments (or any portion thereof) described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.6(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Borrower may, in its sole discretion, classify or divide such Investment (or any portion thereof) in any manner that complies with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and will be entitled to only include the amount and type of such Investment (or any portion thereof) in one or more (as relevant) of the above clauses (or any portion thereof) and such Investment (or any portion thereof) shall be treated as having been made or existing pursuant to only such clause or clauses (or any portion thereof)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that all Investments described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed outstanding under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Restricted Payments. Declare or pay any dividends, purchase, redeem, retire, defease or otherwise acquire for value any of its Capital Stock now or hereafter outstanding, return any capital to its stockholders, partners or members (or the equivalent Persons thereof) as such, make any distribution of assets, Capital Stock, obligations or securities to its stockholders, partners or members (or the equivalent Persons thereof) as such, or permit any of its Restricted Subsidiaries to do any of the foregoing, or permit any of its Restricted Subsidiaries to purchase, redeem, retire, defease or otherwise acquire for value any Capital Stock of the Borrower (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), except that, so long as no Default shall have occurred and be continuing at the time of any action described below or would result therefrom&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the Borrower may (A) declare and pay dividends and distributions payable in its common Capital Stock, (B) except to the extent the Net Cash Proceeds thereof are required to be applied to the prepayment of the Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, purchase, redeem, retire, defease or otherwise acquire Capital Stock with the proceeds received contemporaneously from the issue of new Capital Stock with equal or inferior voting powers, designations, preferences and rights, and (C) repurchase its Capital Stock owned by directors, management or employees and physicians under contract with the Borrower or any of its Restricted Subsidiaries in an amount not in excess of $25,000,000 in the aggregate in any twelve month period&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">any Restricted Subsidiaries of the Borrower that are Wholly Owned Subsidiaries may make Restricted Payments to the Borrower or to other Restricted Subsidiaries of the Borrower&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:18.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any of the Restricted Subsidiaries of the Borrower that are not Wholly Owned Subsidiaries may make Restricted Payments so long as the Borrower and each of the Restricted Subsidiaries that own any of the Capital Stock thereof receive at least their respective proportionate shares of any such dividend or distribution (based upon their relative holdings of the Capital Stock thereof and taking into account the relative preferences, if any, of the various classes of the Capital Stock thereof)&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:13.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">so long as no Default is continuing or will be continuing after such transaction, the Borrower may (A) purchase, redeem or otherwise acquire for value any of its Capital Stock or (B) declare and pay dividends and distributions payable in either (i) cash (in the aggregate for both clauses (A) and (B)), when taken together with the aggregate amount of payments, prepayments, redemptions or acquisitions of Debt pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.9(a)(ii)(x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and Investments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(k)(i)(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> not to exceed $750,000,000, (ii) cash (in the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_403"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:11.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">aggregate for both clauses (A) and (B)), in an amount not to exceed the Available Amount on the date of each such purchase, redemption, acquisition, dividend and distribution or (iii) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (as of the date of such transaction, both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), cash in any amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the amount of all such cash payments exceeds the limitation set forth in clauses (i) and (ii) of this Section during any period during which the Leverage Ratio test in clause (iii) of this Section is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period&#59;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">so long as no Default is continuing or will be continuing after such transaction, the Borrower may repurchase its common stock from its then existing shareholders in one or more transactions for an aggregate purchase price not to exceed $1,200,000,000&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">the Borrower may undertake the purchase of Capital Stock deemed to occur due to &#8220;netting&#8221; upon an exercise of stock options, stock appreciation rights, restricted stock units, warrants or other convertible or exchangeable securities or, upon the vesting of any restricted Capital Stock, the redemption of a portion of such restricted Capital Stock to fund any applicable tax withholding obligations in respect of such vesting, and any related tax withholding payments on behalf of employees in connection with any exercise of stock options or other rights to purchase Capital Stock or the vesting of restricted Capital Stock&#59; and</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:41pt;padding-right:16.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower and its Restricted Subsidiaries may purchase or acquire Capital Stock to the extent required by, or made pursuant to, customary buy&#47;sell arrangements between the parties to any joint venture or shareholders of any non-Wholly Owned Subsidiaries set forth in the shareholder agreements, joint venture agreements, organization documents or binding agreements relating to such joint venture or non-Wholly-Owned Subsidiary, and may otherwise purchase or acquire Capital Stock from parties to any joint venture or shareholders of any non-Wholly Owned Subsidiaries to the extent such purchase or acquisition is permitted by Section 7.6.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding anything herein to the contrary, the foregoing provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> will not prohibit the consummation of any irrevocable redemption, purchase, defeasance, distribution or other payment if at the date of such irrevocable notice or declaration, such payment would have complied with the provisions of this Agreement.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">For purposes of determining compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, in the event that a Restricted Payment meets the criteria of more than one of the categories of Restricted Payments described above, the Borrower shall, in its sole discretion, classify or divide such Restricted Payment (or any portion thereof) in any manner that complies with this covenant.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Fiscal Year. Make or permit any change (other than any Restricted Subsidiary acquired after the Closing Date, and in such case only to the extent necessary to conform to the Fiscal Year of the Borrower or a Restricted Subsidiary) in Fiscal Year&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, the Borrower may, with the consent of the Administrative Agent, change a fiscal year-end to another date reasonably acceptable to the Administrative Agent, in which case the Borrower and the Administrative Agent will, and are hereby authorized by the Lenders to, make any adjustments to this Agreement that are necessary in order to reflect such change in financial reporting, which adjustments shall become effective when the Administrative Agent posts the amendment reflecting such changes to the Platform, and the Required Lenders have not objected to such amendment within seven (7) Business Days.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_406"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Prepayments of Other Debt&#59; Modifications of Constitutive Documents and Other Documents, etc. Directly or indirectly&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">make (or give any notice in respect thereof) any voluntary or optional payment or prepayment on or redemption or acquisition for value of, or any prepayment or redemption as a result of any asset sale, change of control or similar event of, any Debt outstanding under the 2022 Senior Notes, the 2024 Senior Notes, the 2025 Senior Notes, any Debt that is secured on second priority (or other junior priority) basis (including any Permitted Second Priority Refinancing Debt or any Permitted Other Debt that is secured on second priority (or other junior priority) basis), any unsecured Permitted Other Debt or any subordinated Debt (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Junior Financing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; except for (i) any Permitted Refinancing of any Junior Financing and (ii) so long as no Default is continuing or will be continuing after such transaction, the voluntary or optional payment or prepayment or redemption or acquisition for value of Junior Financing (x) in an aggregate amount for this clause (ii), when taken together with the aggregate amount of purchases, redemptions, acquisitions, dividends and distributions pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.7(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and Investments pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6(k)(i)(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, not to exceed $750,000,000, (y) in an aggregate amount not to exceed the Available Amount, on the date of each such payment, prepayment, redemption or acquisition of Debt or (z) if the Leverage Ratio for the most recent Measurement Period is less than 4.00&#58;1.00 (as of the date of such transaction, both before and after giving effect to such transaction (including any use of cash with respect thereto) on a Pro Forma Basis), cash in any amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the amount of all such cash payments exceeds the limitation set forth in clauses (ii)(x) and (y) of this Section during any period during which the Leverage Ratio test in clause (ii)(z) of this Section is met, such excess cash payments shall not constitute an Event of Default if such Leverage Ratio test is not met in any subsequent Measurement Period&#59;</font></div><div><font><br></font></div><div style="padding-left:41pt;padding-right:14.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">amend or modify, or permit the amendment or modification of, any provision of any Junior Financing, any NMTC Indebtedness or any Permitted Receivables Documents in any manner that is adverse in any material respect to the interests of the Lenders&#59; or</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">terminate, amend, modify or change any of its Constitutive Documents (including by the filing or modification of any certificate of designation) or any agreement to which it is a party with respect to its Capital Stock (including any stockholders&#8217; agreement), or enter into any new agreement with respect to its Capital Stock, other than any such amendments, modifications or changes or such new agreements which are not adverse in any material respect to the interests of the Lenders or are pursuant to Requirements of Law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Loan Parties may issue such Capital Stock, so long as such issuance is not prohibited by this Agreement, and may amend their Constitutive Documents to authorize any such Capital Stock.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Negative Pledge. Enter into or suffer to exist, or permit any Loan Party to enter into or suffer to exist, any agreement prohibiting or conditioning the creation or assumption of any Lien upon any of its property or assets in favor of the Secured Parties except (i) in favor of the Secured Parties, (ii) which (x) exist on the Closing Date and (y) to the extent restrictions permitted by clause (x) are set forth in an agreement evidencing Debt, are set forth in any agreement evidencing any permitted renewal, extension or refinancing of such Debt so long as such renewal, extension or refinancing does not expand the scope of such restrictions, (iii) in connection with (A) any Debt permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> solely to the extent that the agreement or instrument governing such Debt prohibits a Lien on the property acquired with the proceeds of such Debt, or (B) any Financing Lease permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> solely to the extent that such Financing Lease prohibits a Lien on the property subject thereto, or (C) any Debt outstanding on the date any Restricted Subsidiary of the Borrower becomes such a Restricted Subsidiary (so long as such agreement was not entered into solely in contemplation of such Restricted</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_409"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Subsidiary becoming a Restricted Subsidiary of the Borrower), or (D) any Debt permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> solely to the extent that the agreement or instrument governing such Debt prohibits a Lien on the property of the relevant borrowing entity or (E) the 2022 Senior Notes, or (F) the 2024 Senior Notes, or (G) the 2025 Senior Notes, or (H) Permitted Other Debt, or (I) any Debt permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.2(o)-(q), (s) and (u)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (J) any NMTC Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that any such restriction relates only to related NMTC Property, or (K) any Debt of a Restricted Subsidiary that is not a Loan Party that is permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (or) (L) any Cash Management Agreement or similar agreement permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> solely to the extent such Debt prohibits a Lien on the property subject thereto, (iv) customary restrictions in leases, subleases, licenses or asset sale agreements otherwise permitted hereby so long as such restrictions relate to the assets subject thereto, (v) customary provisions restricting assignment or transfer of any agreement entered into in the ordinary course of business, (vi) restrictions set forth in any agreement relating to any Liens permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that limit the right of the Borrower or any Restricted Subsidiary to encumber the assets subject thereto, (vii) customary restrictions that arise in connection with any Disposition permitted by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> solely to the assets subject to such Disposition, or (viii) pursuant to any Requirements of Law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Payment Restrictions Affecting Restricted Subsidiaries. Directly or indirectly, enter into or suffer to exist, or permit any of its Restricted Subsidiaries to enter into or suffer to exist, any agreement or arrangement limiting the ability of any of its Restricted Subsidiaries to declare or pay dividends or other distributions in respect of its Capital Stock or repay or prepay any Debt owed to, make loans or advances to, or otherwise transfer assets to or invest in, the Borrower or any Restricted Subsidiary of the Borrower (whether through a covenant restricting dividends, loans, asset transfers or investments, a financial covenant or otherwise), except (i) the Loan Documents&#59; (ii) which (x) exist on the Closing Date and (y) to the extent restrictions permitted by clause (x) are set forth in an agreement evidencing Debt, are set forth in any agreement evidencing any permitted renewal, extension or refinancing of such Debt so long as such renewal, extension or refinancing does not expand the scope of such restrictions, (iii) any agreement in effect at the time such Restricted Subsidiary becomes a Restricted Subsidiary of the Borrower, so long as such agreement was not entered into solely in contemplation of such Person becoming a Restricted Subsidiary of the Borrower&#59; (iv) restrictions on transfer contained in Debt incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 7.2(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such restrictions relate only to the transfer of the property financed with such Debt&#59; (v) in connection with and pursuant to any Permitted Refinancing, replacements of restrictions that are not more restrictive than those being replaced and do not apply to any other Person or assets than those that would have been covered by the restrictions in the Debt so refinanced&#59; (vi) restrictions contained in any Permitted Receivables Document with respect to any Special Purpose Receivables Subsidiary&#59; (vii) solely with respect to Restricted Subsidiaries that are not Guarantors, restrictions under the Constitutive Documents governing such Subsidiary&#58; (A) with respect to existing Restricted Subsidiaries, existing on the Closing Date&#59; and (B) with respect to Restricted Subsidiaries created or acquired after the Closing Date&#58; (1) prohibiting such Restricted Subsidiary from guaranteeing Debt of the Borrower or another Restricted Subsidiary&#59; (2) restricting dividend payments and other distributions solely to permit pro rata dividends and other distributions in respect of any Capital Stock of such Restricted Subsidiary&#59; (3) limiting transactions with the Borrower or another Restricted Subsidiary to those with terms that are fair and reasonable to such Restricted Subsidiary and no less favorable to such Restricted Subsidiary than could have been obtained in an arm&#8217;s length transaction with an unrelated third party&#59; and (4) limiting such Restricted Subsidiary&#8217;s ability to transfer assets or incur Debt without the consent of the holders of the Capital Stock of such Restricted Subsidiary&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that all restrictions permitted by this clause (vii) shall no longer be permitted in the event any such Restricted Subsidiary becomes a Guarantor&#59; (viii) restrictions contained in Debt incurred pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the borrowers thereunder&#59; (ix) encumbrances or restrictions (A) that restrict in a customary manner the subletting, assignment or transfer of any property or asset that is subject to a lease, license or similar contract entered into in the ordinary course of business, or the assignment or transfer of any lease, license or contract entered into in the ordinary</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_412"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">course of business, (B) arising by virtue of any transfer of, agreement to transfer, option or right with respect to, or Lien on, any property or assets of the Borrower or any Restricted Subsidiary, (C) imposed by any agreement governing Debt entered into on or after the Closing Date and permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font></div><div style="padding-left:5pt;padding-right:11.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that are, taken as a whole, in the good faith judgment of the Borrower, no more restrictive with respect to the Borrower or any Restricted Subsidiary than customary market terms for Debt of such type (and, in any event, are no more restrictive than the restrictions contained in this Agreement, taken as a whole), so long as the Borrower shall have determined in good faith that such restrictions will not affect its obligation or ability to make any payments required hereunder and (D) pursuant to any Requirement of Law, (x) encumbrances or restrictions that are customary provisions in joint venture agreements and other similar agreements applicable to joint ventures permitted under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and applicable solely to such joint venture entered into in the ordinary course of business, (xi) encumbrances or restrictions that are contained in any employment, compensation or separation agreement or arrangement entered into by the Borrower or any Restricted Subsidiary in the ordinary course of business and (xii) any encumbrances or restrictions on a Captive Insurance Subsidiary.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">&#91;Reserved&#93;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Anti-Terrorism Law&#59; Anti-Money Laundering.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Directly or indirectly, (i) knowingly conduct any business or engage in making or receiving any contribution of funds, goods or services to or for the benefit of any Person described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.23(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, (ii) knowingly deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to the Executive Order or any other Anti-Terrorism Law, or (iii) knowingly engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law (and the Loan Parties shall deliver to the Lenders any certification or other evidence requested from time to time by any Lender in its reasonable discretion, confirming the Loan Parties&#8217; compliance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">).</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Cause or permit any of the funds of such Loan Party that are used to repay the Loans to be derived from any unlawful activity with the result that the making of the Loans would be in violation of any Requirement of Law.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Embargoed Person. Knowingly cause or permit (a) any of the funds or properties of the Loan Parties that are used to repay the Loans to constitute property of, or be beneficially owned directly or indirectly by, any Person subject to sanctions or trade restrictions under United States law (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Embargoed Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Embargoed Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) that is identified on (1) the &#8220;List of Specially Designated Nationals and Blocked Persons&#8221; maintained by OFAC and&#47;or on any other similar list maintained by OFAC pursuant to any authorizing statute including, but not limited to, the International Emergency Economic Powers Act, 50 U.S.C. &#167;&#167; 1701 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., The Trading with the Enemy Act, 50 U.S.C. App. 1 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">., and any Executive Order or Requirement of Law promulgated thereunder, with the result that the investment in the Loan Parties (whether directly or indirectly) is prohibited by a Requirement of Law, or the Loans made by the Lenders would be in violation of a Requirement of Law, or (2) the Executive Order, any related enabling legislation or any other similar Executive Orders, (b) any Embargoed Person to have any direct or indirect interest, of any nature whatsoever in the Loan Parties, with the result that the investment in the Loan Parties (whether directly or indirectly) is prohibited by a Requirement of Law or the Loans are in violation of a Requirement of Law or (c) all or any part of the proceeds of the Loans to fund or finance any business activities or transactions of any Embargoed Person.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_415"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Financial Covenant. Permit the Leverage Ratio, measured as of (x) the end of any Measurement Period through the Measurement Period ending December 31, 2022 to exceed 5.00&#58;1.00 and (y) the end of any Measurement Period thereafter to exceed 4.50&#58;1.00&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, in the case of clause (y) only, the Leverage Ratio with respect to any Measurement Period ending on the last day of an Acquisition Period shall not exceed 5.00&#58;1.00.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:181.1pt;padding-right:181.1pt;text-align:center;text-indent:28.65pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 8</font></div><div style="padding-left:89.62pt;padding-right:89.62pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EVENTS OF DEFAULT</font></div><div style="padding-right:179.25pt"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:17.75pt">Events of Default. If any of the following events (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Events of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#8221;) shall occur on or after the Closing Date&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the Borrower shall fail to pay any principal of any Loan or any reimbursement obligation in respect of any LC Disbursement when and as the same shall become due and payable, whether at the due date thereof or at a date fixed for prepayment thereof or otherwise&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:15.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower shall fail to pay any interest on any Loan or any fee or any other amount (other than an amount referred to in paragraph (a) of this Section) payable under this Agreement when and as the same shall become due and payable, and such failure shall continue unremedied for a period of five Business Days&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.3pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any representation or warranty made or deemed made by or on behalf of any Restricted Company in or in connection with this Agreement or any amendment or modification hereof or waiver hereunder, or in any report, certificate, financial statement or other document furnished pursuant to or in connection with this Agreement or any amendment or modification hereof or waiver hereunder, shall prove to have been incorrect in any material respect when made or deemed made&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:13.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 6.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (with respect to the Borrower&#8217;s existence) or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41pt;padding-right:20.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">any Loan Party shall fail to observe or perform any covenant, condition or agreement contained in any Loan Document (other than those specified in paragraph (a), (b) or</font></div><div style="padding-left:5pt;padding-right:20.1pt;text-indent:-0.36pt"><font><br></font></div><div style="padding-left:41pt;padding-right:13.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.02pt">of this Section), and such failure shall continue unremedied for a period of 30 days after notice thereof from the Administrative Agent to the Borrower (which notice will be given at the request of any Lender)&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">any Restricted Company shall (i) default in making any payment of any Debt (including any Contingent Obligation, but excluding the Loans) beyond the period of grace, if any, provided in the instrument or agreement under which such Debt was created&#59; or (ii) default in the observance or performance of any other agreement or condition relating to any such Debt or contained in any instrument or agreement evidencing, securing or relating thereto, or any other event shall occur or condition exist, the effect of which default or other event or condition is to cause, or to permit the holder or beneficiary of such Debt (or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice if required, such Debt to become due prior to its stated maturity&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that a default, event or condition described in clause (i) or (ii) of this paragraph (f) shall not at any time constitute an Event of Default (a) unless, at such time, one or more defaults, events or conditions of the type described in clauses (i) and (ii) of this paragraph (f) shall have occurred and be continuing with respect to Debt the outstanding</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_418"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:9.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">principal amount of which exceeds in the aggregate $125,000,000 or (b) if (i) any secured Debt that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Debt, if such sale or transfer is permitted hereunder and under the documents providing for such Debt, (ii) any Debt which is convertible into Capital Stock and converts to Capital Stock in accordance with its terms and such conversion is not prohibited hereunder or (iii) such breach or default is (I) remedied by the applicable Restricted Company or (II) waived (including in the form of amendment) by the required holders of such Debt, in either case, prior to the acceleration of Loans pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:10.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">(i) the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary shall commence any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic or foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment of a receiver, trustee, custodian, conservator or other similar official for it or for all or any substantial part of its assets, or the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary shall make a general assignment for the benefit of its creditors&#59; or (ii) there shall be commenced against the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary any case, proceeding or other action of a nature referred to in clause (i) above that (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of 60 days&#59; or (iii) there shall be commenced against the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets that results in the entry of an order for any such relief that shall not have been vacated, discharged, or stayed or bonded pending appeal within 60 days from the entry thereof&#59; or (iv) the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary shall take any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (i), (ii), or (iii) above&#59; or (v) the Borrower or any direct or indirect Subsidiary that is not an Excluded Subsidiary shall generally not, or shall be unable to, or shall admit in writing its inability to, pay its debts as they become due&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:41pt;padding-right:29.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">an ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, has resulted or could reasonably be expected to result in liabilities of the Loan Parties in an aggregate amount exceeding $100,000,000 or in the imposition of a Lien or security interest on any assets of a Loan Party&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:10.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">(A) one or more final judgments or decrees shall be entered against any Restricted Company involving in the aggregate a liability against such Restricted Company, and not including any dollar amount of liability in such judgement or decree assessed against or attributable to a third-party (not paid or fully covered by insurance as to which the relevant insurance company does not dispute coverage) of $125,000,000 or more, and such judgments or decrees are not paid, discharged, vacated, stayed, bonded pending an appeal, or otherwise satisfied for a period of 60 consecutive days after payment is required to be made, or any action shall be legally taken by a judgment creditor (other than pursuant to a pre-negotiated settlement or payment arrangement) to attach or levy upon any assets of any Restricted Company to enforce any such judgment or (B) any Restricted Company shall enter into any settlement of a claim (including claims by Governmental Authorities for violations or alleged violations of Requirements of Law) and the unpaid amount of such settlements at any time, individually or in the aggregate, amount to $125,000,000 or more and any Restricted Company fails to make any</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_421"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">payment required to be made in accordance with the terms of the settlements, or any action shall be legally taken by a creditor (other than pursuant to a pre-negotiated settlement or payment arrangement) to attach or levy upon any assets of any Restricted Company to enforce any such settlement&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">any of the Security Documents shall cease, for any reason, to be in full force and effect, or any Loan Party or any Affiliate of any Loan Party shall so assert, or any Lien created by any of the Security Documents shall cease to be enforceable and of the same effect and priority purported to be created thereby (other than, in any case under this clause (j), as permitted pursuant to the terms hereof or thereof or solely as a result of acts by the Collateral Agent or omissions to take action by the Collateral Agent, in each case, that are within the sole control of the Collateral Agent (including as a result of the Collateral Agent&#8217;s failure to file a UCC continuation statement))&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">other than as expressly permitted hereunder, the guarantee pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of any Guarantor shall cease, for any reason, to be in full force and effect or any Loan Party or any Affiliate of any Loan Party shall so assert (other than pursuant to the terms hereof), except, in the case of any such cessation that is attributable to an event of a type contemplated by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this provision shall apply only to the Borrower or a Guarantor&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.13pt">a Change of Control shall occur&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:41pt;padding-right:12.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">the Borrower or any Restricted Subsidiary, in each case to the extent it is engaged in the business of providing services for which Medicare or Medicaid reimbursement is sought, shall for any reason, including, without limitation, as the result of any finding, designation or decertification, lose its right or authorization, or otherwise fail to be eligible, to participate in Medicaid or Medicare programs or to accept assignment of or rights to reimbursements under Medicaid or Medicare regulations, or the Borrower or any Restricted Subsidiary has, for any reason, had its right to receive reimbursements under Medicaid or Medicare regulations suspended, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such loss, failure or suspension (together with all such other losses, failures and suspensions continuing at such time) shall have resulted in (x) a Material Adverse Effect or (y) Consolidated net operating revenues for the immediately preceding four Fiscal Quarter period of the Borrower constituting less than 95% of Consolidated net operating revenues for any preceding four Fiscal Quarter period of the Borrower&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">then, and in every such event (other than an event with respect to the Borrower described in paragraph (g) of this Section), and at any time thereafter during the continuance of such event, the Administrative Agent may with the consent of the Required Lenders, and at the request of the Required Lenders shall, by notice to the Borrower, take either or both of the following actions, at the same or different times&#58; (i) terminate the Commitments, and thereupon the Commitments shall terminate immediately, and (ii) declare the Loans then outstanding to be due and payable in whole (or in part, in which case any principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Loans so declared to be due and payable, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder, shall become due and payable immediately, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower&#59; and in case of any event with respect to the Borrower described in paragraph (g) of this Section, the Commitments shall automatically terminate and the principal of the Loans then outstanding, together with accrued interest thereon and all fees and other obligations of the Borrower accrued hereunder, shall automatically become due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby waived by the Borrower.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_424"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Application of Proceeds. The proceeds received by the Collateral Agent in respect of any sale of, collection from or other realization upon all or any part of the Collateral pursuant to the exercise by the Collateral Agent of its remedies shall be applied, in full or in part, together with any other sums then held by the Collateral Agent pursuant to this Agreement, promptly by the Collateral Agent as follows&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">First</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of all reasonable costs and expenses, fees, commissions and taxes of such sale, collection or other realization including compensation to the Administrative Agent, the Collateral Agent and their respective agents and counsel, and all expenses, liabilities and advances made or incurred by the Administrative Agent and&#47;or the Collateral Agent in connection therewith and all amounts for which the Administrative Agent and&#47;or Collateral Agent is entitled to indemnification pursuant to the provisions of any Loan Document, together with interest on each such amount at the highest rate then in effect under this Agreement from and after the date such amount is due, owing or unpaid until paid in full&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:41pt;padding-right:13.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Second</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the payment of all other reasonable costs and expenses of such sale, collection or other realization including compensation to the other Secured Parties and their agents and counsel and all costs, liabilities and advances made or incurred by the other Secured Parties in connection therewith, together with interest on each such amount at the highest rate then in effect under this Agreement from and after the date such amount is due, owing or unpaid until paid in full&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:17.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">Third</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without duplication of amounts applied pursuant to clauses (a) and (b) above, to the indefeasible payment in full in cash, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, of interest, premium and other amounts constituting Obligations (other than principal and Reimbursement Obligations), any fees, premiums and scheduled periodic payments due under Specified Swap Agreements constituting Secured Obligations and any interest accrued thereon (other than to the extent payable in clause Fourth) and any fees and interest due under any Secured Cash Management Agreements constituting Secured Obligations and any reimbursement or other payment obligations, interest and obligations to provide cash collateral in respect of any Specified Letter of Credit constituting Secured Obligations, in each case equally and ratably in accordance with the respective amounts thereof then due and owing&#59;</font></div><div><font><br></font></div><div style="padding-left:41pt;padding-right:9.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Fourth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the indefeasible payment in full in cash, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, of the principal amount of the Obligations (including Reimbursement Obligations) and any breakage, termination or other payments under Specified Swap Agreements constituting Secured Obligations and any interest accrued thereon and the principal amount owing under Secured Cash Management Agreements constituting Secured Obligations&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:22.35pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt;text-decoration:underline">Fifth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the balance, if any, to the Person lawfully entitled thereto (including the applicable Loan Party or its successors or assigns) or as a court of competent jurisdiction may direct.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:16.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In the event that any such proceeds are insufficient to pay in full the items described in clauses (a) through (e) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Loan Parties shall remain liable, jointly and severally, for any deficiency.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_427"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-left:206.57pt;padding-right:206.57pt;text-align:center;text-indent:-0.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 9</font></div><div style="padding-left:104pt;padding-right:104pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">THE AGENTS</font></div><div style="padding-left:104pt;padding-right:104pt;text-align:center"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">9.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:17.75pt">Appointment and Authority. Each of the Lenders and the Issuing Lender hereby irrevocably appoints Wells Fargo Bank, National Association to act on its behalf as the Administrative Agent and the Collateral Agent hereunder and under the other Loan Documents and authorizes such Agents to take such actions on its behalf and to exercise such powers as are delegated to such Agents by the terms hereof and thereof, together with such actions and powers as are reasonably incidental thereto. With the exception of the second and fifth sentences of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, the provisions of this Section are solely for the benefit of the Administrative Agent, the Collateral Agent, the Lenders and the Issuing Lender, and neither the Borrower nor any other Loan Party shall have rights as a third party beneficiary of any of such provisions. The Lenders hereby authorize the Administrative Agent to enter into any First Lien Intercreditor Agreement, any Junior Lien Intercreditor Agreement or other intercreditor agreement or arrangement permitted under this Agreement and any such intercreditor agreement is binding upon the Lenders. The Administrative Agent may effect any amendment or supplement to any First Lien Intercreditor Agreement, any Junior Lien Intercreditor Agreement or other intercreditor agreement or arrangement permitted under this Agreement that is for the purpose of adding the holders of Permitted First Priority Refinancing Debt, or Permitted Second Priority Refinancing Debt or Permitted Other Debt permitted to be incurred under this Agreement, as expressly contemplated by the terms of such First Lien Intercreditor Agreement, such Junior Lien Intercreditor Agreement or such other intercreditor agreement or arrangement permitted under this Agreement, as applicable.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Rights as a Lender. Each Person serving as an Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not an Agent and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; shall, unless otherwise expressly indicated or unless the context otherwise requires, include each Person serving as an Agent hereunder in its individual capacity. Such Person and its Affiliates may accept deposits from, lend money to, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not an Agent hereunder and without any duty to account therefor to the Lenders.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Exculpatory Provisions. No Agent shall have any duties or obligations except those expressly set forth herein and in the other Loan Documents. Without limiting the generality of the foregoing, no Agent&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">shall be subject to any fiduciary or other implied duties, regardless of whether a Default has occurred and is continuing&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">shall have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that such Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such Agent shall not be required to take any action that, in its judgment or the judgment of its counsel, may expose such Agent to liability or that is contrary to any Loan Document or applicable Requirements of Law&#59; and</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">shall, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to Borrower or any of its Affiliates that is communicated to or obtained by the Person serving as such Agent or any of its Affiliates in any capacity.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_430"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:12.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Agent shall be liable for any action taken or not taken by it (x) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as such Agent shall believe in good faith shall be necessary, under the circumstances as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) or (y) in the absence of its own gross negligence or willful misconduct. No Agent shall be deemed to have knowledge of any Default unless and until notice describing such Default is given to such Agent by the Borrower, a Lender or the Issuing Lender.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.1pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">No Agent shall be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document, (v) the validity, perfection and priority of any Lien purported to be created by the Loan Documents or the value or sufficiency of the Collateral or (vi) the satisfaction of any condition set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to such Agent. Without limiting the generality of the foregoing, the use of the term &#8220;agent&#8221; in this Agreement with reference to the Administrative Agent or the Collateral Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable law. Instead, such term is used merely as a matter of market custom and is intended to create or reflect only an administrative relationship between independent contracting parties.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Reliance by Agent. Each Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. Each Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan, or the issuance of a Letter of Credit, that by its terms must be fulfilled to the satisfaction of a Lender or the Issuing Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender or the Issuing Lender unless the Administrative Agent shall have received notice to the contrary from such Lender or the Issuing Lender prior to the making of such Loan or the issuance of such Letter of Credit. Each Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Delegation of Duties. Each Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by such Agent. Each Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Section shall apply to any such sub-agent and to the Related Parties of each Agent and any such sub-agent, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Agent.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.75pt">Resignation of Agent. Each Agent may at any time give notice of its resignation to the Lenders, the Issuing Lender and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, in consultation with the Borrower, to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders and shall have</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_433"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">accepted such appointment within 30 days after the retiring Agent gives notice of its resignation, then the retiring Agent may on behalf of the Lenders and the Issuing Lender, appoint a successor Agent meeting the qualifications set forth above&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if the Agent shall notify the Borrower and the Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and (1) the retiring Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents (except that in the case of any collateral security held by the Collateral Agent on behalf of the Lenders or the Issuing Lender under any of the Loan Documents, the retiring Collateral Agent shall continue to hold such collateral security as nominee until such time as a successor Collateral Agent is appointed) and (2) all payments, communications and determinations provided to be made by, to or through an Agent shall instead be made by or to each Lender and the Issuing Lender directly, until such time as the Required Lenders appoint a successor Agent as provided for above in this paragraph. Upon the acceptance of a successor&#8217;s appointment as Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Agent, and the retiring Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this paragraph). The fees payable by the Borrower to a successor Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the retiring Agent&#8217;s resignation hereunder and under the other Loan Documents, the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall continue in effect for the benefit of such retiring Agent, its sub-agents and their respective Related Parties in respect of any actions taken or omitted to be taken by any of them while the retiring Agent was acting as Agent.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:67.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:67.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Non-Reliance on Agent and Other Lenders. Each Lender and the Issuing Lender acknowledges that it has, independently and without reliance upon any Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender and the Issuing Lender also acknowledges that it will, independently and without reliance upon any Agent or any other Lender and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:67.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:67.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">No Other Duties, etc. Anything herein to the contrary notwithstanding, none of the bookmanagers, arrangers, Syndication Agents or Documentation Agents listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as the Administrative Agent, the Collateral Agent, a Lender or the Issuing Lender hereunder.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:67.5pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:67.5pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.25pt">Withholding Tax. To the extent required by any applicable Requirement of Law, the Administrative Agent may withhold from any payment to any Lender an amount equivalent to any applicable withholding Tax. If the Internal Revenue Service or any other authority of the United States or any other Governmental Authority asserts a claim that the Administrative Agent did not properly withhold Tax from amounts paid to or for the account of any Lender for any reason (including, without limitation, because the appropriate form was not delivered or not properly executed, or because such Lender failed to notify the Administrative Agent of a change in circumstance that rendered the exemption from, or reduction of withholding Tax ineffective), such Lender shall, within 10 days after written demand therefor, indemnify and hold harmless the Administrative Agent (to the extent that the Administrative Agent has not already been reimbursed by the Loan Parties pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and without limiting or expanding the obligation of the Loan Parties to do so) from and against all amounts paid, directly or indirectly, by the Administrative Agent as Taxes or otherwise, together with all expenses incurred, including legal expenses and any other out-of-pocket expenses, whether or not such Tax was correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_436"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:11.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under this Agreement or any other Loan Document against any amount due the Administrative Agent under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The agreements in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive the resignation and&#47;or replacement of the Administrative Agent, any assignment of rights by, or the replacement of, a Lender, the termination of this Agreement and the payment of the Loans and all other amounts payable hereunder. For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the term &#8220;Lender&#8221; shall include any Issuing Lender and any Swingline Lender.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Certain ERISA Matters.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;padding-right:7.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Each Lender (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that at least one of the following is and will be true&#58;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:77pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.63pt">such Lender is not using &#8220;plan assets&#8221; (within the meaning of Section 3(42) of ERISA or otherwise) of one or more Benefit Plans with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments or this Agreement,</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:77pt;padding-right:7.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.58pt">the transaction exemption set forth in one or more PTEs, such as PTE 84-14 (a class exemption for certain transactions determined by independent qualified professional asset managers), PTE 95-60 (a class exemption for certain transactions involving insurance company general accounts), PTE 90-1 (a class exemption for certain transactions involving insurance company pooled separate accounts), PTE 91-38 (a class exemption for certain transactions involving bank collective investment funds) or PTE 96-23 (a class exemption for certain transactions determined by in-house asset managers), is applicable with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement,</font></div><div><font><br></font></div><div style="padding-left:77pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.53pt">(A) such Lender is an investment fund managed by a &#8220;Qualified Professional Asset Manager&#8221; (within the meaning of Part VI of PTE 84-14), (B) such Qualified Professional Asset Manager made the investment decision on behalf of such Lender to enter into, participate in, administer and perform the Loans, the Letters of Credit, the Commitments and this Agreement, (C) the entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement satisfies the requirements of sub-sections (b) through (g) of Part I of PTE 84-14 and (D) to the best knowledge of such Lender, the requirements of subsection (a) of Part I of PTE 84-14 are satisfied with respect to such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement, or</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:77pt;padding-right:7.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.13pt">such other representation, warranty and covenant as may be agreed in writing between the Administrative Agent, in its sole discretion, and such Lender.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:7.95pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">In addition, unless either (1) sub-clause (i) in the immediately preceding clause (a) is true with respect to a Lender or (2) a Lender has provided another representation, warranty and covenant in accordance with sub-clause (iv) in the immediately preceding clause (a), such Lender</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_439"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:41pt;padding-right:7.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">further (x) represents and warrants, as of the date such Person became a Lender party hereto, to, and (y) covenants, from the date such Person became a Lender party hereto to the date such Person ceases being a Lender party hereto, for the benefit of, the Administrative Agent and not, for the avoidance of doubt, to or for the benefit of the Borrower or any other Loan Party, that the Administrative Agent is not a fiduciary with respect to the assets of such Lender involved in such Lender&#8217;s entrance into, participation in, administration of and performance of the Loans, the Letters of Credit, the Commitments and this Agreement (including in connection with the reservation or exercise of any rights by the Administrative Agent under this Agreement, any Loan Document or any documents related hereto or thereto).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:206.82pt;padding-right:206.82pt;text-align:center;text-indent:-0.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 10</font></div><div style="padding-left:104.15pt;padding-right:104.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GUARANTEE</font></div><div style="padding-left:104.15pt;padding-right:104.15pt;text-align:center"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:12.25pt">The Guarantee. The Guarantors hereby jointly and severally guarantee, as a primary obligor and not as a surety to each Secured Party and their respective successors and assigns, the prompt payment in full when due (whether at stated maturity, by required prepayment, declaration, demand, by acceleration or otherwise) of the principal of and interest (including any interest, fees, costs or charges that would accrue but for the provisions of the Title 11 of the United States Code after any bankruptcy or insolvency petition under Title 11 of the United States Code) on the Loans made by the Lenders to, and the Notes held by each Lender of, Borrower, and all other Secured Obligations from time to time owing to the Secured Parties by any Loan Party under or in respect of any Loan Document, Specified Swap Agreement, Specified Letter of Credit or Secured Cash Management Agreement, in each case strictly in accordance with the terms thereof (such obligations being herein collectively called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Guaranteed Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">&#8221;&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> that Guaranteed Obligations shall exclude any Excluded Swap Obligations). The Guarantors hereby jointly and severally agree that if Borrower or other Guarantor(s) shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise) any of the Guaranteed Obligations, the Guarantors will promptly pay the same in cash, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Guaranteed Obligations, the same will be promptly paid in full when due (whether at extended maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.75pt">Obligations Unconditional. The obligations of the Guarantors under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font></div><div style="padding-left:5pt;padding-right:8.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.75pt">shall constitute a guaranty of payment and to the fullest extent permitted by applicable Requirements of Law, are absolute, irrevocable and unconditional, joint and several, irrespective of the value, genuineness, validity, regularity or enforceability of the Guaranteed Obligations of Borrower under this Agreement, the Notes, if any, or any other agreement or instrument referred to herein or therein, or any substitution, release or exchange of any other guarantee of or security for any of the Guaranteed Obligations, and irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety or guarantor (except for payment in full). Without limiting the generality of the foregoing, it is agreed that the occurrence of any one or more of the following shall not alter or impair the liability of the Guarantors hereunder, which shall remain absolute, irrevocable and unconditional under any and all circumstances as described above&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">at any time or from time to time, without notice to the Guarantors, the time for any performance of or compliance with any of the Guaranteed Obligations shall be extended, or such performance or compliance shall be waived&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">any of the acts mentioned in any of the provisions of this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein shall be done or omitted&#59;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_442"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">the maturity of any of the Guaranteed Obligations shall be accelerated, or any of the Guaranteed Obligations shall be amended in any respect, or any right under the Loan Documents or any other agreement or instrument referred to herein or therein shall be amended or waived in any respect or any other guarantee of any of the Guaranteed Obligations or any security therefor shall be released or exchanged in whole or in part or otherwise dealt with&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">any Lien or security interest granted to, or in favor of, the Issuing Lender or any Lender or Agent as security for any of the Guaranteed Obligations shall fail to be perfected&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-34.45pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.63pt">the release of any other Guarantor pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-37.6pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.73pt">any bankruptcy, insolvency, reorganization, arrangement, readjustment, composition, liquidation or the like of any Loan Party&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-40.7pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.78pt">any lack of validity or enforceability of any Loan Document or any other agreement or instrument relating thereto against any Loan Party.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Guarantors hereby expressly waive diligence, presentment, demand of payment, protest and all notices whatsoever, and any requirement that any Secured Party exhaust any right, power or remedy or proceed against Borrower under this Agreement or the Notes, if any, or any other agreement or instrument referred to herein or therein, or against any other Person under any other guarantee of, or security for, any of the Guaranteed Obligations. The Guarantors waive any and all notice of the creation, renewal, extension, waiver, termination or accrual of any of the Guaranteed Obligations and notice of or proof of reliance by any Secured Party upon this Guarantee or acceptance of this Guarantee, and the Guaranteed Obligations, and any of them, shall conclusively be deemed to have been created, contracted or incurred in reliance upon this Guarantee, and all dealings between Borrower and the Secured Parties shall likewise be conclusively presumed to have been had or consummated in reliance upon this Guarantee. This Guarantee shall be construed as a continuing, absolute, irrevocable and unconditional guarantee of payment without regard to any right of offset with respect to the Guaranteed Obligations at any time or from time to time held by Secured Parties, and the obligations and liabilities of the Guarantors hereunder shall not be conditioned or contingent upon the pursuit by the Secured Parties or any other Person at any time of any right or remedy against Borrower or against any other Person which may be or become liable in respect of all or any part of the Guaranteed Obligations or against any collateral security or guarantee therefor or right of offset with respect thereto. This Guarantee shall remain in full force and effect and be binding in accordance with and to the extent of its terms upon the Guarantors and the successors and assigns thereof, and shall inure to the benefit of the Lenders, and their respective successors and assigns, notwithstanding that from time to time since the Closing Date there may be no Guaranteed Obligations outstanding.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Reinstatement. The obligations of the Guarantors under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of Borrower or other Loan Party in respect of the Guaranteed Obligations is rescinded or must be otherwise restored by any holder of any of the Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Subrogation&#59; Subordination. Each Guarantor hereby agrees that until the indefeasible payment and satisfaction in full in cash of all Guaranteed Obligations and the expiration and termination of the Commitments of the Lenders under this Agreement it shall not assert or exercise any right or remedy, direct or indirect, arising by reason of any performance by it of its guarantee in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, whether by subrogation or otherwise, against Borrower or any other Guarantor of any of the Guaranteed Obligations or any security for any of the Guaranteed Obligations. Any Debt of any Loan</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_445"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Party permitted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be subordinated to such Loan Party&#8217;s Secured Obligations in the manner set forth in the Intercompany Note evidencing such Debt.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Remedies. The Guarantors jointly and severally agree that, as between the Guarantors and the Lenders, the obligations of Borrower under this Agreement and the Notes, if any, may be declared to be forthwith due and payable as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (and shall be deemed to have become automatically due and payable in the circumstances provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, notwithstanding any stay, injunction or other prohibition preventing such declaration (or such obligations from becoming automatically due and payable) as against Borrower and that, in the event of such declaration (or such obligations being deemed to have become automatically due and payable), such obligations (whether or not due and payable by Borrower) shall forthwith become due and payable by the Guarantors for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Instrument for the Payment of Money. Each Guarantor hereby acknowledges that the guarantee in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> constitutes an instrument for the payment of money, and consents and agrees that any Lender or Agent, at its sole option, in the event of a dispute by such Guarantor in the payment of any moneys due hereunder, shall have the right to bring a motion-action under New York CPLR Section 3213.</font></div><div style="margin-top:0.3pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Continuing Guarantee. Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the guarantee in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">is a continuing guarantee of payment, and shall apply to all Guaranteed Obligations whenever arising.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">General Limitation on Guaranteed Obligations. If in any action or proceeding involving any state corporate limited partnership or limited liability company law, or any applicable state, federal or foreign bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer law or regulation, or other law affecting the rights of creditors generally, the obligations of any Guarantor under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> would otherwise be held or determined to be void, voidable, invalid or unenforceable, or subordinated to the claims of any other creditors, on account of the amount of its liability under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, then, notwithstanding any other provision to the contrary, the amount of such liability shall, without any further action by such Guarantor, any Loan Party or any other Person, be automatically limited and reduced to the highest amount that is valid and enforceable and not subordinated to the claims of other creditors.</font></div><div style="padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Release of Guarantors. If, in compliance with the terms and provisions of the Loan Documents, (x) all of the Capital Stock of any Guarantor is sold or otherwise transferred (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Transferred Guarantor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to a Person or Persons, none of which is Borrower or a Restricted Subsidiary or (y) such Guarantor becomes an Excluded Subsidiary, then such Transferred Guarantor or Excluded Subsidiary shall, upon the consummation of such sale or transfer or the Transferred Guarantor would qualify as an Excluded Subsidiary upon the consummation of such sale or transfer or upon becoming an Excluded Subsidiary, as applicable, be released from its obligations under this Agreement (including under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof) and its obligations to pledge and grant any Collateral owned by it pursuant to any Security Document and the pledge of such Capital Stock of such Transferred Guarantor to the Collateral Agent pursuant to the Security Agreement shall be released, and the Collateral Agent shall take such actions as are necessary to effect each such release in accordance with the relevant provisions of the Security Documents within no more than 30 days from notice to the Collateral Agent of such transfer.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Keepwell. Each Loan Party that is a Qualified ECP Guarantor at the time the guaranty or the grant of the security interest hereunder and under the other Loan Documents, in each case, by any Specified Loan Party, becomes effective with respect to any Swap Obligation, hereby jointly and severally, absolutely, unconditionally and irrevocably undertakes to provide such funds or other</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_448"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:11.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">support to each Specified Loan Party with respect to such Swap Obligation as may be needed by such Specified Loan Party from time to time to honor all of its obligations under its guarantee and the other Loan Documents in respect of such Swap Obligation (but, in each case, only up to the maximum amount of such liability that can be hereby incurred without rendering such Qualified ECP Guarantor&#8217;s obligations and undertakings under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> voidable under applicable law relating to fraudulent conveyance or fraudulent transfer, and not for any greater amount). The obligations and undertakings of each Qualified ECP Guarantor under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall remain in full force and effect until the Guaranteed Obligations have been indefeasibly paid and performed in full. Each Qualified ECP Guarantor intends this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to constitute, and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be deemed to constitute, a guarantee of the obligations of, and a &#8220;keepwell, support, or other agreement&#8221; for the benefit of, each Specified Loan Party for all purposes of the Commodity Exchange Act.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:188.1pt;padding-right:188.1pt;text-align:center;text-indent:-0.15pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:231%">SECTION 11</font></div><div style="padding-left:98.1pt;padding-right:98.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MISCELLANEOUS</font></div><div style="padding-left:98.1pt;padding-right:98.1pt;text-align:center"><font><br></font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;padding-left:12.25pt">Amendments and Waivers. Neither this Agreement, any other Loan Document, nor any terms hereof or thereof may be amended, supplemented or modified except in accordance with the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">. Amendments prior to the completion of the syndication of the Commitments (as determined by the Administrative Agent) shall, in addition to the other consents required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, require the consent of the Administrative Agent. Subject to the preceding sentence, the Required Lenders and each Loan Party to the relevant Loan Document may, or, with the written consent of the Required Lenders, the Administrative Agent or the Collateral Agent, as applicable, and each Loan Party to the relevant Loan Document may, from time to time, (a) enter into written amendments, supplements or modifications hereto and to the other Loan Documents for the purpose of adding any provisions to this Agreement or the other Loan Documents or changing in any manner the rights of the Lenders or of the Loan Parties hereunder or thereunder or (b) waive, on such terms and conditions as the Required Lenders or the Administrative Agent or Collateral Agent, as the case may be, may specify in such instrument, any of the requirements of this Agreement or the other Loan Documents or any Default and its consequences&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 2.25</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, the Commitments and the Total Revolving Extensions of Credit of a Defaulting Lender shall not be included in determining whether the Required Lenders have taken or may take any action hereunder&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, that no such waiver and no such amendment, supplement or modification shall (i) reduce or forgive the principal amount or extend the final scheduled date of maturity of any Loan, extend the scheduled date of any amortization payment in respect of any Term Loan, reduce the stated rate of any interest, premium or fee payable hereunder (except (x) in connection with the waiver of applicability of any post-default increase in interest rates and (y) that any amendment or modification of defined terms used in the financial covenants in this Agreement shall not constitute a reduction in the rate of interest or fees for purposes of this clause (i)) or extend the scheduled date of any payment thereof, or increase the amount or extend the expiration date of any Lender&#8217;s Revolving Commitment under the applicable Revolving Facility or increase the maximum duration of Interest Periods hereunder or alter the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> (it being understood that if additional Classes of Term Loans or additional Loans under this Agreement consented to by the Required Lenders or additional Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> are made, such new Loans being included on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> basis within </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> shall not be considered an alteration thereof), in each case without the written consent of each Lender directly affected thereby (but without requiring the consent of the Required Lenders)&#59; (ii) &#91;reserved&#93;&#59; (iii) reduce any percentage specified in the definition of &#8220;Required Lenders,&#8221; consent to the assignment or transfer by the Borrower of any of its rights and obligations under this Agreement and the other Loan Documents, release all or substantially all of the Collateral or release all or substantially all of the Guarantors from their guarantee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%">, in each case without the written consent of all Lenders (it being understood that lenders added pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> or lenders under additional Classes of Term Loans or additional Loans under</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_451"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">this Agreement consented to by the Required Lenders being included in such definition shall not be deemed to require the written consent of all Lenders)&#59; (iv) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of the Majority Facility Lenders in respect of each Facility adversely affected thereby&#59; (v) reduce the percentage specified in the definition of &#8220;Majority Facility Lenders&#8221; with respect to any Facility without the written consent of all Lenders under such Facility&#59; (vi) change the application of prepayments as among or between Facilities under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, without the written consent of the Majority Facility Lenders of each Facility that is being allocated a lesser prepayment as a result thereof (it being understood that if additional Classes of Term Loans or additional Loans under this Agreement consented to by the Required Lenders or additional Loans pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> are made, such new Loans may be included on a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">pro rata</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> basis in the various prepayments required pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.11(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; (vii) expressly change or waive any condition precedent in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> to any borrowing under the Revolving Facility without the written consent of the Majority Facility Lenders with respect to the applicable Revolving Facility (but without requiring the consent of the Required Lenders)&#59; (viii) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of the Administrative Agent&#59; (ix) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of the Swingline Lender&#59; (x) amend, modify or waive any provision of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of the Issuing Lender&#59; (xi) amend </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 1.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or the definition of &#8220;Alternative Currency&#8221; without the written consent of each Alternative Currency Revolving Lender, or (xii) amend, modify or waive any provision of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> without the written consent of each Lender. Any such waiver and any such amendment, supplement or modification shall apply equally to each of the Lenders and shall be binding upon the Loan Parties, the Lenders, the Administrative Agent and all future holders of the Loans. In the case of any waiver, the Loan Parties, the Lenders and the Administrative Agent shall be restored to their former position and rights hereunder and under the other Loan Documents, and any Default or waived shall be deemed to be cured and not continuing&#59; but no such waiver shall extend to any subsequent or other Default, or impair any right consequent thereon. Notwithstanding the foregoing, amendments to or waivers of any other terms or provisions relating solely to the Revolving Facility (including, without limitation, the waiver of conditions to borrowings, amendments and waivers related to pricing and other modifications affecting only the Revolving Facility, but not increases in the amount of Revolving Commitments) will require only the written approval of the Majority Facility Lenders with respect to the Revolving Facility (or each Revolving Lender to the extent the applicable amendment, waiver or modification would otherwise require more than the consent of the Required Lenders), the Administrative Agent, the Swingline Lender (if applicable pursuant to clause (x) of this paragraph), the Issuing Lender (if applicable pursuant to clause (xi) of this paragraph) and the Borrower.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Without the consent of any other Person, the applicable Loan Party or Parties and the Administrative Agent and&#47;or Collateral Agent may (in its or their respective sole discretion, or shall, to the extent required by any Loan Document) enter into any amendment or waiver of any Loan Document, or enter into any new agreement or instrument, to effect the granting, perfection, protection, expansion or enhancement of any security interest in any Collateral or additional property to become Collateral for the benefit of the Secured Parties, or as required by local law to give effect to, or protect, any security interest for the benefit of the Secured Parties, in any property or so that the security interests therein comply with applicable Requirements of Law.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.85pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If, in connection with any proposed change, waiver, discharge or termination of the provisions of this Agreement as contemplated by this Section that requires the consent of all of the Lenders affected, the consent of more than 50% of the Lenders whose consent is required is obtained but the consent of one or more of such other Lenders whose consent is required is not obtained, then the Borrower shall have the right to replace all, but not less than all, of such non-consenting Lender or Lenders (so long as all non-consenting Lenders are so replaced) with one or more Persons pursuant to</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_454"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> so long as at the time of such replacement each such new Lender consents to the proposed change, waiver, discharge or termination.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, this Agreement may be amended (or amended and restated) solely with the written consent of the Administrative Agent, the Borrower and the Lenders providing the relevant Replacement Term Loans (as such term is defined below) to permit the refinancing of all or any portion of any Class of Term Loans outstanding as of the applicable date of determination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Refinanced Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) with a replacement term loan tranche hereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Replacement Term Loans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (i) the aggregate principal amount of such Replacement Term Loans shall not exceed the aggregate principal amount of such Refinanced Term Loans plus premiums, accrued interest, fees and expenses in connection therewith, (ii) the Applicable Margin for such Replacement Term Loans shall not be higher than the Applicable Margin for such Refinanced Term Loans, unless any such higher Applicable Margin applies after the Maturity Date for the Refinanced Term Loans, (iii) the Weighted Average Life to Maturity and final maturity of such Replacement Term Loans shall not be shorter than the Weighted Average Life to Maturity and final maturity of such Refinanced Term Loans at the time of such refinancing (without giving effect to nominal amortization for periods where amortization has been eliminated as a result of a prepayment of the applicable Refinanced Term Loans), (iv) the mandatory prepayment and optional prepayment provisions of the Replacement Term Loans shall not require more than pro rata payments and may permit optional prepayments and mandatory prepayments to be paid in respect of the Term Loans not constituting Refinanced Term Loans and (v) the covenants, events of default and guarantees shall be not materially more restrictive (taken as a whole) (as determined in good faith by the Borrower) to the Lenders providing such Replacement Term Loans than the covenants, events of default and guarantees applicable to such Refinanced Term Loans, except to the extent necessary to provide for covenants, events of default and guarantees applicable to any period after the maturity date in respect of the Refinanced Term Loans in effect immediately prior to such refinancing.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Notices.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Except in the case of notices and other communications expressly permitted to be given by telephone (and subject to paragraph (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopy, as follows&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-32.2pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.83pt">if to a Loan Party, to the Borrower at DaVita Inc., 2000 16th Street, Denver, Colorado 80202, Attention of Chief Financial Officer (Telecopy No. (303) 876-0963), with a copy to DaVita Inc., 2000 16th Street, Denver, Colorado 80202, Attention of Chief Legal Officer (Telecopy No. (303) 876-0963)&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">if to the Administrative Agent, Collateral Agent, Issuing Lender, Swingline Lender or with respect to Alternative Currency Revolving Facility, Wells Fargo Bank, National Association, 550 South Tryon Street, Charlotte, North Carolina 28202 (Email&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">agencyservices.requests&#64;wellsfargo.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:113pt;text-indent:-38.4pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.93pt">if to any other Lender, to it at its address (or telecopy number) set forth in its Administrative Questionnaire.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Any party hereto may change its address or telecopy number for notices and other communications hereunder by notice to the other parties hereto. All notices and other communications given to any party hereto in accordance with the provisions of this Agreement shall be deemed to have been given on the date of receipt.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_457"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt;text-decoration:underline">Electronic Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notices and other communications to the Lenders and the Issuing Lender hereunder may (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) be delivered or furnished by electronic communication (including e-mail and Internet or intranet websites) pursuant to procedures approved by the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the foregoing shall not apply to notices to any Lender or the Issuing Lender pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if such Lender or the Issuing Lender, as applicable, has notified the Administrative Agent that it is incapable of receiving notices under such Section by electronic communication. The Administrative Agent, the Collateral Agent or the Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it (including as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that approval of such procedures may be limited to particular notices or communications.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:8.65pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender&#8217;s receipt of an acknowledgement from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return e-mail or other written acknowledgement)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if such notice or other communication is not sent during the normal business hours of the recipient, such notice or communication shall be deemed to have been sent at the opening of business on the next business day for the recipient, and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt;text-decoration:underline">Posting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each Loan Party hereby agrees that it will provide to the Administrative Agent all information, documents and other materials that it is obligated to furnish to the Administrative Agent pursuant to this Agreement and any other Loan Document, including all notices, requests, financial statements, financial and other reports, certificates and other information materials, but excluding any such communication that (i) relates to a request for a new, or a conversion of an existing, Loan or other extension of credit (including any election of an interest rate or interest period relating thereto), (ii) relates to the payment of any principal or other amount due under this Agreement prior to the scheduled date therefor, (iii) provides notice of any Default under this Agreement or (iv) is required to be delivered to satisfy any condition precedent to the effectiveness of this Agreement and&#47;or any borrowing or other extension of credit hereunder (all such non-excluded communications, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Communications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), by transmitting the Communications in an electronic&#47;soft medium in a format reasonably acceptable to the Administrative Agent at agencyservices.requests&#64;wellsfargo.com or at such other e-mail address(es) provided to the Borrower from time to time or in such other form, including hard copy delivery thereof, as the Administrative Agent shall require. In addition, each Loan Party agrees to continue to provide the Communications to the Administrative Agent in the manner specified in this Agreement or any other Loan Document or in such other form, including hard copy delivery thereof, as the Administrative Agent shall require. Nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall prejudice the right of the Agents, any Lender or any Loan Party to give any notice or other communication pursuant to this Agreement or any other Loan Document in any other manner specified in this Agreement or any other Loan Document or as any such Agent shall require.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">To the extent consented to by the Administrative Agent in writing from time to time, Administrative Agent agrees that receipt of the Communications by the Administrative Agent at its e-mail address(es) set forth above shall constitute effective delivery of the Communications to the Administrative Agent for purposes of the Loan Documents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> that the Borrower shall also deliver to the Administrative Agent an executed original of each Compliance Certificate required to be delivered hereunder.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_460"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.15pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Each Loan Party further agrees that Administrative Agent may make the Communications available to the Lenders by posting the Communications on Intralinks or a substantially similar electronic transmission system (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Platform</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The Platform is provided &#8220;as is&#8221; and &#8220;as available.&#8221; The Agents do not warrant the accuracy or completeness of the Communications, or the adequacy of the Platform and expressly disclaim liability for errors or omissions in the communications. No warranty of any kind, express, implied or statutory, including, without limitation, any warranty of merchantability, fitness for a particular purpose, non-infringement of third party rights or freedom from viruses or other code defects, is made by any Agent in connection with the Communications or the Platform. In no event shall the Administrative Agent or any of its Related Parties have any liability to the Loan Parties, any Lender or any other Person for damages of any kind, including direct or indirect, special, incidental or consequential damages, losses or expenses (whether in tort, contract or otherwise) arising out of any Loan Party&#8217;s or the Administrative Agent&#8217;s transmission of communications through the Internet, except to the extent the liability of such Person is found in a final non-appealable judgment by a court of competent jurisdiction to have resulted from such Person&#8217;s gross negligence or willful misconduct.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">No Waiver&#59; Cumulative Remedies. No failure to exercise and no delay in exercising, on the part of the Administrative Agent or any Lender, any right, remedy, power or privilege hereunder or under the other Loan Documents shall operate as a waiver thereof&#59; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Survival. All covenants, agreements, representations and warranties made by the Loan Parties herein and in the certificates or other instruments delivered in connection with or pursuant to this Agreement shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of this Agreement and the making of any Loans and issuance of any Letters of Credit, regardless of any investigation made by any such other party or on its behalf and notwithstanding that the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender may have had notice or knowledge of any Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the principal of or any accrued interest on any Loan or any fee or any other amount payable under this Agreement is outstanding and unpaid or any Letter of Credit is outstanding and so long as the Commitments have not expired or terminated. The provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Letters of Credit and the Commitments or the termination of this Agreement or any provision hereof.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Expenses&#59; Indemnity&#59; Damage Waiver.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The Borrower shall pay (i) all reasonable out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent and their respective Affiliates, including the reasonable fees, charges and disbursements of one primary outside counsel, and one local counsel in each applicable jurisdiction, for the Administrative Agent and the Collateral Agent, in connection with the syndication of the credit facilities provided for herein, the preparation and administration of this Agreement, the Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof (whether or not the transactions contemplated hereby or thereby shall be consummated), (ii) all reasonable out-of-pocket expenses incurred by the Issuing Lender in connection with the issuance, amendment, renewal or extension of any Letter of Credit or any demand for payment thereunder and (iii) all reasonable out-of-pocket expenses incurred by the Administrative Agent, the Collateral Agent, the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_463"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:14.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Issuing Lender or any Lender, including the reasonable and documented out-of-pocket fees, charges and disbursements of any counsel for the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender, in connection with the enforcement or protection of its rights in connection with this Agreement, including its rights under this Section, or in connection with the Loans made or Letters of Credit issued hereunder, including all such out-of-pocket expenses incurred during any workout, restructuring or negotiations in respect of such Loans or Letters of Credit&#59; provided that in the case of counsel such fees, charges and disbursement shall be limited to the reasonable and documented out-of-pocket fees, charges and disbursements of one primary outside counsel, and one local counsel in each applicable jurisdiction, for the Administrative Agent and one outside counsel, and one local counsel in each applicable jurisdiction, for the Lenders taken as a group (unless there is an actual or perceived conflict of interest in which case each such other Lender may retain its own counsel)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the Borrower shall not be obligated to pay legal fees and expenses incurred pursuant to clauses (i) and (ii) above in connection with the syndication of the credit facilities or the preparation of the Loan Documents prior to the initial Credit Extension.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">The Borrower shall indemnify the Administrative Agent (or any sub-agent thereof), the Collateral Agent (or any sub-agent thereof), the Issuing Lender and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses, including the reasonable and documented out-of-pocket fees, charges and disbursements of counsel for any Indemnitee (limited to the reasonable and documented out-of-pocket fees, charges and disbursements of one primary outside counsel for all Indemnitees taken as a group (unless there is an actual or perceived conflict of interest in which case each such other Indemnitee may retain its own counsel)), incurred by or asserted against any Indemnitee arising out of, in connection with or as a result of (i) the execution or delivery of this Agreement, any Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder or the consummation of the Transactions or any other transactions contemplated hereby or thereby, (ii) any Loan or Letter of Credit or the use of the proceeds therefrom (including any refusal by the Issuing Lender to honor a demand for payment under a Letter of Credit if the documents presented in connection with such demand do not strictly comply with the terms of such Letter of Credit), (iii) any actual or alleged presence or Release or threatened Release of Hazardous Materials at, on, under or from any property owned or operated by any Restricted Company, any Environmental Liability related in any way to any Restricted Company or any violation of healthcare laws related in any way to any Restricted Company, or (iv) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, regardless of whether brought by a third party or by a Loan Party and regardless of whether any Indemnitee is a party thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (a) are determined by a court of competent jurisdiction by final and nonappealable judgment (i) to have arisen from the material breach by such Indemnitee or of any Affiliate of such Indemnitee of this Agreement or any other Loan Document or (ii) to have been incurred primarily by reason of the gross negligence, bad faith or willful misconduct of such Indemnitee or of any Affiliate of such Indemnitee or (b) resulted from any dispute solely among Indemnitees&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that that if any Indemnitee shall receive indemnification that is later disallowed by this proviso, it shall promptly repay to the Borrower any such funds. This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.5(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply to Taxes, other than Taxes that represent liabilities, losses, damages, etc., resulting from a non-Tax claim.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">To the extent that the Borrower fails to pay any amount required to be paid by it to the Administrative Agent (or any sub-agent thereof), the Collateral Agent (or any sub-agent thereof), the Issuing Lender or the Swingline Lender under paragraph (a) or (b) of this Section, each Lender severally agrees to pay to the Administrative Agent, the Collateral Agent, the Issuing Lender or the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_466"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Swingline Lender, as the case may be, such Lender&#8217;s Aggregate Exposure Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent, the Collateral Agent, the Issuing Lender or the Swingline Lender in its capacity as such.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">To the extent permitted by applicable law, no Loan Party or Indemnitee shall assert, and each hereby waives, any claim against any other party to this Agreement or any Indemnitee, on any theory of liability, for special, indirect, consequential or punitive damages (as opposed to direct or actual damages) arising out of, in connection with, or as a result of, this Agreement, any Loan Document or any agreement or instrument contemplated hereby or thereby, the Transactions, any Loan or Letter of Credit or the use of the proceeds thereof. No Indemnitee referred to in paragraph (b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed by it through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby.</font></div><div style="padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">All amounts due under this Section shall be payable promptly after written demand therefor (together with backup documentation supporting such reimbursement request).</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Successors and Assigns&#59; Participations and Assignments.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby (including any affiliate of the Issuing Lender that issues any Letter of Credit), except that (i) the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of each Lender (and any attempted assignment or transfer by the Borrower without such consent shall be null and void) and (ii) no Lender may assign or otherwise transfer its rights or obligations hereunder except in accordance with this Section. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby (including any Affiliate of the Issuing Lender that issues any Letter of Credit), Participants (to the extent provided in paragraph (c) of this Section) and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent, the Issuing Lender and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">(i) Subject to the conditions set forth in paragraph (b)(ii) below, any Lender may assign to one or more assignees (other than the Borrower or any of its Affiliates or a natural person) (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Assignee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) all or a portion of its rights and obligations under this Agreement (including all or a portion of Commitments and the Loans at the time owing to it) with the prior written consent (such consent not to be unreasonably withheld or delayed) of&#58;</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.24pt">the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Borrower shall be required for an assignment to a Lender, an affiliate of a Lender, an Approved Fund or, if an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.1(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> has occurred and is continuing, any other Person (other than a Disqualified Lender)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within five (5) Business Days after having received notice thereof&#59;</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.85pt">the Administrative Agent&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Administrative Agent shall be required for an assignment to a Lender, an affiliate of a Lender or an Approved Fund&#59; and</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_469"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.85pt">the Issuing Lender and the Swingline Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no consent of the Issuing Lender or the Swingline Lender shall be required for an assignment of all or any portion of a Term Loan.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.88pt">Assignments shall be subject to the following additional conditions&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.24pt">except in the case of an assignment to a Lender, an affiliate of a Lender or an Approved Fund or an assignment of the entire remaining amount of the assigning Lender&#8217;s Commitments or Loans under any Facility, the amount of the Commitments or Loans of the assigning Lender subject to each such assignment (determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent) shall not be less than $5,000,000 (or, in the case of the Tranche B-1 Term Facility, $1,000,000) unless each of the Borrower and the Administrative Agent otherwise consents&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (1) no such consent of the Borrower shall be required if an Event of Default under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 8.1(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> has occurred and is continuing and (2) such amounts shall be aggregated in respect of each Lender and its affiliates or Approved Funds, if any&#59;</font></div><div style="padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.85pt">each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations under this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this clause shall not be construed to prohibit the assignment of a proportionate part of all the assigning Lender&#8217;s rights and obligations in respect of one Facility&#59;</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.85pt">the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee of $3,500 (provided that the Administrative Agent may waive such fee in its sole discretion)&#59;</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.24pt">the Assignee, if it shall not be a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire&#59; and</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.47pt">the Assignee shall not be a natural person or Defaulting Lender.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">For the purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, the term &#8220;Approved Fund&#8221; has the following</font></div><div style="padding-left:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">meaning&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41pt;padding-right:14.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Approved Fund</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any Person (other than a natural person) that is engaged in making, purchasing, holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.25pt;text-indent:69.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.93pt">Subject to acceptance and recording thereof pursuant to paragraph (b)(iv) below, from and after the effective date specified in each Assignment and Assumption the Assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the assigning Lender&#8217;s rights and obligations under this Agreement, such Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">). Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (c) of this Section.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_472"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:18.45pt;text-indent:70.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.73pt">The Administrative Agent, acting for this purpose as an agent of the Borrower, shall maintain at one of its offices a copy of each Assignment and Assumption delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amount (and interest amounts) of the Loans and LC Disbursements owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). The entries in the Register shall be conclusive, and the Borrower, the Administrative Agent, the Issuing Lender and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Agents, the Borrower, the Issuing Lender and any Lender, at any reasonable time and from time to time upon reasonable prior notice.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:7.95pt;text-indent:73.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:16.63pt">Upon its receipt of a duly completed Assignment and Assumption executed by an assigning Lender and an Assignee, the Assignee&#8217;s completed Administrative Questionnaire (unless the Assignee shall already be a Lender hereunder), the processing and recordation fee referred to in paragraph (b) of this Section and any written consent to such assignment required by paragraph (b) of this Section, the Administrative Agent shall accept such Assignment and Assumption and record the information contained therein in the Register&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that if either the assigning Lender or the assignee shall have failed to make any payment required to be made by it pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.17(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the Administrative Agent shall have no obligation to accept such Assignment and Assumption and record the information therein in the Register unless and until such payment shall have been made in full, together with all accrued interest thereon. No assignment shall be effective for purposes of this Agreement unless it has been recorded in the Register as provided in this paragraph.</font></div><div><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">(i) Any Lender may, without the consent of the Borrower, the Administrative Agent, the Issuing Lender or the Swingline Lender, sell participations to one or more banks or other entities (other than a Disqualified Lender) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in all or a portion of such Lender&#8217;s rights and obligations under this Agreement (including all or a portion of its Commitments and the Loans owing to it)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that (A) such Lender&#8217;s obligations under this Agreement shall remain unchanged, (B) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (C) the Borrower, the Administrative Agent, the Issuing Lender and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender&#8217;s rights and obligations under this Agreement. Any agreement pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that such agreement may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that (1) requires the consent of each Lender directly affected thereby pursuant to the second proviso to the third sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (2) directly affects such Participant. Subject to paragraph (c)(ii) of this Section, the Borrower agrees that each Participant shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (subject to the requirements and limitations of such Sections, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">), and shall be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (b) of this Section (provided that any documentation required to be provided pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.19(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be provided solely to the participating Lender). To the extent permitted by law, each Participant also shall be entitled to the benefits of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.7(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> such Participant shall be subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.7(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> as though it were a Lender. Notwithstanding the foregoing, each Loan Party and the Lenders acknowledge and agree that the Administrative Agent shall not have any responsibility to determine the compliance of any Lender with the requirements of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (it being understood that each Lender shall be responsible for ensuring its own compliance with the requirements of this Section).</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_475"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:113pt;text-indent:-35.3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:21.88pt">A Participant shall not be entitled to receive any greater payment under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">2.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> than the applicable Lender would have been entitled to receive with respect to the participation sold to such Participant, unless the sale of the participation to such Participant is made with the Borrower&#8217;s prior written consent, which shall not be unreasonably withheld or delayed.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-38.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:21.93pt">Each Lender that sells a participation, acting solely for this purpose as a non-fiduciary agent of the Borrower, shall maintain at one of its offices a register on which it enters the names and addresses of each Participant and the principal amounts (and interest amounts) of each Participant&#8217;s interest in the Loans or other obligations under this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Participant Register</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant's interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive, and such Lender shall treat each Person whose name is recorded in the Participant Register pursuant to the terms hereof as the owner of such participation for all purposes of this Agreement, notwithstanding notice to the contrary.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or similar central banking authority, and this Section shall not apply to any such pledge or assignment of a security interest&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that no such pledge or assignment of a security interest shall release a Lender from any of its obligations hereunder or substitute any such pledgee or Assignee for such Lender as a party hereto.</font></div><div style="margin-top:0.2pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding the foregoing, any Conduit Lender may assign any or all of the Loans it may have funded hereunder to its designating Lender without the consent of the Borrower or the Administrative Agent and without regard to the limitations set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Each of the Borrower, each Lender and the Administrative Agent hereby confirms that it will not institute against a Conduit Lender or join any other Person in instituting against a Conduit Lender any bankruptcy, reorganization, arrangement, insolvency or liquidation proceeding under any state bankruptcy or similar law, for one year and one day after the payment in full of the latest maturing commercial paper note issued by such Conduit Lender&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that each Lender designating any Conduit Lender hereby agrees to indemnify, save and hold harmless each other party hereto for any loss, cost, damage or expense arising out of its inability to institute such a proceeding against such Conduit Lender during such period of forbearance.</font></div><div style="margin-top:0.55pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.52pt">The Borrower, at its sole expense and upon receipt of written notice from the relevant Lender, agrees to issue Note(s) to any Lender requiring Note(s) to facilitate transactions of the type described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:0.4pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Adjustments&#59; Set-off.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Except to the extent that this Agreement expressly provides for payments to be allocated to a particular Lender or to the Lenders under a particular Facility, if any Lender (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Benefitted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall receive any payment of all or part of the Obligations owing to it, or receive any collateral in respect thereof (whether voluntarily or involuntarily, by set-off, pursuant to events or proceedings of the nature referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.1(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or otherwise), in a greater proportion than any such payment to or collateral received by any other Lender, if any, in respect of the Obligations owing to such other Lender, such Benefitted Lender shall purchase for cash from the other Lenders a participating interest in such portion of the Obligations owing to each such other Lender, or shall provide such other Lenders with the</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_478"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:9.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">benefits of any such collateral, as shall be necessary to cause such Benefitted Lender to share the excess payment or benefits of such collateral ratably with each of the Lenders&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that if all or any portion of such excess payment or benefits is thereafter recovered from such Benefitted Lender, such purchase shall be rescinded, and the purchase price and benefits returned, to the extent of such recovery, but without interest.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">If an Event of Default shall have occurred and be continuing, each Lender and each of its Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or final) at any time held and other obligations at any time owing by such Lender or Affiliate to or for the credit or the account of the Borrower against any of and all the obligations of the Borrower now or hereafter existing under this Agreement held by such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement and although such obligations may be unmatured. The rights of each Lender under this Section are in addition to other rights and remedies (including other rights of setoff) which such Lender may have.</font></div><div style="margin-top:0.05pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding the provisions of this Agreement, if at any time any Lender, any Issuing Lender or any of their respective Affiliates maintains one or more deposit accounts for the Borrower or any Guarantor into which Medicare and&#47;or Medicaid receivables are deposited, such Lender or Issuing Lender or their applicable Affiliate hereby waives the right of setoff set forth herein.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Counterparts&#59; Integration&#59; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement and any separate letter agreements with respect to fees payable to the Administrative Agent constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof which, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. Delivery of an executed counterpart of a signature page of this Agreement by telecopy shall be effective as delivery of a manually executed counterpart of this Agreement.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.25pt">Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_481"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.3pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK (INCLUDING, WITHOUT LIMITATION, SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT OTHERWISE WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF).</font></div><div style="margin-top:0.05pt"><font><br></font></div><div id="i66fa5437d00449c287748a0afadd48cb_484"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.568%"><div style="margin-top:4.6pt;padding-left:101.85pt;text-indent:-24.9pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">11.12</font></div></div><div style="display:inline-block;max-width:0.862%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.570%"><div style="padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Submission to Jurisdiction&#59; Waivers. Each party hereby irrevocably and unconditionally.</font></div></div></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:41pt;padding-right:7.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">submits for itself and its property in any legal action or proceeding relating to this Agreement and the other Loan Documents to which it is a party, or for recognition and enforcement of any judgment in respect thereof, to the exclusive general jurisdiction of the courts of the State of New York, New York County, the courts of the United States for the Southern District of New York, and appellate courts from any thereof&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">consents that any such action or proceeding may be brought in such courts and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same and agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:41pt;padding-right:18.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, to it at its address set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or at such other address of which the Administrative Agent shall have been notified pursuant thereto&#59;</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:41pt;padding-right:9.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:21.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">waives, to the maximum extent not prohibited by law, any right it may have to claim or recover in any legal action or proceeding referred to in this Section any special, exemplary, punitive or consequential damages.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:113pt;text-indent:-36pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.25pt">Acknowledgments. Each of the Loan Parties hereby acknowledges that&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:41pt;padding-right:16.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">it has been advised by counsel in the negotiation, execution and delivery of this Agreement and the other Loan Documents&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:41pt;padding-right:8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.18pt">neither the Administrative Agent or the Collateral Agent nor any Lender has any fiduciary relationship with or duty to any Loan Party arising out of or in connection with this Agreement or any of the other Loan Documents, and the relationship between the Administrative Agent, the Collateral Agent and Lenders, on one hand, and the Loan Parties, on the other hand, in connection herewith or therewith is solely that of debtor and creditor&#59; and</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_487"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:4.5pt;padding-right:16.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">no joint venture is created hereby or by the other Loan Documents or otherwise exists by virtue of the transactions contemplated hereby among the Lenders or among the Loan Parties and the Lenders.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Releases of Guarantees and Liens.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:19.3pt">Notwithstanding anything to the contrary contained herein or in any other Loan Document, the Collateral Agent is hereby irrevocably authorized by each Lender (without requirement of notice to or consent of any Lender except as expressly required by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) to take any action requested by the Borrower having the effect of releasing any Collateral or any Guarantor (i), if such Person becomes an Excluded Subsidiary as a result of a transaction or designation permitted hereunder or in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, no such release shall occur if such Guarantor continues to be a guarantor in respect of the 2022 Senior Notes, 2024 Senior Notes, the 2025 Senior Notes, any Permitted Other Debt or any Credit Agreement Refinancing Debt, (ii) with (A) the sale of such Collateral, in each case, to a Person or Persons, none of which is the Borrower or a Guarantor, in compliance with the terms and provisions of the Loan Documents or (B) a transaction that has been consented to in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (iii) under the circumstances described in paragraph (b) below.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.68pt">At such time as the Loans, the LC Disbursements and the Obligations (other than obligations under or in respect of Swap Agreements) shall have been paid in full, the Commitments have been terminated and no Letters of Credit shall be outstanding, the Collateral shall be released from the Liens created by the Security Documents, and the Security Documents and all obligations (other than those expressly stated to survive such termination) of the Collateral Agent and each Loan Party under the Security Documents shall terminate, all without delivery of any instrument or performance of any act by any Person.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Confidentiality. Each of the Administrative Agent, the Collateral Agent, the Issuing Lender and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its and its Affiliates&#8217; directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent requested by any regulatory authority, including by any self-regulatory body having jurisdiction over such Lender, (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies hereunder or any suit, action or proceeding relating to this Agreement or the enforcement of rights hereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement, (ii) any pledgee or prospective pledgee referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11.6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or (iii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g) with the consent of the Borrower or (h) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender on a nonconfidential basis from a source other than the Borrower. For the purposes of this Section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means all information received from the Borrower relating to the Borrower or its business, other than any such information that is available to the Administrative Agent, the Collateral Agent, the Issuing Lender or any Lender on a nonconfidential basis prior to disclosure by the Borrower&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that, in the case of information received from the Borrower after the Closing Date, such information is clearly identified at the time of delivery as confidential. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_490"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Headings. Section headings and the Table of Contents used herein are for convenience of reference only, are not part of this Agreement and shall not affect the construction of, or be taken into consideration in interpreting, this Agreement.</font></div><div style="margin-top:0.35pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">USA PATRIOT Act. Each Lender that is subject to the requirements of the Patriot Act hereby notifies the Borrower that pursuant to the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender to identify the Borrower in accordance with the Patriot Act.</font></div><div style="margin-top:0.25pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Interest Rate Limitation. Notwithstanding anything herein to the contrary, if at any time the interest rate applicable to any Loan, together with all fees, charges and other amounts which are treated as interest on such Loan under applicable law (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Charges</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), shall exceed the maximum lawful rate (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Maximum Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) which may be contracted for, charged, taken, received or reserved by the Lender holding such Loan in accordance with applicable law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in respect of such Loan but were not payable as a result of the operation of this Section shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Third Party Beneficiary. None of the provisions contained in this Agreement are intended by the parties hereto, nor shall they be deemed, to confer any benefit on any Person not a party to this Agreement other than, to the extent provided herein, any Indemnitee or Secured Party. The representations and warranties of the Loan Parties contained herein are provided for the benefit of the Administrative Agent, the Collateral Agent, the Issuing Lender and each of the Lenders and their respective successors and permitted assigns in accordance herewith, and are not being provided for the benefit of any other Person (which other Person shall include, for this purpose, without limitation, any shareholder of any Loan Party).</font></div><div style="margin-top:0.1pt;padding-left:4.5pt;text-indent:72pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Acknowledgment and Consent to Bail-In of EEA Financial Institutions. Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the write-down and conversion powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by&#58;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:25.2pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution&#59; and</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">the effects of any Bail-In Action on any such liability, including, if applicable&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:113pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">a reduction in full or in part or cancellation of any such liability&#59;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_493"></div><hr style="page-break-after:always"><div style="min-height:67.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:4.05pt;padding-left:5pt;padding-right:10.95pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.58pt">a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent entity, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document&#59; or</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:15.25pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:14.53pt">the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of any EEA Resolution Authority.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:4.5pt;text-indent:72pt"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:6.75pt">Acknowledgment Regarding Any Supported QFCs. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Agreement or any other agreement or instrument that is a QFC (such support, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC Credit Support</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, and each such QFC, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supported QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">U.S. Special Resolution Regimes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and&#47;or of the United States or any other state of the United States)&#58;</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.3pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.8pt">In the event a Covered Entity that is party to a Supported QFC (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support</font></div><div style="padding-right:9.3pt;text-indent:90pt"><font><br></font></div><div style="margin-top:1.8pt;padding-left:77pt;padding-right:7.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;padding-left:18.18pt">As used in this Section 11.21, the following terms have the following meanings&#58; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%;text-decoration:underline">BHC Act Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:224%">&#8221; of a party means an &#8220;affiliate&#8221; (as such term is defined under, and</font></div><div style="padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:91%">interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Covered Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means any of the following&#58; (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:41pt;padding-right:7.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Default Right</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i66fa5437d00449c287748a0afadd48cb_496"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.3pt;padding-left:41pt;padding-right:14.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">QFC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; has the meaning assigned to the term &#8220;qualified financial contract&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:46.57pt;padding-right:46.57pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Pages Intentionally Omitted&#93;</font></div><div style="height:48.24pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>dva-33123ex31110xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0b7ba143743e4fdc9632814e55d2ecc1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Javier J. Rodriguez, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.00pt"><tr><td style="width:1.0pt"></td><td style="width:277.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2023 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>dva-33123ex31210xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i34650d82afc04a269189209b7127e94c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joel Ackerman, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;8, 2023 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>dva-33123ex32110xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5a9210276d1241c98d9d9c82cf27a9dd_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Javier J. Rodriguez, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>dva-33123ex32210xq.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i31e5305ec720420fa9604d260fd6ec06_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Joel Ackerman, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 8, 2023</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>dva-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.davita.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited">
        <link:definition>0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunauditedParenthetical" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements">
        <link:definition>0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRevenueRecognition" roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition">
        <link:definition>0000009 - Disclosure - Revenue Recognition Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareNotes" roleURI="http://www.davita.com/role/EarningspershareNotes">
        <link:definition>0000010 - Disclosure - Earnings per share (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investmentsindebtandequitysecurities" roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities">
        <link:definition>0000011 - Disclosure - Investments in debt and equity securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.davita.com/role/Goodwill">
        <link:definition>0000012 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Longtermdebt" roleURI="http://www.davita.com/role/Longtermdebt">
        <link:definition>0000013 - Disclosure - Long-term debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.davita.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shareholdersequity" roleURI="http://www.davita.com/role/Shareholdersequity">
        <link:definition>0000015 - Disclosure - Shareholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accumulatedothercomprehensivelossincome" roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome">
        <link:definition>0000016 - Disclosure - Accumulated other comprehensive (loss) income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Variableinterestentities" roleURI="http://www.davita.com/role/Variableinterestentities">
        <link:definition>0000017 - Disclosure - Variable interest entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvalueoffinancialinstruments" roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments">
        <link:definition>0000018 - Disclosure - Fair value of financial instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentreporting" roleURI="http://www.davita.com/role/Segmentreporting">
        <link:definition>0000019 - Disclosure - Segment reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Newaccountingstandards" roleURI="http://www.davita.com/role/Newaccountingstandards">
        <link:definition>0000020 - Disclosure - New accounting standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.davita.com/role/SubsequentEvents">
        <link:definition>0000021 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies">
        <link:definition>0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentrevenuebymajorpayorTables" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables">
        <link:definition>0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningsPerShareTables" roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables">
        <link:definition>0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesTables" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables">
        <link:definition>0000025 - Disclosure - Investments in debt and equity securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.davita.com/role/GoodwillTables">
        <link:definition>0000026 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtTables" roleURI="http://www.davita.com/role/LongtermdebtTables">
        <link:definition>0000027 - Disclosure - Long-term debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeTables" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables">
        <link:definition>0000028 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsTables" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables">
        <link:definition>0000029 - Disclosure - Fair value of financial instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingTables" roleURI="http://www.davita.com/role/SegmentreportingTables">
        <link:definition>0000030 - Disclosure - Segment reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentRevenuebyPayorDetails" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails">
        <link:definition>0000031 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails">
        <link:definition>0000032 - Disclosure - Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesDetail" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail">
        <link:definition>0000033 - Disclosure - Investments in debt and equity securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillChangesinGoodwillbyReportableSegmentsDetail" roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail">
        <link:definition>0000034 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.davita.com/role/GoodwillNarrativeDetails">
        <link:definition>0000035 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtDetail" roleURI="http://www.davita.com/role/LongtermdebtDetail">
        <link:definition>0000036 - Disclosure - Long-term debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtScheduleofDerivativeInstrumentsDetails" roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails">
        <link:definition>0000037 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtAdditionalInformationDetail" roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail">
        <link:definition>0000038 - Disclosure - Long-term debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>0000039 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockbasedcompensationDetails" roleURI="http://www.davita.com/role/StockbasedcompensationDetails">
        <link:definition>0000040 - Disclosure - Stock-based compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesDetails" roleURI="http://www.davita.com/role/SharerepurchasesDetails">
        <link:definition>0000041 - Disclosure - Share repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeDetail" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail">
        <link:definition>0000042 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableinterestentitiesAdditionalInformationDetail" roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail">
        <link:definition>0000043 - Disclosure - Variable interest entities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
        <link:definition>0000044 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsDetails" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails">
        <link:definition>0000045 - Disclosure - Fair value of financial instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
        <link:definition>0000046 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
        <link:definition>0000047 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
        <link:definition>0000048 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofAssetsbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail">
        <link:definition>0000049 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewaccountingstandardsDetails" roleURI="http://www.davita.com/role/NewaccountingstandardsDetails">
        <link:definition>0000050 - Disclosure - New accounting standards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.davita.com/role/SubsequentEventsDetails">
        <link:definition>0000051 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dva_OtherGovernmentPayorsMember" abstract="true" name="OtherGovernmentPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasePurchaseOfInterests" abstract="false" name="TemporaryEquityDecreasePurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_DebtInstrumentPeriodicPaymentStartDate" abstract="false" name="DebtInstrumentPeriodicPaymentStartDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" abstract="false" name="PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" abstract="true" name="EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SegmentRevenuebyMajorPayorAbstract" abstract="true" name="SegmentRevenuebyMajorPayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" abstract="false" name="LongTermDebtPercentageBearingEconomicallyFixedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_OtherSourcesofRevenueMember" abstract="true" name="OtherSourcesofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" abstract="true" name="CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CorporateIntegrityAgreementExpirationDate" abstract="false" name="CorporateIntegrityAgreementExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_TermLoanB1Member" abstract="true" name="TermLoanB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DiscountPremiumAndDeferredFinancingCosts" abstract="false" name="DiscountPremiumAndDeferredFinancingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_MedicareandMedicareAdvantageMember" abstract="true" name="MedicareandMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CommitmentsToProvideOperatingCapitalMember" abstract="true" name="CommitmentsToProvideOperatingCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" abstract="true" name="A2019InterestRateCapAgreementsEffectiveJune302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" abstract="false" name="NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayableFairValue" abstract="false" name="AcquisitionObligationsAndOtherNotesPayableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ExternalSourcesMember" abstract="true" name="ExternalSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CorporateIntegrityAgreementPeriod" abstract="false" name="CorporateIntegrityAgreementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_RegulatoryAndCommercialMilestonesBeginningDate" abstract="false" name="RegulatoryAndCommercialMilestonesBeginningDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" abstract="false" name="DebtInstrumentPeriodicPaymentInterestRateYearOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_CommercialPayorsMember" abstract="true" name="CommercialPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" abstract="false" name="DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseFromContributions" abstract="false" name="NoncontrollingInterestIncreaseFromContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" abstract="true" name="A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessAgreementDate" abstract="false" name="BusinessAgreementDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_PatientCareCosts" abstract="false" name="PatientCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenuesbymajorpayorAbstract" abstract="true" name="RevenuesbymajorpayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_BusinessAgreementEffectiveClosingDate" abstract="false" name="BusinessAgreementEffectiveClosingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" abstract="false" name="SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitions" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_MutualFundsAndCommonStockMember" abstract="true" name="MutualFundsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayable" abstract="false" name="AcquisitionObligationsAndOtherNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" abstract="true" name="TemporaryEquityRedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedLabServicesMember" abstract="true" name="USDialysisAndRelatedLabServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" abstract="false" name="ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" abstract="false" name="DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_OtherReportingUnitsMember" abstract="true" name="OtherReportingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DerivativeEffectiveDate" abstract="false" name="DerivativeEffectiveDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_AgreementWithMedtronicMember" abstract="true" name="AgreementWithMedtronicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AdditionalCashCommitment" abstract="false" name="AdditionalCashCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TrancheTwoMember" abstract="true" name="TrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" abstract="false" name="DebtInstrumentPeriodicPaymentInterestRateYearFive" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RegulatoryAndCommercialMilestonesEndingDate" abstract="false" name="RegulatoryAndCommercialMilestonesEndingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_BilateralSecuredLetterOfCreditFacilityMember" abstract="true" name="BilateralSecuredLetterOfCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SegmentReportingInformationCorporateExpenses" abstract="false" name="SegmentReportingInformationCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" abstract="false" name="ChangeInAccountingPrincipleImpactAbilityToBorrow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_MedicaidandManagedMedicaidMember" abstract="true" name="MedicaidandManagedMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TrancheOneMember" abstract="true" name="TrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TermLoanA1Member" abstract="true" name="TermLoanA1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>dva-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_51b6b4a4-eb7c-4b46-a247-44f0d61cbb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fdb29895-c12b-483d-8215-43f5ef2d1c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_51b6b4a4-eb7c-4b46-a247-44f0d61cbb6c" xlink:to="loc_us-gaap_Revenues_fdb29895-c12b-483d-8215-43f5ef2d1c4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_35bfb08a-f09d-4811-96db-ad4b568e2a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_51b6b4a4-eb7c-4b46-a247-44f0d61cbb6c" xlink:to="loc_us-gaap_CostsAndExpenses_35bfb08a-f09d-4811-96db-ad4b568e2a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152817d6-b114-4ae2-89ba-e22798765818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_49a605b0-0f6e-41bd-aab7-696a2f45846d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152817d6-b114-4ae2-89ba-e22798765818" xlink:to="loc_us-gaap_OperatingIncomeLoss_49a605b0-0f6e-41bd-aab7-696a2f45846d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_ecef5d4e-40a7-4c16-89a7-e55684d3ea29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152817d6-b114-4ae2-89ba-e22798765818" xlink:to="loc_us-gaap_InterestAndDebtExpense_ecef5d4e-40a7-4c16-89a7-e55684d3ea29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d3eac56d-e3d4-44ee-acb3-d3845770cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_152817d6-b114-4ae2-89ba-e22798765818" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d3eac56d-e3d4-44ee-acb3-d3845770cdd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_330d4d7e-e901-4ca2-a070-d44925cff271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_35fed14f-d6a2-457d-876a-b09fb40fea54" xlink:href="dva-20230331.xsd#dva_PatientCareCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_330d4d7e-e901-4ca2-a070-d44925cff271" xlink:to="loc_dva_PatientCareCosts_35fed14f-d6a2-457d-876a-b09fb40fea54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_16942ef2-b230-470b-a4b0-4ff69f55ff1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_330d4d7e-e901-4ca2-a070-d44925cff271" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_16942ef2-b230-470b-a4b0-4ff69f55ff1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_901a9325-d00b-4873-8abd-bc8f8b40c9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_330d4d7e-e901-4ca2-a070-d44925cff271" xlink:to="loc_us-gaap_DepreciationAndAmortization_901a9325-d00b-4873-8abd-bc8f8b40c9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d127f6a-1918-47d6-8285-42d49719fd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_330d4d7e-e901-4ca2-a070-d44925cff271" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0d127f6a-1918-47d6-8285-42d49719fd4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_793f99c4-826c-4aa8-b843-53c2ca6569b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d508fe8a-2088-4d7f-96c6-91ab027c27e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_793f99c4-826c-4aa8-b843-53c2ca6569b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d508fe8a-2088-4d7f-96c6-91ab027c27e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cb74455-128f-4a54-87a2-5babdd114442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_793f99c4-826c-4aa8-b843-53c2ca6569b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cb74455-128f-4a54-87a2-5babdd114442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc19b488-fad6-4315-88d6-20f3f39566b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f45fd029-9d79-4c0d-a082-8e615264cfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bc19b488-fad6-4315-88d6-20f3f39566b8" xlink:to="loc_us-gaap_ProfitLoss_f45fd029-9d79-4c0d-a082-8e615264cfe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_90d3ea58-2f53-4190-878b-915dab96861f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bc19b488-fad6-4315-88d6-20f3f39566b8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_90d3ea58-2f53-4190-878b-915dab96861f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ee935a0b-cf8d-4fe2-9f2b-b87227a8216b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_356d2668-2550-4d91-b8a8-a43e7e4b859c" xlink:href="dva-20230331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ee935a0b-cf8d-4fe2-9f2b-b87227a8216b" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_356d2668-2550-4d91-b8a8-a43e7e4b859c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_14921a59-9450-4e95-b15a-3b5cbf944194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_ee935a0b-cf8d-4fe2-9f2b-b87227a8216b" xlink:to="loc_us-gaap_OtherIncome_14921a59-9450-4e95-b15a-3b5cbf944194" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e84ecf47-7859-4172-9331-02c927dc2362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25890e26-122d-4c91-8eb7-c5776553d8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e84ecf47-7859-4172-9331-02c927dc2362" xlink:to="loc_us-gaap_ProfitLoss_25890e26-122d-4c91-8eb7-c5776553d8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_16cce5ee-c2fe-4f68-8ec6-d4dffb6e5a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e84ecf47-7859-4172-9331-02c927dc2362" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_16cce5ee-c2fe-4f68-8ec6-d4dffb6e5a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87fa6c77-038f-4382-949f-d5274cf6fa15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_27bc0f68-5829-4649-b428-b68b25831f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87fa6c77-038f-4382-949f-d5274cf6fa15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_27bc0f68-5829-4649-b428-b68b25831f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b36d29bc-6c78-49f8-8f00-b141ee297d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87fa6c77-038f-4382-949f-d5274cf6fa15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b36d29bc-6c78-49f8-8f00-b141ee297d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ddf53c73-e7e3-4db4-bcba-40217715dc25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_87fa6c77-038f-4382-949f-d5274cf6fa15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ddf53c73-e7e3-4db4-bcba-40217715dc25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e65b247-bd87-45b1-812e-0f9c49ddce74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e46d6711-8224-4929-bc0f-352bbe647fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e65b247-bd87-45b1-812e-0f9c49ddce74" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e46d6711-8224-4929-bc0f-352bbe647fbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b7f3f37d-ca49-4aef-bf4d-537508391476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e65b247-bd87-45b1-812e-0f9c49ddce74" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b7f3f37d-ca49-4aef-bf4d-537508391476" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1fe0adfc-9250-4ccc-aada-7e1baacc0032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:to="loc_us-gaap_PreferredStockValue_1fe0adfc-9250-4ccc-aada-7e1baacc0032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7721cd6d-c8ac-402a-854d-7035b66deff6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:to="loc_us-gaap_CommonStockValue_7721cd6d-c8ac-402a-854d-7035b66deff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bd3389f1-4a9e-4fe1-86d3-2f16e3269b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bd3389f1-4a9e-4fe1-86d3-2f16e3269b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63849ad1-e28b-4ccc-afaa-0e12ba97efea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63849ad1-e28b-4ccc-afaa-0e12ba97efea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bcc58d19-3214-478f-a152-fc0b00d5bda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9af1d396-bcab-4918-bec6-01d585ff9803" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bcc58d19-3214-478f-a152-fc0b00d5bda9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f34d5aec-9f4a-47c9-b68f-2162abc8c7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:to="loc_us-gaap_LiabilitiesCurrent_f34d5aec-9f4a-47c9-b68f-2162abc8c7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fee47fbe-ddcf-4ae6-a9fe-b217983a53b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fee47fbe-ddcf-4ae6-a9fe-b217983a53b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_65ac86fb-5e60-4252-b888-d7e18354fdef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_65ac86fb-5e60-4252-b888-d7e18354fdef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_712ba82b-a01f-4135-b86a-fca63788fb20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_712ba82b-a01f-4135-b86a-fca63788fb20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12526b0d-6c57-4e0e-b4a8-f832ac1f4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d6df3768-2791-4ed7-9f4b-c2eafe675032" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_12526b0d-6c57-4e0e-b4a8-f832ac1f4b48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_075e453e-6ff7-4f4c-addc-fe9370c2303a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_AccountsPayableCurrent_075e453e-6ff7-4f4c-addc-fe9370c2303a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6fbd2b7a-1dc3-4869-aaa1-f567f8551b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6fbd2b7a-1dc3-4869-aaa1-f567f8551b2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_594b9310-dd6b-4d99-b029-fab3496cddf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_594b9310-dd6b-4d99-b029-fab3496cddf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19376fb3-1cbc-440d-b7c5-913491111bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_19376fb3-1cbc-440d-b7c5-913491111bb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_434d4f91-880c-4ede-b36b-a1a9339defa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_434d4f91-880c-4ede-b36b-a1a9339defa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_d0ac935b-e44d-4ae9-b70f-47074fb02337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6ac239c8-5f53-4a62-ac72-904cd14e4c2f" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_d0ac935b-e44d-4ae9-b70f-47074fb02337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_da0b03b3-cbdf-40ab-97a4-21eab6ed8f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2e0d1131-c73f-42ed-8766-2dd2562c7395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_da0b03b3-cbdf-40ab-97a4-21eab6ed8f35" xlink:to="loc_us-gaap_Liabilities_2e0d1131-c73f-42ed-8766-2dd2562c7395" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6981a86c-baa1-49e9-92fa-93d89569291e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_da0b03b3-cbdf-40ab-97a4-21eab6ed8f35" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_6981a86c-baa1-49e9-92fa-93d89569291e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_709f8835-4613-4fd3-b46b-bb98ac28a039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_da0b03b3-cbdf-40ab-97a4-21eab6ed8f35" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_709f8835-4613-4fd3-b46b-bb98ac28a039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aec7c81b-cbfb-4fa9-8ed2-91434cf9607b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_047fcafd-4c7a-413d-b3b4-ae948695a5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aec7c81b-cbfb-4fa9-8ed2-91434cf9607b" xlink:to="loc_us-gaap_StockholdersEquity_047fcafd-4c7a-413d-b3b4-ae948695a5d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_e7dde0ac-f269-44c3-a5d7-eb6a52a2e973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aec7c81b-cbfb-4fa9-8ed2-91434cf9607b" xlink:to="loc_us-gaap_MinorityInterest_e7dde0ac-f269-44c3-a5d7-eb6a52a2e973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9a58deed-cdcc-41d6-9ee6-6ef642854423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_AssetsCurrent_9a58deed-cdcc-41d6-9ee6-6ef642854423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8b0014cb-895f-4f55-a219-fe94b9b0797a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8b0014cb-895f-4f55-a219-fe94b9b0797a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6295baa8-9950-4667-a958-5a7b6fc801eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6295baa8-9950-4667-a958-5a7b6fc801eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71e0aaac-72ff-414d-850c-9fd9d6a2b804" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_71e0aaac-72ff-414d-850c-9fd9d6a2b804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70aebeec-1896-434c-8c55-b215c05d6067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_70aebeec-1896-434c-8c55-b215c05d6067" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_8ac64da7-c39b-41cf-911b-5e8d840ed117" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_8ac64da7-c39b-41cf-911b-5e8d840ed117" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_11dc7a3b-34dd-449e-8943-f65804db9edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_11dc7a3b-34dd-449e-8943-f65804db9edc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_58b9704c-880d-4617-abb2-001e2a219088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b079b241-831e-45db-ab33-b8e8d6cd7ed9" xlink:to="loc_us-gaap_Goodwill_58b9704c-880d-4617-abb2-001e2a219088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05eed9dc-aaca-4602-8eff-fc53e755fa7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05eed9dc-aaca-4602-8eff-fc53e755fa7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_f7796f92-bb7b-4a13-b997-8c08fe11de4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_IncomeTaxesReceivable_f7796f92-bb7b-4a13-b997-8c08fe11de4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7116794f-9f64-4bd7-a2de-c8cb46af33da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7116794f-9f64-4bd7-a2de-c8cb46af33da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_7d5537f0-d7c6-4b0d-a3f2-caeb18e4bd06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_7d5537f0-d7c6-4b0d-a3f2-caeb18e4bd06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_292c7778-2cf9-4abe-a42a-ddad3d6f7dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_292c7778-2cf9-4abe-a42a-ddad3d6f7dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6cc08a9c-5899-4975-9365-870a5a46483f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6cc08a9c-5899-4975-9365-870a5a46483f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_59a958d5-c88a-4859-89e9-efc436968fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_InventoryNet_59a958d5-c88a-4859-89e9-efc436968fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_a60b8878-e0a8-4a5c-bc9d-cac3e1ba6d60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd858383-d5af-4d80-b696-4e083e22accb" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_a60b8878-e0a8-4a5c-bc9d-cac3e1ba6d60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_be7f6d12-2bd3-4184-894a-8eea39db1a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_be7f6d12-2bd3-4184-894a-8eea39db1a60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3964a5e9-7206-41c6-903a-ce372bf606d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_3964a5e9-7206-41c6-903a-ce372bf606d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_1fa0c032-a710-42cc-bfc0-ae78c878e20b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_1fa0c032-a710-42cc-bfc0-ae78c878e20b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ea7be178-e799-4c6d-adf7-13a12a3b382c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ea7be178-e799-4c6d-adf7-13a12a3b382c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_3c1839e5-38b9-416e-b963-4443e2a5ad9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_3c1839e5-38b9-416e-b963-4443e2a5ad9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4f3ef936-73e0-4ae0-bd22-ad409c5ddb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4f3ef936-73e0-4ae0-bd22-ad409c5ddb7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_a9d7bffb-6e03-4e60-bbdf-5b0a89899683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_a9d7bffb-6e03-4e60-bbdf-5b0a89899683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_8b27926c-6298-4a17-a02d-6d71911476a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_8b27926c-6298-4a17-a02d-6d71911476a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_0083c873-5be6-461a-b41e-b2cfbb700417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_109df6ce-6e88-47fc-8c77-4868459dbee3" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_0083c873-5be6-461a-b41e-b2cfbb700417" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a980bf2b-ef91-4bed-8091-c29f81a36164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_ProfitLoss_a980bf2b-ef91-4bed-8091-c29f81a36164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_eb34e2f0-7807-4018-911a-283ae0cc8cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_eb34e2f0-7807-4018-911a-283ae0cc8cf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5b2b4d4b-5d6c-42c1-8044-2db8694b3f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_ShareBasedCompensation_5b2b4d4b-5d6c-42c1-8044-2db8694b3f19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c55c2a78-07cd-4c4e-a419-c45b9dd8ee9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c55c2a78-07cd-4c4e-a419-c45b9dd8ee9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_5f04b233-5e47-4ef9-b2d1-d2e5c32ddf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_5f04b233-5e47-4ef9-b2d1-d2e5c32ddf6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5c90e038-ab29-4a41-9494-1ac32fa9e7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5c90e038-ab29-4a41-9494-1ac32fa9e7ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3d6dd8b9-24af-455e-b129-dc1c2db9f1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3d6dd8b9-24af-455e-b129-dc1c2db9f1cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f8489c3f-6318-47ab-85a5-18db4a2f2b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f8489c3f-6318-47ab-85a5-18db4a2f2b67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_80953eae-aabb-47ef-ba13-669eba59a142" xlink:href="dva-20230331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_80953eae-aabb-47ef-ba13-669eba59a142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_181c12f3-5231-4ceb-b789-96ebb711143a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_181c12f3-5231-4ceb-b789-96ebb711143a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ffaf6509-55c6-43a0-870d-ca420c64d9b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ffaf6509-55c6-43a0-870d-ca420c64d9b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_24e4d0d9-a5d7-429f-b2e3-f324d1d43d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_24e4d0d9-a5d7-429f-b2e3-f324d1d43d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_204b4132-eed3-4854-aa4e-218e197ad15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_204b4132-eed3-4854-aa4e-218e197ad15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2085805-d766-4325-ae27-84bc84914c95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2085805-d766-4325-ae27-84bc84914c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_8e37f4ec-65c0-4172-9464-b36c5b6b4b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a4068e86-cd9d-436f-acae-c12cd2004c97" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_8e37f4ec-65c0-4172-9464-b36c5b6b4b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_72a0494d-1abf-4b1c-ad79-153134ede02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_72a0494d-1abf-4b1c-ad79-153134ede02a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b399b5c-137c-4356-995e-bb61e087f825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9b399b5c-137c-4356-995e-bb61e087f825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_b83ea828-993b-4ed8-8f1e-fdf7103510be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_b83ea828-993b-4ed8-8f1e-fdf7103510be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_f619bab2-0007-4ba1-b8a4-85ab47450ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_f619bab2-0007-4ba1-b8a4-85ab47450ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_c731baa9-9ed0-4704-b8d8-7be097e745c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_c731baa9-9ed0-4704-b8d8-7be097e745c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_ca87a240-7f54-4840-9e3c-f0818134010b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_ca87a240-7f54-4840-9e3c-f0818134010b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_8157053a-7865-4973-aa9f-085c78f245aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_8157053a-7865-4973-aa9f-085c78f245aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_607bf052-91fd-45ec-a66a-dc9a0fc5919c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_607bf052-91fd-45ec-a66a-dc9a0fc5919c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_21e30993-bd59-410e-b5d7-5cc06b00c95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6720a415-ce7b-4846-92ab-5468ede78439" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_21e30993-bd59-410e-b5d7-5cc06b00c95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab48d0c9-cf91-49cd-9609-6dafd86557c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6e57adda-85e7-47d1-ae16-8443383b7528" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab48d0c9-cf91-49cd-9609-6dafd86557c5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6e57adda-85e7-47d1-ae16-8443383b7528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c91e7540-af0f-406e-af7a-5a530c0057e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab48d0c9-cf91-49cd-9609-6dafd86557c5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c91e7540-af0f-406e-af7a-5a530c0057e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81b11347-6478-4c69-9c62-ef60378ee794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab48d0c9-cf91-49cd-9609-6dafd86557c5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_81b11347-6478-4c69-9c62-ef60378ee794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b84414fd-08bd-47e0-b9bd-09fccde0910f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ab48d0c9-cf91-49cd-9609-6dafd86557c5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b84414fd-08bd-47e0-b9bd-09fccde0910f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c6a692-f88b-4b32-9154-9da9bca47844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_121e7525-d69b-44b5-bdb0-2dc9f28325d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c6a692-f88b-4b32-9154-9da9bca47844" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_121e7525-d69b-44b5-bdb0-2dc9f28325d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c390a428-65cc-4282-bc22-80618d9f7f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_80c6a692-f88b-4b32-9154-9da9bca47844" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c390a428-65cc-4282-bc22-80618d9f7f97" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_d87d9f99-a8a2-4d60-8b5f-01251c3e65b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_a97a6b8e-13a2-403b-8b96-ec84b3a5f531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_d87d9f99-a8a2-4d60-8b5f-01251c3e65b5" xlink:to="loc_us-gaap_HeldToMaturitySecurities_a97a6b8e-13a2-403b-8b96-ec84b3a5f531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_1ee6d941-77a0-4d86-8c78-767932bdd78e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_d87d9f99-a8a2-4d60-8b5f-01251c3e65b5" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_1ee6d941-77a0-4d86-8c78-767932bdd78e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3a007e04-dca5-4912-bc60-b6e4b8f57151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3c6a9b3b-c8ac-44c8-99bf-cd9eb8e69d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3a007e04-dca5-4912-bc60-b6e4b8f57151" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_3c6a9b3b-c8ac-44c8-99bf-cd9eb8e69d90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fb2c44bd-4f84-4e22-9fc4-b6434a51bc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_3a007e04-dca5-4912-bc60-b6e4b8f57151" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_fb2c44bd-4f84-4e22-9fc4-b6434a51bc98" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6d33376d-fced-4349-ac2c-d5cccf9f1665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6dee4f83-a5b4-4d6f-9a36-a4a9a337f532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6d33376d-fced-4349-ac2c-d5cccf9f1665" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6dee4f83-a5b4-4d6f-9a36-a4a9a337f532" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_43dd6397-2aa2-4ee6-9170-f66db69320a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_6d33376d-fced-4349-ac2c-d5cccf9f1665" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_43dd6397-2aa2-4ee6-9170-f66db69320a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_382f5915-4fee-4474-8b32-7a0274521c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_58255694-77ce-44c1-8a11-20205cb9eb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_382f5915-4fee-4474-8b32-7a0274521c59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_58255694-77ce-44c1-8a11-20205cb9eb2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_fdf37471-8043-44cc-ad29-159fdd33ee37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_382f5915-4fee-4474-8b32-7a0274521c59" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_fdf37471-8043-44cc-ad29-159fdd33ee37" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>dva-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended" id="icf87ff10232c45f6bf13300bf1aeff92_CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c50c735-ab8d-4ab4-961f-d859a2dd5a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c50c735-ab8d-4ab4-961f-d859a2dd5a6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_0ef2669a-80d1-4e26-833f-4257b5a123e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_0ef2669a-80d1-4e26-833f-4257b5a123e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_a14a33ac-326d-4e86-92a2-6347897a16cb" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_a14a33ac-326d-4e86-92a2-6347897a16cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_cb7901c1-d579-443e-89b9-a393b2019d84" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_cb7901c1-d579-443e-89b9-a393b2019d84" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_58a15d69-cfc0-411c-8244-37c96b74cb02" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_58a15d69-cfc0-411c-8244-37c96b74cb02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_82e4946d-9c80-4453-b8b7-ce672abafb2d" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_82e4946d-9c80-4453-b8b7-ce672abafb2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_7681d4d8-c867-404e-a014-21a1cdd4da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_7681d4d8-c867-404e-a014-21a1cdd4da4a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_32f68b8a-247c-4f09-9c06-43916a3533ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_32f68b8a-247c-4f09-9c06-43916a3533ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_a775b218-1688-4769-8004-4db41586331b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c7b956a-7941-4a8c-8227-3bf8608cdce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c7b956a-7941-4a8c-8227-3bf8608cdce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_aa0bb4c7-5dc3-492f-8356-186708b367d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_aa0bb4c7-5dc3-492f-8356-186708b367d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c85dd5a8-b187-472a-a72f-520fb900029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockCommonShares_c85dd5a8-b187-472a-a72f-520fb900029f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_07494abb-9330-444f-8fa4-d8fffc1e78ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_07494abb-9330-444f-8fa4-d8fffc1e78ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a78de53-039a-494e-91c7-81847b4c8127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a78de53-039a-494e-91c7-81847b4c8127" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_26c980b0-39ff-4dc1-816c-1b5db717d871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_26c980b0-39ff-4dc1-816c-1b5db717d871" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_74a59e3c-5d62-4444-a2e4-0d474a4dfeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_74a59e3c-5d62-4444-a2e4-0d474a4dfeb6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_484792dd-485c-4dc2-a7ad-f8163d611ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_484792dd-485c-4dc2-a7ad-f8163d611ef5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d228ee8-60a6-4e16-8326-d5c4f4acca53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d228ee8-60a6-4e16-8326-d5c4f4acca53" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bec2ea5-5396-492c-94d4-9727d271575a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bec2ea5-5396-492c-94d4-9727d271575a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_67646103-c745-4f3f-91f7-762bfff0ab17" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_67646103-c745-4f3f-91f7-762bfff0ab17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_60a8a51b-db54-4889-97c5-7cbae7a0c5d4" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_60a8a51b-db54-4889-97c5-7cbae7a0c5d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f30bc10e-a063-4e23-bccc-9828cc60504a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f30bc10e-a063-4e23-bccc-9828cc60504a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d84cb1d3-0fa0-4d61-87ac-90fb791fcb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d84cb1d3-0fa0-4d61-87ac-90fb791fcb87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_67757a06-cc55-4fec-b069-00db87e6431c" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_67757a06-cc55-4fec-b069-00db87e6431c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cf3bf2b7-ce5c-4292-b782-805e0d806429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cf3bf2b7-ce5c-4292-b782-805e0d806429" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ed982e6f-8ec4-4278-9aec-942e6615a4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ed982e6f-8ec4-4278-9aec-942e6615a4ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ed8503-5f0f-4a9d-ac94-c0c9b1a2f489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4b79e9d-267a-4cfb-a6c2-95a8313732ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_774d36cf-08fe-472f-9bdd-468ff8a96452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d106fc37-1641-4446-9af4-af36cadc98a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:to="loc_us-gaap_EquityComponentDomain_d106fc37-1641-4446-9af4-af36cadc98a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:to="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:to="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_91c09d5e-311a-42f8-a7bc-47b1d77886f2" xlink:href="dva-20230331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_91c09d5e-311a-42f8-a7bc-47b1d77886f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_71f2295f-393b-47f9-9e90-c87e663af56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_CommonStockMember_71f2295f-393b-47f9-9e90-c87e663af56b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4fcaf2f7-8777-4f8d-9472-efc8add93dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4fcaf2f7-8777-4f8d-9472-efc8add93dcf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8f0be50f-ec1a-43fc-9de8-18eb183ffd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_RetainedEarningsMember_8f0be50f-ec1a-43fc-9de8-18eb183ffd0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_eb97d90a-c2ae-4cd9-b788-6cf89ce307ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_TreasuryStockCommonMember_eb97d90a-c2ae-4cd9-b788-6cf89ce307ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5aad4c1d-2774-4be1-a6f1-787b4e63146a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5aad4c1d-2774-4be1-a6f1-787b4e63146a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f76d1861-5095-464c-8eb3-3c05a76c4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f76d1861-5095-464c-8eb3-3c05a76c4c37" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended" id="i158b2a64a89547ddb1f07888b47d152d_RevenueRecognitionSegmentRevenuebyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7f3835cf-d7d3-49f0-9926-e668fc4289dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7f3835cf-d7d3-49f0-9926-e668fc4289dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_516aba39-22e1-4a06-8852-6b2b7f2d4ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_OtherIncome_516aba39-22e1-4a06-8852-6b2b7f2d4ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ef84a0ce-96d4-4997-a244-9b8d55e3fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_Revenues_ef84a0ce-96d4-4997-a244-9b8d55e3fc65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_398e941f-cb1c-4028-8bf3-8b25b4203f7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:to="loc_us-gaap_SegmentDomain_398e941f-cb1c-4028-8bf3-8b25b4203f7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:to="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_e9e7e838-2f99-4f03-8b6c-9d137ef5f40d" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_e9e7e838-2f99-4f03-8b6c-9d137ef5f40d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cafa9cec-9997-4e1c-be0f-0329d152a45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cafa9cec-9997-4e1c-be0f-0329d152a45e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_5ee8dbe5-2e01-49a2-810a-660b1845a5ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_5ee8dbe5-2e01-49a2-810a-660b1845a5ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_fb0d5b31-3139-4e6b-84b1-616290ed44b2" xlink:href="dva-20230331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_fb0d5b31-3139-4e6b-84b1-616290ed44b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_8ddd72c4-82c4-420e-9423-56c81638bab2" xlink:href="dva-20230331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_8ddd72c4-82c4-420e-9423-56c81638bab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_2e1767df-a42f-473b-a98f-9aac066ebc2e" xlink:href="dva-20230331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_OtherGovernmentPayorsMember_2e1767df-a42f-473b-a98f-9aac066ebc2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_314564bc-ad24-47af-aa51-0672ae8c129a" xlink:href="dva-20230331.xsd#dva_CommercialPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_CommercialPayorsMember_314564bc-ad24-47af-aa51-0672ae8c129a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_db01de2f-1da6-4970-b754-3c04ccbe3bf4" xlink:href="dva-20230331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_OtherSourcesofRevenueMember_db01de2f-1da6-4970-b754-3c04ccbe3bf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5c492dec-4011-4894-a40a-5ff015771fe1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:to="loc_srt_ConsolidationItemsDomain_5c492dec-4011-4894-a40a-5ff015771fe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:to="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e4c415d2-7e5f-400f-8a91-9ca85f188c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e4c415d2-7e5f-400f-8a91-9ca85f188c8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended" id="iffdaf61676514ee2bed40d909aeea1a4_InvestmentsindebtandequitysecuritiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_a639a840-a2f3-4954-bd95-cbf6e2abd181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecurities_a639a840-a2f3-4954-bd95-cbf6e2abd181" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2c32bfec-08b4-4675-b4d8-ee27fa490d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2c32bfec-08b4-4675-b4d8-ee27fa490d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNINoncurrent_4383deaa-a603-4a98-a00d-a9873a4136c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNINoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFVNINoncurrent_4383deaa-a603-4a98-a00d-a9873a4136c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_40852a10-21c5-4a2f-8eb8-87deefcfdf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_40852a10-21c5-4a2f-8eb8-87deefcfdf9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_f9364da5-cc1a-44c6-ad9c-bdcd5a543668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecurities_f9364da5-cc1a-44c6-ad9c-bdcd5a543668" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_cda1b45b-cd3e-428c-8e29-7922273c35a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_cda1b45b-cd3e-428c-8e29-7922273c35a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_525185a6-ab9d-432b-a7fd-109f84676580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_525185a6-ab9d-432b-a7fd-109f84676580" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_64a7c7e0-cf3f-4cde-88f5-526e9c7f6bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_64a7c7e0-cf3f-4cde-88f5-526e9c7f6bc2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_8dd5dce6-3467-45af-8589-8f164e85fc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_8dd5dce6-3467-45af-8589-8f164e85fc4a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:to="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_912ac9f2-3092-4a1a-82ba-5b7e669d08ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_912ac9f2-3092-4a1a-82ba-5b7e669d08ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_82343486-1871-463e-a321-9b11cf9b1586" xlink:href="dva-20230331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_82343486-1871-463e-a321-9b11cf9b1586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_b6ca40f7-1852-4ea3-bf88-6827a1819fb9" xlink:href="dva-20230331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_dva_MutualFundsAndCommonStockMember_b6ca40f7-1852-4ea3-bf88-6827a1819fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_99686c25-18fc-4d8f-b42e-9fe972f0cffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_99686c25-18fc-4d8f-b42e-9fe972f0cffa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_54cbed0b-f790-417a-af23-8c1f37a7cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_54cbed0b-f790-417a-af23-8c1f37a7cab9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended" id="i617a6051fd3742029cbfd0d7032fb10e_GoodwillChangesinGoodwillbyReportableSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2b4a1bfb-701d-457c-bd6a-7894da5561a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_Goodwill_2b4a1bfb-701d-457c-bd6a-7894da5561a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a473cde-cc77-4f16-b549-2fcd79a70be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a473cde-cc77-4f16-b549-2fcd79a70be6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b8edd475-7265-439b-b25f-bcc08033531c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b8edd475-7265-439b-b25f-bcc08033531c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_8b0f2c8a-31b5-426e-be66-74d0a771f567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_8b0f2c8a-31b5-426e-be66-74d0a771f567" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_390ba5ad-464b-4cbf-be4d-aaee094f2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_1ce51205-40dc-4b07-9010-6bc308980a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillGross_1ce51205-40dc-4b07-9010-6bc308980a28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_39e3e938-ad6a-4c10-b401-85557e2a99df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_39e3e938-ad6a-4c10-b401-85557e2a99df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_73004a59-3f04-4051-885e-c505b7398f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fe6f9f30-93b2-469c-bc34-10553eecdf42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:to="loc_us-gaap_SegmentDomain_fe6f9f30-93b2-469c-bc34-10553eecdf42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:to="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_959ce35f-7a93-4bc1-8ddd-b8ab81c07956" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_959ce35f-7a93-4bc1-8ddd-b8ab81c07956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d76ac1f8-9866-494b-9c6f-4f0f49527445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d76ac1f8-9866-494b-9c6f-4f0f49527445" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#GoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended" id="i34766245aa29458f8d79dd984da05527_GoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d0acc6dc-6aa1-472d-924c-58fb8cef88a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d0acc6dc-6aa1-472d-924c-58fb8cef88a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_9062e598-72c0-4c96-939e-5727eb9f6b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:to="loc_us-gaap_NumberOfOperatingSegments_9062e598-72c0-4c96-939e-5727eb9f6b1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1c1e6928-9752-42c2-b400-bb3210c1e29b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:to="loc_us-gaap_SegmentDomain_1c1e6928-9752-42c2-b400-bb3210c1e29b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:to="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_fa807b00-cc48-4285-952d-c8c1ea6200cf" xlink:href="dva-20230331.xsd#dva_OtherReportingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:to="loc_dva_OtherReportingUnitsMember_fa807b00-cc48-4285-952d-c8c1ea6200cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended" id="i17f3a84faeeb4440a1b033a029332746_LongtermdebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_5254051d-f205-4cb0-847e-1fbc94628c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_SecuredDebt_5254051d-f205-4cb0-847e-1fbc94628c7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_279eb08c-5f75-4241-b9da-9f03948baa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_279eb08c-5f75-4241-b9da-9f03948baa2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_fc102cbd-f166-42c6-8836-d1187580e54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_fc102cbd-f166-42c6-8836-d1187580e54b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2f2d057e-010e-4d57-91d9-c9869c623b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_SeniorNotes_2f2d057e-010e-4d57-91d9-c9869c623b15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_44c6077d-dbe2-4cf5-ab18-efd529ed5961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_44c6077d-dbe2-4cf5-ab18-efd529ed5961" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_00651739-8e6e-4f33-87a7-4b281ccaf9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_00651739-8e6e-4f33-87a7-4b281ccaf9ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cd67e4c5-1429-4213-ab8f-8a393272e87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cd67e4c5-1429-4213-ab8f-8a393272e87d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_d6799e2d-fc12-4d39-9119-2ac2cc3764ce" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_d6799e2d-fc12-4d39-9119-2ac2cc3764ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_be53b0db-bbb1-4ad3-8f77-f6a46db1aac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_FinanceLeaseLiability_be53b0db-bbb1-4ad3-8f77-f6a46db1aac3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_f9df65da-3740-44b9-82b4-dfcf60ef334f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_f9df65da-3740-44b9-82b4-dfcf60ef334f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a08c564a-aba6-4d53-bb9f-7729a678fab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a08c564a-aba6-4d53-bb9f-7729a678fab2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_b6dfc6a3-e4c5-4374-854f-2d830e5eef8b" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_b6dfc6a3-e4c5-4374-854f-2d830e5eef8b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c47de02f-55a8-40f7-b82e-33c18e439c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c47de02f-55a8-40f7-b82e-33c18e439c77" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8544f03-0caa-484e-9dde-05d218fd589b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8544f03-0caa-484e-9dde-05d218fd589b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts_8c5706e7-49d3-4d9d-931c-4e298ec6c2c6" xlink:href="dva-20230331.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_DiscountPremiumAndDeferredFinancingCosts_8c5706e7-49d3-4d9d-931c-4e298ec6c2c6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_aea2abeb-ab82-4b00-978f-4f90c6843063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_aea2abeb-ab82-4b00-978f-4f90c6843063" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_098f3a4d-762a-47af-9804-1684948bd772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_098f3a4d-762a-47af-9804-1684948bd772" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea6a9039-3852-46b0-bba7-610f2ba472d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea6a9039-3852-46b0-bba7-610f2ba472d3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5c2554c1-9884-4aad-ac5e-8172ca0cb0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5c2554c1-9884-4aad-ac5e-8172ca0cb0a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_8fdaf138-d014-498f-b348-72663631a525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DeferredOfferingCosts_8fdaf138-d014-498f-b348-72663631a525" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_0c938885-4351-4ddc-8d40-22032625cbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_0c938885-4351-4ddc-8d40-22032625cbb5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_a5a13283-1f90-4430-8014-ce4cf8a3b434" xlink:href="dva-20230331.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_TermLoanAMember_a5a13283-1f90-4430-8014-ce4cf8a3b434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_40802cab-2e06-4f08-adde-5784347bc129" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_TermLoanB1Member_40802cab-2e06-4f08-adde-5784347bc129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_6e36a78e-1eb0-467c-880b-42b6ea6efbba" xlink:href="dva-20230331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_6e36a78e-1eb0-467c-880b-42b6ea6efbba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6aff00ee-728a-47da-b3d8-72a5647021f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_us-gaap_SeniorNotesMember_6aff00ee-728a-47da-b3d8-72a5647021f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ea7aec7d-bc5e-4bb8-94c8-1220ce140774_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:to="loc_us-gaap_CreditFacilityDomain_ea7aec7d-bc5e-4bb8-94c8-1220ce140774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:to="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5363713c-80ad-4f16-8418-bf820e81fd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5363713c-80ad-4f16-8418-bf820e81fd0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cbe70f9b-10c2-41eb-a480-922c9421e0be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cbe70f9b-10c2-41eb-a480-922c9421e0be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_537fe015-c39f-40a3-97fa-e1203355d13f" xlink:href="dva-20230331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_537fe015-c39f-40a3-97fa-e1203355d13f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_29369f40-d5bf-47b2-ad75-dba4fb6089b9" xlink:href="dva-20230331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_29369f40-d5bf-47b2-ad75-dba4fb6089b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_0824d442-ba2b-4efc-9f3f-92092e32aba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_0824d442-ba2b-4efc-9f3f-92092e32aba1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_098c93d1-887b-4ded-9d45-542c90175560" xlink:href="dva-20230331.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_FinanceLeaseMember_098c93d1-887b-4ded-9d45-542c90175560" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c4bda4b1-f359-454a-91d2-d3841a489427_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:to="loc_us-gaap_VariableRateDomain_c4bda4b1-f359-454a-91d2-d3841a489427_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:to="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b3002952-69d6-4e3f-9907-ee5ccb86f66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b3002952-69d6-4e3f-9907-ee5ccb86f66a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="i504b499d0c2b41ab9d8c3d070271a893_LongtermdebtScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3681ef8f-b19e-4fb1-82d3-cc68e7ab3e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3681ef8f-b19e-4fb1-82d3-cc68e7ab3e2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cc974e65-4b1b-4c41-9612-ed7ee5f46af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cc974e65-4b1b-4c41-9612-ed7ee5f46af4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_43b12a1c-df5a-49e4-bafc-98039f87b9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInceptionDates_43b12a1c-df5a-49e4-bafc-98039f87b9b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_1528ef36-54d3-40be-9783-02bdf47fe5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeMaturityDates_1528ef36-54d3-40be-9783-02bdf47fe5d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_8469778a-12d9-433f-9c80-a99bab4bf67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_8469778a-12d9-433f-9c80-a99bab4bf67b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f7ea6204-e580-4a55-b501-9082cce9ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f7ea6204-e580-4a55-b501-9082cce9ab11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_125e1f2f-0e6f-4d0c-b11b-0645c2b3e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_125e1f2f-0e6f-4d0c-b11b-0645c2b3e1f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c9cd304c-b4a6-4e7d-a81b-69399e300d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c9cd304c-b4a6-4e7d-a81b-69399e300d33" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_189284c0-0167-492f-b6e7-d4f6613eb5a9" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:to="loc_dva_TermLoanFacilityMember_189284c0-0167-492f-b6e7-d4f6613eb5a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc67d383-38d0-4e2b-890b-39a1a3b3cf73_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:to="loc_srt_RangeMember_fc67d383-38d0-4e2b-890b-39a1a3b3cf73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:to="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_efd580b3-0368-487b-8b1b-26828448d4ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:to="loc_srt_MaximumMember_efd580b3-0368-487b-8b1b-26828448d4ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b9080646-fb71-4e33-ac98-7680f8393c35_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b9080646-fb71-4e33-ac98-7680f8393c35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_60e690f7-b0ce-4f5a-b333-e49d766972b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:to="loc_us-gaap_CashFlowHedgingMember_60e690f7-b0ce-4f5a-b333-e49d766972b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_139791e5-56a1-4c57-9cbf-4f70975f9b91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_139791e5-56a1-4c57-9cbf-4f70975f9b91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_de7d4718-8d6a-4f2a-a1ae-522ab8b3b44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_de7d4718-8d6a-4f2a-a1ae-522ab8b3b44b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f2eba63b-5f6a-412b-9883-2ec36721da78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f2eba63b-5f6a-412b-9883-2ec36721da78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a8588a06-cfd6-4c5b-9f94-6a74e4c5fe87" xlink:href="dva-20230331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a8588a06-cfd6-4c5b-9f94-6a74e4c5fe87" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended" id="id8e8615d1c17467eb273c424d695bf86_LongtermdebtAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_09155b18-02b6-4c56-afe0-921fac07582a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_09155b18-02b6-4c56-afe0-921fac07582a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_50f6cde6-5858-45ec-8db4-563cae453651" xlink:href="dva-20230331.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_50f6cde6-5858-45ec-8db4-563cae453651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9921f114-de3e-405e-9a73-7c61ec32f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9921f114-de3e-405e-9a73-7c61ec32f015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_56b37df2-e5d4-448e-81dc-a710c3ad7bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_56b37df2-e5d4-448e-81dc-a710c3ad7bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_9a8765d2-93a1-4a09-9d2d-4f6412b72a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_9a8765d2-93a1-4a09-9d2d-4f6412b72a08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_76035ed9-528a-4382-9f82-5fcd4b46fcee" xlink:href="dva-20230331.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_76035ed9-528a-4382-9f82-5fcd4b46fcee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2e082393-9221-4b17-930e-8b0ab9ee1a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2e082393-9221-4b17-930e-8b0ab9ee1a0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_f55ce18c-8566-484b-bd10-84819bbb9a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_f55ce18c-8566-484b-bd10-84819bbb9a5c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DerivativeEffectiveDate_fdad3aab-24bd-40aa-927f-3517d36ae5a5" xlink:href="dva-20230331.xsd#dva_DerivativeEffectiveDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_DerivativeEffectiveDate_fdad3aab-24bd-40aa-927f-3517d36ae5a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_e8a831d4-5283-4558-9275-24dbd40ff6ef" xlink:href="dva-20230331.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_TermLoanAMember_e8a831d4-5283-4558-9275-24dbd40ff6ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_80a2ccf5-f05f-4ef6-a5fb-a1ebbab060da" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_TermLoanB1Member_80a2ccf5-f05f-4ef6-a5fb-a1ebbab060da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_b51e3997-80dd-4a7a-b84f-48656bef5101" xlink:href="dva-20230331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_b51e3997-80dd-4a7a-b84f-48656bef5101" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:to="loc_us-gaap_CreditFacilityDomain_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:to="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d3bc426d-254c-45bf-a43e-9f6f879e3941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d3bc426d-254c-45bf-a43e-9f6f879e3941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2fb1ac45-a9ad-42bd-9a03-394120e9824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_us-gaap_LetterOfCreditMember_2fb1ac45-a9ad-42bd-9a03-394120e9824f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_88a6d71e-0c66-4db9-bb62-7fc90f6a1b2c" xlink:href="dva-20230331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_88a6d71e-0c66-4db9-bb62-7fc90f6a1b2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_72cece53-cd33-4cd7-a777-35977033ba73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_72cece53-cd33-4cd7-a777-35977033ba73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_bb9db50a-6aa6-4d9f-8d79-2b06a9b4cb88" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:to="loc_dva_TermLoanFacilityMember_bb9db50a-6aa6-4d9f-8d79-2b06a9b4cb88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a6651ee7-b55d-45d7-afff-fff10af819ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a6651ee7-b55d-45d7-afff-fff10af819ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0cc67301-459d-4309-9ffc-f32f75edf83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:to="loc_us-gaap_SubsequentEventMember_0cc67301-459d-4309-9ffc-f32f75edf83f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_671a4098-db43-44c0-b389-c634e64c535c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_671a4098-db43-44c0-b389-c634e64c535c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_f3cb0386-f6f0-4ed2-9cab-9a63a1f33ca6" xlink:href="dva-20230331.xsd#dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:to="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_f3cb0386-f6f0-4ed2-9cab-9a63a1f33ca6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_32e25399-e479-41b7-9ac5-51c26d6fdee1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:to="loc_us-gaap_VestingDomain_32e25399-e479-41b7-9ac5-51c26d6fdee1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:to="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheOneMember_9a608be5-193f-4796-b5f6-deed27edc5dc" xlink:href="dva-20230331.xsd#dva_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:to="loc_dva_TrancheOneMember_9a608be5-193f-4796-b5f6-deed27edc5dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheTwoMember_302f22a7-aa96-47bc-882c-ea092a1ca5ce" xlink:href="dva-20230331.xsd#dva_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:to="loc_dva_TrancheTwoMember_302f22a7-aa96-47bc-882c-ea092a1ca5ce" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="i89312fc9a81c449da7b8a4e2e6aaee73_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_f0d776b1-2e45-486b-a2b8-e2136aac8d49" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_f0d776b1-2e45-486b-a2b8-e2136aac8d49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_d84ba4f3-7663-41af-bd14-a36ec365ab8c" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_d84ba4f3-7663-41af-bd14-a36ec365ab8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_25506eb6-efed-45ee-aa90-54a106988123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_us-gaap_OtherCommitment_25506eb6-efed-45ee-aa90-54a106988123" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:to="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_7e43e7de-f112-422c-932b-6d89a982394a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:to="loc_us-gaap_OtherCommitmentsDomain_7e43e7de-f112-422c-932b-6d89a982394a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:to="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_f5b65425-5855-4679-b2e9-5ef8b37286f6" xlink:href="dva-20230331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_f5b65425-5855-4679-b2e9-5ef8b37286f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockbasedcompensationDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#StockbasedcompensationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/StockbasedcompensationDetails" xlink:type="extended" id="ib98a7b9e3947431ba59c03387f4c6c71_StockbasedcompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_539e32b6-bb9c-40bd-8226-7e2e7555d8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_539e32b6-bb9c-40bd-8226-7e2e7555d8d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_eb4ae8af-d10d-4462-87f2-a28eec376b48" xlink:href="dva-20230331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_eb4ae8af-d10d-4462-87f2-a28eec376b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fbbab356-c254-42a0-aa53-dd0bcb1438b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fbbab356-c254-42a0-aa53-dd0bcb1438b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3ff8d66e-0a72-4471-b6c2-3b3cd8d56f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3ff8d66e-0a72-4471-b6c2-3b3cd8d56f66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_55d4b776-43df-4bd8-bf82-22cf3a896b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_55d4b776-43df-4bd8-bf82-22cf3a896b22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:to="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_597e680d-415d-4ed6-8221-2871f86e37d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_597e680d-415d-4ed6-8221-2871f86e37d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_68def75b-ae22-41b2-8ef8-8309e9946cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_68def75b-ae22-41b2-8ef8-8309e9946cf0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#SharerepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended" id="i6fe2691c11ec4939815033bbaae053fe_SharerepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0fdeb312-1e28-42c8-83dc-8b2cfd827193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0fdeb312-1e28-42c8-83dc-8b2cfd827193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e6bbed08-ecb5-4143-845d-9119fecfb6d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e6bbed08-ecb5-4143-845d-9119fecfb6d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1e832b02-154c-4138-b135-775a15019346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:to="loc_us-gaap_SubsequentEventMember_1e832b02-154c-4138-b135-775a15019346" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended" id="i71c803b6d0204f38ba21c098d990f7e4_AccumulatedothercomprehensivelossincomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_07d2fb58-7b40-4f27-bbc3-af9f2ed36ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_07d2fb58-7b40-4f27-bbc3-af9f2ed36ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_22bfbf18-44af-4192-a544-8050c48e368c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_22bfbf18-44af-4192-a544-8050c48e368c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c70bfb7a-3647-4c1c-b4fa-ca6fa40c2554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c70bfb7a-3647-4c1c-b4fa-ca6fa40c2554" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_77f4f160-6e62-44f8-b7c7-080f510f0dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_77f4f160-6e62-44f8-b7c7-080f510f0dd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d29f5950-f5a0-4334-9321-5d9a56cdbdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d29f5950-f5a0-4334-9321-5d9a56cdbdbb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_eef6c355-c01d-4bc1-8830-f995dd2a0387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_eef6c355-c01d-4bc1-8830-f995dd2a0387" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2700158d-9188-47f7-9371-98eded4f2652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2700158d-9188-47f7-9371-98eded4f2652" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_444cbe13-f4b3-4a11-8280-07b30dbc725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_83c01898-afd9-49ec-b456-c1baec3d3b38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:to="loc_us-gaap_EquityComponentDomain_83c01898-afd9-49ec-b456-c1baec3d3b38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:to="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_3d1f5e3b-1693-45b0-add2-49aadb125a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_3d1f5e3b-1693-45b0-add2-49aadb125a4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a3f91e9c-12c2-44a1-bbfb-dcd31ae0e5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a3f91e9c-12c2-44a1-bbfb-dcd31ae0e5e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_7f23a446-2494-4f93-8c3a-51f4fda5620b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_7f23a446-2494-4f93-8c3a-51f4fda5620b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended" id="i23870a1d00554d9983f94ba6e95a7336_VariableinterestentitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c20b93be-b117-4e14-80b0-8594349cf6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:to="loc_us-gaap_Assets_c20b93be-b117-4e14-80b0-8594349cf6d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_866b9a3c-db3d-4c55-897f-62117f90f608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:to="loc_us-gaap_Liabilities_866b9a3c-db3d-4c55-897f-62117f90f608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:to="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_72845e63-0dcb-43e8-ad8e-4084dc210080_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:to="loc_srt_ConsolidatedEntitiesDomain_72845e63-0dcb-43e8-ad8e-4084dc210080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c358159d-a1eb-4ed6-9491-fdcd52bd071b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c358159d-a1eb-4ed6-9491-fdcd52bd071b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended" id="ibfa3c7544e2e481b8997bb9b555745dd_FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d5a274d7-c836-44c4-83ae-a3d818ecc64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d5a274d7-c836-44c4-83ae-a3d818ecc64b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0e08cf83-1c5f-4162-8b4f-57910a273c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:to="loc_us-gaap_DerivativeAssets_0e08cf83-1c5f-4162-8b4f-57910a273c60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0d7070d5-03f8-4a88-aec0-57a97f581775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0d7070d5-03f8-4a88-aec0-57a97f581775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_f6b93acc-64ab-4336-a9bc-2462e58afd33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_f6b93acc-64ab-4336-a9bc-2462e58afd33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_18036414-631f-4b06-9f20-d3de907734b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_18036414-631f-4b06-9f20-d3de907734b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_497cf0b1-efcf-4fa7-89bf-236bf1fc3a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_497cf0b1-efcf-4fa7-89bf-236bf1fc3a1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_53990189-410c-40bd-8cfb-9a90c4ed714d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_53990189-410c-40bd-8cfb-9a90c4ed714d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3511f812-d259-4f52-baad-e1cd07043e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3511f812-d259-4f52-baad-e1cd07043e9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8694a055-794b-4eb1-ba9e-ed51a9fabe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8694a055-794b-4eb1-ba9e-ed51a9fabe6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9fce9200-8762-4c16-a4d3-5c18e2729797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9fce9200-8762-4c16-a4d3-5c18e2729797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e537a9cc-c9d0-45da-9f80-50d9508b0627_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e537a9cc-c9d0-45da-9f80-50d9508b0627_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_24185461-b686-411d-a074-ed295720a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:to="loc_us-gaap_InterestRateCapMember_24185461-b686-411d-a074-ed295720a43b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#FairvalueoffinancialinstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails" xlink:type="extended" id="i3b9aa4d6f4d4463aa64b2592f1444efb_FairvalueoffinancialinstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_51e06452-62c0-458c-9f93-b5ab76a76cec" xlink:href="dva-20230331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_51e06452-62c0-458c-9f93-b5ab76a76cec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_35c21b5d-7ce6-45b9-adf8-cb804b6f3a34" xlink:href="dva-20230331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_35c21b5d-7ce6-45b9-adf8-cb804b6f3a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_ecda7341-4dab-4ca9-a53e-db7bc684f092" xlink:href="dva-20230331.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_ecda7341-4dab-4ca9-a53e-db7bc684f092" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e267cfa2-7c96-422c-b531-d86cea754a1c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:to="loc_srt_RangeMember_e267cfa2-7c96-422c-b531-d86cea754a1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:to="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0a1130c9-d54b-4a5b-af89-d6068abe2779" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:to="loc_srt_MinimumMember_0a1130c9-d54b-4a5b-af89-d6068abe2779" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_42c4be0e-332c-4e38-9a19-e9ec7dd8ce76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:to="loc_srt_MaximumMember_42c4be0e-332c-4e38-9a19-e9ec7dd8ce76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a74cc2ca-166e-42d2-80ac-c234dd156af3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a74cc2ca-166e-42d2-80ac-c234dd156af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_e0f4b725-5020-4389-aa26-8aba73464442" xlink:href="dva-20230331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_e0f4b725-5020-4389-aa26-8aba73464442" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9b66b0da-197e-4c43-8462-31953e811ecf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:to="loc_us-gaap_RelatedPartyDomain_9b66b0da-197e-4c43-8462-31953e811ecf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:to="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_655aee0b-150d-4fa8-9e14-31736194c044" xlink:href="dva-20230331.xsd#dva_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:to="loc_dva_OtherCompaniesMember_655aee0b-150d-4fa8-9e14-31736194c044" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended" id="i8c50188ea3c943949320972eaf136e38_SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15e54cd4-2076-479f-a9f2-f5ac77d1393f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15e54cd4-2076-479f-a9f2-f5ac77d1393f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_e3e68107-3338-4fcb-b03d-e61daed6f3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OtherIncome_e3e68107-3338-4fcb-b03d-e61daed6f3af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_027e693d-c560-47a9-8544-6116020b60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_Revenues_027e693d-c560-47a9-8544-6116020b60f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f2e15a33-eaf0-46d3-a5a3-f5f244fe0c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OperatingIncomeLoss_f2e15a33-eaf0-46d3-a5a3-f5f244fe0c2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_1cafc028-8a04-406a-8733-2034744fee8f" xlink:href="dva-20230331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_1cafc028-8a04-406a-8733-2034744fee8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_f981374d-aa65-431d-a5bd-1f7db3802a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_InterestAndDebtExpense_f981374d-aa65-431d-a5bd-1f7db3802a6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3f865517-f4a8-4eac-aec5-416e71752502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3f865517-f4a8-4eac-aec5-416e71752502" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b82ba68-ca04-4a59-8c5b-20d7715aa904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b82ba68-ca04-4a59-8c5b-20d7715aa904" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_9cf15d8f-42fe-47d2-9546-f71eed2df8e5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:to="loc_srt_ConsolidationItemsDomain_9cf15d8f-42fe-47d2-9546-f71eed2df8e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:to="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b68d3083-823c-4cf5-bb24-41b24410e67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:to="loc_us-gaap_OperatingSegmentsMember_b68d3083-823c-4cf5-bb24-41b24410e67b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_2567a7f4-9e64-4ef9-82e4-49d3f03fd8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_2567a7f4-9e64-4ef9-82e4-49d3f03fd8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ada1e83-8fad-4f58-9e90-be6c139bba78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:to="loc_us-gaap_SegmentDomain_7ada1e83-8fad-4f58-9e90-be6c139bba78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:to="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_1794ccf7-f54d-4d19-8701-6d36e76822dd" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_1794ccf7-f54d-4d19-8701-6d36e76822dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_118ec75c-9a6d-4ef0-a8f9-96527727eef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_118ec75c-9a6d-4ef0-a8f9-96527727eef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_7d0a1a85-affa-42a8-a481-8b4f328b184b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_7d0a1a85-affa-42a8-a481-8b4f328b184b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_aff93f2b-1240-4290-a1aa-143b6ea7a409" xlink:href="dva-20230331.xsd#dva_ExternalSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:to="loc_dva_ExternalSourcesMember_aff93f2b-1240-4290-a1aa-143b6ea7a409" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_54650bec-0702-4c45-828d-cd399abb08f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_54650bec-0702-4c45-828d-cd399abb08f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended" id="i5ee6ed4e522947bf8b12849b08b53b38_SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_4b34b762-1733-4dff-9d4f-01c9a5fe429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:to="loc_us-gaap_DepreciationAndAmortization_4b34b762-1733-4dff-9d4f-01c9a5fe429f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aeacaccb-8455-48a4-b3fa-68db43e992c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:to="loc_us-gaap_SegmentDomain_aeacaccb-8455-48a4-b3fa-68db43e992c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:to="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_10ba7797-af4d-4d93-a8c0-d06e1dd3f6a8" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_10ba7797-af4d-4d93-a8c0-d06e1dd3f6a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_46c32e98-87b0-4106-b477-c15a82f7c1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_46c32e98-87b0-4106-b477-c15a82f7c1e3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended" id="ibceb7026c48744f5bf7c698cd4449cea_SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d78a86d6-b773-4aed-8aee-e2942aef50bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d78a86d6-b773-4aed-8aee-e2942aef50bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_08a19b92-4961-498a-a679-db9a434c8063_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:to="loc_us-gaap_SegmentDomain_08a19b92-4961-498a-a679-db9a434c8063_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:to="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_5c78b337-5033-4647-af37-df196397536d" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_5c78b337-5033-4647-af37-df196397536d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_842a2c95-256b-40db-9467-17b79b66a8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_842a2c95-256b-40db-9467-17b79b66a8dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended" id="i7e4e728484ec4f61a33fee630e034bd7_SegmentreportingSummaryofAssetsbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:to="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a248640c-137c-4eac-b6d9-ab97cdad08bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:to="loc_us-gaap_Assets_a248640c-137c-4eac-b6d9-ab97cdad08bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_248ec838-10bb-4096-b8d7-bdd5102b55a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:to="loc_us-gaap_SegmentDomain_248ec838-10bb-4096-b8d7-bdd5102b55a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:to="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f2dd6c32-4300-4635-9fa9-827ffa055dd8" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f2dd6c32-4300-4635-9fa9-827ffa055dd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_88a4b7aa-1a81-4d07-80f8-d418dc13bb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:to="loc_us-gaap_AllOtherSegmentsMember_88a4b7aa-1a81-4d07-80f8-d418dc13bb49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/NewaccountingstandardsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#NewaccountingstandardsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/NewaccountingstandardsDetails" xlink:type="extended" id="if19964abf1f947de816aa9b7eeca3547_NewaccountingstandardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_1feddf83-b445-4e89-ba23-98ddf964854b" xlink:href="dva-20230331.xsd#dva_ChangeInAccountingPrincipleImpactAbilityToBorrow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:to="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_1feddf83-b445-4e89-ba23-98ddf964854b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7bcb8193-c2f9-4587-85b7-789ac808465b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7bcb8193-c2f9-4587-85b7-789ac808465b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_63a5c4cf-f1cf-44af-abcb-169e170a697d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:to="loc_us-gaap_SubsequentEventMember_63a5c4cf-f1cf-44af-abcb-169e170a697d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SubsequentEventsDetails" xlink:type="extended" id="i3ffa7cbc71cb49dd85fcb2f5c3a4d653_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate_5caff69f-af1b-4d47-b4ad-253764d515cb" xlink:href="dva-20230331.xsd#dva_BusinessAgreementDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_BusinessAgreementDate_5caff69f-af1b-4d47-b4ad-253764d515cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementEffectiveClosingDate_a10b4b5e-ebfd-4e28-a3b3-f46bfa410c83" xlink:href="dva-20230331.xsd#dva_BusinessAgreementEffectiveClosingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_BusinessAgreementEffectiveClosingDate_a10b4b5e-ebfd-4e28-a3b3-f46bfa410c83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_210e2446-4dd3-4442-aed8-539510921bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_210e2446-4dd3-4442-aed8-539510921bb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment_02bbfd23-35da-4758-8413-76c0f326e89e" xlink:href="dva-20230331.xsd#dva_AdditionalCashCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_AdditionalCashCommitment_02bbfd23-35da-4758-8413-76c0f326e89e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_e7fca820-3500-4069-83bf-64cd612c0f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_e7fca820-3500-4069-83bf-64cd612c0f00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_da7f2341-2869-445e-a942-6351fe33ab09" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_da7f2341-2869-445e-a942-6351fe33ab09" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_680f6c67-eb34-404d-9622-70212b53cc59" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_680f6c67-eb34-404d-9622-70212b53cc59" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_b5add77d-9a4c-432d-8460-103a1d3665fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeInceptionDates_b5add77d-9a4c-432d-8460-103a1d3665fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ddc56ed9-d740-4f6e-9f15-691544576b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ddc56ed9-d740-4f6e-9f15-691544576b9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DerivativeEffectiveDate_497178e7-068c-451c-8371-4e6cb5ca65c9" xlink:href="dva-20230331.xsd#dva_DerivativeEffectiveDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DerivativeEffectiveDate_497178e7-068c-451c-8371-4e6cb5ca65c9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_caf98c1d-8be3-4f10-afa5-91ea4d6b6801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeMaturityDates_caf98c1d-8be3-4f10-afa5-91ea4d6b6801" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_2cf1a158-f472-46cb-bc3f-a47814b05887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_2cf1a158-f472-46cb-bc3f-a47814b05887" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_75d6a865-bd1e-420e-8d22-1407d3d96483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_75d6a865-bd1e-420e-8d22-1407d3d96483" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cae2700-9046-4abe-8ca6-f463eecf821b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cae2700-9046-4abe-8ca6-f463eecf821b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_e3af7829-4e3b-4b62-9ecf-531860df7683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_SecuredDebt_e3af7829-4e3b-4b62-9ecf-531860df7683" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4e6fcbe5-f037-45d9-953d-ffcb81d62d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4e6fcbe5-f037-45d9-953d-ffcb81d62d86" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_6e1fca54-d38f-4719-b06d-8083f252b4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_6e1fca54-d38f-4719-b06d-8083f252b4b1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentStartDate_585d90c0-2365-49ae-b754-58ef40e46a9d" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentStartDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentStartDate_585d90c0-2365-49ae-b754-58ef40e46a9d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_79321fda-a3e7-4d4c-8ea8-801694938bd6" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_79321fda-a3e7-4d4c-8ea8-801694938bd6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_20d85c3f-25ac-45dd-8772-e38a062c59ba" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_20d85c3f-25ac-45dd-8772-e38a062c59ba" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_f295a02c-f429-4b73-a472-45712722885d" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_f295a02c-f429-4b73-a472-45712722885d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_73f99131-1068-40f5-97b3-55eb457c7712" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_73f99131-1068-40f5-97b3-55eb457c7712" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fc4f9577-1fb7-48a6-aebf-00f928385b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentTerm_fc4f9577-1fb7-48a6-aebf-00f928385b27" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_336a7c19-9a53-468b-a5a0-cab55f38f242_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_336a7c19-9a53-468b-a5a0-cab55f38f242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember_8fdb146b-4d33-400d-ad40-690777a7285d" xlink:href="dva-20230331.xsd#dva_AgreementWithMedtronicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:to="loc_dva_AgreementWithMedtronicMember_8fdb146b-4d33-400d-ad40-690777a7285d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_22a63096-808f-46bc-b0a3-3389c374fbc7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:to="loc_srt_RangeMember_22a63096-808f-46bc-b0a3-3389c374fbc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:to="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9de46cc-7c1c-4dfa-8c40-32b70eda241d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:to="loc_srt_MaximumMember_e9de46cc-7c1c-4dfa-8c40-32b70eda241d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e89d5389-98b5-4426-a4bb-802930cd0c05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e89d5389-98b5-4426-a4bb-802930cd0c05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_4a9d78bf-299a-49bc-be67-d7d4de6436c8" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:to="loc_dva_TermLoanFacilityMember_4a9d78bf-299a-49bc-be67-d7d4de6436c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_0c4e2451-089d-4934-a606-58d7a798c437" xlink:href="dva-20230331.xsd#dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:to="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_0c4e2451-089d-4934-a606-58d7a798c437" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_eb5637da-7a97-4276-af4d-bf4b7459f6b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_eb5637da-7a97-4276-af4d-bf4b7459f6b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanA1Member_611ececb-1090-4c81-8769-67438d47873c" xlink:href="dva-20230331.xsd#dva_TermLoanA1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:to="loc_dva_TermLoanA1Member_611ececb-1090-4c81-8769-67438d47873c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_09301116-98b1-4495-9250-1edef8cdcfa4" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:to="loc_dva_TermLoanB1Member_09301116-98b1-4495-9250-1edef8cdcfa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_21890fc6-000a-4b68-93db-d0b72ffe82e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:to="loc_us-gaap_CreditFacilityDomain_21890fc6-000a-4b68-93db-d0b72ffe82e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:to="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75b7a5b1-b4b4-4a10-b96d-176edba9116d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75b7a5b1-b4b4-4a10-b96d-176edba9116d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_04ae7961-3afa-48a5-99c7-b6051ce3b331_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:to="loc_us-gaap_VestingDomain_04ae7961-3afa-48a5-99c7-b6051ce3b331_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:to="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheOneMember_4e858cce-db50-4edf-91f0-980466dc17d8" xlink:href="dva-20230331.xsd#dva_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:to="loc_dva_TrancheOneMember_4e858cce-db50-4edf-91f0-980466dc17d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheTwoMember_5196c874-0e56-412a-a784-261bd6af519e" xlink:href="dva-20230331.xsd#dva_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:to="loc_dva_TrancheTwoMember_5196c874-0e56-412a-a784-261bd6af519e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_10146a77-4196-4467-9e19-9ad8b8751946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:to="loc_us-gaap_SubsequentEventMember_10146a77-4196-4467-9e19-9ad8b8751946" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:to="loc_us-gaap_VariableRateDomain_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:to="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3da2b305-6223-43d7-99fa-0f42714c3d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3da2b305-6223-43d7-99fa-0f42714c3d6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3cafa50f-95e0-4b7e-b645-674deae71564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3cafa50f-95e0-4b7e-b645-674deae71564" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>dva-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_b5d72fff-d5c9-43fe-8328-dc67d92ee671_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b765ffc9-94dd-422e-aee8-09abe33d2f69_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_7e832a98-5e80-42d3-97da-47b5f0f9cfed_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1301c2c5-37c2-4032-8e46-981cd8e55add_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_293c592f-68c4-4b2c-9d96-f522377d9858_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_f68fdaed-6c66-4d99-83f0-8c277bde31f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_10349c4b-c460-447e-9839-442bc4aa32bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_53097111-d1f0-40e2-9262-d44ec1501642_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a7baf2ca-a05b-462e-9ae8-21b46f291add_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_e1990018-5596-4adb-9590-8769372b2940_terseLabel_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_label_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_documentation_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:href="dva-20230331.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:to="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_a8a6ca0f-e65f-49f9-83b9-ef347215b4d2_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_909ba57c-0be3-4465-8eb1-6c2eb473d7bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_283bfd37-26df-414b-ad86-ce0a2091241e_verboseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_ae53dacf-22c8-4e02-9418-7a022dc3bf43_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_76dac311-9458-4441-8a7e-e19534a8c4bc_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8b294e6e-d719-4196-86a4-226e7bb71928_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity on the revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_73e5bdfb-2aaf-499c-a557-f10d363132b1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_efad5b4c-9f79-411e-b86f-d73575ffbf04_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_b42721b4-c4c6-405c-bdf6-8897dc342ff6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_419d1da8-c238-4031-bad5-5f20cfb6d60f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on foreign currency translation:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_ebb97614-7345-4027-9f53-2f77b4add78e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_f42a79e4-7257-4433-bb59-b7e92da1792a_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase Due To Acquisitions And Divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_fe578f2d-de40-47e1-9236-7e74dd35270d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_d5cd5619-29ac-4716-9c81-6e57f26ca1a0_terseLabel_en-US" xlink:label="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member</link:label>
    <link:label id="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_label_en-US" xlink:label="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Interest Rate Cap Agreements Effective June 28 And June 30 2024 [Member]</link:label>
    <link:label id="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_documentation_en-US" xlink:label="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Interest Rate Cap Agreements Effective June 28 and June 30 2024 Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:href="dva-20230331.xsd#dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:to="lab_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_63842e4d-dc0e-4cf9-bc52-042c7b51fd80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR plus interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8e54514d-e074-470b-b555-6d8c260fb908_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR plus interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_16e020b3-0c24-4e30-8452-ce5d898ebf8d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_8b18c7d0-d6ea-4809-9bf4-43b926b07d67_terseLabel_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in mutual funds and common stocks</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_label_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_documentation_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember" xlink:href="dva-20230331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MutualFundsAndCommonStockMember" xlink:to="lab_dva_MutualFundsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_98611e85-6644-4803-b676-de1e43edf33e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_1a12360c-fe6f-4bfb-afd9-83c6342ec217_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash charges, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_ab7191b0-3414-4c89-b35f-0f936b54cb80_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_c451fd81-5ce4-4b4b-8e6c-cfb160c1cf00_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5bb79ac8-1da9-4b1e-adb2-607f6c52f1e2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_beea8546-580a-46f5-9710-ad39fa4e88b5_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d2b0f9f6-b085-4c94-9c58-ca7b2f9248b4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock-settled awards excluded from calculation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_dccf3271-1238-449f-9a4e-742f00112be4_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_01627dec-cc3f-48a1-8e2c-2ffd6a03734e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_52339488-24f7-430b-b5c0-d031f96d9360_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_72ceba41-490e-4894-b259-650b3aa1a4d9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_16ec3449-9dda-4409-80e0-a0e4d66cba72_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_e47a0f18-5edf-4727-aa6b-177125e423f5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerators:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_aeeb881b-e772-4b07-bc6b-a87637f5f7aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_907f3c8a-6e92-46c8-b7f8-7bfedfc11456_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing and debt redemption costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_ae8dd6bc-4810-4e7b-8c62-4b27b2b8e897_terseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:href="dva-20230331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_3f1f6a92-7df6-4a2b-8849-058e028af8db_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_3e3c9e9c-99f3-4d8d-b05a-a85f127d5898_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_06ca6a44-4aba-4054-bdcb-6cdb4b0691a8_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of long-term debt, net of unamortized discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_77bc53f8-ba28-4751-81a1-be0ba1d57653_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate grant-date fair value</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:href="dva-20230331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:to="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_405a2023-e69f-4f23-bcb5-a934d98215c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_cf2e2546-74e1-4add-a817-d86a8603a49d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_d9599456-e709-418a-888d-9a694a2ac953_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of the old Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_38d37dc3-8c31-4cd3-944e-dda54f3e3f2d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_43d3e07d-d86e-463c-a2b9-f525061eb946_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_020f22b0-3d4d-4448-a686-bb982f33402a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_15987b51-cb98-4f12-a43a-7cb5d7d23b1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_edeae15c-b30c-4f70-b220-3bfae5f09eaa_terseLabel_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_label_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage [Member]</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_documentation_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember" xlink:href="dva-20230331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareandMedicareAdvantageMember" xlink:to="lab_dva_MedicareandMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e39098f7-c209-4810-9848-50d0a7ec2c54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_87c10a69-5de8-4d35-8877-d39e42a1bbcb_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_cca16a68-6899-4063-8856-c2466875b24c_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_cbcff711-92c3-43cd-aafc-c97a2f4dc656_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_f87a8cc0-a636-4934-9143-6c7ac7f08e82_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Increase From Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest increase from contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:to="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fd0c9f2-d213-4b0c-90d2-a1a334a77e0b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_b289fb76-4105-49d8-aa66-5742aa5fed5e_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_d2d5214f-8618-4b26-9371-c61668ba0018_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_7553736e-58a7-4df8-90e5-5a2968f90bc8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_aa59755e-a403-49f7-b623-af07138d766c_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_9c8f458f-9201-4681-bd7d-8ffa66a923fb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_42c6759d-53bc-49a6-9728-65e0fcb67c1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_8870c495-75c7-4ca7-82c3-a8ca36162a40_terseLabel_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_label_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility [Member]</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_documentation_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:href="dva-20230331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:to="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_1c8f7df3-275b-4917-89fc-1de67dff2b3c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_ef43f3b1-e45f-42ab-8653-74dc20e057bc_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_e7a79088-032b-4c79-9b39-454af2c3c36e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_58522087-a513-4f84-92ab-370a863a2ce0_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, inception date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_label_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Inception Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInceptionDates" xlink:to="lab_us-gaap_DerivativeInceptionDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_deb2b499-fb68-4319-882d-378841176a10_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5d8cd4db-c550-42e9-863b-c4143dabbb1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_d2f5b4c9-8a47-48a8-8467-a1da96de8b3c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding during period</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_7969a000-7093-454d-9bd7-16741ff694ea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, effective date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIssuanceDate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Issuance Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIssuanceDate1" xlink:to="lab_us-gaap_DebtInstrumentIssuanceDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_cf5bfca8-281a-4921-a0dc-0787c5129f29_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ebaaec17-5a98-455e-abcb-6a98b79f43a6_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanB1Member_16c2faca-614d-4b38-9e0c-935dca3469b6_terseLabel_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1</link:label>
    <link:label id="lab_dva_TermLoanB1Member_label_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanB1Member_documentation_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanB1Member" xlink:to="lab_dva_TermLoanB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_baf0626b-efa8-47ff-830b-adb6b115a935_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_89104d01-66f0-4fef-9fb8-ac24009895a0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_191e7ffd-16a8-4ed4-91f8-9617427e3757_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherCompaniesMember_f9fdb58d-1615-4ddf-9233-db578d7a6240_terseLabel_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_label_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_documentation_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember" xlink:href="dva-20230331.xsd#dva_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherCompaniesMember" xlink:to="lab_dva_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_d4a9cd08-03e2-4f36-b94f-94d17f8b3cd2_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, starting balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_9540365b-8cbe-4f4f-aad1-efef58a2eaaa_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_6da160ac-0416-4dbf-bfdf-af690fed83e0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ab8c4148-bb49-4e5e-8767-8f7b2dbe0c82_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_bfeabd42-3949-4f0c-ba6d-910b1158987f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_5303066c-a22e-447d-a690-82d755cee088_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_9ec9e4c4-6bf8-43fd-98e2-522537302f7b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_d3013dcc-0fe7-4934-976f-61d2181ce1ef_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_2345e4c4-163a-44d0-83d4-c5a5ca4bee11_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from equity method investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_a28b0675-617c-476a-9ce3-2503dcc1870d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_cc76c641-c23b-40c7-bf4b-adca8a0a3108_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b6072913-dda0-491b-b619-230995948a90_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_7f770421-2776-4e4b-88e0-41fe535b686b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_87759188-6cc3-42dc-8612-2c39700258ea_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year Five</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_label_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year Five</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_documentation_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:to="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentStartDate_e19e2ed9-a3fb-47c5-a4d8-014f45404c3f_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Periodic Payment Start Date</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentStartDate_label_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Periodic Payment Start Date</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentStartDate_documentation_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Periodic Payment Start Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentStartDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:to="lab_dva_DebtInstrumentPeriodicPaymentStartDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_59ee3912-bfb8-4244-b0c0-19006f2ad496_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_ccc35c20-698d-4d46-b5a8-9a136cfa7570_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0d837471-012e-4d16-83e0-9bc37f16ceeb_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_127531f3-c164-4e27-830b-7164503c3b5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_90d852a7-0ad0-427e-9c8d-c4e0acdf8bb1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_ba7852ab-24f1-4d27-bb06-ed47e41ecd7d_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_305341cb-2eed-45f8-84d0-7367806097ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_5426f4cf-8779-4bda-8ac1-b23e18427372_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_52d272fa-f318-4fed-89cd-37ca2266b6a6_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8ee72eab-89e5-4341-a098-bf78ab8db7e3_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b98b7e5-6805-4de2-8341-a1ddcbf3917e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1083119c-8163-4c09-b5ee-b091a16be3e0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_c8006124-e914-406c-9a88-d59b021623d5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_d717ddd8-8609-4fbe-8572-7d2191384f35_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TrancheOneMember_39428a63-c599-4ef2-bd22-8ff8a957fac3_terseLabel_en-US" xlink:label="lab_dva_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_dva_TrancheOneMember_label_en-US" xlink:label="lab_dva_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One [Member]</link:label>
    <link:label id="lab_dva_TrancheOneMember_documentation_en-US" xlink:label="lab_dva_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheOneMember" xlink:href="dva-20230331.xsd#dva_TrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TrancheOneMember" xlink:to="lab_dva_TrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6a1d8390-52a7-4f43-bd0d-1f539e411b15_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47803129-d4cf-4420-8a27-971684ee87a5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_53c3bb07-ee78-4e34-bc61-312abfc29801_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_29b3dafb-7354-416f-936c-b91c928ab13b_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3803d381-3bc1-4993-b921-51996309ee13_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_a4bc36a4-c303-49f9-8e50-7fb1cec56659_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_883a4326-8b33-4766-af7b-14fe566be9a5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7f3f116b-5cdf-4ce2-b7de-853d1cd2c80d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_de4ed0af-3d36-453c-b799-ad11e6c6257d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_8b77648a-1548-4feb-ab9d-abbf521808e1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_9ddf9ac7-b7c1-437e-8ec3-d1f9d623a31c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, before accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_d7905295-28f2-4a5f-a0f4-e61ee1bba216_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d2b15d5e-6b1f-436e-b4dd-66190510949c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_1d25a53e-4e03-416d-8db4-8890eed33165_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_41576b9d-52cf-4164-8b09-a62c27c446c3_terseLabel_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_label_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_documentation_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:to="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e320e75-107b-47a3-8973-648882678f0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_25906b52-b6cc-4ec1-bda6-1c55200989c1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_381c0972-2a24-46fd-b9b8-eff7963d7570_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_cdad83a8-cdb3-4a2e-9909-17c0fe56b38f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_3f820b21-6812-4cca-88d1-5c9be6e6b84d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_8131121b-cd17-44fe-b718-ed7ff74480c1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_e1546f18-5abf-4f5d-b595-6fe3b761e344_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_48fa3cd1-308a-47ab-8b92-b6daf4ff8db2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_f6796b31-3b99-47f1-9aa2-b71a70346e83_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_e4124e0b-a6ec-4194-99e5-74d58950f8d8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_d257f8b5-bc5e-4b9b-a017-bea042b2ef05_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7af80443-27db-4607-9c43-0bc96c47735d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_07c8e780-e82a-4958-8f28-3f3c441655ca_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAgreementDate_f07aacef-d337-4f96-bf27-268fa380a7f1_terseLabel_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date</link:label>
    <link:label id="lab_dva_BusinessAgreementDate_label_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date</link:label>
    <link:label id="lab_dva_BusinessAgreementDate_documentation_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date, in YYYY-MM-DD formate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate" xlink:href="dva-20230331.xsd#dva_BusinessAgreementDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAgreementDate" xlink:to="lab_dva_BusinessAgreementDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_3f6ba739-5d1d-44f3-96a6-6b496ac46c94_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_7d198e7b-db2d-41e6-bf39-e0252eda54d3_terseLabel_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_label_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_documentation_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:href="dva-20230331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:to="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2a68a21e-dc73-412c-a6ff-dd7237a49cfe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExternalSourcesMember_045f7c94-c9ea-4586-95a7-366909c0cb4f_terseLabel_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_label_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources [Member]</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_documentation_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External sources.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember" xlink:href="dva-20230331.xsd#dva_ExternalSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExternalSourcesMember" xlink:to="lab_dva_ExternalSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c33286bb-fd90-4077-b20b-1dd379b97e3d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dc078651-f261-4938-bda8-469cefee55eb_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd40f675-b2ad-43de-9906-178e7a1111cc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_8f3c7f97-8fa1-4b65-88f8-98d211eb5f82_verboseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_941d4a0b-6fe3-47fa-989d-8d552165cf64_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_74ca53fb-1e91-48b3-ba3c-dfdd8a5f799e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d492830c-f9ad-4f05-8af1-43015c8d4fe8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_7ad3f446-28be-4930-9569-6ce959de2a70_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_94c917da-e51f-419e-a926-8fa1e05bf6a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_74cefd56-2030-4adf-a354-feee3995b127_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7e16f15e-d990-4fb8-937b-5f2c3642265a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7940b921-d8ef-40ba-8076-bf9b7274d984_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_36a367af-3248-4ae3-ba4c-8679f3f03cb9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ca262195-184e-484c-bef2-1475d0341c3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies:</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_867de72b-8b67-44e0-8348-fb6e7fd81e59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_6bf4da63-5dc0-4ee7-a9ba-1ec75357ca27_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5dd5c8a4-bea8-4d0a-98d5-494c781d344c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_e4a906c3-bfea-46ff-a223-fe1d0858eb75_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_bc7749ee-6f46-4982-9d05-7c431af75fd1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cccb5437-a505-4f7d-b681-c9bf6266a4ac_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ef488eda-0797-4679-84d6-d26bf2e890f4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_65dd8fa8-e3e9-485c-b32c-1985b83502a2_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_5b170f5a-e01f-492a-b36b-1044c73aba0e_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_34b7bffc-9bfa-4c12-9cab-332307e74d41_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_4c62b894-35bf-4976-a672-883c4a6842d4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_b8a45f5e-2fe3-439f-99aa-ce78487beb4c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4e224a07-571e-4b57-b8ab-1db396b7e2b5_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_3109d76e-e325-4851-bd4c-6bc579fe3e72_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of debt instruments bearing fixed interest rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_defbda4e-0bdf-4a9d-9dd6-4a588b1b0c11_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_a15b9f19-2db1-4560-bcab-5fcd08369e8f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_ee9e5ac1-fcb1-4d7f-b8e0-7d380bc6aa1a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_645c10de-7186-4ff9-813b-11acd71fc0f9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e8849157-7b99-45ca-8a1b-fd7efbfde1bf_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and Performance stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0bcd8839-e552-420b-8c61-e39820961acc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_35f15df3-82ee-46c0-9a45-12d777e5839b_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d33a9abf-82de-4417-a0ee-45affdf3fe0b_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_860c1b50-c073-4ca9-b029-b74c91340356_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_25e2df03-2508-408e-99bc-a54ce5ac65c6_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenditures for Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of capital expenditures for property and equipment from segment to consolidated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:href="dva-20230331.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:to="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_378dbc50-29b3-49db-8fdf-40826e4c9503_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_6d18220e-e479-4c19-a882-0064778abbff_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_851ba683-3fc6-4043-952b-3a8f7c040278_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanA1Member_2ebe80ca-0809-4cfd-b1e1-9f7bc04a9b84_terseLabel_en-US" xlink:label="lab_dva_TermLoanA1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A-1</link:label>
    <link:label id="lab_dva_TermLoanA1Member_label_en-US" xlink:label="lab_dva_TermLoanA1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanA1Member_documentation_en-US" xlink:label="lab_dva_TermLoanA1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A-1 Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanA1Member" xlink:href="dva-20230331.xsd#dva_TermLoanA1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanA1Member" xlink:to="lab_dva_TermLoanA1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_3b6091ed-221a-482b-9c40-338788575acf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill by Reportable Segments [Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_41537132-16a3-45e8-8166-32702cafe9da_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e1150e18-57c9-4f97-a37b-418264caf2aa_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_6e22fcf3-ba91-4c92-98f8-8abe8164ff9e_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification into net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1005f111-5f4d-4fc3-94ba-a6b7481c7aee_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_3ff87588-00e7-465a-a541-9c13c25a4208_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_d17acb95-e2e9-4446-8501-26211ec1bd31_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, short-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d4c91f4f-01a5-4f7e-ac01-1dac30ef5252_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total DaVita Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_2baf064d-bd33-480f-bbe9-9a2689a1d890_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out consideration payment period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_label_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Revenue Earnout Period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition contingent consideration revenue earn-out period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:href="dva-20230331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:to="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_17262ebc-575b-4f47-bb41-985b06e1629f_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_2a1d2f7b-ee3c-41fb-bbe4-df927f7d108c_terseLabel_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_label_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sources of Revenue [Member]</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_documentation_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember" xlink:href="dva-20230331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherSourcesofRevenueMember" xlink:to="lab_dva_OtherSourcesofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_85c87004-64a6-41be-88a6-555f64ce5390_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8c985496-5db4-4965-bda1-bff0a677a824_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4bbb2251-7a52-457e-89d6-5fb8ca2df464_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_94b1f3db-4243-4074-bea7-d7a702281f4e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8b985e36-599a-4db9-a9d6-e40a93244dea_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_4433800b-ae25-419f-8afd-4ae33e13305e_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period, in PnYnMnDn format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementPeriod" xlink:to="lab_dva_CorporateIntegrityAgreementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_83c893f5-bb14-4b9a-ad96-9f5af629a4cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_be83bf31-5193-466b-b9c7-6fb8c82b8c9a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2ec9a110-8f96-404a-bb72-028b95f66c2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_8e9af42d-22c3-410e-bb43-91f4337aa556_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_124ef576-5997-4dc9-9464-d724ee4e1b23_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_4997f4d4-8e80-4ae2-9a55-8f33b8d03139_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and Long-term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_df98be78-83e0-471a-a072-063ca89ce6ba_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_836a80ea-f247-45af-80fd-2a50205887b4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_e1304f08-6edc-4b4d-84bc-5de37d00a0ae_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_edf44f30-9e20-4274-b8e5-d9be9eb1c3d4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_c02fd3d0-47ff-40d7-b4dc-76cb35a84cd3_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3a3340b5-f702-4521-96e0-fc3e1443850c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6af6b2c7-1724-4512-84b4-9f46e97ad820_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_e94bb1e3-9b66-4316-9cea-f5006eaab78a_terseLabel_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_label_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_documentation_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:href="dva-20230331.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:to="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DerivativeEffectiveDate_49d5d550-72d3-485f-b884-f6afda482246_terseLabel_en-US" xlink:label="lab_dva_DerivativeEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_dva_DerivativeEffectiveDate_label_en-US" xlink:label="lab_dva_DerivativeEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Effective Date</link:label>
    <link:label id="lab_dva_DerivativeEffectiveDate_documentation_en-US" xlink:label="lab_dva_DerivativeEffectiveDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Effective Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DerivativeEffectiveDate" xlink:href="dva-20230331.xsd#dva_DerivativeEffectiveDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DerivativeEffectiveDate" xlink:to="lab_dva_DerivativeEffectiveDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_1a3b581d-9cc0-4c17-9fbc-58f66233f02d_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_0f31e89c-b221-4c60-8954-59f513216293_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_91bb64ee-deac-4ad1-b873-6edee34e4d5e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2aaa3054-04e7-426c-99c7-b02420a4ec8f_verboseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_695c5c23-2540-4b85-beab-4b014a418644_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7b491830-737c-44f3-b9a8-624d753b6891_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_883d58cb-0364-4b59-a24d-58500dc43a1b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of additional noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_10a94b0f-111c-4665-9929-96082d8fed4c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_86b4cd19-06ce-40a2-a367-690f1b955e94_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_b38bb9e9-5419-4a24-a262-8bdc7b821368_negatedLabel_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount, premium and deferred financing costs</link:label>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_label_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Premium And Deferred Financing Costs</link:label>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_documentation_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount, premium and deferred financing costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:href="dva-20230331.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:to="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a8e4c6ef-93ed-41ea-bf11-822d08f70884_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_706f6cd2-07e9-40d2-baa7-4de0c39598e4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_b0e03b0e-6978-46c9-ac32-a304c58a9cef_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_8553c530-d0db-4c9f-b96b-a937465f14da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_fecda624-b111-47a5-981b-cd75002779fc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8f55438b-922e-4e8b-9deb-4dd7c76cc891_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12891944-6c45-488c-bc72-0934f0b0d7e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_2712c98f-ee35-4445-800d-a3c3e348a69c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_7a748d91-41f0-4a35-8fc3-fb22b3f90ba6_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_7511c328-f7c6-473c-8f7e-613d31efd39b_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Interest Payment, Year Two, Three, Four</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_label_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year Two, Three, Four</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_documentation_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year Two, Three, Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:to="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_d8e89ba4-d1d1-47af-a316-b770144076e2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_54a27b34-45fb-4d5b-9e64-f9ecb1918859_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_4c8c7c48-130f-48f5-8e2a-5dae27036983_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_94230fcd-8250-4a6b-96dd-724d89beae60_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Financing Costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0a097e50-1df0-431f-af04-eaf16135ee89_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_1b18e343-5131-4bcb-8069-d44692682052_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_1d9af25c-65a2-4969-b111-f8d68fee429d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fcae5d90-f7fe-4de3-bfee-974db56f7354_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4f93a533-3909-4d50-b69d-b7edcd5fc0d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0b70e6e9-b09f-4a98-b71f-1a370148f2fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a2aa16cc-2237-4448-8278-2e2840e24ccb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_97098acc-ed13-4050-a90c-447db7c8ea34_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c92223ca-bb9d-4206-853d-2e1d56307203_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_92f2eee6-4a2e-4991-8a7f-b8c6306de506_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_bce328be-cf51-44f7-a548-a9ece7b7abe0_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f448f6dd-d8ee-4efc-bcdf-f5b9ac8e686f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cfbadb05-84aa-4df0-81fd-a290df21023f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_67bcecb0-7ffc-4c1b-b71e-95e31a73ab57_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AgreementWithMedtronicMember_4ac9d18d-88ad-4b4d-9081-8c7b22bf35e3_terseLabel_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic</link:label>
    <link:label id="lab_dva_AgreementWithMedtronicMember_label_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic [Member]</link:label>
    <link:label id="lab_dva_AgreementWithMedtronicMember_documentation_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember" xlink:href="dva-20230331.xsd#dva_AgreementWithMedtronicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AgreementWithMedtronicMember" xlink:to="lab_dva_AgreementWithMedtronicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_57777574-6e16-46d1-86f5-ce00ad8e0447_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_f7724303-6c48-4a75-9082-74aa5a04b8b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7018f64e-d3e7-4bc0-9435-e62259a8f233_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7980c1eb-dc5a-4c8c-a992-a0cf0dfd7436_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_5f16bd9b-aa5e-46dd-beb3-58c10d74698d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_15052024-ebf6-4163-8046-40bb76e2f688_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_a73bda01-2392-415c-8f8a-0b5234cf5d46_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_42df5c95-92b3-406b-8daf-e2b4c7262fd3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e53193e9-a8f3-4d01-8e6d-3b917edd8526_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding during period</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_fdeba872-eda6-4928-9a95-6c6473102a40_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, expiration date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_label_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMaturityDates" xlink:to="lab_us-gaap_DerivativeMaturityDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_51919639-bbac-4ea5-8e0a-41942719908f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommercialPayorsMember_0f85a5bf-c56b-422c-8bee-34015c979f3b_terseLabel_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_label_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors [Member]</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_documentation_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember" xlink:href="dva-20230331.xsd#dva_CommercialPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommercialPayorsMember" xlink:to="lab_dva_CommercialPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_e35bc82b-3588-4146-8949-232ca009f362_negatedTerseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_label_en-US" xlink:label="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests Reclassifications And Expirations Of Put Obligations</link:label>
    <link:label id="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests Reclassifications And Expirations Of Put Obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:to="lab_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c8b4c49a-7eef-40b4-a696-79198716cae2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNINoncurrent_f5624632-0095-4219-88f1-1692f905b8da_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNINoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Noncurrent</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFVNINoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFVNINoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNINoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNINoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFVNINoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFVNINoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_f7700599-5b57-4150-a9d6-9d304c1904dc_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e9e453b7-1125-41e6-a54b-44a80a9d431d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_3398a47f-847b-4dea-8c4f-0ed2a9c1bec3_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_label_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_documentation_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:to="lab_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b58b5fe7-32ab-44f1-9725-ec591bb75e7b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_7dafabaa-4061-4991-92ac-83b4686d4495_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_9e51cecd-d4ac-4fc1-839b-a03c8a8a8b4e_terseLabel_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_label_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_documentation_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:to="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_f13c69f6-6c99-49e9-8f57-e3bb7d0712bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other potential commitments to provide operating capital to several dialysis centers</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_8b3aa4e8-306f-470c-9a81-96055b7f5cc0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e641e80f-bd75-47a3-b455-6e96a7e79933_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_6508b1b8-7e0b-48ac-9e6c-2b8c9c202b35_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_2940668a-a577-46c9-95df-268264e17e33_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_a79a97bb-a934-47fd-9307-68bc8f2d6e95_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment loss, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_338e62f6-3226-4c48-8232-6d6c8a81c568_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ad52c026-cbc5-415b-a4d6-dcc9eee6b4f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_4f4e463a-5c5b-4f46-8c94-677b244c3503_terseLabel_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3218fce2-7d5a-4306-b98e-1d0f64f51b8e_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_919c1075-38cf-42ea-bdb1-172050725c5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_94f23f24-bb52-4107-9f3f-7bf1ea6565ea_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ccb01bab-940c-41bb-9af6-7c0dcd7554f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_cbc61deb-eb8c-4e4b-b144-9dc10c47f0bc_terseLabel_en-US" xlink:label="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Principle impact ability to borrow</link:label>
    <link:label id="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_label_en-US" xlink:label="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Accounting Principle Impact Ability To Borrow</link:label>
    <link:label id="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_documentation_en-US" xlink:label="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Accounting Principle Impact Ability To Borrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:href="dva-20230331.xsd#dva_ChangeInAccountingPrincipleImpactAbilityToBorrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:to="lab_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_68694259-42f0-475f-bb3c-12c7c8ede35f_terseLabel_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year One</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_label_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year One</link:label>
    <link:label id="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_documentation_en-US" xlink:label="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Interest Rate, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:to="lab_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_9eb33a6c-13bb-484c-8f01-d5b9dd473905_terseLabel_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</link:label>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_label_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</link:label>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_documentation_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:href="dva-20230331.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:to="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_f8633149-2e46-49a0-bd6d-acd2c3b87cc1_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_a55f3e38-12b7-483d-baef-2f4a05eb89ba_terseLabel_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_label_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_documentation_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract" xlink:href="dva-20230331.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenuesbymajorpayorAbstract" xlink:to="lab_dva_RevenuesbymajorpayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_1bc173fb-943d-4370-b1af-2d15b8951d21_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_f211d050-dfc1-405b-8599-b2ca2261a365_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date, description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2e102a17-7d36-4174-92ab-46a2485f8bb3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_18078e08-938c-47aa-9514-ff3d59a30c53_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_4585823e-428f-4278-8a8d-a529ba84b7da_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_c98e99e6-8e86-467c-a074-e05f984393c8_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_da7b1169-195b-47ea-b4b5-9350774afcc3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_76c8bdb6-92a1-467b-8ad8-8cd94b7b0815_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3a3e0b99-ee62-4fb4-9076-5d94106a2acd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_83e2b43a-f7e5-442c-ab6e-39076cefc77e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_bc905cc2-c3ec-4bbe-9174-684fa1234c80_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_46776455-efec-45ad-9a30-87dc96c2cf26_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dialysis &#8203;and &#8203;related &#8203;lab&#8203; services&#8203;.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:to="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7bf0644b-c67a-4dcf-87d4-658e9ffb69cb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7c23ad52-e5d8-4a96-ba4b-50c7b0a1a3c9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_bf889737-7d8f-4416-bf26-65735cabf6d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_bb6a2cd6-d7c0-4099-8593-25c723241498_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_1f378894-0778-40f9-bc84-8e42e9ef6c2c_terseLabel_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_label_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_documentation_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:href="dva-20230331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:to="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_cdc068a8-0bc9-4550-996c-3f5e57afa030_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_fa81fb7f-8acd-470f-a925-8d0ac7c13bea_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_1db129e1-a4e7-4e0d-96f1-c495d7c355ac_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_abb83442-7411-4888-81c9-9a6f4f2078e7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_614ff17c-3f3a-4405-b02d-f84a68f39695_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_d621642a-c9d5-4fa8-b3e7-83066d44b41e_terseLabel_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_label_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid [Member]</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_documentation_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember" xlink:href="dva-20230331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicaidandManagedMedicaidMember" xlink:to="lab_dva_MedicaidandManagedMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e7415ea9-ec5e-4405-a850-94dfa0fed05d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7ebf4601-d990-46ce-8fe7-7df68bea5ecc_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed consolidated interim financial statements</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1f0fd7e4-ed06-4482-bd0b-d5aa18014e3a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_bc540f23-21ff-408c-aabc-9b6ea03976d4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_f76fe76b-760a-42e5-a721-6c141afc4e90_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_781375b6-782f-4a3f-8633-119365e63625_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_1e3d205f-d5ba-4594-a224-319704acb128_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_61b9a81e-13c2-4033-8dee-8799ee88bab9_terseLabel_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_label_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors [Member]</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_documentation_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other government payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember" xlink:href="dva-20230331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherGovernmentPayorsMember" xlink:to="lab_dva_OtherGovernmentPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_e6e30e49-a51c-4f9c-800f-ddbde3fd9bee_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5dff1eb3-50b6-4e41-9dc4-8d01a0448fc0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_79e3b327-a5c8-423a-9f29-a4334489456e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_86898a81-99bf-4ac5-b714-741f9cf6221e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_83d56a2c-3384-447d-9447-3593184b1a24_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_337039e1-c5fd-4dcd-9146-6a6171233d4a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_58dd8809-b4f3-47cd-b402-f05d338a726e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fb6064b5-e7d4-4f45-a4cf-f3349fb93865_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_1a6a5c0b-ac45-45a0-97ab-aef8a4d64aff_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a4472406-fd10-404a-b3ec-9626693d5bf4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e00252ae-7ad7-446f-9dda-4dcbdfede408_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4ca48f7d-c4a0-4298-9931-5b87c09c3fbc_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_c8545fbf-834a-4ad2-9217-5cbfea093cb8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_22641f91-bbb2-48fb-9028-36ed347e5455_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b3de219a-ad31-4c0f-a4d0-3238950cd7ec_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f14ebc23-8a0b-47b6-bdbf-bbaa09ea4478_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_7a3268e4-18de-4ce6-82e7-f00c363ffb50_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_9ea9304e-0bba-404c-8de2-6ee18e71d9eb_terseLabel_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_label_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:to="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_42108e18-dc78-4751-b720-cc2b0969456a_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_223fb436-781e-4c22-ad42-067bf2eccdf4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_542f2118-aa10-4dea-8809-52d73c83af2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_1a1eecd6-94d1-4dde-953c-af54307b07e5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in noncontrolling interest from:</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_dfbe4ab7-e986-4120-b8d2-eed726daee3c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_fe9fd6af-d955-4fdc-a447-e15ebe92ccba_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_73f8a1ea-ed65-42e0-ad30-19f92a6d4bc8_terseLabel_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA or Operating Income Performance Targets or Quality Margins</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_label_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B I T D A Operating Income Performance Targets Or Quality Margins [Member]</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_documentation_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA operating income performance targets or quality margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:href="dva-20230331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:to="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2d413347-0188-4f59-bc75-e9b413a1d298_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_1d1ce4ad-ea4a-4c41-87a5-661483bf3ce1_terseLabel_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit and other time deposits</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Deposit Commercial Paper And Money Market Funds [Member]</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit, commercial paper, and money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:href="dva-20230331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:to="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_06bca1f2-f168-4c4e-8d18-3925eb843253_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_6e5f09b1-fa07-48d1-9e7f-94c131723636_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of interest rate agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_d0bbaf0f-5f2a-46f3-a6be-d69b192b9a60_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable, fair value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_4eea1f75-80f1-4ff9-a397-37b145b293df_negatedLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables and prepaid and other current assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Current Receivables And Other Current Assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in other current receivables and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:href="dva-20230331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:to="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_dfc4115a-199b-47c1-b5bb-58741777680a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3d0fd87b-7a00-47fd-8fdf-fb0d50208a0b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ee62576f-1236-4f13-aff4-af81281e2051_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_4db06913-e0f7-4193-bc04-fcd5944ed184_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_613d7c39-82f7-46a8-a877-50e9c204428f_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:to="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalCashCommitment_5287a9ed-6037-4ebd-8223-12e48e4f73f1_terseLabel_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:label id="lab_dva_AdditionalCashCommitment_label_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:label id="lab_dva_AdditionalCashCommitment_documentation_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment" xlink:href="dva-20230331.xsd#dva_AdditionalCashCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalCashCommitment" xlink:to="lab_dva_AdditionalCashCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_c6aaa02a-a291-4258-973a-54a60e58b7ba_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_2e3cf03e-d608-4c7d-b788-7174cb665ab1_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_7fcb2428-e91c-40f7-96bc-b8cccdb158ae_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_53af6551-4bb8-47c6-a09a-89483f5612b4_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_374f2118-5a0d-4af5-aeec-5c944f2fe950_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8e0b86fd-d9fd-4f19-9747-698e77e61a63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_190b0223-066b-4610-90d6-bb7922fd8217_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_6f970b91-216a-428b-95d4-cd54607acc16_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_408fe529-6ff8-4ead-8569-7f5f3d466b69_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:to="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a074ffb4-df92-4a77-80e3-bd301d3f0fe0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c15f4fb-19e8-4018-997e-6acb2b94eaa0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_cb230c9a-7b7e-45f2-9767-3e78b0ad2179_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_cfaddbaa-029d-4c33-8054-276e1886215e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8343df02-902a-49dc-8db9-bfb40af8bb23_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_7dfd104e-2324-413d-af1a-cde6ea63d030_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Depreciation and Amortization Expense by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4cc780c1-be04-4066-b615-82fecffe04d0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_3250aea8-94ed-4a19-a1e9-3bddfe8bb6c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_54f699ae-15d1-4b1b-a06f-cb9875ad4b9c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_13efeb58-9a1a-447e-b914-9fbd62c09e1f_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests subject to put provisions</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Temporary Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:href="dva-20230331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:to="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_a09aec16-da2d-459b-a54d-c51db2fe58b5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_44ad5d41-c05c-4644-b103-4de9ac90fa6e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityOtherChanges" xlink:to="lab_us-gaap_TemporaryEquityOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_445e91c9-b9f7-42d3-b87c-1c8969c05b41_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from asset and business sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ec3c3856-8316-43d2-b153-f4340e8dd502_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_088aa48a-8ba2-4d10-a44d-f0f282a6a7b2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1756509e-e425-4ef2-950d-33a345d62b78_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAgreementEffectiveClosingDate_316e043d-6e73-49a4-b005-8ebd6013f4cd_terseLabel_en-US" xlink:label="lab_dva_BusinessAgreementEffectiveClosingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Effective Closing Date</link:label>
    <link:label id="lab_dva_BusinessAgreementEffectiveClosingDate_label_en-US" xlink:label="lab_dva_BusinessAgreementEffectiveClosingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Effective Closing Date</link:label>
    <link:label id="lab_dva_BusinessAgreementEffectiveClosingDate_documentation_en-US" xlink:label="lab_dva_BusinessAgreementEffectiveClosingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Effective Closing Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementEffectiveClosingDate" xlink:href="dva-20230331.xsd#dva_BusinessAgreementEffectiveClosingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAgreementEffectiveClosingDate" xlink:to="lab_dva_BusinessAgreementEffectiveClosingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_166c480b-4ec1-450e-8b33-4f6adf39e537_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_268b2d33-c577-4d6e-a3b3-f4e20a218e9a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_32cc3754-38ab-4035-b6a6-c0c8114496ca_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_89bf402a-7cef-420c-9cdd-61a51d226bbb_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_cd9a4989-a9f3-4791-a384-bfb83e45a39f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of net realized (gains) losses into net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_43772567-1ef7-4d6b-a875-a648f8da8d5d_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanFacilityMember_c8fe66c4-0981-4e66-a6e4-82a76429e8e3_terseLabel_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_label_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanFacilityMember" xlink:to="lab_dva_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_9c0d11e6-38f9-47b6-818e-b827660cad4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_c46822c7-4026-40c0-bf7d-40c36f27095c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains on interest rate cap agreements:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d5738ba4-e8bc-474a-a9d4-08f7ddb2dbac_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_8dec4e52-2c6b-4180-8a71-9ad3b6961e37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e67b6f61-f2b5-43ca-b6bc-1fb60ea23b49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d9fd6a65-ff04-41cf-9374-7123e0f758dc_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_d1d6807d-5ced-47fa-a220-5f4b270fc03d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_91fef4e1-301a-403b-b9aa-a7d2e15ae63a_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TrancheTwoMember_fd9cf715-de11-47e7-878d-f49e88cd3992_terseLabel_en-US" xlink:label="lab_dva_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_dva_TrancheTwoMember_label_en-US" xlink:label="lab_dva_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two [Member]</link:label>
    <link:label id="lab_dva_TrancheTwoMember_documentation_en-US" xlink:label="lab_dva_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheTwoMember" xlink:href="dva-20230331.xsd#dva_TrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TrancheTwoMember" xlink:to="lab_dva_TrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f16c5bd-3360-4fba-a093-d2a95c9d4565_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_16a82370-6b2c-4826-b6d2-d41ca397ceef_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_27b1eaac-003f-4488-82ea-366cb7d011c2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_06f999dd-4617-40b4-a2c6-a86cea1cbc64_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, long-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_4cd9f473-c37f-45fe-98e9-c4f39acdff2a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_d6bfa18a-84be-469f-a890-5e75373f8052_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_c7629b62-8c81-499f-a1cd-772fd06cc68e_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_96c74699-ba50-4a3a-ba0a-b814a84274ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net payments related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_349f470d-2ad4-402a-b45b-876692674c9c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_56d6cc79-7730-4e5b-95e0-ffe33e92b588_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cbe78aa4-8ed6-417b-bbe6-fcf093390cc3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_7224f516-703e-4c51-98c9-abfba559f442_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c7ff5765-2065-4e8a-8831-628594ac8697_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b6114280-c845-4df3-94a1-89e3195b90ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed incremental from stock plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1428b82b-2706-430a-87eb-43d8f7c91004_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ea52b866-ec2e-44a5-a365-f5a06f145309_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable&#160;inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_7d5a09b3-c300-41f7-a5e8-5fc99baf84ab_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_e8f82399-702f-4c73-87c3-77f9b9312eec_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_label_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:href="dva-20230331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:to="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_558b77e1-1c14-47f0-816c-552df280977e_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_82397188-f54a-4d01-b258-2cd771dceb3f_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_242ea81c-4e31-4af1-b6fb-7c168ab17d37_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4aeae51e-66b8-4dca-84e0-b7c287b70a34_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8fd57130-0988-414d-9f23-bdc8b100f9d0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_54efa3df-b987-40e8-b1c1-8ac62b90b7e8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_82ab8ee7-2093-4df5-86da-26bd8ffb66e1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientCareCosts_ead957a0-7821-46c0-a777-54c6a7e8d554_terseLabel_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_label_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Care Costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_documentation_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts" xlink:href="dva-20230331.xsd#dva_PatientCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientCareCosts" xlink:to="lab_dva_PatientCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_eeb522d5-5a5b-47d5-b5f7-3265906420ec_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4d076715-d222-45f1-ac09-9e343145296f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_708fc3ac-40c9-4950-aa01-afb2a4996fe5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_650029dc-d32e-42d4-8601-6a1a618ad9e2_negatedLabel_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate administrative support</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_label_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Corporate Expenses</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_documentation_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:href="dva-20230331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:to="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths_c454838d-6bd1-4f1a-b6ad-96555a8c0e19_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, between Year One, Two, Three, and Four</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanAMember_0fe8dbd4-3159-4c44-b5c8-48497b74919c_terseLabel_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_dva_TermLoanAMember_label_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_dva_TermLoanAMember_documentation_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember" xlink:href="dva-20230331.xsd#dva_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanAMember" xlink:to="lab_dva_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_4b8693b0-700c-41e0-a56c-4b0f5c706bf1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, table footnotes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherReportingUnitsMember_fe1a49ae-ff1b-4542-8a6f-32c0f9e74967_terseLabel_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Health Operations</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_label_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_documentation_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember" xlink:href="dva-20230331.xsd#dva_OtherReportingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherReportingUnitsMember" xlink:to="lab_dva_OtherReportingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_48d140fe-c42d-450b-b0e1-fcfb989fae3f_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_c529db04-2085-4d91-8441-6b0d2a9bbae2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4b3f5f6e-4793-460f-8b50-02743839b76c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_fa916d5d-b5e1-440b-b59d-f8a9ed20af2d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_6dc38851-65ff-4281-9411-b81d9e27468f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_7a18e96e-ac25-4f3f-82d1-12d6247f987d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a37500cf-b57d-4de2-966e-7a3191f3a0e2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a67e7eca-f81c-4154-81c7-f19199b3fe66_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_662978af-bba4-49cf-b043-a8c4d8ea5555_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt expense reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3b980b2d-33fb-413a-adf3-192778b02b04_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_832e5ac4-febd-44fa-bb39-a0a35da19f7c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_e98e562a-aa98-4a05-b36e-f5fab5bc9bc9_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ac5c28f4-1c60-41b6-b1bb-e9b5aa20e63c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3d243db2-37d6-434f-84e8-477288ddafcd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_933b5e95-e788-4711-b9ff-5a9812e4ddae_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_847794e5-5be0-4d22-84d9-e5469f80c66e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_4bbca6a5-1f65-4c34-9fc1-f8d076e42a1f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5051a7f8-d956-4fc9-a1cb-f0b6a29c1503_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_15273937-41a9-4058-af55-a538a1283b47_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_199c7141-758c-4064-8ff0-e6ed529de5aa_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_bb662b6d-eb35-4148-812b-2d4be78d354a_terseLabel_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:href="dva-20230331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_b0e19d7d-0dc4-4ca5-9139-3d4f67862cc9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Owned, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_1624648a-4876-4ed1-bfe4-698b2c163cd6_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_d092a4c8-59a3-4287-ad36-bc97f6f0804c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_ae165d91-1d48-4ce6-a1b8-c125ff1a803d_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_f1d923a8-b3c9-4e6b-8663-f0257bdb02ad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_f7d61351-7168-4699-8001-b681b57fd7de_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate during quarter</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_852c7550-2b92-472b-996b-9291dc6aa2ad_terseLabel_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_label_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_documentation_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:href="dva-20230331.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:to="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_a833f617-b210-4389-95fc-e0c57e1deaec_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3203a64c-75b8-45f8-9a85-d50b5f1c4408_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_5b2c55d9-a7a0-49ef-bb63-8e27b21ca3d6_terseLabel_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_label_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Provide Operating Capital [Member]</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_documentation_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:href="dva-20230331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:to="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_a3ed75da-80ea-4548-9228-524e1daa7efb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c4c42748-3efe-45b2-8238-c42e45666097_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_78db8016-7a92-4b00-8f23-9d15b4284e69_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseMember_b6c87878-0d43-483d-8b2b-b7b91109d03f_verboseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_label_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_documentation_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember" xlink:href="dva-20230331.xsd#dva_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseMember" xlink:to="lab_dva_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bce3e9dd-0a25-4e1d-b5d7-3c9afaeebf38_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_5e36f13a-2e1d-4fd7-bc24-d6256c5b5ee1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_10466b1e-25c5-441c-b110-446eaa48c739_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e300a618-dc76-4971-ae95-fcf88f5677e7_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_fc7d9f25-1b0b-4aab-8192-d8307b758743_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_ccae74c0-0322-484f-bca3-98db74677ca1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies:</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_21369fc1-2708-4e8e-b3ef-3a5fa576188e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions and other commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_074f5c04-1782-4f2b-b579-ec97b7cc2322_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:to="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_ddb3aef4-532a-4efa-b8d0-9db1c66a2b68_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_09c085af-6a64-4390-9cfe-c572a2a91409_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_ee6aa6b0-0043-4578-8538-c71776afb1a1_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate at quarter end</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_89fffb58-9b0a-4859-bf76-6d044a6edcae_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_84b57882-92c9-432c-bf94-fd5e24d7f347_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_50d08b0a-9bf6-4114-8ace-684d55c7b254_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_d660507a-08ab-4dc2-98b1-8603b7fa3838_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20230331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_da9dde7c-427b-4fc8-b594-536a3bd2bed6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3dfcd49c-16d8-4a3f-bb90-0d0f796a03a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_e2a46053-5f5c-4ae0-be87-40e3762de2c2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_249e8372-0b68-46ce-aede-33d83fc01707_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7afbc9e3-0b67-483b-a155-43cabd22a1e1_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_7f0820a3-4f8e-45fc-b7c2-87c040d2fff0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_87af784b-5993-4885-aea4-2e6beb55ce77_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>dva-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:9c0ea6c9-6a9a-4ab3-bf97-28dc6220a742,g:41aede1b-2d06-4ede-95d2-eca429881bc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20230331.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ecbe9cba-d7b0-4caf-a5ba-0116d5db20c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentType_ecbe9cba-d7b0-4caf-a5ba-0116d5db20c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_45c4c383-e41f-42fe-9076-9db03c3765a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentQuarterlyReport_45c4c383-e41f-42fe-9076-9db03c3765a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_28418443-2639-478c-82eb-8ce561b05a71" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentPeriodEndDate_28418443-2639-478c-82eb-8ce561b05a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_edf37933-ad5f-4893-8d4f-017a6e426cec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentTransitionReport_edf37933-ad5f-4893-8d4f-017a6e426cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b1afc2fd-b0da-40a3-9d7b-82b291509f04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityFileNumber_b1afc2fd-b0da-40a3-9d7b-82b291509f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a74d4468-27ba-4bfb-8395-267e48fd9192" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityRegistrantName_a74d4468-27ba-4bfb-8395-267e48fd9192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b7d7c30b-d845-43b1-8600-c2bd3e7888ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b7d7c30b-d845-43b1-8600-c2bd3e7888ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ea386265-0a73-4af3-ad85-9fdc6fe6cd05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityTaxIdentificationNumber_ea386265-0a73-4af3-ad85-9fdc6fe6cd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_59e33507-d66f-465d-8d39-8907f25179df" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityAddressAddressLine1_59e33507-d66f-465d-8d39-8907f25179df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c89df3cf-bd5f-4249-89f7-2d9a10a249d5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityAddressCityOrTown_c89df3cf-bd5f-4249-89f7-2d9a10a249d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1446e51f-734b-4589-ad02-a26b2c9d9bef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityAddressStateOrProvince_1446e51f-734b-4589-ad02-a26b2c9d9bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ef58f6a4-0387-459d-9258-3c6ad36f1913" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityAddressPostalZipCode_ef58f6a4-0387-459d-9258-3c6ad36f1913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d85d7bcf-ff6b-4f1c-ab14-33113be572a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_CityAreaCode_d85d7bcf-ff6b-4f1c-ab14-33113be572a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b8116180-bd92-45c6-8cda-7fcce4143f2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_LocalPhoneNumber_b8116180-bd92-45c6-8cda-7fcce4143f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5921337f-c211-4ca5-803e-11e8ec43178b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_Security12bTitle_5921337f-c211-4ca5-803e-11e8ec43178b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fcf8bb1c-fcc1-43bd-9210-e6c9f202081c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_TradingSymbol_fcf8bb1c-fcc1-43bd-9210-e6c9f202081c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_31fb953a-e3f3-4344-820d-51ad08e6f3e8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_SecurityExchangeName_31fb953a-e3f3-4344-820d-51ad08e6f3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d59c5023-dea1-46fb-905d-611a1b2a6cbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityCurrentReportingStatus_d59c5023-dea1-46fb-905d-611a1b2a6cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b7b7ec2d-682a-468e-b4b4-012e20077ee2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityInteractiveDataCurrent_b7b7ec2d-682a-468e-b4b4-012e20077ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b6db6dd5-fe0e-4897-99ed-e19cf06ba1b3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityFilerCategory_b6db6dd5-fe0e-4897-99ed-e19cf06ba1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0d534a84-ba6e-49f0-ad0e-88bb5f3c6868" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntitySmallBusiness_0d534a84-ba6e-49f0-ad0e-88bb5f3c6868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_76527856-563e-46cf-8f39-ebfd6f8a798a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityEmergingGrowthCompany_76527856-563e-46cf-8f39-ebfd6f8a798a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_84e37695-9387-4147-8732-59e3514a7d99" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityShellCompany_84e37695-9387-4147-8732-59e3514a7d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_69182f85-e793-47ec-8eef-05ace7f7ad83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_69182f85-e793-47ec-8eef-05ace7f7ad83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_68264b9d-b8c6-4d12-9f2a-35739ec688c6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_AmendmentFlag_68264b9d-b8c6-4d12-9f2a-35739ec688c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3bb6b4f5-1d64-4800-a5a9-7faa1baae90c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentFiscalYearFocus_3bb6b4f5-1d64-4800-a5a9-7faa1baae90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_084b192c-3bef-4123-b2dd-974d7aceea50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_DocumentFiscalPeriodFocus_084b192c-3bef-4123-b2dd-974d7aceea50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0a257958-a3c0-47b4-9f85-c2ea033a669f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_EntityCentralIndexKey_0a257958-a3c0-47b4-9f85-c2ea033a669f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0f51d4d3-4060-4430-a581-9002e12e5fbd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_c6ac0f5d-aa3a-4027-8dd9-2f11c9917847" xlink:to="loc_dei_CurrentFiscalYearEndDate_0f51d4d3-4060-4430-a581-9002e12e5fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_dd6b5318-9d90-44f0-b58b-a863acb985ca" xlink:href="dva-20230331.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_dd6b5318-9d90-44f0-b58b-a863acb985ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_6d3c8cc9-f7ff-4686-9d02-8656839c466b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_OtherIncome_6d3c8cc9-f7ff-4686-9d02-8656839c466b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6b38e015-b4f7-4ec5-9abf-f1be38cae89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_Revenues_6b38e015-b4f7-4ec5-9abf-f1be38cae89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_27686103-ef16-4f8e-b7f1-d6989015a3b0" xlink:href="dva-20230331.xsd#dva_PatientCareCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:to="loc_dva_PatientCareCosts_27686103-ef16-4f8e-b7f1-d6989015a3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0330c7d0-76eb-4cef-aa3e-248a698799a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0330c7d0-76eb-4cef-aa3e-248a698799a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7c99a858-cd3b-4181-927d-daf134b6b087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:to="loc_us-gaap_DepreciationAndAmortization_7c99a858-cd3b-4181-927d-daf134b6b087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_35255797-f433-4fc0-bfa1-25b8901da2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_35255797-f433-4fc0-bfa1-25b8901da2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6cfb8ed2-244e-4df2-b957-a0a8f1694d38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1eba749c-0ecb-4a83-a609-5634af6d40ba" xlink:to="loc_us-gaap_CostsAndExpenses_6cfb8ed2-244e-4df2-b957-a0a8f1694d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_77d81e25-14cf-4a24-9838-43bf78a2774b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_OperatingIncomeLoss_77d81e25-14cf-4a24-9838-43bf78a2774b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_02efe0d9-6d64-4238-a35f-d0e4b971f74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_InterestAndDebtExpense_02efe0d9-6d64-4238-a35f-d0e4b971f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8839c535-1fd6-4741-9354-64c7f0947887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8839c535-1fd6-4741-9354-64c7f0947887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_052b9c9f-7714-47a2-bf88-0c096435df85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_052b9c9f-7714-47a2-bf88-0c096435df85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fc1a4fa8-a572-423f-9311-17a107dad84f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fc1a4fa8-a572-423f-9311-17a107dad84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e3fefcbb-72f7-43c7-b390-9b2b758d7c29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_ProfitLoss_e3fefcbb-72f7-43c7-b390-9b2b758d7c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40d47951-66ce-4bfe-8497-96891c94fc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40d47951-66ce-4bfe-8497-96891c94fc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_958a0e45-719b-4abd-be48-f05ecf60f353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_NetIncomeLoss_958a0e45-719b-4abd-be48-f05ecf60f353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9603edf3-94c2-4a24-a005-902a513c5757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_EarningsPerShareAbstract_9603edf3-94c2-4a24-a005-902a513c5757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_016dafa5-5c64-4273-84a6-b2145c7417d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9603edf3-94c2-4a24-a005-902a513c5757" xlink:to="loc_us-gaap_EarningsPerShareBasic_016dafa5-5c64-4273-84a6-b2145c7417d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f6c5dc7b-9d49-40fc-981c-7db8f2c0dc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9603edf3-94c2-4a24-a005-902a513c5757" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f6c5dc7b-9d49-40fc-981c-7db8f2c0dc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2e8d699c-1c9a-48ea-8778-e60a304cbd46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_b8062b94-e958-4e22-8c5d-9581d7050aea" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2e8d699c-1c9a-48ea-8778-e60a304cbd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fda2e808-1bf6-4bb3-8ef8-8ac8e960bac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2e8d699c-1c9a-48ea-8778-e60a304cbd46" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fda2e808-1bf6-4bb3-8ef8-8ac8e960bac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c97838e-3dd5-46f4-b901-c7147e4a95f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2e8d699c-1c9a-48ea-8778-e60a304cbd46" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8c97838e-3dd5-46f4-b901-c7147e4a95f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_63bcbd54-dbdd-462d-a664-1fd7cecb6c90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_ProfitLoss_63bcbd54-dbdd-462d-a664-1fd7cecb6c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e630f6ff-d0b3-49a9-876a-812411ae2a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e630f6ff-d0b3-49a9-876a-812411ae2a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_85f784e1-c156-40e4-9fcb-1294b9c65c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_e630f6ff-d0b3-49a9-876a-812411ae2a6f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_85f784e1-c156-40e4-9fcb-1294b9c65c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_36e0fd41-162e-46a3-951f-f7f587466ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_36e0fd41-162e-46a3-951f-f7f587466ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f9c98ea5-64a1-43f7-8374-38d70e565b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_f9c98ea5-64a1-43f7-8374-38d70e565b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f8c9e90d-9227-4526-b366-dd492a4ff58d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f8c9e90d-9227-4526-b366-dd492a4ff58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2758d672-edf4-4508-a9a4-2703df6103d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2758d672-edf4-4508-a9a4-2703df6103d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d154e6c9-a86a-4bcb-b97c-e5ae87ac690d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d154e6c9-a86a-4bcb-b97c-e5ae87ac690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e17d4aa7-ac0d-40b7-b343-764bab22756c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e17d4aa7-ac0d-40b7-b343-764bab22756c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e2499293-9bca-469b-96d5-a48caa838f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d4cf581d-fcce-4b4f-8f5d-db6650d24d3a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e2499293-9bca-469b-96d5-a48caa838f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_20639264-b906-43ea-8090-c7e2e62e48ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_20639264-b906-43ea-8090-c7e2e62e48ae" xlink:to="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e728256f-3f7c-4376-92b5-3bffc4a0b04b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e728256f-3f7c-4376-92b5-3bffc4a0b04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_632f70db-815f-430a-b637-bbcf9d75f281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_632f70db-815f-430a-b637-bbcf9d75f281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7a3c122a-9dcc-4b2b-8d38-4b8981e61a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7a3c122a-9dcc-4b2b-8d38-4b8981e61a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2068c719-8283-4c60-b7f2-97d3655bbde1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2068c719-8283-4c60-b7f2-97d3655bbde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bda47ab9-6996-4a7d-ae1b-968c5ac1769d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_InventoryNet_bda47ab9-6996-4a7d-ae1b-968c5ac1769d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_380f7884-7075-4779-9a1a-141ee5e76f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_380f7884-7075-4779-9a1a-141ee5e76f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a10325dc-7a70-4b33-a957-1bc27b27577a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a10325dc-7a70-4b33-a957-1bc27b27577a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_a10cfc8a-310a-4ee3-b4bf-71b6826a8588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_IncomeTaxesReceivable_a10cfc8a-310a-4ee3-b4bf-71b6826a8588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5c075d3a-5d69-4182-91d1-dab5921bc5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_AssetsCurrent_5c075d3a-5d69-4182-91d1-dab5921bc5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_51c321d3-dded-4332-874b-71b10edc4bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_51c321d3-dded-4332-874b-71b10edc4bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c16127c-100b-45b4-be9f-83c004c07206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c16127c-100b-45b4-be9f-83c004c07206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d3a9f94-c157-4dc4-a131-01515952a631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2d3a9f94-c157-4dc4-a131-01515952a631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e094a72f-bec8-4b7b-afff-d4e3cc93f4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e094a72f-bec8-4b7b-afff-d4e3cc93f4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_e5b97db3-6b71-47ad-9617-02083bab3185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_e5b97db3-6b71-47ad-9617-02083bab3185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5fec81d1-1a00-4dd2-9650-69303c48aafe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5fec81d1-1a00-4dd2-9650-69303c48aafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_71ef8510-0622-46fc-adfa-1256f2ea4566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_Goodwill_71ef8510-0622-46fc-adfa-1256f2ea4566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c1593b49-425f-4193-bce1-964f89db4f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_09043bef-32ef-4117-a68b-56ee7fdfcda0" xlink:to="loc_us-gaap_Assets_c1593b49-425f-4193-bce1-964f89db4f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_20639264-b906-43ea-8090-c7e2e62e48ae" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7fcad4c6-ff9f-4804-a22b-225e3d0fd3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_AccountsPayableCurrent_7fcad4c6-ff9f-4804-a22b-225e3d0fd3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6b46f785-cbcc-4980-9129-0133a14bd8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6b46f785-cbcc-4980-9129-0133a14bd8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2ac00e50-1482-494e-ba74-9499d30ec05b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2ac00e50-1482-494e-ba74-9499d30ec05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_884325d0-b5eb-4248-a997-ecd79b033d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_884325d0-b5eb-4248-a997-ecd79b033d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d9672333-197e-41fc-bb97-ed0d07301333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_d9672333-197e-41fc-bb97-ed0d07301333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e34edc45-4c36-46dd-8f4d-0374f69ea814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e34edc45-4c36-46dd-8f4d-0374f69ea814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cbae3ad1-8311-4cfd-a512-9f6634788bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_LiabilitiesCurrent_cbae3ad1-8311-4cfd-a512-9f6634788bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79fddaff-e3c7-47ea-b81c-58d39de2bbb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_79fddaff-e3c7-47ea-b81c-58d39de2bbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89bd2968-8c9e-4c6d-91fa-661629e1d70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_89bd2968-8c9e-4c6d-91fa-661629e1d70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e7853ac6-0d9f-462f-abe1-8614c46cc2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e7853ac6-0d9f-462f-abe1-8614c46cc2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0115920c-a4f6-402c-b4d4-fc2ecc76d915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0115920c-a4f6-402c-b4d4-fc2ecc76d915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21177de7-dfde-4f56-b824-7b59c28f067b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_Liabilities_21177de7-dfde-4f56-b824-7b59c28f067b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67fba7c9-48a9-445f-8492-c054502f9162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67fba7c9-48a9-445f-8492-c054502f9162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_efc61243-9303-49a4-a14f-149e1e68d9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67fba7c9-48a9-445f-8492-c054502f9162" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_efc61243-9303-49a4-a14f-149e1e68d9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1ce4afd1-b3fa-4e3e-93cf-d5016fe5da68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_PreferredStockValue_1ce4afd1-b3fa-4e3e-93cf-d5016fe5da68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fbbbba0f-a693-49cc-b276-f47c9db91ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_CommonStockValue_fbbbba0f-a693-49cc-b276-f47c9db91ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ccd212a8-0bd8-48f5-a2e2-c4794b6e5ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ccd212a8-0bd8-48f5-a2e2-c4794b6e5ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a0d2838e-d84b-4e63-a337-c820a3f8174c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a0d2838e-d84b-4e63-a337-c820a3f8174c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a2bc76d-24a0-49fb-9f83-e6ccc9ed1d51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a2bc76d-24a0-49fb-9f83-e6ccc9ed1d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c8dd3ebe-7c29-4b0e-aeb8-07d906113a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_StockholdersEquity_c8dd3ebe-7c29-4b0e-aeb8-07d906113a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7fe3fbcf-f8f0-49e9-8feb-4a4547ef077b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_MinorityInterest_7fe3fbcf-f8f0-49e9-8feb-4a4547ef077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf12811-5816-40ea-90d1-836727222409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_3b10e7c8-072b-4c1a-845f-2b09b8b11e3d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1bf12811-5816-40ea-90d1-836727222409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_013087d6-4f46-40bf-978a-09b3a3da3532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45b36cd8-33c0-4f05-8bb5-ba2314a26bef" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_013087d6-4f46-40bf-978a-09b3a3da3532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_97c6faeb-8c30-4925-a1da-4d342d0ba15a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_97c6faeb-8c30-4925-a1da-4d342d0ba15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02d3fb3b-b06a-424e-8aeb-7345db04429e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02d3fb3b-b06a-424e-8aeb-7345db04429e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b5d72ec1-5d60-4010-930e-c15c7a086e20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b5d72ec1-5d60-4010-930e-c15c7a086e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2bd4fc32-15df-4294-834d-73545f95f05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2bd4fc32-15df-4294-834d-73545f95f05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8ee67013-5851-4c89-89b3-e42b9faa340e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8ee67013-5851-4c89-89b3-e42b9faa340e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4db77925-62b1-4c7a-9355-86520581d95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4db77925-62b1-4c7a-9355-86520581d95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_728b8394-0713-4833-ad24-fefc985c66b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_728b8394-0713-4833-ad24-fefc985c66b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_99654e03-4e88-4862-aa55-bd060969b941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_CommonStockSharesIssued_99654e03-4e88-4862-aa55-bd060969b941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2cdbe84c-65b8-4d11-adf1-f93b058e86cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d8787c0-87bc-4cfc-b4ca-70c9bad78095" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2cdbe84c-65b8-4d11-adf1-f93b058e86cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fce557e4-4761-48bc-a869-483785af1201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fce557e4-4761-48bc-a869-483785af1201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7be526e-ea91-42dd-97d2-193752aec5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fce557e4-4761-48bc-a869-483785af1201" xlink:to="loc_us-gaap_ProfitLoss_e7be526e-ea91-42dd-97d2-193752aec5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fce557e4-4761-48bc-a869-483785af1201" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_94efc8c8-51bd-4c59-9b63-3e3dd491e72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_94efc8c8-51bd-4c59-9b63-3e3dd491e72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_95869c0b-c447-4bb6-9d16-6bdb39a37eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_ShareBasedCompensation_95869c0b-c447-4bb6-9d16-6bdb39a37eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e200988-4e57-407e-906e-78c948fc12dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3e200988-4e57-407e-906e-78c948fc12dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_653edddc-ffd9-4762-9d9d-8b35388afb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_653edddc-ffd9-4762-9d9d-8b35388afb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_48d069ae-e842-4467-9fdc-51a32a5d0011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_48d069ae-e842-4467-9fdc-51a32a5d0011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ee4bd5d-867e-4f78-8ef1-c5aac4b82ca9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5b318b9e-c677-46df-b085-0491b23b7965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5b318b9e-c677-46df-b085-0491b23b7965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_1dd422d3-b765-409c-a1fc-42f0a00a9890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_1dd422d3-b765-409c-a1fc-42f0a00a9890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_f36b38a2-b6cb-4c3e-9aa9-9a99740d3890" xlink:href="dva-20230331.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_f36b38a2-b6cb-4c3e-9aa9-9a99740d3890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_411cf897-f305-45df-a633-5920a9035380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_411cf897-f305-45df-a633-5920a9035380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9710006-ecc6-4e04-aa2d-2dce95b9ebc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d9710006-ecc6-4e04-aa2d-2dce95b9ebc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_da12b2c3-3706-44d4-86a2-70822bfbdc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_da12b2c3-3706-44d4-86a2-70822bfbdc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_d0b3cb58-bdb6-4d00-afa8-f4771a91cb50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_d0b3cb58-bdb6-4d00-afa8-f4771a91cb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ccce123c-6f5a-49d1-9f9d-7b691f73132f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ccce123c-6f5a-49d1-9f9d-7b691f73132f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e9b3447b-54bf-4750-96f5-a8599b2b289b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b3f36c01-905f-41b6-b198-17651d3b091d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e9b3447b-54bf-4750-96f5-a8599b2b289b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44c43718-cf6f-485f-9c6b-79fbf8f0145e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fce557e4-4761-48bc-a869-483785af1201" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_44c43718-cf6f-485f-9c6b-79fbf8f0145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3cfed7d3-04fb-4db2-8f9d-4792bf9e667b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3cfed7d3-04fb-4db2-8f9d-4792bf9e667b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c9f3a556-245e-4393-87d3-a7d36f98139b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c9f3a556-245e-4393-87d3-a7d36f98139b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_776fb394-86ed-4911-9f0c-bc613af167e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_776fb394-86ed-4911-9f0c-bc613af167e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_c42fb719-2d5a-4f7b-832f-d7c95a193bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_c42fb719-2d5a-4f7b-832f-d7c95a193bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_78167ed0-c2cd-47d2-b7ea-2a4d747db314" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_78167ed0-c2cd-47d2-b7ea-2a4d747db314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_86392d52-6321-4ee6-936d-ec83fd5efd47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_86392d52-6321-4ee6-936d-ec83fd5efd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_6e6d69c4-0a00-4396-830b-adc526c76675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_6e6d69c4-0a00-4396-830b-adc526c76675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d76a5bad-33e7-4516-be5c-397d7e90f0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_d76a5bad-33e7-4516-be5c-397d7e90f0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5304095e-4951-4d2b-b24b-6c260a9745cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_5304095e-4951-4d2b-b24b-6c260a9745cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8f8c9b8-b5f4-498f-8996-5fb96dbee67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_f57e7315-b309-4243-b817-119324c274c7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8f8c9b8-b5f4-498f-8996-5fb96dbee67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b51316e6-c2cd-46fe-8bfa-3bafaad7b8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_b51316e6-c2cd-46fe-8bfa-3bafaad7b8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_ebb13d55-f3ce-4720-aa5a-d90b3ab0179d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_ebb13d55-f3ce-4720-aa5a-d90b3ab0179d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_d4e850b0-388e-495f-a5d5-2a4e91244edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_d4e850b0-388e-495f-a5d5-2a4e91244edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2d4b581e-903a-420f-bccb-f62d57a83205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2d4b581e-903a-420f-bccb-f62d57a83205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_99e0ba11-d338-4cb1-81a5-8c64a9da6dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_99e0ba11-d338-4cb1-81a5-8c64a9da6dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2b5d0453-7c8f-4542-9634-b823779a79c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2b5d0453-7c8f-4542-9634-b823779a79c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_7a763e02-67ae-4286-ad2a-31f99bd8d563" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_7a763e02-67ae-4286-ad2a-31f99bd8d563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_35afd56f-ec75-46b8-b09b-90d8e85b6de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_35afd56f-ec75-46b8-b09b-90d8e85b6de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_4ee2924e-1cb9-40cd-a22e-fcb2b5215d56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_4ee2924e-1cb9-40cd-a22e-fcb2b5215d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf70b40f-455b-44c9-9e0b-0de77edc2e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_93708cb6-ff40-4c87-877b-1f839f62a106" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cf70b40f-455b-44c9-9e0b-0de77edc2e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afbe1d7d-94ea-4467-8d48-a8b52691e9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_afbe1d7d-94ea-4467-8d48-a8b52691e9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eb220f15-c2c6-4eaa-9290-0efc17304133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eb220f15-c2c6-4eaa-9290-0efc17304133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e41164fe-6f0a-43a4-a3a0-ca240c7e1340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e41164fe-6f0a-43a4-a3a0-ca240c7e1340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_539f27fd-b1bc-44ef-ae77-e604f3f6312c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1a4c3310-a98b-418a-a261-a58ce4751fc2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_539f27fd-b1bc-44ef-ae77-e604f3f6312c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20230331.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d5060bf1-7e00-4d64-8cb9-d4ed27db3e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d5060bf1-7e00-4d64-8cb9-d4ed27db3e4a" xlink:to="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d106fc37-1641-4446-9af4-af36cadc98a1" xlink:to="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c845be3-6606-49ab-9dc9-119a97f7fd50" xlink:to="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_91c09d5e-311a-42f8-a7bc-47b1d77886f2" xlink:href="dva-20230331.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_91c09d5e-311a-42f8-a7bc-47b1d77886f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_71f2295f-393b-47f9-9e90-c87e663af56b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_CommonStockMember_71f2295f-393b-47f9-9e90-c87e663af56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4fcaf2f7-8777-4f8d-9472-efc8add93dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4fcaf2f7-8777-4f8d-9472-efc8add93dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8f0be50f-ec1a-43fc-9de8-18eb183ffd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_RetainedEarningsMember_8f0be50f-ec1a-43fc-9de8-18eb183ffd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_eb97d90a-c2ae-4cd9-b788-6cf89ce307ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_TreasuryStockCommonMember_eb97d90a-c2ae-4cd9-b788-6cf89ce307ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5aad4c1d-2774-4be1-a6f1-787b4e63146a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5aad4c1d-2774-4be1-a6f1-787b4e63146a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_f76d1861-5095-464c-8eb3-3c05a76c4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_bef26b09-f660-4383-9f59-02070378fd14" xlink:to="loc_us-gaap_NoncontrollingInterestMember_f76d1861-5095-464c-8eb3-3c05a76c4c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c5b9f900-9d07-4229-8ac6-eed5963fc02f" xlink:to="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c50c735-ab8d-4ab4-961f-d859a2dd5a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6c50c735-ab8d-4ab4-961f-d859a2dd5a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_0ef2669a-80d1-4e26-833f-4257b5a123e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_0ef2669a-80d1-4e26-833f-4257b5a123e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_a14a33ac-326d-4e86-92a2-6347897a16cb" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_a14a33ac-326d-4e86-92a2-6347897a16cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_cb7901c1-d579-443e-89b9-a393b2019d84" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_cb7901c1-d579-443e-89b9-a393b2019d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_58a15d69-cfc0-411c-8244-37c96b74cb02" xlink:href="dva-20230331.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_58a15d69-cfc0-411c-8244-37c96b74cb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_82e4946d-9c80-4453-b8b7-ce672abafb2d" xlink:href="dva-20230331.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_82e4946d-9c80-4453-b8b7-ce672abafb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_7681d4d8-c867-404e-a014-21a1cdd4da4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_7681d4d8-c867-404e-a014-21a1cdd4da4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_32f68b8a-247c-4f09-9c06-43916a3533ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_32f68b8a-247c-4f09-9c06-43916a3533ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_a775b218-1688-4769-8004-4db41586331b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6935ea19-bfd7-4bec-bcc2-ad73037c6024" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_a775b218-1688-4769-8004-4db41586331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c7b956a-7941-4a8c-8227-3bf8608cdce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8c7b956a-7941-4a8c-8227-3bf8608cdce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_aa0bb4c7-5dc3-492f-8356-186708b367d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_aa0bb4c7-5dc3-492f-8356-186708b367d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_c85dd5a8-b187-472a-a72f-520fb900029f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockCommonShares_c85dd5a8-b187-472a-a72f-520fb900029f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_07494abb-9330-444f-8fa4-d8fffc1e78ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_07494abb-9330-444f-8fa4-d8fffc1e78ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a78de53-039a-494e-91c7-81847b4c8127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_d49bc078-5ff8-416e-822c-c1d388bddc74" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a78de53-039a-494e-91c7-81847b4c8127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_26c980b0-39ff-4dc1-816c-1b5db717d871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_26c980b0-39ff-4dc1-816c-1b5db717d871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_74a59e3c-5d62-4444-a2e4-0d474a4dfeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_74a59e3c-5d62-4444-a2e4-0d474a4dfeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_484792dd-485c-4dc2-a7ad-f8163d611ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_484792dd-485c-4dc2-a7ad-f8163d611ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d228ee8-60a6-4e16-8326-d5c4f4acca53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9d228ee8-60a6-4e16-8326-d5c4f4acca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bec2ea5-5396-492c-94d4-9727d271575a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7bec2ea5-5396-492c-94d4-9727d271575a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_67646103-c745-4f3f-91f7-762bfff0ab17" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_67646103-c745-4f3f-91f7-762bfff0ab17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_60a8a51b-db54-4889-97c5-7cbae7a0c5d4" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_60a8a51b-db54-4889-97c5-7cbae7a0c5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f30bc10e-a063-4e23-bccc-9828cc60504a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_f30bc10e-a063-4e23-bccc-9828cc60504a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d84cb1d3-0fa0-4d61-87ac-90fb791fcb87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d84cb1d3-0fa0-4d61-87ac-90fb791fcb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_67757a06-cc55-4fec-b069-00db87e6431c" xlink:href="dva-20230331.xsd#dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_952e48b9-23d7-4483-92d4-3d58bff84142" xlink:to="loc_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations_67757a06-cc55-4fec-b069-00db87e6431c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cf3bf2b7-ce5c-4292-b782-805e0d806429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_cf3bf2b7-ce5c-4292-b782-805e0d806429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ed982e6f-8ec4-4278-9aec-942e6615a4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_76175919-2829-4d88-9fd5-6d26c427a491" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ed982e6f-8ec4-4278-9aec-942e6615a4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ed8503-5f0f-4a9d-ac94-c0c9b1a2f489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ed8503-5f0f-4a9d-ac94-c0c9b1a2f489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f4b79e9d-267a-4cfb-a6c2-95a8313732ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f4b79e9d-267a-4cfb-a6c2-95a8313732ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_774d36cf-08fe-472f-9bdd-468ff8a96452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_43fe2ccc-0114-46f8-a553-9ced1c77ff04" xlink:to="loc_us-gaap_TreasuryStockCommonShares_774d36cf-08fe-472f-9bdd-468ff8a96452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="simple" xlink:href="dva-20230331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_8b9668de-e4d1-47d4-8b37-c2ef496d11f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e9df34ea-d5bb-41ee-90c0-833b417f8956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_8b9668de-e4d1-47d4-8b37-c2ef496d11f5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_e9df34ea-d5bb-41ee-90c0-833b417f8956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="simple" xlink:href="dva-20230331.xsd#RevenueRecognitionRevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_dc1978b9-9454-4d74-88b8-c30c127aec80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9ff52b4b-1dd1-4bd2-b926-29e8daeb9505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_dc1978b9-9454-4d74-88b8-c30c127aec80" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9ff52b4b-1dd1-4bd2-b926-29e8daeb9505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareNotes" xlink:type="simple" xlink:href="dva-20230331.xsd#EarningspershareNotes"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_94cb0123-b91a-4ff4-b1c2-a78f74fd9eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_95156fcd-8d86-433e-9716-27de3bcd33f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_94cb0123-b91a-4ff4-b1c2-a78f74fd9eab" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_95156fcd-8d86-433e-9716-27de3bcd33f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="simple" xlink:href="dva-20230331.xsd#Investmentsindebtandequitysecurities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_89809e7f-e375-4b36-bee8-621e133f584d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8926c67e-2619-491e-9695-b7ce01aa182e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_89809e7f-e375-4b36-bee8-621e133f584d" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8926c67e-2619-491e-9695-b7ce01aa182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20230331.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a78c5d75-1b21-489b-95b4-702d3b07893c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_19660325-2c88-4c70-8284-2f9f64c15112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a78c5d75-1b21-489b-95b4-702d3b07893c" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_19660325-2c88-4c70-8284-2f9f64c15112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Longtermdebt" xlink:type="simple" xlink:href="dva-20230331.xsd#Longtermdebt"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Longtermdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_abf7d210-1572-459e-a07f-506774338b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_3623e26a-f716-4eaf-97f3-bd8729de27c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_abf7d210-1572-459e-a07f-506774338b8b" xlink:to="loc_us-gaap_LongTermDebtTextBlock_3623e26a-f716-4eaf-97f3-bd8729de27c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dva-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75bb96ad-d994-4ca8-adf4-fcdf227d463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_ca06c355-13f3-493b-bd8f-e1183dc23395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75bb96ad-d994-4ca8-adf4-fcdf227d463d" xlink:to="loc_us-gaap_LossContingencyDisclosures_ca06c355-13f3-493b-bd8f-e1183dc23395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_136844f2-c3c9-478a-9d21-42069548e713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_75bb96ad-d994-4ca8-adf4-fcdf227d463d" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_136844f2-c3c9-478a-9d21-42069548e713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shareholdersequity" xlink:type="simple" xlink:href="dva-20230331.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a342be2e-ed74-40a2-90aa-7ae8965a773e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_811c233b-75ed-4746-ace0-68269e4be85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a342be2e-ed74-40a2-90aa-7ae8965a773e" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_811c233b-75ed-4746-ace0-68269e4be85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_49c387f9-9d90-43ee-9e08-dd423548df0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a342be2e-ed74-40a2-90aa-7ae8965a773e" xlink:to="loc_us-gaap_TreasuryStockTextBlock_49c387f9-9d90-43ee-9e08-dd423548df0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="simple" xlink:href="dva-20230331.xsd#Accumulatedothercomprehensivelossincome"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a2d7f92-9ae7-4aff-b1e1-eeaf569337f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bf1a5804-2128-4b90-8631-4d4b584f856f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1a2d7f92-9ae7-4aff-b1e1-eeaf569337f5" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bf1a5804-2128-4b90-8631-4d4b584f856f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Variableinterestentities" xlink:type="simple" xlink:href="dva-20230331.xsd#Variableinterestentities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Variableinterestentities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af9e9a67-da67-4c56-9964-c3d2e885e6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_23c66556-9d83-4ac4-9fd8-0e174f37951e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_af9e9a67-da67-4c56-9964-c3d2e885e6f0" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_23c66556-9d83-4ac4-9fd8-0e174f37951e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="simple" xlink:href="dva-20230331.xsd#Fairvalueoffinancialinstruments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b34d0c79-9692-4991-9aa2-ed950e1ddecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_4b056d30-c8be-46ae-b6bd-6ccf04e3a9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b34d0c79-9692-4991-9aa2-ed950e1ddecd" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_4b056d30-c8be-46ae-b6bd-6ccf04e3a9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Segmentreporting" xlink:type="simple" xlink:href="dva-20230331.xsd#Segmentreporting"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Segmentreporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3843c184-e0d0-4278-81ba-4585bec45fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a48f5ac-0eaf-4e3d-933c-b280686418cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3843c184-e0d0-4278-81ba-4585bec45fdb" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_9a48f5ac-0eaf-4e3d-933c-b280686418cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Newaccountingstandards" xlink:type="simple" xlink:href="dva-20230331.xsd#Newaccountingstandards"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Newaccountingstandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_8e3bf02f-1f2c-4634-a717-ea5fb1eabac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1796348-1ceb-45af-98f6-6ef5a708b192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_8e3bf02f-1f2c-4634-a717-ea5fb1eabac9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1796348-1ceb-45af-98f6-6ef5a708b192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SubsequentEvents" xlink:type="simple" xlink:href="dva-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e5f28d57-dc12-44c7-8d21-bbec8db746bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5541eb46-7c1a-4067-a627-8753ae5bf349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e5f28d57-dc12-44c7-8d21-bbec8db746bd" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5541eb46-7c1a-4067-a627-8753ae5bf349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="simple" xlink:href="dva-20230331.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2a3a4fa2-a29b-4ab9-b086-25b64fd1c573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2a3a4fa2-a29b-4ab9-b086-25b64fd1c573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_0a8222ef-7c1e-49b6-a389-98187444902e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_0a8222ef-7c1e-49b6-a389-98187444902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_c4bdc54d-303b-44da-a579-905b1b4502a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_c4bdc54d-303b-44da-a579-905b1b4502a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_dabed7db-0b4f-44c8-a338-6539d327af2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_dabed7db-0b4f-44c8-a338-6539d327af2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_d95e93ae-758a-4b75-be88-f0b222296a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_d95e93ae-758a-4b75-be88-f0b222296a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b158c493-8cc3-4b41-a506-a4d8ddc181dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b158c493-8cc3-4b41-a506-a4d8ddc181dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_074853ae-1f13-49eb-82af-39a7ccc604e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_856ecfa5-c1a4-4111-b638-59e421178a21" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_074853ae-1f13-49eb-82af-39a7ccc604e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20230331.xsd#RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract_e740c214-9bd5-431c-827f-5323535afc33" xlink:href="dva-20230331.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8818a1c5-5963-4b3d-8e1e-42cc61007135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_RevenuesbymajorpayorAbstract_e740c214-9bd5-431c-827f-5323535afc33" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8818a1c5-5963-4b3d-8e1e-42cc61007135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="simple" xlink:href="dva-20230331.xsd#EarningspershareEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae36fc94-caae-4e34-85f9-eaf1f3e803b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_538c0a83-9cf3-4461-9359-4cff9aa38c39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae36fc94-caae-4e34-85f9-eaf1f3e803b8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_538c0a83-9cf3-4461-9359-4cff9aa38c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="simple" xlink:href="dva-20230331.xsd#InvestmentsindebtandequitysecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_039b3dc8-0d07-4437-8e62-376038448ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_ae776660-c7ce-4b08-be9a-730f80ec8237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_039b3dc8-0d07-4437-8e62-376038448ebb" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_ae776660-c7ce-4b08-be9a-730f80ec8237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20230331.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7415de26-85e4-44e4-ae61-d196180c61bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_216725c1-78c4-46de-8596-d77f254cd69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7415de26-85e4-44e4-ae61-d196180c61bf" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_216725c1-78c4-46de-8596-d77f254cd69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtTables" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_68832b70-bfa1-4b6e-afd7-008a9d0e5ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_85ae4a88-2731-444c-8900-8056195d6675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_68832b70-bfa1-4b6e-afd7-008a9d0e5ecc" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_85ae4a88-2731-444c-8900-8056195d6675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_231eb624-10a5-481c-8952-362eb2fa5bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_68832b70-bfa1-4b6e-afd7-008a9d0e5ecc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_231eb624-10a5-481c-8952-362eb2fa5bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="simple" xlink:href="dva-20230331.xsd#AccumulatedothercomprehensivelossincomeTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_670fa286-33e6-4b73-852e-ddadf774dec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4cba3921-cd03-46c9-8efe-efc548723d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_670fa286-33e6-4b73-852e-ddadf774dec4" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4cba3921-cd03-46c9-8efe-efc548723d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="simple" xlink:href="dva-20230331.xsd#FairvalueoffinancialinstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_79933a99-9eb1-4d12-90fe-c6f2a32f48fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ba39d00d-7191-4bea-95cb-0f02d83b369e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_79933a99-9eb1-4d12-90fe-c6f2a32f48fd" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_ba39d00d-7191-4bea-95cb-0f02d83b369e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5f1401c2-6d79-47de-a4a9-e75223821de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_71a0de7f-9975-47d5-949c-53a0007fbc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f1401c2-6d79-47de-a4a9-e75223821de6" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_71a0de7f-9975-47d5-949c-53a0007fbc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_a823a8ad-4dc6-481f-8b38-5e7b352f3744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f1401c2-6d79-47de-a4a9-e75223821de6" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_a823a8ad-4dc6-481f-8b38-5e7b352f3744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_b905bb28-f013-4e91-8ed7-ad10df016712" xlink:href="dva-20230331.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f1401c2-6d79-47de-a4a9-e75223821de6" xlink:to="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_b905bb28-f013-4e91-8ed7-ad10df016712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_c03ba918-da7b-495e-b799-13f3b05432cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5f1401c2-6d79-47de-a4a9-e75223821de6" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_c03ba918-da7b-495e-b799-13f3b05432cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract_92d6f4e4-5f5f-4da9-9b27-58b66e739643" xlink:href="dva-20230331.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract_92d6f4e4-5f5f-4da9-9b27-58b66e739643" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_398e941f-cb1c-4028-8bf3-8b25b4203f7a" xlink:to="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_e9e7e838-2f99-4f03-8b6c-9d137ef5f40d" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_e9e7e838-2f99-4f03-8b6c-9d137ef5f40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_cafa9cec-9997-4e1c-be0f-0329d152a45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd6c3916-d0e6-4899-82b4-4bd02b88324a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_cafa9cec-9997-4e1c-be0f-0329d152a45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_5ee8dbe5-2e01-49a2-810a-660b1845a5ff" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_fb0d5b31-3139-4e6b-84b1-616290ed44b2" xlink:href="dva-20230331.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_fb0d5b31-3139-4e6b-84b1-616290ed44b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_8ddd72c4-82c4-420e-9423-56c81638bab2" xlink:href="dva-20230331.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_8ddd72c4-82c4-420e-9423-56c81638bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_2e1767df-a42f-473b-a98f-9aac066ebc2e" xlink:href="dva-20230331.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_OtherGovernmentPayorsMember_2e1767df-a42f-473b-a98f-9aac066ebc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_314564bc-ad24-47af-aa51-0672ae8c129a" xlink:href="dva-20230331.xsd#dva_CommercialPayorsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_CommercialPayorsMember_314564bc-ad24-47af-aa51-0672ae8c129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_db01de2f-1da6-4970-b754-3c04ccbe3bf4" xlink:href="dva-20230331.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_fec713bf-8345-484d-8191-3cb9d5b607cd" xlink:to="loc_dva_OtherSourcesofRevenueMember_db01de2f-1da6-4970-b754-3c04ccbe3bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5c492dec-4011-4894-a40a-5ff015771fe1" xlink:to="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e4c415d2-7e5f-400f-8a91-9ca85f188c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cb7f799f-dbd1-401d-8cec-b6e7f558e512" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e4c415d2-7e5f-400f-8a91-9ca85f188c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4ff3d467-5026-44f6-8f24-e394c7fe64aa" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7f3835cf-d7d3-49f0-9926-e668fc4289dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_7f3835cf-d7d3-49f0-9926-e668fc4289dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_516aba39-22e1-4a06-8852-6b2b7f2d4ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_OtherIncome_516aba39-22e1-4a06-8852-6b2b7f2d4ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ef84a0ce-96d4-4997-a244-9b8d55e3fc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_78584366-3b54-4016-bc4e-d52a3b21ed8b" xlink:to="loc_us-gaap_Revenues_ef84a0ce-96d4-4997-a244-9b8d55e3fc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8390bcae-f3a8-4061-ad12-40e817fcbeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8390bcae-f3a8-4061-ad12-40e817fcbeb3" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8b00fbe0-309d-47e3-b507-205a297fec59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_NetIncomeLoss_8b00fbe0-309d-47e3-b507-205a297fec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_22a5fa2a-8ace-48cb-b0f5-ede6403fe122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_22a5fa2a-8ace-48cb-b0f5-ede6403fe122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e2591581-e923-46f6-9777-7c6abb9ba03d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e2591581-e923-46f6-9777-7c6abb9ba03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8629a09a-df15-486d-8e7e-82ced5fe6e88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8629a09a-df15-486d-8e7e-82ced5fe6e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d5123ee3-6906-4fb7-8611-9777eb0cb118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_EarningsPerShareBasic_d5123ee3-6906-4fb7-8611-9777eb0cb118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2833d687-e1c8-4cc6-9f67-cd0e5101bc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2833d687-e1c8-4cc6-9f67-cd0e5101bc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e5072c9e-862c-4ef8-bbfd-1f741995e98d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7af5b45d-f417-4568-a677-9220915d4c5c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e5072c9e-862c-4ef8-bbfd-1f741995e98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2909b41b-b799-4b64-91ec-2f94ff322ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_2909b41b-b799-4b64-91ec-2f94ff322ea2" xlink:to="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:to="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_912ac9f2-3092-4a1a-82ba-5b7e669d08ad" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_82343486-1871-463e-a321-9b11cf9b1586" xlink:href="dva-20230331.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_82343486-1871-463e-a321-9b11cf9b1586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_b6ca40f7-1852-4ea3-bf88-6827a1819fb9" xlink:href="dva-20230331.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_dva_MutualFundsAndCommonStockMember_b6ca40f7-1852-4ea3-bf88-6827a1819fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_99686c25-18fc-4d8f-b42e-9fe972f0cffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_99686c25-18fc-4d8f-b42e-9fe972f0cffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_54cbed0b-f790-417a-af23-8c1f37a7cab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a9466169-704b-44f1-91b3-4852de4d64fb" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_54cbed0b-f790-417a-af23-8c1f37a7cab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_0f615c03-6373-4964-9715-f7ed2a0a054d" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_a639a840-a2f3-4954-bd95-cbf6e2abd181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecurities_a639a840-a2f3-4954-bd95-cbf6e2abd181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_2c32bfec-08b4-4675-b4d8-ee27fa490d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_2c32bfec-08b4-4675-b4d8-ee27fa490d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFVNINoncurrent_4383deaa-a603-4a98-a00d-a9873a4136c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFVNINoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFVNINoncurrent_4383deaa-a603-4a98-a00d-a9873a4136c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_40852a10-21c5-4a2f-8eb8-87deefcfdf9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_40852a10-21c5-4a2f-8eb8-87deefcfdf9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_f9364da5-cc1a-44c6-ad9c-bdcd5a543668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecurities_f9364da5-cc1a-44c6-ad9c-bdcd5a543668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_cda1b45b-cd3e-428c-8e29-7922273c35a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_cda1b45b-cd3e-428c-8e29-7922273c35a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_525185a6-ab9d-432b-a7fd-109f84676580" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_525185a6-ab9d-432b-a7fd-109f84676580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_64a7c7e0-cf3f-4cde-88f5-526e9c7f6bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_64a7c7e0-cf3f-4cde-88f5-526e9c7f6bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_8dd5dce6-3467-45af-8589-8f164e85fc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_886667b7-c3ec-4ab2-bb6c-b7b461c2af67" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_8dd5dce6-3467-45af-8589-8f164e85fc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f8986d0-6fde-469f-9d7f-0513a769375f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8f8986d0-6fde-469f-9d7f-0513a769375f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe6f9f30-93b2-469c-bc34-10553eecdf42" xlink:to="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_959ce35f-7a93-4bc1-8ddd-b8ab81c07956" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_959ce35f-7a93-4bc1-8ddd-b8ab81c07956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_d76ac1f8-9866-494b-9c6f-4f0f49527445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7ae3c7c2-28aa-47cd-bba0-2f8f007570fd" xlink:to="loc_us-gaap_AllOtherSegmentsMember_d76ac1f8-9866-494b-9c6f-4f0f49527445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_2d053a04-e813-48c9-82fd-197bc0ea05e2" xlink:to="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2b4a1bfb-701d-457c-bd6a-7894da5561a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_Goodwill_2b4a1bfb-701d-457c-bd6a-7894da5561a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a473cde-cc77-4f16-b549-2fcd79a70be6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0a473cde-cc77-4f16-b549-2fcd79a70be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b8edd475-7265-439b-b25f-bcc08033531c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_b8edd475-7265-439b-b25f-bcc08033531c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_8b0f2c8a-31b5-426e-be66-74d0a771f567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_8b0f2c8a-31b5-426e-be66-74d0a771f567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_390ba5ad-464b-4cbf-be4d-aaee094f2fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a8af96fc-1fd0-4948-845d-8bdeef5cb506" xlink:to="loc_us-gaap_Goodwill_390ba5ad-464b-4cbf-be4d-aaee094f2fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_1ce51205-40dc-4b07-9010-6bc308980a28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillGross_1ce51205-40dc-4b07-9010-6bc308980a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_39e3e938-ad6a-4c10-b401-85557e2a99df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_39e3e938-ad6a-4c10-b401-85557e2a99df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_73004a59-3f04-4051-885e-c505b7398f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_2e8a721d-e244-47e0-b7aa-28eb3e0fbfd6" xlink:to="loc_us-gaap_Goodwill_73004a59-3f04-4051-885e-c505b7398f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8b18c3-3df9-4375-8a7e-1c888e7fb8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da8b18c3-3df9-4375-8a7e-1c888e7fb8b5" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1c1e6928-9752-42c2-b400-bb3210c1e29b" xlink:to="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_fa807b00-cc48-4285-952d-c8c1ea6200cf" xlink:href="dva-20230331.xsd#dva_OtherReportingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d9512d29-1ae8-429b-9aad-6de28ede747d" xlink:to="loc_dva_OtherReportingUnitsMember_fa807b00-cc48-4285-952d-c8c1ea6200cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_bed766a5-bece-47b8-bb84-ec2ede40c66d" xlink:to="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d0acc6dc-6aa1-472d-924c-58fb8cef88a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d0acc6dc-6aa1-472d-924c-58fb8cef88a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_9062e598-72c0-4c96-939e-5727eb9f6b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d719e6fe-7692-44a1-a561-4cc040806df3" xlink:to="loc_us-gaap_NumberOfOperatingSegments_9062e598-72c0-4c96-939e-5727eb9f6b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4612022e-ed11-4fd1-8d84-822318f738d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4612022e-ed11-4fd1-8d84-822318f738d6" xlink:to="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd5c4b1d-ab66-4335-a18a-58e1413a3fc6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_a5a13283-1f90-4430-8014-ce4cf8a3b434" xlink:href="dva-20230331.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_TermLoanAMember_a5a13283-1f90-4430-8014-ce4cf8a3b434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_40802cab-2e06-4f08-adde-5784347bc129" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_TermLoanB1Member_40802cab-2e06-4f08-adde-5784347bc129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_6e36a78e-1eb0-467c-880b-42b6ea6efbba" xlink:href="dva-20230331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_6e36a78e-1eb0-467c-880b-42b6ea6efbba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6aff00ee-728a-47da-b3d8-72a5647021f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3015e529-3b0c-4d0d-9cce-179c0f41cb09" xlink:to="loc_us-gaap_SeniorNotesMember_6aff00ee-728a-47da-b3d8-72a5647021f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ea7aec7d-bc5e-4bb8-94c8-1220ce140774" xlink:to="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5363713c-80ad-4f16-8418-bf820e81fd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e8aab674-2dd8-4f3d-a4ef-263e6969f50d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5363713c-80ad-4f16-8418-bf820e81fd0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cbe70f9b-10c2-41eb-a480-922c9421e0be" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_537fe015-c39f-40a3-97fa-e1203355d13f" xlink:href="dva-20230331.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_537fe015-c39f-40a3-97fa-e1203355d13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_29369f40-d5bf-47b2-ad75-dba4fb6089b9" xlink:href="dva-20230331.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_29369f40-d5bf-47b2-ad75-dba4fb6089b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_0824d442-ba2b-4efc-9f3f-92092e32aba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_0824d442-ba2b-4efc-9f3f-92092e32aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_098c93d1-887b-4ded-9d45-542c90175560" xlink:href="dva-20230331.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1d5fcff7-1334-4d37-9116-5237ea55b871" xlink:to="loc_dva_FinanceLeaseMember_098c93d1-887b-4ded-9d45-542c90175560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c4bda4b1-f359-454a-91d2-d3841a489427" xlink:to="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b3002952-69d6-4e3f-9907-ee5ccb86f66a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_31fff2c2-914b-4e78-a596-b977e1a35bf9" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b3002952-69d6-4e3f-9907-ee5ccb86f66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0d9ef9ef-9d94-400c-a1c3-d335950d6af0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_5254051d-f205-4cb0-847e-1fbc94628c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_SecuredDebt_5254051d-f205-4cb0-847e-1fbc94628c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_279eb08c-5f75-4241-b9da-9f03948baa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_279eb08c-5f75-4241-b9da-9f03948baa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_fc102cbd-f166-42c6-8836-d1187580e54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_fc102cbd-f166-42c6-8836-d1187580e54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2f2d057e-010e-4d57-91d9-c9869c623b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_SeniorNotes_2f2d057e-010e-4d57-91d9-c9869c623b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_44c6077d-dbe2-4cf5-ab18-efd529ed5961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_44c6077d-dbe2-4cf5-ab18-efd529ed5961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_00651739-8e6e-4f33-87a7-4b281ccaf9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_00651739-8e6e-4f33-87a7-4b281ccaf9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_cd67e4c5-1429-4213-ab8f-8a393272e87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentFairValue_cd67e4c5-1429-4213-ab8f-8a393272e87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_d6799e2d-fc12-4d39-9119-2ac2cc3764ce" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_d6799e2d-fc12-4d39-9119-2ac2cc3764ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_be53b0db-bbb1-4ad3-8f77-f6a46db1aac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_FinanceLeaseLiability_be53b0db-bbb1-4ad3-8f77-f6a46db1aac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_f9df65da-3740-44b9-82b4-dfcf60ef334f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_f9df65da-3740-44b9-82b4-dfcf60ef334f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a08c564a-aba6-4d53-bb9f-7729a678fab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_a08c564a-aba6-4d53-bb9f-7729a678fab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_b6dfc6a3-e4c5-4374-854f-2d830e5eef8b" xlink:href="dva-20230331.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_b6dfc6a3-e4c5-4374-854f-2d830e5eef8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c47de02f-55a8-40f7-b82e-33c18e439c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_c47de02f-55a8-40f7-b82e-33c18e439c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e8544f03-0caa-484e-9dde-05d218fd589b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e8544f03-0caa-484e-9dde-05d218fd589b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts_8c5706e7-49d3-4d9d-931c-4e298ec6c2c6" xlink:href="dva-20230331.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_dva_DiscountPremiumAndDeferredFinancingCosts_8c5706e7-49d3-4d9d-931c-4e298ec6c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_aea2abeb-ab82-4b00-978f-4f90c6843063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_aea2abeb-ab82-4b00-978f-4f90c6843063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_098f3a4d-762a-47af-9804-1684948bd772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_098f3a4d-762a-47af-9804-1684948bd772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea6a9039-3852-46b0-bba7-610f2ba472d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea6a9039-3852-46b0-bba7-610f2ba472d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1eb4b05d-cbe2-4e60-a590-20dcb10f0e73" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5c2554c1-9884-4aad-ac5e-8172ca0cb0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_5c2554c1-9884-4aad-ac5e-8172ca0cb0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_8fdaf138-d014-498f-b348-72663631a525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DeferredOfferingCosts_8fdaf138-d014-498f-b348-72663631a525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_0c938885-4351-4ddc-8d40-22032625cbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_cca18569-349b-47f2-b4b0-6ecad2788f5d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_0c938885-4351-4ddc-8d40-22032625cbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_b89edf47-3f35-4a16-bdeb-2182698543ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_b89edf47-3f35-4a16-bdeb-2182698543ac" xlink:to="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8438c1ab-b77d-416f-a17c-7b7c4e70dbd3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_189284c0-0167-492f-b6e7-d4f6613eb5a9" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2faf7197-51af-4f08-b123-bc815ae1caec" xlink:to="loc_dva_TermLoanFacilityMember_189284c0-0167-492f-b6e7-d4f6613eb5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fc67d383-38d0-4e2b-890b-39a1a3b3cf73" xlink:to="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_efd580b3-0368-487b-8b1b-26828448d4ac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f15f3dd7-0d87-4591-a54b-1c3327cb49c8" xlink:to="loc_srt_MaximumMember_efd580b3-0368-487b-8b1b-26828448d4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_b9080646-fb71-4e33-ac98-7680f8393c35" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_60e690f7-b0ce-4f5a-b333-e49d766972b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d0a59a6f-9e9a-45dd-b78d-9ef222770c8e" xlink:to="loc_us-gaap_CashFlowHedgingMember_60e690f7-b0ce-4f5a-b333-e49d766972b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_139791e5-56a1-4c57-9cbf-4f70975f9b91" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_de7d4718-8d6a-4f2a-a1ae-522ab8b3b44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d627ca16-3954-4e42-b878-4ad8dc5b348e" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_de7d4718-8d6a-4f2a-a1ae-522ab8b3b44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f2eba63b-5f6a-412b-9883-2ec36721da78" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a8588a06-cfd6-4c5b-9f94-6a74e4c5fe87" xlink:href="dva-20230331.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b75aee7-142c-4702-971c-bd46d1307aba" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_a8588a06-cfd6-4c5b-9f94-6a74e4c5fe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2faf9b9b-1359-4862-976a-e538c0046fc6" xlink:to="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_3681ef8f-b19e-4fb1-82d3-cc68e7ab3e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_3681ef8f-b19e-4fb1-82d3-cc68e7ab3e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cc974e65-4b1b-4c41-9612-ed7ee5f46af4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_cc974e65-4b1b-4c41-9612-ed7ee5f46af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_43b12a1c-df5a-49e4-bafc-98039f87b9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInceptionDates_43b12a1c-df5a-49e4-bafc-98039f87b9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_1528ef36-54d3-40be-9783-02bdf47fe5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeMaturityDates_1528ef36-54d3-40be-9783-02bdf47fe5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_8469778a-12d9-433f-9c80-a99bab4bf67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_8469778a-12d9-433f-9c80-a99bab4bf67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f7ea6204-e580-4a55-b501-9082cce9ab11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_f7ea6204-e580-4a55-b501-9082cce9ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_125e1f2f-0e6f-4d0c-b11b-0645c2b3e1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_125e1f2f-0e6f-4d0c-b11b-0645c2b3e1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c9cd304c-b4a6-4e7d-a81b-69399e300d33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9714df45-19f7-48ff-999c-69d8bab0027b" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c9cd304c-b4a6-4e7d-a81b-69399e300d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ac176ed9-093e-47fa-a2c3-704e6899cab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ac176ed9-093e-47fa-a2c3-704e6899cab2" xlink:to="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5eb96635-dc44-4ab3-bcbe-a84b6eb0461a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_e8a831d4-5283-4558-9275-24dbd40ff6ef" xlink:href="dva-20230331.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_TermLoanAMember_e8a831d4-5283-4558-9275-24dbd40ff6ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_80a2ccf5-f05f-4ef6-a5fb-a1ebbab060da" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_TermLoanB1Member_80a2ccf5-f05f-4ef6-a5fb-a1ebbab060da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_b51e3997-80dd-4a7a-b84f-48656bef5101" xlink:href="dva-20230331.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9686a27e-387c-4573-965f-d697e2e5c3cb" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_b51e3997-80dd-4a7a-b84f-48656bef5101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6cb679fd-6e23-4ea4-8dd3-fba338e5f95f" xlink:to="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d3bc426d-254c-45bf-a43e-9f6f879e3941" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d3bc426d-254c-45bf-a43e-9f6f879e3941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_2fb1ac45-a9ad-42bd-9a03-394120e9824f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_us-gaap_LetterOfCreditMember_2fb1ac45-a9ad-42bd-9a03-394120e9824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_88a6d71e-0c66-4db9-bb62-7fc90f6a1b2c" xlink:href="dva-20230331.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e4242330-94cb-477f-b8cb-dffb9bef7653" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_88a6d71e-0c66-4db9-bb62-7fc90f6a1b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_72cece53-cd33-4cd7-a777-35977033ba73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_bb9db50a-6aa6-4d9f-8d79-2b06a9b4cb88" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_94115d29-00f1-4c6e-b924-bce831f4fdbd" xlink:to="loc_dva_TermLoanFacilityMember_bb9db50a-6aa6-4d9f-8d79-2b06a9b4cb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a6651ee7-b55d-45d7-afff-fff10af819ef" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_0cc67301-459d-4309-9ffc-f32f75edf83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e349589d-310e-4389-9c53-4b9c7f0be78c" xlink:to="loc_us-gaap_SubsequentEventMember_0cc67301-459d-4309-9ffc-f32f75edf83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_671a4098-db43-44c0-b389-c634e64c535c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_f3cb0386-f6f0-4ed2-9cab-9a63a1f33ca6" xlink:href="dva-20230331.xsd#dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_391d4188-5ed2-45a1-834b-99a5e725b113" xlink:to="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_f3cb0386-f6f0-4ed2-9cab-9a63a1f33ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_32e25399-e479-41b7-9ac5-51c26d6fdee1" xlink:to="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheOneMember_9a608be5-193f-4796-b5f6-deed27edc5dc" xlink:href="dva-20230331.xsd#dva_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:to="loc_dva_TrancheOneMember_9a608be5-193f-4796-b5f6-deed27edc5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheTwoMember_302f22a7-aa96-47bc-882c-ea092a1ca5ce" xlink:href="dva-20230331.xsd#dva_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_a27efdb8-7ddb-4de4-a674-d0840abd3cfd" xlink:to="loc_dva_TrancheTwoMember_302f22a7-aa96-47bc-882c-ea092a1ca5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_722cae08-3484-45e1-b8ca-134e0848f3c4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_09155b18-02b6-4c56-afe0-921fac07582a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_09155b18-02b6-4c56-afe0-921fac07582a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_50f6cde6-5858-45ec-8db4-563cae453651" xlink:href="dva-20230331.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_50f6cde6-5858-45ec-8db4-563cae453651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9921f114-de3e-405e-9a73-7c61ec32f015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_9921f114-de3e-405e-9a73-7c61ec32f015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_56b37df2-e5d4-448e-81dc-a710c3ad7bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_56b37df2-e5d4-448e-81dc-a710c3ad7bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_9a8765d2-93a1-4a09-9d2d-4f6412b72a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_9a8765d2-93a1-4a09-9d2d-4f6412b72a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_76035ed9-528a-4382-9f82-5fcd4b46fcee" xlink:href="dva-20230331.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_76035ed9-528a-4382-9f82-5fcd4b46fcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2e082393-9221-4b17-930e-8b0ab9ee1a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2e082393-9221-4b17-930e-8b0ab9ee1a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_f55ce18c-8566-484b-bd10-84819bbb9a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_f55ce18c-8566-484b-bd10-84819bbb9a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DerivativeEffectiveDate_fdad3aab-24bd-40aa-927f-3517d36ae5a5" xlink:href="dva-20230331.xsd#dva_DerivativeEffectiveDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f3390e7-ef89-4c0b-94d9-836d063a7d5f" xlink:to="loc_dva_DerivativeEffectiveDate_fdad3aab-24bd-40aa-927f-3517d36ae5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9b3baa6e-1d9c-4b64-92bb-7c64557fa754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9b3baa6e-1d9c-4b64-92bb-7c64557fa754" xlink:to="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:to="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_7e43e7de-f112-422c-932b-6d89a982394a" xlink:to="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_f5b65425-5855-4679-b2e9-5ef8b37286f6" xlink:href="dva-20230331.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_f76a4835-52a8-4407-9529-1f308e383be1" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_f5b65425-5855-4679-b2e9-5ef8b37286f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_85780899-de9c-4dac-9665-aff027b42c17" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_f0d776b1-2e45-486b-a2b8-e2136aac8d49" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_f0d776b1-2e45-486b-a2b8-e2136aac8d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_d84ba4f3-7663-41af-bd14-a36ec365ab8c" xlink:href="dva-20230331.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_d84ba4f3-7663-41af-bd14-a36ec365ab8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_25506eb6-efed-45ee-aa90-54a106988123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_b7082e1a-83ab-499d-a449-59906c27059b" xlink:to="loc_us-gaap_OtherCommitment_25506eb6-efed-45ee-aa90-54a106988123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/StockbasedcompensationDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#StockbasedcompensationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/StockbasedcompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_440df8bb-6486-450a-8b72-c09c013c9de4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_440df8bb-6486-450a-8b72-c09c013c9de4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:to="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_597e680d-415d-4ed6-8221-2871f86e37d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_68def75b-ae22-41b2-8ef8-8309e9946cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6277352c-cff7-406a-9d3f-29095942cc8e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_68def75b-ae22-41b2-8ef8-8309e9946cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7934cf72-674f-4dcf-ad12-26ff448bfaf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_539e32b6-bb9c-40bd-8226-7e2e7555d8d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_539e32b6-bb9c-40bd-8226-7e2e7555d8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_eb4ae8af-d10d-4462-87f2-a28eec376b48" xlink:href="dva-20230331.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_eb4ae8af-d10d-4462-87f2-a28eec376b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fbbab356-c254-42a0-aa53-dd0bcb1438b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fbbab356-c254-42a0-aa53-dd0bcb1438b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3ff8d66e-0a72-4471-b6c2-3b3cd8d56f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3ff8d66e-0a72-4471-b6c2-3b3cd8d56f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_55d4b776-43df-4bd8-bf82-22cf3a896b22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_90cac3db-d8b6-410a-808a-edaceacdcbc3" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_55d4b776-43df-4bd8-bf82-22cf3a896b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#SharerepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5c4b5f84-14a6-4724-95ea-b3b6eac8c145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5c4b5f84-14a6-4724-95ea-b3b6eac8c145" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e6bbed08-ecb5-4143-845d-9119fecfb6d7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1e832b02-154c-4138-b135-775a15019346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_eb71585a-3f60-4db5-8f4a-c2aa7f2a1b59" xlink:to="loc_us-gaap_SubsequentEventMember_1e832b02-154c-4138-b135-775a15019346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_51dc7f7f-2bd6-4a7d-88c8-cb88ead4800c" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0fdeb312-1e28-42c8-83dc-8b2cfd827193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_10f3e464-457c-417b-a146-b029a392ed84" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0fdeb312-1e28-42c8-83dc-8b2cfd827193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6de4c194-71b9-41b1-b4ef-debb7caeb850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6de4c194-71b9-41b1-b4ef-debb7caeb850" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83c01898-afd9-49ec-b456-c1baec3d3b38" xlink:to="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_3d1f5e3b-1693-45b0-add2-49aadb125a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_3d1f5e3b-1693-45b0-add2-49aadb125a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a3f91e9c-12c2-44a1-bbfb-dcd31ae0e5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_a3f91e9c-12c2-44a1-bbfb-dcd31ae0e5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_7f23a446-2494-4f93-8c3a-51f4fda5620b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c00c0fd6-477c-4fc6-83cf-5ab3fda5ba0e" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_7f23a446-2494-4f93-8c3a-51f4fda5620b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72753f5d-26cc-479c-9e8e-8238fa79ac3b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_5e4a97fc-a7c4-439f-9c4e-e4dc48357eba" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_07d2fb58-7b40-4f27-bbc3-af9f2ed36ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_07d2fb58-7b40-4f27-bbc3-af9f2ed36ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_22bfbf18-44af-4192-a544-8050c48e368c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_22bfbf18-44af-4192-a544-8050c48e368c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c70bfb7a-3647-4c1c-b4fa-ca6fa40c2554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_c70bfb7a-3647-4c1c-b4fa-ca6fa40c2554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_77f4f160-6e62-44f8-b7c7-080f510f0dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_77f4f160-6e62-44f8-b7c7-080f510f0dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d29f5950-f5a0-4334-9321-5d9a56cdbdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_d29f5950-f5a0-4334-9321-5d9a56cdbdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_eef6c355-c01d-4bc1-8830-f995dd2a0387" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_eef6c355-c01d-4bc1-8830-f995dd2a0387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2700158d-9188-47f7-9371-98eded4f2652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2700158d-9188-47f7-9371-98eded4f2652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_444cbe13-f4b3-4a11-8280-07b30dbc725f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_93e642a5-9c52-4537-b166-42b9e29b4d98" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_444cbe13-f4b3-4a11-8280-07b30dbc725f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7a95d489-b9e5-4de7-a938-6f80fcbdfaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7a95d489-b9e5-4de7-a938-6f80fcbdfaee" xlink:to="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:to="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_72845e63-0dcb-43e8-ad8e-4084dc210080" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c358159d-a1eb-4ed6-9491-fdcd52bd071b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4b8790df-f5f2-48ba-9b73-06cf62185247" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c358159d-a1eb-4ed6-9491-fdcd52bd071b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a5d70892-9b69-4e38-af04-46338faa11f5" xlink:to="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c20b93be-b117-4e14-80b0-8594349cf6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:to="loc_us-gaap_Assets_c20b93be-b117-4e14-80b0-8594349cf6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_866b9a3c-db3d-4c55-897f-62117f90f608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0b6c8228-7c03-42ba-b269-e44416c712fc" xlink:to="loc_us-gaap_Liabilities_866b9a3c-db3d-4c55-897f-62117f90f608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a2c4f6ea-d9a4-4549-8f3b-e652e4eb7d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a2c4f6ea-d9a4-4549-8f3b-e652e4eb7d43" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_18036414-631f-4b06-9f20-d3de907734b2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_497cf0b1-efcf-4fa7-89bf-236bf1fc3a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_2834c175-34b5-4269-ba14-7bde8dd65bd1" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_497cf0b1-efcf-4fa7-89bf-236bf1fc3a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_53990189-410c-40bd-8cfb-9a90c4ed714d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3511f812-d259-4f52-baad-e1cd07043e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3511f812-d259-4f52-baad-e1cd07043e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8694a055-794b-4eb1-ba9e-ed51a9fabe6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8694a055-794b-4eb1-ba9e-ed51a9fabe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_9fce9200-8762-4c16-a4d3-5c18e2729797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_beac1997-312f-466d-8f8b-568628313b84" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_9fce9200-8762-4c16-a4d3-5c18e2729797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e537a9cc-c9d0-45da-9f80-50d9508b0627" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_24185461-b686-411d-a074-ed295720a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_68d12fe1-a09d-47ee-a654-6ec49c4bd79a" xlink:to="loc_us-gaap_InterestRateCapMember_24185461-b686-411d-a074-ed295720a43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_2473c01b-9879-4b6f-a267-3747c5ef17ab" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_d5a274d7-c836-44c4-83ae-a3d818ecc64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_d5a274d7-c836-44c4-83ae-a3d818ecc64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0e08cf83-1c5f-4162-8b4f-57910a273c60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_5bca02dd-3f63-463e-8e09-1252fc375bf2" xlink:to="loc_us-gaap_DerivativeAssets_0e08cf83-1c5f-4162-8b4f-57910a273c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0d7070d5-03f8-4a88-aec0-57a97f581775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_5eb06157-a8fa-414e-8047-91588e47957d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_0d7070d5-03f8-4a88-aec0-57a97f581775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1a692e4d-9087-41dc-ad0c-bf20c058255d" xlink:to="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_f6b93acc-64ab-4336-a9bc-2462e58afd33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_d2156af1-3393-42e9-acb3-71b88d8e0397" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_f6b93acc-64ab-4336-a9bc-2462e58afd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#FairvalueoffinancialinstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aeff92fa-7d00-4fc7-bcf2-ab1b8c1ceb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aeff92fa-7d00-4fc7-bcf2-ab1b8c1ceb2f" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e267cfa2-7c96-422c-b531-d86cea754a1c" xlink:to="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0a1130c9-d54b-4a5b-af89-d6068abe2779" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:to="loc_srt_MinimumMember_0a1130c9-d54b-4a5b-af89-d6068abe2779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_42c4be0e-332c-4e38-9a19-e9ec7dd8ce76" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47796fca-756d-4370-b688-4392eb760278" xlink:to="loc_srt_MaximumMember_42c4be0e-332c-4e38-9a19-e9ec7dd8ce76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a74cc2ca-166e-42d2-80ac-c234dd156af3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_e0f4b725-5020-4389-aa26-8aba73464442" xlink:href="dva-20230331.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d4d8a84b-ea9b-401e-a1a2-d05e9fb03c85" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_e0f4b725-5020-4389-aa26-8aba73464442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_9b66b0da-197e-4c43-8462-31953e811ecf" xlink:to="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_655aee0b-150d-4fa8-9e14-31736194c044" xlink:href="dva-20230331.xsd#dva_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_707bb1e1-20a6-46f9-8b16-ffbaa1357aa3" xlink:to="loc_dva_OtherCompaniesMember_655aee0b-150d-4fa8-9e14-31736194c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_699cf116-283c-4340-a160-0f4f19184419" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_51e06452-62c0-458c-9f93-b5ab76a76cec" xlink:href="dva-20230331.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_51e06452-62c0-458c-9f93-b5ab76a76cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_35c21b5d-7ce6-45b9-adf8-cb804b6f3a34" xlink:href="dva-20230331.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_35c21b5d-7ce6-45b9-adf8-cb804b6f3a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_ecda7341-4dab-4ca9-a53e-db7bc684f092" xlink:href="dva-20230331.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_7923c2bf-fd6d-4b17-9e7f-bdf6f895cc64" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_ecda7341-4dab-4ca9-a53e-db7bc684f092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c61ed68b-d944-4311-99d5-ae2f769f9ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c61ed68b-d944-4311-99d5-ae2f769f9ef2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_9cf15d8f-42fe-47d2-9546-f71eed2df8e5" xlink:to="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b68d3083-823c-4cf5-bb24-41b24410e67b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:to="loc_us-gaap_OperatingSegmentsMember_b68d3083-823c-4cf5-bb24-41b24410e67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_2567a7f4-9e64-4ef9-82e4-49d3f03fd8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bd57283a-453d-4be7-877f-72bab71f36d4" xlink:to="loc_us-gaap_IntersegmentEliminationMember_2567a7f4-9e64-4ef9-82e4-49d3f03fd8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7ada1e83-8fad-4f58-9e90-be6c139bba78" xlink:to="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_1794ccf7-f54d-4d19-8701-6d36e76822dd" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_1794ccf7-f54d-4d19-8701-6d36e76822dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_118ec75c-9a6d-4ef0-a8f9-96527727eef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f9bf5de3-d7aa-4089-95a7-dd310d40086b" xlink:to="loc_us-gaap_AllOtherSegmentsMember_118ec75c-9a6d-4ef0-a8f9-96527727eef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_7d0a1a85-affa-42a8-a481-8b4f328b184b" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_aff93f2b-1240-4290-a1aa-143b6ea7a409" xlink:href="dva-20230331.xsd#dva_ExternalSourcesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:to="loc_dva_ExternalSourcesMember_aff93f2b-1240-4290-a1aa-143b6ea7a409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_54650bec-0702-4c45-828d-cd399abb08f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_01f8ce92-0a41-44d6-9e1a-1f05c8b0cfea" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_54650bec-0702-4c45-828d-cd399abb08f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6c6d6aa2-04aa-4535-adb6-637f683d36dc" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15e54cd4-2076-479f-a9f2-f5ac77d1393f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_15e54cd4-2076-479f-a9f2-f5ac77d1393f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_e3e68107-3338-4fcb-b03d-e61daed6f3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OtherIncome_e3e68107-3338-4fcb-b03d-e61daed6f3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_027e693d-c560-47a9-8544-6116020b60f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_Revenues_027e693d-c560-47a9-8544-6116020b60f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f2e15a33-eaf0-46d3-a5a3-f5f244fe0c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OperatingIncomeLoss_f2e15a33-eaf0-46d3-a5a3-f5f244fe0c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_1cafc028-8a04-406a-8733-2034744fee8f" xlink:href="dva-20230331.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_1cafc028-8a04-406a-8733-2034744fee8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_f981374d-aa65-431d-a5bd-1f7db3802a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_InterestAndDebtExpense_f981374d-aa65-431d-a5bd-1f7db3802a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3f865517-f4a8-4eac-aec5-416e71752502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3f865517-f4a8-4eac-aec5-416e71752502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b82ba68-ca04-4a59-8c5b-20d7715aa904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_189cfb25-57ca-418e-87cf-d1bfa6c94377" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4b82ba68-ca04-4a59-8c5b-20d7715aa904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_54ea3fad-5b4d-45c4-97de-1b2b93a0fc70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_54ea3fad-5b4d-45c4-97de-1b2b93a0fc70" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_aeacaccb-8455-48a4-b3fa-68db43e992c9" xlink:to="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_10ba7797-af4d-4d93-a8c0-d06e1dd3f6a8" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_10ba7797-af4d-4d93-a8c0-d06e1dd3f6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_46c32e98-87b0-4106-b477-c15a82f7c1e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ed2a5800-c962-4d16-8f48-a6abe836c85a" xlink:to="loc_us-gaap_AllOtherSegmentsMember_46c32e98-87b0-4106-b477-c15a82f7c1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_e4ba4ab5-d9cb-4bac-a3d9-86f04541d6be" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_4b34b762-1733-4dff-9d4f-01c9a5fe429f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1a78d291-af5e-40ca-819a-4c91861c76d0" xlink:to="loc_us-gaap_DepreciationAndAmortization_4b34b762-1733-4dff-9d4f-01c9a5fe429f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ff1630ce-ff15-4398-84b9-d0d8c19ed853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ff1630ce-ff15-4398-84b9-d0d8c19ed853" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_08a19b92-4961-498a-a679-db9a434c8063" xlink:to="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_5c78b337-5033-4647-af37-df196397536d" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_5c78b337-5033-4647-af37-df196397536d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_842a2c95-256b-40db-9467-17b79b66a8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7d83f80-e843-4d35-88e2-1296cf02692c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_842a2c95-256b-40db-9467-17b79b66a8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_29772fa6-a90d-4466-9ef4-33e8f36e5bd2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d78a86d6-b773-4aed-8aee-e2942aef50bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1304423f-f90e-47e8-9d84-b1c7f0fcc630" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d78a86d6-b773-4aed-8aee-e2942aef50bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20230331.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0efcdfc9-ba25-42e2-97ee-7432a7afe89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0efcdfc9-ba25-42e2-97ee-7432a7afe89f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_248ec838-10bb-4096-b8d7-bdd5102b55a7" xlink:to="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f2dd6c32-4300-4635-9fa9-827ffa055dd8" xlink:href="dva-20230331.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f2dd6c32-4300-4635-9fa9-827ffa055dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_88a4b7aa-1a81-4d07-80f8-d418dc13bb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e16540f7-b744-41af-8a79-5e22006d86ab" xlink:to="loc_us-gaap_AllOtherSegmentsMember_88a4b7aa-1a81-4d07-80f8-d418dc13bb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c53c2928-ed5b-4b26-8123-c53fd451da75" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1da26a23-7253-464e-85cb-e6445ecc9423" xlink:to="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a248640c-137c-4eac-b6d9-ab97cdad08bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2cadf63c-b544-4cad-86e8-d78abb368f0c" xlink:to="loc_us-gaap_Assets_a248640c-137c-4eac-b6d9-ab97cdad08bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/NewaccountingstandardsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#NewaccountingstandardsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/NewaccountingstandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_3c7eb64a-c8d5-4438-8294-411f5dfcc79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_3c7eb64a-c8d5-4438-8294-411f5dfcc79a" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_7bcb8193-c2f9-4587-85b7-789ac808465b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_63a5c4cf-f1cf-44af-abcb-169e170a697d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a6a0ab1e-fa94-4a78-8347-d49bd77972c8" xlink:to="loc_us-gaap_SubsequentEventMember_63a5c4cf-f1cf-44af-abcb-169e170a697d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_34b875a8-9965-47c2-9f13-710dfdf7ad86" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_1feddf83-b445-4e89-ba23-98ddf964854b" xlink:href="dva-20230331.xsd#dva_ChangeInAccountingPrincipleImpactAbilityToBorrow"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_5a42c440-a566-4d84-91af-0cb4c43f8499" xlink:to="loc_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow_1feddf83-b445-4e89-ba23-98ddf964854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="dva-20230331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1b4b1d6f-71e5-46f9-b188-7dc5c456e280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1b4b1d6f-71e5-46f9-b188-7dc5c456e280" xlink:to="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_336a7c19-9a53-468b-a5a0-cab55f38f242" xlink:to="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember_8fdb146b-4d33-400d-ad40-690777a7285d" xlink:href="dva-20230331.xsd#dva_AgreementWithMedtronicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_95050f70-58f2-4c13-915d-cfcce53b6a67" xlink:to="loc_dva_AgreementWithMedtronicMember_8fdb146b-4d33-400d-ad40-690777a7285d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_22a63096-808f-46bc-b0a3-3389c374fbc7" xlink:to="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9de46cc-7c1c-4dfa-8c40-32b70eda241d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c8726214-6ab9-461a-bc61-f1add86ead83" xlink:to="loc_srt_MaximumMember_e9de46cc-7c1c-4dfa-8c40-32b70eda241d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e89d5389-98b5-4426-a4bb-802930cd0c05" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_4a9d78bf-299a-49bc-be67-d7d4de6436c8" xlink:href="dva-20230331.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bd2f0d05-70f1-44b1-8d6f-0aca3433dcc7" xlink:to="loc_dva_TermLoanFacilityMember_4a9d78bf-299a-49bc-be67-d7d4de6436c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_77a4bf45-9a9d-4484-b8a8-2c4deeee32c6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_0c4e2451-089d-4934-a606-58d7a798c437" xlink:href="dva-20230331.xsd#dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca9b15ab-ed47-4d22-a61c-828f85d87a2f" xlink:to="loc_dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member_0c4e2451-089d-4934-a606-58d7a798c437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_eb5637da-7a97-4276-af4d-bf4b7459f6b8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanA1Member_611ececb-1090-4c81-8769-67438d47873c" xlink:href="dva-20230331.xsd#dva_TermLoanA1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:to="loc_dva_TermLoanA1Member_611ececb-1090-4c81-8769-67438d47873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_09301116-98b1-4495-9250-1edef8cdcfa4" xlink:href="dva-20230331.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b081dfbb-d114-4187-8295-1b2122de7603" xlink:to="loc_dva_TermLoanB1Member_09301116-98b1-4495-9250-1edef8cdcfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_21890fc6-000a-4b68-93db-d0b72ffe82e9" xlink:to="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_75b7a5b1-b4b4-4a10-b96d-176edba9116d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_59fdcc82-437e-43bc-bd29-830455427513" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_75b7a5b1-b4b4-4a10-b96d-176edba9116d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_04ae7961-3afa-48a5-99c7-b6051ce3b331" xlink:to="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheOneMember_4e858cce-db50-4edf-91f0-980466dc17d8" xlink:href="dva-20230331.xsd#dva_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:to="loc_dva_TrancheOneMember_4e858cce-db50-4edf-91f0-980466dc17d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TrancheTwoMember_5196c874-0e56-412a-a784-261bd6af519e" xlink:href="dva-20230331.xsd#dva_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_d10ddc8d-4e1c-4630-9b7a-25a4c91e7a47" xlink:to="loc_dva_TrancheTwoMember_5196c874-0e56-412a-a784-261bd6af519e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ad4f8246-1f55-4e5e-b8ca-3ef4b0833ab9" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_10146a77-4196-4467-9e19-9ad8b8751946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_84a7c423-d8b7-47fb-8a20-f34e82e3e296" xlink:to="loc_us-gaap_SubsequentEventMember_10146a77-4196-4467-9e19-9ad8b8751946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8580fe7d-1bd3-4e2d-88b6-ec292998c8e4" xlink:to="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3da2b305-6223-43d7-99fa-0f42714c3d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_3da2b305-6223-43d7-99fa-0f42714c3d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3cafa50f-95e0-4b7e-b645-674deae71564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_c2c07d7e-e55c-47ed-adf4-f6be57a884b7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_3cafa50f-95e0-4b7e-b645-674deae71564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_094e22ca-cf77-4340-ab6c-8a689c400383" xlink:to="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate_5caff69f-af1b-4d47-b4ad-253764d515cb" xlink:href="dva-20230331.xsd#dva_BusinessAgreementDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_BusinessAgreementDate_5caff69f-af1b-4d47-b4ad-253764d515cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementEffectiveClosingDate_a10b4b5e-ebfd-4e28-a3b3-f46bfa410c83" xlink:href="dva-20230331.xsd#dva_BusinessAgreementEffectiveClosingDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_BusinessAgreementEffectiveClosingDate_a10b4b5e-ebfd-4e28-a3b3-f46bfa410c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_210e2446-4dd3-4442-aed8-539510921bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_210e2446-4dd3-4442-aed8-539510921bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment_02bbfd23-35da-4758-8413-76c0f326e89e" xlink:href="dva-20230331.xsd#dva_AdditionalCashCommitment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_AdditionalCashCommitment_02bbfd23-35da-4758-8413-76c0f326e89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_e7fca820-3500-4069-83bf-64cd612c0f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_e7fca820-3500-4069-83bf-64cd612c0f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_da7f2341-2869-445e-a942-6351fe33ab09" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_da7f2341-2869-445e-a942-6351fe33ab09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_680f6c67-eb34-404d-9622-70212b53cc59" xlink:href="dva-20230331.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_680f6c67-eb34-404d-9622-70212b53cc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_b5add77d-9a4c-432d-8460-103a1d3665fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeInceptionDates_b5add77d-9a4c-432d-8460-103a1d3665fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ddc56ed9-d740-4f6e-9f15-691544576b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ddc56ed9-d740-4f6e-9f15-691544576b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DerivativeEffectiveDate_497178e7-068c-451c-8371-4e6cb5ca65c9" xlink:href="dva-20230331.xsd#dva_DerivativeEffectiveDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DerivativeEffectiveDate_497178e7-068c-451c-8371-4e6cb5ca65c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_caf98c1d-8be3-4f10-afa5-91ea4d6b6801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DerivativeMaturityDates_caf98c1d-8be3-4f10-afa5-91ea4d6b6801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIssuanceDate1_2cf1a158-f472-46cb-bc3f-a47814b05887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIssuanceDate1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentIssuanceDate1_2cf1a158-f472-46cb-bc3f-a47814b05887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_75d6a865-bd1e-420e-8d22-1407d3d96483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_75d6a865-bd1e-420e-8d22-1407d3d96483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cae2700-9046-4abe-8ca6-f463eecf821b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8cae2700-9046-4abe-8ca6-f463eecf821b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_e3af7829-4e3b-4b62-9ecf-531860df7683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_SecuredDebt_e3af7829-4e3b-4b62-9ecf-531860df7683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4e6fcbe5-f037-45d9-953d-ffcb81d62d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4e6fcbe5-f037-45d9-953d-ffcb81d62d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_6e1fca54-d38f-4719-b06d-8083f252b4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_6e1fca54-d38f-4719-b06d-8083f252b4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentStartDate_585d90c0-2365-49ae-b754-58ef40e46a9d" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentStartDate"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentStartDate_585d90c0-2365-49ae-b754-58ef40e46a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_79321fda-a3e7-4d4c-8ea8-801694938bd6" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearOne"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne_79321fda-a3e7-4d4c-8ea8-801694938bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_20d85c3f-25ac-45dd-8772-e38a062c59ba" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour_20d85c3f-25ac-45dd-8772-e38a062c59ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_f295a02c-f429-4b73-a472-45712722885d" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentInterestRateYearFive"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive_f295a02c-f429-4b73-a472-45712722885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_73f99131-1068-40f5-97b3-55eb457c7712" xlink:href="dva-20230331.xsd#dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid_73f99131-1068-40f5-97b3-55eb457c7712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fc4f9577-1fb7-48a6-aebf-00f928385b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d6443409-8afd-4d6e-bf30-4c42c32d25f0" xlink:to="loc_us-gaap_DebtInstrumentTerm_fc4f9577-1fb7-48a6-aebf-00f928385b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>dva-20230331_g1.jpg
<TEXT>
begin 644 dva-20230331_g1.jpg
M_]C_X  02D9)1@ ! @$!*P$K  #_X@0>24-#7U!23T9)3$4  0$   0.5VEN
M  (0  !M;G1R4D="(%A96B 'V0 %  \ #@ >  !A8W-P35-&5     !,3E8
M                        ]M8  0    #3*TQ.5B
M                                             !%D97-C   !4
M '9D;6YD   !R    &%D;61D   !4    '9V=65D   "+    (9V:65W   "
MM    "1L=6UI   "V    !1M96%S   "[    "1R6%E:   #$    !1G6%E:
M   #)    !1B6%E:   #.    !1R5%)#   #3    !YG5%)#   #;    !YB
M5%)#   #C    !YW='!T   #K    !1B:W!T   #P    !1T96-H   #U
M  QC<')T   #X    "YD97-C         !Q,96YO=F\@5&AI;FM0860@3$-$
M($UO;FET;W(                      -BR0       _____Q$!  ",#Y<
M                          ",#Y<      (P/EP                !D
M97-C          =,96YO=F\                      -BR0       ____
M_R ,B0#X"XD                           #X"XD      /@+B0
M            9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0                 T     H(     ,[M
M ' &- #-      @   #Y$@ $     /#]?R0(        )@   #B,0@#*#D,
MV;=  /AU0@   '9I97<      !.D_@ 47RX $,\4  /MRP $$PL  UR>
M 5A96B       $P)5@!0    5Q_F;65A<P         "
M     0   H\    "6%E:(        %P+   RCP  "%%865H@        =#0
M +T0   195A96B         FG   $%\  +F"8W5R=@         )   "&0PK
M'3LV>5;D?ARTZ___  !C=7)V          D   ()"[L>&3D*6U"$<[FT__\
M &-U<G8         "0   AX+VR'>/BAA\(UAP.C__P  6%E:(        /-1
M  $    !%LQ865H@                     '-I9R      04U$('1E>'0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0D 9-+574YO)M
MI#W*X'X\5)9R>;!&WJB_RK/VL?:.G]I14ODW8KD?)S]+V^9-1116A(4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,7Q'_RQ_X'_P"RUG:==_9)E?/!
MX8#T]?PJ_P"(C\\8_P!EOYUC]J^;QU5TL=.I'>,H_A%'KX>"GAHP>S3_ #9V
M?6EJAHUS]HMU!/*?*?PZ?I5^OH:51581G':23/*G%PDXO=.P44459(5D:[>[
M%$"GEN6]AZ?C_GK5^]O%LHR[<GH!ZFN6DE:9V=SDDY->9FN+]E!T8/WYK7RC
M_P $[<#0YY>TE\,7IYO_ ( RNITI-EK$/]G/YDFN6(S78PIY:*OHH'Y"N;)8
MWG4GT44OO?\ P#7,9>["/=M_=_PX^BBBO</-"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3WI=NA'!!';(L<2A%48"J, ?@*DHHKB.X**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** &R1K,I1U#*1@@C((],&N#\2^ S$&N-/!*]
M3%U(]U/4_3\J[ZBM*-:=&5XOU71F5:A"O&TEZ/JCPPC!P:2O3?%'@V/5PUQ;
M )/CD9VK)]<=#[_G[>;W%O):NT<BE64X92,$'T(_7Z<UZ]#$0KJZT?6/4\?$
M8>=!V>L7L^C(J***V, HHHH Z7PSXQFT8K#.3)!T _B3W&>P_NG_ /7Z3:7<
M5]$LT+AT89!!R*\1K7\/^(KC0)=T?S1L<O&3@'MD<<$5Q8K!J?O4])=5T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V2-95*.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 4->_Y!UY_UZS_ /HMJ\:KV77O^0=>?]>L_P#Z+:O&J]++OAJ>
MJ/,S+XH>C"BBBN\\X**** "BBB@ HHHH **** "BBB@ HHHH *?#-);L'C9E
M8="I*D?B*911:X)V.HTOQ]?V6%FQ.O'WOE<#/]X?U!KL='\76&L817\N0X^1
M_E)/L>A_#GVKR:EKEJX*E/9<C\MON.NECJM/=\Z[2W^_<]SHKS#0?&]WI>(Y
MR9HAV)^=1[-WQZ'/M7H>EZM;:Q%YMNX8=QT93Z$=J\ZMAYT7[RNNZV/3HXFG
M77NNS_E>Y<HHHK$V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH X_P ?>'Q=1&_A'SQKB0#^)!_%]5_E]*\\%>Y,H8$$9!&"
M#R*\F\5:&=#O&11^[<;HSCMW7_@->E@*_-^ZENOA].QYF88>S]K'9_%Z]S%H
MHHKO/."BBB@ K3T#69-$NTG7I]UU_O+W'X=1Z'VK,HJ9P51.,MFBX3E"2E'1
MH]PM[A+J-)8SE74,#[&I*X/X?:]L8Z?*W!):(D]#U9/QZC\:[RO$K4G1FXOI
ML_(]VC55:"FNNZ\PHHHK,T"BBB@ HHHH **** "BBB@!"<5R^IWGVR4D?='"
M_3O^=:NN7ODQ^2OWG'/LO_U_\:R+*QDOGPO '5L<#_'Z5XV9UI5ZBPM*[=TY
M6[]%\MST,%3C3BZT]%T_S&6EI)>/L0>A)[#ZUT]G:)91A$_$]R:6UM4M$"(/
MJ>Y/K4U=F!P,<+&[UJ-:OHO)'/B<2Z[LM(+9?JPHHHKM.<**** "BBB@ HHH
MH **** "BBB@ HHHH **** /,_B)_P A,?\ 7NG\VKEZZCXB?\A,?]>Z?S:N
M7KV\-_!A_A/!Q7\:I_B84445L8A1110!U?P^U4VMZ;5C\LRG S_&O(/U(!^O
M%>DUXOH\YMKZVD'\,\9_#<,_I7M%>5CZ:A437VE^*T/8R^;E2:?V7^#U"BBB
MN,[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:]_P @Z\_Z]9__
M $6U>-5[+KW_ "#KS_KUG_\ 1;5XU7I9=\-3U1YF9?%#T84445WGG!1110 4
M45N>%?#R^(9I8WD*"- >%!)R<=2:BI45.+E)V2ZETZ<JLE&.[[F)BDKT5/AK
M8C&Z>8_38/YJ:D_X5OIW_/6X_P"^T_\ C=8?7J/=_<=/U"MV7WGFU%>D_P#"
MM]._YZW'_?:?_&Z1OAOI_P##-.#[LA_38*/KU'N_N#^SZW9?>><4E=Y-\,UZ
MQ71^C1\?F&_I63>?#_4[;)C"3#'\#;6_\?Q_,U4<71G]O[]#.6#K1W@WZ69S
M-%3W=C<6#;)XGC/HRE?RSUJ"MTT]4[F#33LU9A1113$%%%% !5K3]1N-,E6:
MW<HP[]1CT([@]Q56BE**DK2U149.+O%V:/7_  ]X@AUZ .A D4#S$Z$'N0/[
MI/0UJUXIIVH3Z9,L\#;74_@1W4^Q[UZAX8\2Q^((3D!9D WH.F#T89[']/U/
MDXG"NBW*.L+_ ''KX7%JLN66DTODS;HHHKE.L**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "L?Q3H@URR:-1^\3YHS_M#M]&Z5L44
MXR<)*2W3)G%3BXO5-'AK*5)!X(X/'OSUZ'L13:[#Q]X?%G)]NB!V2O\ O!V5
MSSD>S8Y]_K7'U[E*HJL%-=>GGU/"K4G1FX/I^70****T,@HHHH ?%*T#K(AV
MLK!@1P00<@UZ_P"']876[-)QPWW7'HXZ_P"(KQWI6[X2\0-H=T V/*E*K(/3
ML&'TSS[9QDURXVA[6',OBC^74[,%7]E/E?PS_/H>KT4@.>12UY![ 4444 %%
M%% !1110 4UW$:EF.  23]*=5:ZMFO/W;'$?&<?>)Z_@/U^E3-R47RJ\NBZ7
M\QQ2;5]%U,A+>36YVE/RQ@XSQD =!]><_C6Y#"EN@1!@"EBB2!0B  #H!3ZQ
MPV&5"\G[U2>LI]WY>1I6K.I9+2$=%'^NH4445T&04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'F?Q$_Y"8_Z]T_FU<O74?$3_D)C_KW3^;5R]>W
MAOX,/\)X.*_C5/\ $PHHHK8Q"BBB@">P_P"/F'_KJG_H0KVVO$K#_CYA_P"N
MJ?\ H0KVVO-S'XH>C/4RWX9^J"BBBN ] **** "BBB@ HHHH **** "BBB@
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MU<O74?$3_D)C_KW3^;5R]>WAOX,/\)X.*_C5/\3"BBBMC$**** +%AQ<P_\
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MLT+E74\$<]>H(Z$'N/RYKU;P[KT>OVPE4;77 D3/W6Q_(]J\K$X5T7S+6#_
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MYK*)S_GFDHKU8PC!6BK+R/(G.4VW)MM]PHHHJB HHHH **** "BBB@ HHHH
M*N:=JMUI4GF6\K(<\XY5OJ#P?RJG12E%2335T^C*C)Q=T[-=4>G>'/&D.K[8
M+C$<Q]_D8^Q/0^WZFNFKPP'%>A>"_%IOL6=VW[P#Y'/\0'\)_P!KT]?KU\S%
M8/V:YX;=5V/3PF,]HU"I\71]SL:***XCO"BBB@ HHHH **** "BBB@ HHHH
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M]O#M2HP:[)?=H>#B8N-::?\ ,W]^HE%%%;&(&EK1L/#NH:E@P6[D'^(C8O\
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M$QEIFQZNO/\ WRHK!XZBNK?HC>. KO=)>K/,Z*].;X?:6>@D'T?_ !!JK/\
M#:T88BN)5_W@KC\@%I+'47W7J@>7UET3]&>=T8KJM0^'M_; F%DG')P#M?\
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M_M[(9GE2/_?8+_,T)-[:B;2U>A/16%<^-M)MN//WGT16;]< ?K6;/\2;)?\
M5P2M_O;5_D6K6.'JRV@_NM^9G+$T8[S7WW_(Z^BN#E^)KG[EH!]92?Y**K/\
M2KTYV00CTSO/\F%:+!5W]FWJT9/'4%]J_HF>BT5YJWQ&U)NB0+]$?^KFD_X6
M)J7I%_WP?_BJKZA6?;[Q?VA1\_N.@^(T:MIT;'JMPN#]5;->;UM:OXMO=;@\
MB<1A=P;Y5(.1GN2?6L6N_"TI4:?++>[^X\_%U8UJG-':R6O="4445N<P4444
M 36;^7/$WI(A_)A7MU>'P?ZQ/]Y?YU[A7FYC\4/\)ZF6_#/U7Y!1117 >@<Q
MX^TO[=8>>HR\!W?\!/#?T/X5YE7N,L2S(R.,JRD$>H(P17C.JV#:7=2V[?P.
M5^HZ@_B,'\:]/+ZMXNF_LZKT?_!/+S&E:2J+[6C]45****[CSPHHHH *U_"V
MH_V7J4$A/REMC=?NOP3^>#^%9%%14@IPE%]4RZ<W3G&2Z,]THK,\-ZA_:>GP
M3$Y;9M?UW+\IS]<9_&M.O"DG%M/=,^@BU))K9H***;)(L2L[' 4$D^PY-(9Y
MK\0;[[3J'E \0QJOXM\Q_F!7+U8O[LWUS+.W621V_,]/PJO7NTH>SIQCV2O^
MI\_6G[2I*7=NWIT"BBBM#,***,XYH Z/P)IWVW4D<CY85,A^O1<^^3G\*]1K
MEOA]IOV.P,Q&&F<G_@*_*!^>:ZFO&Q=3VE65MHZ+Y'N8.G[.E'O+5_,****Y
MSH"O(?%?_(5NO^NI_I7KU>0^*_\ D*W7_74_TKMR_P#B2_P_JCAS+^''_'^C
M,FBBBO4/)"BBB@ K9\'?\A>U_P!]O_0&K&K9\'?\A>U_WV_] :LJ_P#"G_A9
MKA_XM/\ Q+\SUNBBBO#/?"BBB@#S/XB?\A,?]>Z?S:N7KJ/B)_R$Q_U[I_-J
MY>O;PW\&'^$\'%?QJG^)A1116QB%%%% $]A_Q\P_]=4_]"%>VUXE8?\ 'S#_
M -=4_P#0A7MM>;F/Q0]&>IEOPS]4%%%%<!Z 4444 %%%% !1110 4444 %%%
M% !1110 444UG5 68@ =23@4 .HK*N_%.EV7^LND)]$)D/\ XYFLJ?XC:='P
MB2O_ ,!51^K9_2M(T*L_A@W\C*5>E#XII?,ZJBN&E^)HZ1VGXM+C] O]:K/\
M2[H_=MXQSW+-_(BM5@J[^S;U:,WC:"^U?T3/0J*\V;XD:B?^6< _X"^?_0S_
M "IG_"Q-3](?^^#_ /%4_J-;LOO)_M"CW?W'HM[&)K>5#T:-P?Q4BO$\8 Q_
MGTY^E=,WQ"U)P01%R"/N'_XJN9_SZUV8.A.AS<UM;6LSBQM>%?E<+Z7O=6$H
MHHKK.,**** %'6O5?!$GF:1;^H,H_P#(C?TKRJO4O ?_ ""(?]Z3_P!#-<68
M+]U%_P!Y?DSNRU_O9+^Y^31T-%%%>6>L%%%% !1110 4444 %%%% %#7O^0=
M>?\ 7K/_ .BVKQJO9=>_Y!UY_P!>L_\ Z+:O&J]++OAJ>J/,S+XH>C"BBBN\
M\X**** "NS^&G_'S<_\ 7)?_ $*N,KL_AI_Q\W/_ %R7_P!"KGQO\"7R_,Z<
M%_'A\_R/0:***\8]L**** "BBB@ HHHH **** "N?\=R;-)F']YHA]?G#8_2
MN@KDOB1/LL(H\\O./R56S^I%:X=7JP_Q+\-3'$NU&I_A:^_0\XHHHKW#P0HH
MHH *!110!Z/\-DQI\K\_-<M^B+_^JNMKG? 4/E:3&W]]Y&_)MO\ [+715X==
MWJS?]YGOX=6I07]U!11161J%%(2 ,FN-\0^/DM]T-AAV&09#R@_W1W/OT^M:
M4J4ZSM%7_)&=6K"C'FF[?F=7>ZA;Z='YEQ(L:^I/7V ZD_2N3U/XCQ1Y6SBW
MG^_)E5_[Y')'XBN&O+R:_D,L\C.Q[L2??\,>@X]JAKT*6 A'6;YGVZ'G5LPG
M+2G[J[[LV+[Q=J=_PT[(/2/Y!]/EY(_$UD.S.2S')[DG/MU[TE)77"G&G\*2
M]$<<ZDJFLFV_-W"BBBJ("BBB@ HHHH **7%)0 4444 %%%% $D'^L3_>7^=>
MX5X?!_K$_P!Y?YU[A7FYC\4/\)ZF6_#/U7Y!1117 >@%<#\2-,\N2*]4<./+
M?_>'*'\1D?A7?5F>(]-_M:PF@ RVW<G^\O(_/I^-;8>I[*K&72]GZ,QQ-/VM
M*4>MKKU1X]1117MG@A1110 444"@#N?AOJ6&FLV/4"1/KP'_ /9>E=W7C>@Z
MB=*OH+CLKC=_NM\K?7@_G7L8.>17DXZGR5>9;35_GU/9P%3GI6>\';Y=!:P_
M&=]]ATN<@X,@$8_X%P?_ !W-;E<%\2[[,EO:@_=5I&^K':O\F_.LL-#VE6*Z
M)W?RU-,5/V=&;ZM67ST.(HHHKVSP@HHHH .M2VEL]Y-'#']Z1U4?4G%1@5U'
MP]T[[7?FX8<0)GVW-PH_ 9-9UZGLZ<I>1K0I^UJ1CW?X'HUK;)9PQPI]V-%4
M?11@5+117A'O[!1110 5Y#XK_P"0K=?]=3_2O7J\A\5_\A6Z_P"NI_I7;E_\
M27^']4<.9?PX_P"/]&9-%%%>H>2%%%% !6SX._Y"]K_OM_Z U8U;/@[_ )"]
MK_OM_P"@-65?^%/_  LUP_\ %I_XE^9ZW1117AGOA1110!YG\1/^0F/^O=/Y
MM7+UU'Q$_P"0F/\ KW3^;5R]>WAOX,/\)X.*_C5/\3"BBBMC$**** )[#_CY
MA_ZZI_Z$*]MKQ*P_X^8?^NJ?^A"O;:\W,?BAZ,]3+?AGZH****X#T HHHH *
M*** "BBB@ HHHH ***R]<\16F@Q[IFRY'RQKRQ_P'N:<8N;2BKM]$*4E!-R=
MDNK-,D 9-8&J^-]/TPE%8S..T?*CZMT_+-<)K?BJ]ULE7;9%GB-20OXGJWX\
M>PK')_SWKT*.7]:C_P"W5^K/.K9CNJ2_[>?^1U&H?$'4+K(A"P@_W1O;_OIA
M_("N>N[^XOCNGE>0_P"TQ;^9XJO179"C3I_#%+Y:G%.M4J?%)ORZ?<%%%%:&
M04444 %%%% !111B@ HHHH **** "O4_ ?\ R"(?]Z7_ -#->65ZGX#_ .01
M#_O2_P#H9KCS#^$O\:_)G=EW\9_X'^:.AHHHKRCU@HHHH **** "BBB@ HHH
MH H:]_R#KS_KUG_]%M7C5>RZ]_R#KS_KUG_]%M7C5>EEWPU/5'F9E\4/1A11
M17>><%%%% !79_#3_CYN?^N2_P#H5<979_#3_CYN?^N2_P#H5<^-_@2^7YG3
M@OX\/G^1Z#1117C'MA1110 4444 %%%% !1110 5Y]\2KO?<6\ /W(V<_5CC
M\_E_7TS7H->/>)-0&IZC/.IRN_:O^ZHVC\QS77@(<U7FZ17YZ''F$^6ER]9/
M\%J9E%%%>L>.%%%% !115G3;0W]U# /^6DJK^H!/X4I2Y8N79-_<5&/-)+NT
MOO/6O#UO]ETZUC/40(3]6&X_J:T:0  8%+7@-W;?=GT*5DEV04A(49/ %+7'
M?$#7C:Q"QA;#2+F0CLG0#_@1_3ZU5*FZLU!=?R(JU%1@YOI^9D>+_%[:DS6M
MJV(1D,PX,G;M_#_/OQ7)T4O6O:I4XTHJ,=OQ;[L\.K5E6ES2W_!+LA****T,
MPHHHQ0 4M:6C>'[S7&(MT^4'#.QP@/?G^@YKMM,^'ME:@-<LTS>GW$_)>3^?
MX5A5Q5.EHW>79'32PE6KJE9=WL><*I<[0"2>PY/I6A;^&]2NON6LN#W*E1^;
M8KUNUL;>Q7;!$D8_V5"_RJ>N268O[,5\V=<<M7VIM^BL>5Q>!-6DY,*I]9$_
M+Y2:L+\/-3Z_NA_P,_X5Z916?U^MY?<:?V?1_O?>>4ZGX,OM)MWN9C'L3;G:
MQ)Y8*,#:.Y]:P:]7\<?\@:Y_[9?^C4KRBNW!U95H-RW4K:>APXRC&C-*%[.-
M]=>K"BBBNDY0HHHH D@_UB?[R_SKW"O#X/\ 6)_O+_.O<*\W,?BA_A/4RWX9
M^J_(****X#T HHHH \E\7:9_9FI3(!A'_>)V&&.2/P;-8M>B_$;3O.M8[I1S
M$^UO]UNGY'^=>=5[6%J>TI1?5:/U1X>+I^RJR71ZKT84445N<X4444 +][BO
M6?!^I?VGID+$Y9!Y;>N5Z?FN#7DO2NQ^'.I>3=2VC'B5-R^FY.OY@\_2N3'4
M^>E?K%W^1V8"IR5>7I-6^9Z'7D/BB_\ [1U*XE!^4/L7TPOR_KC/XGO7J6L7
MO]G6<]QW2-B/][HOZXKQC)/)//UR?SK'+H:RGY6_4Z,RGI&'S?Y(2BBBO1/+
M"BBB@!0*]1\":=]ATU'(^:8F0^NT\(/RY_&O-M-LVU&ZBMTZO(J_0'J?P'->
MT11+ BQH,*JA0/0 8 KS\PJ648+KJST<NIW<JCZ:+YCZ***\X],**** "O(?
M%?\ R%;K_KJ?Z5Z]7D/BO_D*W7_74_TKMR_^)+_#^J.',OX<?\?Z,R:***]0
M\D**** "MGP=_P A>U_WV_\ 0&K&K9\'?\A>U_WV_P#0&K*O_"G_ (6:X?\
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M1M-*NG'4Q[/^^R$_K7D>:]'+H:3GUV_5GFYE4=XP6UKO\A****] \T****
M9[5T?A'PN==D,LN5@C8 X_C. =H]!CK_ $/3GD4R$*!DD@ >YKV?2=/32K6*
MW0?<0 GU;JQ_$\UR8VLZ4%&.CGU\D=N"H*K-N6T+:>9/!!';(L<2A548"@8
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MRRO4_ ?_ ""(?]Z7_P!#-<>8?PE_C7Y,[LN_C/\ P/\ -'0T445Y1ZP4444
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M^E'\;#A?]U><?7D_G705Y^(QW-[M/1?S=?D>EA\#RVE4U?\ +T^8V.-845$
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MM,B!&&E)E(_WL8_\= K=KP\1/VE6;Z7T]$>]AH>SI076VOJPHHHK(V"BBB@
MHHHH *\E\91>3JUR/5E;_OI0W%>M5Y]\2-.:.XBNU'RNFQCV#+DC\P?TKKP$
MN6M9_:BU^IQYA!RHW7V9)_+;]3C****]8\<**** "MGP=_R%[7_?;_T!JQJV
M?!W_ "%[7_?;_P! :LJ_\*?^%FN'_BT_\2_,];HHHKPSWPHHHH 0@,"",@UY
M!XDTDZ+>R08^3.Z,^JMT_+D?A7L%87BSP\->MOD \Z/)C)X!]5/U_G^-=.$K
M>QJ:_#+1_HSFQE#VU/3XHZK]4>444^2-H6*.""IP0>"".O\ DTRO8WU/%M8*
M***!!1110 4444 %%%% !1110"+VALR:A:%>OVF''OEQ_.O9J\Z\!>'WN;@7
MTJ_NX\[,@_,_3/\ P'O[_0UZ+7DX^:G5LOLJS]3V,!!PI-O[3NEY!5;4;&/4
M[:6WD^[(A&>X/8_4'D59HKE3:=UNCK:333V9XI?V4FG3R6\HPR,0?3UR/7.<
MU6KT_P 8^&/[8B\^ ?OT'0<;U'\/U';\J\R=2A(8$$'!!XY''3L?6O9P]=5H
MI_:2]Y'B8F@Z$FOLMZ/R&T445N<X4444 %%%% !1110 4444 %%/CC>5U1%+
M,6   R22< 8K4UGPW<:'#;O,1F4-E1SM(P<$^N#_ )ZU+J14E%NTGLBU3DXN
M25XK=F11115$!1110 M=_P##2XW0W47]V1&_[Z!'3_@(KS^NH^'MY]GU(Q$\
M2Q,OXK\P_0&N;&1YJ,O*S.G!2Y:\?.Z^\],HHHKQSVPKS]$/C36VWG-O!G Y
MP5!P!]7/)]J[NY9EBD*]0C$?7'%<;\,POEW9_BW1?EAL?KFNBC[E.I47Q+E2
M?;FW?X'/77/4I4W\+NVN_+LB?Q7=75K>V5G93&$2@( N HRX4'&.V:6;1/$,
M"EX]0#L!G;TSQTY!%5O'+2IJ>GF%0T@*E 3@%A(-H/(X)QGFH]0\2Z]%*ME+
M##!)* %(_P!HX&&WLM;0C-PI\O)\+;YDKNS>O<PG*"G4YN?222Y6[+1678OZ
M/<KXWTZ6&[5?,C; <#H2/E<>AXY _E5?P)?RVD\^E3GF,N4&>A#8=>V1SD?B
M>];/A/P\= MV61@TDC!G*YP,# '/7O\ G6 @">,"$Z$MG'J;;)_6HO&7MH1U
M@ES1\K/H7:470G+2;:C+S33W.[HHHKD.PH:]_P @V\_Z]9__ $6U>-XKVK4K
M9KVUG@4@&2&1 3G +*0#Q]:X/_A6M[_SWA_\?_\ B:[L#6ITE+GE:[1P8^C4
MJN#A'FLF<A@T8-=?_P *UO?^>\/_ (__ /$T?\*UO?\ GO#_ ./_ /Q-=GUJ
MC_.OQ.+ZI7_D?X'(8-&#77_\*UO?^>\/_C__ ,31_P *UO?^>\/_ (__ /$T
M?6J/\Z_$/JE?^1_@<A@T8-=?_P *UO?^>\/_ (__ /$T?\*UO?\ GO#_ ./_
M /Q-'UJC_.OQ#ZI7_D?X'(8-&#77_P#"M;W_ )[P_P#C_P#\31_PK6]_Y[P_
M^/\ _P 31]:H_P Z_$/JE?\ D?X'(8-+BNN_X5K>_P#/>'_Q_P#^)H_X5K>_
M\]X?_'__ (FCZU1_G7XA]4K_ ,C_  .1I*[-/AG<'&ZYC'KA6/\ A5F+X9@?
MZR[)SU"QX_4L?Y5+QE%?:OZ)C6"KO[%O5HX.EKTJ#X=:=&<R/*_U8 ?H,_K6
MG:^%-+L\;+5"1W?,ASZ_.36<LPIK9-_@:QRZJ]VH_.YY1:V-Q?-M@B>0^BJ6
M_E70Z?\ #_4;LAIML [[CO?\E/\ ,BO2D18P%4  =@,"G5A/,*C^%*/GNSHI
MY=3C\3<O+9'/:7X'T[3L,ZF9_63!7\$''YYKH  H  P!2T5R3G*H[R;;\SLA
M3C35HI)>04445)04444 %%%% !1110 4444 17%M'=QM%*H9&&"#R#7GOB+P
M+-8[IK(&6/J4ZR+_ /%?S]1WKT>BM:->=!WB].J>QC6P\*ZM):K9K<\,P1Q2
M5Z]JWA>PUC+2Q[7/_+1/E?\ P/X@URE_\-[A"3:SJX]'RC?3(R#^GK7HT\=2
MFO>]U^>WWGFU,!5@_=]Y>6_W'&XI*U[GPGJMKPUJY]T_>>_\))JB^F7<9PUO
M*/K&P_I73&K"6TE]Z.>5*<='%_<RM15@:?<DX$,G_?#?X5/%H.HS?=M)C_VS
M8#\R,4.<5]I?>2H3>T7]Q0HK?MO VK7'6$1^[LH'Y D_I6W9?#7O=7'&>5C'
M_LS?_$UE+%48?:3]-3:&$K3^RUZZ'#JNXX'4\5TVA^!KO4R)+G,$7H0/,/T4
MYQGU/UYKNM,\.V&D_-!"-W]]OF?\ST_#%:5<=;'N2M37*N[W.VCEZAK4?,^R
MV*NG:9;Z5"(;=-JCKW8GU)/)-<I\0- ><"_A!)1=L@'7;V;\.A]L=LUVM(1G
M@URTJLJ<U-:OK?J==6C&K3<'HNENAX9UI:]'UOP!;W[M-:MY+GJI&8S].Z_A
MD>U<I=^"M5M?^6&\#H8V# _AP?TKU:>*I5%\2B^ST/(J82K3?PN2[K4PJ*NO
MHFH1_>M)AS_SR?\ PIT>@ZC)C%I/SW\I\?GBMN>'\R^\P]G/^5_<RCTYKI/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_1.jpg
<TEXT>
begin 644 image_1.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    9DE$051X7NW7
ML1$ ( S$,/9?&BY=8(#PA=1Y!*_=+   @'']2FI,K@   !C7KZ3&Y H  (!Q
M_4IJ3)X&  #XRZ4   !97 H  )#%I0   %E<"@  D,6E    65P*  "0Q:4
8  !9#B6 &7->8$+7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_11a.jpg
<TEXT>
begin 644 image_11a.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    9DE$051X7NW7
ML1$ ( S$,/9?&BY=8(#PA=1Y!*_=+   @'']2FI,K@   !C7KZ3&Y H  (!Q
M_4IJ3)X&  #XRZ4   !97 H  )#%I0   %E<"@  D,6E    65P*  "0Q:4
8  !9#B6 &7->8$+7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_161.jpg
<TEXT>
begin 644 image_161.jpg
MB5!.1PT*&@H    -24A$4@   S    0@" (   "V&RY9   2JDE$051X7NW6
M,0$ , R L/HWW?X3,)[D1 &S  "DY@T  /QER   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!F
MR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!FR   8H8, "!V
4L 3;==Q-8Q<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    9DE$051X7NW7
ML1$ ( S$,/9?&BY=8(#PA=1Y!*_=+   @'']2FI,K@   !C7KZ3&Y H  (!Q
M_4IJ3)X&  #XRZ4   !97 H  )#%I0   %E<"@  D,6E    65P*  "0Q:4
8  !9#B6 &7->8$+7     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    7DE$051X7NW7
M,0$ , S#L/(GO=T+@"Z']!F"Y[P&  !@5UY)-@  P*Z\DFP  (!=>271
M?[D4  "@BTL!  "ZN!0  *"+2P$  +JX%   H(M+ 0  NK@4  "@RP74!2)J
00B#[;P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_21a.jpg
<TEXT>
begin 644 image_21a.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    7DE$051X7NW7
M,0$ , S#L/(GO=T+@"Z']!F"Y[P&  !@5UY)-@  P*Z\DFP  (!=>271
M?[D4  "@BTL!  "ZN!0  *"+2P$  +JX%   H(M+ 0  NK@4  "@RP74!2)J
00B#[;P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@  !#<    +" (   #DV/%%    7DE$051X7NW7
M,0$ , S#L/(GO=T+@"Z']!F"Y[P&  !@5UY)-@  P*Z\DFP  (!=>271
M?[D4  "@BTL!  "ZN!0  *"+2P$  +JX%   H(M+ 0  NK@4  "@RP74!2)J
00B#[;P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_68a.jpg
<TEXT>
begin 644 image_68a.jpg
MB5!.1PT*&@H    -24A$4@   !D    *" (   #.R6(!    *TE$051X7F-@
M8/A/"4(&#)C2)"$4LU!XE(%!:Q9F$)"$AH19*#S* #7- @#51!H#AM807
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_74.jpg
<TEXT>
begin 644 image_74.jpg
MB5!.1PT*&@H    -24A$4@    <   !I" (   !YSJZN    *$E$051X7F-@
M0 +_80!9<%1T5'14=%1T5'14=%1T5)0H43@+&0Q>40!KA0TLQV-Q,0    !)
'14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131384179520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131384231792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="nump">$ 2,760,034<span></span>
</td>
<td class="nump">$ 2,716,281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">112,665<span></span>
</td>
<td class="nump">101,274<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,872,699<span></span>
</td>
<td class="nump">2,817,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_PatientCareCosts', window );">Patient care costs</a></td>
<td class="nump">2,058,189<span></span>
</td>
<td class="nump">2,018,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">331,614<span></span>
</td>
<td class="nump">294,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">178,071<span></span>
</td>
<td class="nump">172,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income, net</a></td>
<td class="num">(6,820)<span></span>
</td>
<td class="num">(7,046)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,561,054<span></span>
</td>
<td class="nump">2,479,247<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">311,645<span></span>
</td>
<td class="nump">338,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(100,774)<span></span>
</td>
<td class="num">(73,791)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="num">(1,786)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">214,623<span></span>
</td>
<td class="nump">262,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">43,955<span></span>
</td>
<td class="nump">57,013<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">170,668<span></span>
</td>
<td class="nump">205,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="num">(55,121)<span></span>
</td>
<td class="num">(43,596)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 115,547<span></span>
</td>
<td class="nump">$ 162,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares for earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">90,497<span></span>
</td>
<td class="nump">96,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">92,483<span></span>
</td>
<td class="nump">100,503<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PatientCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PatientCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131384092576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 170,668<span></span>
</td>
<td class="nump">$ 205,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized (losses) gains on interest rate cap agreements:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized (losses) gains</a></td>
<td class="num">(3,539)<span></span>
</td>
<td class="nump">41,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications of net realized (gains) losses into net income</a></td>
<td class="num">(15,742)<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized gains on foreign currency translation:</a></td>
<td class="nump">33,561<span></span>
</td>
<td class="nump">62,212<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">14,280<span></span>
</td>
<td class="nump">104,377<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">184,948<span></span>
</td>
<td class="nump">310,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(55,121)<span></span>
</td>
<td class="num">(43,596)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to DaVita Inc.</a></td>
<td class="nump">$ 129,827<span></span>
</td>
<td class="nump">$ 266,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131383919696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 317,132<span></span>
</td>
<td class="nump">$ 244,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">94,265<span></span>
</td>
<td class="nump">94,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">49,965<span></span>
</td>
<td class="nump">77,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">2,057,809<span></span>
</td>
<td class="nump">2,132,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">106,770<span></span>
</td>
<td class="nump">109,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">324,405<span></span>
</td>
<td class="nump">413,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">89,393<span></span>
</td>
<td class="nump">78,839<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,603<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,039,739<span></span>
</td>
<td class="nump">3,155,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,216,373<span></span>
</td>
<td class="nump">3,256,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,617,018<span></span>
</td>
<td class="nump">2,666,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">186,758<span></span>
</td>
<td class="nump">182,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">241,747<span></span>
</td>
<td class="nump">231,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">44,520<span></span>
</td>
<td class="nump">44,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">291,321<span></span>
</td>
<td class="nump">315,587<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,090,311<span></span>
</td>
<td class="nump">7,076,610<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,727,787<span></span>
</td>
<td class="nump">16,928,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">447,969<span></span>
</td>
<td class="nump">479,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">796,742<span></span>
</td>
<td class="nump">802,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">618,931<span></span>
</td>
<td class="nump">692,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">394,607<span></span>
</td>
<td class="nump">395,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">242,193<span></span>
</td>
<td class="nump">231,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">64,651<span></span>
</td>
<td class="nump">18,039<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,565,093<span></span>
</td>
<td class="nump">2,619,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">2,455,144<span></span>
</td>
<td class="nump">2,503,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,417,532<span></span>
</td>
<td class="nump">8,692,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">100,229<span></span>
</td>
<td class="nump">105,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">771,087<span></span>
</td>
<td class="nump">782,787<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,309,085<span></span>
</td>
<td class="nump">14,703,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,398,829<span></span>
</td>
<td class="nump">1,348,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">590,251<span></span>
</td>
<td class="nump">606,935<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">290,034<span></span>
</td>
<td class="nump">174,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(54,906)<span></span>
</td>
<td class="num">(69,186)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total DaVita Inc. shareholders' equity</a></td>
<td class="nump">825,470<span></span>
</td>
<td class="nump">712,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests not subject to put provisions</a></td>
<td class="nump">194,403<span></span>
</td>
<td class="nump">163,566<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">1,019,873<span></span>
</td>
<td class="nump">875,892<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 16,727,787<span></span>
</td>
<td class="nump">$ 16,928,252<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385138832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">$ 5,395,966<span></span>
</td>
<td class="nump">$ 5,265,372<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="nump">$ 40,945<span></span>
</td>
<td class="nump">$ 49,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">90,650<span></span>
</td>
<td class="nump">90,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">90,650<span></span>
</td>
<td class="nump">90,411<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380712224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 170,668<span></span>
</td>
<td class="nump">$ 205,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">178,071<span></span>
</td>
<td class="nump">172,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">25,373<span></span>
</td>
<td class="nump">24,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(3,621)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Equity investment loss, net</a></td>
<td class="nump">3,044<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charges, net</a></td>
<td class="nump">5,864<span></span>
</td>
<td class="nump">4,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">81,850<span></span>
</td>
<td class="num">(66,270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets', window );">Other receivables and prepaid and other current assets</a></td>
<td class="nump">66,595<span></span>
</td>
<td class="num">(17,966)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(615)<span></span>
</td>
<td class="nump">3,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(20,535)<span></span>
</td>
<td class="nump">21,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(74,144)<span></span>
</td>
<td class="num">(95,927)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(6,486)<span></span>
</td>
<td class="nump">26,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="nump">39,251<span></span>
</td>
<td class="nump">52,473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(5,516)<span></span>
</td>
<td class="num">(11,701)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">462,557<span></span>
</td>
<td class="nump">322,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions of property and equipment</a></td>
<td class="num">(147,705)<span></span>
</td>
<td class="num">(123,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from asset and business sales</a></td>
<td class="nump">13,474<span></span>
</td>
<td class="nump">11,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of debt investments held-to-maturity</a></td>
<td class="num">(25,000)<span></span>
</td>
<td class="num">(5,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchase of other debt and equity investments</a></td>
<td class="num">(4,643)<span></span>
</td>
<td class="num">(2,726)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from debt investments held-to-maturity</a></td>
<td class="nump">50,258<span></span>
</td>
<td class="nump">5,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from sale of other debt and equity investments</a></td>
<td class="nump">3,856<span></span>
</td>
<td class="nump">3,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investments</a></td>
<td class="num">(7,904)<span></span>
</td>
<td class="num">(2,962)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distributions from equity method investments</a></td>
<td class="nump">1,120<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(116,544)<span></span>
</td>
<td class="num">(118,366)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings</a></td>
<td class="nump">611,829<span></span>
</td>
<td class="nump">354,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on long-term debt</a></td>
<td class="num">(880,552)<span></span>
</td>
<td class="num">(398,990)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing and debt redemption costs</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(236,232)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(54,837)<span></span>
</td>
<td class="num">(65,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net payments related to stock purchases and awards</a></td>
<td class="num">(7,902)<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">4,725<span></span>
</td>
<td class="nump">4,929<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from sales of additional noncontrolling interests</a></td>
<td class="nump">50,832<span></span>
</td>
<td class="nump">3,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,283)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(275,912)<span></span>
</td>
<td class="num">(341,571)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">2,307<span></span>
</td>
<td class="nump">3,363<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">72,408<span></span>
</td>
<td class="num">(134,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of the year</a></td>
<td class="nump">338,989<span></span>
</td>
<td class="nump">554,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of the period</a></td>
<td class="nump">$ 411,397<span></span>
</td>
<td class="nump">$ 420,581<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in other current receivables and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131379846016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Non- controlling interests subject to put provisions</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Non- controlling interests not subject to put provisions</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,434,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,881)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(822)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,390,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 755,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">$ 540,321<span></span>
</td>
<td class="nump">$ 354,337<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (139,247)<span></span>
</td>
<td class="nump">$ 180,640<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 104,377<span></span>
</td>
<td class="nump">104,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,571)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,774)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(233,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (233,318)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">843,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">595,403<span></span>
</td>
<td class="nump">516,459<span></span>
</td>
<td class="num">$ (233,318)<span></span>
</td>
<td class="num">(34,870)<span></span>
</td>
<td class="nump">174,552<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,348,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,398,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 875,892<span></span>
</td>
<td class="nump">712,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">606,935<span></span>
</td>
<td class="nump">174,487<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(69,186)<span></span>
</td>
<td class="nump">163,566<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">90,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 14,280<span></span>
</td>
<td class="nump">14,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,523)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,287)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,031)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,031)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 1,019,873<span></span>
</td>
<td class="nump">$ 825,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 590,251<span></span>
</td>
<td class="nump">$ 290,034<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (54,906)<span></span>
</td>
<td class="nump">$ 194,403<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">90,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseFromContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest increase from contributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseFromContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests Reclassifications And Expirations Of Put Obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasePurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Purchase Of Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasePurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in temporary equity from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387094608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidated interim financial statements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387232672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition [Text Block]</a></td>
<td class="text">Revenue recognition<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,047)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,927&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,628&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817,555&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's integrated kidney care (IKC) revenues include revenues earned under risk-based arrangements, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386931904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text">Earnings per share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:68.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387042256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in debt and equity securities</a></td>
<td class="text">Short-term and long-term investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,338&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,965&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,872&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,693&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385150672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,076,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,211,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any goodwill impairment charges during the three months ended March 31, 2023 and 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations continue to be impacted by the effects of the coronavirus (COVID-19) pandemic. While the Company does not currently expect a material adverse impact to its business as a result of the ongoing COVID-19 pandemic, there can be no assurance that the magnitude of the cumulative impacts of the COVID-19 pandemic, including certain conditions and developments in the U.S. and global economies, labor market conditions, inflation and monetary policies that may have been intensified by the pandemic, will not have a material adverse impact on one or more of the Company's businesses.</span></div>Developments, events, changes in operating performance and other changes in key circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2023. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2022 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131383916224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,968,519&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,659,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,924,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,417,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,692,617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Term Loan A, Term Loan B-1 and the revolving line of credit have each been amended subsequent to March 31, 2023. See Note 14 for more information on these amendments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of March&#160;31, 2023.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March&#160;31, 2023, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,254 and deferred financing costs of $16,797, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $35,024 and increased by a debt premium of $13,546. As of December&#160;31, 2022, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $3,497 and deferred financing costs of $18,816, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,203 and increased by a debt premium of $14,018.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first three months of 2023, the Company made regularly scheduled and other principal payments under its senior secured credit facilities totaling </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$54,011</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Term Loan A and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$36,472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company's 2019 interest rate cap agreements described below had the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $568,786 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2023 and December&#160;31, 2022, which are classified in other long-term assets on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:17.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5">Debt expense (offset)</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the LIBOR cap from the Company's 2019 interest rate cap agreements, the Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2023 was 4.60%, based on the current margins in effect for its senior secured credit facilities as of March&#160;31, 2023, as detailed in the table above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 4.55% for the three months ended March&#160;31, 2023 and 4.53% as of March&#160;31, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company&#8217;s interest rates were fixed and economically fixed on approximately 53% and 93% of its total debt, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding under the facility, of which there were none as of March&#160;31, 2023. The Company also had letters of credit of approximately $151,358 outstanding under a separate bilateral secured letter of credit facility as of March&#160;31, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to March&#160;31, 2023, the Company amended its senior secured credit facilities and entered into several forward interest rate cap agreements that become effective June&#160;28, 2024 and June&#160;30, 2024. For additional information see Note 14.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386860528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2023 and December&#160;31, 2022, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government conducted a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. After its investigation, the government and the named states declined to intervene in the matter, and on April 5, 2023, the U.S. District Court, Northern District of Texas, entered an order unsealing the complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Grenon v. DaVita Rx, LLC et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The complaint has not been served on the Company. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. In November 2022, the Company learned that, on April 1, 2022, the U.S. Attorney&#8217;s Office for the District of New Jersey notified the U.S. District Court for the District of New Jersey of its decision not to elect to intervene in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and filed a Stipulation of Dismissal. On April 13, 2022, the U.S. District Court for the District of New Jersey dismissed the case without prejudice. On October 12, 2022, the U.S. Attorney&#8217;s Office for the Eastern District of Pennsylvania notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Bayne v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The court then unsealed an amended complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. In January 2023, the private party relator served the Company with the amended complaint. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023 District of Columbia Office of Attorney General Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In January 2023, the Office of the Attorney General for the District of Columbia issued a CID to the Company in connection with an antitrust investigation into the American Kidney Fund (AKF). The CID covers the period from January 1, 2016 to the present. The CID requests information on a number of topics, including but not limited to the Company&#8217;s communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF. The Company is cooperating with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#8217;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resolved Matters</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covered the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. In February 2023, the Department of Justice notified the Company that it had closed its investigation. </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Noncontrolling interests subject to put provisions and other commitments</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $10,099.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380750064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based compensation</a></td>
<td class="text">Shareholders' equity<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the Company granted 1,322 stock-settled restricted and performance stock units with an aggregate grant-date fair value of $101,467 and a weighted-average expected life of approximately 3.4 years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had $204,451 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.4 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Share repurchases</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not repurchased any shares subsequent to December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387079200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive income</a></td>
<td class="text">Accumulated other comprehensive loss<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,871)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,539)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,310)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,906)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,857)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,870)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386958768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable interest entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable interest entities</a></td>
<td class="text">Variable interest entities (VIEs)At March&#160;31, 2023, these condensed consolidated financial statements include total assets of VIEs of $308,455 and total liabilities and noncontrolling interests of VIEs to third parties of $178,382. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2022 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387023040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">Fair values of financial instruments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2023:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a reconciliation of changes in noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2023, see the consolidated statement of equity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the Company had contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $59,351 if certain performance targets or quality margins are met over the next one year to five years. The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2023, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $175,000. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2022 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2023 at their approximate fair values due to the short-term nature of their settlements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387016928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure</a></td>
<td class="text">Segment reporting<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. IKC business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. IKC business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2022 10-K for further description of how the Company determines and measures results for its operating segments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872,699&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income before income<br/>&#160;taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,731&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,071&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,944&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,789,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,084,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,727,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,928,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387042256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New accounting standards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New accounting standards<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (ASU) No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company could elect to apply the amendments prospectively through December 31, 2022. In December 2022, the FASB issued ASU No. 2022-06,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which extended the election date to December 31, 2024. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company does not expect application of this ASU to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386958768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent events<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Launch of Mozarc Medical</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;25, 2022, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (Mozarc Medical) via a deconsolidating partial interest sale from Medtronic to the Company, which closed effective April&#160;1, 2023. At the closing, the Company made a cash payment to Medtronic of $44,651, subject to certain customary post-closing adjustments, and contributed certain other non-cash assets to Mozarc Medical. Additionally, at close, the Company and Medtronic each contributed $224,415 in cash to launch Mozarc Medical. Pursuant to its agreement with Medtronic, the Company has also agreed to pay Medtronic additional consideration of up to $300,000 if certain regulatory and commercial milestones are achieved between 2024 and 2028.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward Interest Rate Cap Agreements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;21, 2023, the Company entered into several forward interest rate cap agreements with an aggregate notional amount of $1,000,000 that have the economic effect of capping the Company's exposure to Secured Overnight Financing Rate (SOFR) variable interest rate changes on specific portions of the Company's floating rate debt (2023 cap agreements). These </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 cap agreements are designated as cash flow hedges and, as a result, changes in their fair values will be reported in other comprehensive income. These 2023 cap agreements do not contain credit-risk contingent features, and become effective on June&#160;28, 2024 and June&#160;30, 2024 and expire on December&#160;31, 2025. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second and Third Amendments to Credit Agreement</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;3, 2023, the Company entered into the Second Amendment (the Second Amendment) to the Credit Agreement. The Second Amendment modifies the Credit Agreement to, among other things, transition the interest pricing on Term Loan B-1 from LIBOR+1.75% to a forward-looking term rate based on SOFR (Term SOFR) +1.75% and an additional credit spread adjustment (CSA), as well as to update the successor interest rate provisions in the Credit Agreement with respect to Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;28, 2023 (&#8220;Effective Date&#8221;), the Company entered into the Third Amendment (the Third Amendment) to the Credit Agreement. The Third Amendment modifies the Credit Agreement to, among other things, refinance its Term Loan A and revolving line of credit with a secured Term Loan A-1 facility in the aggregate principal amount of $1,250,000 and a secured revolving line of credit in the aggregate principal amount of up to $1,500,000. The facilities bear interest at a rate equal to one-month Term SOFR plus an interest rate percentage (initially 2.00%) and an additional CSA. The Credit Agreement, as amended, continues to include customary affirmative and negative covenants and events of default for financings of this type.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Term Loan A-1 facility amortizes on a quarterly basis beginning September&#160;30, 2023 at a rate of (i) 2.5% per annum during the first year following the Effective Date of the Third Amendment, (ii) 5.0% per annum during the second, third and fourth years following the Effective Date of the Third Amendment and (iii) 7.5% per annum during the fifth year following the Effective Date of the Third Amendment, with the balance due on April&#160;28, 2028. The new secured revolving line of credit has a five-year term.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385145296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Condensed consolidated interim financial statements</a></td>
<td class="text">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's integrated kidney care (IKC) revenues include revenues earned under risk-based arrangements, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term and Long-term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time </span><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s. The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Long-term debt</a></td>
<td class="text">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New accounting standards<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued Accounting Standards Update (ASU) No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company could elect to apply the amendments prospectively through December 31, 2022. In December 2022, the FASB issued ASU No. 2022-06,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which extended the election date to December 31, 2024. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company does not expect application of this ASU to have a material impact on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386960768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment revenue by major payor (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RevenuesbymajorpayorAbstract', window );"><strong>Revenues by major payor [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482,767&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,776&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,579&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,976&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,047)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,368)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,590,113&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,552,927&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,628&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817,555&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenuesbymajorpayorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues by major payor [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenuesbymajorpayorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387636016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"><tr><td style="width:1.0%"/><td style="width:68.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.644%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,161&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,483&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387016928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,485&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,338&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,965&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,872&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,821&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,693&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,322&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,329&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,341&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,485&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,022&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131386962352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill by Reportable Segments [Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying value of goodwill by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,350)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,328)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,076,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,211,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673,486&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,090,311&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380698736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,498,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,344,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024-2039</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,701,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,968,519&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,529)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,659,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,924,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242,193)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,417,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,692,617&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Term Loan A, Term Loan B-1 and the revolving line of credit have each been amended subsequent to March 31, 2023. See Note 14 for more information on these amendments.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of March&#160;31, 2023.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March&#160;31, 2023, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,254 and deferred financing costs of $16,797, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $35,024 and increased by a debt premium of $13,546. As of December&#160;31, 2022, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $3,497 and deferred financing costs of $18,816, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,203 and increased by a debt premium of $14,018.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of March&#160;31, 2023 and December&#160;31, 2022, which are classified in other long-term assets on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:17.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.294%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.914%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended <br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5">Debt expense (offset)</span></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, <br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387080528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Comprehensive income</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,871)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,186)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,674)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,539)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,132&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,212&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,975)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,742)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,404&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134,310)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,906)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,857)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,870)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387123248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2023:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,398,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a reconciliation of changes in noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2023, see the consolidated statement of equity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131381336240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,583,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,605,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,612,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575,096&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,954&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,169)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872,699&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817,555&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,865)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,305)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to consolidated income before income<br/>&#160;taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,774)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,791)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,786)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,731&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Summary of Depreciation and Amortization Expense by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,071&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,944&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock', window );">Summary of Expenditures for Property and Equipment by Reportable Segment</a></td>
<td class="text">Expenditures for property and equipment by reportable segment were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,705&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,108&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Summary of Assets by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"><tr><td style="width:1.0%"/><td style="width:61.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.065%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,789,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,084,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,727,787&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,928,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of capital expenditures for property and equipment from segment to consolidated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380932208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment Revenue by Payor (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 112,665<span></span>
</td>
<td class="nump">$ 101,274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,872,699<span></span>
</td>
<td class="nump">2,817,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(23,415)<span></span>
</td>
<td class="num">(22,169)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember', window );">Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,482,767<span></span>
</td>
<td class="nump">1,464,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">93,238<span></span>
</td>
<td class="nump">83,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember', window );">Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">205,776<span></span>
</td>
<td class="nump">189,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember', window );">Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">203,629<span></span>
</td>
<td class="nump">197,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember', window );">Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">889,909<span></span>
</td>
<td class="nump">887,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">19,019<span></span>
</td>
<td class="nump">15,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,590,113<span></span>
</td>
<td class="nump">2,552,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,047)<span></span>
</td>
<td class="num">(22,169)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,482,767<span></span>
</td>
<td class="nump">1,464,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">205,776<span></span>
</td>
<td class="nump">189,655<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">82,044<span></span>
</td>
<td class="nump">80,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">835,393<span></span>
</td>
<td class="nump">834,579<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,180<span></span>
</td>
<td class="nump">5,976<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">282,586<span></span>
</td>
<td class="nump">264,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(1,368)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">93,238<span></span>
</td>
<td class="nump">83,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">121,585<span></span>
</td>
<td class="nump">116,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">54,516<span></span>
</td>
<td class="nump">52,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">1,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 12,839<span></span>
</td>
<td class="nump">$ 9,836<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131384237840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 115,547<span></span>
</td>
<td class="nump">$ 162,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average basic shares outstanding during period</a></td>
<td class="nump">90,497<span></span>
</td>
<td class="nump">96,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed incremental from stock plans</a></td>
<td class="nump">1,986<span></span>
</td>
<td class="nump">4,161<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding during period</a></td>
<td class="nump">92,483<span></span>
</td>
<td class="nump">100,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc.</a></td>
<td class="nump">$ 1.28<span></span>
</td>
<td class="nump">$ 1.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc.</a></td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock-settled awards excluded from calculation</a></td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385298048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in debt and equity securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">$ 58,341<span></span>
</td>
<td class="nump">$ 82,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="nump">39,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity Securities, FV-NI</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="nump">39,143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">94,485<span></span>
</td>
<td class="nump">122,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesCurrent', window );">Debt securities, short-term investments</a></td>
<td class="nump">43,338<span></span>
</td>
<td class="nump">67,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">49,965<span></span>
</td>
<td class="nump">77,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Debt securities, long-term investments</a></td>
<td class="nump">15,003<span></span>
</td>
<td class="nump">15,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">44,520<span></span>
</td>
<td class="nump">44,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember', window );">Certificates of deposit and other time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">58,341<span></span>
</td>
<td class="nump">82,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">58,341<span></span>
</td>
<td class="nump">82,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember', window );">Investments in mutual funds and common stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="nump">39,143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="nump">39,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">6,627<span></span>
</td>
<td class="nump">9,821<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Long-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFVNINoncurrent', window );">Equity Securities, FV-NI, Noncurrent</a></td>
<td class="nump">$ 29,517<span></span>
</td>
<td class="nump">$ 29,322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFVNINoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFVNINoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131379703472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Changes in Goodwill by Reportable Segments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 7,076,610<span></span>
</td>
<td class="nump">$ 7,046,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,350)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="nump">13,701<span></span>
</td>
<td class="num">(15,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,090,311<span></span>
</td>
<td class="nump">7,076,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">7,211,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(120,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,090,311<span></span>
</td>
<td class="nump">7,076,610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="nump">6,400,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="nump">6,416,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="nump">6,416,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">659,785<span></span>
</td>
<td class="nump">646,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="nump">13,701<span></span>
</td>
<td class="num">(15,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">673,486<span></span>
</td>
<td class="nump">659,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">794,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(120,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 673,486<span></span>
</td>
<td class="nump">$ 659,785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385152432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other Health Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131382622640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">4.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt principal outstanding</a></td>
<td class="nump">$ 8,701,254<span></span>
</td>
<td class="nump">$ 8,968,519<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DiscountPremiumAndDeferredFinancingCosts', window );">Discount, premium and deferred financing costs</a></td>
<td class="num">(41,529)<span></span>
</td>
<td class="num">(44,498)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Carrying amount of long-term debt, net of unamortized discounts</a></td>
<td class="nump">8,659,725<span></span>
</td>
<td class="nump">8,924,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(242,193)<span></span>
</td>
<td class="num">(231,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">8,417,532<span></span>
</td>
<td class="nump">8,692,617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 2,344,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 1,183,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayable', window );">Acquisition obligations and other notes payable</a></td>
<td class="nump">$ 117,856<span></span>
</td>
<td class="nump">120,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">2023-2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">6.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue', window );">Acquisition obligations and other notes payable, fair value</a></td>
<td class="nump">$ 117,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 264,612<span></span>
</td>
<td class="nump">273,688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">2024-2039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="nump">4.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">165,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Revolving line of credit, fair value of amount outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of the old Variable Rate Basis</a></td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 1,444,427<span></span>
</td>
<td class="nump">1,498,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 1,433,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of the old Variable Rate Basis</a></td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 2,624,359<span></span>
</td>
<td class="nump">2,660,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 2,584,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of the old Variable Rate Basis</a></td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">$ 3,254<span></span>
</td>
<td class="nump">3,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Financing Costs</a></td>
<td class="nump">16,797<span></span>
</td>
<td class="nump">18,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Financing Costs</a></td>
<td class="nump">35,024<span></span>
</td>
<td class="nump">36,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt Instrument, Unamortized Premium</a></td>
<td class="num">$ (13,546)<span></span>
</td>
<td class="num">$ (14,018)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Obligations And Other Notes Payable, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DiscountPremiumAndDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount, premium and deferred financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DiscountPremiumAndDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reference rate used for variable rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131381409328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt Schedule of Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest and Debt Expense<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Long-term Assets | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 112,687<span></span>
</td>
<td class="nump">$ 139,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="num">(20,975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="num">(4,716)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | Maximum | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest rate margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131377316432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 21, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average effective interest rate during quarter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Percentage of debt instruments bearing fixed interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate', window );">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | Subsequent Event | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DerivativeEffectiveDate', window );">Derivative, effective date</a></td>
<td class="text">Jun. 28,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | Subsequent Event | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DerivativeEffectiveDate', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember', window );">Bilateral Secured Letter Of Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR', window );">Secured Debt Outstanding Principal Balance Subject To LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">568,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DerivativeEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Effective Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DerivativeEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt Percentage Bearing Economically Fixed Interest Rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=dva_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=dva_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=dva_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=dva_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387518112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 22, 2019</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementPeriod', window );">Corporate Integrity Agreement Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementExpirationDate', window );">Corporate Integrity Agreement Expiration Date</a></td>
<td class="text">Oct. 22,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember', window );">Commitments to provide operating capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other potential commitments to provide operating capital to several dialysis centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,099<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Period, in PnYnMnDn format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131381434416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based compensation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</a></td>
<td class="nump">$ 204,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">1,322,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted', window );">Aggregate grant-date fair value</a></td>
<td class="nump">$ 101,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (in years)</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131381390512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>May 08, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380968032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (69,186)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(54,906)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">98,685<span></span>
</td>
<td class="num">$ (1,178)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="num">(4,716)<span></span>
</td>
<td class="nump">54,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="nump">1,177<span></span>
</td>
<td class="num">(13,674)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="num">(3,539)<span></span>
</td>
<td class="nump">41,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="num">(20,975)<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">5,233<span></span>
</td>
<td class="num">(344)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="num">(15,742)<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">79,404<span></span>
</td>
<td class="nump">40,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(167,871)<span></span>
</td>
<td class="num">(138,069)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">33,561<span></span>
</td>
<td class="nump">62,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="nump">33,561<span></span>
</td>
<td class="nump">62,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(134,310)<span></span>
</td>
<td class="num">(75,857)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(69,186)<span></span>
</td>
<td class="num">(139,247)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">28,845<span></span>
</td>
<td class="nump">117,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="nump">1,177<span></span>
</td>
<td class="num">(13,674)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="nump">30,022<span></span>
</td>
<td class="nump">103,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="num">(20,975)<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">5,233<span></span>
</td>
<td class="num">(344)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="num">(15,742)<span></span>
</td>
<td class="nump">1,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (54,906)<span></span>
</td>
<td class="num">$ (34,870)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131385149632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable interest entities - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 16,727,787<span></span>
</td>
<td class="nump">$ 16,928,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities and noncontrolling interests</a></td>
<td class="nump">14,309,085<span></span>
</td>
<td class="nump">$ 14,703,452<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">308,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities and noncontrolling interests</a></td>
<td class="nump">$ 178,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131383782640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 36,144<span></span>
</td>
<td class="nump">$ 39,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">25,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,398,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">112,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">36,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">112,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">25,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,398,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380782928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple', window );">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</a></td>
<td class="nump">$ 175,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | EBITDA or Operating Income Performance Targets or Quality Margins | Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Business Combination Contingent Consideration Acquisitions</a></td>
<td class="nump">$ 59,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | EBITDA or Operating Income Performance Targets or Quality Margins | Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition contingent consideration revenue earn-out period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131379587664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 112,665<span></span>
</td>
<td class="nump">$ 101,274<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,872,699<span></span>
</td>
<td class="nump">2,817,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">311,645<span></span>
</td>
<td class="nump">338,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SegmentReportingInformationCorporateExpenses', window );">Corporate administrative support</a></td>
<td class="num">(24,588)<span></span>
</td>
<td class="num">(35,827)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(100,774)<span></span>
</td>
<td class="num">(73,791)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">3,752<span></span>
</td>
<td class="num">(1,786)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">214,623<span></span>
</td>
<td class="nump">262,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,590,113<span></span>
</td>
<td class="nump">2,552,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">282,586<span></span>
</td>
<td class="nump">264,628<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,896,114<span></span>
</td>
<td class="nump">2,839,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">336,233<span></span>
</td>
<td class="nump">374,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,605,980<span></span>
</td>
<td class="nump">2,569,120<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,612,160<span></span>
</td>
<td class="nump">2,575,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">361,098<span></span>
</td>
<td class="nump">406,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | External Sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,583,933<span></span>
</td>
<td class="nump">2,546,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,180<span></span>
</td>
<td class="nump">5,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">22,047<span></span>
</td>
<td class="nump">22,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">176,101<span></span>
</td>
<td class="nump">169,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">106,485<span></span>
</td>
<td class="nump">95,308<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">283,954<span></span>
</td>
<td class="nump">264,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(24,865)<span></span>
</td>
<td class="num">(32,305)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">1,368<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(23,415)<span></span>
</td>
<td class="num">(22,169)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,047)<span></span>
</td>
<td class="num">(22,169)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (1,368)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SegmentReportingInformationCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SegmentReportingInformationCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131380694128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 178,071<span></span>
</td>
<td class="nump">$ 172,944<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">166,961<span></span>
</td>
<td class="nump">162,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 11,110<span></span>
</td>
<td class="nump">$ 10,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131381245984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 147,705<span></span>
</td>
<td class="nump">$ 123,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">130,966<span></span>
</td>
<td class="nump">107,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 16,739<span></span>
</td>
<td class="nump">$ 15,595<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131387920992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment reporting - Summary of Assets by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 16,727,787<span></span>
</td>
<td class="nump">$ 16,928,252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,789,095<span></span>
</td>
<td class="nump">15,084,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,938,692<span></span>
</td>
<td class="nump">$ 1,843,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131388280704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>New accounting standards (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 01, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow', window );">Change in Accounting Principle impact ability to borrow</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ChangeInAccountingPrincipleImpactAbilityToBorrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Accounting Principle Impact Ability To Borrow</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ChangeInAccountingPrincipleImpactAbilityToBorrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140131379848032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 28, 2023</div></th>
<th class="th"><div>Apr. 21, 2023</div></th>
<th class="th"><div>Apr. 03, 2023</div></th>
<th class="th"><div>Apr. 01, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to Acquire Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,643<span></span>
</td>
<td class="nump">$ 2,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of the old Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt Instrument, Term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanA1Member', window );">Term Loan A-1 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, effective date</a></td>
<td class="text">Apr. 28,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Debt Instrument, Frequency of Periodic Payment</a></td>
<td class="text">quarterly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DebtInstrumentPeriodicPaymentStartDate', window );">Debt Instrument Periodic Payment Start Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne', window );">Debt Instrument, Periodic Payment Interest Rate, Year One</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour', window );">Debt Instrument, Periodic Interest Payment, Year Two, Three, Four</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive', window );">Debt Instrument, Periodic Payment Interest Rate, Year Five</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid', window );">Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid</a></td>
<td class="text">Apr. 28,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanA1Member', window );">Term Loan A-1 | Subsequent Event | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">SOFR plus interest rate margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,624,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,660,831<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of the old Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuanceDate1', window );">Debt Instrument, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  03,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1 | Subsequent Event | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">SOFR plus interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, inception date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 21,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Tranche One | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DerivativeEffectiveDate', window );">Derivative, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 28,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Tranche Two | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DerivativeEffectiveDate', window );">Derivative, effective date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Term Loan Facility | 2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember', window );">Agreement with Medtronic | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAgreementDate', window );">Business Agreement Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 25,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAgreementEffectiveClosingDate', window );">Business Agreement Effective Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Payments to Acquire Other Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AdditionalCashCommitment', window );">Additional Cash Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">Other Commitment, to be Paid, between Year One, Two, Three, and Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RegulatoryAndCommercialMilestonesBeginningDate', window );">Regulatory and Commercial Milestones Beginning Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RegulatoryAndCommercialMilestonesEndingDate', window );">Regulatory and Commercial Milestones Ending Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalCashCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Cash Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalCashCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Agreement Date, in YYYY-MM-DD formate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAgreementEffectiveClosingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Agreement Effective Closing Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAgreementEffectiveClosingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Interest Rate, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentPeriodicPaymentInterestRateYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Interest Rate, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentPeriodicPaymentInterestRateYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Interest Rate, Year Two, Three, Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentPeriodicPaymentStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Periodic Payment Start Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentPeriodicPaymentStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DerivativeEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Effective Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DerivativeEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RegulatoryAndCommercialMilestonesBeginningDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory and Commercial Milestones Beginning Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RegulatoryAndCommercialMilestonesBeginningDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RegulatoryAndCommercialMilestonesEndingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory and Commercial Milestones Ending Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RegulatoryAndCommercialMilestonesEndingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reference rate used for variable rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuanceDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the debt instrument was issued, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuanceDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanA1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanA1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=dva_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=dva_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=dva_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=dva_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>dva-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dva="http://www.davita.com/20230331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dva-20230331.xsd" xlink:type="simple"/>
    <context id="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i22bc6acfc3254044911840db1912bb40_I20230505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9371851bf60946538246702a8ff6a696_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id10db692f34a4aad9a81d68a86468a88_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id37fcf42001e43c795ed70694ccbfda3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f89c44809d7411ba9977e1269611500_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifb96decbd5ff48ecbcf4ff701f865932_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5878fb3ce344989a3a50ed0fbd3d5c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae59202d18bb409ea44ff98f022007a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i510e587c5c7d43579eff92128d1feffe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d636acdefa14579a4055e30a18c2ea1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0bbcdfa0ff4549d8b4c3b8d5daf4ccb3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3de0a77acc61440791bc64a61b53a9b8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibf4ab925c36b4946a9f265610af5c18b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i87376613e9424279b6a5359fa39d039d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3461f689329041ac8cfa8e508d1cde1a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4ca924f1ecfc49c69630f7b1f711fc6b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i31f3006d566c4ef08a32c52c2e496eec_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id541c72e0cbf46bfb9a30e55268d305f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie60f56cdc6a54c9fa3d7371a7e301cae_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic119590b905b456ea28d952ba0ebba06_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2b64c02b45c8429281f3cad0048fd5a8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i29cc4e5470a24e859cdd1e50d0578b3a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12c3e24420bd492ca1237403f848d3ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1013614d759840f6b8be015cc3fec9fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb86b3a098944b288b2c33833a89c53f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb7fdd7915974832a1894f287fbf74d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b52b3eff79543e5aac806c75366b585_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6e5eb5a52daa4593b04658664913519d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ca7b69def744ed1951191362496db5a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i93c65854bb094f5391c31be7458fbc46_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib352cd5ae86642f9b567f560e60aa612_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i987691c3f208415a9e66921b89163e85_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i736bf7e4b947486db010c69b98f797e4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id011923f6bef4bbeb4834a6883fd2f71_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i46d427c61e12494a9abcd31dabc719a5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie0056bc5a97b440586b4432e43698c40_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i607a0441599c46398e2c421e5264a57d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1091f89c58124befbd0b2e279e7bd5b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf31608c04e04edd937b2b95514487b7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i924864e1995e4749a67469d38a0bd5eb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9c073a8ecff340d59dd625febdf0c88d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib80166e629e549cf924c2644ec659ac8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i716d73cc3cb1416fa1be96a2530344da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i94201913127b40309f173dba20dd161d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i51fc1a1f1e2a4010893b526540e40610_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3ebdd5494e2e4158a83cdce6c45ab4a5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i575a2fbf0f754d31b03e7240b518b771_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id30740c932b843f3a92ff50f65a092df_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8de7abdf687142db96dbc1fc809e6fa0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iefb5c62e8a584a25b642428ebeb54320_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i81154e11a8604522914cf349e50404c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c80ef7e66ba4116b2a34b46479e1285_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib5c6adb0ddf6453aa8f739edc4c66791_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id51aad86feab47bfaa419694af81fd6f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b4872f694e94741ad47978f27eb53ff_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idb309d7ddf66423d8e01bc5bd81b6dbc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05abc10dff1c4497a2d0e5f6502b16a5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i127075439443455492ab04c3c885a932_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i819376c882e444d183ee1f39d65e27b0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7a8bf0e6f1bc434e833f7644ec2930a6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2cb19b8caaef4726a92cbe29d6bf4bbf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i83decc5ca955447b80861e67476e8c7f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i168a2cc625074281a784a717f9630a3b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i86ebec9ed12d4a7b914fb6a4d2803206_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i76335814a9534b91a6933754d6ee880a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifd540dd8932e46899710b99d728179e5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida9b8b6291464081b6d6d46abed3ff45_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8680e140680144f3b9565b2256e74132_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i56b2480a61fd485aa01e45ea32bad4a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i871145753f01486ebf685b738fce5959_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2057b25571d24d71b857b3e76d1bedf2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia4719531412846d6a89583a6b2671ae7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic9a4724707ff4691ad93ad034dc2a2ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i669e1068f034489a9989b759ab694a1b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i44d323ea48e843f2b86a68ff4beda64c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibfb12c8e4c1b49beabe60ce0a500841a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6c237a00597482b8cfeabc140184f16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5169176a56184e19a1d27cfa20139011_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icde1e71194074e608dc7cc2f2b99ec8c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ica637bc0d87441efa9e4e45677990b7b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0a7f3900fa4a40d883391d98a93f7b4b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i055d4c5e34fe4929931b589f587c0980_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7198d297bdbd4b59b53e63fef3467ee5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d592dfa62de45988c9d46b6d5b78881_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic71000b0b41248f6bcafcb915b93a223_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i35e1c944e685419abccf81e69b562a8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4b1ae9717e3b49f0a0d0440253c6b938_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5ebb307dc0b4487ba3d84d58c6c92d94_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1fd9ed34d6454f8abc969538f9cfe069_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9aef3a0c4afb46c6a2d663bf6a8df708_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iea574cb23af34671b3007a1894b492a2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id07c0f702252454e8659bb3afea6d865_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3088bbf478db44e4b5510c92e9e067e7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id20d8e4a0d5946c0bde607ba39e21075_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0cdf2cf3734745dab39d9af19b881af8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i751eb7e2aba74631a5d35b56d603cd36_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i633c8deded1e4748a5ea3a5e79109ccd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i889d0be36d854ef0ac45dccf0c11123b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iee7df1686fc84aad9568e0474639a756_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i48a9bca6cbb340b49899150f84ae8847_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7ffe4e826bca45929bab4478c1fc082b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i24848738473b434ab56999f3662f285e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2191bc56fe124cba99e0476a60dc454b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i680d044b226c493c92a0d22937dd96da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i918d80ef2d0d471b9ec39e92120325bd_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5b4fc0c1fe9e48f688e101428dafafd4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if822c0b60f1343e596dc95916fa9ff3c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4bd27b8f4d024843b9742ab7f8244ea4_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">dva:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-21</startDate>
            <endDate>2023-04-21</endDate>
        </period>
    </context>
    <context id="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">dva:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-21</startDate>
            <endDate>2023-04-21</endDate>
        </period>
    </context>
    <context id="ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2019-10-22</startDate>
            <endDate>2019-10-22</endDate>
        </period>
    </context>
    <context id="i54adb3547d1b4238b88fd5e40fb8c84c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-05-08</endDate>
        </period>
    </context>
    <context id="i02a973488e20476fb47615a3f807fa05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaee3aa16cbfd44e2990ae90b171f5177_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic2eff4db03344e16b162f4f02fc9a3ee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic7c88296b2e04e0db089b890c001d849_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibafc68641e624afe9be140dc2f3a0305_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id299644831124bbb8821f8f5c4c9630b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24b757354ef544ffb213fab994384fa4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9de0c5885b59490495ce7284b4d660cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd8a058875e44febb4f2f422c3462dea_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if7db854d9b914c0b9a64e428f1c82c9e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic8f35fdf8c6145ccbf5f634642c80724_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic2983185f3e94a5fa5decfdf5bfb04fc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i909208b4b7f844719f7ac20ac839d43b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibd476b66dd8f482d92e7bc8eea43966e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i980c082ed2474373bd9567687f6e1049_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie720dbf8a8414299bf7ee67eb13867c2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i07abf49a236e4f8194d87f88f8b4b431_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1acf2afce18e45c098496603eec3a1e2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia7bf666f9c43437ab5aa6ee983cffdd7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie3fcc5081c0343a9a1c14dd4e8eb166c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0cdccc91fa064c2b8622899fe4990f76_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i594302e643444e72a196b7a7758e44c3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1cf2d70aa9324948a2cc832ba7bd6142_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a53a270c4e04f138e74b1e7cfe51819_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d4c1594069844e69f63a91f84862402_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f6608bb6cb94997a8b0a4397ff14ad0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i49f4a76215494ab98201d3f4c7c27890_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8145bc790f464c6097f88871f5552d27_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-01</instant>
        </period>
    </context>
    <context id="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-01</endDate>
        </period>
    </context>
    <context id="i06a8ea352a2743ed93515924f01db624_I20230401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-01</instant>
        </period>
    </context>
    <context id="i0788ec757ea94bf4a9145a7a7ed57852_D20230421-20230421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-21</startDate>
            <endDate>2023-04-21</endDate>
        </period>
    </context>
    <context id="i3966a9b63d8a4d6bbeaa5dd9fd9ff21a_I20230421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-21</instant>
        </period>
    </context>
    <context id="icc23cd3becc842dfa58d5e0e248e0c6a_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="i2b3dd1537dba44f5900ed9f64c91677b_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="i16b6c4f2fa614fecaa2c78eec44d5f17_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="ibe1c2673f7634b01be99ea30dec31d8b_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="i1f284922a3174384b3458e6319e9275c_D20230428-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanA1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <context id="ibb64289566f34b759fe950fa1ae62823_D20230428-20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-28</startDate>
            <endDate>2023-04-28</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>dva:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18xLTEtMS0xLTU5ODk4NQ_30906576-8d41-43b5-86e7-99b284e5871d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18yLTEtMS0xLTU5ODk4NQ_bd96d244-78c6-4491-9304-fccf5c8db70e">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N18zLTEtMS0xLTU5ODk4NQ_d2cf1d36-35c8-4a93-851f-d12da770bfca">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N180LTEtMS0xLTU5ODk4NQ_1fb39a1b-0b06-4293-afae-735e9e9167f2">0000927066</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80L2ZyYWc6ZDU5ZmEzZTEzZTAzNDYzZTgzMzQ4ODA4ZDIwYjRmNmQvdGFibGU6NmM5Y2U4YTUyYWM0NGJiMzlkYmQzOTczNzJjN2JlOTcvdGFibGVyYW5nZTo2YzljZThhNTJhYzQ0YmIzOWRiZDM5NzM3MmM3YmU5N181LTEtMS0xLTU5ODk4NQ_889d0f0e-d4dc-4182-aaa4-67afccf612f1">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMS0yLTEtMS01OTg5ODU_a400d795-b980-474d-887d-329c38ae3d6e"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMi0yLTEtMS01OTg5ODU_7cbdf07b-9cde-4a50-b386-cfaf3a8479e0"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfMy0yLTEtMS01OTg5ODU_9a39558b-8053-44b0-9459-91084cbd25b3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNC0yLTEtMS01OTg5ODU_198878fa-42e2-41fd-8d1e-8505ff70cdb1"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNS0yLTEtMS01OTg5ODU_c442d33e-2bd4-4b8e-a216-6fe10e6a1e63"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNi0yLTEtMS03MTE5Mzc_f4c67f3d-a8e1-4ef0-b123-1a805b2a1ecf"
      unitRef="shares">90650000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yMi9mcmFnOjhlNjk1MzE2ZmM0OTRjNmFiMWQwNGY5MjdhODE5ZDkyL3RhYmxlOmY0ZDY1ZWFkNzVkNDQ2Nzk5MjMxMzFiZDRlZWVhM2RiL3RhYmxlcmFuZ2U6ZjRkNjVlYWQ3NWQ0NDY3OTkyMzEzMWJkNGVlZWEzZGJfNi0yLTEtMS01OTg5ODU_3f579fff-547f-4c17-a53a-a7b0dee253d5"
      unitRef="shares">90411000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80OS9mcmFnOmEyMjk5NjFmMDE5MzRlMzM5NWU0NGE1MmVmOTc0ZDEyL3RleHRyZWdpb246YTIyOTk2MWYwMTkzNGUzMzk1ZTQ0YTUyZWY5NzRkMTJfMzY_ef92970e-4d55-436d-9503-43f6dc78e5d2"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5">http://fasb.org/us-gaap/2022#InterestAndDebtExpense</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dva:CorporateIntegrityAgreementPeriod
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81OC9mcmFnOjExMjkyNjBkNjc5MzQ4N2JhZDJiYzI2MDU4NDllZDRjL3RleHRyZWdpb246MTEyOTI2MGQ2NzkzNDg3YmFkMmJjMjYwNTg0OWVkNGNfMjE3_eba5fcc5-20c3-4dbd-924b-b7e5a605d0f5">P5Y</dva:CorporateIntegrityAgreementPeriod>
    <dva:RegulatoryAndCommercialMilestonesBeginningDate
      contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3MzU1_707788c9-729d-4b75-995e-20490a6eca8d">2024-01-01</dva:RegulatoryAndCommercialMilestonesBeginningDate>
    <dva:RegulatoryAndCommercialMilestonesEndingDate
      contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3MzYz_1d057f54-8d4d-4ec3-b381-d959b696686f">2028-12-31</dva:RegulatoryAndCommercialMilestonesEndingDate>
    <us-gaap:DebtInstrumentTerm
      contextRef="ibb64289566f34b759fe950fa1ae62823_D20230428-20230428"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjg3L2ZyYWc6MzBmNjU0YmRjZjBiNGM2NGIxN2JlN2E3ZGFhM2UwOGQvdGV4dHJlZ2lvbjozMGY2NTRiZGNmMGI0YzY0YjE3YmU3YTdkYWEzZTA4ZF8zODQ4MjkwNjk3NzQ4_7460863d-624b-4484-98b7-910d260398d3">P5Y</us-gaap:DebtInstrumentTerm>
    <dei:DocumentType
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgx_d7758478-9bc9-44a3-9569-539560a33483">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YTk4YjUyY2E5OTBlNDI5YTkwNzg1ZjNlMTAzYTc5OGUvdGFibGVyYW5nZTphOThiNTJjYTk5MGU0MjlhOTA3ODVmM2UxMDNhNzk4ZV8wLTAtMS0xLTU5ODk4NQ_8f31ba53-bc55-455d-a22d-dcb7e7988981">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xMzA_76046771-dd2e-45e2-ac94-045cecd0f0cc">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YzExNjExYzUwODQ2NGI4OTk5NDIxYTVlNTZjYjRlYTIvdGFibGVyYW5nZTpjMTE2MTFjNTA4NDY0Yjg5OTk0MjFhNWU1NmNiNGVhMl8wLTAtMS0xLTU5ODk4NQ_6936b076-e99c-489f-b0bf-18e6b6f19f16">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgy_48f21ab9-2c97-417c-a997-14a5442d3b46">1-14106</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgz_0573966b-70a5-43d3-b02f-e46173f3b22e">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MWJlOWE4OWE0NTZmNDBlMzgwODQ1ZTQ0NGI5OTVhZmQvdGFibGVyYW5nZToxYmU5YTg5YTQ1NmY0MGUzODA4NDVlNDQ0Yjk5NWFmZF8wLTAtMS0xLTU5ODk4NQ_fb287964-d20d-49f6-8d76-58929f541a82">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MWJlOWE4OWE0NTZmNDBlMzgwODQ1ZTQ0NGI5OTVhZmQvdGFibGVyYW5nZToxYmU5YTg5YTQ1NmY0MGUzODA4NDVlNDQ0Yjk5NWFmZF8wLTItMS0xLTU5ODk4NQ_ba9dddb7-da60-463a-b65f-61f336ad9ffd">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18wLTAtMS0xLTU5ODk4NQ_6849fed7-bf6b-441a-979f-74c3d1274c4f">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTAtMS0xLTU5ODk4NQ_33984e5e-65b9-4370-92a5-b56eb753ea79">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTEtMS0xLTU5ODk4NQ_393e4b3d-9fa1-40af-9d41-7ee91060e795">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6MjAyOGJhN2I3ZWQwNDZjMmI2MzA0ZGU3NTM4YmM1OTcvdGFibGVyYW5nZToyMDI4YmE3YjdlZDA0NmMyYjYzMDRkZTc1MzhiYzU5N18xLTItMS0xLTU5ODk4NQ_ef5f4c74-d170-4627-8a58-74f78133117a">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc2_350cabd3-ca9e-491f-af71-b34e28110732">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc3_fbf80282-32c5-4491-8bfe-49c858db0612">631-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTAtMS0xLTU5ODk4NQ_f475b947-3dc9-4b6d-8bb7-6b95ed3fadd4">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTItMS0xLTU5ODk4NQ_9000ca04-f8cc-4b4f-872e-775f8f399852">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6YjM4NTFhOWI2ZjRhNDcxNmFmMGVhM2QzZTFmNzEzOTUvdGFibGVyYW5nZTpiMzg1MWE5YjZmNGE0NzE2YWYwZWEzZDNlMWY3MTM5NV8xLTQtMS0xLTU5ODk4NQ_6e574b42-0a25-461c-ac04-2c860694c22c">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc4_e535ac2f-36d9-40e2-a90c-eef467f37b1d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODc5_40766985-e0f5-4d6f-adf6-917895861f49">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml8wLTAtMS0xLTU5ODk4NQ_e1c783d6-1040-430c-9ec5-f13a0a0d5579">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml8yLTMtMS0xLTU5ODk4NQ_5c37b328-2993-49ea-94fc-5df449909349">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGFibGU6ODVkMWU2ZmNjNjFhNGFiMGE0NTA3OTBmYjQ0NWYwOTIvdGFibGVyYW5nZTo4NWQxZTZmY2M2MWE0YWIwYTQ1MDc5MGZiNDQ1ZjA5Ml80LTEtMS0xLTU5ODk4NQ_80a7240f-c270-4130-ac4f-dafa29a380f4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODgw_1992feee-613b-4542-82d1-298da9e75288">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i22bc6acfc3254044911840db1912bb40_I20230505"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xL2ZyYWc6MWJkNDA1NzFkZDRmNDU2Nzg1N2I2YmI4ZmI3ZTM2NDkvdGV4dHJlZ2lvbjoxYmQ0MDU3MWRkNGY0NTY3ODU3YjZiYjhmYjdlMzY0OV8xODY1_a5449207-3234-4da7-961b-f1117529c0c6"
      unitRef="shares">90700000</dei:EntityCommonStockSharesOutstanding>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMi0xLTEtMS01OTg5ODU_3fa03466-e9dd-4057-bfd5-deba90357879"
      unitRef="usd">2760034000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMi0zLTEtMS01OTg5ODU_384d1e22-5c3b-4813-a9e0-ca3641744dd9"
      unitRef="usd">2716281000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMy0xLTEtMS01OTg5ODU_828c136c-4ef3-4583-b2d1-187c61f03d2a"
      unitRef="usd">112665000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMy0zLTEtMS01OTg5ODU_ee496f91-73e3-4afc-94f8-8f0249792818"
      unitRef="usd">101274000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNC0xLTEtMS01OTg5ODU_6b258bcf-db23-4bd4-9d18-5ff5401973d5"
      unitRef="usd">2872699000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNC0zLTEtMS01OTg5ODU_88212bfd-d1cb-49c8-a6c6-b306d7403ae7"
      unitRef="usd">2817555000</us-gaap:Revenues>
    <dva:PatientCareCosts
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNi0xLTEtMS01OTg5ODU_b2e84c2c-deea-4d56-a931-63742d7292a7"
      unitRef="usd">2058189000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNi0zLTEtMS01OTg5ODU_ea28bff5-eede-46a7-84bc-0038d55de43e"
      unitRef="usd">2018529000</dva:PatientCareCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNy0xLTEtMS01OTg5ODU_90867fe5-9bdc-456a-854a-572a5b4b6e14"
      unitRef="usd">331614000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfNy0zLTEtMS01OTg5ODU_18d97999-5a4a-4d5d-acc3-173675c0ecb2"
      unitRef="usd">294820000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOC0xLTEtMS01OTg5ODU_08f7835c-e464-4827-8b74-d917dc866b4c"
      unitRef="usd">178071000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOC0zLTEtMS01OTg5ODU_c6569282-c942-4fd1-8ef1-811688095353"
      unitRef="usd">172944000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOS0xLTEtMS01OTg5ODU_6ad00ec1-bd93-4cd4-9852-8b360c44ea36"
      unitRef="usd">6820000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfOS0zLTEtMS01OTg5ODU_937cee91-c5d9-43f2-9cb4-eadcbe9a0cba"
      unitRef="usd">7046000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:CostsAndExpenses
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTItMS0xLTEtNTk4OTg1_80f642fc-2d78-4f35-b40a-250cdb4a3578"
      unitRef="usd">2561054000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTItMy0xLTEtNTk4OTg1_85655b03-9fb4-4fcb-8109-bc68a9c26633"
      unitRef="usd">2479247000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTMtMS0xLTEtNTk4OTg1_b0d175c0-a7f3-4e3d-9690-671c4a84d140"
      unitRef="usd">311645000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTMtMy0xLTEtNTk4OTg1_5a7ba2ca-f697-4d18-b131-3d66fba70290"
      unitRef="usd">338308000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTQtMS0xLTEtNTk4OTg1_f15620cc-0918-4077-96bb-87d4aa01bba1"
      unitRef="usd">100774000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTQtMy0xLTEtNTk4OTg1_62453d3d-5a5a-429a-8253-ee0542f04574"
      unitRef="usd">73791000</us-gaap:InterestAndDebtExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTYtMS0xLTEtNTk4OTg1_d669662b-b535-4564-a449-68f00da1d6f3"
      unitRef="usd">3752000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTYtMy0xLTEtNTk4OTg1_f17fd82a-9ecd-4a5f-a8c6-aab87d4b648e"
      unitRef="usd">-1786000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTctMS0xLTEtNTk4OTg1_0b050668-6d2e-4172-abe5-56936c267735"
      unitRef="usd">214623000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTctMy0xLTEtNTk4OTg1_9987ad9a-e995-43c7-a2ad-3c81901afec5"
      unitRef="usd">262731000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTgtMS0xLTEtNTk4OTg1_e9d2020f-160a-4203-8293-7f080ee0248d"
      unitRef="usd">43955000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMTgtMy0xLTEtNTk4OTg1_51a69c3d-7346-4807-9195-0883d908b126"
      unitRef="usd">57013000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjEtMS0xLTEtNTk4OTg1_ba730741-4faf-4712-b2c4-c3851c5cb76e"
      unitRef="usd">170668000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjEtMy0xLTEtNTk4OTg1_c818008d-c283-4239-bd62-ab39249912f7"
      unitRef="usd">205718000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjItMS0xLTEtNTk4OTg1_fc07cdc8-927c-4e24-b112-84270091e1d8"
      unitRef="usd">55121000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjItMy0xLTEtNTk4OTg1_a958a782-c3b9-45b4-be0b-85cc2068ae80"
      unitRef="usd">43596000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjMtMS0xLTEtNTk4OTg1_bbf4b0a5-0184-46e1-8e75-c4636722bb7b"
      unitRef="usd">115547000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjMtMy0xLTEtNTk4OTg1_79974fc3-2a56-4071-9928-7d1dcbaa57b7"
      unitRef="usd">162122000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjctMS0xLTEtNTk4OTg1_f6aa773e-1189-4d1b-aa38-e596d6a84675"
      unitRef="usdPerShare">1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjctMy0xLTEtNTk4OTg1_2651fa94-aafd-4f51-9796-324a431d0d55"
      unitRef="usdPerShare">1.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjktMS0xLTEtNTk4OTg1_0b8a76f3-3bd0-487e-a6f0-25cd1b4976ac"
      unitRef="usdPerShare">1.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMjktMy0xLTEtNTk4OTg1_9cf396df-8680-4ae3-a118-2bc4f9489ec1"
      unitRef="usdPerShare">1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzItMS0xLTEtNTk4OTg1_92d0d129-a6c6-413d-81b2-52ef41886e25"
      unitRef="shares">90497000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzItMy0xLTEtNTk4OTg1_16cbecc8-5494-415d-b662-8c34476dd58f"
      unitRef="shares">96342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzMtMS0xLTEtNTk4OTg1_1f8aad4c-6ff8-453e-b9ce-a77c3b8ee8ec"
      unitRef="shares">92483000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMy9mcmFnOmI5ZmY5ZTRiOTcxMzRmOGM4OWQ5YmJiMTkyOThmNmQyL3RhYmxlOjY2NTlmM2MyYmZhOTQyMmJiMzNjNmY1MTk5ZDQwZTZjL3RhYmxlcmFuZ2U6NjY1OWYzYzJiZmE5NDIyYmIzM2M2ZjUxOTlkNDBlNmNfMzMtMy0xLTEtNTk4OTg1_ddd308b6-e57e-41b0-b763-5dc719676dd7"
      unitRef="shares">100503000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMi0xLTEtMS01OTg5ODU_ba730741-4faf-4712-b2c4-c3851c5cb76e"
      unitRef="usd">170668000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMi0zLTEtMS01OTg5ODU_c818008d-c283-4239-bd62-ab39249912f7"
      unitRef="usd">205718000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNS0xLTEtMS01OTg5ODU_442d6029-9d63-4b87-a178-04fdc007eb58"
      unitRef="usd">-3539000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNS0zLTEtMS01OTg5ODU_2b1d8eb4-0a73-4288-9689-914827c8e781"
      unitRef="usd">41132000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNi0xLTEtMS01OTg5ODU_4fbfb323-1e14-49b8-aee1-94adbad47114"
      unitRef="usd">15742000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNi0zLTEtMS01OTg5ODU_a8948232-360d-4a3e-8dd4-0f7554771d23"
      unitRef="usd">-1033000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNy0xLTEtMS01OTg5ODU_369f65ed-3661-442b-af83-64273dcb6d67"
      unitRef="usd">33561000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfNy0zLTEtMS01OTg5ODU_475413f5-8abd-4a00-b995-5aa2a3acb3c1"
      unitRef="usd">62212000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOC0xLTEtMS01OTg5ODU_daf1423b-768d-43ec-b79b-f14482de0409"
      unitRef="usd">14280000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOC0zLTEtMS01OTg5ODU_b135fd13-267b-45e4-94dd-cb282a017235"
      unitRef="usd">104377000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOS0xLTEtMS01OTg5ODU_2e060014-c396-419e-a228-d4449eb91867"
      unitRef="usd">184948000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfOS0zLTEtMS01OTg5ODU_5be56f84-6f17-4061-a27b-2fd77e877b38"
      unitRef="usd">310095000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTAtMS0xLTEtNTk4OTg1_f272ac16-74f0-4bc8-8d12-d14f01584c5b"
      unitRef="usd">55121000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTAtMy0xLTEtNTk4OTg1_d1cf6c65-2acb-452f-b896-220dd0ddcda5"
      unitRef="usd">43596000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTEtMS0xLTEtNTk4OTg1_56e7728c-91f9-4fa2-802b-c1400075e00c"
      unitRef="usd">129827000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xNi9mcmFnOjgyOTQ5M2U1NTNkNTQ0Y2E4ZjFkNmZhMDcwNzYzNTljL3RhYmxlOmIzZGMyNTlmNzA3ZTRiNTY4NmU0MmM3MzZmNmEwNzlmL3RhYmxlcmFuZ2U6YjNkYzI1OWY3MDdlNGI1Njg2ZTQyYzczNmY2YTA3OWZfMTEtMy0xLTEtNTk4OTg1_e788172d-58c0-4fbf-975b-a65a3b2a59d0"
      unitRef="usd">266499000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMi0xLTEtMS01OTg5ODU_d4de1b76-c388-4298-a75a-24d6d305f58a"
      unitRef="usd">317132000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMi0zLTEtMS01OTg5ODU_2b7af28c-3f79-483d-8346-07b9bc03e422"
      unitRef="usd">244086000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMy0xLTEtMS01OTg5ODU_175d31db-ff6c-4b8f-8b7b-101b96a601af"
      unitRef="usd">94265000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMy0zLTEtMS01OTg5ODU_074f248c-7852-4abf-9e47-00727acbff09"
      unitRef="usd">94903000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNC0xLTEtMS01OTg5ODU_22b260f5-cd5a-4d40-acb2-02b2f07b4046"
      unitRef="usd">49965000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNC0zLTEtMS01OTg5ODU_4e595628-618b-43bc-8eb0-6817fc336c21"
      unitRef="usd">77693000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNS0xLTEtMS01OTg5ODU_0d8a96b7-8129-4123-8978-ef2197929e43"
      unitRef="usd">2057809000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNS0zLTEtMS01OTg5ODU_735a6516-df05-4e7d-95c6-a1b371670540"
      unitRef="usd">2132070000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNi0xLTEtMS01OTg5ODU_96f8d670-2efb-4977-a41b-1ab6a3dc4f85"
      unitRef="usd">106770000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNi0zLTEtMS01OTg5ODU_adddd102-3c48-40b0-b011-f979a1368381"
      unitRef="usd">109122000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNy0xLTEtMS01OTg5ODU_862ac6bf-8254-43b4-b0e8-cc17e179abc6"
      unitRef="usd">324405000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNy0zLTEtMS01OTg5ODU_8990edf6-172c-4ef9-b856-2c71fa2e6431"
      unitRef="usd">413976000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOC0xLTEtMS01OTg5ODU_9d51f0b9-9af2-452b-8de2-75e89aa8ed08"
      unitRef="usd">89393000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOC0zLTEtMS01OTg5ODU_82423afc-8ea1-4588-87d7-b79dc99e8645"
      unitRef="usd">78839000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOS0xLTEtMS01OTg5ODU_74799f00-2d35-492b-80bc-5b2bc266e811"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfOS0zLTEtMS01OTg5ODU_55abb1ed-a3ca-4977-8e66-26b7128ca4ef"
      unitRef="usd">4603000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTAtMS0xLTEtNTk4OTg1_0a224087-4540-447e-9b60-ab5fb5bc31c3"
      unitRef="usd">3039739000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTAtMy0xLTEtNTk4OTg1_c774e529-0e9c-4a19-9f10-2421ec1393d0"
      unitRef="usd">3155292000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTNmNGFhNTM2MjY5NGExMWI2NTg1ZjViZjcxNWMwZjBfNjM_44b067bd-98b9-488d-bcfb-f5f01d41daa6"
      unitRef="usd">5395966000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTNmNGFhNTM2MjY5NGExMWI2NTg1ZjViZjcxNWMwZjBfNzA_79e4df7a-8176-4be7-9fbc-172cf8cb6592"
      unitRef="usd">5265372000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMS0xLTEtNTk4OTg1_33c260bc-4cd5-4011-9d76-12704dfa1c1c"
      unitRef="usd">3216373000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTEtMy0xLTEtNTk4OTg1_14c7ed95-4b50-4195-8f6b-adafecb9c7b2"
      unitRef="usd">3256397000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTItMS0xLTEtNTk4OTg1_5800248a-a01e-4c79-8a96-fca9860a18f8"
      unitRef="usd">2617018000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTItMy0xLTEtNTk4OTg1_df60e49f-ba86-4b3e-95fa-6b9113871009"
      unitRef="usd">2666242000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246N2ZmYzFlNjRlMDBiNDk2YWFjZGQ3NTFlMDM0YWUwODlfNTg_0faecde1-ae9b-4042-a29c-2ca8106805ab"
      unitRef="usd">40945000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246N2ZmYzFlNjRlMDBiNDk2YWFjZGQ3NTFlMDM0YWUwODlfNjU_500ae4ae-829e-44c6-847e-deef20f0e08a"
      unitRef="usd">49772000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMS0xLTEtNTk4OTg1_5fc1d314-0b44-4c1a-8131-0c0931d3f2eb"
      unitRef="usd">186758000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTMtMy0xLTEtNTk4OTg1_382e16e6-305d-4433-8551-5f066c890ad5"
      unitRef="usd">182687000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTQtMS0xLTEtNTk4OTg1_51120588-dc88-46ba-99c0-cec3d3eac9d4"
      unitRef="usd">241747000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTQtMy0xLTEtNTk4OTg1_80adbc24-2155-4eb0-87b9-026410f9f0e8"
      unitRef="usd">231108000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTUtMS0xLTEtNTk4OTg1_1b1a0f7e-9088-47cd-af20-c4804f60aa62"
      unitRef="usd">44520000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTUtMy0xLTEtNTk4OTg1_f0619720-299e-4972-add5-4d0c9c02a1b3"
      unitRef="usd">44329000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTYtMS0xLTEtNTk4OTg1_d936296e-4afe-4169-a987-0238cf684404"
      unitRef="usd">291321000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTYtMy0xLTEtNTk4OTg1_fe1b1a89-e8a5-42a4-9b88-2a76f45770a0"
      unitRef="usd">315587000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTctMS0xLTEtNTk4OTg1_1ffdf122-6c61-43ee-9005-dcbb7a3b953e"
      unitRef="usd">7090311000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTctMy0xLTEtNTk4OTg1_a5f240dd-350a-4461-b843-826dcc5eda4e"
      unitRef="usd">7076610000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTgtMS0xLTEtNTk4OTg1_b86bcfa0-3dad-4c22-ae58-8e54c2af2851"
      unitRef="usd">16727787000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMTgtMy0xLTEtNTk4OTg1_28084c17-62c7-416a-b067-5f05589a1308"
      unitRef="usd">16928252000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjAtMS0xLTEtNTk4OTg1_598aa6c6-a605-4899-8f7c-43045b659ed6"
      unitRef="usd">447969000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjAtMy0xLTEtNTk4OTg1_26c3229b-09cd-460a-9a3c-a2d66e709be2"
      unitRef="usd">479780000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjEtMS0xLTEtNTk4OTg1_8a3f46e2-0d26-447f-a268-17918e6a7abd"
      unitRef="usd">796742000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjEtMy0xLTEtNTk4OTg1_6754fa81-2504-4a60-ab98-b1c4b5401614"
      unitRef="usd">802469000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjItMS0xLTEtNTk4OTg1_edda8b73-e382-4263-9315-ee80dad99991"
      unitRef="usd">618931000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjItMy0xLTEtNTk4OTg1_b1ded387-9023-4909-8656-8452adb0d9ec"
      unitRef="usd">692654000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjMtMS0xLTEtNTk4OTg1_6f0af2e7-c4ac-4f3c-9d77-4b1685ce8d6d"
      unitRef="usd">394607000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjMtMy0xLTEtNTk4OTg1_c5119bae-6c0e-4e33-93c9-7046075dd95d"
      unitRef="usd">395401000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjQtMS0xLTEtNTk4OTg1_84d89b85-6e74-4136-aed5-0637dd07261d"
      unitRef="usd">242193000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjQtMy0xLTEtNTk4OTg1_7314e56f-6927-430a-a61d-4989d1ea5b26"
      unitRef="usd">231404000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjUtMS0xLTEtNTk4OTg1_5a1907da-252b-4354-9d17-d10013b8f016"
      unitRef="usd">64651000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjUtMy0xLTEtNTk4OTg1_06062662-e8e8-4c9a-b0d7-8ed2204355f5"
      unitRef="usd">18039000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjYtMS0xLTEtNTk4OTg1_a1ae2ce5-30d6-45f8-afb4-f5b17bb32c8a"
      unitRef="usd">2565093000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjYtMy0xLTEtNTk4OTg1_665cc2b2-8c59-4a28-b2b7-0ef31f3dab98"
      unitRef="usd">2619747000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjctMS0xLTEtNTk4OTg1_34e526ba-61fd-456f-b79a-096b52667a4a"
      unitRef="usd">2455144000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjctMy0xLTEtNTk4OTg1_357a49a5-f1ae-4015-af4f-b8db4a5b2522"
      unitRef="usd">2503068000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjgtMS0xLTEtNTk4OTg1_fb347adf-ea3b-4259-bf1e-0cb3122e11ae"
      unitRef="usd">8417532000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjgtMy0xLTEtNTk4OTg1_d4cbec37-a98a-4f53-993e-3e8d7e8d9f30"
      unitRef="usd">8692617000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjktMS0xLTEtNTk4OTg1_d3e6fd6b-2a93-4ff6-a68c-bec68583786c"
      unitRef="usd">100229000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMjktMy0xLTEtNTk4OTg1_b8c7cae4-b9dc-436a-989d-3e857fb201be"
      unitRef="usd">105233000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzAtMS0xLTEtNTk4OTg1_46736403-9989-42e5-8a69-cfcf97d48d0b"
      unitRef="usd">771087000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzAtMy0xLTEtNTk4OTg1_e945a819-c946-4f64-9a73-626780a675cc"
      unitRef="usd">782787000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzEtMS0xLTEtNTk4OTg1_7c985872-abf3-4428-b871-63c4acd9af7e"
      unitRef="usd">14309085000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzEtMy0xLTEtNTk4OTg1_9dc7cafd-1162-49d1-aee4-137c9d5672c5"
      unitRef="usd">14703452000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzMtMS0xLTEtNTk4OTg1_538f62d9-fde6-4e7e-8eb5-78b0c5bf2846"
      unitRef="usd">1398829000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzMtMy0xLTEtNTk4OTg1_cb3ecbce-a2a6-4ebb-94df-d5d952948b64"
      unitRef="usd">1348908000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfMjE_0c6275de-778d-4486-adb5-cfda19f88866"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfMzU_55d0f0c7-afde-46ac-ade5-fde9c8eeca7d"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246YzExMDk1MTE3YjAwNDU1Njg0NGQxMTA4MGRlMDM3OWRfNTc_71faf43a-e25b-4eee-838e-e693e3ffd4d1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMS0xLTEtNTk4OTg1_0ffbac19-47d7-4317-a334-c65b61863e15"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzUtMy0xLTEtNTk4OTg1_57d24ec6-e63b-4f73-91c0-2f5e006b14e6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMTg_59352851-ed4b-4345-8fef-1e792f64992b"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMzI_ab7d5aa5-759f-4346-a116-f332d4376781"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfNTQ_5af54960-f8d1-43a6-8245-295177586b45"
      unitRef="shares">90650000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMC0xLTEtNTk4OTg1L3RleHRyZWdpb246NTk5NzViZTE0NGVlNDQyZThiNGViM2Q1MTk5MTAxNTJfMTIw_f3daae59-319a-462b-8a6f-33219228a1ef"
      unitRef="shares">90411000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMS0xLTEtNTk4OTg1_a33feaa3-591c-408c-9b1f-f1ee918b0539"
      unitRef="usd">91000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzYtMy0xLTEtNTk4OTg1_52712a09-690b-44e3-be67-d99fb0e5fc99"
      unitRef="usd">90000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzctMS0xLTEtNTk4OTg1_12e32374-a6a5-4f22-8a50-df273982e89d"
      unitRef="usd">590251000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzctMy0xLTEtNTk4OTg1_ae8dfec8-52ff-4b8d-97b7-1acb7047f46a"
      unitRef="usd">606935000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzgtMS0xLTEtNTk4OTg1_711845c9-fa66-4c2f-864c-4a161460ab58"
      unitRef="usd">290034000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfMzgtMy0xLTEtNTk4OTg1_15bbdc47-42d3-4a47-9044-a1c8ccd3f9a2"
      unitRef="usd">174487000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDAtMS0xLTEtNTk4OTg1_74ec5c12-c5ee-4397-985f-2211f0d30a1d"
      unitRef="usd">-54906000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDAtMy0xLTEtNTk4OTg1_5553485b-a3d8-45af-9a75-be9a13d19fcf"
      unitRef="usd">-69186000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDEtMS0xLTEtNTk4OTg1_c73c1e72-bba9-4c37-bf80-e083c5f4dc54"
      unitRef="usd">825470000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDEtMy0xLTEtNTk4OTg1_113eef0a-4515-4d39-a408-c7ee1573fce5"
      unitRef="usd">712326000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDItMS0xLTEtNTk4OTg1_c574c38d-3ee7-4a39-9eab-e984af25426e"
      unitRef="usd">194403000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDItMy0xLTEtNTk4OTg1_f73d716b-33ee-4cac-b87c-f1ccce679d0a"
      unitRef="usd">163566000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDMtMS0xLTEtNTk4OTg1_d4e52fe1-4a48-4be0-84a3-833b6902e537"
      unitRef="usd">1019873000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDMtMy0xLTEtNTk4OTg1_bf0a9edd-29e4-4554-b8cc-ac7c9d2711d0"
      unitRef="usd">875892000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDQtMS0xLTEtNTk4OTg1_8c85d6ca-9ffd-43e6-84af-70be62b2ab14"
      unitRef="usd">16727787000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xOS9mcmFnOjI0NDA1OTg3MDY2MTQwMzU5MDhlYjQ1MGU3NjYzNTQ0L3RhYmxlOmVkYTliNTgwMTliYTQ1Y2U4NGI4NTI3NmMzNzhjMzIzL3RhYmxlcmFuZ2U6ZWRhOWI1ODAxOWJhNDVjZTg0Yjg1Mjc2YzM3OGMzMjNfNDQtMy0xLTEtNTk4OTg1_986797a1-f4b3-41a1-826d-469794fe4cfa"
      unitRef="usd">16928252000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMy0xLTEtMS01OTg5ODU_0964aa91-5ded-490f-b4ed-a1fb022b76fb"
      unitRef="usd">170668000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMy0zLTEtMS01OTg5ODU_11765e71-7398-470d-b867-5c026bd3d140"
      unitRef="usd">205718000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNS0xLTEtMS01OTg5ODU_6e8ea53e-ef07-4141-a887-7125f22ab312"
      unitRef="usd">178071000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNS0zLTEtMS01OTg5ODU_8c490a9f-47ce-4f63-a652-3cbcf4986641"
      unitRef="usd">172944000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOC0xLTEtMS01OTg5ODU_a53719ac-173d-4fbc-9a67-074606ab9fb2"
      unitRef="usd">25373000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOC0zLTEtMS01OTg5ODU_ffed8da2-5ec8-417e-8241-7e4c4e914d21"
      unitRef="usd">24904000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOS0xLTEtMS01OTg5ODU_2f0348b4-4a38-4900-b698-de554b59bc9b"
      unitRef="usd">-3621000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfOS0zLTEtMS01OTg5ODU_d2f92785-9ea3-44fe-9e0c-67f1b1cd5de5"
      unitRef="usd">-41000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTAtMS0xLTEtNTk4OTg1_12ed301d-7b28-4fe9-a957-c42f5df54a2b"
      unitRef="usd">-3044000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTAtMy0xLTEtNTk4OTg1_a7334f7b-2479-499f-b16e-7dfad510f11b"
      unitRef="usd">-664000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTItMS0xLTEtNTk4OTg1_12fcf930-8833-4d73-8ea6-381af517abac"
      unitRef="usd">-5864000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTItMy0xLTEtNTk4OTg1_fe0c402c-1785-4c02-8514-3a877e89f98d"
      unitRef="usd">-4714000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTQtMS0xLTEtNTk4OTg1_e0416221-bbf1-4686-b5b6-cc2344201f43"
      unitRef="usd">-81850000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTQtMy0xLTEtNTk4OTg1_6f35ba91-ec17-4441-b86a-53a6bd3f6af8"
      unitRef="usd">66270000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTUtMS0xLTEtNTk4OTg1_fa46bd7f-5a1e-480b-a8c7-b1206fbc8853"
      unitRef="usd">-2758000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTUtMy0xLTEtNTk4OTg1_59958c3d-aed9-4ae1-9b83-57e9ba8a8101"
      unitRef="usd">-849000</us-gaap:IncreaseDecreaseInInventories>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTYtMS0xLTEtNTk4OTg1_35def917-ac7a-44d0-955b-46abb39d8e9d"
      unitRef="usd">-66595000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTYtMy0xLTEtNTk4OTg1_e3aa9f8a-3634-4b2b-8735-060c70afa251"
      unitRef="usd">17966000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTctMS0xLTEtNTk4OTg1_9ed78d1c-97ee-41f8-a68c-d8d63246e01f"
      unitRef="usd">615000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTctMy0xLTEtNTk4OTg1_ac45e9fb-70c1-41a5-bb10-19e1602ab926"
      unitRef="usd">-3520000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTgtMS0xLTEtNTk4OTg1_98a901ba-f3d9-4d62-bfdf-9c319e5c29ee"
      unitRef="usd">-20535000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTgtMy0xLTEtNTk4OTg1_e4f75c3f-86f6-43c9-bee0-666a292cbdca"
      unitRef="usd">21402000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTktMS0xLTEtNTk4OTg1_e1127442-a0b3-4b0b-af29-26cc37eacac9"
      unitRef="usd">-74144000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMTktMy0xLTEtNTk4OTg1_1e089303-3cbc-44a5-9f77-5524134b7b99"
      unitRef="usd">-95927000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjAtMS0xLTEtNTk4OTg1_a6bec4c5-ae56-46a3-906b-5c782a0a02ae"
      unitRef="usd">-6486000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjAtMy0xLTEtNTk4OTg1_e1cac19e-3269-4a57-ac3a-27871ae44876"
      unitRef="usd">26912000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjEtMS0xLTEtNTk4OTg1_7f7d0a0f-3c17-4a60-9486-6467f159a157"
      unitRef="usd">39251000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjEtMy0xLTEtNTk4OTg1_12424722-ec6f-4eb6-ac47-cb819b932414"
      unitRef="usd">52473000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjItMS0xLTEtNTk4OTg1_2d05c86c-74ea-4c82-b30b-dea804ae8734"
      unitRef="usd">-5516000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjItMy0xLTEtNTk4OTg1_0faed132-ebb8-4ad8-a93b-baf678fb647e"
      unitRef="usd">-11701000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjMtMS0xLTEtNTk4OTg1_9b13edf6-8745-4a98-b92e-98dfae0e2385"
      unitRef="usd">462557000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjMtMy0xLTEtNTk4OTg1_9c77b170-e2b0-4812-aeb6-fc06856e7f8d"
      unitRef="usd">322195000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjUtMS0xLTEtNTk4OTg1_93354d07-61ea-4c19-bcdd-3c52dcbecbc0"
      unitRef="usd">147705000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjUtMy0xLTEtNTk4OTg1_5229e746-5981-4aee-a590-41b217f1d5d8"
      unitRef="usd">123108000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjYtMS0xLTEtNTk4OTg1_2ad45c18-16f3-45c2-ae32-4169ed7506b1"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjYtMy0xLTEtNTk4OTg1_44b79c81-9787-45e9-8b6f-c6ccc2b37441"
      unitRef="usd">5166000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjctMS0xLTEtNTk4OTg1_45ed4aca-f94c-4e3e-89a2-0887f27c6d5e"
      unitRef="usd">13474000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjctMy0xLTEtNTk4OTg1_8c563d90-3118-4945-8cd8-8b9818fdd690"
      unitRef="usd">11353000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjgtMS0xLTEtNTk4OTg1_27becd3f-48b2-489c-9186-959b59fc174b"
      unitRef="usd">25000000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjgtMy0xLTEtNTk4OTg1_f17dc3b6-7dc9-49b7-bd90-5b488552fa0c"
      unitRef="usd">5070000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjktMS0xLTEtNTk4OTg1_8666e8fb-0e59-42d6-88bb-13f52b572214"
      unitRef="usd">4643000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMjktMy0xLTEtNTk4OTg1_3f226f85-ca64-4c3c-bc44-1ed730d8b98b"
      unitRef="usd">2726000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzAtMS0xLTEtNTk4OTg1_36c94951-496e-491c-9796-13a866de5a66"
      unitRef="usd">50258000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzAtMy0xLTEtNTk4OTg1_fab1852e-c014-4a47-b916-a76f41a60214"
      unitRef="usd">5070000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzEtMS0xLTEtNTk4OTg1_de658a53-9273-4772-878c-19e52dca99b2"
      unitRef="usd">3856000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzEtMy0xLTEtNTk4OTg1_3d62d2e4-6b76-466d-a008-7faf71883b52"
      unitRef="usd">3773000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzMtMS0xLTEtNTk4OTg1_61196ffb-cedc-4f3c-9346-1868df4649f3"
      unitRef="usd">7904000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzMtMy0xLTEtNTk4OTg1_eb8c9b80-1b00-4104-b274-ae2a1bf0bd1e"
      unitRef="usd">2962000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzQtMS0xLTEtNTk4OTg1_abd75638-bd17-459a-b29a-4d107dd51b6e"
      unitRef="usd">1120000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzQtMy0xLTEtNTk4OTg1_500cd352-4a7a-4741-8290-f12a1cfc4087"
      unitRef="usd">470000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzUtMS0xLTEtNTk4OTg1_82247d7b-df80-46ff-9b91-90a784dac760"
      unitRef="usd">-116544000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzUtMy0xLTEtNTk4OTg1_9b49f316-f53e-4a74-9b45-b40a3895a1bc"
      unitRef="usd">-118366000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzctMS0xLTEtNTk4OTg1_24bd38e7-cf54-4e4e-b25a-698a2369826f"
      unitRef="usd">611829000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzctMy0xLTEtNTk4OTg1_24545b85-6b0b-4504-95a0-e86a1c950c95"
      unitRef="usd">354285000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzgtMS0xLTEtNTk4OTg1_e43b4465-2b49-4379-bec0-d4b8e70bba72"
      unitRef="usd">880552000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzgtMy0xLTEtNTk4OTg1_2cf321c8-987a-41a1-83cf-4b5253dfc57e"
      unitRef="usd">398990000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzktMS0xLTEtNTk4OTg1_2c9c6c3a-bd0b-4c6a-8b0a-ea4caaf9bf3a"
      unitRef="usd">7000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfMzktMy0xLTEtNTk4OTg1_0811ac73-0400-44d2-8c5d-3bb9feaac308"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDAtMS0xLTEtNTk4OTg1_f168bdb2-7559-4a3e-b5e4-95212fd255cc"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDAtMy0xLTEtNTk4OTg1_ca8f0ddf-fc26-4931-94a4-d90ad4092d85"
      unitRef="usd">236232000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDEtMS0xLTEtNTk4OTg1_1e4ea9cf-eb32-4cad-8660-2143fcef9826"
      unitRef="usd">54837000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDEtMy0xLTEtNTk4OTg1_06995dd6-4a8e-4a18-8fb8-a6eb9b993416"
      unitRef="usd">65452000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDItMS0xLTEtNTk4OTg1_3580a6bb-17f9-4c35-aa15-4b4e1de9fba5"
      unitRef="usd">7902000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDItMy0xLTEtNTk4OTg1_3fb15f01-e6e7-4ad2-abe6-e77aa5a23980"
      unitRef="usd">501000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDMtMS0xLTEtNTk4OTg1_522b21e6-958e-4b0c-a88b-b267add5a081"
      unitRef="usd">4725000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDMtMy0xLTEtNTk4OTg1_b5a5b7ea-cdcb-4ebf-8802-763aefa57df1"
      unitRef="usd">4929000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDQtMS0xLTEtNTk4OTg1_0b681603-99ff-4706-b192-8b3ed72b660c"
      unitRef="usd">50832000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDQtMy0xLTEtNTk4OTg1_ed05b9fa-dc75-47de-82fb-92120266ba37"
      unitRef="usd">3673000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDUtMS0xLTEtNTk4OTg1_c6e09039-7d9c-4dda-99b0-004cd3deea46"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDUtMy0xLTEtNTk4OTg1_dc91d6e1-fa0a-4fbe-8e82-55ff44623bbc"
      unitRef="usd">3283000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDYtMS0xLTEtNTk4OTg1_7938a415-2a83-4ea2-8fee-8de1b0df58e7"
      unitRef="usd">-275912000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDYtMy0xLTEtNTk4OTg1_02f7b998-ccae-4d05-b073-815b4659ce74"
      unitRef="usd">-341571000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDctMS0xLTEtNTk4OTg1_24c45ef4-9040-497b-b191-947e64db7e09"
      unitRef="usd">2307000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDctMy0xLTEtNTk4OTg1_0cf8e489-a210-4eeb-8c83-7491d168694b"
      unitRef="usd">3363000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDgtMS0xLTEtNTk4OTg1_1346fada-eaa7-4125-ba69-bc238f7e4578"
      unitRef="usd">72408000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDgtMy0xLTEtNTk4OTg1_9a9d58ce-9040-4f51-a9f8-ada1e0873213"
      unitRef="usd">-134379000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDktMS0xLTEtNTk4OTg1_9f23df61-d3cf-44da-be72-eeec93070640"
      unitRef="usd">338989000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id37fcf42001e43c795ed70694ccbfda3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNDktMy0xLTEtNTk4OTg1_f48d00d5-7c17-4c2b-915c-0dcbc47d7eb2"
      unitRef="usd">554960000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNTAtMS0xLTEtNTk4OTg1_76565deb-a4a3-4bb0-b57c-cb21abc05729"
      unitRef="usd">411397000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6f89c44809d7411ba9977e1269611500_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yNS9mcmFnOjkyZWI5NTQ4NDVmYTQyMDE5ODVkZDNmNTI2NzcwZWQ2L3RhYmxlOmUxNmU0NTlkOWM1NzQwZjc5NmVkZTA0MDAwOTlkYjM4L3RhYmxlcmFuZ2U6ZTE2ZTQ1OWQ5YzU3NDBmNzk2ZWRlMDQwMDA5OWRiMzhfNTAtMy0xLTEtNTk4OTg1_fc9f5a55-a06c-43f1-8c0c-359155dfd676"
      unitRef="usd">420581000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ifb96decbd5ff48ecbcf4ff701f865932_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xLTEtMS01OTg5ODU_75e4f8ee-108c-46f2-bfbe-23dca92199db"
      unitRef="usd">1348908000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0zLTEtMS01OTg5ODU_973eafd5-4e89-49a0-aec9-42d8fd1a7911"
      unitRef="shares">90411000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ae77fae4a094315a39b9f136cdb4b0d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS01LTEtMS01OTg5ODU_8cdb1a7d-b4be-4fb6-8b60-8c904bb92964"
      unitRef="usd">90000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5878fb3ce344989a3a50ed0fbd3d5c1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS03LTEtMS01OTg5ODU_f861cd99-fa7f-4794-adab-447f61e7859a"
      unitRef="usd">606935000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae59202d18bb409ea44ff98f022007a5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS05LTEtMS01OTg5ODU_c614c038-3e0d-47c3-9a25-7c8f981415e9"
      unitRef="usd">174487000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i510e587c5c7d43579eff92128d1feffe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xMS0xLTEtNTk4OTg1_0af1f3bf-912d-4423-a634-441aa6d8fdd3"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i510e587c5c7d43579eff92128d1feffe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xMy0xLTEtNTk4OTg1_1f3ac51d-04d6-4376-8dbc-5a2af8d5b733"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5d636acdefa14579a4055e30a18c2ea1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xNS0xLTEtNTk4OTg1_8ebc165b-bd19-4e5b-8974-7c0ea4852d35"
      unitRef="usd">-69186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0bbcdfa0ff4549d8b4c3b8d5daf4ccb3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xNy0xLTEtNTk4OTg1_85abe8f0-1624-40aa-a683-b828ad02143b"
      unitRef="usd">712326000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3de0a77acc61440791bc64a61b53a9b8_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNS0xOS0xLTEtNTk4OTg1_1657cec8-ca7d-4158-abbe-e0e6cb2d7afc"
      unitRef="usd">163566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xLTEtMS01OTg5ODU_0eb16f97-3fe4-4e9e-8e19-e94d36cff7c7"
      unitRef="usd">36692000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ibf4ab925c36b4946a9f265610af5c18b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy05LTEtMS01OTg5ODU_8a480b61-e633-48f2-a810-212aff912b94"
      unitRef="usd">115547000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xNy0xLTEtNTk4OTg1_3a8044e1-695a-4bcd-872b-0f9e274d9aca"
      unitRef="usd">115547000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfNy0xOS0xLTEtNTk4OTg1_a29935c4-bedd-43d9-aa25-1fb069484c2e"
      unitRef="usd">18429000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3461f689329041ac8cfa8e508d1cde1a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfOS0xNS0xLTEtNTk4OTg1_96bc6df9-9be3-4ed0-b455-7ef76f2055c7"
      unitRef="usd">14280000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfOS0xNy0xLTEtNTk4OTg1_e7885851-5839-4415-aa85-701bfef7196c"
      unitRef="usd">14280000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtMy0xLTEtNTk4OTg1_5401f3dd-c8ac-4bae-9a33-e54b2154d99b"
      unitRef="shares">239000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5cf2a45662c04d9c9c4a98cb037eab7b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtNS0xLTEtNTk4OTg1_6f1970fd-c000-4f23-a8a8-bc2f37cabfe4"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtNy0xLTEtNTk4OTg1_fc871454-575d-451f-bd32-6a9031601aca"
      unitRef="usd">9523000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTEtMTctMS0xLTU5ODk4NQ_db32a0f0-66f1-4a4f-bf14-05f0085ca7ae"
      unitRef="usd">9522000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTItNy0xLTEtNTk4OTg1_3ef4e6fc-1ceb-4f52-9b70-3162f31f35ef"
      unitRef="usd">24847000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTItMTctMS0xLTU5ODk4NQ_4ed6883d-1101-4bec-a327-4b08775e12e9"
      unitRef="usd">24847000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTQtMS0xLTEtNTk4OTg1_c05c3c11-f9e8-48d6-82ea-6118363d8c7c"
      unitRef="usd">35550000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTQtMTktMS0xLTU5ODk4NQ_99e01cef-706c-4d92-bbbc-635378f1e4d3"
      unitRef="usd">19287000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTUtMS0xLTEtNTk4OTg1_93f5431d-8054-4355-9d64-df35f9ec1f43"
      unitRef="usd">3748000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTUtMTktMS0xLTU5ODk4NQ_b5308202-591d-4c42-a088-cf736a4d900d"
      unitRef="usd">977000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtNy0xLTEtNTk4OTg1_83025aad-986f-40e1-b614-ed9d5402140b"
      unitRef="usd">13023000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtMTctMS0xLTU5ODk4NQ_492a4cce-505c-481c-8176-6fccd9050332"
      unitRef="usd">13023000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i87376613e9424279b6a5359fa39d039d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTYtMTktMS0xLTU5ODk4NQ_45a53919-7286-4f31-baa6-58ba870852bd"
      unitRef="usd">30718000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i0728c04e26d14c5eab162ce79eb4189d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtMS0xLTEtNTk4OTg1_3b583f44-11c7-49b2-bc1c-e3356c47c7de"
      unitRef="usd">45031000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i9597061cae994f219c4ffd592b6248ee_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtNy0xLTEtNTk4OTg1_c31d6c6e-9252-446b-af07-3548605dfc65"
      unitRef="usd">-45031000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ifb607f360e694d06addb1bdb754bc97c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMTgtMTctMS0xLTU5ODk4NQ_e429563a-460a-4f28-83e2-b86bcaf5adea"
      unitRef="usd">-45031000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i4ca924f1ecfc49c69630f7b1f711fc6b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMS0xLTEtNTk4OTg1_9c0239cc-42a0-410e-8cce-07e116943ef8"
      unitRef="usd">1398829000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i31f3006d566c4ef08a32c52c2e496eec_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMy0xLTEtNTk4OTg1_d63756a7-1023-4029-8eb7-900d21b93f46"
      unitRef="shares">90650000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31f3006d566c4ef08a32c52c2e496eec_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtNS0xLTEtNTk4OTg1_04927413-95a0-4f30-9270-3aadd5e4d61d"
      unitRef="usd">91000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id541c72e0cbf46bfb9a30e55268d305f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtNy0xLTEtNTk4OTg1_99c50a59-f399-4080-84e5-08de172fb3ec"
      unitRef="usd">590251000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie60f56cdc6a54c9fa3d7371a7e301cae_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtOS0xLTEtNTk4OTg1_5c016cfd-c098-444d-90c2-c950f1be3246"
      unitRef="usd">290034000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTEtMS0xLTU5ODk4NQ_41e953e8-5c42-412f-964f-2a5be7777099"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia0a676e1021d4e6cab12dfabb9fd1829_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTMtMS0xLTU5ODk4NQ_bcd4352b-1ea9-4496-96f3-abe35b9f9f16"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic119590b905b456ea28d952ba0ebba06_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTUtMS0xLTU5ODk4NQ_964ae440-e0f0-4e77-84cd-35bbc2f82854"
      unitRef="usd">-54906000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b64c02b45c8429281f3cad0048fd5a8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTctMS0xLTU5ODk4NQ_979e6386-e022-43e8-afc5-0d1ddc9dbda5"
      unitRef="usd">825470000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29cc4e5470a24e859cdd1e50d0578b3a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjJlYTRlYzVjZWE0NjQxYmVhOTczOTM4ODM2MmQ2OGU5L3RhYmxlcmFuZ2U6MmVhNGVjNWNlYTQ2NDFiZWE5NzM5Mzg4MzYyZDY4ZTlfMjEtMTktMS0xLTU5ODk4NQ_495897d0-ef3e-4bbf-a5d3-ddae31b0c92b"
      unitRef="usd">194403000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xLTEtMS01OTg5ODU_5dd15ff7-453f-4a85-982f-6beae2bcb471"
      unitRef="usd">1434832000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0zLTEtMS01OTg5ODU_daf031f2-8aed-4a7c-8de4-cb0d70049fb6"
      unitRef="shares">97289000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fae5b61ab1a4a5398ea0b2ce4b95c44_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS01LTEtMS01OTg5ODU_55aebaca-8bd3-48c4-a807-ce9d0622e460"
      unitRef="usd">97000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12c3e24420bd492ca1237403f848d3ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS03LTEtMS01OTg5ODU_d0f6b214-7f59-474a-9cef-07697e30806b"
      unitRef="usd">540321000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1013614d759840f6b8be015cc3fec9fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS05LTEtMS01OTg5ODU_174cc51e-95fb-4686-a0fc-42c1740a6098"
      unitRef="usd">354337000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xMS0xLTEtNTk4OTg1_688b92b4-ff3d-4ca7-af9f-c8352c1ec81d"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53ea3ef9da8b45118b3c4b2eddc665be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xMy0xLTEtNTk4OTg1_3ec4c832-c5dd-4e5c-bfc1-0163c57c232a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb86b3a098944b288b2c33833a89c53f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xNS0xLTEtNTk4OTg1_3c12de4d-d6a4-4282-998d-914525264635"
      unitRef="usd">-139247000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idb7fdd7915974832a1894f287fbf74d5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xNy0xLTEtNTk4OTg1_04abfb62-4ec1-453b-86fb-ecc8d03d7d14"
      unitRef="usd">755508000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3b52b3eff79543e5aac806c75366b585_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNS0xOS0xLTEtNTk4OTg1_d7731232-e7bd-4aa8-a632-19822fbdead7"
      unitRef="usd">180640000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xLTEtMS01OTg5ODU_272e330e-122f-43cf-8e49-e9c2aa0b07dd"
      unitRef="usd">28381000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6e5eb5a52daa4593b04658664913519d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy05LTEtMS01OTg5ODU_529cb430-6be1-4b13-8025-19b783360399"
      unitRef="usd">162122000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xNy0xLTEtNTk4OTg1_b2d24089-ad20-4aa4-9473-e2c227cf6155"
      unitRef="usd">162122000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfNy0xOS0xLTEtNTk4OTg1_29d04e22-6849-4746-b471-91838b46d45d"
      unitRef="usd">15215000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i93c65854bb094f5391c31be7458fbc46_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfOS0xNS0xLTEtNjQ5MTY3_a2f81fe6-cc36-4139-91d5-6fee6c9cb269"
      unitRef="usd">104377000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfOS0xNy0xLTEtNTk4OTg1_9dfeca21-e89e-4e11-bfa1-13523b012cca"
      unitRef="usd">104377000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib352cd5ae86642f9b567f560e60aa612_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtMy0xLTEtNjQ5MTY3_effa9b9c-babc-4eac-bdd5-cf493827fe83"
      unitRef="shares">53000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtNy0xLTEtNTk4OTg1_6f5da130-f2c3-4068-84a3-0d5ca408ba02"
      unitRef="usd">3488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTEtMTctMS0xLTU5ODk4NQ_24965180-0837-4b85-a5a3-9942d39e6d56"
      unitRef="usd">3488000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTItNy0xLTEtNjQ5MTY3_675b1fc2-0a40-4b33-a287-08409270ccdc"
      unitRef="usd">24626000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTItMTctMS0xLTY0OTE2Nw_e24b3df9-f97e-4716-9f1f-f85cb50c38f9"
      unitRef="usd">24626000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTQtMS0xLTEtNTk4OTg1_50a99086-2cb4-4a5e-ada8-574e51bca09b"
      unitRef="usd">42881000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTQtMTktMS0xLTU5ODk4NQ_58ca138f-9a40-4248-b5bf-37143ad5baff"
      unitRef="usd">22571000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTUtMS0xLTEtNTk4OTg1_d5c4966c-db6f-4dda-983c-bcbcccb6657e"
      unitRef="usd">3197000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTUtMTktMS0xLTU5ODk4NQ_8d615ccd-8041-44ba-92b1-bdf67a815459"
      unitRef="usd">1732000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtMS0xLTEtNjQ5MTY3_68884746-f244-4a50-a902-cffe7211241a"
      unitRef="usd">2421000</dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtNy0xLTEtNTk4OTg1_dddcab34-5f89-45ea-a15c-b160b7ee0a17"
      unitRef="usd">883000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTYtMTctMS0xLTU5ODk4NQ_4ba9c3a8-6a56-4efc-877c-0318c60e0158"
      unitRef="usd">883000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctMS0xLTEtNTk4OTg1_0146bdf5-4bee-4175-b2e4-a3c01e5fd6d9"
      unitRef="usd">822000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctNy0xLTEtNTk4OTg1_7a6220bd-b075-4103-957a-c1aec203c4d3"
      unitRef="usd">1774000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTctMTctMS0xLTU5ODk4NQ_097ab30e-c9a2-495d-81d4-92cc05fc3f82"
      unitRef="usd">1774000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtMS0xLTEtNjEyMDUx_402ba0a1-3bf6-4ab4-831b-54c147396698"
      unitRef="usd">-34835000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i987691c3f208415a9e66921b89163e85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtNy0xLTEtNjQ5MTY3_aadd8894-fe6a-47e7-8c71-cab8c76e1094"
      unitRef="usd">34835000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTgtMTctMS0xLTY0OTE2Nw_36c7490c-ca02-489e-88b3-6589505c9096"
      unitRef="usd">34835000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i728f1823cafb4151bd9a6cf4d22946f9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTktMS0xLTEtNjQ5MTY3_6c510611-fced-4181-9c5a-399ece45a256"
      unitRef="usd">464000</us-gaap:TemporaryEquityOtherChanges>
    <dva:NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations
      contextRef="i1ca7b69def744ed1951191362496db5a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMTktMTktMS0xLTY0OTE2Nw_a075b3a7-c3b1-4e8c-b573-0f30e6d085cc"
      unitRef="usd">464000</dva:NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTEtMS0xLTY0OTE2Nw_403b8af9-a134-4a00-b4ae-7398634bf9ed"
      unitRef="shares">2104000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i293e656b073a45a4968c963bc1aec9cc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTMtMS0xLTY0OTE2Nw_bcfc3e7a-62bf-452a-84cb-182dfe01740a"
      unitRef="usd">233318000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic767a888cb40405e8cf480c9da1df15a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjAtMTctMS0xLTY0OTE2Nw_ec169c33-0b6d-4e0e-9b97-bef0b7d7e2d4"
      unitRef="usd">233318000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i736bf7e4b947486db010c69b98f797e4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMS0xLTEtNTk4OTg1_2beffc08-0b8a-4c5d-8b7f-468a6b5a4b93"
      unitRef="usd">1390757000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMy0xLTEtNTk4OTg1_e8cdfbca-1c91-42fe-9a02-cd5a1c714bc6"
      unitRef="shares">97342000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ed95d06a1fa42b8aa669573b1e60bb4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtNS0xLTEtNTk4OTg1_78e04cc0-a954-4c5e-a890-a18106636ac5"
      unitRef="usd">97000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id011923f6bef4bbeb4834a6883fd2f71_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtNy0xLTEtNTk4OTg1_d845f5ef-974f-4104-900c-a8382fbdf82a"
      unitRef="usd">595403000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46d427c61e12494a9abcd31dabc719a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtOS0xLTEtNTk4OTg1_65636024-648e-4783-988a-34820077a654"
      unitRef="usd">516459000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ie0056bc5a97b440586b4432e43698c40_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTEtMS0xLTU5ODk4NQ_90ed68f2-24d9-474d-9d22-00d1f917e88b"
      unitRef="shares">-2104000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0056bc5a97b440586b4432e43698c40_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTMtMS0xLTU5ODk4NQ_45cab272-82c0-4f8d-be2b-f19307581e27"
      unitRef="usd">-233318000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i607a0441599c46398e2c421e5264a57d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTUtMS0xLTU5ODk4NQ_18387e9c-a332-43c2-89de-d2a3a9586e7d"
      unitRef="usd">-34870000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1091f89c58124befbd0b2e279e7bd5b8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTctMS0xLTU5ODk4NQ_a2725dd3-e251-4698-842a-8d308c784a77"
      unitRef="usd">843771000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaf31608c04e04edd937b2b95514487b7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8yOC9mcmFnOmRjNGZmNzFiNTk0MDQxODM5OTFiNDEzNjFiOTdkMTk2L3RhYmxlOjk5Y2EwZjY2ZWQ1YTRiYzg5OThkNTY1NGIxNjhhYmIxL3RhYmxlcmFuZ2U6OTljYTBmNjZlZDVhNGJjODk5OGQ1NjU0YjE2OGFiYjFfMjEtMTktMS0xLTU5ODk4NQ_1c6e8444-52b8-4d16-af10-4eadb954a01c"
      unitRef="usd">174552000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNC9mcmFnOmFiOTJkNmQ5OTkwODQ1ZDg4ZTAyZDBjNzEwZTVhMDNlL3RleHRyZWdpb246YWI5MmQ2ZDk5OTA4NDVkODhlMDJkMGM3MTBlNWEwM2VfMTU5Mg_070d92e7-544f-4d4e-b682-30fc1566a535">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNC9mcmFnOmFiOTJkNmQ5OTkwODQ1ZDg4ZTAyZDBjNzEwZTVhMDNlL3RleHRyZWdpb246YWI5MmQ2ZDk5OTA4NDVkODhlMDJkMGM3MTBlNWEwM2VfMTU5Nw_e8300871-1046-4799-bfa8-545e4c804577">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 (2022 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjc0Mw_cd3ed0f3-b34e-4469-95b8-bf63a1d41c1b">Revenue recognition&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are significant uncertainties associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's integrated kidney care (IKC) revenues include revenues earned under risk-based arrangements, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.&lt;/span&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjczNw_6633b58c-54d9-446e-b4ef-ea850a5bf9e8">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;887,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,047)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,590,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,552,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. integrated kidney care (IKC) and other ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i924864e1995e4749a67469d38a0bd5eb_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy0xLTEtMS01OTg5ODU_fe7c825f-5ec7-4900-a1c6-f8cdac6e7f73"
      unitRef="usd">1482767000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy01LTEtMS01OTg5ODU_c4c71893-b20a-4ab6-9a7c-56255368da4b"
      unitRef="usd">1482767000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9c073a8ecff340d59dd625febdf0c88d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy03LTEtMS01OTg5ODU_7874e190-d62a-4cee-a703-82d7b2760325"
      unitRef="usd">1464086000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMy0xMS0xLTEtNTk4OTg1_4b3ab67f-c959-4e38-90ce-345da7950a0e"
      unitRef="usd">1464086000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib80166e629e549cf924c2644ec659ac8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC0xLTEtMS01OTg5ODU_230beee0-740c-4194-baad-223794893cc3"
      unitRef="usd">205776000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC01LTEtMS01OTg5ODU_9ff0a6ac-23a0-4e7a-8d5a-82e98d7c0579"
      unitRef="usd">205776000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i716d73cc3cb1416fa1be96a2530344da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC03LTEtMS01OTg5ODU_1d09f019-7b71-43f8-99a4-8de863bc43a7"
      unitRef="usd">189655000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i94201913127b40309f173dba20dd161d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNC0xMS0xLTEtNTk4OTg1_71ddbfb2-ed34-4a1b-81e3-a094ce3a2d4e"
      unitRef="usd">189655000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i51fc1a1f1e2a4010893b526540e40610_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0xLTEtMS01OTg5ODU_3703972e-107c-4b95-a5c8-71bc7d8ebb11"
      unitRef="usd">82044000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3ebdd5494e2e4158a83cdce6c45ab4a5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0zLTEtMS01OTg5ODU_1364c263-de3d-40a4-8082-b2a82c4279b8"
      unitRef="usd">121585000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i575a2fbf0f754d31b03e7240b518b771_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS01LTEtMS01OTg5ODU_eb743c44-aee6-49b9-aac2-5968827291c9"
      unitRef="usd">203629000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id30740c932b843f3a92ff50f65a092df_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS03LTEtMS01OTg5ODU_423d214f-8646-4c82-b77d-6c8d022d9001"
      unitRef="usd">80800000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8de7abdf687142db96dbc1fc809e6fa0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS05LTEtMS01OTg5ODU_1ece4130-25d1-4f8e-8de4-1d1177a4313d"
      unitRef="usd">116895000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iefb5c62e8a584a25b642428ebeb54320_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNS0xMS0xLTEtNTk4OTg1_2217308e-9825-467e-8dca-da4cc5fb6cff"
      unitRef="usd">197695000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i81154e11a8604522914cf349e50404c3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0xLTEtMS01OTg5ODU_b7acd163-3fdb-49bb-8526-602de126a5fe"
      unitRef="usd">835393000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0zLTEtMS01OTg5ODU_6a050139-4043-43a5-add2-ad8c41952368"
      unitRef="usd">54516000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi01LTEtMS01OTg5ODU_cdfb01d7-a025-4f20-abe8-2bb197d241f1"
      unitRef="usd">889909000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2c80ef7e66ba4116b2a34b46479e1285_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi03LTEtMS01OTg5ODU_4dfbc8e0-511b-436d-b3a8-6673073d4969"
      unitRef="usd">834579000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi05LTEtMS01OTg5ODU_7b15d94c-83aa-466c-893e-35ea463b0535"
      unitRef="usd">52425000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfNi0xMS0xLTEtNTk4OTg1_4c9b72f8-8cad-4f64-9d24-aa7d2a12f815"
      unitRef="usd">887004000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="ib5c6adb0ddf6453aa8f739edc4c66791_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC0zLTEtMS01OTg5ODU_ef85141f-0576-4f9c-ae32-a3f09a1b57f6"
      unitRef="usd">93238000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC01LTEtMS01OTg5ODU_66eb30d5-998c-439a-afa5-10944984e275"
      unitRef="usd">93238000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="id51aad86feab47bfaa419694af81fd6f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC05LTEtMS01OTg5ODU_dcb7aa6d-a4ee-4374-a634-2601bfca9081"
      unitRef="usd">83596000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib2e80ad41daa448a95457b6c793b27ee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOC0xMS0xLTEtNTk4OTg1_2268c2d6-4716-4743-bb8f-c9f2269a3502"
      unitRef="usd">83596000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i2b4872f694e94741ad47978f27eb53ff_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS0zLTEtMS01OTg5ODU_f3e64f8b-97a1-47cf-b740-b2372a3148a6"
      unitRef="usd">570000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i62def9b4b1d047dfa4a481a0efc18f0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS01LTEtMS01OTg5ODU_4452cbbb-2be2-4169-a632-72e43bcf9083"
      unitRef="usd">570000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idb309d7ddf66423d8e01bc5bd81b6dbc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS05LTEtMS01OTg5ODU_7fb813b0-aa29-4480-b850-7b84ca5f9a5a"
      unitRef="usd">538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i94201913127b40309f173dba20dd161d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfOS0xMS0xLTEtNTk4OTg1_93cd0bda-4ef2-423e-8806-5dbf3428f031"
      unitRef="usd">538000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i511b5081af944cf7b61af6c08e9ffbe8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtMy0xLTEtNTk4OTg1_25e702fb-50fe-4f75-8f18-f634f327a4c4"
      unitRef="usd">1206000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i8668d9bfbf2f4b5f8ef9182b6870ff50_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtNS0xLTEtNTk4OTg1_37058556-c8ef-4da7-b8e7-5aa2ec0f3982"
      unitRef="usd">1206000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idc61fdfca1a844cb8887d6fbcd3c4f8d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtOS0xLTEtNTk4OTg1_32d57803-46e9-4eef-ba74-53bd8ca9372b"
      unitRef="usd">1338000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i491376472e1b4f1a9ae47a97f77862c7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTAtMTEtMS0xLTU5ODk4NQ_4ce48973-8597-48ca-8594-9391e4c9bcad"
      unitRef="usd">1338000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i05abc10dff1c4497a2d0e5f6502b16a5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMS0xLTEtNTk4OTg1_047882b3-cb76-4fa3-b5b3-a4bde6038842"
      unitRef="usd">6180000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i127075439443455492ab04c3c885a932_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMy0xLTEtNTk4OTg1_6eb8143c-13a2-47f1-a649-c498f7eb454b"
      unitRef="usd">12839000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i819376c882e444d183ee1f39d65e27b0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtNS0xLTEtNTk4OTg1_c3ecddc2-7f59-4d0b-a068-abda917d7e3d"
      unitRef="usd">19019000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i7a8bf0e6f1bc434e833f7644ec2930a6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtNy0xLTEtNTk4OTg1_ece575d5-d402-438b-9590-34492477709d"
      unitRef="usd">5976000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i2cb19b8caaef4726a92cbe29d6bf4bbf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtOS0xLTEtNTk4OTg1_9e8fb413-f299-47a9-be35-543f7ec2c02a"
      unitRef="usd">9836000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i83decc5ca955447b80861e67476e8c7f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTEtMTEtMS0xLTU5ODk4NQ_30298290-5225-45c7-b1c4-ee0bcb4fbab8"
      unitRef="usd">15812000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i168a2cc625074281a784a717f9630a3b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMS0xLTEtNTk4OTg1_db8532b3-4e58-4621-b01e-090883ea5e30"
      unitRef="usd">-22047000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86ebec9ed12d4a7b914fb6a4d2803206_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMy0xLTEtNTk4OTg1_f1373eeb-87f5-4b79-8070-e0f0ed1f7598"
      unitRef="usd">-1368000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76335814a9534b91a6933754d6ee880a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItNS0xLTEtNTk4OTg1_1f800feb-6dfc-4e79-b681-2f44bffc290f"
      unitRef="usd">-23415000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd540dd8932e46899710b99d728179e5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItNy0xLTEtNTk4OTg1_9e10ae8c-ea82-434b-9395-2d971e1bf307"
      unitRef="usd">-22169000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida9b8b6291464081b6d6d46abed3ff45_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItOS0xLTEtNTk4OTg1_96387c46-d6cf-44a5-84fc-28ef1fdefcfb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="i8680e140680144f3b9565b2256e74132_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTItMTEtMS0xLTU5ODk4NQ_332f8955-c309-4f40-8115-f562d360afda"
      unitRef="usd">-22169000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMS0xLTEtNTk4OTg1_752a25ac-326f-4a5b-9474-d2d6ef1cb745"
      unitRef="usd">2590113000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMy0xLTEtNTk4OTg1_deabb999-4de8-4b53-90b9-95adf2996a58"
      unitRef="usd">282586000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtNS0xLTEtNTk4OTg1_cd384467-e756-4f87-b068-c89041b665f8"
      unitRef="usd">2872699000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtNy0xLTEtNTk4OTg1_de66ac3c-1867-4fbd-98f4-29b064230969"
      unitRef="usd">2552927000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtOS0xLTEtNTk4OTg1_12e0d5b6-6550-4d09-9d5c-41c79d065cc8"
      unitRef="usd">264628000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RhYmxlOmExMmY4NDViOWU0OTQ2Yjc4ZmIyNjA2ZmUxODIyNmVhL3RhYmxlcmFuZ2U6YTEyZjg0NWI5ZTQ5NDZiNzhmYjI2MDZmZTE4MjI2ZWFfMTMtMTEtMS0xLTU5ODk4NQ_b2a04dc2-d2a7-4bd3-ae06-5b22eed4c2c1"
      unitRef="usd">2817555000</us-gaap:Revenues>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8zNy9mcmFnOjEyYTk5NjAwMGU4ZTQ3NzdhYjIzY2M1NzU4N2NkYzYzL3RleHRyZWdpb246MTJhOTk2MDAwZThlNDc3N2FiMjNjYzU3NTg3Y2RjNjNfMjc0NQ_e6fc18af-103d-41fc-bdce-65caddb40cd2">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are significant uncertainties associated with estimating revenue, many of which take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's integrated kidney care (IKC) revenues include revenues earned under risk-based arrangements, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.&lt;/span&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODc4_7620559c-2fc5-405c-9ad1-5b36b162cb80">Earnings per share&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODg5_4b7b07fb-b44b-4d41-9dc6-7721101e74c1">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RleHRyZWdpb246OTQ0YjY3MGUwZTM3NDFkYjkzMzgzY2ZlNDhiNGU3YjJfODgx_6020f65e-1dd4-4432-9b12-0a8269b2789a">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.549%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNC0xLTEtMS01OTg5ODU_c12dd4b9-6b67-4f76-a7a9-8fcf59b1ef1f"
      unitRef="usd">115547000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNC0zLTEtMS01OTg5ODU_bbeafba1-4eb3-4372-b21b-b4279933d8b3"
      unitRef="usd">162122000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNy0xLTEtMS01OTg5ODU_a3eebe34-378a-45c7-9f55-035c6c59f027"
      unitRef="shares">90497000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfNy0zLTEtMS01OTg5ODU_27bd346e-9a00-40f1-92d4-043549138954"
      unitRef="shares">96342000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOC0xLTEtMS01OTg5ODU_3365ce0a-a196-449f-bbc6-d8b3aafaaeae"
      unitRef="shares">1986000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOC0zLTEtMS01OTg5ODU_ddf60d4a-b939-4389-8987-971443f0a2de"
      unitRef="shares">4161000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOS0xLTEtMS01OTg5ODU_a59efa4c-f0b3-4368-860e-c61a629eb339"
      unitRef="shares">92483000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfOS0zLTEtMS01OTg5ODU_a02c9d85-a99a-49fb-82dc-abd4ca9c2b5d"
      unitRef="shares">100503000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTMtMS0xLTEtNTk4OTg1_f6aa773e-1189-4d1b-aa38-e596d6a84675"
      unitRef="usdPerShare">1.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTMtMy0xLTEtNTk4OTg1_2651fa94-aafd-4f51-9796-324a431d0d55"
      unitRef="usdPerShare">1.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTctMS0xLTEtNTk4OTg1_0b8a76f3-3bd0-487e-a6f0-25cd1b4976ac"
      unitRef="usdPerShare">1.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTctMy0xLTEtNTk4OTg1_9cf396df-8680-4ae3-a118-2bc4f9489ec1"
      unitRef="usdPerShare">1.61</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTktMS0xLTEtNTk4OTg1_386f01a8-5909-46f1-a453-3bf15cd509ef"
      unitRef="shares">1295000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80MC9mcmFnOjk0NGI2NzBlMGUzNzQxZGI5MzM4M2NmZTQ4YjRlN2IyL3RhYmxlOmE1ODU4NGZmYjJiYzQ3ZDA4YzFiYzQ2OTVlNzA5YzhhL3RhYmxlcmFuZ2U6YTU4NTg0ZmZiMmJjNDdkMDhjMWJjNDY5NWU3MDljOGFfMTktMy0xLTEtNTk4OTg1_d6813e86-9c7d-468a-9932-c2437c017120"
      unitRef="shares">171000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI2_79c6570f-1fdb-41e9-ba90-c195af049049">Short-term and long-term investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stocks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securitie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI3_9d3b8594-1773-4e93-9b68-52df5efffc5e">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stocks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0xLTEtMS01OTg5ODU_353e1ff0-5441-4c15-84b5-9df8ae4e6c07"
      unitRef="usd">58341000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0zLTEtMS01OTg5ODU_cddaeb6b-9bc4-47ea-80cf-b4f958d0a55e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="ic0cb2d0b7ceb4b9d84ab20d7309aab1d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi01LTEtMS01OTg5ODU_e6ec9ae5-15c2-4d0f-8bfe-e728580044e0"
      unitRef="usd">58341000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi03LTEtMS01OTg5ODU_d1b23c75-bb82-4edb-a37f-1f9bb1a795a5"
      unitRef="usd">82879000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi05LTEtMS01OTg5ODU_bb8d549c-966c-4fba-af5b-cf9729cfde1c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i56b2480a61fd485aa01e45ea32bad4a5_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMi0xMS0xLTEtNTk4OTg1_94ef8e88-45ef-4e3b-a32d-098417c8ace1"
      unitRef="usd">82879000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i871145753f01486ebf685b738fce5959_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0xLTEtMS01OTg5ODU_65b43176-5c78-48bb-b205-fde54e67872d"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i871145753f01486ebf685b738fce5959_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0zLTEtMS01OTg5ODU_0f4dc040-18c5-484f-be3b-51068a2e895e"
      unitRef="usd">36144000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i871145753f01486ebf685b738fce5959_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy01LTEtMS01OTg5ODU_a50a566f-5719-49d9-b7f3-92693eb55c2e"
      unitRef="usd">36144000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy03LTEtMS01OTg5ODU_b6ad6895-a547-4ca9-b70f-619507900ec7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy05LTEtMS01OTg5ODU_082c0c5a-2e2e-440d-8572-6abed55f4d8f"
      unitRef="usd">39143000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i2057b25571d24d71b857b3e76d1bedf2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfMy0xMS0xLTEtNTk4OTg1_47f6a233-2bff-40d3-a4b6-1b49367d9347"
      unitRef="usd">39143000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0xLTEtMS01OTg5ODU_eed41a61-bafa-409a-bc97-45654af39c52"
      unitRef="usd">58341000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0zLTEtMS01OTg5ODU_abcc6453-9570-45dc-9d68-432df3d9464b"
      unitRef="usd">36144000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC01LTEtMS01OTg5ODU_92ddd3d4-6f1c-4aea-95c1-86349a02fc77"
      unitRef="usd">94485000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC03LTEtMS01OTg5ODU_2ff3a43d-24a4-43fd-827a-fcc93b3668dd"
      unitRef="usd">82879000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC05LTEtMS01OTg5ODU_09f569ee-4f5c-452d-982d-1c296cc28b28"
      unitRef="usd">39143000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNC0xMS0xLTEtNTk4OTg1_d1d7a9c8-6f93-435f-bcb7-ef2b56adbf93"
      unitRef="usd">122022000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0xLTEtMS01OTg5ODU_52259eb1-c5aa-47d1-abe1-dce46b772bc7"
      unitRef="usd">43338000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia4719531412846d6a89583a6b2671ae7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0zLTEtMS01OTg5ODU_37f62060-c56a-44dd-9090-b76b862a913f"
      unitRef="usd">6627000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS01LTEtMS01OTg5ODU_4ced5f08-db69-4e57-a3c6-cb1c9caae679"
      unitRef="usd">49965000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS03LTEtMS01OTg5ODU_b452de38-e7b6-42c5-ba84-4ba133a85618"
      unitRef="usd">67872000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic9a4724707ff4691ad93ad034dc2a2ae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS05LTEtMS01OTg5ODU_613b288d-da33-4ce9-b3eb-311fe564e3b5"
      unitRef="usd">9821000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNS0xMS0xLTEtNTk4OTg1_8dee98c2-7b3e-4a13-b279-8bd583bb61ad"
      unitRef="usd">77693000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0xLTEtMS01OTg5ODU_faf06e87-c44c-4ffa-aa68-b8fa45fdb21b"
      unitRef="usd">15003000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFVNINoncurrent
      contextRef="i669e1068f034489a9989b759ab694a1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0zLTEtMS01OTg5ODU_7365cd17-1f50-4bd4-bc8b-dbf34e553424"
      unitRef="usd">29517000</us-gaap:EquitySecuritiesFVNINoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi01LTEtMS01OTg5ODU_9bd4a6c7-2800-4051-93a3-31b57f56948a"
      unitRef="usd">44520000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi03LTEtMS01OTg5ODU_daea1bb4-63bb-4e8f-8124-5ce64b58dc8c"
      unitRef="usd">15007000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFVNINoncurrent
      contextRef="i44d323ea48e843f2b86a68ff4beda64c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi05LTEtMS01OTg5ODU_bcca010c-79c5-41d4-b47b-b6b5ae29d84f"
      unitRef="usd">29322000</us-gaap:EquitySecuritiesFVNINoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNi0xMS0xLTEtNTk4OTg1_e893fcc3-6ba8-49af-8a66-2772c6f6ea87"
      unitRef="usd">44329000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0xLTEtMS01OTg5ODU_c2bd4c81-2be6-47cd-9e96-8bc145ca66ba"
      unitRef="usd">58341000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0zLTEtMS01OTg5ODU_74847739-0b75-4f9a-897a-27226f78e771"
      unitRef="usd">36144000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:MarketableSecurities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy01LTEtMS01OTg5ODU_6f6aac06-2e22-4a2d-b112-0f446fed78a6"
      unitRef="usd">94485000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy03LTEtMS01OTg5ODU_36ec7e1b-5ae7-4063-90d5-7b3a702e70af"
      unitRef="usd">82879000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy05LTEtMS01OTg5ODU_83eaaba4-2709-440f-b311-e1db5d60f80b"
      unitRef="usd">39143000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:MarketableSecurities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RhYmxlOjVkOWM3Yjg1OTljMTQzNzZhODViOGFhNTljYzAwMjcwL3RhYmxlcmFuZ2U6NWQ5YzdiODU5OWMxNDM3NmE4NWI4YWE1OWNjMDAyNzBfNy0xMS0xLTEtNTk4OTg1_dd431a4b-42be-4697-8084-7e3cf4d2459c"
      unitRef="usd">122022000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80My9mcmFnOjAyYmM2NmM2YmQ1ZjQxYzU5NjUxOGY1YjBmYTlhZWQyL3RleHRyZWdpb246MDJiYzY2YzZiZDVmNDFjNTk2NTE4ZjViMGZhOWFlZDJfOTI4_d38e8426-17ce-4e8c-847a-7a1f15e35f3f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. The Company's long-term debt investments are bank time &lt;/span&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;deposits with contractual maturities longer than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securitie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s. The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjgxNg_6b22450d-aa68-4e6f-9a9d-c8432fd03628">Goodwill&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,076,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,211,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any goodwill impairment charges during the three months ended March 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operations continue to be impacted by the effects of the coronavirus (COVID-19) pandemic. While the Company does not currently expect a material adverse impact to its business as a result of the ongoing COVID-19 pandemic, there can be no assurance that the magnitude of the cumulative impacts of the COVID-19 pandemic, including certain conditions and developments in the U.S. and global economies, labor market conditions, inflation and monetary policies that may have been intensified by the pandemic, will not have a material adverse impact on one or more of the Company's businesses.&lt;/span&gt;&lt;/div&gt;Developments, events, changes in operating performance and other changes in key circumstances since the dates of the Company&#x2019;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of March&#160;31, 2023. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2022 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of March&#160;31, 2023.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjgxNA_d3156f2c-6c06-4434-9def-2d438427038f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying value of goodwill by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;659,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,076,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2023:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,211,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,090,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ibfb12c8e4c1b49beabe60ce0a500841a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS0xLTEtMS01OTg5ODU_5f73f810-ebb2-4a62-bf19-c38cc068b65f"
      unitRef="usd">6400162000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic6c237a00597482b8cfeabc140184f16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS0zLTEtMS01OTg5ODU_a43448c7-a867-4bfc-b464-dc8312dcf8c8"
      unitRef="usd">646079000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id37fcf42001e43c795ed70694ccbfda3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMS01LTEtMS01OTg5ODU_08cb9125-46e0-44d3-ba55-c5c800458c46"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi0xLTEtMS01OTg5ODU_a92e299c-4570-4351-b6b0-13e1fde5a6a1"
      unitRef="usd">16750000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi0zLTEtMS01OTg5ODU_b752d676-63f2-4470-8da5-384e0c520001"
      unitRef="usd">32297000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMi01LTEtMS01OTg5ODU_6aabf4c8-5c39-4ee0-a597-fba51d7f4233"
      unitRef="usd">49047000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy0xLTEtMS01OTg5ODU_c358baf6-04df-4484-b2d3-8e573ad71555"
      unitRef="usd">87000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy0zLTEtMS01OTg5ODU_3f4a180b-f31a-42fe-a36a-9275b9646ff8"
      unitRef="usd">3263000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMy01LTEtMS01OTg5ODU_3e4333fc-6c3f-407a-b2e4-432e3e36c356"
      unitRef="usd">3350000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i5169176a56184e19a1d27cfa20139011_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC0xLTEtMS01OTg5ODU_b5ec7a1c-8a2b-4ae5-915a-d5e999f9ae20"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i35e82a405673440da2fb86baef8aafc9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC0zLTEtMS01OTg5ODU_9c77dcf0-11af-4244-b2c4-e048a094478d"
      unitRef="usd">-15328000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic0d32d721195461caa0ab95a1e81283e_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNC01LTEtMS01OTg5ODU_dedd61d8-7592-4800-a9f2-1caede5c2a8f"
      unitRef="usd">-15328000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS0xLTEtMS01OTg5ODU_ee04e463-d372-4e1f-b854-3d5d402ee577"
      unitRef="usd">6416825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS0zLTEtMS01OTg5ODU_0251269f-1119-4f07-b3ae-d9f6998987b8"
      unitRef="usd">659785000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfNS01LTEtMS01OTg5ODU_46996806-38a8-483f-8ca6-b3150d53222b"
      unitRef="usd">7076610000</us-gaap:Goodwill>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC0xLTEtMS01OTg5ODU_373bfe63-4861-47f2-ae00-d3698af07598"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC0zLTEtMS01OTg5ODU_532fa89e-4485-468f-9833-1df7a3ba8478"
      unitRef="usd">13701000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOC01LTEtMS01OTg5ODU_00b7b520-0a16-49b2-b8aa-d82e7281614c"
      unitRef="usd">13701000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS0xLTEtMS01OTg5ODU_1d36fb3d-25ef-4739-9344-62e1e6cf75c4"
      unitRef="usd">6416825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS0zLTEtMS01OTg5ODU_4a0915c7-7ff4-4b10-8c27-6e2f08ba1590"
      unitRef="usd">673486000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfOS01LTEtMS01OTg5ODU_4047906a-7176-4683-93cc-92f9cd244576"
      unitRef="usd">7090311000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItMS0xLTEtNTk4OTg1_553fc4ab-8995-474c-85f9-faacd3f8ad74"
      unitRef="usd">6416825000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItMy0xLTEtNTk4OTg1_adea51c3-ea51-4bfd-8e80-3d731b219861"
      unitRef="usd">794391000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTItNS0xLTEtNTk4OTg1_f8444d82-a06e-4e8f-a413-ea341ed3ba1d"
      unitRef="usd">7211216000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtMS0xLTEtNTk4OTg1_6281b63f-2028-47b6-8d06-8b1e46926cf9"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtMy0xLTEtNTk4OTg1_b5f81d2f-ba1f-4f06-859a-dc97343475fb"
      unitRef="usd">120905000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTMtNS0xLTEtNTk4OTg1_29487cf1-1304-4ba9-8e14-bc9c23e00286"
      unitRef="usd">120905000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtMS0xLTEtNTk4OTg1_142a1039-ca53-4012-a0bb-c46a8cc9aa77"
      unitRef="usd">6416825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtMy0xLTEtNTk4OTg1_2c832dcd-2c24-48d0-8ad2-41dd1f751ab7"
      unitRef="usd">673486000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RhYmxlOjk4MWI5MTMyZTk0NzQxNTA4YzlkMjcxMDA2MjRkNGMxL3RhYmxlcmFuZ2U6OTgxYjkxMzJlOTQ3NDE1MDhjOWQyNzEwMDYyNGQ0YzFfMTQtNS0xLTEtNTk4OTg1_f44636aa-c610-4828-a59b-43eea0cf7e05"
      unitRef="usd">7090311000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfNTQ5NzU1ODE0NDM4Nw_3a93f571-e13b-4509-b779-95f93d1814cd"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i0a7f3900fa4a40d883391d98a93f7b4b_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml80Ni9mcmFnOjhhYmVkNTZiM2Y2NDQ0YTA5MWJkYzU2NTYxODI4NDk2L3RleHRyZWdpb246OGFiZWQ1NmIzZjY0NDRhMDkxYmRjNTY1NjE4Mjg0OTZfMjY4Ng_055c96b3-f823-4bf0-bbae-056b36687302"
      unitRef="segment">0</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg5Mg_7300c43a-5b7a-493b-a916-cce008eb1773">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024-2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,701,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,968,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,659,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,924,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,417,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,692,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Term Loan A, Term Loan B-1 and the revolving line of credit have each been amended subsequent to March 31, 2023. See Note 14 for more information on these amendments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March&#160;31, 2023, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,254 and deferred financing costs of $16,797, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $35,024 and increased by a debt premium of $13,546. As of December&#160;31, 2022, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $3,497 and deferred financing costs of $18,816, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,203 and increased by a debt premium of $14,018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first three months of 2023, the Company made regularly scheduled and other principal payments under its senior secured credit facilities totaling &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$54,011&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on Term Loan A and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$36,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company's 2019 interest rate cap agreements described below had the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $568,786 outstanding principal balance of Term Loan A is subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of March&#160;31, 2023 and December&#160;31, 2022, which are classified in other long-term assets on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5"&gt;Debt expense (offset)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#x2019;s interest rate cap agreements for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the LIBOR cap from the Company's 2019 interest rate cap agreements, the Company&#x2019;s weighted average effective interest rate on its senior secured credit facilities at the end of the first quarter of 2023 was 4.60%, based on the current margins in effect for its senior secured credit facilities as of March&#160;31, 2023, as detailed in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s weighted average effective interest rate on all debt, including the effect of interest rate caps and amortization of debt discount, was 4.55% for the three months ended March&#160;31, 2023 and 4.53% as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company&#x2019;s interest rates were fixed and economically fixed on approximately 53% and 93% of its total debt, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had an undrawn $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding under the facility, of which there were none as of March&#160;31, 2023. The Company also had letters of credit of approximately $151,358 outstanding under a separate bilateral secured letter of credit facility as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to March&#160;31, 2023, the Company amended its senior secured credit facilities and entered into several forward interest rate cap agreements that become effective June&#160;28, 2024 and June&#160;30, 2024. For additional information see Note 14.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg5Mw_5a1ab909-7eef-4098-93ed-7491a7f4c52f">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,498,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,344,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024-2039&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,701,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,968,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,529)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,659,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,924,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242,193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,417,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,692,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Term Loan A, Term Loan B-1 and the revolving line of credit have each been amended subsequent to March 31, 2023. See Note 14 for more information on these amendments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March&#160;31, 2023, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,254 and deferred financing costs of $16,797, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $35,024 and increased by a debt premium of $13,546. As of December&#160;31, 2022, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $3,497 and deferred financing costs of $18,816, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $36,203 and increased by a debt premium of $14,018.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:SecuredDebt
      contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy0xLTEtMS01OTg5ODU_2c263feb-16e4-41ed-a66b-55c8144996e8"
      unitRef="usd">1444427000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i055d4c5e34fe4929931b589f587c0980_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy0zLTEtMS01OTg5ODU_a9d8727d-b63d-486b-97a2-383242570651"
      unitRef="usd">1498438000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy01LTEtMS01OTg5ODU_c3331276-b6a8-4185-8633-747b18bae023">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i7198d297bdbd4b59b53e63fef3467ee5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy03LTEtMS01OTg5ODU_861a3e40-cbba-4b7d-b9ec-96e4bdd3dba3">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMy05LTEtMS01OTg5ODU_fdc49f55-7d84-4cb8-b086-9be2dcf19b8f"
      unitRef="usd">1433594000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC0xLTEtMS01OTg5ODU_e59a676e-85fb-4240-8c9a-7bcecbe06e0c"
      unitRef="usd">2624359000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i9d592dfa62de45988c9d46b6d5b78881_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC0zLTEtMS01OTg5ODU_1b1d5385-889e-4dd2-a672-f68d44cce26f"
      unitRef="usd">2660831000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC01LTEtMS01OTg5ODU_41a19ef5-7143-40dd-9ee0-eb89d35e48e8">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC03LTEtMS01OTg5ODU_1895e14c-20e6-4c94-8929-9931e1e7c623">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7d0832a485024d1e8ed3e1e23fcec5e2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNC05LTEtMS01OTg5ODU_a03dd028-57de-4ab7-8e65-50d2496cc7b7"
      unitRef="usd">2584994000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS0xLTEtMS01OTg5ODU_9ffb17c2-a379-4afa-8032-1ea816ae1954"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i35e1c944e685419abccf81e69b562a8d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS0zLTEtMS01OTg5ODU_a9b515a2-4e22-4898-b254-3299017aac5f"
      unitRef="usd">165000000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i4b1ae9717e3b49f0a0d0440253c6b938_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS01LTEtMS01OTg5ODU_4351c971-935c-4e5e-9783-fc9fff8d9b5c">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i5ebb307dc0b4487ba3d84d58c6c92d94_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS03LTEtMS01OTg5ODU_b707292b-7d39-4899-ac4f-5ba54c8e48f4">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNS05LTEtMS01OTg5ODU_574b8072-6c8a-4885-8b5b-9c98fe80d7a7"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:SeniorNotes
      contextRef="i1fd9ed34d6454f8abc969538f9cfe069_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy0xLTEtMS01OTg5ODU_fe68ed96-add5-49f0-ac1e-747680f43def"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i9aef3a0c4afb46c6a2d663bf6a8df708_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy0zLTEtMS01OTg5ODU_9d0acf48-c329-4df9-867b-d5172ccf7285"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy01LTEtMS01OTg5ODU_523b4df0-f5a9-4ddf-9269-e934adea1802">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ida896f89fe5a4cfe8a72ed35bcb79530_D20230101-20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy03LTEtMS01OTg5ODU_d0749068-61a4-49ac-91cb-7bb0a5a7367b"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1fd9ed34d6454f8abc969538f9cfe069_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfNy05LTEtMS01OTg5ODU_ff96dd02-c958-4239-a0b3-22926b9d4fab"
      unitRef="usd">2344375000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="iea574cb23af34671b3007a1894b492a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC0xLTEtMS01OTg5ODU_9f763c79-1fc0-4d04-b72f-dfab18b54403"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="id07c0f702252454e8659bb3afea6d865_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC0zLTEtMS01OTg5ODU_51c7b6f5-784d-487a-9a0b-d232ee747dd5"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC01LTEtMS01OTg5ODU_01404d5f-75cc-4f31-907f-3839a1ec427e">2031-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i49d0a2912f9140a98bd93a1bbcf505c6_D20230101-20230331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC03LTEtMS01OTg5ODU_4b09b6f6-96f9-4702-987d-649f68752444"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iea574cb23af34671b3007a1894b492a2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOC05LTEtMS01OTg5ODU_506b0a6b-8cf4-45e0-bdf2-2f81f1098c39"
      unitRef="usd">1183125000</us-gaap:DebtInstrumentFairValue>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS0xLTEtMS01OTg5ODU_f03beb7f-c8c0-471c-ac02-433c021300cd"
      unitRef="usd">117856000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="id20d8e4a0d5946c0bde607ba39e21075_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS0zLTEtMS01OTg5ODU_96a2008e-6337-4725-96ee-f081b7c891e8"
      unitRef="usd">120562000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i0cdf2cf3734745dab39d9af19b881af8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS01LTEtMS01OTg5ODU_e8a0b587-9cd3-4fea-86c6-0eb5132a7925">2023-2036</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS03LTEtMS01OTg5ODU_98a03291-1e50-4321-bc52-e758810e9e5d"
      unitRef="number">0.0682</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dva:AcquisitionObligationsAndOtherNotesPayableFairValue
      contextRef="i3088bbf478db44e4b5510c92e9e067e7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfOS05LTEtMS01OTg5ODU_d44717fd-7731-49e8-a5a6-fcb4b84fbf8f"
      unitRef="usd">117856000</dva:AcquisitionObligationsAndOtherNotesPayableFairValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="i751eb7e2aba74631a5d35b56d603cd36_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtMS0xLTEtNTk4OTg1_610c4c74-7b65-4718-b802-0f4c3701b690"
      unitRef="usd">264612000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i633c8deded1e4748a5ea3a5e79109ccd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtMy0xLTEtNTk4OTg1_d3179cd5-dbf8-47ba-9814-61bd336ba85d"
      unitRef="usd">273688000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i889d0be36d854ef0ac45dccf0c11123b_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtNS0xLTEtNTk4OTg1_9083e5d4-81e2-467b-8ce0-f80545930c04">2024-2039</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i751eb7e2aba74631a5d35b56d603cd36_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTAtNy0xLTEtNTk4OTg1_a0772a8b-e722-43a3-92db-d27d68b7dc57"
      unitRef="number">0.0453</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTEtMS0xLTEtNTk4OTg1_49edcade-36f7-4422-b39f-814e2a95ce71"
      unitRef="usd">8701254000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTEtMy0xLTEtNTk4OTg1_dc7a7c4c-b85b-402b-b9b5-97a78a81a474"
      unitRef="usd">8968519000</us-gaap:DebtInstrumentCarryingAmount>
    <dva:DiscountPremiumAndDeferredFinancingCosts
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTItMS0xLTEtNTk4OTg1_71098fa0-db83-420d-87af-e3fb38a7175d"
      unitRef="usd">41529000</dva:DiscountPremiumAndDeferredFinancingCosts>
    <dva:DiscountPremiumAndDeferredFinancingCosts
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTItMy0xLTEtNTk4OTg1_339cd4b7-24ef-44af-8f8d-782a6cd24fc2"
      unitRef="usd">44498000</dva:DiscountPremiumAndDeferredFinancingCosts>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTMtMS0xLTEtNTk4OTg1_dfa5e0a3-f1e9-4072-a3aa-4b08bda6a74a"
      unitRef="usd">8659725000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTMtMy0xLTEtNTk4OTg1_91e56c1b-2ab1-4ef7-a335-93282d3c4266"
      unitRef="usd">8924021000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTQtMS0xLTEtNTk4OTg1_5c1f984b-8a43-4b0e-9c14-68aadd748251"
      unitRef="usd">242193000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTQtMy0xLTEtNTk4OTg1_53c52afe-3b82-4448-b67e-cf00b3d9d707"
      unitRef="usd">231404000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTUtMS0xLTEtNTk4OTg1_a81c6e5a-e417-4d36-a3dd-108f7837dc0b"
      unitRef="usd">8417532000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjcyZDU1ZmZkNTgyYzQ2ZDlhY2FlMzNlNGU0NWY4MjE5L3RhYmxlcmFuZ2U6NzJkNTVmZmQ1ODJjNDZkOWFjYWUzM2U0ZTQ1ZjgyMTlfMTUtMy0xLTEtNTk4OTg1_f7c6727c-2f0b-4b27-93e6-d36e75574dcc"
      unitRef="usd">8692617000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="iee7df1686fc84aad9568e0474639a756_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfOTUy_98393f7f-1cd0-4d45-ad67-cd65c8c6eac0"
      unitRef="usd">3254000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="iee7df1686fc84aad9568e0474639a756_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfOTg3_23b543fc-847a-4a41-8788-be440cfafb34"
      unitRef="usd">16797000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i48a9bca6cbb340b49899150f84ae8847_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTA5NA_d56fd142-03b1-499c-a8d8-6c7d3fd487fa"
      unitRef="usd">35024000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i48a9bca6cbb340b49899150f84ae8847_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTEzMg_2101c2e9-6208-4dd1-89a1-66d81e541205"
      unitRef="usd">13546000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i7ffe4e826bca45929bab4478c1fc082b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTI0Ng_06d1c5c3-a36f-4db5-afd6-05cb650dbc16"
      unitRef="usd">3497000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="i7ffe4e826bca45929bab4478c1fc082b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTI4MQ_0d2adb4e-c817-4cd6-935a-5f30a95ed253"
      unitRef="usd">18816000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i24848738473b434ab56999f3662f285e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTM4Mw_08956d04-3813-4265-9d8e-daf24c415d25"
      unitRef="usd">36203000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i24848738473b434ab56999f3662f285e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTQyMQ_0008c3af-11a0-433f-a9a9-76c143ff05ad"
      unitRef="usd">14018000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i3664f777d8a54600996903ffeb7727e8_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTU3Nw_ee82cd5d-ebaf-4219-84cd-07d6d1b6538b"
      unitRef="usd">54011000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i5b58aab48a784712b4a56ee57a00cc63_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMTU5OQ_df7ff595-5b63-4fba-a4ea-fe66a2c68e49"
      unitRef="usd">36472000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR
      contextRef="ia0610b6ebebc4c8ca4ca91bf6ba8aac7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwMjYyNQ_84e1c861-b5c9-4a5b-bd7d-4d55207f977f"
      unitRef="usd">568786000</dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg0ODI5MDcxOTA0NA_83117bb9-2b69-4d58-b320-bec2c63dc4ec">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzkxNg_ce7043dd-f9f3-40e0-99aa-789d292cb201">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of March&#160;31, 2023 and December&#160;31, 2022, which are classified in other long-term assets on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended &lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMS05LTEtMS01OTg5ODU_8db90c83-ebac-494e-8ba2-e7f424793fe5"&gt;Debt expense (offset)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2191bc56fe124cba99e0476a60dc454b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xLTEtMS01OTg5ODU_ebc2bef9-f251-479f-9ae1-75247cd2182c"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i680d044b226c493c92a0d22937dd96da_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0zLTEtMS01OTg5ODU_5d747c93-9e3f-407d-83ff-9e87450cd0e7"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi01LTEtMS01OTg5ODU_c21bc8f6-98bd-4391-a45c-8113cb32ac8b">2020-06-30</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi03LTEtMS01OTg5ODU_01571da2-755c-4a82-adc4-a86a665967a1">2024-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi05LTEtMS01OTg5ODU_400d317c-7cee-47cd-bfe8-0bf3cc3a94d0"
      unitRef="usd">-20975000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i455307d75fd14899b6807d61c8e4a8f3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xMS0xLTEtNTk4OTg1_f47e8ea8-5b0d-4e16-8b07-0910c50eaeb0"
      unitRef="usd">-4716000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i918d80ef2d0d471b9ec39e92120325bd_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xMy0xLTEtNTk4OTg1_2fc8be62-9058-4f5f-89c0-724b7cf3d315"
      unitRef="usd">112687000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5b4fc0c1fe9e48f688e101428dafafd4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RhYmxlOjI3NDc0ZDU0NjE2ZTQ0NzE4ZjgxYTFmY2JkNDhkMGE3L3RhYmxlcmFuZ2U6Mjc0NzRkNTQ2MTZlNDQ3MThmODFhMWZjYmQ0OGQwYTdfMi0xNS0xLTEtNTk4OTg1_914e921c-aa3c-4c63-b5ca-168c99bfe628"
      unitRef="usd">139755000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="iee7df1686fc84aad9568e0474639a756_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzA3Nw_39ae6e1e-243d-4d96-911b-ad1fcb910f3e"
      unitRef="number">0.0460</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5Nw_d4e7d99a-522d-4653-9d1d-b56237319c65"
      unitRef="number">0.0455</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzMyNQ_57d14ac7-07cc-4c3a-b13a-1b90129de0d5"
      unitRef="number">0.0453</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzQxOQ_bbfb1a73-12b3-44f4-bdd5-3fb0c748c2e4"
      unitRef="number">0.53</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzQyNg_40de8865-e7cc-44c7-a670-5cdec094a7d5"
      unitRef="number">0.93</dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic71000b0b41248f6bcafcb915b93a223_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNDc3OA_1bc58756-3382-44fc-ab3b-c0581d7b9f54"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="if822c0b60f1343e596dc95916fa9ff3c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNDk5OA_0d5da24f-b3b1-4fbe-9435-c7419074788b"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i4bd27b8f4d024843b9742ab7f8244ea4_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzI5ODUzNDkwNTA2OQ_55aecf66-c5cd-4cf6-b557-f0700d8df5a5"
      unitRef="usd">151358000</us-gaap:LettersOfCreditOutstandingAmount>
    <dva:DerivativeEffectiveDate
      contextRef="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfMzg0ODI5MDcxOTEwOQ_419b03d8-f996-4d44-842e-9a9b332f3b2e">2024-06-28</dva:DerivativeEffectiveDate>
    <dva:DerivativeEffectiveDate
      contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81Mi9mcmFnOjhiMDk5NzhlYzg0YjRmMWViMTA1ZmU1ZDBiMjkyOGYzL3RleHRyZWdpb246OGIwOTk3OGVjODRiNGYxZWIxMDVmZTVkMGIyOTI4ZjNfNjA0NzMxMzk3NDY4Nw_f6720574-3cc1-4a90-9dd4-b19b112f89d5">2024-06-30</dva:DerivativeEffectiveDate>
    <us-gaap:LossContingencyDisclosures
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQ4NTg_3996f2e1-493c-4b32-9b44-e8b0ae596ac6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;contingencies&lt;/span&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#x2019;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#x2019;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits, governmental investigations (which frequently arise from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of March&#160;31, 2023 and December&#160;31, 2022, the Company&#x2019;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#x2019;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Governmental Inquiries and Related Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 U.S. Attorney Texas Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#x2019;s Office, Northern District of Texas. The government conducted a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#x2019;s relationships with pharmaceutical manufacturers. After its investigation, the government and the named states declined to intervene in the matter, and on April 5, 2023, the U.S. District Court, Northern District of Texas, entered an order unsealing the complaint in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Grenon v. DaVita Rx, LLC et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The complaint has not been served on the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2017 U.S. Attorney Colorado Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In November 2017, the U.S. Attorney&#x2019;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#x2019;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 U.S. Attorney New Jersey Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2020, the U.S. Attorney&#x2019;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#x2019;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#x2019;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. In November 2022, the Company learned that, on April 1, 2022, the U.S. Attorney&#x2019;s Office for the District of New Jersey notified the U.S. District Court for the District of New Jersey of its decision not to elect to intervene in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Doe v. DaVita Inc. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and filed a Stipulation of Dismissal. On April 13, 2022, the U.S. District Court for the District of New Jersey dismissed the case without prejudice. On October 12, 2022, the U.S. Attorney&#x2019;s Office for the Eastern District of Pennsylvania notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Bayne v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The court then unsealed an amended complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. In January 2023, the private party relator served the Company with the amended complaint. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 California Department of Insurance Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#x2019;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#x2019; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2023 District of Columbia Office of Attorney General Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In January 2023, the Office of the Attorney General for the District of Columbia issued a CID to the Company in connection with an antitrust investigation into the American Kidney Fund (AKF). The CID covers the period from January 1, 2016 to the present. The CID requests information on a number of topics, including but not limited to the Company&#x2019;s communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF. The Company is cooperating with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#x2019;s reputation, required changes to the Company&#x2019;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Antitrust Indictment and Putative Class Action Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#x2019;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Outpatient Medical Center Employee Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#x2019;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#x2019;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#x2019;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#x2019;s business, results of operations, financial condition, cash flows or reputation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Resolved Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Department of Justice Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covered the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. In February 2023, the Department of Justice notified the Company that it had closed its investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <dva:CorporateIntegrityAgreementExpirationDate
      contextRef="ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfNjM5Mw_c48e5207-2974-44f8-8dab-773a413fd336">2019-10-22</dva:CorporateIntegrityAgreementExpirationDate>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQ4NTc_8e9e4d7c-803d-4549-82cb-b9830a0bc8ac">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $10,099.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:OtherCommitment
      contextRef="i54adb3547d1b4238b88fd5e40fb8c84c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml81NS9mcmFnOjYxYjhlMzk4ODE1OTQzNzBhNTVjMGE4MzYxYWUzMzg1L3RleHRyZWdpb246NjFiOGUzOTg4MTU5NDM3MGE1NWMwYTgzNjFhZTMzODVfMTQwMjg_cd83d5f4-d311-4370-a40b-014f10b2a041"
      unitRef="usd">10099000</us-gaap:OtherCommitment>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTU1OQ_6328f5e5-3ba3-464f-805b-532ad670cd75">Shareholders' equity&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the Company granted 1,322 stock-settled restricted and performance stock units with an aggregate grant-date fair value of $101,467 and a weighted-average expected life of approximately 3.4 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had $204,451 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.4 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTA2_6632973d-7f0a-4ee1-9331-592404071715"
      unitRef="shares">1322000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted
      contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTkx_0b6fbcdd-86ea-47a0-aabb-171d729d6d64"
      unitRef="usd">101467000</dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id4e9d0462bb8482083e4124513a1841c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMjQ4_ccb1754f-03e9-41cc-8fff-3d1a801e8d1d">P3Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfNDI4_13c1e2d3-9aa0-4a85-9161-d55e6e4dd429"
      unitRef="usd">204451000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfNjY1_6fd1770d-2c6e-4b43-b68f-4db62d3e880e">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfMTU2MQ_58c32727-2201-42c7-905a-547428cd61ea">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not repurchased any shares subsequent to December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82MS9mcmFnOjZkMDc0Y2FkYzU4OTRmNzM5MmMyZWU2OTgyMWEyNmY0L3RleHRyZWdpb246NmQwNzRjYWRjNTg5NGY3MzkyYzJlZTY5ODIxYTI2ZjRfODE0_3f3ebbba-055c-46c4-90bb-0c8c89ac9011"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RleHRyZWdpb246ZjNkMWY2NDE2NWYwNGNjM2E3MjdjMWVhYWM1YTM5YjlfMjUw_a3a94e14-ffb2-4117-9310-ba366407e449">Accumulated other comprehensive loss&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RleHRyZWdpb246ZjNkMWY2NDE2NWYwNGNjM2E3MjdjMWVhYWM1YTM5YjlfMjUy_9206a879-74b7-4796-8b84-dbe683b66c2a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.606%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,674)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i02a973488e20476fb47615a3f807fa05_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0xLTEtMS01OTg5ODU_063b88ce-6d28-48ff-bf0a-787577356967"
      unitRef="usd">98685000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaee3aa16cbfd44e2990ae90b171f5177_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0zLTEtMS01OTg5ODU_2e86d510-83a2-4565-b30f-c602f7945f34"
      unitRef="usd">-167871000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic2eff4db03344e16b162f4f02fc9a3ee_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi01LTEtMS01OTg5ODU_c9e25ac4-d793-4985-8bf1-b4421739d94a"
      unitRef="usd">-69186000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic7c88296b2e04e0db089b890c001d849_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi03LTEtMS01OTg5ODU_dccb865d-f455-4473-8153-29a37430869f"
      unitRef="usd">-1178000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibafc68641e624afe9be140dc2f3a0305_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi05LTEtMS01OTg5ODU_2cc58e95-dcce-4964-8331-1d628801381a"
      unitRef="usd">-138069000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id299644831124bbb8821f8f5c4c9630b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMi0xMS0xLTEtNTk4OTg1_48990589-289a-4701-93ae-c9fab67a07be"
      unitRef="usd">-139247000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0xLTEtMS01OTg5ODU_cd441300-9600-4269-a50c-13e506f0486b"
      unitRef="usd">-4716000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0zLTEtMS01OTg5ODU_415f2125-dd00-4f26-bd1b-0b105ab87592"
      unitRef="usd">33561000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy01LTEtMS01OTg5ODU_8ef2fedb-71fd-4349-bca0-e9270e6c7928"
      unitRef="usd">28845000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy03LTEtMS01OTg5ODU_d86930e2-4aab-48e7-a7b2-5e2e8f73fd7a"
      unitRef="usd">54806000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy05LTEtMS01OTg5ODU_d9e058f0-4e28-4c5d-83ad-1b71ae6a5838"
      unitRef="usd">62212000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfMy0xMS0xLTEtNTk4OTg1_d63af9f3-8234-4ee8-9e80-4516d4f20e11"
      unitRef="usd">117018000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0xLTEtMS01OTg5ODU_6544763a-6d02-4967-8f00-5b1cf65656f6"
      unitRef="usd">-1177000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0zLTEtMS01OTg5ODU_5e659736-5e1e-431d-b59b-2d37b19cff19"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC01LTEtMS01OTg5ODU_5a9ec472-30ed-4ba0-bb6c-a59c6199452e"
      unitRef="usd">-1177000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC03LTEtMS01OTg5ODU_6d120bd8-7384-409d-9bf5-562db29c7998"
      unitRef="usd">13674000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC05LTEtMS01OTg5ODU_726da2ac-c365-4307-9b13-38f8e64ddf61"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNC0xMS0xLTEtNTk4OTg1_80d7ae1c-889e-47f9-9324-1b196a9a182a"
      unitRef="usd">13674000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0xLTEtMS01OTg5ODU_86b15f7f-b99e-445f-ad56-4ebd7806702e"
      unitRef="usd">-3539000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0zLTEtMS01OTg5ODU_5f793022-56e1-4a2b-9e0c-69edbe5ea543"
      unitRef="usd">33561000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS01LTEtMS01OTg5ODU_0f3e9f91-d2f4-40be-9bd5-9444e1183b62"
      unitRef="usd">30022000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS03LTEtMS01OTg5ODU_04975989-f0c4-4856-aa12-bec01bef785b"
      unitRef="usd">41132000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS05LTEtMS01OTg5ODU_d02e7115-e6ea-45ca-82c8-4421247e49e5"
      unitRef="usd">62212000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNS0xMS0xLTEtNTk4OTg1_25facb6a-e86b-4e85-98b0-548b16f71a1e"
      unitRef="usd">103344000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0xLTEtMS01OTg5ODU_1b78d859-035e-4963-9946-5a0e11521044"
      unitRef="usd">-20975000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0zLTEtMS01OTg5ODU_7722004a-eccb-4ab7-8769-2c979538a9b7"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi01LTEtMS01OTg5ODU_3ec984ae-2881-4668-959d-87e056ae818f"
      unitRef="usd">-20975000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi03LTEtMS01OTg5ODU_c4d29985-9cbe-4761-8ea3-a4a0329ce270"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi05LTEtMS01OTg5ODU_da744c93-bb64-4232-a430-aa52c5c96909"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNi0xMS0xLTEtNTk4OTg1_13ccd0b7-0ac6-4ec0-8eea-23c7374b0183"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0xLTEtMS01OTg5ODU_8a7ec589-1616-411b-af60-7591735effe2"
      unitRef="usd">-5233000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0zLTEtMS01OTg5ODU_2b51742d-129d-402d-90f2-089685101015"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy01LTEtMS01OTg5ODU_c0ec2a35-5707-496f-86a1-0e73e8cfe353"
      unitRef="usd">-5233000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy03LTEtMS01OTg5ODU_36d67e90-18e6-4452-9b29-0035865e6ab5"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy05LTEtMS01OTg5ODU_32a2934f-1e24-4b20-8504-0f08606c6b1f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfNy0xMS0xLTEtNTk4OTg1_e68cdf53-6bc6-4694-be49-269a8d13c23f"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id244d570733142ccafce88cf9e2bc05b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0xLTEtMS01OTg5ODU_47a052f4-ac01-4099-926d-4ef318751e90"
      unitRef="usd">-15742000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2a91825cf1e34ed0b9d24fb60a89ce64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0zLTEtMS01OTg5ODU_a6ca5fee-ec19-4fdd-acb2-5adca8cf6c6f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i92ae1a6cece7494f9ec374098e63d551_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC01LTEtMS01OTg5ODU_cdf8900e-47d2-4abb-8cc9-1002674b6acc"
      unitRef="usd">-15742000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6f0cc503855545a4be019ee15acf1c14_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC03LTEtMS01OTg5ODU_5ffd7f20-b535-49f6-b150-a42d61178351"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i24b757354ef544ffb213fab994384fa4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC05LTEtMS01OTg5ODU_afb708e9-0b9a-4a4f-8679-09f58dfd662d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i71ce3bd2723c4f13b957233adc6f7e4d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOC0xMS0xLTEtNTk4OTg1_7e72eac0-939f-47f9-ac2f-b03054626b02"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9de0c5885b59490495ce7284b4d660cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0xLTEtMS01OTg5ODU_1b5cc39a-b11e-4198-9dab-2caac4aa6f93"
      unitRef="usd">79404000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifd8a058875e44febb4f2f422c3462dea_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0zLTEtMS01OTg5ODU_b426740e-9469-4eea-98e3-459394923a57"
      unitRef="usd">-134310000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if7db854d9b914c0b9a64e428f1c82c9e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS01LTEtMS01OTg5ODU_39e843f3-2897-4329-8693-cca6983c4d9f"
      unitRef="usd">-54906000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic8f35fdf8c6145ccbf5f634642c80724_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS03LTEtMS01OTg5ODU_b3c31526-e6a9-4559-8edb-352d3a980e90"
      unitRef="usd">40987000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic2983185f3e94a5fa5decfdf5bfb04fc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS05LTEtMS01OTg5ODU_e3709b69-7d9f-4ca4-91cd-abf313a1fef2"
      unitRef="usd">-75857000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i909208b4b7f844719f7ac20ac839d43b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml82NC9mcmFnOmYzZDFmNjQxNjVmMDRjYzNhNzI3YzFlYWFjNWEzOWI5L3RhYmxlOjhkZThmZmQ5ZTQ0NzRmM2RiZDU3ZTllMGMxNGQ1OWNjL3RhYmxlcmFuZ2U6OGRlOGZmZDllNDQ3NGYzZGJkNTdlOWUwYzE0ZDU5Y2NfOS0xMS0xLTEtNTk4OTg1_96ff525b-47cf-4479-914c-2f2252ee82f7"
      unitRef="usd">-34870000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfNDc0_918e76b0-658d-479c-9cea-b7f8e2cf2372">Variable interest entities (VIEs)At March&#160;31, 2023, these condensed consolidated financial statements include total assets of VIEs of $308,455 and total liabilities and noncontrolling interests of VIEs to third parties of $178,382. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2022 10-K.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="ibd476b66dd8f482d92e7bc8eea43966e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfMTQ1_94a6d3f9-16e9-49cc-9f51-1e4fba15f46f"
      unitRef="usd">308455000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="ibd476b66dd8f482d92e7bc8eea43966e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83MC9mcmFnOjAxZDU5MWYyZDQyNzRiMjhhYjBlNmZmMzBkYjRhOTJiL3RleHRyZWdpb246MDFkNTkxZjJkNDI3NGIyOGFiMGU2ZmYzMGRiNGE5MmJfMjQw_aa9b24a1-d871-47ef-9dc5-5b66d3f48643"
      unitRef="usd">178382000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM3MA_56c88b73-654e-4c57-93c5-b2155b679f8a">Fair values of financial instruments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2023:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a reconciliation of changes in noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2023, see the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the Company had contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $59,351 if certain performance targets or quality margins are met over the next one year to five years. The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and key performance indicators. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of March&#160;31, 2023, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $175,000. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2022 10-K for further discussion of the Company&#x2019;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon quoted bid and ask prices for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at March&#160;31, 2023 at their approximate fair values due to the short-term nature of their settlements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM4Mw_c1e51097-c253-4798-816e-eec71446c372">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of March&#160;31, 2023:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,398,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a reconciliation of changes in noncontrolling interests subject to put provisions during the three months ended March&#160;31, 2023, see the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi0xLTEtMS01OTg5ODU_281d308d-e46e-46bd-bfcb-a0ea2275f1a8"
      unitRef="usd">36144000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i980c082ed2474373bd9567687f6e1049_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi0zLTEtMS01OTg5ODU_cd5dd7bb-1c88-4d0b-8087-a3f047e6051b"
      unitRef="usd">36144000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi01LTEtMS01OTg5ODU_277acfc8-a20f-42f0-8aa2-a0fbe81664f5"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMi03LTEtMS01OTg5ODU_965dc0dd-4adc-4888-834a-442c8fd60f95"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="i1acf2afce18e45c098496603eec3a1e2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy0xLTEtMS01OTg5ODU_c7b7cb11-3d5c-47a1-8bf9-e43905c02148"
      unitRef="usd">112687000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia7bf666f9c43437ab5aa6ee983cffdd7_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy0zLTEtMS01OTg5ODU_045764dc-3115-458a-a5ca-dc78f588e326"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ie3fcc5081c0343a9a1c14dd4e8eb166c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy01LTEtMS01OTg5ODU_dc46a59d-e0a4-47ed-9a4a-8b5d6b515521"
      unitRef="usd">112687000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0cdccc91fa064c2b8622899fe4990f76_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfMy03LTEtMS01OTg5ODU_d8e0893e-981c-4296-bb56-df970b25c40a"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS0xLTEtMS01OTg5ODU_0c1a5715-adc3-4d5a-9cb0-0d9e045d23e8"
      unitRef="usd">25098000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i980c082ed2474373bd9567687f6e1049_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS0zLTEtMS01OTg5ODU_c97f5928-533b-4b1c-ab9a-a6721c9d3e28"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS01LTEtMS01OTg5ODU_22127622-631d-44dd-9a02-f0d3a977065c"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNS03LTEtMS01OTg5ODU_33cd6c5d-d8d3-4605-93e1-aa0e0a9530fd"
      unitRef="usd">25098000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy0xLTEtMS01OTg5ODU_f235c4a2-bbae-41c7-8644-35eae5f22ab3"
      unitRef="usd">1398829000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i980c082ed2474373bd9567687f6e1049_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy0zLTEtMS01OTg5ODU_93c4a62b-d5a1-414c-9ee9-acbe7ab54561"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ie720dbf8a8414299bf7ee67eb13867c2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy01LTEtMS01OTg5ODU_a10533f6-99ad-4e41-b4e6-ab47f85af24a"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i07abf49a236e4f8194d87f88f8b4b431_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RhYmxlOjM1ODM3NDU4OGExODRkNjRhZjk4ZDdmMDFiMDkxNmY3L3RhYmxlcmFuZ2U6MzU4Mzc0NTg4YTE4NGQ2NGFmOThkN2YwMWIwOTE2ZjdfNy03LTEtMS01OTg5ODU_6261ce93-ed1c-4af3-bb1d-53640ca8c3c1"
      unitRef="usd">1398829000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfNDM4MA_591e074c-0aca-4143-be0f-ccd4dd5086b9">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="i594302e643444e72a196b7a7758e44c3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTIxMw_93e35a0c-0397-4aac-8795-1adfe8a4dac3"
      unitRef="usd">59351000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i1cf2d70aa9324948a2cc832ba7bd6142_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTI4OQ_513c8da8-52a1-4f0a-b6d7-86f3d0bfb094">P1Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i9a53a270c4e04f138e74b1e7cfe51819_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfOTg5NTYwNDY1OTI5Ng_2260732e-a43e-442e-baa1-b2a6ff7ded9d">P5Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83My9mcmFnOmQ0NTlkNmE3NjM5YTQ4MTQ4ZWE4ZjI1OThjN2VmNjNjL3RleHRyZWdpb246ZDQ1OWQ2YTc2MzlhNDgxNDhlYThmMjU5OGM3ZWY2M2NfMzQ1Ng_3c8a6de3-c978-4bed-b51b-d7f53c8b4f27"
      unitRef="usd">175000000</dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3NA_24aa97b6-01d4-4275-a93a-f422149c3430">Segment reporting&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. IKC business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. IKC business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2022 10-K for further description of how the Company determines and measures results for its operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,605,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,612,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to consolidated income before income&lt;br/&gt;&#160;taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,789,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,084,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,843,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,727,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,928,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3OA_783bb8b1-a5a3-404e-8991-18e74ee4801e">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,583,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,605,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,612,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,575,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,169)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;361,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,865)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,305)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to consolidated income before income&lt;br/&gt;&#160;taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100,774)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNS0xLTEtMS01OTg5ODU_a167b8cc-7afd-4886-ba2d-b6c7ae993928"
      unitRef="usd">2583933000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNS0zLTEtMS01OTg5ODU_bedbd1ea-9ea5-42fc-ae4b-49d01872f43a"
      unitRef="usd">2546961000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNi0xLTEtMS01OTg5ODU_70c8bf7a-723c-4312-aaba-9115159caec8"
      unitRef="usd">22047000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfNi0zLTEtMS01OTg5ODU_6fc57123-1842-42af-b3e8-69b1cf23eedd"
      unitRef="usd">22159000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfOS0xLTEtMS01OTg5ODU_356db94b-31f1-4e0a-bfa2-e3b075d0a71a"
      unitRef="usd">2605980000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfOS0zLTEtMS01OTg5ODU_70556a35-c9b6-49fa-84f1-f09263d481f4"
      unitRef="usd">2569120000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="ia84e31cad3034b27ac449f5dcfba8a30_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTEtMS0xLTEtNTk4OTg1_f7096d5c-bde1-4ec6-93af-2195424a095d"
      unitRef="usd">6180000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i51d61e79ed6f484a8b9342657aa3914e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTEtMy0xLTEtNTk4OTg1_1959fdda-172c-4337-8730-e6ce406c8310"
      unitRef="usd">5966000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i5dfaae6ece7c4b16ab644012f3a0c417_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTItMS0xLTEtNTk4OTg1_e599d542-4db5-441b-a73e-54f9f4bfa562"
      unitRef="usd">0</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0378570fa0b84ce2bc4fcedbe50429ad_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTItMy0xLTEtNTk4OTg1_7f3076e0-74ad-438b-bc81-5ab30110b3df"
      unitRef="usd">10000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTMtMS0xLTEtNTk4OTg1_7f63181f-4bbe-4bef-af7b-bf4744d708db"
      unitRef="usd">2612160000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTMtMy0xLTEtNTk4OTg1_00e4ee48-f57e-45e3-ad72-7c7bd9cd963a"
      unitRef="usd">2575096000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTUtMS0xLTEtNTk4OTg1_d7733ae0-5e6b-4ce5-bb56-1222df979f1b"
      unitRef="usd">176101000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTUtMy0xLTEtNTk4OTg1_5de1bae2-2dcb-4760-9a5c-14292e918c45"
      unitRef="usd">169320000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTYtMS0xLTEtNTk4OTg1_4442d4b0-01b3-4596-affe-9a4184d21a02"
      unitRef="usd">106485000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTYtMy0xLTEtNTk4OTg1_22975769-5edf-471f-9852-b09d153fbe8d"
      unitRef="usd">95308000</us-gaap:OtherIncome>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6f6608bb6cb94997a8b0a4397ff14ad0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTctMS0xLTEtNTk4OTg1_2b7b16e7-7be8-435f-845d-0753e9becd3f"
      unitRef="usd">1368000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i49f4a76215494ab98201d3f4c7c27890_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTctMy0xLTEtNTk4OTg1_2dff8b7f-d326-4f19-bc74-6d38e656dd8c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTgtMS0xLTEtNTk4OTg1_15183bb5-d3fe-422d-9691-314c797eb040"
      unitRef="usd">283954000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTgtMy0xLTEtNTk4OTg1_dd8b905f-9749-4fcd-8cac-a65e113b0e38"
      unitRef="usd">264628000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTktMS0xLTEtNTk4OTg1_984c3c0b-e5b0-4a92-a675-c8d42c9e2576"
      unitRef="usd">2896114000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8145bc790f464c6097f88871f5552d27_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMTktMy0xLTEtNTk4OTg1_430f189d-a7f5-4351-859b-627a12b01ad1"
      unitRef="usd">2839724000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76335814a9534b91a6933754d6ee880a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjAtMS0xLTEtNTk4OTg1_d82ddccd-49e4-4144-8386-1c9e74d181b3"
      unitRef="usd">-23415000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8680e140680144f3b9565b2256e74132_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjAtMy0xLTEtNTk4OTg1_26e32b19-17a0-48d6-9abe-c8096eb0515d"
      unitRef="usd">-22169000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjEtMS0xLTEtNTk4OTg1_47c05d52-0b86-49ac-9544-e1fe02894076"
      unitRef="usd">2872699000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjEtMy0xLTEtNTk4OTg1_75ee6ab0-dfcc-4001-a474-4ca33d6c3097"
      unitRef="usd">2817555000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d4c1594069844e69f63a91f84862402_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjMtMS0xLTEtNTk4OTg1_eb6518db-a690-4fcf-8813-45dfb79c2b24"
      unitRef="usd">361098000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaea7c61aecac4da580365d4d4923f5e9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjMtMy0xLTEtNTk4OTg1_bf76c374-ac1a-4215-8f23-a99b4b480b27"
      unitRef="usd">406440000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i48d2e864dbd64392851e2fd5e4550c6b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjQtMS0xLTEtNTk4OTg1_1198ceb5-4ecc-4a0b-b8c8-e1e793913d81"
      unitRef="usd">-24865000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4824dedca46740a7afd5141874cd3c07_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjQtMy0xLTEtNTk4OTg1_032a29d5-4332-4d43-b242-7b5a12f267eb"
      unitRef="usd">-32305000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iad131c570baa47fea7c6546ec8c7caa3_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjUtMS0xLTEtNTk4OTg1_25bdf997-7848-40b5-8e56-48f1945d8dc7"
      unitRef="usd">336233000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8145bc790f464c6097f88871f5552d27_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjUtMy0xLTEtNTk4OTg1_66da7aed-f824-4c99-8383-3860e24584b7"
      unitRef="usd">374135000</us-gaap:OperatingIncomeLoss>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjctMS0xLTEtNTk4OTg1_b4de4c1c-bd4a-481f-95c2-779bd6dd7d8e"
      unitRef="usd">24588000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjctMy0xLTEtNTk4OTg1_127dcaa5-e636-483f-a1c3-15b0fff9b1f3"
      unitRef="usd">35827000</dva:SegmentReportingInformationCorporateExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjgtMS0xLTEtNTk4OTg1_72550dfb-97b8-4a62-8d8f-e35748ba669a"
      unitRef="usd">311645000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjgtMy0xLTEtNTk4OTg1_3ea48883-013c-4f50-9461-89f3ce52717b"
      unitRef="usd">338308000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjktMS0xLTEtNTk4OTg1_9bc28b00-4561-4fdd-bc5b-cc0fc953148c"
      unitRef="usd">100774000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMjktMy0xLTEtNTk4OTg1_62453d3d-5a5a-429a-8253-ee0542f04574"
      unitRef="usd">73791000</us-gaap:InterestAndDebtExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzEtMS0xLTEtNTk4OTg1_d669662b-b535-4564-a449-68f00da1d6f3"
      unitRef="usd">3752000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzEtMy0xLTEtNTk4OTg1_f17fd82a-9ecd-4a5f-a8c6-aab87d4b648e"
      unitRef="usd">-1786000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzItMS0xLTEtNTk4OTg1_13c34971-e02a-4b7d-b964-1f9bc4bf881a"
      unitRef="usd">214623000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmZmNDEwMGU0M2M1MzQ1NGM4MTgwOTY4YjFlZjhhOWYxL3RhYmxlcmFuZ2U6ZmY0MTAwZTQzYzUzNDU0YzgxODA5NjhiMWVmOGE5ZjFfMzItMy0xLTEtNTk4OTg1_0948ad32-5e62-4456-bf0b-9c7148746eef"
      unitRef="usd">262731000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3OQ_196486c4-e9d3-46b1-9d9e-c7d15378af5f"
      xsi:nil="true"/>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ4MA_2836e034-2e58-41a6-a56b-9c65337e0e1e">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationAndAmortization
      contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMi0xLTEtMS01OTg5ODU_1c081c98-9f2a-439a-b7b0-1f05fcd34ff3"
      unitRef="usd">166961000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMi0zLTEtMS01OTg5ODU_7a724b66-3e9e-46bd-8704-4221e5e069c1"
      unitRef="usd">162019000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMy0xLTEtMS01OTg5ODU_7a96c084-378f-43fd-b1c0-4dec1e0b5a50"
      unitRef="usd">11110000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfMy0zLTEtMS01OTg5ODU_9279d679-477c-4f70-85ae-5541808daf15"
      unitRef="usd">10925000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfNC0xLTEtMS01OTg5ODU_92f84b97-cf17-4912-8d6f-506346ff21eb"
      unitRef="usd">178071000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOjA5NzZiYTQzMWVkOTQzNzQ5MDBkMjI1OThkNzA3NTRlL3RhYmxlcmFuZ2U6MDk3NmJhNDMxZWQ5NDM3NDkwMGQyMjU5OGQ3MDc1NGVfNC0zLTEtMS01OTg5ODU_29e4648f-031d-41d7-bbb2-84c8c9530523"
      unitRef="usd">172944000</us-gaap:DepreciationAndAmortization>
    <dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ3NQ_646cf866-07c7-4835-bd95-00e8676d0a74">Expenditures for property and equipment by reportable segment were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMi0xLTEtMS01OTg5ODU_bf708a18-159d-44df-bddd-5eb83408e723"
      unitRef="usd">130966000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i84b4744293bd499dbe42ecc5841730ea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMi0zLTEtMS01OTg5ODU_583e4a90-311a-48b3-9e98-7bc07338e734"
      unitRef="usd">107513000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifa250d078ba241db8b0f5d72b73d64f4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMy0xLTEtMS01OTg5ODU_e50db122-79d5-4824-8a15-d39adaae0161"
      unitRef="usd">16739000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if4b27685c35f44bd95d69ed1c36212c7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfMy0zLTEtMS01OTg5ODU_30e6bd6d-7dde-47e2-a161-5c3603cf4eca"
      unitRef="usd">15595000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfNC0xLTEtMS01OTg5ODU_11300a95-b00c-422e-8c7b-ebc8a7c55605"
      unitRef="usd">147705000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i077fc0f3cf034cdba0eac50e3f57ced2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmFjNTIwZTMzZDNmZDRhNjU5NjBiNDhlMTI2MzUzOGQ3L3RhYmxlcmFuZ2U6YWM1MjBlMzNkM2ZkNGE2NTk2MGI0OGUxMjYzNTM4ZDdfNC0zLTEtMS01OTg5ODU_127abb88-a8ee-4bc9-9d11-e61a7a11b4e4"
      unitRef="usd">123108000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RleHRyZWdpb246MDJiMWJhODUzYWM4NDUyYzgxYzJiNDg0NjZjYmNlZTZfMTQ4Ng_1db79051-27d0-4901-af1e-fe9173944804">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,789,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,084,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,938,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,843,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,727,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,928,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="icde1e71194074e608dc7cc2f2b99ec8c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMS0xLTEtMS01OTg5ODU_be5dd787-b4d3-4931-97db-dd41003b2efb"
      unitRef="usd">14789095000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7a9711074ad04b2b8d04b9a4947d42ef_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMS0zLTEtMS01OTg5ODU_9117a315-3c2a-4125-95d8-5322b521eaf6"
      unitRef="usd">15084454000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ica637bc0d87441efa9e4e45677990b7b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMi0xLTEtMS01OTg5ODU_733b3278-80ce-4372-9de2-e6673ac95836"
      unitRef="usd">1938692000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic8b8d6c5269e40ea96edc61e395e0e6f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMi0zLTEtMS01OTg5ODU_c34dc26d-1c02-4588-8e80-564c4acf694a"
      unitRef="usd">1843798000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9371851bf60946538246702a8ff6a696_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMy0xLTEtMS01OTg5ODU_9f9762d0-3739-4edc-b5e8-a5cc455912e5"
      unitRef="usd">16727787000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id10db692f34a4aad9a81d68a86468a88_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83Ni9mcmFnOjAyYjFiYTg1M2FjODQ1MmM4MWMyYjQ4NDY2Y2JjZWU2L3RhYmxlOmU3Njg1YmEyZmEwODRhYTI5YzlmZDliNGEyM2JiN2MxL3RhYmxlcmFuZ2U6ZTc2ODViYTJmYTA4NGFhMjljOWZkOWI0YTIzYmI3YzFfMy0zLTEtMS01OTg5ODU_443663e8-6b96-4985-b0ed-c289bfaa6b03"
      unitRef="usd">16928252000</us-gaap:Assets>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83OS9mcmFnOjI2MzA1Y2Q1ODI2NTQ4MGZhOGEzMjFjZmMxY2MxYWEwL3RleHRyZWdpb246MjYzMDVjZDU4MjY1NDgwZmE4YTMyMWNmYzFjYzFhYTBfMjA1MQ_cdf92344-e060-4739-a33b-4b791ca8e7d8">New accounting standards&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued Accounting Standards Update (ASU) No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company could elect to apply the amendments prospectively through December 31, 2022. In December 2022, the FASB issued ASU No. 2022-06,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which extended the election date to December 31, 2024. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company does not expect application of this ASU to have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <dva:ChangeInAccountingPrincipleImpactAbilityToBorrow
      contextRef="i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml83OS9mcmFnOjI2MzA1Y2Q1ODI2NTQ4MGZhOGEzMjFjZmMxY2MxYWEwL3RleHRyZWdpb246MjYzMDVjZDU4MjY1NDgwZmE4YTMyMWNmYzFjYzFhYTBfMTUzOTMxNjI3OTk3NTU_7ee6f39e-dafa-4010-857c-549620b8b9cf"
      unitRef="usd">0</dva:ChangeInAccountingPrincipleImpactAbilityToBorrow>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xNTM5MzE2Mjc5MTA5Ng_775a73a5-3cd0-44bc-bfdb-58949042ab89">Subsequent events&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Launch of Mozarc Medical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;25, 2022, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (Mozarc Medical) via a deconsolidating partial interest sale from Medtronic to the Company, which closed effective April&#160;1, 2023. At the closing, the Company made a cash payment to Medtronic of $44,651, subject to certain customary post-closing adjustments, and contributed certain other non-cash assets to Mozarc Medical. Additionally, at close, the Company and Medtronic each contributed $224,415 in cash to launch Mozarc Medical. Pursuant to its agreement with Medtronic, the Company has also agreed to pay Medtronic additional consideration of up to $300,000 if certain regulatory and commercial milestones are achieved between 2024 and 2028.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Forward Interest Rate Cap Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;21, 2023, the Company entered into several forward interest rate cap agreements with an aggregate notional amount of $1,000,000 that have the economic effect of capping the Company's exposure to Secured Overnight Financing Rate (SOFR) variable interest rate changes on specific portions of the Company's floating rate debt (2023 cap agreements). These &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 cap agreements are designated as cash flow hedges and, as a result, changes in their fair values will be reported in other comprehensive income. These 2023 cap agreements do not contain credit-risk contingent features, and become effective on June&#160;28, 2024 and June&#160;30, 2024 and expire on December&#160;31, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Second and Third Amendments to Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;3, 2023, the Company entered into the Second Amendment (the Second Amendment) to the Credit Agreement. The Second Amendment modifies the Credit Agreement to, among other things, transition the interest pricing on Term Loan B-1 from LIBOR+1.75% to a forward-looking term rate based on SOFR (Term SOFR) +1.75% and an additional credit spread adjustment (CSA), as well as to update the successor interest rate provisions in the Credit Agreement with respect to Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;28, 2023 (&#x201c;Effective Date&#x201d;), the Company entered into the Third Amendment (the Third Amendment) to the Credit Agreement. The Third Amendment modifies the Credit Agreement to, among other things, refinance its Term Loan A and revolving line of credit with a secured Term Loan A-1 facility in the aggregate principal amount of $1,250,000 and a secured revolving line of credit in the aggregate principal amount of up to $1,500,000. The facilities bear interest at a rate equal to one-month Term SOFR plus an interest rate percentage (initially 2.00%) and an additional CSA. The Credit Agreement, as amended, continues to include customary affirmative and negative covenants and events of default for financings of this type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Term Loan A-1 facility amortizes on a quarterly basis beginning September&#160;30, 2023 at a rate of (i) 2.5% per annum during the first year following the Effective Date of the Third Amendment, (ii) 5.0% per annum during the second, third and fourth years following the Effective Date of the Third Amendment and (iii) 7.5% per annum during the fifth year following the Effective Date of the Third Amendment, with the balance due on April&#160;28, 2028. The new secured revolving line of credit has a five-year term.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <dva:BusinessAgreementDate
      contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTU5OTg3_4abb4c8c-0b88-40af-8218-52027d0a5bbe">2022-05-25</dva:BusinessAgreementDate>
    <dva:BusinessAgreementEffectiveClosingDate
      contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODQw_15a75f34-8d18-4295-9d59-8bc30153af56">2023-04-01</dva:BusinessAgreementEffectiveClosingDate>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i2f80b1319fb14cc1bfa994858bbe01e1_D20230401-20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNDE2_9a442891-bc23-4cd8-9575-27872347e145"
      unitRef="usd">44651000</us-gaap:PaymentsToAcquireOtherInvestments>
    <dva:AdditionalCashCommitment
      contextRef="i06a8ea352a2743ed93515924f01db624_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNjIz_1787ff2c-5129-4c13-b03d-7c50244aa68d"
      unitRef="usd">224415000</dva:AdditionalCashCommitment>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths
      contextRef="i06a8ea352a2743ed93515924f01db624_I20230401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV82MDQ3MzEzOTYwNzM2_7d761497-f791-4109-a49e-35fa521c2035"
      unitRef="usd">300000000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <us-gaap:DerivativeInceptionDates
      contextRef="i0788ec757ea94bf4a9145a7a7ed57852_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NDg3_bac543f8-f3a5-4456-92ef-63b67f418bf6">2023-04-21</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3966a9b63d8a4d6bbeaa5dd9fd9ff21a_I20230421"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA3ODg5_5c070845-68ea-4a7d-b940-71582cc2e58b"
      unitRef="usd">1000000000</us-gaap:DerivativeAssetNotionalAmount>
    <dva:DerivativeEffectiveDate
      contextRef="ie6ba5fa255fc483985d3b21380331f55_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NDMw_419b03d8-f996-4d44-842e-9a9b332f3b2e">2024-06-28</dva:DerivativeEffectiveDate>
    <dva:DerivativeEffectiveDate
      contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xODY5MTY5NzY4NDQ5MQ_f6720574-3cc1-4a90-9dd4-b19b112f89d5">2024-06-30</dva:DerivativeEffectiveDate>
    <us-gaap:DerivativeMaturityDates
      contextRef="i9ff2cbf9b6b04712a42d892078640b69_D20230421-20230421"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV81NDk3NTU4MTUxMzYy_b65fb505-defe-4765-a026-86b2bf6d9cd2">2025-12-31</us-gaap:DerivativeMaturityDates>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="icc23cd3becc842dfa58d5e0e248e0c6a_D20230403-20230403"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzA5NTA2_dca09de8-2811-4c52-bdc9-3bd1feb4de22">2023-04-03</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i530a9540af994a81a1bfb28e20625fdf_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODYz_1895e14c-20e6-4c94-8929-9931e1e7c623">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2b3dd1537dba44f5900ed9f64c91677b_D20230403-20230403"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExODg0_e6f7e0d9-7550-4d3a-8398-6eeaa3d01a92"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentIssuanceDate1
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xODY5MTY5NzY4NDUyOA_4081e7db-ea59-4ec0-a352-ab45fa800bbd">2023-04-28</us-gaap:DebtInstrumentIssuanceDate1>
    <us-gaap:SecuredDebt
      contextRef="i16b6c4f2fa614fecaa2c78eec44d5f17_I20230428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV85ODk1NjA0NjYxNDEw_7ffb5ea3-dc34-4be6-baeb-136933bc7ef9"
      unitRef="usd">1250000000</us-gaap:SecuredDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibe1c2673f7634b01be99ea30dec31d8b_I20230428"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV85ODk1NjA0NjYxNjE2_3941546c-76d8-4d17-8820-66720477dc6c"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1f284922a3174384b3458e6319e9275c_D20230428-20230428"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTM2_5e5bcb08-423b-4cba-b16a-934846627dc5"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTky_f3a9a687-9b1d-4e75-ae70-3b2c65a70cc6">quarterly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <dva:DebtInstrumentPeriodicPaymentStartDate
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8xMDk5NTExNjQyNTQ3_684ad259-b600-427a-9dc7-a25d445e3095">2023-09-30</dva:DebtInstrumentPeriodicPaymentStartDate>
    <dva:DebtInstrumentPeriodicPaymentInterestRateYearOne
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzExOTk0_f88d72da-963e-4c65-88a3-b4d4dd49ce1f"
      unitRef="number">0.025</dva:DebtInstrumentPeriodicPaymentInterestRateYearOne>
    <dva:DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDAz_3d17f774-1ae7-4d77-a32d-2e59d916a8cf"
      unitRef="number">0.050</dva:DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour>
    <dva:DebtInstrumentPeriodicPaymentInterestRateYearFive
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDEy_7ee0fc47-cbdc-4339-a9e9-e848ec047b40"
      unitRef="number">0.075</dva:DebtInstrumentPeriodicPaymentInterestRateYearFive>
    <dva:DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid
      contextRef="ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428"
      id="id3VybDovL2RvY3MudjEvZG9jOmExMTEzOTU3ZmJhMTQ3NzhhOTVlNWE3Mzg3MjM4YzgyL3NlYzphMTExMzk1N2ZiYTE0Nzc4YTk1ZTVhNzM4NzIzOGM4Ml8xMjcwL2ZyYWc6YjMwNjdlYjA2OGE0NGU1YmIwYmVmY2MyZDdkZDFjMTEvdGV4dHJlZ2lvbjpiMzA2N2ViMDY4YTQ0ZTViYjBiZWZjYzJkN2RkMWMxMV8zODQ4MjkwNzEyMDM5_6045144f-3c58-4b77-818c-ae0d6b3327a2">2028-04-28</dva:DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>77
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M NIFV DB]VAV1BTHJ057<_3"H QFZ7\T03<9EY+*6[2".B@15)N4*0K14$A
M(E%,-HBL!#4IE9TF*<%'9NR#P,["$I9A":]F[&)8FE074-%)9CY[@=>NY*]N
MY;NNAYO3%Y4\HZL\GVF<$2G391H3W2"DOFH,CMN1OJ%]BPH5.J7<&%P^CU%=
MCAM$/J[HJ9NYCN<URVF5<EKO#7MY"*%I0U=BT!:$H"S^C:!@,)D9N8V'L%4C
MYGE!Z%;HUZU"C-T+Z6B7_-M7^4_5F@H4GY6ZRX%NUR/HXY93(=I@Y?A>%#4S
M=9UC"W2N<IUS1;)W<SV G=%H^6V_6J4:[#S7<=K!!;HG'=N]2O<;E;)3Z2(%
M7424$NEBJ\@BHT@?;P[[3 F> <BJK&+-'=JMG_8@<''UN#39^5[0#B_HPD==
M^*JN=RD:DM=4$=TU[QI%X'H+P>T6CJHBZG8X#/UVNR+"/IFL<BI69N"4<%:V
M3!732+E;#K7W9I2K[#_H8==,;$>88E*&66.E+WA&EP#IW$50[44Q?!8+Q3=F
M?EMP!=.@>5W#P$Z%-H#O2\[5VT+_0/DO0/]_4$L#!!0    ( &N(J%;K0R$T
ML <  +$A   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&ULK9IM<]LV$L>_
M"D;MW+4S<80G@F3.UHPBNU?-N(DO<M+I2UB"+#8DH9*0G7S[6XHR*1$/MF?R
MQB:E!?C' MC?+JCS1UU]K3=*&?2MR,OZ8K0Q9OMN/*Z7&U7(^JW>JA*^6>NJ
MD 9NJ_MQO:V47.T;%?F88BS&A<S*T>1\_]E--3G7.Y-GI;JI4+TK"EE]?Z]R
M_7@Q(J.G#SYE]QO3?#">G&_EO5HH\WE[4\'=N.MEE16JK#-=HDJM+T93\F[&
M>=-@;_$E4X_UT35JAG*G]=?F9KZZ&.%&D<K5TC1=2/CWH&8JSYN>0,<_ATY'
MW3.;AL?73[W_MA\\#.9.UFJF\S^SE=E<C)(16JFUW.7FDW[\71T&%#7]+75>
M[_^BQ]961".TW-5&%X?&H*#(RO:__'9PQ%$#PCT-Z*$!?6D#=FC ]@-ME>V'
M=2F-G)Q7^A%5C37TUESL?;-O#:/)RF8:%Z:";S-H9R:SCQ\6'Z_GE]/;JTOT
M?GH]_3"[0HO?KZYN%^B772EWJ\RHU:_H#'U>7*)??OX5_8RR$MUN]*Z6Y:H^
M'QM0T?0U7AZ>^+Y](O4\\0]9O46,O$$44^9H/@LWOU3+KCD];3Z&L7<.H)T#
MZ+X_YNEONEC 6%W#:-MQ=[MF>[VKMW*I+D:P?VI5/:C1Y%\_$8'_XQK4#^KL
M9(BL&R(+]3Z9R7J#8++0LKE0_^RR!YFKTC@GK^U*[+MJ8L##A)&8,'#UP_%X
M;#/*.4Y$9W:BE'=*>5#I)U6;*EO"BFNU-J*?T=MV&!\)23D5T4"NRRK%S*TV
MZM1&0;6+C:[,F5%5 5OB :07/I&1]7B>II9(VRJ.1>H1*3J1(BARNESJ'<B"
MF+M4X,B[7+U!I3(NF<(20'$4)S@="'78P0K!,79+C3NI<5#J')Q8&EUERNG$
MV'HJP2(^>F@KSF66$DK=VI).6Q+4]M%L5'7D0Z?"Q'HT:W;%<)YM,TY8&GOV
M3MHI3(,*;RJUE=EJOV?T7NUR5U7@4"3K6KG796HI25)VM.):O;95G"0L=<LE
MN"</?F:ZE[I0R,AO1WYU\@1; H:3[C#APK>_R1$<25#BK38R?X$?#]V<S#R&
M*67#G>,R)%%$4\_R)#W&2! A,/V0VE7F>Q<SMTTT\F[U0V^G:Y4(%@\GWVD8
M"1B<1W%/)1+&TD?0*TU6WJ-<02*&JB;C.M/KLQW<!'S-[.@C2(Q),E3N,A2"
M<I^O>TJ1,*;FI9'E?0;+]:#3[V8;/"01<61I==E1D?B<W".*A!EU!2L!%D6A
MS$8?QX9G@$5L%E%.8AX/=3OL&"$X\>CNJ47"V+K6Y?V+T$IL&'$>42M N,P8
M]06Q'EDDS*R6"WFG-K!N;3#1%+!)ADIMNR9$>)="3S 21MA_M5X]9GGN%&<S
M*<:0(!%+G<LP%H)XV$]Z?)$PO]I8&_"?C2$B8AK'B;4H798I36CDV?FT9Q;%
MP6KA>CY]/[^>W\ZO%FCZX1)=_>_S_/8O9_40A-^KRX<?U-OIL'L.TC 'NR1R
M*[_[*$UMM'$>IV*(0)==G$*6Z9F;HT(N3,##5LSD799GQI-$4AMGH#'FP_K&
M89=@RH4G8-">>C1,/7!EM6OJ&UUL55G+]C #XO*=*M4Z<Z]]:J-,$$C5AKO3
M99="-<0]JGOBT3#Q9H<4: L53R-8KY$>X/LYQ]N$8RGD:,/-Z[2+.":>(?0D
MI&$2.H;0A^V5NG/RF[HX2(F5(KOL&.'8Y_B>@S3,P:,D.;3W;+H)+B)K>=AF
M),&^3)[V$*1A")ZFR<\M! <'(Q%AVZ<.0T'2XR3D5&]/0AHF89]<O'81V_2C
M/(H(YT/M#L,(,RP\B1'M,4G#F+Q^?LTZJCK(W2+K#,=EV(0+XG$PZS')PJ7=
M,"MZQJW,KMX(QI0.T>&TBRCSU'FLYQL+\^U2K14LWA4DFT_;S:/4AE<<0[H[
MC&(NNX3&OB2.]9!C8<BU6^TY?]KP(IQ!/I<,CR*<EC%FW)<JL:-#1Q9,E6:Z
M*+(V;V\/'W79;#15+D'U.Z?L(#E?FS+]J-Y.A]\3DX6)^4&7S8@KG>=->,E*
MV A0Q]2HWMW]K98&&8VV.\!1I1^RYJ6(>R8==2%+D\3>&BY#GJ2^2HSUW&11
M<![;"M(]84'BOGK"?E!OI^/L2<O"I+VIGH+ PNCEUS?HB\QWZ@V:US7D:\[A
MVS@=EIU!DU.A/6U9F+;-QH+\Y<4J;8RFP\3 9>/3V5.6A2D[7:VR)M.">-4<
M3)YE)5K*;0;QRRG3)F:48FKE, X[@47*(H_<'JPL#-9/RDCX:(64K$K8LN[]
M:".3IACBY5"EHP2-.??%?]Z3E8?)"N7#KMCELGE%<CCEA4*B4IOFS>H#)#"Z
M=K\FL=%Y%O$4BX%PEYU(B??%3H]8_I*CU$OY!18 @JSV+:HW$G3K?*6J^M_[
M(TOSW2G=9BF4\MPZ^'?8Q80RZI/>,Y>'F>L-Y:4VKPOGW(';E',\3'U==H)%
MPC>4'LH\7'VVLQ#PM5U $DS2Q#H6=A@F<93XSK'YT1O ,#>M!*<[T/8HYM:;
M2,^QD-/2>2PT/GJ?WOR8X0]9W6=E#37"&IKBMS&0JFI_']#>&+W=OV*_T\;H
M8G^Y41(6=F, WZ^U-D\WS5O[[E<:D_\#4$L#!!0    ( &N(J%;D)+5$;0,
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M)3I;@^W@AOYTB=Y3X7Y2B&T.U9QEQ;E#+/:-D<10+0E3[86V]B%EO<8'Q'5
MC*9SB$LJ1YYS/&+HEH3IUFYWND&*#E,5K5^GBDVK<93AJ1\<8CCQM3S$T"\)
MT^_U/EJ4!J^";;/J-'\=(G.,,A]F0[LD/+Y:+8.+=YV8'7,I2N/Q&=. W"&(
M"8Q37]R/'L^&R?+3_G$">RBZQQ% J/P%Q?!H0A=VI=J'7D'=Q=VI^&J&!Q3:
M&Z(J=+[K[YTZVCR*<#2M30XIC!.?9PS7DC#7#D^?=?%GX%W)^JOWVD=_4RN;
M;5-$(NO!M8.4U2B-4U_.&U(F85*^>#%\0"58LMNJ:71 :BY<,_#(J'#J9?,P
MQIEJ(Z:*V7)Q3/+$0]K$D#8)D_;K]&+Z&46OT9:)BI=.G5+K]0$"(<ZM&'3(
MH2C.ICFV&+UKLV'BMGL%J07=T7[_ILK^[OXUI[/NY9[)_7-X=-&_K&2VZ=^=
M^DJ%<E@+:K926T8?4Q5'HG\=J?\@^;9[HV?)I>2;[G+-:,F$%E#?KSB73Q_T
M#^Q?"CO]/U!+ P04    " !KB*A6SG5 M^8-  "(IP  &    'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;+V=;W.;RA7&OPJCWNDD,U$,+ B4VIY)S)_=G=XD
MC9/;Z73Z DO84B.!+D)V\NV[R(K0+JN52)[IFUB*.;_#HN<@X-FSOGPJJZ_K
M69[7UK?EHEA?#69UO7IS<;&>S/)EMGY=KO)"_.:^K)99+=Y6#Q?K595GTVW0
M<G'AVO;H8IG-B\'UY?;_/E;7E^6F7LR+_&-EK3?+959]?Y<ORJ>K@3/X\1^?
MY@^SNOF/B^O+5?:0W^;UE]7'2KR[V%.F\V5>K.=E857Y_=7@K?.&^T$3L-WB
MCWG^M#YX;35#N2O+K\T;-KT:V,T>Y8M\4C>(3/QXS&_RQ:(AB?WX<P<=[',V
M@8>O?]"3[>#%8.ZR=7Y3+OXYG]:SJT$XL*;Y?;99U)_*)YKO!N0WO$FY6&__
MM9YVV]H#:[)9U^5R%RSV8#DOGG]FWW8'XB# (4<"W%V >VX V040)< _%N#M
M KQS,_B[ %\)<(,C :-=P$C-$!X)"'8!@1K@'PD(=P&A$D".[=)X%S!6C]*Q
M ,?^\<G96P4]?^1;O419G5U?5N63537;"U[S8BNZ;;R0R;QHZN.VKL1OYR*N
MOK[Y\/[VP]]9]/9S'%FWG\6/W^/WGV^M#XD5_^,+^_POZ\6FR#;3>9U/7UI#
MZ\MM9+WX[:6UGF55OK;FA?5Y5F[663%=O[)^D]Y?7M1B!YLT%Y/=SKQ[WAGW
MR,Y\+NMLH0F[^;FPR!SVOBR&UJ0LZJI<B-\]B)VO<S&H>BW.%G?_%05LU:6U
MVM36JBH?Y\T903>FV)SEIEPNQ7E ?)23KYKHQ!S]=BJ.O$B<+:Q5-I\.Q?&=
M9*NY?KRIF?4IK\7Y,I]:>5858KRZP= 31UJ<@M>;ZOO1X; 3PYE,-LO-(A-B
MLLIZEE?B^"_%>7W6G' ?<VM1KG5[Q7_Z@RS*^MP/\T)4SKY\W'WYN-O4WK$#
MDB]7926^6*S\S\V\_OY*')FLJIN=N,L663')K:RVHGSRVB+.*\NU74=7%L8D
MS5?DF_4JF^17 W&LUGGUF ^N__H79V3_35<L2%CT#!MM8<UW[>.UXQ$O).[E
MQ>-A$2"3)DA8BH11)(PA81P$DZJ [*N ;.GD2!6P8M*<&'+KA5#Z]M7+[3?!
MOCCB;7%8__XD"M02US5/637]CZX0"+(0D+ ("8N1L 0)2Y$PBH0Q)(R#8%*U
M>/MJ\8S?&>_%7<^\$%]\N:X"C+%]*P )BYYAP<%7@1N2T%&^") I$R0L1<(H
M$L:0, Z"2=+V]]+VC=*.YNNZFM]MZB/7RN^,X7W5C81%?D?=0\\-._)&YDR0
ML!0)HT@80\(X"";)>[27]\@H[YOF'L,D;V-X7WDC8=&H(V_BC -%W,B,"1*6
M(F$4"6-(& ?!)'$'>W$'1G&_G8B+]/7V:</:RHJI-15WY.MZ7F]$+IW8C;B^
M8D?"HJ![I>*YZID<F3%!PE(DC")A# GC()@D]G O]M H]H_-0YKFH=JFFLS$
M_:I6X$9$7X$C85'8O5@)7?61##)C@H2E2!A%PA@2QD$P2>#CO<#'1H$GV;RR
M'K/%)K>J?+E]:BM^%+56Z$947Z$C8=&X*_3FZ:.O2!V9,T'"4B2,(F$,">,@
MF"1UQVX]+-LH]@^-E:"UFXQQ?94-I44[VJ&VO9&G"!N:,H'24BB-0FD,2N,H
MFBSO XO6Z6DRY<54L9A^SZJ]Q>1J2\&8HW<I(&G1CG98"@X9VX&OWJ!"TR90
M6@JE42B-06D<19/+H;5<';/G^BY_F!=%7XO5#.VM_ZXO&OB^;X>R8"-HUEB3
M57V&DVBV\3V;J+>_J68[XGN$*#RJV<Z6-V&:38:B?EU/87'-ADYHC[P6*$NB
M]1\=HV$C3;)X974%\F)>[&:LO#Q/+% ?$DJ+H+1X1PLD2;GA6%45U&2$TBB4
MQJ TCJ+)==$ZC8[9:I3GZ[RR[GZ],J#^))0606DQE)9 :2F41IVNL]LYQ4,M
M2A1-KHK6I'1\XW25&VG.V;,5_T8K=JA=":5%4%H,I2506@JE42B-06D<19/K
MHG4W';.]V4Y,$5\%ST9G=K?(FXF34?;'O,XL5DQ>:PL%:GPZ7;/2&;F.^H [
M@F:-H;0$2DO//"(4FI5!:5PW!M]U_"/7_JUMZ9A]RP^:><0[%;]HYA._U HV
MZ-Z)V!X)E#N6&Z=K)>JVB\S[V%N*4&\22DNA- JEL3,_+8[**BNV]1X=L_EX
MVUR,6UDS"=9:B<OPPXMPK5BA1B24%D%IL=,U-GVBWHI"K4@HC4)I#$KC*)HL
M^M:/=,R&I"IZK="A1J2C-P\[C^B026,H+3EO""DT*872&)3&432YV:<U&EVS
MT;@5\7"=U_4BGSX_5!DVW9G3[?6'N/C(MDV?^;?FM79ZMSE!7XF[70_1]4;N
M2)$X-&D,I27G#2&%)J50&H/2.(HF2[PU&UW'_'!DEA4/SYV=15GHNNJL^ZI<
M:I^7N%"/$4J+H+082DN@M!1*HU :@](XBB:72FM$NF8C\F2W@SF^=SU@&SNA
MSB24ED!I*91&H30&I?$=3;I<=%T_</3/6-S67W5/^:LG&A_,\;V5#C5,H;08
M2DN@M!1*HU :@]*XV[6MG>"@*5W6>>N7NF:_M'</A)G76_==(RX,B7HQ#W4Y
MH;3DG &DT)042F-0&D?19#6W/J=K[L8\J\G!S.BM8$T;I1,$GJIAJ'D)I27G
M#2&%)J50&H/2.(HFJ[AU)5VS*]FKD\',ZJUF3==DM_L@@B:-H;3DO"&DT*04
M2F-0&D?19#6W;J5[AENI52ZTG1)*BZ"T&$I+H+042J-0&H/2N-OU2H>'_2>R
MOEMOTSW16+F[UK#*>ZL^M5K8.S.LM^@U;9$N(<11+1]HVAA*2Z"T%$JC.]KH
MU %FT+0<19,EW3J7KMFY/"[I4\:]&=Q;WM#.2B@MAM(2*"V%TJBKL61=Q_;4
M"H#:GBB:O+I;:WL2L^T9]V\W,Q/[2I]T3<*PF=>C-+5$T*SQCF9LM]'LF3]N
M&FZ4"VS==L[(\Y5&"ZK)J3_%:H#-U(! F;G--=LY@>?[1YZ5D=8H).:N1+GG
M1I&(TE9P6BY0YQ!*BZ"TF'1['<<!\5Q55U!+$$JC4!J#TCB*)A=%:PF2$^O!
M*@TW^2^6!=1 A-(B*"V&TA(H+872*-&9=-T+"&A2CJ+)97&P/JS9/^R_3+*^
M'+#+PV+7A]4X4N+[>*RV!,?0M F4ED)I%$IC4!I'T>2":(U&\FS]_!]63(8Z
MD%!:!*7%4%H"I:50&H72&)3&432Y<%I/DY@]3?/BR>;@WL4 ;=@D75^1C$9C
M==4V:-($2DNA- JE,2B-HVBRREO/DY@]SY,S"\WQO84.76J6="W'(6D61U&5
M#C4ZH;042J-0&H/2.(HF*[WU0XG9#STYL] <WUOI4%^4=#TT$GB="WZHWPFE
MI5 :A=(8E,91-%GGK2]*S+YHKUDL9E9OS4,;/DG79/5\FZBK*T.3)E!:"J51
M*(U!:1Q%DT7?.J?$[)SV7;B0:(L!:J)":=&.)BTC0,9AZ([5<H#ZHU!:"J51
M*(U!:1Q%D__L3VNC>F8;]>3"A=J'GE[7$0P#/U1O'&^\KM$7."[I-(.:=[+O
M0QG-WHV5"_U$LV<C>S3N3$+4;.<$GA>J2Q)J<JKK56E0P]'8"96#P74I1\0?
MC?3NJ->ZHUX?=[37BH1Z%6AL0]MS'%4$4.<32HO/&T("39I":11*8U :1]%D
MP;?.I]?/^>RUU*!>\E#S$TJ+H+082DN@M!1*HU[7_.R<NJ'&)XHF5T5K?'KF
MOXQY]E*#'M3:A-(B*"V&TA(H+872*)3&H#2.HLEU<? G,(TVT2\L-6@&]RX4
MKWO]Y_B^NG)U!,T:0VD)E):>>40H-"N#TKAN#*%W<%,NJ[8U'SVS^?A32PWN
MF/*?T'9#6[UR[]J#FLTB\Q[V%B+4;(324BB-0FGLO ^+HY+*<FU=1,_L(O9=
M9]",ZWUJA9J*4%KL=2U*EZAKWD-3IE :A=(8E,91-%GUK:/HF1W%<Q8:-"-Z
M*QUJ*D)IL:=9Z%;5.=11A-(HE,:@-(ZBR3IO'46OWRJR6IU#C41/TU\Y]CO+
M<D.3QE!:<F0(:K<.-"F%TAB4QE$T6<2M0^B=L2KL+RVH:4[06^+=[C[7"[NW
M@]#F22@M.6\(*30IA=(8E,91-$GB?NOZ^;;Y$> O+*CI0[LHH;0(2HNAM 1*
M2Z$T"J4Q*(VC:'*IM*:I;S9-3TY[-<?WK@>H60JEQ5!: J6E4!J%TAB4QOVN
M93UTQN[!C 19Z:U;ZIO=TI/37LWQO94.-3^AM!A*2Z"T%$JC4!J#TKC?-6;'
MP3&9M_:G;^[[[+V>IIG76_:ZGDQ;O=N+H$EC*"TY;P@I-"F%TAB4QC4'A-C!
MP?(8LE1;1](W.Y*])FB;6;UEVK6KAIHYU1$T:PRE)6>.(85FI5 :@](XBB;K
MN?4J?;-7:5ZS1SO3VM<XE;8S#@/E;'.CV3!T?4]=>R8R[V)OP7:SCM5GV9IM
M_+'M^AT9=K=SQ[9-E%48J&8[=;Z29I.A[XUM=:JI[NB.O<.5@N1/NK7Y?+/-
M][,+\>@UT'7&Q%#4WKT;\R[UOJ"$FGOG#2&!)DVA- JE,2B-HVBRVEM[SS?;
M>S^_PHY>[U G$$J+H+082DN@M!1*HWZW+;-STH8Z@2C:<TE<K&=Y7D=9G5U?
MKK*'7&CX82[NGQ;YO<#;KP/Q15+-'V;[-W6YNAHX ^NNK.MRN7TYR[-I7C4;
MB-_?EV7]X\V%X#^5U==MCNO_ 5!+ P04    " !KB*A6@VD7SXT$  !I"P
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MB-$L?=9(,O9R /\7#GG2+\3 ,%W/_@%02P,$%     @ :XBH5FSB-WA0!P
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MR6ZM;0'KN?CYF2(719#1"TW5UL(S(3L.C!Q>9[H8(C(C:E\V:KX>9'C+=OI
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M,RYX;6RM6=ER&[L1_144KWPC54;DK%R\J$K>*D[9N2[;21Y2>0"'((EX%AK
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MT=!)\6F-7C-?IB^0<G8R/MN9NHKV3L;DV%C2Q0H$:;]&*H4AD)K#H9837>N
M5(*H,Y=2A!] J(AD;8Q5.ZC]?1P%0YFIB]<K3<R5@S];<TQLZIL[TL77#/(#
M<,.O<'KX<XM)AK2HY]?][7&P;_0.0P8&"$(:WQI O  06.Q#$6YH\$31+WT\
M T[E8&2"^),[WD_ES]+Y=5?Z236-6]5+V6@9&#\B+1#V9Q<4(Q3R&1 UV<"]
M:74YDG'2C1VF_\60&T5L8.0N+:<*H:@8(]3*$;J+\"E_%#-KNA8G]=4J6(ZG
M!&=F5=BAB'5).&NL**..D'Y/86$/5X"LH,>VAA7H&CH_XW+E1=HA2)N0.Y$?
M0)FZ:S7%F8\XC+WT6<%&?;3FN]<29> \:3D<0E)%'_1&2?4^B<743^U2+T0A
M/=6JVA4]O[4>GX@S"-N:&R44U:!\JHZ)^XX8OA% KXP:1$_VC22%*1)R4NX;
MK]M8VZ2E(&:AG:.<_6-FR?D&3[[O*E78-/*"\M2<JP%2<;J@^+PDP].S[Y;"
MM\SGF_+XM@46WR$3SCKAZ;CPO%] K^6J61=1$>!-0C?$8^S01 P54!7 '9>Y
M,_CI<V> 8GC\<?TMX082/D/"#; -^X3G"F"MX@B0Y?$HR(-MZE> TI"))&P(
M+5G2AJF^P4GI3O\:JF%KM/_;PLHE("=TA#3@2A&!O +\N&Y<9]D+;0DP0?$'
M ?G;NSRXO+H^%"Z4#/NK0%#CK.HF>?!_(:0@Y;RZ!I=<QS;LNI8,C=U[#A!@
MRHUJ?79_)[$PE>$;=&'GPZ<D#\("Z0FW*]# L#I>1?%D(]@00B$CX9),@A2;
M08?*[UV3NQ$AT(0N",+,A!R%SHR&PL3@0]V<ABL-$N 82DT_9S!VL5"P8EPX
M@M,W'26S%[^]8<PHZY4;%$9RAR$4F[CK$ F(5&:KYX) K)0,J K=EE0 K$S9
MA:@Y%'-EFK[&SBTC/>E\VI.)_NW-]YD"*\)._3]?3T8@*^AP])V$AQ/@>@NO
M966]S1@V#;Y?SS2O[[$M'.2SL]82>KE/08@+J=YVK'M;$^O=DHZ\Q$E</G5!
MV-P7#(J2[L9A__1)(BB6"/KE4?O=?TS]07WQ32WJE29#JYUV5*RK*.LN-U!S
M[W&W!@:=HV>^PP'_-_]W45.HGXW+9Y 6,286BQ&X%!??N.6+.#<LORUH_H+K
MP W\EHP5'7XL-!12^3\6)+E33)'G02CHP6\VE//&G_L&$AS+4L$9(./6H6K0
M-9WKH@+K7+_C>J1T\30V03;( #XD?73$5RYQ1N7*/>>YS7=/E=)V+J/K2?)E
M>8"Q7''-JA:*,3-#7 >$*COG>K'FXF]XCM2""K"F%2266&)!KJH2*1NI>ZC<
M#XN40ZY3@PAXJ>16"&[71/3$3!LCZ4$[LJ^*T@F!__T9DU5$'F!;@B-;)@$*
MJGNM>H0?\E':,+4X,VQP$<=.,NQP1T">,=0B/H3+D#]"TI#G(@(3W&9O+^@:
M9RP<ELL249%D3S&?RS6B43,3U7 \D] J/HTOUW'V-+*0Q 1N70>$-.0WA%57
M?3&^H$8,;195.'1(J13C90A4?? ;=2/DK>0.Z SL<:/+C9?'2J>+#9W5^$DJ
M0^[R5E:U76JOQ*& *L9#MVO-9CNA8,P3@^VH0/>#RY8RKI!">,>#(1$W+E0,
MU_>U#74'7\Q8G=U]% Q),_3F0ASAY6F6HXA_Z6K0%1A7W027W883,=PG@U^A
MEM*X>Q!ZH=EU;17,@H&72_G%Q$"&[!]B#AW[4(V<Q30X5P/[(Y,2%&)D/$&O
MYI(F/G)W$WZ HJ$2:CI5&P) *L9W'O<JSD[%10[$UPVY[>RZ/K%"+#F9<)Q+
M$%]O.GC69Y37<6DM)A&G0?+]!K<,+B&7)ABR%. J-OW2V562S=9\;6N==0M_
M0[3S7.%?4%%RKM44FJ'*CHD.F-KN2--V)&:<9(68"1_2=E2U"/)-U8Y< 6><
M@HN%;7[X)ATQJW34TP,' 42TL0^YOR84')]9J9S=8?N;")=.$QZ[@?"@+"2&
M81;_..74,K V\UP** .'8=ULM5Z><,"Z$L;N&01,C)__%1838JIK4DJ>(OK8
M9UK#A#\DO(E]7[IJ%AA*_C?0$/-8FND;5!7"AJ'"^U-2MBB\>Q+(UHHH26RA
M1'\*IRX;'R=_*-)#*B$Y;I/2EZST85AF7U_CFEJVXF/G(R2+?J86EWQ5\7.4
M[<#.WND!VOW./LQU7>O&:&Z\$8;;3B6^5-8/0N'@SO=2L5!04.HK._\)C[7)
M)AW$J>Q<UM-AES:4"MG;P0T D_(X2%3M:BT88;V_I6Y.;H$&K'X6BO81OP?E
M/F4-&&2R3S;5"E!&C\L2L,B%2:@HUJK&$#BVXT/Z,.PY1J%LY^VHX\(KF=<;
MDU%K#$WHG*8870!V))& L&6:>:81%K"ZAK=^3ZT9V 3T:6'8O?]B7*O)2+)*
M_1+BUFMD:%/XE$_(H;,K6ZL.QF\_&,H@'YX^>70:G'BNI3XN!FV2/QK.;&Y"
MD_&F:VD"(I8%R8_[V(Z "P.9L>,EVQ;TL+-ODMQM4(L485NFD',Q_ 4X2J87
M.Y3IV^R@$,ZT,S8QDVTDD$ I+A_F<E9ZH^\H;]:VI/CT8/3QL*_MZ750PEXP
MZ 4#=!9?WTN.HQM5SF5H]> RR9K<"&R0:0&/D@I_HL'#T/1^?_/IXI#8<^#E
MU]P")*'#;Q[$D%/S0 [)LPS-.9[^4+6>A3XA-LNG1.A$.^;A5<WYW$&V+R(K
M[#=T!WP,-1C#8%RNRG 24FDJHT M"4T KS%6"GX]CZF=G0_5Y28$-="2B@4C
M#[&I4;%.3>5.C0R(' P<M^M:BK<I9VV59T2/PW_(A2I*0$ 7!;DM<D]R9F)S
M%>"G+2-UD00&9GPX#5R%\[/U[MFZ:Y0X&W<5]I@,C<W:%-.V;\LF,%=UU0LI
MH8*1OK$"['8-%? M(8VHED$KH7>QYDQ%>FJF<R/=\B0(N699?DUPNS:W%$AS
M V"<#=$3IO.4;X2V$Y>9UV?70K$N#F?'A'G;C$V?3>X9I/V.49\M0S[$RS!-
M6W5Y4JD?8&/Q;[9,MT^=I12E8SZ'V%'D.D(LRZQX?HTTJ=;*#D:0*&V) GV8
M4IP\XAC2]*GB6D"$0;-H2JG=N\K<?K/.W[%F\Y1=RDV<J'NTD6> MPSN\8 S
M1SBX$N89I[T=FT.?G>4M(NVI'O3Q'E69,9EKQ2+Z*4U'IIG;'$C[<;3[3_MN
MG>Z*XW&#&?4-9=ULG??72"6Q#P9$/BW2R+ZG=&T6B=5CH['CF\5Y4"I%Y9IT
MK/$$.,Q'C$9/_W+*MS&V7]#\8)/Y!G<P%U-8_' ,,'11U]D\?OLA<;F?3!DE
MOBE64@$7S[/D>*224)!5@=N$NKL%&QO;R-2S2^+*PR K[M& YV)^])3]?*/3
MLX9+6H"]@6YUU]+@3)'?:>D?9BBLB671H0U7QVHH&R!)L+-E*%NMDJS^/?6,
M;%.WFMVS7>RMMA3Q/FP<F69ZM2;7CG(QK!C(.,@P57F.Q.=447T?I<GMI'$C
M[%>D*WI[,RUWYC?F6]9F:W+K9OO6P]$;. ^:O/GNP<"4<KUEK/G@ZOW;0Q8;
M6PL,'3Z<)- UJ30;JLU=$R,^/O:OX92F"N^$K#<M,NZZJ)8@& HZ1FIK;8D8
M[G?W)1[G.C+#B0!3Z/^LI2EZ9W=)"8CR<5=28K HQ3'<F/AW:>HZ#%AQV89H
M_<74\46,=^\NC]:&3E/G9[MD1KWU1 :S7=-(7D[4-T878TS8\_+<X_SRW..]
M;[]]@.S)D$Q=Y_>YN(H^0! M#QR896SC]=6]LG]U;MM[=_M/#O%L^/;=[^LA
MEH!42GX'+S,-EA!UH3W#;[LR8I(!J-%K3NS\]#2^Z061%-R'B%LV?/>^,I%A
M>7($:ENIFQVGB\GFEAAH;HE'<?/,6'*[?M4/I.67]$B%1G.#G,:GUQ[B!!H2
M/VONTGL-_W5Z4IS\]-/1-O$?#UY]1728\0N^+E2.PENP^=O\#O%%>'6V?SR\
M@ P0/-,-08(IEIX</84\;7BI-WSPIN47:2?&>[/@/P&D*V7I ?P^-9!9_$ '
MY#>K7_T_4$L#!!0    ( &N(J%;NC_UD/@,  +$'   9    >&PO=V]R:W-H
M965T<R]S:&5E=#$U+GAM;)55VV[;, S]%<(;MI<TOB1IARX)T-NP/10HVET>
MACTH-F,+E257HIMF7S]*3KP42#+L(;$NY.$Y)"5-5\8^N@J1X*56VLVBBJ@Y
MCV.75U@+-S0-:MY9&EL+XJDM8]=8%$5PJE6<)<EI7 NIH_DTK-W9^=2TI*3&
M.PNNK6MAUY>HS&H6I=%VX5Z6%?F%>#YM1(D/2-^:.\NSN$<I9(W:2:/!XG(6
M7:3GEQ-O'PR^2URYG3%X)0MC'OWD2S&+$D\(%>;D$01_GO$*E?) 3.-I@QGU
M(;WC[GB+_BEH9RT+X?#*J!^RH&H6?8B@P*5H%=V;U6?<Z D$<Z-<^(=59YM-
M(LA;1Z;>.#.#6NKN*UXV>=AQ^) <<,@V#EG@W04*+*\%B?G4FA58;\UH?A"D
M!F\F)[4OR@-9WI7L1_.'2EBLC"K0NO> 3ZVD]30F1O;[<;Y!N>Q0L@,H([@U
MFBH'-[K XK5_S(QZ6MF6UF5V%/!6V"&,T@%D238Z@C?J98X"WN@ WDT0!C\O
M%HXL=\*O?1H[B/%^"'\ZSETC<IQ%W/X.[3-&\W=OTM/DXQ&"XY[@^!CZ_(%,
M_GCB^ZN W-1\YISP;;N/YS^0]E04#L'#=6NE+H$JY)]%A+HK)/I" I<AK_HZ
M#(+9%;L+O8;2"DULDPY&608N!'!(I'B-\T-6YGY;Z (:M.'ZT#EVAM!J28Y;
MG2HV %&6%DM!V(&>%'ZX%-+"LU M@EG"VS1)!^/3LX G8!5.&Q8GXADM7QZ
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M5L S88>0C0:0)FFV!2_KQ68M7O8(WF=;"BU_"W\?!G!LM#-*%B)<#UW G!O
M\H/#+.%$:J%S*11<L!/Y+I*#[X<+1Y9OTX^'.A0(C!\FX+^P ]>('*=1XVO9
M:XQF+YZ-=I.W6^2->WGC;>C_>);_BP6O+D_?N]>'!'P\>178;PYI %2Q+L@-
M7P'ML/"KKLML+/N&NKN&2IVK58% AGA#.(?LY.[[,O[]/$OV!^.=G?:(0I!B
M;E(%.MZKC>8Z9(UB'67/^0Z&#!.3MH!&V#;+XX[V]@?9?CJ$+Q6'0R6N$1:(
MFN'X$V,(3S2OA"[1L_320 M:<2RG>^O8U(W0MR^9A;4^+BA:2ZHZ^A8D.WZN
MBC)L,<T<K?8L&:"&I34UKPSWK$"76[G@-G&M3X80TBP0OU_HR?TL-I3Y7%(8
M)6\^#A^Z8_&]V5&C+=L)Z<NL-(4QTGO[(7P89L]=>)C@?!]*J1TH7')J,MS;
MB<"&J1@,,DT[B1:&>*ZURXI_)&A] .\O#:ON#%^@_S7-_@!02P,$%     @
M:XBH5IT0H6H?"0  :!@  !D   !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
MG5EK<]LV%OTK&#73)C.*GGXEL3UC)\TTLYMNMDZ['W;V T1"$FH2H %0LO+K
M]]P+D*)L67E\:$U"P'V>>^X%<[ZV[M8OE0KBOBR,O^@M0ZA>#X<^6ZI2^H&M
ME,$O<^M*&?#J%D-?.25S/E06P\EH=#(LI3:]RW->^^0NSVT="FW4)R=\79;2
M;:Y58=<7O7&O6?A#+Y:!%H:7YY5<J!L5_JP^.;P-6RFY+I7QVAKAU/RB=S5^
M?7U$^WG#7UJM?>=9D"<S:V_IY4-^T1N10:I062 )$G]6ZJTJ"A($,^Z2S%ZK
MD@YVGQOI[]EW^#*37KVUQ7]T'I87O;.>R-5<UD7XPZY_4\F?8Y*7V<+S_\4Z
M[IV>]$16^V#+=!@6E-K$O_(^Q:%SX&STQ(%).C!ANZ,BMO*=#/+RW-FU<+0;
MTNB!7>73,$X;2LI-</A5XURX?"^U$RM9U$K8N9AK(TVF92&T\<'5B'[PY\,
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MU@$EW!B@LA0EUV0\@% B7"]7%Z"\;^CUH=S@OI8B(+Q;KN[?PV<[C+Y'X^D
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ML\ 60)87X'ENC-]=<(#NGYOK_P-02P,$%     @ :XBH5KRI<K.9#0  ."4
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MQ8#\$#*':+A-D9-&23C9ACF]0GVS,2KPM&QAQK>DDA9)?$P+!';Z36?\)8T
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M=!ON'@XHVKOM8=B#XC"Q<;:424K3[:\?)3E> J392T)2Y,>/I$3/CTK_, V
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MXVU<WU^!3#IES)2T$LVH?1/K#LQT'EO,[1#B>LBS"GG2=_)P\E5)VQCRB]S
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M&HP^/A('#0]'8KK]'R7Z_8[Q^HZ+;R"#:H85JYT9\'> %2O%MN \AIT["6B
MC>\MK^//3((=B:.4!+8X)B^+7@O[O8L/QY D<3-(>4(YELJAJ(RW+C\5J(6[
MXFGL"^O:-/>@?K:_14Z;R]/S\N8*^L4U)$U*F*.J=Q9CY5+-M:X9&+ER5ZF9
M-'@Q<^(2;\*@[ +\/I?2= .[07^WGOP'4$L#!!0    ( &N(J%;;@E!*R@<
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M\ $'G[\Q*D=< 1@?J__&K8*8+34]# K$.%R3VB&-NVVU[H8TDU'?_@2A\$C
M>/1J"@^HH,&'&KS9?XS2D5!0)L;JO0FKU&5+30^#HBYA;R^0Z';7,,'<:V__
M-]EAX?7M6!.*C<0.>X&@9-ZIJ 8?9/#Y&Z.:)!1KB;$:<<(J4=E2T\.@B$K8
M:\2);G^-,X[;/P=-9H21OB3>>M!J7^H1AMU!W0UM)JO>#6U",8_8DWEZ2X"P
M\."$&H-MA&(;,1;;"*ML8TM-#X-B&[$OV]0"V@.3Q*/M'6\&,]^C;4*?;CUD
M7%S(E]6SUQF:)P]QOGDZM_FT>;[[M'JJN?7Y&3XZWSREK60V#XU?!NDRC#,4
MR;M"TCETBV6>;I[#WKS)D_OJ4>;;),^3=?5R)8.%3$N#XON[),E?WI0':)Z&
MG_T/4$L#!!0    ( &N(J%8H/A8-G ,  -X*   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;*U6;6\:.1#^*]9>=&JEAGUE@1P@A=#J^J%5E%S:SV9W
M "M>F[.]D/OW-_8N&P(&M56_P'H\,Y[G\7AFQCNIGO4:P)"7B@L]"=;&;&["
M4!=KJ*CNR0T(W%E*55&#2[4*]48!+9U1Q<,DBO*PHDP$T[&3W:OI6-:&,P'W
MBNBZJJCZ;P9<[B9!'.P%#VRU-E803L<;NH)',$^;>X6KL/-2L@J$9E(0!<M)
M<!O?W,61-7 :WQCL],$WL5 64C[;Q>=R$D0V(N!0&.N"XM\6[H!SZPGC^+=U
M&G1G6L/#[[WW3PX\@EE0#7>2?V>E64^"84!*6-*:FP>Y^QM:0'WKKY!<NU^R
M:W6C@!2U-K)JC3&"BHGFG[ZT1!P8H!^_0=(:),<&V1F#M#5('= F,@=K3@V=
MCI7<$66UT9O]<-PX:T3#A+W&1Z-PEZ&=F7ZD2C"QTF0#>+EKJH!X1-?D 0HI
M"L89=>S+)1%U!8H:J32AHD3JA,3X&D&MH21&DH+RHN;4@*6:%8TBX[7!;3@]
MYMT<#&5<O\<#GQ[GY-W5>W)%PF97$R;(DV!&?S@0_+.6M4:W*+QZLQZ'!NFQ
M(,.BI6+64)&<H2(E7Z0P:TT^BA+*M_8ATMIQF^RYG247'7ZAJD?2^ -)HB3U
MQ'/WX^;)A7#2[JI3YR\]X^]K=V$W/G(:X\QO;*O)C=[0 B8!E@L-:@O!],\_
MXCSZRX?L-SE[@S/K<&:7O$^_8O%CHI 5$&J,8HO:T 4'FX]S^HT92CZ+HN>C
MH/&;.[^V_FVG<=SO9X-QN#T$YU'+D]C>T=83=K\+NW\Q[.^NXN##H%N\IM7^
MR;2ICA58&\QK?#&DK)7]PW?#9.G#T1PT. AP%&6C8Q@>K3S-SJ#(.Q3Y112W
M&AL"@L +4(#EWE!.EDI6!"M9\4PVG KOT\Q/@HE'P_PHXE.E+,YC?\"#+N#!
MS]&^KT^_0OS@E-(D&Z9',$ZUXBCJ1ZD?R+ #,KP(9.;21;PF_VM=_<EGT)PS
M/(ROEPR/0/B4\J$?PJB#,+H(8=Y2_SM C'P@^D<@?$KG$BJ.7EMJ=/D-",.N
M71KAA-(D_K4&8[C-LAU5I2;P4O :NTSS-O9M$CNKMVU%IPF3C(ZQ^+0&QUC"
M@TD!N\'*#5":%+(6IFELG;0;TF[=:'(DG]GAS4T@KVZ:R0_;UHH)33@LT674
M&V"=4<TPU2R,W+AY9"$-3C?N<XT#*"BK@/M+*<U^80_H1MKI_U!+ P04
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ME<H[MOZ-5(:&1;V(I:+\!.LJUG- M!*2956R4I#1?/.-?U8#L96@ZI@34)6
M=A."C@2_2O!+HQMEI:UK+/%LPMD:\"):52L.RK$ILY4;FA?3>"^Y^I6J/#G[
ME;%X3=,4G(&K!.<+(@#-07UU_@SNR))QB><I ?=DH690"O#QFDA,TT\JZ^'^
M&GQ\_PF\+_+^3-A*X#P6$U<J<<4MW*@2<KD1@CJ$^."&Y3(1X)<\)K$A_\J>
M#Y&E@*M&I1X:]#(TE\A:\0;S<^##SP!YR#<)LJ=?DZA.1Q8Y?CU3?EG/WS=3
M_]PQ]:F:>(UY_*]II#>%!N9"Q<+P12QQ1*:.>O(%X4_$F7UX!P/OJ\EE3\4:
MG@>UYX&M^NR2+&B>TWRA'M44YQ$QN=V4",H2Q:KU- N], B@-W&?MHV8X@8!
M&L ZKJ%Q6&L<6C5>1#]65-!B43*VO37[T,G8% NW/ S&WB T.PAJ!X'5P;5:
M2(6D<J4$F!Q8LP]U$+0<G/G^T#,["&L'H=6!>AC4>IVK!9-SDD?/0*U!@,F$
M<(#C_]0J6BY;)F]A2P[T0P_NM$X[Z@P.?30RJQ[5JD=6U6JAVM/:H]9]0V_L
M^7!7GRFN^0@T!(YK@6.KP)<EYS.8$_6/@2CH1JMLE6))8D"S)::\&%@0)9@O
MS+TS;BM#$"(8[#BP"GGC*@,]#4%OSS-\J*^J8+,ED)J<X8XQ^YW?ZFP+[_#(
M'JL*[&\R8Z"ERR#2(I%5Y,/Y_3F(*4Z?!36/MC7_T"6HKVI-MYKCL#>0PUY)
MWE>UIF_-<M@#S*L:VTT6#& P0JWGRA3H>3! '=VH>0Z/ [H]_>!):2,=!F$7
M$*%F.CP.ZO;T@UT8L#[J^%L"-=7AJ; .V\3>_3MH#6D*UD"'QQ(=ME'=T=_[
M YLB-=3AR:D.VUCO<'$*KB/-==0WUU&;Z[N-8[_G6SUIHJ-CB8[:H#;/SBL"
MFR(UT9&=Z'\4#^F'=R,$T=>+/%+=AODS* :#1AT#WROB^ZK6M*\1CWI#/.H5
M\7U5:_K6B$<](!X9R#T<AZ-6=YH('WCAN*,Y->#1<8"WIQ\\)6W ^PB-.^"(
M-.#1<8"WIQ_LPO3>C@*_PX5&/#H5XM'K7MT-8;9W=Z19CXYE/3(@//0'H]UW
M7U-<\X%H2M2D1R<G/3*\P(\'_K@US*< O:]![_<->O^U+_#V.[_5F<:]?RSN
MJP+!OC8SQ9G:S-W:3<B(&K]BDT6 B*URN=E8J*_6&SD7Y?:%J\,WNT W:OAI
M+D!*'E6J=QZJM9!O-E8V)Y(MR[V).9.29>5A0G!,>!&@?G]D3+Z<%#>HM[=F
M_P-02P,$%     @ :XBH5NVW--ZT @  ;0@  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S4N>&ULK99M;YLP$,>_RHE54RMMA4!*IHX@->G65EH?U*S;BVDO
M'+@$J\9FMDDZ:1]^-A":5 E;I;P!/]W/][>/.Z*ED(\J0]3PE#.NADZF=7'J
MNBK),"?J6!3(S<Q,R)QHTY5S5Q4225H9Y<SU/2]T<T*Y$T?5V)V,(U%J1CG>
M25!EGA/Y>X1,+(=.SUD-W--YINV &T<%F>,$]4-Q)TW/;2DIS9$K*CA(G V=
ML][I>&#75PN^45RJM398)5,A'FWG*ATZGG4(&2;:$HAY+7",C%F0<>-7PW3:
M+:WA>GM%_UQI-UJF1.%8L.\TU=G0^>! BC-2,GTOEI?8Z#FQO$0P53UA6:_M
MAPXDI=(B;XR-!SGE]9L\->>P9A!X.PS\QL!_8>#[.PR"QB"HA-:>5;+.B29Q
M),42I%UM:+91G4UE;=10;F]QHJ69I<9.QQ="I$O*&+R'&R(EL8<*A^>H"67J
M" Z <OB:B5(1GJK(U69+:^@F#7Y4X_T=^ "N!=>9@D\\Q733WC6NMO[Z*W]'
M?B?PFLAC"'KOP/?\ !XFYW!X< 0*YR:R]!;_QO^/\U>X#C>#]EB#BAO\ZUA_
M?#$S<*4Q5S^W'5^-Z6_'V$_X5!4DP:%COE&%<H%._/9-+_0^;M.Z)]B&XGZK
MN-]%?U9,\X)0::\#DHS(.2KX P?;M-? L +:;+.(O<A=K OJ6K'AY4GKY4FG
ME[<Z0PF72)C.X+9 &_"";PWL3M!K;V9/L W-8:LYW$\LAOM4O"?8AN)!JWC0
M><LW93XUURQF<(^%D)I,&<*DSA$V&G>GBU$-'G3$9.?6KQ7FKF7N',W'8@N:
M@D247-=)L1UM:^9952I>C(],+:U+WS.F+L0FQ<TI5\!P9I#>\<#$HJR+6]W1
MHJCJPU1H4VVJ9F;^!U#:!69^)H1>=>P&[1]&_!=02P,$%     @ :XBH5GEW
M(ZLQ"0  9SX  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULM9M;;^.X
M%<>_"N%NBUTTB<6KI6D2()<&G6*F&R29Z4/1!\5F8F%ER4O1SJ3HAR]UL6E)
M%!6Y5!X26R&/SI\B#W\Z),_?4O%;MN1<@A^K.,DN)DLIUY^FTVR^Y*LP.TO7
M/%'_>4G%*I3JJWB=9FO!PT51:15/D>>QZ2J,DLGE>7'M7ER>IQL91PF_%R#;
MK%:A>+_F<?IV,8&3W86'Z'4I\PO3R_-U^,H?N?RVOA?JVW1O91&M>))%:0($
M?[F87,%/-VR65RA*?(_X6W;P&>12GM/TM_S+Y\7%Q,L]XC&?R]Q$J/YL^0V/
MX]R2\N/WRNAD?\^\XN'GG?6[0KP2\QQF_":-_QDMY/)BXD_ @K^$FU@^I&]_
MXY4@FMN;IW%6_ 9O95G&)F"^R62ZJBHK#U914OX-?U0-<5 !=E5 5074K$ Z
M*N"J BZ$EIX5LFY#&5Z>B_0-B+RTLI9_*-JFJ*W41$G^&!^E4/^-5#UY^25-
M7D\E%RNE_5F"GV^Y#*/X%W *OCW>@I]_^@7\!*($/"W3318FB^Q\*M5=\[K3
M>76'Z_(.J.,.&'Q-$[G,P%^3!5_4ZT^5MWN7T<[E:V0U^#449P##$X \A W^
MW-BKW_+YOCJRN(/W+8@+>[C3GFJWSTDFQ49U;PG^]445 )\E7V7_-K56:8V8
MK>6C]E.V#N?\8J*&9<;%ED\N__0'R+R_F*0Z,E833O;"B<UZ*3Q*5.?AF00B
ME!PL-B)*7L&:BRA=F,27%J%7F,Q#S/;2._,(I>?3[:$NZYV/U$7WNJA55WU(
MG("W(A3P!0BW7*C05M=\ D()UJFZEH\3J4*<23?MT(T;NJV>':F;[74SJ^ZG
M5(9Q&0;6ZC'.H[7ZJB)_)M7 5X_5I*NTR YD^3,/(DH:N@SE N93&.S+U5R>
M[5V>V;M@E,W33:(>DFJ/5;19 >5J'L6Y$.J!O41)J'2H'CE/,VF,7:7]V8%C
MIP12%#3\-Q4C)/#-[OM[]WVK^S>A$.^Y>^$J5P'2%Q W.E_"B\N;1!41,OJ/
M4K6H1!OU^"U'?4:#&6H.,$.Y !$/0;.B8*\HL(\=GF5JVE*MG^2C0N13M<G-
MH-V>B" 8-,>#J1R&Q"-F-Z&GISWO YV]WMK&N<UK-Q2!,XI1PU-3018@!F<=
MKA[,T-#JZB-/HE2 ?Z229^ NW0AP7X2;Q^@'>'I+P9WB('#/Q3QO\]L-5Q?5
MIW<U9T="OAM%66\X= YR9:W>/$@W#W(Z_U;F7(EW9*TN7K,'M,[PM;YA%(M;
M@1?-J*=^FMT7M[IOLV#=14T)T#TF5"8A;,R7K!7'[#<_MOTU*D [*S0ZWPGX
M&DHE3HT^1>-&$N@Q^/=-<@: I_!4\2GVC%UN#$B FA*@'1-:DN_"2(#O8:PB
M3SX?QVFV$6;I;0I F! \:SU4JP?'*M10 >U440NX3TO!^2[B\BU/>N(M^#4Q
MB[?><W#8<62MWD*:6Z#O-N9:.6BP>$?6ZN(UXD [X_3&W*#5S6$125LQMTTW
MS8+U%V1--\A.-\?$W,ID\QVE/3KM]SZR^9'&(63'H>$AM\?@'7\^ Y"6$1<:
M$PIC$ [2A(.L$/%_1-S*<*TK0A_#UC1J]^!8A1ICD!UCKN:_;Z(L*A)[Z7,<
MO8;YQZQXFTOED@N0%,%X';Z'S[%9JM.\BBMK]?;0S(2(T_B*'%%0)7X,ID*:
MJ9 =@5QT!FKH]S.?LF:WI^T(C#S*4$< UI"$/@!)T<&07>V"U*+(&2UX-A?1
MNNOUN,=ZGO@\5<&*&9_>&/"$-#PA.SR-D3VK;MF<FIC?? FW^W:L=HU%R)[/
M&=AS3\!+'LBW>2 WRO8_V(O'X"&D>0C9>>ANGV6+>9CQ0^5&559K@V.5(VOU
MU+\&+>RY3?X[8J<J^S\&B6%-8K@'G(8]^,I:[?6/$0:;@[@J5T]%8.9W)%NQ
MYBC\ 8XZ/BCW6%=!F>1!.3 ^J3'X"A\L4=GYJGQ2O'Q.AIB\2RE7,7E=OMP:
M&P%_<"7#[M&QBC5!87O6Z8%OTWA;],U\1*8O8"[X(C)K<DI/KJS5A6MZPM1M
M1'*43:K$CY&;PAJ[L!V,'OE\DR_\W'9D\W$[ ]5\*:^*U)"0T<YW<JS!"-O!
MJ*M''E) ?G6W%F1?>*MN9E4R!@QA#4/8#D/#W]-[#%YM7M5[.BK>TQ$Q]KXQ
M0 AK$,)V$.IZPN"_X,OGZU\?C)J=TI K:_7] )J&B%L:(DYIR)6UNGA-0V1@
M7NI6XT3>%Q3_@S1>@.^AB'+Z!P]Y6NXZS"(C+?7<K>A0?X9G,_I'8UN,D;$B
MFK2(G86>\O>_+VF8@"NC-J=+<*ZLU;5JMB)N]_\0IXDJ5];JX@^V -DQJV_"
MK:K77F&)^D&SYH8?TIYV2> 3W$']1 ,1<;U$UV.P?QZR&SCVH6@*(F.MT)$V
M'T&",0V:^WGL'ARK4+,4L;/407RQ3:YV*X.'VA@\131/$;=K;L3IFILK:W7Q
M&JV(':U<3ZX]NYAZ)M<Q*(MJRJ(]6Y?VG?_ZU+1<=6VO/_3)N[)65ZNQBD*G
MW9XZW=ODREI=O.8H:N>HONF5MM?W$$-$!>SFOE+4SJDQYOFX8[\?U?A#[:FE
MX=-KC\':]&I<X; ;./:A:.:A']C0=-3T2MLTA*A/@M;T:O?@6(4'&Z#MA%.+
M,+8)UFYG\& ; YNHQB;*W$8:1PQ4B1^#J*@F*MJSD]KM!-MSMYX)UE[[V+;0
MI$7MB:9J@\\N^-Z429R[<![%D8S,FW[L)@=WAC%HBVK:HH';D> TB>7*6OT0
MA,8K9L>K,1:PF7EO%6FNY-I=.U:Z9BTVB+5.@"R&^DN:RJ1KMQMSRENNK-4;
M0/,6&[C3ZMO!N8O=81-C*[1!#!M.P;0I#).@XX  TPC&^A"L.N^B%V1ONLZ[
ML/8^;\AF03,=8RKF^Y!UN*K9B?7EB^Q[)^W5!_>F,3"*:8QB@Y;B/C:<G!*5
M*VOU!C@X4-:7B!K0,=OK;I@6^;5ZQS048\C#'1U3\P\;R#^'(_^^/%QF=+N]
M#G<*,6U'=E,YXL%F>G-Z<)1WQ<5K<<(Y T7@*4_U[J_N3U%?%6>'I[IX>03[
M:RA>HR0#,7]153T%6Q,@RE/-Y1>9KHN#P<^IE.FJ^+CDX8*+O(#Z?]Y1=U_R
M&^S/EE_^#U!+ P04    " !KB*A6;)VK7] $  !Z%0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S-RYX;6RU6-MNXS80_96!NBBR@!.)\BU);0..DW1=)$V0
M2_NPZ ,M43:QDN@E*=M;].,[E!S)\LI"$BAYB'7A',TYFB&/.%@+^4TM&-.P
MB<)8#:V%ULMSVU;>@D54G8@EB_%.(&1$-9[*N:V6DE$_#8I"VW6<GAU1'ENC
M07KM7HX&(M$AC]F]!)5$$94_+E@HUD.+6"\7'OA\H<T%>S18TCE[9/IY>2_Q
MS,Y1?!ZQ6'$1@V3!T!J3\PDY,P'IB+\X6ZN=8S!49D)\,R=3?V@Y)B,6,D\;
M"(H_*S9A86B0,(_O6U K?Z8)W#U^0;].R2.9&55L(L*_N:\70^O4 I\%- GU
M@UA_85M"78/GB5"E_V&]'>M8X"5*BV@;C!E$/,Y^Z68KQ$Z VSL0X&X#W+T
MTCD0T-X&M%.B668IK4NJZ6@@Q1JD&8UHYB#5)HU&-CPVK_%12[S+,4Z/;D0\
M/]9,1LA]IN$1R\1/0@8B@$LF^8H:E6$:*RT3?'M:P=$ETY2'ZC,<P_/C)1Q]
M^@R?@,?PM!")HK&O!K;&S R^[6VSN,BR< ]DT89;$>N%@JO89WXYWD9&.2WW
MA=:%6PMX2^4)M$D+7,=M5^0SJ0^_9%X>[M:DT\Y5;J=X[8-XN91?;_ >3#6+
MU#]50F5 G6H@T]3G:DD]-K2P:Q63*V:-?OV%])S?JE@V!%;BW,DY=^K01Y7E
MTX+?<6J!HQNAL( >F!=2I7C F0^!%!&,[R93K"4M,,83$6O!51"PM-7A7DC3
M^2UXU!3E0S13I=DX$!(F(D(:"S/%I,],KW^]VFAS988U?15C#I(:D$KIZ_E,
M8VP3IC1@B6-O8+-<;7 R5:Q*^%JH=PK?S87OUB;J.N0,\FP?4"N8T"6,YY*Q
MK(4+3?](L!C;3EKH3I4FM8]Z:SDV!%92I9>KTFNJ!7M-<FX(K,2YGW/NO[(%
M6\#R=^YC1531KL?"2CE)*^50J4QJX]_)]#1G>OIZIILES[K\(-5ZL!+53A75
MVOAW4CW+J9[59G>G%TQ"L6Z/E6+8T_]!HWU?F\-;>Z AL))<Q"D<CM-4YV^1
M&J+=%%J9]XZS(Z]=@*FID18$E$M8T3#!+IE+7(*S&Y5*9-B]%-M\"ZQ&A+B]
MT_[ 7I4X5HQKG_6[W7Q<.7NWR-ZMS7Y"U0*N\2L#OC!_SN-YTQ5>__PWO^N&
MT,IJ%?Z2-&8P2:,.LRFT,N_"8Y)Z4S:.1)+YP/3SA66.#+\O]XTE];PD2D(L
M&1]RC\E3CU@I4O;8_DY9'[L.UO5^^7^$T2.%TR/U5B];"RJ-;V:Q6_ <X]=]
MR/]%WKO6&Q?'HF84C"57IL<N$VE^[O&6\%LP8X&0#)[HIE*D[L\B=?JDMZ_1
M1]@^4O@^4FNQ1D]FD;P1-(9KZO&0ZQ\XD]S2#8^2J/$YI5'KV!1:6;C"/))^
M8W-*0]YOR_LCG"0IK"2IMW]_"N,=:0@TG5R4F5WX2X%(4R T+XY*,4Y_6A+;
M7<?\[3?&1]A(4OA(4F\D;Z87=P^P#!.U1R^B$A?<2FH9(G%WN#DGCKM/K%'#
M9^_L;N'W^SS=]%/@F9>3;73E5_.-Q7&ZG687P[-=R=N4F8*0!1CJG/1Q:I+9
M1E]VHL4RW2N;":U%E!XN&/69- /P?B"$?CDQ#\BW6T?_ U!+ P04    " !K
MB*A6GV)@0F\&  #:+@  &0   'AL+W=O<FMS:&5E=',O<VAE970S."YX;6S-
MFEUOVS84AO\*X15#"[2Q/OR5+C%@1RF6(4&")%TOAEW0$FUSE4B'HNP$Z(\?
M*<FBZ<ILC9T RX4CRSKOH1[QD'HEGFVX^)HO"9'H.4M9?MY92KGZV.WF\9)D
M.#_A*\+4+W,N,BS55['HYBM!<%(&96DW\+Q!-\.4=<9GY;X[,3[CA4PI(W<"
MY4668?$R)2G?G'?\SG;'/5TLI=[1'9^M\((\$/EY=2?4MVZCDM",L)QRA@29
MGW<F_L<H[.N \H@_*=GD.]M(G\J,\Z_ZRU5RWO%TBTA*8JDEL/JW)A<D3;62
M:L=3+=II<NK W>VM^J?RY-7)S'!.+GCZA29R>=X9=5!"YKA(Y3W?_$[J$RH;
M&/,T+S_1IC[6ZZ"XR"7/ZF#5@HRRZC]^KD'L!"B=]H"@#@A^-B"L \+]@-Z!
M@%X=T"O)5*=2<HBPQ.,SP3=(Z*.5FMXH89;1ZO0IT]?]00KU*U5Q<GS-V>*#
M)")3L&82?4"3)*'ZBN 47;&J7^GK\S8B$M/TG3KB\T.$WKYYA]X@RM#CDA<Y
M9DE^UI6J.5JT&]>I+ZK4P8'4(;KA3"YS=,D2DMCQ774:S;D$VW.9!D[!R4J<
MH,!_CP(O"-O:XPZ_P2H\/!P>_4SV45NX=39A<V7"4B\\H!?IZW'%<BD*56<2
M_76M#D!7DF3YWRVMFU9JO78U/7Q\S%<X)N<=-3[D1*Q)9_SK+_[ ^ZV-%*18
M!"1F4>PU%'LN]?&7LO!)@O":"#60(3*?DW*L4;U7]7N22R2P) A+]%1@H78A
MPI(VP,Y$QP*NQ'RO5-.#\WKLG7B]ONHYZUUV0$DM=OV&71^&75((RA9;?FWL
MG(F.9=<_P*Z_QPXHJ<5NT+ ;.-G=$1&KJM74^+P:6VE3RSF:$5PBF]-GQ=>B
MV8;/F>M8?)68'UCXONMX0"DM>,,&WM )3T]*Z%%/2N4@N,-R6G.[C#GC&8UQ
MFKZ@3R7$JRW$^P,0G3F/A3AL@WBZ#Q$HI05QU$ <.2&6_*XY9N@3CFE*Y0OZ
MAAZ*64Z>"CV?7*[UY[=RNK+AH0N\0I.%(*3JK)=-V?]1J"DH&*$)2ZKMT$,W
M))NI0?,;>A28J=M2=,M:\3M;>RQ^2+$(2,RZ2J?-53H%G>5/(2E"BD5 8A9%
MWS.WL9ZSMT=$T#76G?3]SC25'!@*?B"FNG9U*Z>+H]=Z9^L4.!8=E)K-;L<"
M^/_/D>)QPUNOCK.YQW9R4+4(2LV^5(&Y5 'H<%'+0:&$5(N@U&R4QE[Y3M]Q
M[(CA%BM'C-!SC1B@E@I*S69G3)7O=E7W9,W3M;X1T[_H.]Q8D(3*5G*@O@E4
M+8)2LS$:?^7W8:L9U$:!JD50:C9*8[=\M]^ZP<\T*S(TXT+%ZIX98Y5.SV6<
M(:DF&]'TV:JOHGDUV5'2]NQJZLYW-.M*;;!C%WRO_-MS#%!I;8S&>/ENYW6H
ML%MN"%JA@7HL4+4(2LTF:]R8/X*M=5"_!*H60:G9*(UE\IU>XA5J'=15@:I%
MM9HU<O3MD<-^6&XL4^!V.==$ZJ>=JL8O#D[>;HECR8"J15!J-C[CF@(?M* #
M4%<#JA9!J=DHC:L)G+?Z=4_,=Z8;7LA<8I:H$FYE"6IK:K7A[K.\O6D9*J$-
MR'B5P&TOIC15OD3@%#V0N%"(4%V\M]OB;:Q[*R[0=T.@:A&4FDW6.)F@!UO%
MH&X&5"V"4K-1&C<3N%\7'5_%H':F5AM:$Z4?]D?[I?P:1B4P1B5P&Q7SL&W2
MR@34=H"J15!J-CGC38(A;*F"FA%0M0A*S49IS$C@?C>TA_*]?L5&>4)C=(=?
MZCV"LIBN<-J*%M2<U&J[E=OO>;Z_7[BOX3H"XSH"M^O8SKPENULSLAE2:(I3
MS&*BK?(_));HD:/KJ^GM?2M"4,]1JUD(!Z/A:+#/\#7>TH3&<H1NRV$&O^D'
MOW41"ZC? %6+H-1L=L9OA+!^(P3U&Z!J$92:C=+XC=#M-_[K\.>6/QIM\)W#
M#P>]8;!7NE!);68[J]'<%N2!,,I%XS]LUW'@N8I;\FA.L(O27L-WA,9WA+"^
M(P3U':!J$92:C=+XCA!HF=J/E_BY,QU-^<!"M?U)&2IKQ:^[LQ@X(V)1+JK.
M4<P+)JMUP<W>9N'VI%RNW#6'5ZN^;[!84):CE,Q5J'<R5 T5U4+JZHODJW)I
M\8Q+R;-R<TEP0H0^0/T^YUQNO^@$S7+V\;]02P,$%     @ :XBH5OK):=#L
M @    H  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULK59=3]LP%/TK
M5QF:0-J:-*$?=&VD4IC& UH%8WLVR6UBD=B9[;;TW^\Z":&=2@:L+XF_SO$]
MQ[[R':^E>M IHH''/!-ZXJ3&%"/7U5&*.=,=6:"@F854.3/458FK"X4L+D%Y
MYOJ>UW=SQH43CLNQN0K'<FDR+G"N0"_SG*G-.69R/7&ZSM/ #4]28P?<<%RP
M!&_1W!5S13VW88EYCD)S*4#A8N),NZ/9T*XO%_SDN-9;;;!*[J5\L)VK>.)X
M-B#,,#*6@=%OA3/,,DM$8?RN.9UF2PO<;C^Q?RVUDY9[IG$FLU\\-NG$&3H0
MXX(M,W,CU]^PUM.S?)',=/F%=;W6<R!::B/S&DP1Y%Q4?_98^[ %()[] +\&
M^*\%!#4@*(56D96R+IAAX5C)-2B[FMALH_2F1),:+NPIWAI%LYQP)IS)/.>&
MCL5H8"*&F12&BP1%Q%'#9YC&,;=^LPRN1'5IK/O'%V@8STYHQ=WM!1P?G< 1
M< $_4KG4Q*/'KJ'H[!YN5$<RJR+Q7X@D@&O:.]5P*6*,=_$NJ6JD^4_2SOU6
MPN^1Z8#O?P+?ZY[MBZ<=?LU4!X*NA?M!2SA!XW10\@7O<7JT)[[SBN]T/Y]-
M[Y$N6(03A_)7HUJA$W[\T.U[7_:)/1#9CO331OII&SM)5X54S"#=(8.)XF8#
MTT0A6C=@CHK+>)\!K:QO-: ]Q!YLD"G=(K;7B.W]A]C+QX*K*H<H7W&?ZG;Z
MYE:_>*U;\>\\Z7XCOO\/\<^7W$@HE%SQ&($>'2M:)!"Q@AN6[=/=ROS6TSX0
MV8X)@\:$P8$S?7!(Z0<BVY$^;*0/VV^G25%!(0V)Y_1F1*^\#W92XXI&,X@)
MN-%<0T0P_#LG*\-:HWBK8159OR2S5<\J['K>&>76:ML)=^N1S5$E9>U!0<JE
M,-5[VXPVY<VT?-7=Y^55;41/2\*%A@P7!/4Z TI95=4;5<?(HGRR[Z6A J!L
MIE2BH;(+:'XAR>&Z8S=HBK[P#U!+ P04    " !KB*A6_#@23(T#  !K"@
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MG(VIZ:AZLJDW1I9NFGB4AF83M\QH&D1E!>A^):79;:R!=KZ<?0502P,$%
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M;%<CPK@MT;8ZQGY7%1ANPWYP6UE="9[IE_7^M\PJH-8=*#;U\[,K3M]1R9/
M1^U(;3OH'>2C&:DA.WPMVJ'-]F#F>WY;GVWF>[.PJUH,M6$_MC5L=!/#=!<A
M!&71-Z $83(M;PN)_]'-12?"^UV_E$9#>6LFPE <OB&,PT$Y/I2W9N8,R>$
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MN3Q9[BB^+5;XEEPIGA6;&TIB*G(#?7[%N7K:R2]0+Q(O_@=02P,$%     @
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MTX.[86U>29 VP.S/A=";B6W$[MTM?@%02P,$%     @ :XBH5B93=HR=!0
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M>BA5U4Y7$R,+U\*NI:&&V U3^@1!90_0_D92KU)/[ 7-1\WX+U!+ P04
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M9>7(JV/#U85@J_+D[1T3@J7ESR6-%C0O#.3S>\;$YJ)X07-X>_8_4$L#!!0
M   ( &N(J%:@![Z'$0,  $D+   9    >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;+5676_:,!3]*U965:VTD0\@0 N1^.BT2JM6E75[F/9@D@NQFMB9;:#=
MKY_MA)2PE*U2R@/$SCTG]]Q[<.YPR_B#B $D>DP3*D96+&5V8=LBC"'%HL4R
MH.K.DO$42[7D*UMD''!D0&EB>X[CVRDFU J&9N^6!T.VE@FA<,N16*<IYD\3
M2-AV9+G6;N..K&*I-^Q@F.$5S$'>9[=<K>R2)2(I4$$811R6(VOL7DQ=1P-,
MQ#<"6[%WC;24!6,/>G$=C2Q'9P0)A%)38/6S@2DDB692>?PJ2*WRF1JX?[UC
M_VC$*S$++&#*DN\DDO'(ZELH@B5>)_*.;3]!(:BK^4*6"/.-MD6L8Z%P+21+
M"[#*("4T_\6/12'V (JG'N 5 .\0T'D!T"X ;2,TS\S(FF&)@R%G6\1UM&+3
M%Z8V!JW4$*K;.)=<W24*)X,YK%13I.I(QK@D=(4^H'G>4L26: ;*'"'!><EI
MA,:I#ON=;UP]*C<)0(LGM.,YFX'$)#E7-/?S&3H[.4<GB%#T-69KH0C$T)8J
M;?UP.RQ2G.0I>B^DV$8WC,I8H"L:053%VTINJ=G;:9YX1PEO,&^AMOL>>8[7
MKLEG^O]P[T@Z[;(%;</7_D<+[LH67-/\_ZEK_..S"D?7$E+QLZYV.7>GGEL?
M A<BPR&,+-5( 7P#5G#ZSO6=RSKA#9%5RM IR] YQA[\936\9[4ZY3F=;^CT
M:;4)W%[?Z;E#>[.OJ2[,&W0Z95@EVVZ9;?=HMO>M>0M%!"=/@M1Z^BC\M7UI
MB*RBU"^5^F]H3[_),C1$5BE#KRQ#KUE[YG2]?=_Y_L _M&==F.>X@WI[]LML
M^T>S_2)CX*?O^I[K78YI2))$'^BZ)B2$6K\>Y7MMHQHBJT@?E-(';^C709-E
M:(BL4@;7>7ZS.\TZMN"K')7JXQPXMB[,&7C= \?:>T-)"GQE9C6!0K:F,G]7
ME[OE/#@V4]#!_D3/B6;8>:;)ATSU)EX1*E "2T7IM'KJG.3YW)8O),O,Z+-@
M4@U2YC)6LRYP':#N+QF3NX5^0#D]!W\ 4$L#!!0    ( &N(J%;Q,R/?' ,
M &D+   9    >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;+5676_:,!3]*U96
M5:VTD2\(T$*DTG9:I55#9=T>ICV8Y$*L)G9J.U#^_6PGI,!2MDKP K%SS\D]
M]YXX=[!D_$DD !*]9"D50RN1,K^P;1$ED&'18CE0=6?&>(:E6O*Y+7(..#:@
M++4]QPGL#!-JA0.S-^;A@!4R)13&'(DBRS!?C2!ERZ'E6NN-!S)/I-ZPPT&.
MYS !^9B/N5K9-4M,,J"",(HXS(;6E7MQ[3H:8")^$%B*C6NDI4P9>]*+NWAH
M.3HC2"&2F@*KOP5<0YIJ)I7'<T5JU<_4P,WK-?MG(UZ)F6(!URS]26*9#*V>
MA6*8X2*5#VSY!2I!'<T7L5287[2L8AT+1860+*O *H.,T/(?OU2%V  HGF:
M5P&\74#[#8!? 7PCM,S,R+K!$H<#SI:(ZVC%IB],;0Q:J2%4MW$BN;I+%$Z&
M$YBKIDC5D9QQ2>@<?4*3LJ6(S=#MB_)+3&3!02!E&C3FRD%<KA"F,;I]+DAN
MX-,56C.=W8#$)#U71(^3&W1V<HY.$*'H>\(*H5!B8$N5N'Z\'55)CLHDO3>2
M]-$]HS(1Z);&$&_C;26X5NVM58^\O83WF+>0[WY$GN/Y#?E<_S_<VY..7S?!
M-WS^/YKP4#?ACI9OJ';ZKZ\J'-U)R,3OIMJ5W.UF;GT,7(@<1S"TU'LN@"_
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M,E&S,' =H.[/&)/KA7Y /5V'?P!02P,$%     @ :XBH5F3X3%W$ @  [@D
M !D   !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULK59=;]HP%/TK5EI5K;21
MX"0D:2$2A4W;P[2J:;=G$R[$JA-GMH'R[V<G(8(N16O+"_''/8=S?*\_AALN
MGF0&H-!SS@HYLC*ERFO;EFD&.9$]7D*A9Q9<Y$3IKEC:LA1 YA4H9S9VG(&=
M$UI8\; :NQ/QD*\4HP7<"217>4[$]A88WXRLOK4;N*?+3)D!.QZ69 D)J,?R
M3NB>W;+,:0Z%I+Q  A8C:]R_GD0FO@KX16$C]]K(.)EQ_F0ZW^<CRS&"@$&J
M# /1GS5,@#%#I&7\:3BM]B\-<+^]8_]:>==>9D3"A+/?=*ZRD15:: X+LF+J
MGF^^0>/'-WPI9[+Z19LFUK%0NI**YPU8*\AI47_)<[,.>X"^]PH -P#\OP"W
M ;B5T5I996M*%(F'@F^0,-&:S32JM:G0V@TM3!83)?0LU3@5)[#4.5$Z(247
MBA9+]!DE=4817Z"QE* DFFW1+O!R"HI0=J7C'I,INCR_0N>(%N@AXRM)BKD<
MVDKK,NQVVFBXK37@5S3\(**'W/XGA!WL=L GQ^%32%LX/H3;>C7:)<'MDN"*
MSWV%;YPD7QZ2+ALUSNO&F?UV+4N2PLC2&TJ"6(,57YSU!\Y-EZD3D1U8=%N+
M[C'V^($KPA"IDMMEM$8/*K0Y!]9Q?Q#@( B#H;W>-]$5&.$0^[@-/!#HM0*]
MHP(?>TD/S2EA6TD[%1Z%OS45)R([<.JW3OUW5IM_2HLG(CNP.&@M#CY4;34Z
MV"\B+P@C)_)?5%M'H.^$GN=[W=46M *#HP)_J@S$Q5F(^_AF7*24,7/\F66@
M*71*/LKWUMR<B.S >MA:#]]9?N$I+9Z([,!BU%J,/E1^T;]G6.2&^AA[47T=
M<:'G!E'XHOCLO=O8O(3T];:DA40,%AKI] *]%T7]NJ@[BI?5!3WC2E_W53/3
M#S(0)D#/+SA7NXZY\]LG7OP74$L#!!0    ( &N(J%;E#7"\/0(   X%   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;+5436_;, S]*X17#"TPU(Z3
MMD/F&.C'AK78AJ!9M\.P@V(SL5!9<B4Z:?_]*#GU4B#-3KM8I,3W^$A3RM;&
MWKL*D>"Q5MI-HHJH&<>Q*RJLA3LV#6H^61A;"V+7+F/76!1E -4J3I/D-*Z%
MU%&>A;VIS3/3DI(:IQ9<6]?"/EV@,NM)-(B>-V[ELB*_$>=9(Y8X0[IKII:]
MN&<I98W:2:/!XF(2G0_&%R,?'P)^2%R[+1M\)7-C[KUS74ZBQ M"A05Y!L'+
M"B]1*4_$,AXVG%&?T@.W[6?V3Z%VKF4N'%X:]5.65$VB]Q&4N!"MHENS_HR;
M>DX\7V&4"U]8=[%G9Q$4K2-3;\"LH):Z6\7CI@];@#1]!9!N &G0W24**J\$
MB3RS9@W61S.;-T*I <WBI/8_94:63R7C*/_&?1-%85I-4B_!D="EL*6#PRLD
M(94[@@.0&KY7IG5\YK*8.*T'Q\4FQ467(GTEQ4VKCB$9O(,T28=P-[N"PX.C
MES0QJ^ZEI[WT-/".7N&=M7.'#RUJ@H\K_NY2MI?!#_S8-:+ 2<03[="N,,K?
MOAF<)A_VZ!OV^H:!?;BGM>=_6SNU1K-=((\T.3 6+BNAE^B[^R),ZD(V"N'7
M%R:$:\+:_=Y5V_ _U#;J:QOM[?T_I,N:,Q.(N522GH ,S(WE%+O*Z!*=AD3^
M"5GE21:OMK7%6^/M7XJOPBZE=J!PP9CD^.PD MO=OLXATX2)GQOB^Q/,BA\L
MM#Z SQ?&T+/C+U'_!.9_ %!+ P04    " !KB*A66X-=KHD,   QG   &0
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MYJ(4V@/QP!,]/.A$#R@MA-(HE,:@- ZE"13-U* V0;Q]-H7=U;6'=Y8<U/*
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M.EF^]@;D1LX>9'[@3;2]@IWU"O5$H#0*I3$HC4-I D4S1:W=%=_%)FX?ZK)
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MHU :@](XE"90-%.1:QNO@ZV: +O_.G8#=NP.[-@MV+%[L&,W8?\>5DV@K9K
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ME&18'79N2J4F4+;4MX;GQY<?CB]N?/D74$L#!!0    ( &N(J%:AE^J4R0$
M * >   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-V;ENPD 4A>%7
M07X AKN8+()4:=)&O(!%AD4LMCP3!=X^" IRK!1IHCF5-;9\_<O%)VL\>X_[
M)F_;8]ILNS0Z'?;'-*\V.7?/(:3E)AZ:-&Z[>+Q<6;7]H<F79;\.7;/<->L8
M=#*9AO[GC.IE]G/F:''NXE\FMJO5=AE?V^7G(1[S+X/#5]OOTB;&7(T63;^.
M>5Z%T_Y^.H7K0<:7R=7H[6->]6\?4H7200I!6C[((,C*!SD$>?F@&H+J\D%3
M")J6#WJ H(?R08\0]%@^Z F"GLH'R01EG! D#; FT%J0:R'P6A!L(1!;D&PA
M,%L0;2%06Y!M(7!;$&XAD%N0;B&P6Q!O(=!;46\ET%M1;R706P<?VP1Z*^JM
M!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM
M!'K;8+.$0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]'O9U ;T>]
MG4!O1[V=0&]'O9U ;Q]L=A/H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z%VC
MWC6!WC7J7?^GWBF?]S'=>VYK?/Y_4ITO]\;[XZ_+V\G!2[CB'."'],LW4$L#
M!!0    ( &N(J%8HM&@3PP$  (D>   3    6T-O;G1E;G1?5'EP97-=+GAM
M;,W9R6[",!0%T%]!V5;$>( . C9MMRV+_H";/" BB2W;4/C[.F&06M&HB$J]
MFT2)[7=?;.EL,G[;6?*];576?I(L0[ /C/EL297VJ;%4QY&Y<94.\=$MF-79
M2B^(B<%@Q#)3!ZI#/S0UDNGXB>9Z78;>\S:^]H6I)XFCTB>]Q_W$)FN2:&O+
M(M,ACK--G7]+Z1\2TKBRG>.7A?4W<4+"SB8T(S\''-:];LBY(J?>3+OPHJLX
MBVU+YL.N))]VESC3HYG/BXQRDZVKN"3UUI'._9(H5&6Z+WK3G1SB#M/^RJ_.
M;\MT!<:9,V>LCR?FZ/*XXY$TJ_LV%B(7BNY//"7&TE=_'S6GG5/^R^RXO1_&
MK=KS\*R]7;_'7\_X5/_"/@1('Q*D#P72QQ"DCQ%('[<@?=R!]'$/T@<?H#2"
M(BI'(96CF,I14.4HJG(45CF*JQP%5HXBJT"15:#(*E!D%2BR"A19!8JL D56
M@2*K0)%5H,@J4625*+)*%%DEBJP215:)(JM$D56BR"I19)4HLBH4616*K I%
M5H4BJT*15:'(JE!D52BR*A19%8JL0Q19A_\IZ[LQJ[_^.=K<TTH7]3&?M7^@
MIY]02P$"% ,4    " !KB*A6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &N(J%8 EO2D[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( &N(J%:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ :XBH5B#W8[K)!0  U!X  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( &N(J%8<G \Z>P4  (85   8              " @0P.  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !KB*A6H^_E[.,#   .#
M&               @(&]$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ :XBH5NM#(32P!P  L2$  !@              ("!UA<  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( &N(J%;D)+5$;0,
M " +   8              " @;P?  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " !KB*A6.+T(3I$(   @)@  &               @(%?
M(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ :XBH5LYU
M0+?F#0  B*<  !@              ("!)BP  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( &N(J%:#:1?/C00  &D+   8
M  " @4(Z  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !K
MB*A6;.(W>% '  "U$0  &               @($%/P  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ :XBH5H!X^2 L!   S0D  !D
M         ("!BT8  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " !KB*A6 7_F'6@$  #_"@  &0              @('N2@  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( &N(J%9I[JTFEP0  !4*
M   9              " @8U/  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ :XBH5O@CZ'K!"0  _QH  !D              ("!6U0
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " !KB*A6KA8?
MK<P4  !E/0  &0              @(%37@  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( &N(J%;NC_UD/@,  +$'   9
M  " @59S  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
M:XBH5A4NXUNE P  , @  !D              ("!RW8  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " !KB*A60@P9DO0"  "F!@  &0
M            @(&G>@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( &N(J%:=$*%J'PD  &@8   9              " @=)]  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ :XBH5LMP3)Y1!@
MHQ   !D              ("!*(<  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " !KB*A6YW>S=6 $  #$"0  &0              @(&P
MC0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( &N(J%:Q
M[(7^. <  ,41   9              " @4>2  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ :XBH5KRI<K.9#0  ."4  !D
M     ("!MID  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &N(J%9YUAHJPP8  /<0   9              "
M@>NV  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ :XBH
M5NH-::M' P  3@<  !D              ("!Y;T  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " !KB*A6F83,2G(#  #&!P  &0
M        @(%CP0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( &N(J%9TBT;R504  &</   9              " @0S%  !X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ :XBH5MN"4$K*!P  &3\
M !D              ("!F,H  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " !KB*A6*#X6#9P#  #>"@  &0              @(&9T@
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( &N(J%9MS[5E
M:00  /@6   9              " @6S6  !X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ :XBH5E_7C]+>!   ZAH  !D
M ("!#-L  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !K
MB*A6[;<TWK0"  !M"   &0              @($AX   >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( &N(J%9Y=R.K,0D  &<^   9
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M970T,"YX;6Q02P$"% ,4    " !KB*A64LJQ-E,"  !E!0  &0
M    @($(_P  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M &N(J%9&X/9E?P4  # >   9              " @9(! 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ :XBH5C'I_)V- @  @P<  !D
M             ("!2 <! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " !KB*A6)E-VC)T%  "<*P  &0              @($,"@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( &N(J%:'%?71K@,
M . ,   9              " @> / 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ :XBH5JC1V:<M!P  R"T  !D              ("!
MQ1,! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " !KB*A6
MH >^AQ$#  !)"P  &0              @($I&P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( &N(J%;Q,R/?' ,  &D+   9
M      " @7$> 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ :XBH5F3X3%W$ @  [@D  !D              ("!Q"$! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " !KB*A6Y0UPO#T"   .!0
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M+G)E;'-02P$"% ,4    " !KB*A6I"'^9Y $   \(@  #P
M@ %*. $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ :XBH5J&7ZI3) 0
MH!X  !H              ( !!ST! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ :XBH5BBT:!/# 0  B1X  !,              ( !
M"#\! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #L .P 4$   _$ !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>208</ContextCount>
  <ElementCount>286</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidated interim financial statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Revenue Recognition Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionRevenueRecognition</Role>
      <ShortName>Revenue Recognition Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Earnings per share (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.davita.com/role/EarningspershareNotes</Role>
      <ShortName>Earnings per share (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Investments in debt and equity securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Investmentsindebtandequitysecurities</Role>
      <ShortName>Investments in debt and equity securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Long-term debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Longtermdebt</Role>
      <ShortName>Long-term debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Shareholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Shareholdersequity</Role>
      <ShortName>Shareholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Accumulated other comprehensive (loss) income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</Role>
      <ShortName>Accumulated other comprehensive (loss) income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Variable interest entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Variableinterestentities</Role>
      <ShortName>Variable interest entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Fair value of financial instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Fairvalueoffinancialinstruments</Role>
      <ShortName>Fair value of financial instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Segment reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Segmentreporting</Role>
      <ShortName>Segment reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - New accounting standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Newaccountingstandards</Role>
      <ShortName>New accounting standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables</Role>
      <ShortName>Revenue Recognition Segment revenue by major payor (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningsPerShareTables</Role>
      <ShortName>Earnings per share Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Investments in debt and equity securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</Role>
      <ShortName>Investments in debt and equity securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Investmentsindebtandequitysecurities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Goodwill</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Longtermdebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Fair value of financial instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsTables</Role>
      <ShortName>Fair value of financial instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Fairvalueoffinancialinstruments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Segment reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingTables</Role>
      <ShortName>Segment reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Segmentreporting</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails</Role>
      <ShortName>Revenue Recognition Segment Revenue by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails</Role>
      <ShortName>Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Investments in debt and equity securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail</Role>
      <ShortName>Investments in debt and equity securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail</Role>
      <ShortName>Goodwill - Changes in Goodwill by Reportable Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Long-term debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtDetail</Role>
      <ShortName>Long-term debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongtermdebtTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>Long-term debt Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Long-term debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtAdditionalInformationDetail</Role>
      <ShortName>Long-term debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Stock-based compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/StockbasedcompensationDetails</Role>
      <ShortName>Stock-based compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Share repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesDetails</Role>
      <ShortName>Share repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Variable interest entities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail</Role>
      <ShortName>Variable interest entities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail</Role>
      <ShortName>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Fair value of financial instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails</Role>
      <ShortName>Fair value of financial instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/FairvalueoffinancialinstrumentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail</Role>
      <ShortName>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Assets by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - New accounting standards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/NewaccountingstandardsDetails</Role>
      <ShortName>New accounting standards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/Newaccountingstandards</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="dva-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SubsequentEvents</ParentRole>
      <Position>51</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. dva-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 12 fact(s) appearing in ix:hidden were eligible for transformation: dva:CorporateIntegrityAgreementPeriod, dva:RegulatoryAndCommercialMilestonesBeginningDate, dva:RegulatoryAndCommercialMilestonesEndingDate, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtInstrumentTerm, us-gaap:GoodwillImpairmentLoss, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued -  dva-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="dva-20230331.htm">dva-20230331.htm</File>
    <File>dva-20230331.xsd</File>
    <File>dva-20230331_cal.xml</File>
    <File>dva-20230331_def.xml</File>
    <File>dva-20230331_lab.xml</File>
    <File>dva-20230331_pre.xml</File>
    <File>dva-33123ex31110xq.htm</File>
    <File>dva-33123ex31210xq.htm</File>
    <File>dva-33123ex32110xq.htm</File>
    <File>dva-33123ex32210xq.htm</File>
    <File>ex101-formssarawardagreeme.htm</File>
    <File>ex102-formpsuawardagreemen.htm</File>
    <File>ex103-formrsuawardagreemen.htm</File>
    <File>ex104-secondamendmenttocre.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dva-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="679">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>83
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dva-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 679,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 208,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dva-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 467,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 10,
    "http://www.davita.com/20230331": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 18
   },
   "keyCustom": 35,
   "keyStandard": 251,
   "memberCustom": 28,
   "memberStandard": 34,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.davita.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Earnings per share (Notes)",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.davita.com/role/EarningspershareNotes",
     "shortName": "Earnings per share (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Investments in debt and equity securities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.davita.com/role/Investmentsindebtandequitysecurities",
     "shortName": "Investments in debt and equity securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Goodwill",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.davita.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Long-term debt",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.davita.com/role/Longtermdebt",
     "shortName": "Long-term debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.davita.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Shareholders' equity",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.davita.com/role/Shareholdersequity",
     "shortName": "Shareholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Accumulated other comprehensive (loss) income",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.davita.com/role/Accumulatedothercomprehensivelossincome",
     "shortName": "Accumulated other comprehensive (loss) income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Variable interest entities",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.davita.com/role/Variableinterestentities",
     "shortName": "Variable interest entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Fair value of financial instruments",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.davita.com/role/Fairvalueoffinancialinstruments",
     "shortName": "Fair value of financial instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Segment reporting",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.davita.com/role/Segmentreporting",
     "shortName": "Segment reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - New accounting standards",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.davita.com/role/Newaccountingstandards",
     "shortName": "New accounting standards",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.davita.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "menuCat": "Policies",
     "order": "22",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables",
     "shortName": "Revenue Recognition Segment revenue by major payor (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.davita.com/role/EarningspershareEarningsPerShareTables",
     "shortName": "Earnings per share Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Investments in debt and equity securities (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables",
     "shortName": "Investments in debt and equity securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.davita.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Long-term debt (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.davita.com/role/LongtermdebtTables",
     "shortName": "Long-term debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Accumulated other comprehensive (loss) income (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables",
     "shortName": "Accumulated other comprehensive (loss) income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Fair value of financial instruments (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables",
     "shortName": "Fair value of financial instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Segment reporting (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.davita.com/role/SegmentreportingTables",
     "shortName": "Segment reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
     "shortName": "Revenue Recognition Segment Revenue by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i8e2f2c8535274ee1a11b9edde413849c_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails",
     "shortName": "Earnings per share Earnings per share - Reconciliation of numerators and denominators used to calculate basic and diluted earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Investments in debt and equity securities (Detail)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail",
     "shortName": "Investments in debt and equity securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "id10db692f34a4aad9a81d68a86468a88_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
     "shortName": "Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "id37fcf42001e43c795ed70694ccbfda3_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Goodwill - Narrative (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.davita.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Long-term debt (Detail)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.davita.com/role/LongtermdebtDetail",
     "shortName": "Long-term debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
     "shortName": "Long-term debt Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i24bf8dcffbcf49a6876a587c3a5d0072_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongtermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Long-term debt - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
     "shortName": "Long-term debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "4",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtPercentageBearingFixedInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "ie8a7dbaff57e414c9caea8d4533cbbe9_D20191022-20191022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Stock-based compensation (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.davita.com/role/StockbasedcompensationDetails",
     "shortName": "Stock-based compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Share repurchases (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.davita.com/role/SharerepurchasesDetails",
     "shortName": "Share repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i2fccb5398dea441a84f691c11cbe6ffd_D20230401-20230508",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "id10db692f34a4aad9a81d68a86468a88_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Accumulated other comprehensive (loss) income (Detail)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
     "shortName": "Accumulated other comprehensive (loss) income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i02a973488e20476fb47615a3f807fa05_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Variable interest entities - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail",
     "shortName": "Variable interest entities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "ibd476b66dd8f482d92e7bc8eea43966e_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
     "shortName": "Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i8aa0e86f4d8345c3b6c7f1c78f4c394b_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Fair value of financial instruments (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails",
     "shortName": "Fair value of financial instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail",
     "shortName": "Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:SegmentReportingInformationCorporateExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
     "shortName": "Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
     "shortName": "Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i13b6b0a8d91b4840a73b3e2f9b502f54_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
     "shortName": "Segment reporting - Summary of Assets by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "icde1e71194074e608dc7cc2f2b99ec8c_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9371851bf60946538246702a8ff6a696_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:ChangeInAccountingPrincipleImpactAbilityToBorrow",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - New accounting standards (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.davita.com/role/NewaccountingstandardsDetails",
     "shortName": "New accounting standards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i067bc26e7e1c4fea9be37d4b636fc9cc_I20230701",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:ChangeInAccountingPrincipleImpactAbilityToBorrow",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireOtherInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.davita.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "ifaf0ddcf55e14f6680d0e09fc7071645_D20230428-20230428",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentIssuanceDate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i7ea58a938e0c42d4a9d7c243b445d5dc_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Revenue Recognition Revenue Recognition",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.davita.com/role/RevenueRecognitionRevenueRecognition",
     "shortName": "Revenue Recognition Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20230331.htm",
      "contextRef": "i9bf69460e8824ea18767dc4bf9ec823d_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 62,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dva_A2019InterestRateCapAgreementsEffectiveJune302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Interest Rate Cap Agreements Effective June 30, 2020.",
        "label": "2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]",
        "terseLabel": "2019 Interest Rate Cap Agreements Effective June 30, 2020"
       }
      }
     },
     "localname": "A2019InterestRateCapAgreementsEffectiveJune302020Member",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Interest Rate Cap Agreements Effective June 28 and June 30 2024 Member.",
        "label": "2023 Interest Rate Cap Agreements Effective June 28 And June 30 2024 [Member]",
        "terseLabel": "2023 Interest Rate Cap Agreements Effective June 28 And June 30 Member"
       }
      }
     },
     "localname": "A2023InterestRateCapAgreementsEffectiveJune28AndJune302024Member",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.",
        "label": "Acquisition Obligations And Other Notes Payable",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayable",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Obligations And Other Notes Payable, Fair Value.",
        "label": "Acquisition Obligations And Other Notes Payable, Fair Value",
        "terseLabel": "Acquisition obligations and other notes payable, fair value"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayableFairValue",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalCashCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Cash Commitment",
        "label": "Additional Cash Commitment",
        "terseLabel": "Additional Cash Commitment"
       }
      }
     },
     "localname": "AdditionalCashCommitment",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AgreementWithMedtronicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo).",
        "label": "Agreement with Medtronic [Member]",
        "terseLabel": "Agreement with Medtronic"
       }
      }
     },
     "localname": "AgreementWithMedtronicMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_BilateralSecuredLetterOfCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bilateral Secured Letter Of Credit",
        "label": "Bilateral Secured Letter Of Credit Facility [Member]",
        "terseLabel": "Bilateral Secured Letter Of Credit Facility"
       }
      }
     },
     "localname": "BilateralSecuredLetterOfCreditFacilityMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition contingent consideration revenue earn-out period.",
        "label": "Business Acquisition Contingent Consideration Revenue Earnout Period",
        "terseLabel": "Earn-out consideration payment period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_BusinessAgreementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Agreement Date, in YYYY-MM-DD formate",
        "label": "Business Agreement Date",
        "terseLabel": "Business Agreement Date"
       }
      }
     },
     "localname": "BusinessAgreementDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_BusinessAgreementEffectiveClosingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Agreement Effective Closing Date",
        "label": "Business Agreement Effective Closing Date",
        "terseLabel": "Business Agreement Effective Closing Date"
       }
      }
     },
     "localname": "BusinessAgreementEffectiveClosingDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.",
        "label": "Business Combination Contingent Consideration Acquisitions",
        "terseLabel": "Business Combination Contingent Consideration Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitions",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit, commercial paper, and money market funds.",
        "label": "Certificates Of Deposit Commercial Paper And Money Market Funds [Member]",
        "terseLabel": "Certificates of deposit and other time deposits"
       }
      }
     },
     "localname": "CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ChangeInAccountingPrincipleImpactAbilityToBorrow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Accounting Principle Impact Ability To Borrow",
        "label": "Change In Accounting Principle Impact Ability To Borrow",
        "terseLabel": "Change in Accounting Principle impact ability to borrow"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleImpactAbilityToBorrow",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/NewaccountingstandardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_CommercialPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Payors in healthcare industry.",
        "label": "Commercial Payors [Member]",
        "terseLabel": "Commercial Payors"
       }
      }
     },
     "localname": "CommercialPayorsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommitmentsToProvideOperatingCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments to provide operating capital.",
        "label": "Commitments To Provide Operating Capital [Member]",
        "terseLabel": "Commitments to provide operating capital"
       }
      }
     },
     "localname": "CommitmentsToProvideOperatingCapitalMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CorporateIntegrityAgreementExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.",
        "label": "Corporate Integrity Agreement Expiration Date",
        "terseLabel": "Corporate Integrity Agreement Expiration Date"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementExpirationDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_CorporateIntegrityAgreementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Period, in PnYnMnDn format.",
        "label": "Corporate Integrity Agreement Period",
        "terseLabel": "Corporate Integrity Agreement Period"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementPeriod",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_DebtInstrumentPeriodicPaymentInterestRateYearFive": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Interest Rate, Year Five",
        "label": "Debt Instrument, Periodic Payment Interest Rate, Year Five",
        "terseLabel": "Debt Instrument, Periodic Payment Interest Rate, Year Five"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterestRateYearFive",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_DebtInstrumentPeriodicPaymentInterestRateYearOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Interest Rate, Year One",
        "label": "Debt Instrument, Periodic Payment Interest Rate, Year One",
        "terseLabel": "Debt Instrument, Periodic Payment Interest Rate, Year One"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterestRateYearOne",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Interest Rate, Year Two, Three, Four",
        "label": "Debt Instrument, Periodic Payment Interest Rate, Year Two, Three, Four",
        "terseLabel": "Debt Instrument, Periodic Interest Payment, Year Two, Three, Four"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterestRateYearTwoThreeFour",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_DebtInstrumentPeriodicPaymentStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument Periodic Payment Start Date",
        "label": "Debt Instrument Periodic Payment Start Date",
        "terseLabel": "Debt Instrument Periodic Payment Start Date"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentStartDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid",
        "label": "Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid",
        "terseLabel": "Debt Instrument, Periodic Payment Terms, Date Balloon Payment to be Paid"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsDateBalloonPaymentToBePaid",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_DerivativeEffectiveDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Effective Date",
        "label": "Derivative Effective Date",
        "terseLabel": "Derivative, effective date"
       }
      }
     },
     "localname": "DerivativeEffectiveDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_DiscountPremiumAndDeferredFinancingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount, premium and deferred financing costs.",
        "label": "Discount Premium And Deferred Financing Costs",
        "negatedLabel": "Discount, premium and deferred financing costs"
       }
      }
     },
     "localname": "DiscountPremiumAndDeferredFinancingCosts",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBITDA operating income performance targets or quality margins.",
        "label": "E B I T D A Operating Income Performance Targets Or Quality Margins [Member]",
        "terseLabel": "EBITDA or Operating Income Performance Targets or Quality Margins"
       }
      }
     },
     "localname": "EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ExternalSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External sources.",
        "label": "External Sources [Member]",
        "terseLabel": "External Sources"
       }
      }
     },
     "localname": "ExternalSourcesMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Member]",
        "label": "Finance Lease [Member]",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in other current receivables and other current assets.",
        "label": "Increase Decrease In Other Current Receivables And Other Current Assets",
        "negatedLabel": "Other receivables and prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate.",
        "label": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate",
        "terseLabel": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingEconomicallyFixedInterestRate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_MedicaidandManagedMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Managed Medicaid Member.",
        "label": "Medicaid and Managed Medicaid [Member]",
        "terseLabel": "Medicaid and Managed Medicaid"
       }
      }
     },
     "localname": "MedicaidandManagedMedicaidMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicareandMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicare Advantage",
        "label": "Medicare and Medicare Advantage [Member]",
        "terseLabel": "Medicare and Medicare Advantage"
       }
      }
     },
     "localname": "MedicareandMedicareAdvantageMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MutualFundsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds And Common Stock [Member]",
        "label": "Mutual Funds And Common Stock [Member]",
        "terseLabel": "Investments in mutual funds and common stocks"
       }
      }
     },
     "localname": "MutualFundsAndCommonStockMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.",
        "label": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseFromContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest increase from contributions.",
        "label": "Noncontrolling Interest Increase From Contributions",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromContributions",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests Reclassifications And Expirations Of Put Obligations.",
        "label": "Noncontrolling Interests Reclassifications And Expirations Of Put Obligations",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestsReclassificationsAndExpirationsOfPutObligations",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies.",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherGovernmentPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other government payors in healthcare industry.",
        "label": "Other Government Payors [Member]",
        "terseLabel": "Other Government Payors"
       }
      }
     },
     "localname": "OtherGovernmentPayorsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherReportingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Reporting Units [Member]",
        "label": "Other Reporting Units [Member]",
        "terseLabel": "Other Health Operations"
       }
      }
     },
     "localname": "OtherReportingUnitsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherSourcesofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).",
        "label": "Other Sources of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSourcesofRevenueMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PatientCareCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.",
        "label": "Patient Care Costs",
        "terseLabel": "Patient care costs"
       }
      }
     },
     "localname": "PatientCareCosts",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.",
        "label": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "terseLabel": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple"
       }
      }
     },
     "localname": "PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of capital expenditures for property and equipment from segment to consolidated.",
        "label": "Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]",
        "terseLabel": "Summary of Expenditures for Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_RegulatoryAndCommercialMilestonesBeginningDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory and Commercial Milestones Beginning Date",
        "label": "Regulatory and Commercial Milestones Beginning Date",
        "terseLabel": "Regulatory and Commercial Milestones Beginning Date"
       }
      }
     },
     "localname": "RegulatoryAndCommercialMilestonesBeginningDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_RegulatoryAndCommercialMilestonesEndingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory and Commercial Milestones Ending Date",
        "label": "Regulatory and Commercial Milestones Ending Date",
        "terseLabel": "Regulatory and Commercial Milestones Ending Date"
       }
      }
     },
     "localname": "RegulatoryAndCommercialMilestonesEndingDate",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "label": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "terseLabel": "Dialysis patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RevenuesbymajorpayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues by major payor [Abstract]",
        "label": "Revenues by major payor [Abstract]",
        "terseLabel": "Revenues by major payor [Abstract]"
       }
      }
     },
     "localname": "RevenuesbymajorpayorAbstract",
     "nsuri": "http://www.davita.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.",
        "label": "Secured Debt Outstanding Principal Balance Subject To LIBOR",
        "terseLabel": "Secured Debt Outstanding Principal Balance Subject To LIBOR"
       }
      }
     },
     "localname": "SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentReportingInformationCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.",
        "label": "Segment Reporting Information Corporate Expenses",
        "negatedLabel": "Corporate administrative support"
       }
      }
     },
     "localname": "SegmentReportingInformationCorporateExpenses",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentRevenuebyMajorPayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Revenue by Major Payor [Abstract]",
        "label": "Segment Revenue by Major Payor [Abstract]",
        "terseLabel": "Segment Revenue by Major Payor [Abstract]"
       }
      }
     },
     "localname": "SegmentRevenuebyMajorPayorAbstract",
     "nsuri": "http://www.davita.com/20230331",
     "xbrltype": "stringItemType"
    },
    "dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.",
        "label": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty"
       }
      }
     },
     "localname": "SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.",
        "label": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]",
        "terseLabel": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One"
       }
      }
     },
     "localname": "SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior secured credit facilities.",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted",
        "terseLabel": "Aggregate grant-date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasePurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Purchase Of Interests",
        "label": "Temporary Equity, Decrease Purchase Of Interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "TemporaryEquityDecreasePurchaseOfInterests",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions"
       }
      }
     },
     "localname": "TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.",
        "label": "Temporary Equity, Increase Due To Acquisitions And Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "label": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityRedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests Temporary Equity [Member]",
        "label": "Temporary Equity Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Non- controlling interests subject to put provisions"
       }
      }
     },
     "localname": "TemporaryEquityRedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanA1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan A-1 Member",
        "label": "Term Loan A-1 [Member]",
        "terseLabel": "Term Loan A-1"
       }
      }
     },
     "localname": "TermLoanA1Member",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B-1.",
        "label": "Term Loan B-1 [Member]",
        "terseLabel": "Term Loan B-1"
       }
      }
     },
     "localname": "TermLoanB1Member",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche One",
        "label": "Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche Two",
        "label": "Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "TrancheTwoMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedLabServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US dialysis \u200band \u200brelated \u200blab\u200b services\u200b.",
        "label": "U S Dialysis And Related Lab Services [Member]",
        "terseLabel": "U.S. dialysis"
       }
      }
     },
     "localname": "USDialysisAndRelatedLabServicesMember",
     "nsuri": "http://www.davita.com/20230331",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r240",
      "r461",
      "r462",
      "r465",
      "r466",
      "r529",
      "r598",
      "r677",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r240",
      "r461",
      "r462",
      "r465",
      "r466",
      "r529",
      "r598",
      "r677",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r240",
      "r278",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r358",
      "r360",
      "r361",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r240",
      "r278",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300",
      "r350",
      "r351",
      "r352",
      "r353",
      "r355",
      "r356",
      "r358",
      "r360",
      "r361",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r403",
      "r537",
      "r569",
      "r599",
      "r600",
      "r617",
      "r628",
      "r635",
      "r682",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r403",
      "r537",
      "r569",
      "r599",
      "r600",
      "r617",
      "r628",
      "r635",
      "r682",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r395",
      "r403",
      "r431",
      "r432",
      "r433",
      "r536",
      "r537",
      "r569",
      "r599",
      "r600",
      "r617",
      "r628",
      "r635",
      "r676",
      "r682",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r342",
      "r344",
      "r345",
      "r346",
      "r395",
      "r403",
      "r431",
      "r432",
      "r433",
      "r536",
      "r537",
      "r569",
      "r599",
      "r600",
      "r617",
      "r628",
      "r635",
      "r676",
      "r682",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r307",
      "r308"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r160",
      "r176"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r25",
      "r32",
      "r119",
      "r223",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r27",
      "r32",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r31",
      "r32",
      "r207",
      "r562",
      "r577",
      "r581"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r223",
      "r224",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r28",
      "r32",
      "r119",
      "r526",
      "r572",
      "r573",
      "r646",
      "r647",
      "r648",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r656",
      "r657",
      "r658",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r104",
      "r105",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-settled stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r274",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other\u2014Ancillary services",
        "verboseLabel": "Other\u2014Ancillary services"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock-settled awards excluded from calculation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r28",
      "r32",
      "r119",
      "r646",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r158",
      "r175",
      "r205",
      "r237",
      "r286",
      "r292",
      "r298",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r461",
      "r465",
      "r489",
      "r634",
      "r678",
      "r679",
      "r721"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r199",
      "r209",
      "r237",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r461",
      "r465",
      "r489",
      "r634",
      "r678",
      "r679",
      "r721"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r131",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Condensed consolidated interim financial statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r108",
      "r109",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "verboseLabel": "Contingent earn-out obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r57",
      "r201",
      "r602"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r52",
      "r57",
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r52",
      "r149"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r98",
      "r99",
      "r100",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and contingencies:"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Noncontrolling interests subject to put provisions and other commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r656",
      "r657",
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, Ending balance (in shares)",
        "periodStartLabel": "Common stock, Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r33",
      "r220",
      "r222",
      "r230",
      "r558",
      "r566"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to DaVita Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r113",
      "r114",
      "r123",
      "r220",
      "r222",
      "r229",
      "r557",
      "r565"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r112",
      "r123",
      "r220",
      "r222",
      "r228",
      "r556",
      "r564"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r41",
      "r227",
      "r555",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Accumulatedothercomprehensivelossincome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r159",
      "r161",
      "r174",
      "r240",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r512",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR plus interest rate margin",
        "verboseLabel": "SOFR plus interest rate margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r161",
      "r174",
      "r380"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total debt principal outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reference rate used for variable rate of debt instrument.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of the old Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r371",
      "r488",
      "r613",
      "r614"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Debt Instrument, table footnotes"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r19",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Debt Instrument, Frequency of Periodic Payment"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r16",
      "r152",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt interest rate during period",
        "verboseLabel": "Weighted average effective interest rate during quarter"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentIssuanceDate1": {
     "auth_ref": [
      "r18",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt instrument was issued, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Issuance Date",
        "terseLabel": "Debt Instrument, effective date"
       }
      }
     },
     "localname": "DebtInstrumentIssuanceDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r210",
      "r612",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r19",
      "r240",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r512",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r19"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r19",
      "r92",
      "r93",
      "r94",
      "r95",
      "r151",
      "r152",
      "r153",
      "r173",
      "r240",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r512",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt Instrument, Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r151",
      "r153",
      "r683"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r151",
      "r153",
      "r683"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "negatedLabel": "Debt Instrument, Unamortized Premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r55",
      "r106",
      "r446",
      "r452",
      "r453",
      "r654"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r443",
      "r444"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred Financing Costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r55",
      "r80"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts of interest rate agreements"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r212",
      "r213",
      "r488",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r24",
      "r133",
      "r154",
      "r211",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInceptionDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the entity entered into the derivative contract, in YYYY-MM-DD format.",
        "label": "Derivative, Inception Date",
        "terseLabel": "Derivative, effective date",
        "verboseLabel": "Derivative, inception date"
       }
      }
     },
     "localname": "DerivativeInceptionDates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.",
        "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r132",
      "r134",
      "r138",
      "r140",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r129",
      "r132",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r137",
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "verboseLabel": "Amount of debt expense reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeMaturityDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.",
        "label": "Derivative, Maturity Date",
        "terseLabel": "Derivative, expiration date"
       }
      }
     },
     "localname": "DerivativeMaturityDates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r136",
      "r138",
      "r141",
      "r143",
      "r144",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r126",
      "r129",
      "r130",
      "r142",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r392",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r408",
      "r435",
      "r436",
      "r438",
      "r442",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r231",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r258",
      "r260",
      "r265",
      "r266",
      "r267",
      "r271",
      "r478",
      "r479",
      "r559",
      "r567",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income",
        "verboseLabel": "Basic net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r231",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r260",
      "r265",
      "r266",
      "r267",
      "r271",
      "r478",
      "r479",
      "r559",
      "r567",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income",
        "verboseLabel": "Diluted net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerators:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r268",
      "r269",
      "r270",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r500"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r91",
      "r194",
      "r223",
      "r224",
      "r225",
      "r241",
      "r242",
      "r243",
      "r246",
      "r254",
      "r256",
      "r273",
      "r317",
      "r382",
      "r439",
      "r440",
      "r441",
      "r449",
      "r450",
      "r477",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r526",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFVNINoncurrent": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as noncurrent.",
        "label": "Equity Securities, FV-NI, Noncurrent",
        "terseLabel": "Equity Securities, FV-NI, Noncurrent"
       }
      }
     },
     "localname": "EquitySecuritiesFVNINoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r206",
      "r487",
      "r604"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r206",
      "r487"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r371",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r482",
      "r533",
      "r534",
      "r535",
      "r613",
      "r614",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r481",
      "r482",
      "r483",
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Fairvalueoffinancialinstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r371",
      "r396",
      "r401",
      "r482",
      "r533",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active\u00a0markets\u00a0for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r371",
      "r396",
      "r401",
      "r482",
      "r534",
      "r613",
      "r614",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable\u00a0inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r371",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r482",
      "r535",
      "r613",
      "r614",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r371",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r533",
      "r534",
      "r535",
      "r613",
      "r614",
      "r625",
      "r626",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r518",
      "r520"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r519",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Finance lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r203",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r202",
      "r321",
      "r554",
      "r611",
      "r634",
      "r665",
      "r672"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r324",
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r331",
      "r333",
      "r335",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r323",
      "r330",
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, before accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r323",
      "r330",
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r55",
      "r322",
      "r327",
      "r334",
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r107",
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r326",
      "r611"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "terseLabel": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Domain]",
        "terseLabel": "Health Care Organization, Revenue Sources [Domain]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r74",
      "r309",
      "r320",
      "r663"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesCurrent": {
     "auth_ref": [
      "r73",
      "r661",
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current",
        "terseLabel": "Debt securities, short-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "auth_ref": [
      "r73",
      "r661",
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Debt securities, long-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r35",
      "r155",
      "r168",
      "r187",
      "r286",
      "r291",
      "r297",
      "r300",
      "r560",
      "r610"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r36",
      "r55",
      "r76",
      "r167",
      "r185",
      "r283"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity investment income, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r238",
      "r255",
      "r256",
      "r284",
      "r445",
      "r451",
      "r454",
      "r568"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r164",
      "r184",
      "r644"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r233",
      "r312"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "negatedLabel": "Equity investment loss, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r651"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r651"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r267",
      "r407"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Assumed incremental from stock plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r78",
      "r79"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Debt expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r278",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination",
        "verboseLabel": "Elimination of intersegment revenues"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersubsegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in subsegment consolidation.",
        "label": "Intersubsegment Eliminations [Member]",
        "terseLabel": "Intersubsegment Eliminations"
       }
      }
     },
     "localname": "IntersubsegmentEliminationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r208",
      "r603",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r189",
      "r190",
      "r591",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r643"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r75",
      "r156",
      "r171",
      "r191",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments in debt and equity securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Investmentsindebtandequitysecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r13",
      "r237",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r462",
      "r465",
      "r466",
      "r489",
      "r609",
      "r678",
      "r721",
      "r722"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities and noncontrolling interests",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r163",
      "r181",
      "r634",
      "r653",
      "r662",
      "r717"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r200",
      "r237",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r462",
      "r465",
      "r466",
      "r489",
      "r634",
      "r678",
      "r721",
      "r722"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Revolving line of credit, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity on the revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Carrying amount of long-term debt, net of unamortized discounts"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Percentage of debt instruments bearing fixed interest rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Longtermdebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r19",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term debt, weighted average interest rate, at point in time",
        "verboseLabel": "Weighted average effective interest rate at quarter end"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r340",
      "r341",
      "r343",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-term and Long-term Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r23",
      "r162",
      "r180",
      "r237",
      "r313",
      "r350",
      "r353",
      "r354",
      "r355",
      "r361",
      "r362",
      "r489"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests not subject to put provisions"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r96",
      "r115",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Partial purchases"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r236"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r236"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r52",
      "r53",
      "r56"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r37",
      "r56",
      "r169",
      "r186",
      "r198",
      "r218",
      "r221",
      "r225",
      "r237",
      "r245",
      "r249",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r264",
      "r286",
      "r291",
      "r297",
      "r300",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r479",
      "r489",
      "r610",
      "r678"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r117",
      "r122",
      "r218",
      "r221",
      "r255",
      "r256",
      "r648"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r87",
      "r117",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/NewaccountingstandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r59",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251",
      "r257",
      "r271",
      "r310",
      "r311",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r439",
      "r440",
      "r441",
      "r447",
      "r448",
      "r449",
      "r450",
      "r455",
      "r456",
      "r457",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r539",
      "r540",
      "r541",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/NewaccountingstandardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies",
      "http://www.davita.com/role/Newaccountingstandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest Items [Abstract]",
        "terseLabel": "Changes in noncontrolling interest from:"
       }
      }
     },
     "localname": "NoncontrollingInterestItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r110",
      "r382",
      "r656",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- controlling interests not subject to put provisions"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r286",
      "r291",
      "r297",
      "r300",
      "r610"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r517"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other potential commitments to provide operating capital to several dialysis centers"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year One",
        "terseLabel": "Other Commitment, to be Paid, between Year One, Two, Three, and Four"
       }
      }
     },
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Commitments and Contingencies:"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized (losses) gains on interest rate cap agreements:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r26",
      "r29",
      "r498",
      "r499",
      "r501"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized gains on foreign currency translation:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r32",
      "r224",
      "r502",
      "r504",
      "r508",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r224",
      "r502",
      "r504",
      "r508",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Unrealized (losses) gains net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r30",
      "r223"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Related income tax benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized (losses) gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Reclassifications of net realized (gains) losses into net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r91",
      "r219",
      "r222",
      "r227",
      "r502",
      "r507",
      "r508",
      "r555",
      "r563",
      "r646",
      "r647"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r188"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-Term Investments [Member]",
        "terseLabel": "Long-term Investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash charges, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Long-term Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (loss), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred financing and debt redemption costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r232"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Net payments related to stock purchases and awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r45",
      "r458"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r44",
      "r72"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "negatedLabel": "Purchase of debt investments held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedLabel": "Purchase of other debt and equity investments",
        "terseLabel": "Payments to Acquire Other Investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions of property and equipment",
        "verboseLabel": "Expenditures for property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchases of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r645"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r235",
      "r649"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distributions from equity method investments"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from sales of additional noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r42",
      "r72"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities",
        "terseLabel": "Proceeds from debt investments held-to-maturity"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "terseLabel": "Proceeds from sale of other debt and equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r650"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from asset and business sales"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r198",
      "r218",
      "r221",
      "r234",
      "r237",
      "r245",
      "r255",
      "r256",
      "r286",
      "r291",
      "r297",
      "r300",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r460",
      "r463",
      "r464",
      "r479",
      "r489",
      "r560",
      "r610",
      "r630",
      "r631",
      "r648",
      "r678"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r81",
      "r182",
      "r561",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.",
        "label": "Property, Plant, and Equipment, Owned, Accumulated Depreciation",
        "terseLabel": "Property and equipment, accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r32",
      "r224",
      "r502",
      "r506",
      "r508",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification into net income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r32",
      "r34",
      "r224",
      "r502",
      "r506",
      "r508",
      "r646"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "totalLabel": "Reclassification from accumulated other comprehensive income into net income net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r30",
      "r217",
      "r223"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedLabel": "Related income tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r67",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r66",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r68",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Depreciation and Amortization Expense by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r85",
      "r86",
      "r88",
      "r89"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r85",
      "r86",
      "r88",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r402",
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r402",
      "r527",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r57",
      "r58",
      "r157",
      "r178",
      "r201"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted stock units and Performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r96",
      "r179",
      "r576",
      "r581",
      "r634"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r194",
      "r241",
      "r242",
      "r243",
      "r246",
      "r254",
      "r256",
      "r317",
      "r439",
      "r440",
      "r441",
      "r449",
      "r450",
      "r477",
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r277",
      "r278",
      "r290",
      "r295",
      "r296",
      "r302",
      "r303",
      "r305",
      "r391",
      "r392",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Dialysis patient service revenues",
        "verboseLabel": "Patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionRevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r606",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r226",
      "r237",
      "r277",
      "r278",
      "r290",
      "r295",
      "r296",
      "r302",
      "r303",
      "r305",
      "r313",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r357",
      "r359",
      "r361",
      "r362",
      "r489",
      "r560",
      "r678"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r32",
      "r718",
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r19",
      "r92",
      "r93",
      "r94",
      "r95",
      "r151",
      "r152",
      "r153",
      "r173",
      "r613",
      "r615",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r136",
      "r138",
      "r141",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r334",
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r611",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill by Reportable Segments [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r64",
      "r65",
      "r69",
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r404",
      "r406",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r3",
      "r161",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r305",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r338",
      "r339",
      "r611",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r286",
      "r289",
      "r294",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Segmentreporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r165",
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted-average expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/StockbasedcompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r595",
      "r596",
      "r597",
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r197",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r305",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r337",
      "r338",
      "r339",
      "r611",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r22",
      "r91",
      "r194",
      "r223",
      "r224",
      "r225",
      "r241",
      "r242",
      "r243",
      "r246",
      "r254",
      "r256",
      "r273",
      "r317",
      "r382",
      "r439",
      "r440",
      "r441",
      "r449",
      "r450",
      "r477",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r526",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r273",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r91",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r96",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r91",
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "negatedLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r71",
      "r634",
      "r653",
      "r662",
      "r717"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total DaVita Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r111",
      "r121",
      "r194",
      "r195",
      "r224",
      "r241",
      "r242",
      "r243",
      "r246",
      "r254",
      "r317",
      "r382",
      "r439",
      "r440",
      "r441",
      "r449",
      "r450",
      "r477",
      "r502",
      "r503",
      "r508",
      "r526",
      "r573",
      "r574",
      "r653",
      "r662",
      "r717"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r509",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/NewaccountingstandardsDetails",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r509",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r509",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/NewaccountingstandardsDetails",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r509",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/NewaccountingstandardsDetails",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r530",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Derivative Instruments [Abstract]",
        "terseLabel": "Summary of Derivative Instruments [Abstract]"
       }
      }
     },
     "localname": "SummaryOfDerivativeInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r21",
      "r237",
      "r313",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, starting balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.",
        "label": "Temporary Equity, Other Changes",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "TemporaryEquityOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]",
        "terseLabel": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "periodEndLabel": "Treasury stock, ending balance (in shares)",
        "periodStartLabel": "Treasury stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r5",
      "r91",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Purchase of treasury stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Share repurchases"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r91",
      "r96",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable interest entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Variableinterestentities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r120",
      "r461",
      "r462",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r259",
      "r267"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average diluted shares outstanding during period"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r60",
      "r61"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average basic shares outstanding during period"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumeratorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares for earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r258",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/subtopic&trid=2208821",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r637": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r638": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r639": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r641": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r642": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>84
<FILENAME>0000927066-23-000104-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-23-000104-xbrl.zip
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MO>!:IM_/8Q[\=J_;WNBZ?+<SZ.YV7+<=MF(,+EWXOMM++2T(:KJ\'D<GU'N
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MD2UZM ,&20X^@S%>^)V/S/_[[]81:5W8T^YU=:=):HV]_&BGUJ[N[*+F=1.
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MQ%J&QMD:CO@<=-=H=N5@W ,<_G]SH_&1I_5 "C.+UQ_G)":_MX/I#WMA?2R
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M4_:"#T >;2O4NIW4&[UN"TCE\21%U!\][*_7#[;AIEMOFCHK^]4F@,\W@1G
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MB'@QE2NEH+5+Z3457(R4(<^U]X+P&-*6JTZI,HT\+[&E'.D_X'T*&<]PFNS
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MSK\'FD>+F9Y3(DPQ)2G8!K6,,@-,36L=J1 D$L5+4")E/BQFBA+!.NV(*6+
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M@WYQ1EFVT0N2(&^C,HIA1K2V488@9+"8*B%="4J6+Z@"D9(H$)+&IMH?A(K
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MBOH)PTX^V$M)KV'?KX M=%+CBQ]R;:/03*"@%&'!8"6%]([9J .$F]1_VDS
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MYDM$G2*B'M^G9T%[$ ^*&4!C&JCY?^R]>V\;.=(]_%4$88%W%^C*P_MEYH$
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MJ?9,8LRZ/<PKN205P>WUV7=H9PN.K6X?]#>KSYJRTPH%;( "%B2:43II,4J
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M;I!V"H^"Y0UB^;JRB$A@+1-XB<X; >DEI#F;-(9'+ED3)*>JK[%,29MJ3>R
M_V.>=';X15Z4*+C-99Z]\,<6$EH#";U:%!1>4T&T2/QC8OJ!A0:CE4SF#54N
M"L48RJX,C1,+X1:9-\65T4Y%43"\?@PO"(F0S0*E(2B3Y ,Q#+1-Y@$Q4D3&
MI40F'Y3&O.*K[Z04%\5=$'BYEUB\$FO6#F73MGFJ<4O\#S'ZB D!X00&1D/V
M1" .WEDK#;6:T]#MR0II5%&\LF H+HC6 K<IP5" NQ;@7M<(AD?"D/= .3+
M6$*O58R"(L([QX,W; Y<*2J!V^0[W %_PYHSU2SEGK;UP;_6]_@/A7*;35Y7
M"+<YPGVSJ)2L$M9%@X!ZXX&YI)E,X I4X.D7$TD:R6X/BTH26<G&[+)M25M7
MR*V0VQHS]!5R:Y3<KJM)HI!B#DL0Q,GL-3:04VWEV%W.5:Z9F,N()'+31%6$
M[W)N/A?2))_<#RCE\K"9@[W?#OX\.#YX\J*SU]_O/'GV\N#XU8T>JEL\_I5Q
MH:GG_?@\G^Z\86!:35C+YV6CCH-=[\\=L.?VG$L/,)MVSLRG964_5MYI:ML#
MWUG?/$@)TYA]=C%]GLYG3\DVW+2D>;LDRSC7RACA!!B!.#"E-:@H'3"*&,_I
M&8,7.1I'5EJTJ932ANRQ0DGM>;3[L*H*):V?DA:L+.$H(=H"TLX#$\B -M2!
M(5Z(()&V(0?[2EU)M;+'ONSK_T2$X,#8P;".FBT;_)L(#OSS:X<7"FJ<@I:D
MX56&1B8" >2)R+578F(?H0!+C5401AKKNSVI12573Z95=OM;B^)&PP,+BM>,
MXNM"0DC.8AHQ(!PQ8*8NGJ056.R8Y0QA@5FWIQ"IV.JV3=GZOZ.K:'(>\N.=
MYAK*\WQW.>."#:,0!^74P=J%Q9/3L^'X4PC/0YU(K9#3.LEI2?[=X+U15E((
M:0B!$4%!4\PA!(5\6FG2?[C;$UA5Z>T663GE!$([)4;!\V;Q?%UL6.R#ITJ"
M3O0+3",-2O"<Y) 3XRWR.KB$9TTJP5F+\+P#7HL+ '3.<J[0>5[=\;7L_\6E
M<5]9_R^)ZE.AJ<9I:DE&21&1B21(<,PX8)&Z7&!( K-8*.Z"\L)W>U3GTM=M
M2C]7/!OME!T%S!L$\T*I6(ZQMB: <"@ "S3;$$Z#1"RAEWNO>0UF7C'4ID-)
M.^#@6*(YOB96\,'.BH-CS3(CI\DZ3KV]GSI[;^0?F[/!S QKFCJRJ4-JGU,Q
MCIHGJB69(Q7S2EO%003)@&$JP 3/ 0DJO4>2".QSYDA28;UR4</B[&@MMIM2
M'07;]X?MZR)$4LP"%Q'2N,H<-V; )#@#TTI[' RW1,PS13)4'!\;KCGDQJ>A
M,S,?;PK)+?90\T&L>6-KWO/'YF-QOZZ!A99DB.0&:R2] <*)32S$&23VD9!6
M'(2I51'AQ$*"58*WR1(J;HUV"HP"X\W ^+J80 ()(@2!H(("YG0^8><EJ. )
M00G6/-;5,2I$'V#$QAR-Y!'A[=85Q^.DMCL76<Y6WCMIY.CS-I-68QZ/LN>[
M1K9:DD728!.("QPH\@(8CPI,M PBMUA:2XG+->U(Q06O4&..C6W)=5# OU&7
M2 '_>L&_$%TJN'/$$E".:V"&*+#$2D A4ARISZ&F\P+JNL%Z.-N8"Z!M\N5K
M 8T2!M*Z,)"2/G<=_+4DIR5E@9-<PTO@Z)-X$1&L3/86TL*F#X1,RU'F+\9Y
MA=G*GMOB-&DMHM<<"U(0O29$+Y06Y0FSVG"(R2X!AC!/Y@A+L%;>LKP/PPFI
MS1%$*R3:5"]X!P)"_BS1'^V+_BB$U!PA+4D&&2UETO@(P5 +C"0[R48< #E+
M,2$!)Y[J]E3%L*PX;2I=VI:Z0!XTK#<;^%%@W2BLK^L,SYP-CLI<,L< BYR"
MUC0 #<K+]'\=*<JPK@^[X%)ZXUZ+>!67QOTEZRB6SSH8Z=V2<EXTB.B%!6(T
M38P4<SXSY2#1E%!<4:F$Z_;2O*A(JXH*%D]&.V5& ?*&@+QPBE8YZ4Q@8+7/
M20B%@1Q&FJ4%E]$2A&W(0.85H2OOIQ8'QEU@N!]B2!#PG<&7J-+5 CX>-!,U
M)2DN>_U+)-I55@J%CIJCH\]+LJ.F,:."H6S?* V,! XJC1ZXZ**6GBF/;+<G
M):Y0JTH,%O=%.W5%0?,FT7Q=7 3->!JX!-]$R<E*$ RTD10$$5(A(R1WR4J0
MBC18F*9%7HOMBBYMR&^QNX%E:X@J+?S4'#\MR3HJG59<20+&1@J,Y8@R)3$(
MFI-UI$4GRFS\L(HBG00';\C^:4T\:8->CMV%_1KB20OL&X7]=5FB??9Y1 \8
M"P),>PPF! :8)D+P7$CB> U[B6C%5J\JM2G8[X!/Y/'X]'0P.PVYZ$W.7IJ1
MF)H>1NY[LJ4)B^P^[]&H'GTD6RY'L^\W7309#X<Y4'B0ZYJ%:1KPZ;E]&]RL
M,QMWSLYGG;/)^/U@FK>?RS[;FB7I\^!#.,WGV;\=G(.+L7GR?^<Y!Y693#ZE
M=_=.<PV/LH@UMX@MR2N7!C,*XC5$'Y)M'60 %2P'J2QRW$:BF$B+6$6UJE39
M@WO (&]*@!:0WSO(%_+-61J<=0$,,1GDUH)F/H+G7G.BF;*"U2!GJM*H!!AO
M%*)S//S2A.K<!D9:H63I&O3QEO;8IN/A_.#]Y;TO;@'Y^E\PKKW2]],O3R>7
M.]O3V=B]Z_S[7]];[9Z&R8L3,PF-2-N%1>]+6U[DICPUDZ/)BUG.Y_Z7&9Z'
MKW_[8B5#926[Q4KV<G;X^-N5+-UO&/[[_-/KO_V932/UZG-ZYOUW.#T[??5V
M[T-__R7NOWV#^G\\2_VWQP[_>#X\W$_W_/MY+C7S#W*"2.X#2*D\,*8$&)_4
MKHO>8!V54B*I7?0(+4F[VCDSD\[[/)Q5Y\:)-LW#/%V3^?3M)*MGU'3O?'8R
MGB30^**A6COS/K_\AW./(G(23#*T@ GCTLP+/)M=VJD0G)&^V^-58LS%F3>?
M51WS9:Q_;=$,/)A.SZ_/OCCX&#Q\#I-QF7CW./'ZQ^X?B:.)C!H(A-ND_4,R
M\*D*$(2F@<;HF<?=7II*87'>#>JA_<\7Z9%D0%L,YXL;M\%P7@^X:N%04-44
MJJ[[O5",:;9B#4SZG/T4)V:FE($3W JL! V89^FM"":_ML@@?A!>KQ:!MRFO
M5P'O&L%[W9_%I2<L.)$6L7P^-4H*&CL$)/* D+"8!=%&\&[:F]5*LSWOO8Y'
M+;#9YPTI!GMS4'WU0_6:WN?]SW\-7N?G_2/US?ZS3Z^/3P;I]>"0I/:GSY.*
M_=@__G_Q\/C-/UQ33M)80_ LIP=F'%0,$7"0B;,%TYK8]AKL5V98L=:W9MI]
M/OC'6.FY,1PDUS%/.P$&8P&14N(9E4*J9#0QCEINKR],P&7&>IE\[9E\Z1G^
MX29RI@6"J#Q.D\\(2.//@6B.I>1*6)9,$XTJP9?,O1S.=+?)UI0$+I-MRR;;
MX?'!AW]RQDL3N :*M0$FB,U'I2(DIL.:$&5PB/5L8WC)$GO!='-'T;=^HE:*
MS[GVSQ@9G\^FL_0BQX:96>?03-S)_%.*JTZFUQI*^\&%4QLFWWQ$JDYZZK.0
M.N%]&'Y:Q4&V"Z>PUK":71C8A3SN1AX+B; IC<$8"CS9S\"0<J MCA!Q"!HK
MBSC5"?RECOG#!><:5O\"SI\"YX*7BTA,#-(@-$JV+PL4;! 2O-;1HL"CTQF<
MBQJPG'C<$,SV4JMSCYMAY\P,/ Q&'3?/;%9"R===K^M+US]-/7\PNL@H=X6%
MBMW1'#LM24.-2:"$2@9&& XL$I+L!H[ 1R*I5B0HG0,:DN% 2N6N!PSHQBIW
M%4!O%M#7Y88)RL?@%' 2(S"K/&AI)6#CK$1,1B9,MR>0J#1MZ@ASBS;5MD5S
M/ \SD][TG6 FH]3^DLII_:?6YCW^Y*+#]YP[/ST?YLW"_1 ';E".KS3(3$O2
M44N,%>-.IPDE!#!'(J35Q0$S6& FD+$\5^Q)4@/1-E4J+JZ*=DJ- N@- _JZ
MU,#<6N^8!$8\33!.KS1BR93 3CGG:=2&='M8LHIM4T(G/YB>#<VGW-CP?0[8
MU)6[YH_Y"N3.N,ZG[<:G9Y-P$D;3P?O0&8ZG.W;(_]\;T4O3])CIU9)BS)?#
M42?F?7QU,.:I]/Y,(](/LZ-X;#X6TFV*=%.[EJ@H%AQWF(#C(0"C.I&NXA'2
MBHDC\A09G!TVK-)(+'#N?XJKY@$@_.<%5$%X"Q&^L&'$.66*6S#4*V#<Q)PG
MDX,-VF#JL8XN=GM"5UBU!.%-^FX(;WU*HGF&S'WSUV!F.@D>C^;Q,R?CH0^3
MZ?_7"74J@%*,_3Z]/;6K^6)$YJD9"FLUQUI+LF<Z21T.DH"U1@/+]8EL5 @"
M4M3QR+SCK-M3A%=,-K77W9K4F0VZ?G87^DWYA0KTUPS]!3\0IDE*().T"N;
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M32N+'!BE+%@B9)K.W""%<P4I2=H43E^<)FV/&2G@O@=P7U<EEAMN93#@O+/
M@HV@%"(@!34A&BY]K,&M6W4*;L=\)XLE&:8YH"0_3!X(,VQ6JVRM9=46K7(X
M&(WKPC+9E,J659@4'FN0QY8DX$-6J,1&%+2.$9A$ BS6!)2EP4MBA:C+\Z)*
M+=F,+G$F#P76:U4I!=9KA_5"UF"/N-71@'>2)UC[ (I$"YK@-'Y"6$-E+KX@
MMJGXPD/SG3S]LGF31$GQFMR[$OF2\/S'A%5B77^2JY:DT',B((VH!NFU ^:]
M26+$(D HK434AV"8:&-(?O&4;,NFS6T0723(BK"^+D&\T]B+@-.T0@98M$F"
M!$6 \Q@9$X3:G/B.5D0M2I"M#RS9NJR_RW+<K>($V>&DGAO/^OOE[&!)ZKD.
M;GNU*%FDILHPS($812$-,@$50R(X'[!%/G(5DGE%)*\T;B#$I#59?QMTI^PP
M06P\ZV\AB'43Q$)8+8G2:JW .1.238,X6"0I*,PM$UR[(%D2/PQ77#80N-*^
MK+_+=5F;)=&3&(.;U74E/[H3,WH3.A,S"YWYZSK?6E9,U5PWY1I/[Q-&<E1N
M#KW-OIK)P.7@W/QY\=ILRFLS'[:C^.1BT)ZG,3L:91;,_W_R=9B>?QFA_,'>
MR'_[QI4K"S<VQXU+4\@ZQD-DH!%#P+2T><LIGX*403!O94 Z5[2C:/$<4?'V
M/!0B:-S94XB@[42P())<5($I#8;@1 0A6% NV5.2:>RQ4&FAL-E#1,7*FU3M
M<Q.U60IE[]!@Y'+>E=#Y=YKO]:O_9#_1FB70PS0.[U,?K42 3]/CYJIY\PFP
M?S$1TN_#\SP$5ZEV3K^%,9MCS"7I;C%E(AJ?T\T9"0R39%8:H<$Z0E64@7&I
MNCU)*H940_OZQ??4>GIIA^^I$,T6$\U"U2JC/5<N7-AHD6,P.BI(W(,#4I(2
M3+N]1$<5E8L!SL5_=1\GL6ZMS#IFUK'AS6 TROM].</>2>A\"F92O%8WL*;'
MR%NA2:3,,&.\-@I[H8P2+/]4_QQDLL1DK6*L4%YSE+<DLZ^.25Y'@<'7*<99
M4EDV2 (A!*<IDD@PE*Q1JBJMVG2FHSBF&L8Z30HI,H(0#HPZJ7GP:? U<\Y&
M;VB-=5RPODU8ORYO(E,>(<]!.ISL*$<L:,P=(.^LR_5\@R7='N>LTF+EPN3%
M][0^&1/2VQ<"YJPV(7Y2><Z?^!>:QL6/S^TP?%&?J]F*;>O=?]UC_SR4!4)3
MB17'-@JDF>!4$28D(D;%*(S0HEX@UNV9*PM$8PO$\9+\RU)PP7VPD.0^!68M
M LNE V<)-M8A+HGN]AC&%=4K[U(V#K5[=L45SBV<VS#GBJBT8TPA[65"G35:
M2QDP272+,4=H;H 7SMTFSET0Y4Y';C@'@X0#1B,&Y9 #RI,VYSYZ(47B7((J
MKA9CYK:5<VM)_S\SD_YH^M</WO?^-_VX;/BIF;P9C.H_+[YE.1?R"<&F@8O1
MCY!+,G)?A- 9C6>ASHZ=@.K#*)\C2*_J#JIS5%Z<*###U+CT1GT0Y]&7\;G^
MH!>WI_DIS\;3.C_#+W6ZR\'[\.N'@9^=7++&E6]=C!OZ^A5C4PO.9S=_I2U=
MR+[MBJL_<VMK"C$88ZJYC-9@)J4RF@=N)%624.44^8>H[N673B:73W!FW@2P
MDV#>@8GI 7\QPP_FT[3[/]_.K#2M+AK$]*-\4O:N/=;[7SM)]USR&/?:W7)I
M=^_O_75PO-<YZ#^^>0ZVI:V/C_HOCOX\V-\[?K+?>7&<_CE\TC]^T3GZO?/D
MV<N#XU>M?X)_GX_,N1\D&OA/^]OJQ\.AF<Q=#--\/G": UUF)^/S=%L_O?D)
MKI"SK@5PS>)?N:E>.5R^^]DT_'+YXE<_F)X-S:=?!J.Z,?67?KVXUP6A93A>
M6S7J[II_?(%4K1])3#)8+SQ"%W_X L>/:AQ?6P@O/E./!+OY8_0(W_S5[]Q6
M/.)4_-1=O_\9)\VWE3T2@FY)6_DCI/F6M%4\4F1[VDJ8VI*VLD<<ZRUIZS;Q
M@'Z$Z<_=]3[ZE6JR-6U5MYP#/]C3^.%^)9<+URYQ"LTEQF:\'_)'NJ.6V,<G
MDV1%G:;K3J9Y'R.93(=FXDXZ%%>=[$'^QI:]Z*5KYA*>]\GW>ZYEO;'<%[3<
M?+_Z5)/QA_EK]M4S>9-Q_KT-K_;-A/YX!+4M=24!4/W[UR1 ^;?IN7V;3ZC-
MQO6O9^>SSED^Z#G-R3^_UW.W[JT;,<;XE?XG#ZW_]\U?@YGI'(S<H\[5!"%U
MRAGY:R>[ &>?UMO#.S[!LS?ICI-\!4;\WB@T=.GRUA&T.WQ]VX[4#VVVSTMI
M=KY?K;AQTGAPK+SW)4OOG G,P,-@-*<1<Y8(>U@Z]Z<[]WF8F?2FK[LSF$F.
M!%ZSAGAP.#^^75WR,AE_B'3GSD_/Z[HZ]7P<ST["Y$(OG)XE.19&T\'[4+\S
M'$_7/$\;OLD=U $F11W\Q&ALW7RO;8R59G%3$WGKNF[O='P^FC4[L=9SZ</I
M\S)=MWVZ;D5?'8]O)^F_MZ!N9V#\[=;4W\S0C%S(4>_[P853&R:7KF*RMO.6
M]QQ@>;N>^=D R_;&3][NN>\0/QFM%CXXZW/R795>N,ABE A');BFY+8'&(_#
MZ=EX8B:?YC[1QV8R^93S"M8\]^6X]M/Q)#=H;S8O3I4#'(['_6\2W!]<>OZV
M(ZCRZ/%%4.7I\[?]/UZ?]C__/N@?OT.'^\\^'NT?\J/C]/O^D\_]M[\/CH[]
MN\/C=U^#*M_^O^&KX^?I;_[U]O7?Z>^\??;QU>E?J6TNM?>0I>^3P]-GY.B/
ME_QZ4.5ANJ[_QU]O^W^G-A\_(_W]WP?I'CRUCZ=G8H>?7WUZO?^*O3X>QOY%
M$/OA"X2/CM_PH_V7_T@>6%0A $;* 1.1@,V9F GUSFB"M?:VV\,59:K2)6?$
M0\@9L2)WS".@KA]Y,4'*: (S2#.*N:':ZHBI<-XRB_RMSS_7KM$7V5\R5Y5'
MY[/IS(QRYQ4B:) (/E\G BUI,-%S8$%I8-H@,,&E5\2KZ+&1&N-N3Z.*X89C
MJUO/ D4L%;&T%K:K>>YB+WFNEWY&(17JNQOUX>O4I]*P)8+SD 8OY$(4 I05
M")33B%FKB18L4U^AO4)[NTQ[CBNIHJ4N4,:TTH8:CH)'T7KJN<.;IKTB!QOC
M1'J=$Y/9CYW7.LTYF<M^:I93>UE@3$:!@U1<FVY/(%%ING)U\D*,A1BWF1A-
MX#I1G\?*6H9T,(S%J%7,)XZ1-+P0X]82([].C$Y@YA!50 /RB1@=!6U(3A2D
MTI!CAGG0W1Z6K&*JX<0/K2?&XBZ[I;N,8Q22F'+<2<\HESKU2*Z\JSR.Z66X
MM;?](L*H)HX+W]G%WVMY,=(M@?_'Q7KH)N)(;02-2<(_(Q2,H"R]PL:(["OS
MM+%BI%N&_R*,BC!:"\^M0Q@54OQY4KR>F24QHG$<>T#,"V!4"E#>.N"&F*@\
MMY(64BRD^(!)\2XI]KD75!CG0S28)5(T#'$>*#)8.1+,=_QH-V36+W9C^SBR
M?UTXJF =%MR"]5@#"^F5TI(EPQ$%PQ0GGO)N3^@**[$%"?,+.Q9V7(=D1-8Z
M'PV*D7&FO;+,49LDA#<Q)]BFQ9>VQ9QX73<J;FQ0$0$6))G0R)AD3"L*5A%E
M/"*84=OM24PJ2A9)L>C&PHP[Q(S4!V2D-"Z[H!F2&ELGF!'8<FJTO76-D<*,
M[6/&HX5";B*7VW(*7 Y,89@K,-8&""@(9XF7)KIN#PM:<;$US-A0D:4YGSV2
MO-V4]OCJV=1<+G-\&GZYS2FIGZ[,4NY1[E'N4>ZQC?=HZ(#>?&T@CTC+%X>+
M"LII25BE#/(#VB=?5HF4*(=8(,)CYG@P-EF)+D@=+,-*W[W2\;6S:6D(#NH1
M*%*V,2G[:?&$&0IIW**60&-(-G[0 53 &H)FG@H7HW2RVZ.B$IHT)&1;9,67
M>[3\'KO.LC8R8S7AC@K+-!-&1R*XP,A$[K"R=V;9+[3ZYW@Z_:%G81)\"*?Y
MU^)F6#LW+P0S*L,4L@)#$)0"4Y& 41@!P<3$J#&QFG5[&/.*LZ:"&0LYEWL4
M<KYM5@:!9*0"!9'4$A+I62VVWDK.K-/2%7)^..2\N#M&C4*,!0Q"<P-IQ#TH
M22R@J .1S&OCS"ZP\ZZS@))4"H%ILI@((U);83CE.AJJ/:(_80@7%F@O"RSL
M!!FB->6.@0W> Z->@\D'3G"TN>BX8HZ$Q *J8F3EJO,-DL /_'F7-8Y28\/W
M>:-<6:XL5S:\>4K;[1T_R@E^.V[)!FK9/RWW*/=X0/?XGKA?PF /3MQ3)G 4
M2E.B$</&*1>-"APICYT/V-Q9W-?<^4WLR5>MGX3_43PV'XMD;TJR'RT+]=?"
M.N&C!FT#!18\ LLX!QFB%)$@SO.6%V8542LG%?K.*K\NN[U ^YZ\=P7:&X?V
M=9]<D$IQQ3%P174^],V3-:X2M!&V,<$;:^%V -IKBO)IG]55KBQ7MOG*'<AK
M7Y]7Z)@/9N([Z?E'/^4"*+N6FTUPXR(QC M!'&)>.^V8T<I91&4P5MX]JJ2>
M! ?3Z7GP^^>3O%N1GF+LY]ENZI^_F6GP61PE961R$XO8N8/8.<R1(=?%#F<(
M1^K3Y%7& ;,F@#:40D@"EF">!E;;;H_0-NT[%# WG,)E0TC^RPS/0P%R(T!>
M<$B(B+5$,4W<-*V Q9RT2AD%UI%(I3/)=,EQ7@7&VP7CNR0=T3S- (&="5JG
M"8 3CF/T7!,K"%,A-(OC_-G166[3],G','&#!.GBF6@4X]<7Z^B4Q(PSX))[
M8!Q'L)X2$$8CFF",ZV@A77%"5T\OTD:(EWN4>Y0E8)/^Z+($W*^]=NQF\_RD
M+_G1_CO6?_:/MY08%!&()/F &986@8@9(!X14MP9:<)\$5@\:[73BT!#T36M
M]Z.E[\YFPY '-_]FLZU5U\V>2WUWQ>SJA(_Y=0FYV;9[[/J^:^.FSIY_>SZ=
MG8;1;'H\WDL]EUM@AD_-P!^,'INSP<P,:]>%O>ZZ>![^[WPP'<S"BS!Y/W!A
MOD ^#V[\9E3?I5XKR[+8W+)XL&@9T1!9$-$!=L$"BYR MA)!LHI(I#A2'F*W
M1UBE5C]&\0#W;,L]=N,>N[YL-&X>E65CFY:-)=84"UXH13W@/.C,!@>&$IE>
M(24E#YCD6B]EX5AO2I\VVU2/3\SH3;K;8-09?7,X[HI--;@X)]>)D_'ISR6
MVS976[E'N4>Y1[G'/7C@MB4!W/Y@.C]GG1WD/Y4#;FLU^5WV+!I+ N??F^L)
MX/:#R_730EZ7OQF.V0TYC_\[3YI<='=SNOO9;*'"FD/<48<Q1!T4,.4%*!(,
M"(P5%=0K)UVW1WG%^6*(_>TW,1Z@X"[W*/<H]RCWV'G5T'C&G,/!:#RI*R7,
ME<"E=/C]NG2XJ5Q"D0[KD ['[ZZ[[+0."+L002+A@'E-P%KK0%!.I8HXL%R>
M%>N*+*G.?"_B8<<27S_.V%C)[MG:6*V6F#T'HZ_<]<UHY#<*>VV(O5XN&CZ:
M1LXH]J 09\ HYZ"]8. CY<D6<CBRQ%VTDDP]X$C]<H]RCW*/<H\2YGW/V4*S
M=%@N!VY4$$4#W%4#+%HPEE.DTL@ UTD*,,<(&*04N"BI,,FB0<AW>UJV*>/O
MCNW=[+EY>$Z>\ATS\AT_>)]@,9B=)W24<.DMN\>#]);=1[CTCQ>,_?-P/+Z*
MGKV1W[^"G6)@-K>XO%H,A%84$6Z,!ZU$!(8"!BLP@^"UYRR76T:VV\.T0DO.
MB)9XMG*/W;C'KB\(C05"EP6A70O"LA!G30Q+E@!PQ!TPA1TH+ 6(Z%PR-7@:
M7+(#2\*N0WZ#3H,"^<U"?L'!P'@:6XTU2*($L$B3"C1& %?6*(D4)]9W>Q15
M$J^\S["Y?=+VI68L5Y8KVWSEC@4>_&X&D\[[?&ZN,PFG:24ZS_^,9B4(X;X*
M<.^YI AR(X['SX-/GY63C6O0 &\6 PVHY8I&Q@!C)X%I2\"ZI/P#I5PX)IWT
MB248KQ!]R#D!RSUV@.\VG"-QFIXWO?I1_.C\W.C!J/#>&GEOP?_M*/;"B0":
M< *,"0LF(@F4,R40]]$)?B/O[71ZK'*/W;C'SB\!#?B^RQ+0GB5@B<<[,**Y
MH :80";GPE:@:$@*6 GK3.3&!U,6@9\XH=T^#T>YLES9YBL+H,J5Y<K[=&DO
MWY]JLQO[-S,T(Q<Z9M8Y-!-WTJ&XZI!Z=_YN>W)V//%A O-G^84F;>+'YW88
M.I>/<''!;'SV2U8NT_%PX+]\^$,KH&W]]J][[)]66T=W,(Z8,YJPB(.+CFDG
MM* H2HNCQ#@Z8?\Y^*E]@,=F,OF4.FOO- U#CA,8GN>^>SJ>Y ;MS>;G"TSJ
M^YM.5Y>@@>:LIK=/EIQ,=&E<M7/ B$' , J@<M 0D@'C9"C3$%6WARNJ5:7(
MRN7 &D?@%H49K9F6MX=^EM85S-F:$1*>"^%8B$@92APGC@2F10CNM@ST>'QZ
M.A[5&?'G)02/SF?3F1GESBM<TBB77'?">T$E%T8"3B,%#!$-*E@)^5P3P5;3
MR$2WIU$EEJ1WVG$B*9JN:+J&-5U3C%ISZ<D\3\27/!-W%G*%7N](KPNE'A'3
M1#),0?,LU=+@0GH# 35I]O+ O,#Y^.C*<1V%6@NU%FK]+K5ZSK"3)"!GDZ:Q
MT6I#4>"<".4IXG'3U%ID;8.\>UW6:NTX,EQ#I%HG6:L0*!8X(.4#EB1:&ERW
MQY.N);R0;R'?0K[K)=\@4.3">2<,9RZ?9/*22FQDH"A'^!7RW5[R/;HN>KE#
M6+BZOKE6P!CSH)$CX#1'$=M 2?8ID$2^B+)"OL4[N1[OI$%&2!$P(MBS()RQ
MF/AHK-718T7TK?=')O7QE$\U]URX*B_^WE4:B8./P</G,!D7!KFK5_+XR<*Q
M2!PTIT$!SRF7&"81M& 1B.$VR/0?TKJ;N$(13'XM'%($7!%P:Q5P39'I.@1<
M8=X5F/=P(>.=\XQR8@$'DTQGID5BWDC!).'&TW#KB$5AWL*\A7DW= C"8:RY
M1E8C;AD7P1#E=0*H0<&F'^)FZKWA[$,QHMM(Q"\7BB<(9@)C" **"%A2O:"8
M\Y!8V#H2%5&<=7N<51J)U8LG% HN%+Q3%'P'!B96,(=(8E^G&-%$X4B=\0@Q
M%3TWJG@OMYEX%\ZD::F#H$HDXB4$6/9"F.@X((^]=_\_>^_>U$:2K(U_%07G
M_9TS&Z%BZWZQ]T<$8VP?YEW$>(S' ?\XZ@J-A<3J8AM_^C>K6\* P-R$D:!B
M9[&D[JZN6S[Y9%95I@DN6+&RIJEH<U4V117X+?#[P/!KO.=1@+!9RJ,6QH=
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MY$T1Z445Z1DCRRE!@U02298H\!"0:QVL0 RP&GL!;!+GJ#:T3<V\<JT7D5Y
MD?8X,!H4& A&<$F\M=@Z(RR)FE#-8A'I117IV>@JUKK$O4;"LYQ,'.P+*XQ"
M"0P,$A28B(S5R<0Q7R21GM/RW'*8#AM5WA99C<:#GZS5/LVXTK\M@NWP<5"-
M1K&WG=)?^>1,##O]]S9O(OM]/(0:#X<?H%(%B6Z#1)=%)&5".YLDPCPD(!>:
M(T<#0SH*Q6Q01 BQLJ9G4>@?MW5L+)!KMHCOP]L)-Q3?PC+F)MLSA@-+W!*-
M'4J,6,1IBL@R:9&A2C@CN4Q)@^'0IG(V*$81[R<AW@]F,Q3Q_M7B/6-$L,@9
M8RGO(F>@NK&RH+HC1YS1R"*#7X7,XLTN\?0]BG@_JY6'-_T!?.VUFOA/OCG2
MUZ_WA-IP.+Y/TN9GX>UX,+MB9P -Z-;G:=9[X<_QP!_885QOCF1"?Z[_&)WS
M^)6J;S&@[W'0+]!U"^CJO)JU.IR(7EGBD;;4(6ZC0(8(BX*(QIAD;*0XIU6I
M]TXOD .D^#07T/X80H/AT]SEO?"5>PG]C#EBO%+!)XP(L<!7*,^N!L]1_'_L
MO7EW$\FR+_I5M'AWO]/]GM*=\]!]%FNY,7"\#[8;<#<+_F'E: MDR5L#8#[]
MC<PJS3+8(+!LU]WWN+&EJLK*C/C%'(&YMMAPKG0H8R49U=^AL#3LOL7LO@%[
MI&'WK63W%?,DQ! D"1HI82CB>32T-8DB./08HO!Y"L!VL?L]KSZB&TM5N]?I
MJW<T=U59HPC!BMN N:-.Y_\8RPU7@=.8KMK1L\E=W3CXKJD[BJ!412X9"DP!
M^$:2D-."(Q9$X)C&*)0J=4=$MC7][@D>U^*)VYJ7WZ#:W4,UKP'(I!=4FLAQ
MM$;&X"6)S(B(HVQ0[291;<6"Q%00.*D$%B0QB">LD&,VHF"2-$8;K5PN-Q*F
MK;Y_*E&#:0VF;<];WT#O]0;3?@"FK9C)')!+:BP1TWFFNV8):6]EGE\A<!",
M4NI*E9&2;4F^.V?_IZ#:5PSI2=LE>(WX92"\S=]L-J$)^38AW^L(+L)RJ9+5
MP1#'-<=6,<<B3<8)3)/@:UL--B'?[9-S1VM"O@P.,T7)0,1)@KA*%-F(,0I,
M&FU!E1=&-R'?>\#ER5)0;+#2SE).@M,.)Q$4=8H%R=,-<'FCTGX7JZ^8Z:"T
M)JM-S.GDN7I>)V0T8XB$I"QS5G,%K$Y86^'OKIIO.'U[.?V;6@<WG+Z]G+[:
M(@,[Y03%"%LB$3>.(J>M14'3J*@FDG"_A9Q^SP*]90C$),K+FBAOXSN\/!X2
M(HF*$,.QXE%B';SRGB;J3 9M7WR'UT#J!GXW!K]KHKP$C*?D6$!4Q 0V%3/(
M,,Z1I'"*TB<E/&^BO VJW7M4LY(IYW'0BG,2DS611RZD4L9D#:9!M1M$M17S
MD5MLB/ *J90XXHY@I#U52$::L':6"(,!U11K<RT;3&LP[5YBFF&*:$' Q,9@
M8PL&)K94."?5)FFED0VFW2"FK49Y,5<&2XL443*[Q!AH:MXC0Y/Q@7(N5-5+
MTN V(S^\E^0FK>C)*B:$S*L!/!MVIEWA'G-ONV:"^":>T*SR"ZN\UTZ5WR^-
MZFZBCT%SC\UF$J@=);:<TF;S ;_=/7K7-+UUKWAG]+E->]Z>#OK#)OJQN08<
MQ_NCR8"7P^/W'*XE;X5@R7/KD#9&(*ZX1UHD [1D?6!)VZ VZ7_;OEAG@T9W
M%8TV[#%KT&CS:'2QA$8V1"N(9RC_)P]C"4A'C1$+BA%'B=&2@(UI>)N9;8K&
M-EC48-'/]'0U6+1Q+#I<UHR2YIP'39'%,B(>=4*6DPQ-#,1)8,Z2D/U=E!#X
MO^_VXF]?;LAML3-WO1^?C4L'OU;G[-QV!F46MS^U@Y-[U_?X!LVU_;+W,<R=
MQ_[T.)ZM %:3F/Z-6'6P:L5)JHF3+.4D1 U6G)-(!PP_'(E<&BI],AO+3&^Z
MI6YS=Z(-6SW79.I&"_E.SEZVB)Q(F@2:$*@;*=>+ U,+8U'P1C'.N!+)/7A(
M*&X;O.J=:5H@WPFFWK3YT##U3V7J%=."&JZ53P01AG-ZD#5(1\*1\\93%C$(
M<;EE3/V]L:OKNCKJZ&VUB.4 [CU-$]KDUFPW.#;IWG<"^IZO6BJ$4TLP,\A;
MP1#')/M7G$.>2ZN]-]9NM*O7!EEFRWW##6 V@-EDDM]^P%PV *G7C 8?$/44
M=$4=,-(V4,1)""0I0:Q3&TLE;^"R@<L&+ILD]5L#EZM1.\XED]8B+PD&N*0Z
MCR5UB+,8+?9)12PVF*6^!8!9+//?1A8>!_\-G0\/)R]U.#X#]O /_QO^.'F%
M,SLXZ?3*6LP$N#J]$'NCWZDJ"/J3^9%F?CP^C:U'_3-X\D4KP.9L0X>&^Q&[
MZL;_>7'QYE4X=X!K1T^?=-Z\>DX.S_8_OWGW&A_NO3@]V'O_Z?79BW=P'3E\
M]Y@?O#O!1\=OTN'Q<W'X^6]RM ?KVH.U?'S+K&%)*((B8<!Q AOD0*M$1B3#
M M&$^_#@8:\_6N&ZUB#Z_DD/**:52>"D/H(UX=Q6*!.>6R.@F-'I(,;6&5##
MZ; 5@8C#4DI[Z5Z6.T7N3!FZ\,=MXH?_&K;ZYW%0.H4,"^EW>F-X]W[+Q;(_
M/L>]W479D9A2]".X(I5??7_0[]D/G<%XV/KET=$_^WN(F%];<-L0SSI^I_7J
MM-.-Y:M3[NO#6\ 1U1W@1MV+5OQT#C=MV1:0/[R.[;9L $0:3AZ?U]*!A[IZ
M;%[+PO^'$QV.NZ/)2OJ]DWX^MLDBIFMHYX\'L%389'BA7A^N'HX'I41A=&I'
MY>HS"[0Q&H<X?;'*;=WY,%G#])77/*#3\]UQAMF6!QRUG5[>Q="I-C132(@?
M8K=_7IJMP+?+??[>>;E3/CSI]AV\,M!GKW_6B<-VJVL!T&%-@_=Q-'>K_*!4
M=70I%P)=QI$=7+3. >\]7%F]SYF]:)U:6+B+L0>7C&)OV$F=V1G.%EY8()]%
M^?[E^P\/A&>U\J+Z@^D>S>AG<C!QN,0'F0UKBBKKO@6<\=]+2ZY 5U-CE;9:
M6.\X5]0DPX.A28,HH)2"Q-^;.^-V"WXI_P50Z650@4.OF0RH!/Y1L+Y4R4S;
M'\Y]]7V\:/G. (AP.,K?&K9@?WW%1P'.:+AT!"7NKOX8 N4,@8]ZL/3N6HRS
M^8R&%1V6,R^,:,=#H Y8CSV)Y6N%][N=F*E_U.H,JV/O=M[';B8A.)1\W91[
M$MR^]<%VQ]7",I>OD,@@GO<'Y>VSJ!VV/O;'W9 9LIL9NMP3+H#[ %MG-,B<
MY^U@<)$OL6>Y:5'A>[AQ@>!*C9K@\$[K\2<?0;^!?5UZ\-.8=_JB];X3>GE;
M+;S)XF+R;4,<^D''P3:D\: <!QS#87\46P3G[5B\)]!'T;%*1E#J].",,M?
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MT(@V(A+NX0RB!*O8<*0--2C']'++9R_I#W"@?85?OELYW#J;]NH.M'6O>"M
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MP&GY/".C77VQRYFF^KD$<Y449U10R@GHH<%Q'*6-*0@& LY3^ 3$V!>G\6U
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M#>Y9]+H;<]AU,1=F8F>5P$'VQZQXND 6@Y92>4I"T9BGE,DKRBPX^V_;J]V
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M? C?WV>O/S_IOG[UY!T\[_/1JWVQ3.)OWAV^/WCUFA[N/::'KUY_/'QZ^.Z
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M>T18%%@FS+5T#Q[RMB+?X_-;#R _5(U;>N2EF5!WD^VOP?74&J*I\(E$QF/
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MK9"Q$DFPTEN18D31$X-X"@' (X] !276@O@ <V9SQDP#'+<&..Y.?4>C>OP
M'%D-5(2D#<8Y03OD><K.(>V]04!-5"KNI/6^43WN$X)L772CP8V;QXV5\(A(
M*:A$,7*""<1-DL@1@9'E-$A"E&8BSV9MX^\/<#;8<1>Q8RNK.QJS9;.PL1*#
ML<DIK*-!8*9:4#=XSHM0\*M)0H<4I*2A,5L:X+CQX$VC=/Q?]MZ]J6UD6Q_^
M*J[4.762^KG9ZE:WI$[VFRHFD#G,&9O)0"9%_DGU32!B;+9D0\BG?]?JEGR'
MD(0$0U0U0\#6I2_K\JQ+KW7_TF,U^I.ZE#EE(B)CF8?N+<JPG.@HC@1/6*(C
M]L!0QZ]PMF-WB$/M:#500[-2"^R6!=K"#)['L,YV--$#-]V&[Q.&&[=:_W6/
M"_1HM(2T+C(BRX06DLN(2V% =F1<<\ 8D<D_[-W.&7X+18!E(UOY?^?R?TW7
M&ZJ%,3$ 1TVQYS:5&9%6:<*,4H8KE>0R?O(RE5T>W7%UR#O@K7M.__FNB5X_
MRU]>OMYV:39;LGY-V""WF8I M*;"@>'NM.8YRSEC)@8$9IVZ7K1>$RUH9>S]
MR=B5P*+FZ/>/')$\D83CR6F9N9AP 9B;2Q8KD6*#1-Z-:71GO<6^B[<>LF1M
M\>LOA%^_2LJF5F>"6ZDEY0;=90EWG&4Y-1DSTK52]@%)V=6J>M)E/,YCPC*9
M$AXS2;)$QL08E<@L-K#O^9.7@G=EE/Q@(=N"V%;(/@X0^Q72U61Y+'*;9R:A
M'(Q*G8L\ ?S*F<FBE'$O76_A.VZ%ZOT)U968M(Y-3 5+B$L40%<A0*@ZJTDL
MF(V5S"*?1LNCKLR^N_1/"U];F?HKR-2O@:R& 72AF<!.DER)7 F0;"!DA<YU
MQ'-SO5!M(>O&2=>5T+V+TTCJ1)+48NS-*$XD-98HG<<T5C1W.7OR,A7=3*Q*
MU]8OT K65K!^<Z)V)%F4::[3/.,\I3)/E6&1,EDL+8]U*U@?D&!=S6J029X+
M)C3AJ0')RE-)T.=#6,Z88,YE+$_Q3&LW2Q^XQ]4G._QKK.!U+YN9]"=GP$$&
M_K;%Q<M_PX]F"F>J/"Z&?BRRD7#%T+KA^#E+O:C]R8S+D'$/3QQV-W.EJ\:=
M$EBH8]1Y1QV7SIW!T'S3L]+![#\[VQD %\&KRVF*D:]PN= :K:-*AQ?@PMN.
MJH"#];CC/IT#-^*;.L"@( Y*>-_Y*"12@'#P&^,+9E9C^ ??7'5&>?W,K<Z!
M<YW^" :7(.]V\DF)? [/'JMB4&U-B<:O.>X$"IQB./$94&$7/#,K2FDL19IK
M17F:9DH*)U0:9RF+,Y.Q#UC$_4M;]\-W*EV[4S3:"E;=ZL]_+]#>DK35>2)Y
M$KDL8]PIFJ5):@W7>#XF8[%=>RQF4;[^H\H"B7ROII-=6-OQU4Y1&2"(2>D.
MX66_#4;FX_V*S+C7B,S3[4\HHGKOCJ[>[[RY O%7]$Y/3HY.?QOT02CV/O_V
M\>CT;WCO'P6(OX'[W[^OWK^SYYKQI+?S&D3=QT_O3T'D[>R!^-N[VO_]=='[
M_2U[#Z*X]_O?1?_W7=$[^R/O[YCH@Z292Q,=D41D%F2>-$0:IPAJ-\=,SN*4
M!04(].CL-JH=&L69BAVVC 4RS&W&$FNU,)8JH2/)GW0<:*%SV()Q.7%/7C8;
M,.-4AUM0 '$]_6=OMWJV*GWF&6+CA="_ES@VD-$75^GE]KC34Z4Y"5P0TVX'
M2;B+,J9"*8,3JYQ=E#!Y,51#4ZC!O*P!03.86-<9C\;P!0@W%P00KB[^^U]?
M@6^TY4 0"0PVRWG&K&0NU0:K-O-8)LD-L8XE6.-'\2#0RD]G/1@_( VN$AOG
M6%C62<*E =;+!274<13P(N=X:C2.LBX7J]U\.FIHZ_T> '<5@\!0^"E<ACM:
MC@8#5% -U\TH E3>^*0H;>=<E?ZN>R*1/V<#;^ED+9V<OKG\H)2$^Q0E-DLI
MB&B7$VF-( )W((8-2#C64$^S;IRM'@O<Z@!& E!SHBY<1SLW!/+HP$*#J /2
M,2=J>.RJ!MD,U1@4(I(#_H6&B!I>_0]055GB=4'87!;CDUJRE)T"/CB=V./P
M%5")<>40J0X><-;)R]$9_#8"<69!)Y2%]I K@"$6!T*<?]&M19UMAHS&5H=&
MY/^VUB"GZ_1(+;ZY /E^/JH*O/IYB47/P>1Z<5G8\4D3QIB[JT;IT>P6I6&T
MD_'UM\PA<N.0#^])1=%X"63._?P*>!E/X>5)V4SA7!T[H@%D?R0JAQD^5X-+
M=54]^=>BY@:U78](XI"_=L%>_EN7_[I^0W_^.J]'N3O;_^P=;G?V^J^V-GZL
M_?W#W8/.X7[GU7Y_9[=_L+N#OQWL_[FWLWT(?[S>ZV_W7^UM_]DY.(0/>KO]
MPX/Z,-#3*2!\MO'3?#H9JHDMQILUUO5L^M2"SE9E4./5"1BCM6@>3>"QMNJ"
M*6H<V/OG8#[Z[SL@*M7JQ*YGF@VU#NE]68>O55'^HP83-S,(JXVQ"*\:)]J;
MJ'\X^-@_VXW[ISUQ=/B&P[OX^W>[_/WI'MT_/#GMLW_.^J?>(;8 -P">T/UW
M;]C1H6&]SX.3_L[QI_[.R>#H\.2L=_I6P+OB]^^.6 ^+O.WTXM[V!Y&8+--I
M##8A=X0;D1(9 ^#0C H ':G,,[5L$^K<1;$5E.8VYZFQ*D\-U12>D)N(YOFR
M38C+WKG =??H<Z;JBV$%5WA=?[-9N-;H^O(P%H>=I%F:49NDD4UYGC/0>4HI
ME[DLCS,JQ9,'8'X>SA!4Y\PI3\$>&N73-<8E!F V5B!,@G78O;W54$WTJ3-C
M!&OG$Q ]Y>BBJ&#%P7HOG77NS-OV[C^38GPU=]N<DTW!>-S9^:A4Y55]X;..
M5FC;3LYAZYJAX5C#9HZ=.1D6_YGXF:CQU, =:5BD"_]" )^3X=S?Q1!&%Z8"
M+YZ<G8_]&/WML'$?W3B8.Z: E4(8.YH,X/W!K7<.]%6C5OA@S1)U5V;@WV1&
M9V?%V%.K!]K3C3B!.8/5,UI<AO4KO_3DHIDTBO=Z0^'F\<)^PCZBGW)2EN$P
M5U54P9>)&Z_.89-@2N@/G;OII' E^ANN.@-WX095\&\"Z\'C]96_\_64#[>-
M&4V058X[!V,8I2IMU?EM!/]TGK[>/OCMV=8*._Y *7U@3IR=#-Q^/I77P;^P
M/;1S5F2O7JW]X=_-VOR&2W.(%/(+2W7>N_Q@J!,TDBDQ3,3HZ<M(1A-'G#,I
MY3PQWM.W**4?AO#+062-+CW[>DD S ^#A8=4\]:EAZ[IB^IKV/!KN$]Y1;;&
MH?=\*9OI!@"6^'6L9]$8G3X&9! 8GE?N>?/+"UM4YP-U];P8^E7Q-[VHGU5;
MJFC>+H6 _+:%KV<VV%84[+#ZY&O]YOKK+?_54D K?,?%5L;DM5]'6_3:[VYZ
M+(#!A'[;8V_^3L37O[0=["8.EO%;/?8+Y[:_6.1A]=(UF1S!,OPY>0OIEZPF
MS["'Z/Z]MM;OXY__F\D(_80(WKRA[,U=]'M>N"!S ^ZK_.<8>2U07>'@:R7@
MOWCZ)Z*A#ET)WO]"*WD  _ U-X;CS@B#TWYE9N@Z+&> V/.+QMI%\XOFUV3>
M'/$?K*Y7O+A>CZLB^?I5"CC]%F1R)V4_-CO/[ O5V>^B7E&[GNUZMNNYN>MY
M1R6&?,9?NI6*C9'^ZU=@;WCAJG$3NFU<9Q7:SM[$_IX^((\TW_H!Y4U_1<Y(
MIE3DLB3G-HNY,+%.3)I3DV8Y-['D^K8Y([N>@@ZF!/3ZHE\\D.21;_/[U2G1
M/;J_TXO[.V_Y_N^[G_9W_O[8/_W[Y/WI1_Y^QY[U=EX7O9V/G_IG1_%R2G3O
M\UO>^VS@G<<PMEW>__T-Z__^^@S>\['/CBY[[_8N]P]WV?M3F_>*U4(_+*,V
MCC)+'$\<X8FV1.=&$]A/Q5@J<JJR)R_CI$O7-/IY\)VZ6H'T2 62S"(39<Q9
MQE,>I[&V4B1IDJ5YXFC$92N0-D0@K53%,598FVI-J,DRPFVD219E*5%Q'O'4
M)9&@NA5(K4#:A+E]A4!R*8NLSC.5<<J9E#I/G4M2IVF<):EA=R>0-J^&]D.1
M12NU8UB:*I.;C"@6Y82S/"* =!F HUR[C"8)S\4C[F/:"J-'*HRB5.F<2\7B
MQ/$\HQ+LMC3/LAQ/OO*8ML+H_H712LT5F0AK(FL)5]80G@$Z F-;$8Z5='*;
M1+G<2&%T1V&0A^,3N_; ZNW]86N6X+$)V'53?#0"E@)L8-A?EF:."Q/)C,LD
MB6+G3*RHNS7:VX&17OAS*P_JP-U#D+!7J[XPD^K4:$I); 5(V%11DNE<$L=C
M&<$N,LHSS&9GW>3[RUK=(.7NJ2M**XT>J312J<Z3),FEX3&/ ?L)I1+GL/IE
MGEN;WHTT:J'>MPJB%1]8Q$6:<$!Y,:6"<)$IHH11Q&)$1629BUERU[V;6D'4
M"J(?[@2+<^QBF5$3@2!24F'K2FNYRYRF26):6+0!TFC%"V8-3Y20EKA(<3RB
M;HE48'AF6MA$"RH$HRTL:J711LSM:[Q@QAIC),U5E'##=)8PEDF9.RYEE*=)
M"XON5Q"M>,!LYJ),QHY(T""$,YD0K45";"[32#-A>*0V$18]KL9SZQ.!Y\[I
M?5.&X1="$??UC(>:B-@N6;MD&YCN^K!=^Z]\=8%C+#WI5#DDH\FX,](P+G^L
MO?7N_RK \:ZR77^;5#",JGHU.M/%T!/1C,3@MZJPKO0?-]KUJK5T[PI@]M=T
MO8P,52*E@BAK8L*M4$0:'9'(2A=Q85GLLB<OF>A&,ML@?-D:NJV\^AG)L-\M
MKUI;^%M%U6J:K$QS(5E&1!QKPC48Q$I+1522,FJDC1W+-M$6;F55*ZM^1IYL
M*ZON35:MIM&"#$H3QD@24TLXMQA B!C)(VP6EJ91(DPKJUI9M1%SNX<TVM8.
MO%^!M1)HB&-C$R,LL9D%.S")!)&QHP3M_DA)$4>YW4 [\%>(,QPN%6J\"Q?N
M0W6_MA[K=LG:)=O )?O%XB+]KRXNW(9*?A&(?%>ADK^GM:@7B6W:]LN#@6GY
MX!8>WQD\7G-.(F>Q,%PQHK5RA,-VDBSAG,3"*2=RQI3&GC7=6&;=C,D-0LBM
M1=^*JY\1*?DN<=5Z'K]54JU$260,<BIAFEBA*$@J;HAT3A)EM,-S,%PDM/4\
MMG)J(^9V#U&25D[=BYQ:B9 H&HDXSA,BI;*$.TZ)YBXA2O,TSX3*&=_(S.96
M3K5RZF=$2%KS[_Z$U4IT)&$)-4[&Q%D\AJ'R& Q!:HF($QX9E9G8T,TT_[Q?
M[E^^F<K+A])_^O6H#/UH@/"+01$Z:&''KUESUV]H[F4G9=T1"_XOG>N<P0-.
MJHX;8O?5M8VK*^?\]0M=7*>]6W%((2*SIN/]?)NWC5_P+Q4UAKTXA^7%.1>+
MEUZHLAA-JL[HW U)6,G2'1<5;H>=NQ@;B\'$?(OTL\EXH@:=' B^>C;M.C;"
M68_,Q[KC6>D\ 91VI5D1/+$X\SL1.J[!C3"\48F?-'W10@,-("-LZ!8ZI]4?
M=K&OD3H_'P#' $]L=0Y@CWW[7HX2%$958KN(CBTJ,ZF0<JYO?+J9F_FS^DON
MY]/F:GNS'H=_ 9^8JX>I9KZO(]GV!R&IBU(PN"-E%)K>H"5<E!-C++=61%FB
MY7)'LIMJ)]V."WQ/ZEFGP;.1Q59XDS%(SL^-P"M 6I[5??24.9ECNL%51QEL
MP0I/NKY=8>@JZ/L1^M=A8U%\=LUHR#A5 ;2LRKH1C7_#?$,R;-3H&]G4/.K[
MBUVZP<#W&?,L5[J!N_ -6V9-$&N&;GHACCO_"2URO,"'\:+ Q_E4'6Q>%@34
MW(("N\/8+K')WU7A!A:ONL!/BS.0 #CE$?;('DS;'X*\*,;81%!-!N-.=0G[
M4;=27&R':$<PI^%HW-$.GG,1U 3<XO>DH\ZPU6!8.N/;,FK<2-#/GYL6D;!(
MX\%4C80VC<5-M'#9/*?I=0X[9XL\=W[6=6-RMXY$IFL#=S22<FM92<WD8/)(
MY.#V=?WKNO-=]#HGRM8]5*\]Y80T/3*%YS;?+%X9T)"A97HUO\NP>4@V=2?W
MY@WGZJKA0\3HL*BCRZ$K_?#\DU!5ZCHA"GOW 7@9@X*$KR?G"&0\VW[R>PE;
M^%]?88P(R>.(N83'G'.7,D5EHE.5IB)SG)MXK;Q?9Y78"_45.5O;<^OSJ V3
M;]88:%CT#X\N^SM'\,R]3[W+#S)VL5 1:(]8IF!C*$.R5 I"E<U=IKA5)G[R
M4LAN+.B*@=$I9@UQSUWIEWQH0"P!:Z*P!8[^#X NE'.!6ZNZ&RL0.M@/GCB'
M0#:=F] #-3FS::24C!F7/%/,F"QF6J7:)I2S&]##//W,4<<U]/,W2-3AQ.T"
M+P(K_@4C&=D%.@*98)X#H+\$U0BP]-<F'K[_YH.@L<FLRHA@Z/7/(T5T8C%(
MF<<VTKF.)'_R<C1TG2N0<"O"'X3,C;!1B5BQ-#+<13RG<>92KJE+3>X$S:AL
M-_Y>-E[TCS\PED1IS!Q1/'98&-41K8 $-%-)GJ< '*5]\C)'X(4[O]*#/,":
M.30YPP]UL]@ /]#\_I*6!($"8 E;U8*:FAIG:YI:=^O^UP%"CM!@AVOQH?!)
M!2 '=GP&AT!?JT\(VBQ:H2;X [K!3#P#-%-\#J#UZ>YO>X<[V\^ZH(<]&?E+
M/KJK!8D(P 1,O_&HK*Z?>C7#9+>9-*Y1TU?7W^H08P>HA5.T'A-ZR(TH(1],
M#%C \-E<RW $"E4Q:UHXY^O &<QU ._.(._LFCF\\3]5 V/+HOK84?9T4N'T
M/*@,S<<K!/06N1[AG<>J\W-"WTEM[OOE>&C([UJ*AJWY!L<1+%?8*"#N(79;
M1^@]"FM^ J]%0 =[7GB\/'OO .PG=!DA:<Y>#PJWMI"\D^L,;8;S@0M44],_
MXF]/0LV8+,#]*^S)C W?$3J>%.?=&8>=%!70LV\#VCQCQ@-GQ:? *\'(6L\*
M-8B%K5)@4< ;\\EXXBD; 6W-*<U8:^K!408>F=J-@1TL%@=J#-/ ^SC.RWK@
MG7$)>QMP2YCK='IS(%B[\:5S*#W +/3KZ9O=SZC][=;!%OX.$@$)U0NW,%'\
MMCH'00&L-&\8-TOMO3^!_/TJKUM=W/3Y[;8.Z.2LZ2Q?C*OFO?A"]^D\2+"Y
M-:_Y'2BMT)/P?L\K6YT;[!)8?W@E&(JPJ+@NKOZ]GG(@>I0R -G4\6Q'PH:$
MJQ;W ]Z$2G_LV2O(Q]J2#,+#/_<Z7@E/NY9C8"&^W3*1<4HS076> #))1)R!
M*DPCIK(\3U0BOUB)"G'%7V"N@G1&_U-8J)UZP?:&<UZJ]>&3:F?B#D>O_"+L
M#=_5*[L=%C8L5*]>W=:"68=%>I_?4, ? #M58EU,C$PSPK6S1,.V$IOF K[3
M/&?IDY<T%5V0^2MFR\S]6G5HZGF&<63,)7TV[W_/&Z_CS!-?U7ABR@3(3ZQ#
M(_)_US@S:O)NWN'#S.F+"@VBDY$%/75\%<1P8(VI_?Y-NF1.MZZ)% 2$$1AV
M0;G6.HUC+O3Y*.#FYUX:@GB=-;M'E^_<72'\\SR:W:(T+-YD?/TM*TV)[TEO
M4[ZT.G,_3\IF-.? H$0#GW\D*H?!/E>#2W55/?G7(C(!6%(_7.+;OW;N+WV7
MXVN!S\]?LI6S07[)=K;_V3O<[NSU7UT/TC9EK/W]P]V#SN%^Y]5^?V>W?["[
M@[\=[/^YM[-]"'^\WNMO]U_M;?_9.3B$#WJ[_<.#.O_C:<TDSC[;^&D^G0P5
MF#;CS1KK>HY["J)N ,#)2][J!-!;C:]&$WBL!4#E/F%P &%C^!Z-&;4ZL>N9
M)OQ<DG-!529IEF;4@MZW*<]SEBFIE'*9R_(XH]C:XV'8&C-%M=;[CGH$$2,8
M5 4&2C"LZJ:QAER9)D;B-R%<-/0J$==[SD:L8Q^ZL,'X!>MN+@#3Q!"FH3BP
MFZ_.T2K &$]G$/K;!PM\Z\ON_B4-"9.S3H\?FBFX[V<U@PQSR^-1!5A.<SX+
M='*HJ@Z/X2\8"8?M#*N)NAV6&[?@AJN4\09U,! *[_68^_!<785/@C4&GY<3
MMQ IZ\).(>:?#Y[AF_SJ>SM,JP&:;Q[<KY]9>#C8=$-_6PC&K3[5^VN\G3]O
M/<"RP*XAT7T9=H'1N,:0P8_A6< *<_;!@GO% H/4**\Z&95C@M85('MO= ;"
M*\JY&-GM<),7*HI2&DN1YEI1GJ8@4X03*HVSE,69R=B'-'GR1?*])]5!V598
MR=6?/SBJ?^".<9W_;GQ6.R '!B/T:1W":WX;C,S'>[9O^D5MWYQN7QV=OH;K
MCVF/O3[=!YNE=P;7O.O!YV]X?^>(';$_3M^_>\N6[9O>SA]%[]T?)_L[;S\?
MO8/G[[R]@O%\.OK\1P&V3M0_?7]Z=-8?O#]\G_OQ;W]@7"F9ZH1$U'+"62J(
MDK$B.6>,<FEB'D=/.E-XLHU6H@9"2S/CE-"*I[@1+HZ2V$0)#$++E1R >O%G
M'L.5#*(%XE^K2[_\SL4Q&B%SE6>9=HYQH!.,+Z61S)+(")7KZ('IWJD!-SKW
MH03TNA:- P\%'>8?E85WF.5>&WO_T=3U@Q*R<30-E.Z@T\IKUL8EU7FZ>E/S
MW;/N[(E[__=J^OG<Q[6XQWRV 9[DGSX?7UQX Q9$8 BJ8NCWO Z(P'MA-0?.
MITX,KL(35Q_SK#N?3E%XY59BT0!T/%NPA4#/E=YN!-OT'*ELJ_/ -/FZS:[<
MN?)SG.UZ%7AIZA'XEKW^]NT,EWPL[-!= 38HW?Q.8F8=^ALQN '(OU-AY-7_
M=CH!TK2%F04V\#%U&EYP2<SGTM4^CNVJ4)V_5/!SGHX*=-?#UZA"GV[_M?VJ
M\\<_SP)B^%I:]Z'BW&,$3$=HEGF:/^)#.?5*UX$8H+RP*&NVXD0!W6GTYAJ?
M.N "?K5!Q\R<-N$!T]L,O/)X5%[-@54F?J!S"(1R69PWR:8GH\N%+(ZI!S@L
M8!WQJ1H7^13EK\Z_]?G<Y/,1K<^G]?FT/I]?Q>?S1=RYA%.SW)@D3]/(6(#:
MF561RX6(X $)MU$D?WB^\]\+QQ#V\_U&OO]5CO)B_.>HJEZ7H[,:PU>'HU=S
M^NA7-I[VMS^D6:QUIBE10L6$1]R13$I**"80.<>SB+IE8^AA(-$<>&ATZ:,^
M'B%-SLX0!P)NJ*;&G(\%8[I&_<D,&81Y=9X"^O'0'0'4FO,NU]X(&&@!]=3I
MW=.\&?^73YIY?AN4G_BEK%%=@RA*ZTH\CS10YY5[WOSR D#;^4!=/2^&?F'\
M32_J9]4P!+'+TIDDOW/AZYE6WHJ"9JZK!M5OKK_>\E\MG90*WZ5L*XVO_SK:
MHM=^=]-C*=U*J/RFQ][\G?A!@V6W'M": ZO-/H+D=)MQY1<J2'VQR)9<N73-
MJ=F@>7_.V=+T=M7]KCF+UHEI]Q9%R7[*FM_K\>/E9?S>*FY!LJ'<PS.57HAV
MFN$]*,I!Q')7$[Y-Z;K'M'#LA[/6/;#K;0\2;T@9@?6;<["$GY[?AL2OF_BW
MTNS&%5?XCB*57RA$T2[G)G#V#Y0!ZPN,;EZAS?7B8,%U_8,J'S]<\KRODK0/
M=\4> 4/?4!V$LBVV.1R]?JMV9NGVXP(U?1U_NAN-_RB)]H<J]4>Y8H^ S6_0
MVTQLDN)>OU6[GWQ"PP!0XJ0TJRV2OV;>CZT VKHI/IH":"KC+J9&V3B*N6:I
M,IS+7%B3:Y6I.+IUS8%9!,;K!8RRX+%A',*[8GSR:E+!>KARKSE*BJWHX3][
MJ#X]C",[WQB5"=70SMZ?]7=V+WN_OXUZK$?]<1Q\[N'QY?[A$8?G#=Z?PEC?
M'7U:KH;V_NPHZAUN7[X_?//YZ//;S_V=MQ%&<O9WMD7_]*3HO?OG;/_W7?'^
M]/7:GJ&*)JG.C"&IRBWA6980K9@E6.E<.2ECB8WX6%=D<5?&\?=60[M!$/ZH
MXHU?0-&M['JDLDM0FU"72F>3G&=<95K&G"4B52J6E#LONU@CNU@KNS9==JV4
MQ];.:DN=(M(I03C+#5&.:\*EC6B6LIS'RLLNGG1ELEIH9=-DUR, NC?8LP\!
MZ/H3Q<M1_VM-%/9U"[%6>SQL$6MSI5SBC,,L=9HHG7 >49;'*C*<IBT\?% B
MMEB%AVED,IVGBJ0L-H3'E!&E-$A<2@45TBAG$!ZR;L33#:J4>]>NEU^>TZ,X
MS40:Y2K2&3>.:<-S ^K7B8@SJ6P+IAX8IZ^ J20W(J4L)C3C#,"4RHF.7482
MJ;%67.R<M9[3@>TWGM,?')+:O $_E"O;A=T4['^#?930S<?^BP>KK@MH?9,Q
M4*_,K5,N'A]^B"TWH#AXE,B,<Y?(/(F5I'G&LX3Q:'VYT18_;"A^V%_C2(Y%
M8K7DFL0TIX0[K%J:*T9<K*-4V$BEU#MCDDAT9;9:/NK;G#%?D\5TGU[F5DS<
M+M[D5&H2"E:E,MPJD45Q(BRW7+(X%TZV9L8#$Q,K9D8:"9&H6! C=4*XS!7)
M. B,/)(L 2V1T9Q[GVTBNY0]<#'Q"$#= W?H[M?=*.XP&^DN\G-^TC,> ?W=
M8%3$Z883WY?29KX&%#QRO7_7>2:>[_?\X<E6G]^5/N\%7>ZA?__P(P>=3C_D
M:203*PS1UB'N-PF1L<H)HU)PQE4DA7WR,NG2.\/\#Q36/VX.OO-LBY:#?Q0'
M7RUQ,#"JS*U5A*8,8WQQ2K(TCHA+C.-18K*81D]>@M6>)!O/P8\ \=R N#<>
M\;3Y$_>;/W&MT-S 9N</0U[NK2(>)Z2T H.D5@O".=5$I;$C@N<RYSI7(F&/
MN-MYR[X_+"EB@7U;-OTZ-EV&-6D>1VGB(I)R90'69)IHDU$BE :12B,=V_S)
M2_K=5DF;S/!=7ARQZ2[$0]_ <S$ZW$:#-S(:_$ :E#X,D=I;13XI[!/-:$ZX
MU@X;!.5$Y2G(U9RGG-LTRJSV,5[*NB!#'W;PIHWQ/JP8;\O\=\O\RW@JBIRO
M\TARD0+S"Q<395-&4I-J*XV527W:!ON#R;MR%;61VQ_@1WH M6*\*53;T-LK
MM=E_>!VI^P[RWM4@'P$=/^0(\!?KH[0AX>M@ L\L<UG"K;8)QU/H@CJ66^&X
M$)%)=)LQ^K 0Q=M5<\*F:1PK%Q'A$DVX<8)H+1)"&6,VEZG,J<9^HTD7=GGC
M0T]M\/@[>)UQZZQ1/$EYI+ 4A:"<9BDW-C91VJ9]/CA>7[8>A'54*\<(LP9X
M/4TB(I4PA'(FF9,T,UP KR>R&]]9UF=K'CS2,'/(ZG1WD5[W2P2J[AQ+M<DY
M/T1N'JUB),XYLUQ')*(Z)ES(A*@\=R \03]RRZB*&$:QDB[/Q,:'LMI@\^9@
MI):'?Q0/+V,?QF0JTD2"G6-SP#XT)S(3C.A(6BKB7+O,/GDI13>.LHUGX4<
M?1ZR1^GN,NQ^"<LRR9,DRK1.C)9<RE1E.E( @=(\IUS9MH#E Y.N9A4A,9UJ
MFKB4I"!'"8]%3C(N+(E2$3NI':A'S//IQLEW"]?6A[2YG,YESE6:,"JXY$K+
M#+ 0[#PWJ6%I)J.?[T-J<VZ_G<E7()3-\TRG.;$Q2PC/J23:I)PD-LY<(A)K
M,W-G.;>M^^B[W$<\V_S&!2&I;TT/][LXM/ +)_?\J*A=F]QSA_+U>!5$44&Q
MOZL ^9H[PAFS1":2DIB" I6ITQ&/GKQD6 1<\#NR43<FK^\.?5"_-.O_F"!>
MR_IWR_K+T J@DY816$TRY1*@E;$D,\H0E0A'::PC%V.)UX1W$W97[JDVJ^_7
M/4DQ=..5QMKM.8IO2Z6V-*9&I)%6BJ>Y3ZP6/'$F ZM7J;A%6QL@<C^NHBV9
M<0,J41,G=$2XD@RD;2J(R2QG1CHFT@13J3.9="G];KS5GJ-XC,R?42XT@/,H
MYPDW2233/,NRE.9""&99B[<VA/F7\1:/HYQFTA*5Y@+]U91D0FJ2L%11IB,*
M4MTS?RR[*7O@S/\($-<-GJZ-1UR[@^*L&"HO2D9YIVC+<[Q\^A4B-DWB6("<
M55+$7$NJ$AG'J> V<2[+(G4+?%7!A.&W5M;^<%E[NKTFPSQCUAJP:+ETG'#*
M.<GB+"$40%;*+<VHCD'6QEU.5Y.GGFU.TD6;-_7M3)PE6>0HC^ ?V/\\UE(D
M0C,F$B !&K-;X*26B7\F$Z_$_A(7,TTEH:D":RFS"9%*.["6(IDX'0DJZLXD
MR6IGD@UBXD> A6[P/CV$%@^O1D,/?-78V6OQSS<CZ5^A5>@M)[_9VN,KE(?4
M>2)Y$@'<8]PIFJ5):@W7N70F8[%M/6P;H#/65*7EJ8F$%8Q$.L,R\\H0*0#]
M.9J[B&621[6'+67=1'YW0ZNOXHX-;WC<RK=?2+Y%:9J;*(]-'L7<6*TBIXR(
M7)R+U#A[&W#<RK>?(-]6BML)YQ*E(V)S8PB0 26*IV#B&A7'-C%Q)%,OWVC:
M%>*[#P;=HWQ[!*AYO66Q(8)S??F5@]I).#IWI1K#J#MGJCPNAIVG@U%5/?NN
M1AIS5!0#J=C11 _<6C+:;#&[GH?NU'O3KN:C% @WF-&4;7[R[$(MS._)JGZD
M(/)Q0L4[+]JYW^B6< CU3U L+6J\.]2XIGZGTXF@F=5$)3+"5+^<9!G%8^4V
MUZDT3#/^Y&6<T&XD'^%AJ58T/5+1=.<E15O1]*-%T[)!J_,4K%:P8)6ABG!&
M!<ER%A,EI>::9Y%F8-!RK'/!V_I ]YOV\A PZC?6#VW#Y7=P@NN:<'DK5'^H
M4'VSYE07E9EQV*3&H9=019KHS&3$8:>V6-+89IAJR+M9TJ:_/%I^_NYC62T_
MWQ,_KY1@CYEBTF+6<(SMIWA,P&)C)-5"49:S)'4:[#?6C:.-YN=' (\>_CFL
MZAH7?WL6:S/.8K7B]8>*US7UJ)G0-I<R)6G&,\(C $Z9$PGA64XE%S:S!FS0
M.$ZZ+(X?]KF,]E#6 SF4U4J!'RT%ED%6DEA R<Z2') SX49*/#,0DSA+(L>X
MR+A&*9#R+HU_>&)%FUOQ^'(K_G8@,DPQ**;GLE:A6.&YO3,>H7B9Y2S7'VL'
M$L#5?_U;E_^JR6ZL/KGJNW(S-G,=-SG_XE&NV",0# \\Q^+5J#P?@3!P'67/
MBF%1C5$R7+A.-3F'+\:_6,G7K_%XW5G.OKU0S^M$N+\=+KJ'80%\P1BF6[3[
MZ=P-JS;G]2Z!V9I"KYI;QPTU1%NNP"C#,MK",)*F4MO$VM1FSGNS1;::O'![
M[]?FY2VTO'WW^>HM;]\K;R\;792!B%9*$)?$Z'")<Z*HB0D5.@*REIKF,1A=
MHINQ=)-Y^Q$ IP<>^%\XX[EL4+5573?C%&3KU?JA G9-@=>4"1'97!.9ZHQP
ME3"2V2PG+A8IS[1*$JE P%+:3?A=]1':&-]V6^!U(\\*ME+@1TN!99@5.\6S
M+(M)1&-#>"XB G*=DDS"MCK!4IIB D&<W6$KHM:W_8NZL':<'G=<L)]:=]7/
M U>^192KQMM#BUM06["M9+T[R;JNI*LV+--11+@ ><IS:XDV0A,#&M-($5..
M#4J .KIINEK3<8,LV-8[M0'>J9:5?R(KKR0 ,"YB&ULBE,"C*%*1C(F8.!<)
MSO*(@\7TY&4:=U.YVI5^@SCYP2&@S1OP0[GR5W/RA0;@=39$*$G1Q<8"O]BY
MGGMUX>$6]$?#T:(1WZJHNU91G]>4-[-)(I.$::)%+!!R<J(XER3)\BBRBMK$
MATNZJ6 ;WU"X/=QSKX#SNL,]+7O_//9>1J Y37.;,45 .%O"E<B)RDQ"E-)9
M:KE..&8ZT&Z:)>TQG_:8SVTBH>LR1SL^7_0;<Y7#U)9K3N&,OB]$LG'+^*TU
M).]B@39;4]VOD[,)&34-FHOA!-:MCBD!Z?_F23U<=XB$OOMI7"I8^F*HRJN]
ML3NK0+_A*,O18. U7'"VM,KM[I3;WII#Z;&)N4PI<1%H.*Y32[0$ $MSJ9$B
MLHRJ)R\9Q7Z#=WS*Z@Y8<L-+&+7"N17.]Q_8;X7S0Q'.*Q4&),^4C1D1+F&$
M<Y$0G4>:2)-2GJ4\ 9,!F\&R;AJO.K\?EW#>4//E7V,%BP/_VN+B9;,%_<D9
MB D3_C:!X3RG-7*@ON .4-FGJG@^+ ;_WY-Q.7&KY;_GS[;MY]Z-<  K7N2P
M^IAK77\/'(U,CO*A3L.N#D?S%LLAC/*WP<A\?)BL/'#_^_?5^W?V7#.>]';^
M -;[XV1_Y^WGHW?P_)VW5\B61Y__*/H[QU'_]/WIT5E_\/[P?8[CWW_S@0(D
MRA+#B9,V)CS1E$@K'3&II2).,Y6+_$G'@;P[=_56K!(#4$A#3K5NX&BTGH^J
M K?G>>D&_E#1B\O"CD\:Q3%W5\V3T>P6I6&')N/K;YGC/.-0:/]\_<=P3#29
MRJ' *',_3\IF-.?JV!%=.O61J!P&^UP-+M55]>1?"W,Z*X;-PR6^_6OG_M*?
MT5P<S[TNV<K!5+]D.]O_[!UN=_;ZK[8V?JS]_</=@\[A?N?5/BC+_L'N#OYV
ML/_GWL[V(?SQ>J^_W7^UM_UGY^ 0/NCM]@\/ZG)P3VOYZ.RSC9_FT\E036PQ
MWJRQKN>XIW:$5?:JCAJ"TC]1 -<ZQ; S/AE-X+&VZG;<)^- 10,*#-]W0-*K
MU8E=SS3AYY**"_HARXU)\C2-C(UYG%D L;D049;IA-LHDD_N7A.VJN_.51_O
M;7]@69PXL$0(<R(CG*J$*)$@!DU$'*<N<M2MJ+YY:>W+&'FX*!OSM1A:6.?G
M+/76]'UPQXX[+\%*"12+'*+.\-39Y_!!G2;9T5>=TA]'0XPWK0MPJ8"I*K!\
M!H/1Y=P!_V5),#?S!/5\@,8$K?9FZO6#&_7N@;5!OCVOW//FEQ<-^"R&?B+^
MIA?UTVM,@$!B"53[E0Y?URHRC;8B)E%+UD[W^L6U MWR"G3)3@C?)71+Q-=_
M'6W1:[^[Z;$TW8H2]DV/O?F[C,<_9K#BMH]].!;,]0&8+X9\Y<JE:[Q400O^
M'&],>JN2'X<GI7.=,[CNI.HXD$6VTU.E.>G$M/O#RS'<<LWOU=VWO(S?6_'C
M*SP&FTTYB#;N:L*W*7/RF!:._1J53AY@(9IOZR!S)T?P-FXM;A_"^.KY/YH(
M!8UUHB.564DUS[",<:QCQW*I1<1RP;\Z?#R/QK>'=GL.B_\"$8;3;='_C.]X
M\[GW[I^/^_!O__,;T=OY[6/O=(_N'YY\['_>CON'?P^6(PR]G8]Q'^;3W^E]
M>O_NC8!_X_[.Q\O>[V^N>J=OQ?[O;^+>CJ']W__)>T6(+O0.(GCFL0 ;\ ,U
M44:-S(C,,?H;2T5TJB-"\TCD:+KGF+E(DZ0KD^\.,#RP<\BMX&L%WW(]4:YY
MRCF3L;9<2JL=9\X8D7&:QI%37QV:;07?SQ%\GY<%7ZI2QG62D-A)AP$=2[(T
MXH0S1IUP42(-1<''NA'][G[4[='K'Y+WN='B] =TO'FXIS:_0L3FBHG(1FFF
M%>/4ZDQ'N; ITVEL$YZWV'(S1>S5*K9,E4P 7G(2IUD.V#*W1 />)!P6F+I(
M"R4B$+&T2^GFMQ!KSV%_.T=SS=(D$R86.>?:2F$3Z2PU<0+"T7Q]$?:6HW\.
M1Z^ )LE2:9-4$IZF6*\FC4@FE"-"<)I%F54Y%5A5H2O9795B;V'1G;L: 7_>
MD]#X+MB\/B'Q>E#]"YG@W[<TCT;1W/FIEE;1_ 1%TW^U"ATERS.N94I,3E/"
M)<7RB$E.1)3$/,ESL-$U*)HTZT;I';LEOXN7'H;'LI6DK23]R4=06DGZ<R3I
M"F1GTO&$@_T=Q=023FU*M-8@3KG)L!!:)!@&>%+6E7RU$-ICD:0;BO5O/CNR
M\3F4/RB#%WL!+&?OOE+GQ5@-?+T+6XPGI:M>C\J_2JR',;X"B;+[GTEQCMF9
M<WF\2VF\N-:_<"YOW'_S(>&)R;,D(5%J4JSK+PCZ8T@$^Y2DB8U4RH,J\ GY
MVV,?\Z(ZSG.9ILYQX'!M)%4JCO.(*IJS;#GW=WZ/4+1WSNM=\FFVKMFGZW)K
M7>D6DVN73U1]>[+M^D3U+TVO3=)MDW3O7U6T2;IMDFZ;I-LFZ;9)NFV2;IND
MV^:JW4.2[E_JJCX=N6T Q9>N,;_^&JCA>-X&^P5<.F>O3_N'>Y?O#WN?W^_T
MS][O_'W2/WTK^J>_@>UU,N@=[K'>Y[>?T3VS[-(!6XWV3G\;]#[W/_;8^X_]
MWW=9__ CZ_V^%^W__O93[_3H<_^PQ]_OV+4YNSI/HPPL:D*%M(1SFX,19RT1
M3F<QCS*7>I=.''5ELEJ0\$&EKK4YNZT<W+B<W58.WHL<7'%MBRQV7,F(Q)1B
M UH=$^ED1E)MHC2.00[&'+-1TJZ@WUVYKDWA;5-XVQ3>>TKA;27N/4C<-1F]
M#K954\9(*JT B<LX 2 JB(VELDJYB";^T$0WC;_[S$2;T;O!#'[7&;TM@]\+
M@Z] *L##B;:)):FUCO#4,:* IPGL=!+%)N?.*&!PT16R3?#=6#=EF^"[J8BR
M34O;K 3?5N_\?+VS+M^7TCB*E!1$1Y'!,[B.9";5Q&F3J=0(D41XL(2GW32Z
MXW;H&Y2EUN;[MH+UD>3[MH+U7@3K"J"G+%5:9QE1F0- KXTDTE)*7$)5JBC5
MW*&/E,5=>M<=YC=(L&ZH)3!-_UTI$G^GXD+<JK3QTEXWE7U_8H7>[:IRX^KZ
M_-U?-W67]X\_4*M3&0E8SM1&A$M86)531W(G:1I+SK.(/[PRO-N=:G)VAF[U
M4=Y1G@!NG1C\[8G ;4+OHTSH_=Y$V5OE=VY>UMXT*[9SR\3'Q[H0.\ZX,^W*
M9BT6<QG;',$V-Z;-C5E$<<8ZZE)*)8]2[I(HLR8UAN5,2\1QYL/>[?QH ;K]
M"J;<V[A_>DR/SG:OWI_M7NZ#*7=TN">./@_ K!L48)Y=]1A@.-9;;09V:-C^
MSC_POC_.C@ZW>?_WUR>]T\'I_KOW'_??[47PG,]'9WOQT>?7>=.E<2'MSPEK
MTRPEFF,+(AE3(E.KB;4<]CW6S.5X)IYWTTQVH^^/S[29?ZUT>]C2+5429!M(
M-F4CKIG.\!^IN.2IY< N7KHQREKI]M.EVVII*4I3%5-!8H.%B"D31 J;$1$S
MI@6C3N6)CSQ'&>]R<<='U7^<=&OSY-H\N6O1ETIB3%:U6<HY=;F2CCLNDC25
M,M*I;M'7/<FG-8<NTCC6,4LSDD7&$1ZGC$CK&'%)DL;*2)'%*)^Z,LZZB60;
MGQS39K]].]MF@"02(U@"_!HY)1-G34)=+(6+7-+"BOMCVQ5886)N#4LLH29B
MA(L,&-AE$1$)-UP9C&%@0ELWXW$WE=\= ;M#MKTC=U7@/K;%Q(:#B/E03QT)
MN-/ XXVQQU_+!KR+!7HTTES&*<T$U7D229Z(.&,\22.FLCQ/5"*3%H3=DS1?
M<_Y YC)-F(U(G,:2<%"[1 N7$26,X4)(RIP(YP]8VDVS]&<D-'P5VSP,'UDK
M0%L!>GL!:FED-9@\><P55\I*E5&;9"I+./[,6CA\;P)T!0YS'B=)#!(ST3(A
M7&:8<>N REDF=:Y4HB/?[JLK6=9EXKO-V(T1H+<HM[B:A85))9[,%*44K+LT
MUXKR-,T46'I"I7&6LC@S&?N08C_SFS)1Y$_(L%F?UT7CK;!IJS]_<'X73&#;
M&" '6-+CO\K1$'XUSJ>%_@4;;*["STW)Z]H_:'@:TS&WZ1%[0_=W]E@?VZ#_
M_OYD__?=S[W3UZ?OSWJ?CH WC][M7J[D=9T>?>[M_'/Z?N<MA]]I?^?X$G@<
MWMF[ZKWKGP%?PA6O@=]_RWNGV[3WYH.QN60QY\1%240X AL5QYIPG4IJ5.92
MFRV79.1Y&ELP8 &V,F#B/%-*15K&3FK'Q6I)1B0E-=T*H$ UM*JTU<W%%=>6
M2_SBJV]*.EO(Q0+"%#^2*_P3GV/5T,+<(A,-'SQ=F,YP-.Y<N7%'V=$Y&*2W
M23;;H*RZO6%=*@]8,^IVQB>N\WK[X+=.455 0IT95W8.IC-^>XZF=^?I]L';
M9YW^:,O?2R+>[323WXQ] O'D2@>"I/,WCA?^!+S0>7HX.@<1EO'LV?/.:X59
MI>- M:/<SW\WSYT95_CG^B? I:^+H1J:0@W@,\P_A 7:^L&3OW&J'=B+^:W
M2JH7A847 %'"W&"@[M.YLP6*U%!=]9-Q_JM0>56=GP^N<)M]7M#OV]M_=<8C
M+TM0GW?.1K;(066&&_#^$V>/\?K2#<*G)\5YU>U4$WT*J^=O!BVKBF''E,48
M9J60NM08;FC6],^]W_;_[N#+@8=.7-DI<9']147EQVO0PP./TJYCBVHJV;8Z
MA[!/H$&&UNN(#KQE? +WX"KX[$_G]["X<' K#'.((QTUI$Y9MR9WG AN^:O1
M&6S:%<QW,H"E&=0S\(OB+YA[%ZQL=1X>[K\$%'-\TEE)*-OJ &M-/\5/UG#7
M;-,8B9+N9K'/-=2_P#\[>$D)U%7SSL%D"-"\LX/7PT?32^^3-[J=RY,"MAT$
M;J@-B@/U>XQ,[T49[/7R!O*M6A @$?VA0+.55YUZ;Z>D'2@8'CLJJT"X=N05
M@O*WSM-6%XC4#":HU/S'(QCFI7,? PU>CH@O7QK8SV)><5D_'9FB"V]4%0P=
MF$4[ ]0(;QF2$DOE5T"5"D<9N*)T9S"R*2<O/*H>Z&4Q&(0'UL\;K7W>'!/]
M,1DTDX_Q-<!JYD0-CUUXUHF":[[F#%&2:L,2ESIJ>.X4 ((XM5PG<9(;:9I<
MLC2ZQ@[$LM^O_/OWAO.X$5:X.!^X/5AP,][6*-FO#D>_C<IR=+EH+>;%)[!E
M/KMR-#44HU\-5!Z^A;GT/O5/]^+]PX]Q__#MA]2Y)(^E(U;EBG# ["03J2&"
MRX1%.M/2Y$]>#D<KQEZG\&N.,G:.YO\'5$78!2_$_3X$*FT$KAVY@*""M/<2
MMU8S0:340AUN]T2F.K"%J$P&<V\L0"J;^9A /M7. -/&P8[86@1FWV/"499&
MFVO$\?LRX@XFNG+_F<!B[U[X WV;8:U]ZIV:RS_9^ZNC=R8Y.NU=]D_MX.AT
MFP%#1?W?W]*CL[W+H[-_SH"IKM[OV(_O=UZ?PO,O[.__</N_?PS>L\&%/CTO
M@"E9G_U3]':.X%UO(GA7<73Z6_'^W7M@JC\^]MG?'WOO>I]Z_V2?^H<]T?N\
MR^#=HG>X+?K''](4B4AAVA*>RN':$)U;340FN8PX4SJ3R]9;*E4N\HP*S03/
MXT@K9VCJF!&66>W<LO4VVX*.\WOP#6;;E]^Y9&&R/)51E+G<9%SE'&2YRI-<
M)"J/*+/TUF>+-LS*^U--AH :0 KU1I\!-W9Z )]!53PP V]_V+F)[UF>19K&
M5.::<F.HSI64/!.9UBZBCM9\SQN^Y]%"\XW?)A6\L:JVCTOGY2PBOT55BR(Y
M@!N\#33+%;ERJB1N^.O)!=;;>0/C]G,2^X?'\0>NM,;^.B3"H[<\4CG)&,V(
M@-5.;:0$[ .>V[D*(IR)YKC*(E]W%\P8?]P&]& Q1"-FV%'-[@!< XP)A#PN
M1\/"=,%&,5L>@0(<15)'50HF7%780I4%4.%3/./66#O=V:W/4"5[>T!UANX2
MT:UUV,T#W_*QL$,'UI0J'<E'9H+(]2QP#^ Y3/4#(@Q#?;K(7,\Z%X6"1UHW
M4^B(9<\5V-BH]/W,JG&G LS6R<O1V6Q(.*(%P!U@OQF,\/TS,/LSV6%J0KR"
M4<!$6O:XB3T^[^\ UCW]>-G_O/L)?K_\0$%GBCSF)+/ %)Q)0:05DF3: !@1
MH&E$\N3E]GE9# *#3(^V+?+'5F<[6&,F[,,BOYPIB]#2J.H$*,V7(T!BFE$6
M<,9_?85]\TU4]%4U$GP>[=[P EC!?_$@8F'W+'&/+OL[N^R#5)RS3%(")FA,
MN+$9 ; O"$L1X'.P2;EX\I+S;B)6^T6N=W!-JO'(GTP^'U5C4I-81]G32;T]
MP=/DO6F%GJ")TMP;'%]H?'OJJ\\U(_$MR$6@7VN+X,E#.:S&0:XMTC&^9$:T
M3J'TFWOGUY!PE*C,J5@PQ5(>.RMC085D'#"=U0GCM8E^+>6B-)P-^17,#09Y
M5HP?3!V/^R?6T[W/'R@099XSL, IDT"L-"8ZBBU)C8@8YTHEF7WRDC'>Y73U
M&!?Z13U9 3T- IQ=)JN_)F4U44'>H?*_'BK,$]J)@BL'U2A<[EVT(#?G:$]-
MM]Y;YH5UY=2HGYSC]3^3&!LQZJ7FC YW)FYOV(>W'%ZZP87KH1)N)>GMB/-S
MCWU(;9I0+E,"!B EG$:2*"X=B46N!*.&13%(TCB*NF#BK"'.?"H%2W<\&:CQ
MJ+RJ!>49J&WOP &+"'0<H%,@.*SJ8$X*L&QM1[OQI7-#[ZGU]\ OV=:WV&8;
M9G:^'I67JK2 S&NDZWWOK]1Y9PHJJ\=E@D9IECF3BM0IR77.E00-K%*5.BO2
M3+ &+;$&+;$5U],.//7".ZW!H EA+43:50NU;P&UMT5_!RQ1K8S@<9Z1')U4
MG(N$2.9RDL0Z27-.,YTO0FUV#=:^P1:M@'<Q6I371#XUYWSDSP"13_5/%120
MMU[ALV.\8#BJ=8HZ0Y__U\+R6":)DCJ);::X30",*R6LE3G\ES.J&C7"OMBA
MN*$VGXC6KT>U[0?5ZH];4%R\OW,L/@@3I5'&!4E NQ.N4DNTY!%)J<B8,<R!
MP80G+J+K-(B/N/FX@ _IP6:/SA#XAN ;4 =0U'D3<)O%)-PGP.F3TH?]#IR9
M('GN V$.468UH7VXRTO>IP?[K_]^UKE09>%+ 2V1K(]"51B%P* PQL@[/A\
MP^1U3'3VXGPP"NX,?Z]U>MQYBB2W1/G/?(RD<IW;A"QJ65X+7(YG-V!V'GP]
M#['Y"U=7%ZKS->?NJM/LHMDM2E>C 5@+U]ZR4M;EGI0*39=69^[G23DK2G/L
MB"Z=^DA4#H-]K@:7ZJIZ\J]%M0DZLWZXQ+=_[=Q?_EN7_WIYK5;^^4NV/C2T
ML_W/WN%V9Z__ZGJ@M"EC[>\?[AYT#O<[K_;!:N\?[.[@;P?[?^[M;!_"'Z_W
M^MO]5WO;?W8.#N&#WF[_\* ^5_QT&I]XMO'3?#H9J@F82ILUUO4<]S3D$H3T
MG^I$8=-FGW@SFL!C;=6M<XHZYZX,WV-RA5J=V/5,<U,VX7>$F>YIP=:(=F_$
M6%?!9M:GUX*!#IKATJ=4.;^\7?Q"@5E430;C[E3+^-5V1=G)%?RX4(.)J[,Y
MM*L+X7FD57N5T,=>NA,']O<%*B[,\VA4R[JQU;DKN/8A;\L!99*RJ#[6(;]C
M] OD3OF&W<&G56>/S+SKHYO!ODNT$MCU1>2&9[',A(TUHW&&$>5<B!O /KJ4
M9M!KZEEO7>I?@?-[EQ\XE>A" IPO,;'?<DXRSAR1 (WCF.58'NC)RS\F0U?#
M_"SD0RW#?+_]-Z84H.-*YQ)[2_*4,L69S20#<R_AD4YDN]5WG'2POW,D>H='
MHO_YB/=WWHC>FP]YDK)(I)S$QE#B6Z!):SG10 24LCR35LQO=AS=L-F FXOR
MBQS^'=N^:F#U4-84XZO6FK]QZVE_QR=P\=[A6QCGT=4'G8A<BTB Y9EC>Y9$
M$!6QA&2)9F#(6VDLFY5!K#<_&/1B-7CV"/QJ!V@>6D_'AR=%:3O;LY1>L -?
M>64W\[$]+A<;&-.Q 47K#( G9G,E,HL5*!C/7&02-0U(QDU <HW30X_WAM6X
MG.#R[%48-3!>(M.6+V^G?0^WV0=K5"2MRPC+* AD(QC1UD@2:TMSI[EUC"UX
MV>*O=K+Y/.Q [5,:[SQ=]^FS:<K$$O6'),V5AX13 *Y:>P\\JXN..<RT]_!S
M? *($6#BN 3"]MX%?]_4@0)S-'5>_J$KSSI_CH!O?B,TI'7<1,XBQ@X@F"PC
M)5<9553GFF6.10D3N<UOD:RX2,X[KC)E<1Z*B_]3NWK0_?.;JHKJEZ9;3,0X
M^OR!9E(XR@TLJ /4:"2@1LDDD3*F6!C4)-A)VJ>9_S^ZE8K_7D$0F(K4.'[)
M8#3ZZ!USN/'>&Z9#?ONP@_ZVSE-/$<'U]O^N=?$.)ZB\EI,O=&PM%7%JM>(\
M%V T.BOS!,9,DS35:V7=S-W+;Z843Q '8%8INS^<IQ0Z]>T2]LL3S''TP25Y
MZB(K22I$!&9&K B:>R1Q3JG81E1)$'1(*BM^W?_V6AH]_W-1Y"!M*K_R<ZD5
MG:>O#K:?>7OYTH$AK+PVGX03:BANJHDQKJI&Y9+GUA^0JKR?MABN%V@^  %W
MG-?Y'@M2ZIMBC9N+$'*51]8:L,"!R_,DR2(;N4CF)HU2FO"979XUJ#UK$<+=
M&VUOK_:W/_ H XEJ-7%*8.T2$Q%,?B!*<Y&K+(JTMHN1N&P]2.@\19<HBU[,
M3C+A=O@/Z8MG7\ 02S Y0(BE#[^ ()8?\6T HG3A0(?S&2HS+MSV<J)T%Z/!
M!2H3)'H?]0D/#O'#3E5'>.;N0XP1#GY>-<P_"S*>AV-$WQQEI(E.#,]9KA+@
M)&>48B;-G#.<6Y'3=!IES&Z.,M:1*>2J-J9X#?>(_1T8V^EVU#\]^M3?V;W\
MD.9@]CH5$VMB3K@&L**5TX3&B8QC;5*72XPI,G%-3-&KGBG17$M<MR*;K\]T
MTHX:EJ1QGB8QUQ'53DJ8301['5.;Z=L2SY\PVOT\<%A]QOFJISX59Y.S<!P.
MIO1*G<,WXZN6NFY%7:>[[$,L.14\,21-; :@AJ8DRUA$$G2S\32U)C%(7>*:
MB'60BK7L03FH0>_-@(D:H],?J<G]9P*4!,2#QT3#R= I(NZ<#R88)5@&-*[$
M\) Z=IVG!5!8@9FBUY_*7(N=:<XR+AE3,4UYG'$=<Y&Y)*;2298*LQ8%M-CY
M+K'S88]]$$YHHR-,>,?R'D8KHFFBB(QYQI.$ 9V))R_9UAH*^^]G:\ S0.3Z
MV.62R@UQIC-_++H[/=?E(70XK>SFDIM5GA<H)Q!&X#N&*/CP#S.Z<*"?F\("
M_N 9BC_K<C49C'U]@;S)JJBFYSK'5^?NH:%H#VK6 PD0^^48'N630=3/!=NO
M2W_JSUSMYW_!ZP!EF?K(P"_/3A^O/N2QDBK)4B(UM8"G4T&42R,2:V82H=+(
MF.3)2Y"X)<C3P=4*BM8HM^8*2?R@K0U!K_EM7=K+@S&,L(V!W6A.]78^BCZ,
ML7_ZYJH/\_F09%Q9!G:43J((!&H*8M2:E"@F+.?"Q9$4&!TX'\]'0J)K#*J9
MA@8I]K1X]I7Z]9NH8Z9?XUN32I,]C-KU"(AA?^A:'3LG%*(/>9;9E%F@AB1V
MH&,3 5 .[ ;-+;>62^-HCCIVG7L*$US4$':X8R=EDU\(RK'"2E  Z$+CP>:+
M1>.[R0I<,HV[0$T/AYP.+T>')X A7H\F94M7-5U=]7:V/W^(P2C(TY03"CH&
M3(041$W,+&%.2"L!Q6580D-LK8%NZ^FJ\E$8]-4@P2#"RF'5P2! 4JN^A=;\
M0X#<'@Z]O889M70VH[/=*RS5$N6&I\1H:PB/L1@@6&G$93QS!HQ1S:,G+].O
MD5]Y353?)K^\NPV_T6K@G75V\L5<D1^)EA"F5SL^A@>S&0V;CT>_N;]485L,
M=4M:ZXD/2<0%Y3PGL1$9EIM,248S R@ZL@DFC:6*K7-(9ZN9)&A #;%^XI<<
M;/Z((1#EA?,[X2.%MZKA\\LFQ&?7)\3?OK91QI[<018]EYC[<R=Y])M996D/
MK(4.^]$E'Z]-<;JI+_N:ND\;55:PIX9 3BB*?;Y^^J+J[!25F508C/709'L8
MNM*B-)@5VGP%*"ADD> U?_O4:'_)_GE]N'BYQM=74+W8V'I>KY<R)F85S3;/
M=?:5E.#K"+YIW"YU)55?717KRM"(O%DLF@A7_T#BZ3:)[]7<&H<C9IBTOYRY
M,G<-(I\Z'G3F5*@U&D!2[JP_[^BU7?#X#]1E\),JK+1C3OS#T9,?2E/Z6J?H
M4$7EJ$/QT4KE#O1AJ=&/"O\_N7XL3YK"K].;__*IM"X<= M#^!/^.0Y'*^J:
MGMOAN!R54C0'!&Z8;ZB26CN(UX=L=]0_0 ;_4_GT"5A<?]:NJ;8ZK>R:3_ D
M05W);WI>SHS*T5!=%.6DZCQ]M?_/W@ZA\MD\*<R-1>G1!,8^*:>PLSIQ+I@X
M@^(_DP*V_:KK+\#7PDB:\K?^#WAGCA4W,,A\X=#WW>WH8C#PCNIP%'U05PK%
M P\7JA@T%0U'>,"B\NM63;!LH?.Y;DZ%O!2 -0!ZX*.SXE,]8[_DW7K70PQ\
M+F@#SPM&%S[Q'*[U\YL 693S!^*!/B<E3C1$[^>'U,7*W>Y\'+X-JPJ?65#,
M!8!D-:5_EV,M7W.%;VH6N',!-V/QHKE)5,V6E>H\3,]OCT=<N ^+11]]O5&\
MX7@PTEAP.)S'Q/M@A# ]D$L?G3]?$GBQ/D(R\F>"YPLZXFY-5\ /P:DS+/Q8
M+23Z!)*;(P8,Q9:>0O )-76-YCA\5AC2+ B$IJ:O/\,4J 3V"9?,'8/-$L)I
M"!SAXV,<[W!J1\]M35,ZJ PCG=OT*I1)#@SNS^V0D.^&);*ZGOV/2__]7.FL
MIIQ+X?_8!H.GCN[UMI]USH'8.VY8 GG6@1Q<29@U\.(H\,C(?,1#09/2G&"I
M5Y@CO.-LJ[,]F*^+.:V=',X/=:>,[#7$]"J@%+AH/"I]$:\\4-:-8G&K\Z[
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ML9#V%,16[L QP&7\OC)X]Q%N'8NWA!6<PW.U,G.YV:J>0IR:&:5:847^()W
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MW@+5&[PN;/@(%&I&.";)"LG**POGDJR0K%R-K!R85MX:46FY,U'7K]N9^$/
M 95Q0"'\$<]IR;U'RY'X'.:9: IL$G7L)4Q>6H$A/8) 36XYB,IPZ?@=YKG/
M/G,]!@<)G!=_A%<M^9HY+LA4N&2S4+# 9<%"L)4G?'PD[G4EF0J'$"=<3H7G
M:_G8RF)2]%3H.-(L 8@29)B1S5>^N(__\G9F^2N;K^\M1ZY#_NAM-%:D%PIB
M326AU==OGZU9L+C7)UJ_W__^)CDB1B^.OM60+INH5=]-QMJDN_OKKJ8GWQ6'
MRO?V1<KG-%Q>A^V)9BP#.'AM/,(=[I7W^CB&H 4L<X+[._SD,A \50APF;?G
MJ3+2!@92X0/@GS-/F"[>>UL)P/G.\.OI&AY'#[H"LNKWUH&_"';S.3>.CP/]
M[#IW?WYX^(4M!?=#$", @3#E:Z;"=I]WBTXT]SX"?3OB.D*P@FCF5Q&FNNE/
M^!3 %0:[?W)R_?2RBI7H,(R-$.W,GXM$O%:@I^ZFGN!?[_@<)GO/[6>^]F]^
MR$L$B$-,P(F,2Z^Z^C_]8>K!F 4S*A:\R2746[>K==6*JNJW_D ;&Y-2^JW*
ML& 3#/7#AMW_W:!73AG39.LR6:-?9??<M56^:%M/MAXM,)Z59)_'H!R52D?Y
MLO!@QUC"<PN?"32F2I2A;RLQ_OGE/?M59T;7Z+$G7V/IOXTJSOXJN205CI#U
MIMU/W#,7K*=WF-RPD(9E&AJ467]Y.A9:LE6/ZDVCLW$,B;U&4CXLX?BX.P*%
M4'HX:7]19_FC:DU#;Z':O)VA,>[Y<*QC,+J-Y[4WI[A9KHGSNI@*GZ.FIM0#
MYUK&N+(P2$J+K;#$>GO@C<ZP<GVS^D6B$>::A;G!B/K@$.;.>FW>_%SLEH?;
MZI0:2ZFQ5Y@::XRKXIX2_,[-HB'U6ZDYB_3+E)0D#E7H<W=@0/SU[>_-]@[]
M:%M+RTF"?BQT4D<1/<R+7*-7ERC;HU3,&G.G0OD+XLZYN:,3<^K+G+YV]G9?
M#=S0&YX>^\4-N TK=>35-,<(WET;^4LDH#RE=J0A&9WQJ&JUP8:U82 H7PV4
M]0-K;!&4"<IU6OC@=<FAM<=QRUUDQG6G?E)C')KEQ69YG+B^!D:K;O8YC5KA
M4/#JM8QQ9=<3%+S:GJ"NH=[XJ"Y"7),0U^]6[3U*B"/$O>Z&Y>P7+'3_5>%R
M4M?.?C]9F^,Z1:Q>9<3JK5%!)5&<W;FY0\U<:LR= PN=$H/.YH._^N[TU^((
MHF8NA^_J=- X^ZX^).[4ECMZ\_V0+>=0KZM=QG/7P&V]X=&JFQ>:1PN&:;5G
MM-KBZXW_7N62)I56W]1@/L)O4_#;.W8\*N&7\'O.HV2%PTJ3H-MRW]?M2!N=
MVW=<&_NX ;&GM0F6I"FV)N14-E^X1-SISIZ;40#J27J:#&77BI<F5] 9!'%T
MU],*&DA,N2]P@-,U8BE)T#1B5[75J%.,*8U!<;L4MTLQ;7$49=4\I_KYRPEQ
MC4)<"VYH"'%-0MRM3G5K:LP=HXJG@VX"&VDQ4MCN!N;[%!A:7^Y0V&Z-N7/@
M?1PQZ%P,,@;77COC6OQ %+9[^*Y.YPP*VR7NI&&[S>]\U7(.]7I:U2J3=%AO
M9MCNSOO@ R.)HKZT!26GJ-KAT0A4;X'J#5X7!WP$"C4CUI)DA62E_[IRSB0K
M)"O7(BL')H@W3E)>G/"U.ALKYQ*VRM?X0\ !!'&<(?P1SVG)O4?+D?@=YGEH
M"NP"=>PE3%Y:@2$=AD!-;CD(RG#I^!WFN<\^<ST&YPR<%W^$5RWYFCDNR%RX
M9+-0L,!EP4*PE2=\?"1N9B69"F<4)UQ.A>=K^9#+8E+T5" YTBP!B!(LF)'-
M5[ZXC__R=F;Y*YNO[RU'KD/^Z&TT5B2&!2&HDM#JZ[?/UBQ8W.L3K=_O?W^3
MG""C%T??:DB73=2J[R9C;=+=_757TY/OB@/G>_OBYG,*94>>QW:08QG P6OC
M$>YP*[W7QS$$+6"9$]S?X2>7@>"I(H/+O#U/E9$V,) *'P#_G'G"=/%:W$H
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M*\]=86BGDC\<98%3F%G<7ON6'T_1U]B7!?PSHM2"XU_]T,;5P;07P 0\*B^
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M(1E3B*>YZP8K0&( 2 3;ZW$1?[$4H+H\2;,?W SND$S(1#.0@^9AR9"NN/4
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M_.V_.47D0ZWO4SY'C8JIN=6UC$'YY)1UV;BLRTG5V\WZA4@2X)H$N/&( $>
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MK 9+\R-?6^[:,@:5SSZM\F]1XCTEWE/B_0D3[Z-5]!'UVW[+)#O^^YO<KR*
M==.?\"D@+0QV_V0KI^G\2D;BQ)AL>%DS?RX265OQ1W$W]03_>L?G,-E[;C_S
MM7_S0UXV0#!B DZD=[?JZO\D\R&+9K2S.,*&"$JO\NEH*4>\!P3:EEF"NH5I
M42^L)ZM C-$I%U-ZZFP.LALLX+^6YP?L]Y![P#.4-)E:#1*[XIZ8H7S*IT"D
M@\7&8P9[YCZ+1<E>LSG\C:T\"Y8/LV>S4,HWEP6. 6D^Z@*I'-0T87@.^Q
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MV >G:&[,T3(P17Q"S;NT C2HX0"1GH%,OI+?186?Y*DYB.P->>AU<-^ $>&
M+9_1W^*6*SUCHT/JSN5KD&6L]L/%:%AS,7I(%U</@?EL^5_9!VX&KN=7T[]G
M$9:*JU%685KESDGMILA(]&.@>KCP>;3PE2>>+#?TT762]8PI:8N%[2$^JC\X
M3@@C?E8F'8C,!Q LIG?O_L)NX71MR+^^40X9>-5:<(\IW]=[88KE% 0N.H@;
MTM$6^1M>]E]I[)]NR/R%&]HS=&R(>8@&(8J:%8LQ+BPO6SCE9%I8*.U1R"I=
MJA(9'"+P9Z[\*.?XBJ3R5V71PGNV%_QK_N0M8M?\G>VZLMA<3MSS]#245^2E
M-V0TU$)P^:*;]%@/5OY[X%CH)ZZ;![!^U[XECT"I"^T=Z"5IELIG/LMR<O*1
M3[$?QM=N#M<[DWKK'6/G]MV,;?UOCB<>+5]=!?W&I6MZSGZ$O3%8;XK-WWQY
MJHYL@+(&P(6X\]L"C_*P[X4>"+O?N&N,+YF[O9DUDQ40T]4P_-C')?IL[KE+
M]G\<%*>W9I$7,BE[6>2A;!@EXBJ=:[6,<7S[^8S[T4QY[+])9PZHN>]T;3 9
MLFE4$I(_<<N6CJ&,-88.!B=@/ P6KF?]1^GD>?Z6TM^$C\8>;'@>:2HUZ^8#
M&\/-7.%+GLDM$[WCWU96Y)9&PTU.7Q7GS!:VW!K5ML!45%HTLQ^HQ>#N$R_F
MI2O?<D= ?7!1;>HS8&M?ZIJ!],0A =,*J.172?PJHZ/X5?I&W?TJ0"#S#@;
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M!LV3X\HD:PO4VH/7N81A2"5@8KWO)&XRI>\5-).X]CCY-8[+J^E^/$$+.[D
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M2W5,J"AD5$EY2;UE<S.J6];@OBOF$.FJ!TOS8MRM^MR;V7L_^])B,U)9>!7
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M.MF&Q43>#KFTIG<M>1L:$LCO'[T1U%8\^LZ*T+2:ZC/AO_:"GY'4H LO837
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MM=O@=B'RP$4;O#8(UBL."ETU<84%&8HSS,44LVU^QM("^4/8#QH29'QT[?;
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MN1[-*7)B9VGW4%ST>V17&]<@)F.SBAHX^>"T2W%)]'2UX8?TY-Z)[)I'EM9
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MK0W!)Q=E8I8)R]%Y.=CA??O& I>/?G658>XM5ZF0'<D]F:G*E<HN'RO97,!
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MU]+9Y+H8ZR&(3/ME+BY(*YPIFYSU;?[&X]N%N^AGW+MPU_J%#6-8[V;C^,^
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M<3K-L^D@TF3P,F0(G%M0F=<\%+(ZG/9**A^+2:W+O<_??(1D]?TT>6N5VEZ
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M&Z!&4"PD<+'0WHV>1963Y<TO+VZ&[ _SZ&[SJ)52>PB6K)P>M_$N>S]N /:
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M;6H_AQ3 *V.!VV!K@6QT-R\.G&B\9Q?E-Y3M4>,]72>&:8\AG=4OZ"]JL\&
M;@1F;%;9"J><RE$5PU'*DC.Y#IE)%9)='YA9_:Y#Q%X2"H-"@A6Z6U R.!T#
M9*.4SC&2D]O<;#] [&4NS[,P[4KC#D3$5(RL;2R5JOVVR8DWY.-5YSX$:5QA
MK<V/[Q$\U!C*%MJ_M5[M+N(^=J8.S0"%<D:Q"%S:.*]M%DSR@,';F# Q%_I1
M].$5O(_\5ZIR*^'UX3'LX#E'+:/PPD%.NF9*U'9.G/A,GY>D-/';MN[1]NA#
M77O,^;Y5]#A"731-<G32 6>AFF3>0'#)0DA)<R:"UMB\ <"IA+JV8L-6H:YM
MM-)[O&,3,#]JJ&LK1=T9^-A%ROVG-G&C%2N$PM:-F&,!A]:#SD(P9I(S^*/5
M4&BG\6V$>Y105Q$IU0P-4)+5ZNQ2@R^U1+^PI2#3.J7326W:1AE;A[JVD>0!
M0UT.5:A5 S@Z#BHQ"XX5,K,5=RER&8)JG=;\,$-=NRB_H6P/$>KZ+?^.,8XO
MNW:VTQF.$D[2HM'4=(?(UMW/VSN0M07<&W&KPKTW"D/AQ2N;LN,&T0>;<T2I
ME1W<_>C])AH]^^SJV6\FXQ'],W9[R?3UY.E'''W(+T?7?V(XBD,2]C>/1J,2
M4=5VK=H8XHU3X"L?60RU(6-QRK>>DWN#WF<GNN/Y+R\^89R=S;OAOA\_&4\F
MX]\'O.24BI,0R,4CQ]YY"-4#](X^)LT[?;/VQ\I-:=OW'GZ).BR7KN]IO>JD
MA^UM5TG-O3BI@K.Z]K?TM<>$C8+V9B[!<I9**A9I^7\@,^Z@ 9CC\._P.GTP
M<9IZT?U?E_2DYY]KB(%^;5X](\3@N)<01?&@M"-+0@<+UGF,CCEE="_%CFY#
M.59LYH!<6%5]9$^=]%6AYGM8RQ(Z&P#KL[#1*E!'+&>TK^KNI\,><C\H,= @
MP\ SD-M9&XI8!TXJ2_Z(#ZG>NA&Q>:W<PQ)BDS)%!^/#-N+NGP?+GMX2=52Q
M0.'TAU*T%2.-'KCQF5N&QMO6J2TK@1RI4LW^BKI;_3M(>:TQW#+)Y7N4>_C\
MZYZT?]K*)A!O^/FR%+0Q1,O)FO0I.5UB$$5'B2H9+6]JIY&'?^.IWXS=9)22
MBGEP6.KM19,A%,EJ42(1I4A"-R](N@[+/O[X,N9]]F&2.Q/K&<[R0$<LQ=0F
MRX4'&AQ-D* P@=#2&I4TUW$3IWOEPX^^&NRFP^L.\_Y":^@5KP3TO)0<9\//
M^2EY-&0C=P"1LZ""SI!#'6X6#E &"4694%!Q%IW<1:NK7G:*6MY;J#WL_+=N
M@RVZ:7_.TUGWC8'@+ NEJD.>).U/2@#FY$!+KSGS@H?0.LWD7E"/G!W]"+]A
M<X1*W[.4.IGB^5.<?GPZOK@8=J &3 2BJI @=4)RD#690*HZR":R(H7)SM]G
M&=SU_$>NVV:BZZ'4<4>O;W">7>:7H]_(3GK_>S[_G'\=CV8?IX-L2T0G&&&L
M9X_,T/!E*&!43(8+ LI:&R:;X'KDM.A-!;=ILG,_ZTK=M_G#Y7G]_M>S4:HX
M___RKK6WB62)?M__4KK]?DA7*Q&X2*Q@LP*TJ_O)ZB=82\;(=F#Y]UOMV"&V
M)_'8TV-CPP=$8C%SYM29KNIR=56:AK'[]&;\"=>D";JSJ_1AW#0K[Q6=SHP+
M"LP@R%)$![@O8J"XI#EQ[GRGSK7[W?7,I3 PS=N".'BN=2>D_VOB"J8R)*N@
M-,8RO,QA%Q&L8@PT891YR4.05=3P_98_@Q0.)'A;![W'5[](T_$75R+85TU(
MGPO1!=9LY*6+46M$XT0 @4^+?DT1H(0[&KE2,M=N:?48EC-71%6JMR70>]+S
M=UR+POG?)W=QSK.;\F7**,8@58H6HBZ-N#,^L<U4@K)4XJJEE;?#Z: %T,6)
MH2_IVXHP?9S#=V#W>]O%.B6LIMHD#409%*FD 0,837%[JX*7P2FYV0"SU1$\
M<ODSMVHMXK9M:>N]W6_<_'8ZGG^[6W2"R]8$BDN-3[@-S92 RTZ"I:ED3SWZ
M)3K8>[T&Y<QM7Y/HEFQ0[]*8%\G/7S6S^?2V[$Y>S6:W#MU/P49'+&3J*&Y9
ML] ,! H2?. 9G-"&"D^D,;6/?CP!YV*$4(?P%C'TS@VN8WN19F$Z7D0BU_E/
M-QV7:HFW"/3*S<KWHC(J9Y0$'VD"P4@"$S$TI8+HR&.IZJI]F'8??!<IEXHF
M:=%/[]&JZV 7F-Y]GB87KYN'8.G(!)>8)@0L*:E.O!+@KU3)@?.40C:,UBY9
MZHKM(G53R10MFND_C2V%VVF*!>\H<9>U81:C'U[.RRD&%B& Y-0H$K-6U9>4
M![>_$,L?2FB+<0].+*ZPE">ZSL\1SGC^TH5%4? ;]\_XYO;FKC)XW'QX[C[C
M)_-O(PQY<_!)0B9<8R@<RZ!*'B'G4H 3%:M?9[L/O@N1QV F:='/P7G(]E7L
MY73!1OAVG?_ <'H2QV'YA=I()9J#DP(B-QF$IA8\41A5$\,SD\P+7W^_T@W;
MA>AF$%.T:.;@G.7=+OLAR UD[^9NNBR\,*AD$@@P7BI^K4,>-"*6)F5!DE#.
M=FG1U>UN9V[_@6AML?S!J<J=$!=SXM)L7B*>_R<WO6[22%O.:(X.'$^Z%-\$
M,,D9E"E55EAN?%1]-=!RWTM70U^J6W31,V&Y!]CW7R?OT=;IY>1V.F(D&EEV
MWTRZDIF+N(1IW)8G;AQ1+$CK76V!/ 3PLRGE8/);)'-P7G1OU"_'7](H,RL=
M80$W3276]IJ7E U#W)HRS9C!A;&V5,J-?S:)[$UV2X54K[+))]&^3].;V8M%
M,N;3I\FD6?UZ<I7^<.,XTCQ;2SD%2I0!0;($JST'*9-'\$$C_KXJV8'AT@53
MTP0MVJF<8"UH1SF(;*760+/791*2 I=\!D*R988;Z=FP2?:"XLQU48G>%HOW
M3HEN'BQ9G#@D5B3&@H.0$5EY7'!>853DE+%!$,+KY[E:<!RM4]L@::Z^Q/XH
MQWHW"@3OF@AQKIP.N'6V;M&WSGAPZ/4@."]EQHTU$[6G6K3A.%FSM=[&?;H*
M<W^2!ZC$W\2T/'#6!=5 )W3;$9WF>&Y_B^V00 ^ZCR<&*XDD61.0" 371<K!
M4AGQ%0@A2>Z54[6C@V.*8,>1W&-I8!^6*S=:NS\K]-=X_O%-BO/II!F'58^H
M'#T5I1-Z+ WP"8G@(BY[RA*MM=.LV[[RJ7L</_*K88/)  16/&$WF\Y';TO7
MB;N&@,PI7MH &E(2XLH'\,1QX!S=%M<B^]#I'<:K/GA_\:?O[^[:#<_>:1].
M7\434?<@EE+J F,?M]S%FO5?T=W^MP?YF^;KP5S%57833C":*48%*.<MPJ$.
M?% 4,G4Q&I5<[+;Y.K4!'_&=]>VW#V&5[;;\8GH))-F8A H!T/T'7-*S X-+
M"'#F-4G1,4$[M:?88;FUFQ[//_:B?5*#LP$ZKZUG9!:23,9&B?(#:[P$(9@"
M)[Q'A3++28@DD-K'B[=1G+V/K$3P &=.UQ'][FY6G52ZX!IH8_L8IM-L;?O:
M[$D)]"1\@*WMH_A\9)E$(D&33!&?IV"BRD!<<%QP'D.WP/B'%<*.[>VQ=+ /
MSY6WMR4'_WKBFOM*L^5<=V>C-CX#L]:!L"4L24I#U%'$I$09%M]A8]M^]>-O
M:>LP/ZE*VR#._/L1Q=7#OAW/_KYKDZ91J%E(L @2'[7,$S;.  L(#?]P%FI7
M;SZ%YX(<?"72*_8-V,;V?-(L)C,]['C8 =M@[OYQ7*=R^;6L^*@\*IE@D #@
M"8S!64^E\Y!*_RM1CJLX54Y!,I.-C$8[EL]>'CL#@5.H8Q_F:V>]BRM_6-WS
MW'V^3^3.[D_(_G;;)&:>-;'\@Q/\3V+I"4G %55("L044BP7B)THD"9JIRUN
M<;GN$$#TQ7&*4*.612<G,L< @<GK2?,!P=^4..R^;VOR4G$='6AGD0RF,93.
M(@*^2UX+:;/RM1O:MN&XF$"D-\D5^]0\AFFU\>V :J#0HQW1:8*._A;;(8$>
M= \09CR"SA-#8\8]=*2TS.XI_9N9E4 ]HXS%I!6I76QU3!'L""V.I8%]6!XH
MQ_",KAHL4YI"*AV5B2W%9 9WW5I94%IP@Y[1:!XZ! >;USV^LZ_!=4M6X2"B
M*C>@76&Y6F$AEA-*J2J9KY(JP>>Q3!*@"9DV(8;LQ!Y&N[HTHQU$U "K[/K)
MT;LO&:FQ) <%A!!73AD;L#SBDQ*O&0:/AJ7:(ZFV45Q,G-63X &ZP*TC6HTC
M[8!IH!BK#<]I(JR^MGK2]#V('OR]7V+#4"&&8,K82IWPKY*0CJPT+R5"2@PL
M)*T=6QW/^#LBJV/8?A]^![#YV_1E\NE+:0BPWB[@SA%IZ;63Z(.\\&4R!B7@
MK8I M4K1.XL^JO:TD"<!'=_5][?99"C"!\BR_)EF97K60NE$N*2MHL!==N58
M#08A-FCPBD@:$O<8DU6V_8/;7XRO/Y32 ?I\+J$L1=P%S$#>?0W(:=SZP69I
M-V\/3@=8U-=!14IB#*8,HBCU88H3L+C*E'/7(EB:M!.U:S".8. =KGL8^^Y#
M9>T4R-0UX6.Z;E;%@R(9:4+ 5<WCUE"DF,'2C( ,$4K%0'6GR>R;USV^B^U!
M\:02/[4S'W=8WG^=++%(:E4P6@!)4H&@S('31@!3U$?E,G[>9;S&YG7/W%:'
M\3/ >OG87$ 7139,**!9EIG&,H$W& ;PE(4GIO3HKYWU^,'&KE8/AVI07;'A
M]1.P5L,!.P#[N:>I[F6Z[M,S#^#].$O#$J 13@?!.$13V@[H[/$%8 0R%R4+
MP!.SM:OASF.:ZC!ZV(?NX76P]%N44*%<6031@8$02H--BW.KB-)H=%MB8 W\
M>--4]S)4IVFJ^[ \1%+D03/=A< QKB0YZ0@8G/ RWB^",5Y!"LPR:TTP252V
M^B:&BXD'>I&[;>S>TQ(>XED)N@.BH1(E6VA.E"WI9:4G3-Z#XB'R)MO( @M$
M1YT@28E;')W*\?(L("N?I';&"%\]>7(DH^_*H QL\WV8'::4*$Z:146D=\W?
MUSFG:8H%W^M75]=OEZZ'1\<\)Q(40X\F>$378[,#D@735 0>5>W2Y4[ 3K#S
M[VG![1JCRO0/X/F7?=:OOZ1I,_[P<?YRW+@FC)L/!>>[29[>?_*JB>F?=U_=
MY_+)"GPH8UY(!BL3*5T,,0Y60I;2FYA<TE2JVF%"+\!GKZGCF>O1]>B__]D@
M[S7^^.LORU^7O[R;I5]_^1=02P,$%     @ :XBH5@VN2/>)9@  D'X  !,
M  !D=F$M,C R,S S,S%?9S$N:G!GY'P'5%/=MNY&4 25B( ( D$!:0K25&H4
M!$0$I L( 0%I M([45%06A $%($(B*%'*2(U]-Y;!*2WT&NH(7D;__/_YR_G
MGG?N??>]<\=X:XPU,M?:.VOON=:<WYQSS960OY-'@9.WE524 (I#%!2"%((
M0!ZGXE!14(#?U=)04KFC"%!0   5G;Z- W#H) #8.[@Z:RG+<]XS,.2D[@<.
M Q" #N   #-SE\=JVDHZ %CNJ.L!?RV;?0#%P6>W('B=\Q_<\,\*O86EBSD
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M;#7CMVS''W\IZ4LQ+ ]I9-N.5\U9R'_6[Y\%2LRB9-4_V6F"B&V_(@/G1,B
MR2QQH,A[3NX\HN$. E>,N))C4E9Z=<6,Q%!9BV!%;X/! ].7EP<ZWTN4ZU7+
MGBTP7VM!4X(F+(# "<4PS4J,[\I,#^P.W""*U2%.5,-2?12][NW:,C' ;?P%
M%;XW3T^IH#?AHP1PD;^U5?PWGK8X%%A&!CCGVW<)*#*@6.#9ZR/TIPYO X]J
M[5Z.AY:K"@=;@,8S\;]$/$:)3"MKVX$VYEZT1SLX&$\Y._7$!4<S72M2Z1=*
M[48+Y&J&+Q>]"KZ]H;-M]T"DV O9;4JRM=78UMOU(!*^D8'R;C!0[X.:I SM
MUVOT"+K#O:9[]#^2@:K";NQ,=OW^)HKH\+K\["P9J!8?W<N%=INFS/?X@(Y5
MWCQX[PQC]+#:2JMWK:M_&!3ZUG'6X"H*0I!^]+;JC@CQ1 %VE8@0TV4S9MG'
M8A4D3>>5/:_./G01U]EROWKZ1*YGHAB^27^MW?!9H9JL=E& FK3$0Y ID9^X
M8MA-.!LFJALWU'1YN<>\(WQTBTDO6"LX,K] 44E=:-7=&@Q4(9[/V+T!_/77
MU]<9DJB+*/<^;DADFO"C;1EFHRZN7,%I;],/:7Q9-DD:0YZJ'S^J?MT@X@1>
MRG3#++%^8U\CZE55\:4F*=!4.<V/.=GF3L5$J4ZV%O,E%ZG_*UF/7R)R!",^
MX'ZN=8__JIQU^YY"86>Q7BWC!"\-_Z7N"T[:(2&]XIYV_%HW1L,A'$0"WH=>
M+:>Z?AAZVMFOF-/]-ADH98]NE^1H#?<C%=3CBFXG9QZ6P*%1VE4'ZADPN^,*
M"EJ^Z &D0!FS*;->NN=^-E6F.NE\PIL,!!%>]"UT.57[X3C"I<C 2PS[K%'Y
MJ55*:X_K5V32;V<%='\VVVB7ZZ]3<YZP]KGG(AP,B]7..PSOUX@FBA%W.3"*
MG)*36K@(GS^XJFH>].D/KP&G-+H2='.RX]:W'CE!6>J'>3&C,'CJG1]OX *E
MQ4*QZVQ:]G#%G@95+XFB >VU.CJQNNOLU+AXDD31<7Z'IR=-:>\EWV(\#P#X
MPW)?JLVBCS7N]?)FH8=VO%CULN8,+IUC9T3D')S&N!'QOW&=**81]+#)"[#Y
M(=A[?6%CY1J-'1KD[I;&=&\SKC"0=!Q6Y7D-,Z%#!AC 6?HJ<C!5O)]!Y^,M
M8CX#@9<O^UIZNYHD!SJM.>ED((EV<V#=!0J:(8+H2*!_&@@MH[+_G8>F_JMJ
MS-1/% =?^CUJ=Q*[R^04_8>FRP3BJ7#LM.LH%@E!37J?8-0T$5G\U7[3MU)Y
M\&GIZ&OWWCM"O2+1- ^#9.<\C6S9T=COC@DE Z)2>_N".6 T:]#E$5(X::7U
M1B!3#;Z^UWZZ1[PY3$B;J>91J!A27O;E*#)5!V/=*Y[I]X#A1)6%.ZP&W0-=
M@_@+-OLJC.T085?J=U[G335VL+ERM,#V[[N8?(*>SO3)-O0K%FNN&1V">MG1
M[>NG1QTDM.I^LN1RI^=35\ZI<:[U<[/? WI!/=QUT<&G\J5?2,WXHAD5,JW>
MRM&=.J=IV]?YXZ:_/KMTP ]HJA'FRLKIHLVSF-Q;" ^1JET::2<23L,E>"-N
M5831F.7;QA",ZT=UG^YLNEO_3Y/%9?K;]&<.SYW>=7;\%FT.762SPDNAJHK"
M%,9E/TJ>[A3_Z&$^A1FKY%UC2I62$""*.+:CAZVT"J3@;)%K\UOL?DS3S(FP
MGB5$;^Y-V/?K1NM^O5%..? AJY:B-S-?UY'-Z%EC^N8YV*LT$J_X.JOJF#K\
MZ8+6G=?'2P[O1L 2]/P>U ECW6C7PRUO$%L]JT_5\Q+)0'R77K.0L=46%^\[
MN0CX%1_AS<T$,@"+(0-;NS"2 ')Q49J$N$0&EC<0$R82BK %/$)Z[S5L0)ND
MN)4WT*V='_7BV\M];NU]VZK/9A'.LIG5 K<^>:IK!J]_C_!#9"LTEV@L*RJ+
M+D.*R$"%;%7PVC$XPUP,PGE.H3O0\;*?G&_?$+(FY-MGH?,J1[Q#Z\A C_^S
MW,1#6>[Y9>QA26^U8K:0&<5$R,WDS_GMK#;%,<PM:_%DX/A;>&.N/J&]P,$M
MQT;^KGNDS4["W5]2V:>#^=+YLM.^*Z</JM@+#[V^M>L-39/!A0T;JIB)1]R^
MW%![:[&RSFMQUF3POG"-/70)7B=[2F,_&HN>,G[+^B-JTD=U_=J7#:^Q-E!S
M@XZ!HI+A]3?@<?T T5@1*MA/M9R\A? ZPCSW;4=CK'ME*R>F%%%=7-3I:/Z>
MU\$=-%>F$[!8ZCE!7&_ DQL-7)SAT1/C^#V!.%_17HYANL*O:$PM.Q1?"PK&
MV]F_>&8"X>G9 ]:-Q=/7/X8S.L_@89C;XP4:+PL93GVU/@]?OL("^N%KR(9]
M.]M[WM'E3&B/9)',5VCE<>]-P[R.=\\.W7M"K>7)%.LR'B;4,;:40@:>H"Z3
M@8EW&/[2GAS'MMEI+TG2!6[(!SR,-CMN/M"D_ >JT1_-MLZ+<&;U<-Q01JNN
M'E-%+NU@2',4(!@Q9<L>,T::O)H*OJJH/[@^:C'!FR277(I(]:$.S%]>*),[
M>JOZT7%0/JYR^[/#:-N9Y*./YA@57>W=4'I[1_'^S1&)(BU\<9YZ4O@2BW&*
M"GV".HO"H>HYJ>"XTI#:B]IZ19RCKXI)NN$<085188N6_M/;<61 /]32;EAO
M> ABG%SZ7FW5/_63Z<4Z16@U;YO<.]C5245W5F7DPO+G6*X&1RT7<$*>NA,]
MMS(R S(UC%R$\''W!G1=L8(+;9^"%4U'F3B?B1X%38A(U^\W8+U0O\=HS54&
MDKPYJ:Q[I\"9L#B&#8"L)-();O?":D"7+COT()-X[#3;_6HR8*Q-!N29%J/'
M.F]U2A7',W$&+$EFCTV4P4D^POM[&BLY,B8<;C_NVZ=N23_V?'M72[L\^Q%2
M.[DTC\109O2W>U)^1^? T_36]MJPB[2PX;U_=F/*'%-I^0JI(V5_^1M!2K 9
M-B;=BYW))0,C^0>IJQ5DL"/!CO!L_'J#N<N3X-*G]9PZ[=1Z],[NN<9-@5>B
M5?@RA\KK74!I%OE[ED3K%-"8=4FYKOAA0O2Z3!_+COD.=G7AQ;YM$HW: '_A
MY)T95MLU&V$Q[^#UYI%75T4MC"I>(_4N*&W-YD/ZON3X&F28/,:I?R #+O1D
M '\FYZVI0+./<F]\7@M?O5USI\UVXM<61HMXB#?F MJ&&>)T:M]"$T2>%IS6
MC_B&A9'E4]^)<V(D1-W7<.-AA+-(C!7Q\U[_ FIPP(-(,@(YPY.![0Q88?[R
M#K&0#& [R<"J[H2.+L)*86?DQRM2%VI-N"RQ(ZXV%.L^Q[ 1#5F3>"@9:?;&
M=$0>LH:A2]72F73[N-;;A?!F;1FYY]>R)2589T]HWH,3]$4QCQSML3%.NWJU
MJ!KVVR.'Y*,@F[$VFU,BNP'WFBET'W433Z2\[4*<<B)JJ"<7J5T=9X_N.SUF
M2%D/\X-=IB#6NO9MB1A_B.35U^Y(I_)_4(2^[;KQQE JO?>%KJ>*J"%?\H?_
MR#O[?V]]?U;M7M=O;CX>A6\?5P<,:3SDF" #V?I\G]Z'@/YLCQK_A;ABGY1:
M-UDY8Z&QQ>DS%MQ6/=Y[SR29],K.CM.%"F6_&(?$"4'9#U+)^S0828P=Q&A0
M6VL^CR CHP8UTZS_-+L#/L;HS,&S:+-TGM$=E:1.PIBM;*9)A)QQ@+W,P9$!
M+T_']FS/K8G@1;FSMM(\<:W?Z&1J."; R--\A:D>B6[7>)^%N. ^1? 2<"Y+
MW4G!@@#9)/OX9X1'2\,+N$G4; ?5CY_OL-GF?FS)Q44Z)+VOP8@ZZ;89PNI[
M*33-Q@E'G4P&M$DNE;BDYU5**CJ)A0.P3)F%AZ*:46@-54?A3H;[0ZJ>TP8)
M":^FWDYAVW>83C#J?XB."7%XN6Y4TKO<>W!LX2_I/B-OWA!A5RTF> N2Y/5E
M@J.>A>,[4?&!5H]Z_(5L'M>]6/6#8PQ?WRU("6'M<FK+CU0#5\^-X62O;<B&
MV>@'WX.WHN_DR4\9:U"YX-*XDJB_$8LP>BM+91S81SR:!;A#-]N''B&X!DJS
MU)DZ?9OOP2H(*]\*C)W++F"A"GH?RO.0=Y^I>E$WGV>"(1%I\]J=]QO[AURE
M#-4,%MI/E>?YT$P^NQ&H;"D71,TR4WA'AVF0J-1U)=^C,_PLS059Y1^P&.6I
M^TJ"0TG: ]U::[A>#B9OD[J/*9WV^,T#O_VG,TJ[L7S(CEHS=XV-N&+FO::S
MW[WM2A1LR32OBBO<E"6JJX/Z[4YZKZ& - _8P<F)QA9\6BQU@Z?W/LM>R!!<
MO 3%>P_]%+D_;+HXF_"M%MO49B^LK#FS; L\9SLI>\]?82250W)5<#;XXBBW
MRGD'*^K#.I&79=L@LD'JM^KCHQ(+AIY7\:=J^;@B$=H!+*&/'>+EA#"%23RU
M-;%:XKE%!\=YN&?0H/>AJ*IB$JFG9\1AY.'A<[!N2H4O\I<796\?;=A1<'1,
M]AU)KR#:X3*#M^W1CX+MZJ">+[OQDN8;O)0K.7VEH?;JWMFNX2@Y=,%3],(L
M;Y\AL?BP%R28#$P*NH$PK[&!,<&<6X437SA@Y]-)T5Z(51X2M)=E&EZ-W"8#
M2A9=X?Q\F+MK:@G':IF]&2A81DY[A2&A3Q<0C1C5SH(2>V?HE2.3YLZH4O0/
M!)>)9%^V3=R;79U9V1)[4V\W*HX,Y<=^,"&[6(;G8;JM[#S;8GDG0J.%W0VK
M5Y7S.PUV.?+H2A[EU=8_U.Y5%T.N9-.N&3K9R[+*NO9$VNF -NGCY8,3;2VD
MW^TA%"-?HM88H(0E5&MF+,;Q!/$,XOF*$[PNG70!A(]'#_Z<@F3J\H61@8@,
M,H#CAT6[N/VA:?Z*!-KT*L<7) G8*L=!#/32)^E %PRDMEY=RJ=J"7)][OLE
M8!WJ@I<E P(%F7,J'PU5G2>DF9_.U;^ OCI?ZK^Y:2QOE?CPQY*SQ@;'$W?H
M),'L\G#_,/P0$6X>R_QJDT8)QH8]_*,L:SMNW>@!CU]Z(I<)PRI!;CKW5?O.
M=&0PP?QHI:% <\,:KZ1:X85!/Y#K#,X_I\8$IA,RAFRTO&+6<MG6PW7+/ZP@
M!-"*_(HJXKW=^*;0>./N/&/-V6&VU8]2Y=^%1-CJ1R;-%S04%G?C9C.K*6J]
MF9\1#1V_6+F/E%).NA"O(VC(@%TW;A[74FNZ'S<3.*1OWEUE+IMR-WW5U:^M
M+I@OAZOT'V7HDC"(!JEU4ID5&>BT-Y$P:?Y3.\9XI8>@_.Z=[]T-,W NO69^
MZH<[X@1L8GJ&5"1,>G'?\@^M[9%1U:F=A&O"$]4S.QP!X'="?<S^A$M4+E6Q
M]*4.HCFIMPA4IKA0V]/VZ!^J#CLM#LV)[RKK_"K9@C>+US5>NL.M>J@JG"[:
MJI !&W\X7K!0.+U9LWXG=CR<K0XE(2'W!1$@:<N77*;0^!,+NE8(J]T%QVSR
MGO!0E#P>X=]=L;OR!I'8*X:4L>28Q92FJ49JQCY$_?!)8-*_7;QG_Y%A1GI,
MB?='6ON\7F:%;5M])Z_; 6A3-A(?&NV9S'ML1;@M3J$W:LUPQJNL%95>[ UL
MJAR0O<;ZM?-% ILKB[=#61=BAY)&QQ],&-J0 3&$?_+/+3!6P\[/*TM)Z::5
M#I/0<:X'H$>@]M2H#W5B:0J*C;M6N2#&A5A((62A7Z9JC$=B[4=&[8_+&J*.
MPW.:5Z^M66-N!HP5)(>J.@DB2@JH)Q5T4[?]4C&:YW:QVQ0&,FX0V+=^2P+J
M9IG!M$[T;*ZO3#<T*=H_')81E^2VTB5*\VPJ*"_-%'%2"29P6BID#I=!_22K
MF!??1AM9Z 8[,F=H>M'\%">)CV1&$*R$QD[<TRWE90U>]6UNF$Z0U'9_8^@/
MKI=NQ(&FL0MJ5^\VXSUL1"/UEXIWD^;D4M*VH(;-J;/:?/RU=8:?[O/RJ:A8
MX[1_F+^VO#OG?.;04?R-258W9S( (8AYF9J:KU\?5$9$K&%CN?"":1C:C^R2
MW\I#M]);=9Y;?+5.S["9S3!L?K3/?I2Z@Z"]S<:Z6C3J8\#*?X2%Y2G':(3?
MGGXA+MY7H<N_V;W06LX@\"S[U;3Z.5BVNZG 6F.WCZKN7/B=JEAQ)L525__0
MR;3DX(UV[E\EFX"BGL,.%/M:AIO AK Y^DE$)4&'TNX**<QW3,MQ?Y4>X<].
MD5@4URK3K-OX>+J/0*ZJ5<:&5<F+S$4;18(A3 >< %.'GWBCK=-CWF7_L2@V
M6<CI1V*3;&.FVPSJ) &1W_;UEO^]SZWA2\J4*]0$B1R.V*]I*=T>^% GB;(7
M5X5*A/6<=\.(Q6^69>HO+D;A98%-=FR;'2L?QIZ'R3+UZX;,A4$/[T)<#_B^
M#VAUM6H 4834[1\K#]_OIZ37'&VJ\06CRB?[(T0?)J8+Z55:?O2N'^;418P-
M9@V%$L5+^.SWDD\,+WB9[T3IIR677ABT+^O?H.&.-.)FFI03!"$Q&[?O!NLJ
M\RX-JD6L,163@1STKOY#.%$%$410/FU)O :Z81L/U4#[ES1YX'*=E6/&&2F4
M&M#(&8U9L"M)!=;OR6+IA\ML[EVC8CN(1?0#]=.VF;7W_!.YP)4=-B #'AG^
M\?Y,,^;X; %AY5V.1+C!O,HNI@>/3PY>;[]YL [KL-^A>T[*."_Q>?V^#WK=
M=FI^L!IQ!#HFPZ:_FH%X]>+ "?N;XZ>27VBN4G:P=P4&19+P@UU+MN9B.OW^
M%ZXH"&CH!+"$)HVI^T._;]T;-]P4PRV\-]/>[-G84TX#%7$\$7^PQ=7BJ]"^
M"8>N#\OL7Q[I*VT& \!7672IGW[(IUS*<R;,H1^S>4\P31XINU.NTFV7$3N-
MY!4)T67 3^R(\#%J!B]>DX]ENE3P$1>6>W1 :>*%5GUB D7VH# P%WN=6?<E
MXNN/"7S)2YCAJSXTJ,P:/7V,MCK;#T8:9OAJ/;YB3] C<$,B$\D71GJBB!F[
MOM+=#"PV[SER2D%,$!"D#D\N+L2'33S)V5+QSFO!8]0=@P8,\-Q093)PTC:+
M#)S(/O- \)7^_F@.C/-T9+VF'ZC-L7W&#!M6"9W!<P60H,+-BK<&O&SQE 5D
MX,($+,Q%K)*GY.VD?%:9PJ$LV9<R?1MS59AJ;F*H@&:ZZG@(/';XX)A1X$]7
M42-8_T7OZ^#/G,^DGDDCO2WYDC+Q$BFR/M6&#;B+D>9A$U,1WI<IX[TYD@OL
M6N6@<RAS[)4%?Q4<9>)5OJ9X?_,UC"J&@4'U>X^3D4,9Q..$_B^.-3BVWH7*
M/V'^X1,^I!LX%&$>1@JQ7<W8-/Y#<R-W.1"=(=/2/!Z4 D)Y2?NUG\='\K9!
M5(5>A1$:$1L"$W]LSH"Z<0@NW#);B>" PAHV6/F22\T'_[(I,2'',[A4^/7]
M7FXN8L0.M1]3(C5-1#"_2Q4A+7Q!M2R2"KZRK/4%;6=OX<V#[_?8"B^-+/6L
M'?R ,:_RUT%DC2H9WFV\%776:4"ON""[F<KN8ZI?'9O-04,O52,K,E#3:FZZ
M8_IZF1+[,SN)^]3>=Q%#<%!ZF=ZE1XW;G]US:!R#^OIVHC:#'.M3O40';Z]Y
MW0Z%<]L#,0VCH=[!F[N8$R_*2B/5V&YCSC5_!D1 &U\]GG"TZ<IT^?"=J1HS
M)B\E_2D\L;-B%@IQR/F\]>B<B9SFNB3'6S9(#H)V07SDF,V WO''@69$QZ!'
MNZ$KD [:ON3DG O9QE.6_=9A_&;I6MOF'D-SH".2I?;LU]1.$9+14^J2+JN/
M)<TUJE'3BXGUG^6"UG,2@XO=>&[?UG2WT$&S?G&*+):Y<M/Z>^8AVLBC,B>5
M-=5R2L8YWGPM5'$..&3J8?Z),(<XJ3S1ZBRQV)664:GF)B/0,\32!$DA@L_(
M%#N8/2ED4"'*JJ<TIZNF>1O3!L';=0O6RTC"^@F"H)1_6@W8,,\G!9:%EV;Y
MVNO"IH.)XK*AY?=[LHFYB/ D W^>+C)0L,#S_/C7J[Q[S0W$77^)=$5G)?53
M6D9HEQQ-[9"0_DP.EJ[(PE++5#)@.2=J?T8%X8E=N;C$\5V2*')/=UG>]J-.
M3->MG=T(U\GQ+?4J<&%N'K@QD&"]IWTWKUF:5NR>=#[A(_?.MS@Z2_]8UTUJ
MO ^R8M5$T"1@94)K_5Q<*U(D8IXT[[<TDS2SFL/F)V?-GSV^L,\R$ML[]3Y@
M0%5#Q]U54]$K*./ 6MSP<X^YK"*]$<:"'!5#UI4^F!M;YO&RX,[+$VE/GR0#
MAAL:+[V#^K-. X\?1B!&^ -A.8>]LKT]:=T#W@]KK,!7- 1%TKW27(.)<"(8
M=0M^&_TESH$'27F\MN/IIK/TRUQX>8MDL;&!D0V^\J[WI.6[9VD$[E%(6UF*
M6JZQU("@VRR;+5:+FG=5!D<GEYIT!B%&I!^)U9Y^_WY/8.2* 3AHB^S=W\<(
M\[V_-Q@EH/D>5R7",JZY"(_5$Q$IHM;)P03(3\LJF+/MY/Z@+ 8R%GG*3U)>
MI+XC;C+3I5+4R[NL$/L6=FUPM^_,QP26D0+21 K-A4SYH<6M1 SH! ;['!S3
MIG[W]T0_R?Y^F1OT=\D'D^&SVY?) ,WH.#9,FWCGX-!;S<$COY@BNOZ>8&A:
ME89L[P21BM&DYX*#@JTM_GS>8CW-_BR['T"^GFS\)8-9FEEG>*Y+6)6S1BMR
M-AR0W(E=@25A=-.$%DS+:?/J<@\_;CISB(+-"I5M'Y2#5]_[E-49>.%9C4+,
MILV06),K\CC<[MKE^@)8.1@M^'OR8"F,$Z-7=IM:CA1=<)_@6N*=I-,81]#.
M70=,M7I[ZW33DWTS<\F J(UINE9OCM40&7C-=GK5\,.MUYK*EA3*DP*W^7+L
MVQ)^T\(\0A@MSBC$ B]*W32QC.G8]=%[P3C!>SK.W2Z#,?ECG.WLAE68G:',
M $_C,\VE+*G+LK5W,9JK?6\D3LBF4LX$S%#OHR;8?%RV]6,3!?NK]38[2H:D
M8=HUM9J;3&QZK<;>-'\[5<KW@<9>2.U-9TN9N9L303MNL\;I?*#)\T-R@:52
M90'5VOOH._F(7=, TLY91*I7?Z@_C7=*5[/E:GUGW(%PSWS\<QAV%X>=9/<B
M R9Y9 #_%<.*L?QSAZK0MJUW2DM+.9_W02ZA=/TGUR6P0-3JN@L9N!]+!N1S
M1/_4]G5<X5DCML4SKXZM$Y$WP._5R?YE1RH+QIINSS$)N44&5!C[IAYX=E;9
M,-_<58)),NJ]081H$)V(+?-D@!:]S;/#H0;*7['O]J\9+SSBA-&5V&.SEV%Q
MR)6<NF\C@<&*V94+EO!.NUS0G!%!&_-RZS&V DTZ^:=3Q,^F2<,-#[VT8%O?
MA=?%N8<'7N47>#-TWM.7N])E_VU]"W53SQ$'^!>\A]6\YR$#^E39I,U>DF+F
MO;&Y9FM8\<B[^"_BYJ6X$43#/#Z'#OXJQW_J ]1 A71;((]XNTRRGXJK6[I]
MS<SP(I/'IOU<9U3]7;@MZ55BB*)7IJ]2S_ODZ]B;B+GI*-+I"ZFSS/LKB.T,
M3)J>7_DJPEIS?2\\8%S<=L#UD7=VU>B^;IZ)HY$A-L31[9O,JQHSCR,[.@&O
M$R=1AK4YQ$O\FNCF2TNDB?;:WC#;^,Z!1KNAGT)R^6!V)-[ON-0,1YXCOM4O
MU ^J)'V!#<-G3,9,',Q7%8B\Z3%$,<)/TU;A32TRL2B\V,?A'5I*[4&D6AGI
M(#%-ZRZ)UN1Q<85F\E-Y/[NLZ-F6:3I@W/-UD4BG/R<5L!T*K2N3*<\>G\7F
M96P@5C2$15)M!$(6K?<UM< 0=:+])]3A5KZF[,>FWS@'X[</PRUAJ4B>L!<6
MFII:M(_?P'6:T5?5G2+Q[:[)>3)7TQ VLRMWU(T>X@@_L/SM.!:BG7HI/^_I
M[B$Q_/F>2+N'SX+Y<V]]$91F.TP5M2 I'NB%J3F[G#_'<5=&@14S/B)",M47
MUA->:B6TY!4:<+L3VS6J,G$EMSG:XLW[!4GH]CY4?CJ_A\-P JBLV<=! ]HF
M^8$.61'G,>C&[2QW3Z?!OXQ9;D>2*-AC%[/M]VD_O*)%B=6*EW0(RP=-M$O'
MG&76'M"-_AH>,NGS5LJ_[8U/L_XZR&11VY/_(OY:58ZL,8.^GA]VXTB6;?^*
M!_'%(F+$<9\B4X ,5*&V#7*@V_EDH 8KU@?ZX"OMOO\E'YSA.Z*^!4;HA6V<
M,QDTX0'A%PI",TZ'#'2\\+'W*D+60I2\WSE6_XR2'G/\DY_8223</?T 8%>Y
MQ@C,"0HLUTH9Q^XV?^3MI(DX2.UDI9.X;#I77H',5^@JS_7O"][JR(0%GB"&
MIIJ\D>-/79?*$ R,';>>94>/=TUL'-NWS2.J%L/<AT7:G5N)+[/U:$OVKA"L
M6R>LA0L0-]OEDTO[R[EM>4D&%;!18=3^<1"SK8@7U32ZH'NC9&!5AY1BE+O7
M2.HX.(V1/%QWH3 :HA162=0)7I4Q/8Y J?M'=U^MN:122:78P+4$)0D4H=;G
MC=]*,22UMMK;VXF%G#5AVKDOG+KL9@9.Z_RU@V,SA]GM>GWI>=]]--H-X",#
M#6'[@DV9/:749(#S)6(XB@PH2-2^%1Y2) ->_G>6FN'+%MBB'7%7<1!3K;+^
M)V%J#J+>^5'70^BP=1!NY@2RJYAVLIQ;([>*;[VY#<:CUSZG:!>DGPE9%:[6
M9E,M8$6-V2UWK <?_-/'+X[R8="^IQ"OW+%9P\(DFOU?8DD9\W8)*XQR>E%G
M$7Z3CHU?R<!"0:=^D/%PULC6N^6QWO0;"#?0$3-@?<'X_(FH7=@J!!DYXGKE
MC#O+$84FR):RRW+WO*%6JE1;IS[Q=8+AYQ0.FQ)_*WV?-*/9SIW84Q?MYC3@
MIE)1&SD:VMM(1B^C:X6HY<9H^-ZDL_*X8&!I:1Q)X>*:V)>E&A2BFB, :1M8
M1GOOJ+)!N=5@THQ>"^\E_KW,\H7OY:ON:$2U>H,LUPYU]]0DLJ9/(4_R8CUO
M$:_<D$^7EOY]_CI45>2&,MO<[4^Y]MBKH$$0>/E;?,'OI/+;OO&I&[_!)91Z
MMP9<<42"SXN?VK*2^,EHI;W7_^ 7J13XPX]AI\3;A6YA=!Y/-".V@O@0]*^W
M]?T,$KFZ$059%YX<_SK42%I;@\FAPNR#TA<RZHR%K? M3N+[V?S*V3EEFA,]
MFHH^5L]^D9KK'^AFQLI3 T$W]2ZW!H:"#&R:1 _APO!2K[HP'[XMY%Q%%(\(
M^GG"$GS.2$[J1X6C&_7?V4L@4-K]%3HSJ5:E[.7&A[-@+"-^0:KQ 0&<],AM
M9E!ZV5L=] ^O"NV)&@T$;.E^=,QDSR2^7\_ZW+$9_:"8UV.MIYL)9J7DF*D'
MEZ4['\R'>;1R((F4V:HVC[:BE(\CO)5UH5I.FD^-E:N'I!<]IL>"3E[P*[Q*
M"Z.(,L"E+\PVF2CE\^\9OD9Z;'.$V3V*>5Q/Z_>]4\>/T50G7].$?GGAY];+
M/]G(</C;1@;=7S<R#C_:EB;);V*7"TE/>L.,Y.C ,<HP>XMDX(.$)7Q;FPP<
MDZ@^^ .)[=CIG_O_+,L'7^.P^GTVM<?W#[ZJCZ?C:#61-R"8)*&Q>J!ZY@=_
M6W3(YW?>J%U-%FQB&KH[A]H]B;''7!793L*W:U_:MIH#IR:'LN.O9QFSREQJ
M].*.^WQZ5 2]:-<,7>&8CG\PW15<XG<RE8?J1T+D7*OH=1:)IQG;(QK=-(KF
M8N&=:RES0["+.)KL[8PM(Q[CKXJ)7%KR)-Y,?QD?VGI>XA9&/AS>ET(&"O7G
MVJ6^FA=_Q"[.D)0UTWQO] CEGCMV%#9T=I"T:T9\DN.]1!K?7DK4!Y$XOQ;[
M;CRSTS@B11U5S5AN&*^=K86NO4 L]JO\;;?@E_K@[V]/@(&RUG >N@7&71VM
M7I;>J"=D8)(>L@=&;/B'W]8A8\*KF,:$?H]5U#9T.CP0%!(^PK,_^>>TK%O$
M  QLO@^Q?[IW0G>A^ _-6<N1$QHZ7N]B07L#RH-'XL^#T?I6*]TD.0?$?"3X
M(-VZ/S;;PTA4Y?!WW<](,G*(UW@09SWKO_XEA3 S<BIGZX=1!>1'6/S^O8GU
M'03\#NX##ND9=9<U,45FSKED$[.7<079XF+L>=1%=WJ6:0?O-,TPE=K<I[%B
M^.Z-IJ)W??@OH^FY#BH@W(Y3D@QO9^X^T1B[K345$FLQ\D/'O)6[)+]\O:]4
MUG'36*I/K.?Z\_U[#K#T;-;KP!G&@M&K[B/N?K1Z*NXW;MW2C*I@+*CWO8X+
MRY*O.UU]JR@BO+$#LDV_+U>@DUZ<=]<8<5Z@1\=T>M?_H7((T60@2B([\P%]
M1,LU4?=%(JP=^[^J^\ZPIKINVZVHV  14! D("(E-,%0A2A\B(" =*5*44JD
M]QH5*2+EI2M2A( T(2I%6@B($GI+ .F]]Q)"2;F!M_H]]]Q[GO/CGG-_Y-_>
M&];::XXYQEQCKLW2U*7>B\K7FU03O#ZX[E1U4[;TL9%)]^B:^I?S?S"7'P!S
M:3;".W#3Q%(8.TU[=LGY&6%VCQY6AE7@[#=ZUB>$E<H9TFKR@:://]#_H9N-
M\$JR=N_^IE^0;V Z@DD13)*[=36M/F[>Z *9'5=4,_VQ7+XY ?3.$N78VS#R
MP[/N_!UH_WUT<TZ1ZA/1I1_^_7T<I0%Y7^<^^IB8'>O)FOJ6AX^!BL8G?T(S
M0!30E: U"3++?+P!W+QPFG );M-%)HSX:.:,M2Q?&UYY<GU)HV+@>]H#_MH!
MN72C.J3A.H;XO B^G$2.5-L(7Z[K2;"5$L85YF341R N2:A=+([$]Q50%V6E
MYOV#H+P+[>7;;R$N#H'KJ6G_0?JJZ";2^3 >R4R'6A'9^)<WC:;)W_0#_(F]
M+A>K"FG"D]4J%GJBS;(ODW@'6[WX8"7>C6G9B6"<,P5/]>GQ>V"4UAUOKH_
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M4@"ZK=IER"1#51CVYZ108#F7S5"O_L(^OYII&?[)3U^S@2PK+#)3%DKO;<_
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MC58F,VB?WII5J!H\@ A_97OZ\Z]CO4PAN/GZSJ(<MER(39\&_4RX,OLM-C[
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MG"I1JU6TWD,3/&4#X^RR109M#11DN/PQ"YBXG>0**D)UI_UF4K NE_N(1^O
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M?/4OCW4C%IK/)^"X2FHB:Y:9J-#9[/'?_SW!_SD_$*7_?P%02P,$%     @
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M5#73&=&2*0DSD6402THA270$B8CSG$N5((TO,Y5/=SXUYFRVRO/EXA::[N[
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MR'I\@:U*8*,3L+J F-36<?US$H%&*W?[^.+!/+];&7.(!F;P2T?'*G4^K&"
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MK%X;\W*GDO+'^G2^JO^DY"S/N4@332!G,8$X3Q$DB"'(5<09DFF>I8GK(>2
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M-J&X*,[3!.D$"I1AB%6<-[4]<O//-$I$PE._] ^7R3,UDG@B='N/Z&GV7SA
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M)!(OQQ^OWJ=F^NX(7Y=Y$[OB>Z8@]AL&]\W](.".L,W?Q?6)Y& K^B 7$+U
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M+_'<2()/C?%JI2"W6H%=S<&.ZG62M)WG6O5!K?_5NG;>#@2MI\/*@ !:%*Y
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MC6\:)7X7Q<,(.C6S9$=/>TM:AP^OF<>04+51T??B>:!Q=KVO?O[1&_R:^\G
MO5X/W%;-M=OC5E'PHO:,;W0%Z[SQC;8_#Q^^,_2H!+M?'TC,D:_EAP7[\#9_
MX/Z")P+:%(MI:\6X)+K8W.1E$I$XCA14.*<V!RV%C) 81E&&\YPPSK579.5
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M^O^@OK>A[O;JHEPNS(]"-2E]RF;SN@F&KY^HB^+,5;WIFJ$H2C5""*8:2V-
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M-2<-OT@PI^\:1BN_T_4_Y8:RI=P),-GU09 0 A.69";HT[3P$"DD(@X0#TF
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MVS?D<OG U@A@K+@!Q@Z@#?%4U_'4^%S^BHR)^LA?D3D"[JEXYI7 SZ9@INL
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MO5'^4I%;46T/T)W6PPYW7(;&[8AG), G.NBY 1W]*\!;"[H-J&XMX!]\VC,
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M87X>9:4FH'_1M0!/^E_<2,=]$.QH:!Q@IR&F&M%:^?V^:#>@,L"$=)M+&AO
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M;D"K=;V*\1CKY8*2KZ@O*YG3QG^YP' 4">9T\\!MV:H@0QNRH$(D&8]BB&G
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M2B3#*(Z2V.7P8S1-Y_9E_&.UWNI6E<UKE=<_Z 7Q6M9UKO2:>=5:6[<3@<S
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M<_?L07B;G>?P;C__\Y%L5JJU[9TH.2),HJC@"RPYRJ(D!&&NE@\P@ASD,DX
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M'J:WZ=V)(=ZM&VU8)-Y/N7XAR+UX>EYOR.:UO-/P1>Q*60LBHA3IDD<1AQA
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M88"1OE:715F6$DDC$KGQ7H_0/3,COE8]4Y%>!V+E2$=NVR_N)R6>L)[XZ.0
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MH[F$+ T?Z^XU>#):JRC^H+:;+['N!SOOXA7;:?S-7F5]DEXIO=^%*]4./EN
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M]MWJ\YI=XGIBLDPN)0_%EEK\[NJ[;$82-=HXZ9,RYK'KWD.VZ(WEQWGR/@3
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M/99GGZZWP<3:[#@*#5RE0O(0"KR3KCXJ*=8%8:UJGHBY2\:X8!DD(7.DK#N
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M>?36 4COR[G7PJFM3XDZ>INC!!,MK^V*,WA#PF2".1E#E+QYJ^K'*1JY']#
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MSK<.K1\E:-P(>S2@':J241&6OX;[)+;N ['II'V];^I#OYO?V8YF)1E&Z8*
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MNZC<Z L^$5E%[7CMZ23K(#)6(*84@624M0U."M8\J?HD55W>H(X!P4:*Z]$
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M@A(%E)41@G>E3F]*S!B,Z79SUWOQ\L@2XU[7/0-46HEW9)2\F)^?XZ(6EO[
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M@M.%.Y=<ZW?KCQ+4$WP.T?=\*.%WD61^P!:_G<YP+;&)==HI:0S(2.<KR<I
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M2!F[FO6<UX7#^-T=;/XDZWN>IO%/_+;Z<3&=Q>D7O)PPSS69UZZV+%DU S2
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MS<$P[@[F,"[1?LT<D/D$RN8,:+0"DZ/R485DFYMJ3]$SKJW63NJ/PNE$$70
MIVVNUWN\SF_PRT9-"\6=5J8.]'1U-")/M!RKR 807EO!4#5OP[Z7D%X =*J<
MYZV9W@%RSJCQW]W-[D#C158)/'.6>)(B8"+7/13!(M-.:'VV:-T9US5NXX>N
MS^KN8-7!5EOGP.RYRK\;)1DB,I%2G<@E:[9F!I>9!RZT*%%:32L[2\KB$T1U
M$JGI!D=[\R-;";6+'J_K=*P/E9>K5*U?O_XQG22-PJID(3I)QYJ*"IQ$.BUE
M<N3TQ6A4:UMB'QTC-[)L*^R]@P].X'L7Z'FP2Y<3EIF+Q4G@4==V;$: "ZJ
MMIXS6IR,IO5LI(<TC-SA]ZRH.8G?'9R*.SFA3[(HDS/'M05T!>N<4V(14Q8\
MU\YE9<FV;FU"'D99)\'F7L_',XBW ]"^OED2=Y;+-_.K,)UM*Y.OB;,DLUK7
M-26Q;[BXD<*$)<LL2QJ8+ X4.@>8(Z-]67L=:\>M;5W%/8#,<0_8<Z!E_KRB
MZ^(0?I!:?\NX)+@V6#A(66?%B.P!8Y!UM)QSB<X<V?PJY1%2?MHX=QNUV4*
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ML)"524X+-SYSR]!XVSKW8"\AW0%GB)"?ALX CG< FZ&*^\XOUJA$5(H!:F-
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MHK,*6-:&/#:!@-8I$(:'9+#0[W]4 ;/ON>-ZITWE/(Q7'2CXQZJT,:GBA#+
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MFU /$DMQQ=.JIV<A;:2T+; ?<8'1*@0E-SH"@:\M.\48","@!D???HP2GLT
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M+ZO!,PZC&H\['D+H7[]OQB8'"56V4DL21<CVO'GW\9OI/AN,^N'7TP!F:I[
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M?O:V^H=P49E6>A68#GHV\'ZU[I6?O=W=*73[X_-PT(>7%.Y-D(^\AD%X>#J
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M"9P8KMC.I=AM2;.]V[M=0F98UY9Z_Y)]/6[O#5OQF]_WV9O'X_\ 4$L#!!0
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M,VC2.>G5372/",B:2O$V@#T!.-E E8&]\P !X(!0"E4&TF-:I6B/..05NAN
MVE&K,Y$%C(L+K5F(\I"L"=C=#K(0>(/K^M:,,*7D7:2."*F">5-_5O/\+Y+M
MRR?&]G\U1>1[DGX6Z/5(?MX2LP$L2NICU!%%@#"B-6%V G_%NZQR>W^B*XO,
MV)."<A5(M07RGS<M4XNX#G3Z*6GCJ-0G8DY81I'F&>-DR%<'^M2_*VY* H_B
M,6*1(6^!V2<(&D4>)=(8;3Z9#*,+GQ16;U@9+O^&:06APU*5J6%@8//DW#D!
MN CW32V6-HX&Y\09<G]6&<>?\3MRRD8=U__&IWV%1&Q2H^2),BX+O*_8E,,B
M[4!/%+JEN^9[)L)Q&3MGDF>)%VBF.,G2*2 DDQ@PX1I1V-X47Z0,F#XQ&?"^
M'FYTFN=VG=A-+=@@%,+*;#9."ER0*EH0IH;U'6J-FS?],>0$TNP%JF7+8+N3
M6\N:X29S).W=3Q1L]Z"B2:,OPR:I>)N[>U%P*=0R,=I,[A:*.!.K[ HS$VL(
MGGR/$#(ZA<ESFETQ')@<05,)DG,9AE2%-IT DC]!E8Z%T>&%]4),+2P5IE-#
M\&%4G%N:QJ;C;$)*?TP_FA:B2HQ2.X/% ^D:E<!Y<F#(Q$0!C+*P(J2'G1$M
M!D5F!5"3+4O#6#/L-]1$<MW2P^U<R@J[*A@(HX'S6Z/(V J!_1;-I$A+;/!:
M2!NQH&X>00A5H.L>YPM[ADAEH4TR:9CWTE8(A#;86I/A&2X-;2XMY0?<;O82
ML=<[(&/>5.H\75-BEK;E["6ZC\)0#6R/+&Q\AIS@"?O)@<__IPZ\:_CN@])N
M9M-=NS8SSIH>]NN1@=/=I]B2*5K?^]E[LVG"*=BU%><K-MPK ^<.%5>Y2B@N
M@#T:\FI2#KKVRGDH7.UA-MDEUTNED3@>8@U,AWIC?T7 >4]L[*;13>N+5"<N
MGY@Z<9%0=(4@BA4PQW2[MN5&R18UKP9RU&F5$BY%< %M?FE2'N -347\;)1E
M'1OQ.0SA(XS48Z@(<Q6+X,*/\XGQ>H:H1TS)PR0MVE,3+LG,<TA+Z.[0$R9]
MM%6[+^DBS9[81?J)'++(M/\AKK?NCV_V<PS\EZ;Z?-ZJ&-=JZ-B\',Z-@4I
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M>JJD21&SX3@WMD5#&K7?[B->B=8=L\ODN7B\@7N&C]61!]WPY1]R$J2"G>)
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M3.@(=0V.ZO ;PLW@&$YM;_&R+*[2"F\Q_SY@^8:SXY!#(,ME6H.L_#=L!P]
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MKHG7K2O<K"7N%+Y25541I_($4(^:24U%L\2BG"E@4?)$,","O:ZB RRIQW4
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M356:<9Z:>2WB(ZJJ67!;06S R?H1U<<*7!A%^4D5"G>8O$F%''S\$%9UZ&R
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M.</=@0\K5+<MW_6#7W[:I__[@'?V!GSLN--?_N^#,Q8ANQ9/[,X?<^__-D*
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M?@!RT!C7("*[$HB+(9OP()KBE4  ^0T"?\PBF!/1(OQ7/NSC?7K4@=GJAS>
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M%? 6$#@$D$B!0+]%LYP$XI$[+JX'CMNOP#+A660H^.#LBOG\#/"1<.K92!4
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M).47.EV!JY4&:"B:VD]?X?W0=^-H_A6)#;_^LQ_\6A1#(?\]"O3($SX4>_U
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M@?[X=R#\8,@]YV\UD;%/<==./$[E-9<_ 43D4E'#(X#Y08@Z1^OX R-W6L@
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MF0SUJ7?=N^M>Y=8*WVZPCS#F#3QZ]\?E?2_YREWO4_<. '6#2[JXNCQ[(-#
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M[8W+NF75JVH)^?D2LAD5P196=I55L3>,%6:LN[S)]QM;YL\_G;8^W&.G)E5
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MXV7^L&VA:C45I[9Y[L4[,7&Y)73&D^H<7"/J#XZHYCD4<XEYJN(O!C;W'AT
MF$7<]EST*QBB?VRH,[RJN&NB\\H*!#9^I)(]Q@9V5A=53ZH9=]\VSV?5^Q8)
M+Y1A&]D$:#*GOI&4TV-#;:LGU;2MMLWS8IV+ 8]=J@%<68G64 O6244M6.;Y
MK.ZP?PCW+%FI&M"THNSTQ- 8Y),7K5>5:\=M2"VT W;5>WCHW<D2:'>]\\L'
MP[!I>>[0R;:LHTMRAT[*K:,Y;-H0,IG"/@F_#K96_:P\R^[JS."\_#>)YFJ$
MS@FHV),7:V(8\;XKTC<#F-F>A9'CDU#\HO_X8#OAQ.737QQ/@A5?^J!(2GT.
M2>I1!)%C<5<UL:-UR]OJRP?-XTX;OQT!J4:V_JZ:5I.F]3ZRY^^=GC1/]\MO
M[S=;R;WW-'8P \:69!3P(BPJG'#O?]\=O)N1I'[99RUZ*AWG/2WU^UH['F^@
MM6/G= NM'>OFA-6IF'E@8#W":Q^X 5F*+\,P!M%;-%+)&_LI>^*)NPV6&$%4
M+XZY:MN&'3<KR.B&^D=.JFAC/C"P;B'&DY.-[B8:B8"=C8!35#!NY\10 _-I
M%0W,!P96+;SE*)$Y$UY1/EKCYR;QTQC_1Z:JIC/NQT%($1$U>O[8Z&F,8R-!
MSYL^*#PJK;JKE.CJ8:FA662G56S6?6!@3<)S)TQX*$L*%%;PM#<T;^QTG?IM
MYB"J,3DX":)26J,S3M(;:PS]L3'4F/2;;#^";'PN*/=DNTHC&VJ4_;%1=GO%
M <O3'W@X8F?HJ@&NREWG;X)UC:@_.**:EZ<#HJGJ/\CNT(DI;*QZ0-9_6Y2$
M.U8/C0V-=CPMCW9\FYT*.^RN=WO7N^]=/W3QPCVU+/RC>W?7O7ZX[%6O4>'6
M,&N)X_65,<LH/MLQL%'A33#D7B(%H$?UUG^JHN1:/4YJ,J*:%Q]PQB=.Q%UV
M'_G65XFI]W$_=&R'!TX5[5?+3(/;0M@J5N?H&.CU[\;1R ]RK/7:QSB5@>M8
M5915:X3=),*:Y_X'[.Q.)J!V<;?&SA\<.\US_O>\@1]80E5 K/'SQ\9/\[S_
M5TZDO/_5PTU#"\55%#?-\_E?R%Q&TIYX))2ME)3]P/]35+7!BK%X6\4&*QT#
M0P  .R>8)51%];[&S4WBIGG.?PQ+<5W@G3%U6B-$K:!86J/I1NW[YCG\0:O_
MC+Y^//T_.V&8$0!J7/VA<=489U2F)2#Z\K2)OVKH:6A1F-,J%H7IF-CN[])[
M%*%L8(#M8[@W95VK@G&I-:)N%%&-<3TEB'KONX_"LRHHCM:HN5'4-,;)E-8P
M'$]<?RH$^R@\,7 B=NOR2MJ>:DS=**8:XW!*,=5[= +?P^,>5*<K_E1!+#TU
MM/S;:7GY-Z.QU!BW4\5;P)P:VF:CJGAIC,LIP<M/_J,(B'FR7-H^FDJ' 1\K
M_]-G83L6#\3//W6./\@?CDT_'@*Z44&>:RIN5[&%3,?$[G#=82 J:D,]-;4(
M115K375,[ GW):0B:I39+^P:0S>%H:W]*M9)Z9C8'NZ*]_T O5)1%8N_UPBZ
M800USP_U\T^GK0]W H9\%""-GAX4X&>-I3\6EIKGCKH75AQ@-_ASWXIK<;3&
MTHZ)O>&Z7N3L/8@@\ ,G'*,=M<;2'QU+S7-+26\4A4C?/'D@EHZ<"=66=N!J
M-:/Z3PVMY-?:+R_E]S:+2QRRLYOK\TM95^+VKG?6.^]=5Z_[R]80:DE)B==&
M**.XZ:&!-2726OQ8LN?2@[^!KYX% JYFZ_<;A?]ODZ&:C+C&:%0EB-MUYY&V
M@BJ6H8FGK?WR[+ZW*08<L>[%Q>7=Y^[#Y>\]$ E^[UUWKQ^J5UKJ=%MQ^$OE
M@-?%**/8Z9&!<L"=F/@!-7J]$W_%3E!5GZFA>2>M_2HFGAP9>>Z/)ZZ#/:?8
MDQ.-*-BOP7J153E<S9B$3$/6*H96'1E85^J63W7%:0K^JQ&U1E1 5&-LJJ5<
M=3Z@NH)8:VAP7U6QUIBP_TQ>?Q@'B+35BSPU&#NK&'MZ9&"5J=N HE((PB@!
MG/G!! $N6.^;$T:"VJ964QZH(.ZJ(=Y8U^V3TY/7Z;J]K,-V>_(->VS+W9'S
M16J878.<_KMR>\]AMD^U]/MNS1BXQQQG+X]0FVT@WMJO.XB_AK7QQ^X@?F1@
ME;O?'>"E\F2\PV=K]>*'%^",R1U*D/3?0DS0(@ZRVT??_UI%'#6T77UKOXHY
M1$<&EK;[S!T/5 FRW,A4(E6%L:JJ18VQF_4TFI=2]!# B%P6LI76QNY@X+@.
M:,8UBZT1UAC?^)M)TVSM&QL47U$<-<8MGJ9NV#(:#H,WDXZALFY#YM:GF /S
MC?R@@O5Q:BS>-!8;XR^?3Y/3C<15Z9&+.(A&(F#=4#E\:B:\.?1M53$SZ<C$
M@GEW'"/HJHB;IH;+MZH8+G]D8HF\<Q$Z0R]Q1E:Z'V.-KYO&5V.\YVE/<3^,
M]LY</T0+;%=:"RJ(J,L8@8&(^C8S.H[9=>]3U=,YMH=/R_(Y7AF?C.*?QP;F
M<UPYPC/5!V T7VQ7\  _-C!/XUSTJ]=N(1.::QI>5K&_XK&!*1EG(^X-!7,\
M=LVC."#+_L<8I$P15E"^7.K>VQJ^5C'&_=C S(S/(AB*P-2CO,;/U\5/8^Q*
M"7[><U<%FS0;R$N[82BJ&,ZWU.^\-4RM8CC?L8'Y&&E+L!"/_QOR*-T";ZVD
M96FI^V-;^-JNH@GTV, 8Z3O UL"Q(F$SE4=<130U5:%J5U.A,B]*^L()+>ZR
M_PH>5! ]3:T7TJYBO9!C P.D;P,Q4=P3Q5-YZDOC%#6U\>VD;&@HLS2],'*B
M&',"TVK-C'OVZANR)?"KM>DY-YBHI,IH:+>^JI*D@1'@UV)(.;?LUA7V4-0X
MNCD<K6)+R6,3@[YUZ1XMA=/YT!T,A*6JI"7">;5#:9;VG-D:*E?30F=@;/A\
MBY0*1G\O;3VS-3RMIGW.P.CO-]#*IT;33:.I,1ZYA5U2*,\&KW_V/3&%:P1Z
M>+?FM#4*&^.T2_NEC_L\&/IH62;_1XVD/SR2&N.O2Y#TPL&R!M2.PG_$$@<5
MC"=;VHK.0#1]F_'?)ZSW>^_ZX9[=7+#SWD7WRU7UNOIL#YV6A7^WRU-@WWSX
M]XF!X=^]1^WP.!<#'KLUZ]P@ZZQBNO>)@2'BW<G$5:ZW:M?7:)N:S7!0GLWP
M-D_Y4_;P6X]U/_4JF=W57B:$;^MX/SCX<8_W4P./=^"<ON-1+"-&)K!N'(U\
M+)QA&,ZOPCNWA?-+>6<YSIN,K.8=\[+ *^/P_^Q*((1K+/W1L=08YU.J,7VS
M8G?"(S^8HB3ZZ%2SA62-J1O&5&/\3YFX<-6IIS]EW:&HI%G4U*CP@RI&A9\:
MF!9V+EP*\I.J_7D<53,XJL;3C>*I,4ZF;))-MBQ65?FIJ6D,!U6,F3XU,!GL
MVO?VDH,?<)40E71_&?4O%:LJLM@:=3>*NN8EB%W[.NLFEHT)*IF64N/I9O'4
MO$RQ/YQH-/)=O(/=>FL4_=%1U,#,J3,11-SQ6._N\K[+/O,H$I6LY=XV-8'J
MH#R!2@WQPATDY<=+>O.MW6#PH&XP^!H.TL(&@VOZ0?>;!ZMZ3PUSNK?VV:<O
MW;ON]4.O9Q@K6L'I?K"M!+BE3O?R!+A\R]3G^-SG^ZP:=?BV]LWQNJ>-JT9"
M=U 1%4Q:WAJB+SUSJYCI"1AJC*L]P=";/AR2JI;%%\_R/=WYI\;6'QY;C7&Y
MI^U2A..%$8_$N))&]P-34Y .JIB"!!AJC*L][4<5]P-?,E29XPD7_  >5)<J
MA[*FQM0?5#&F'E#6&,=[AJF.A5U)9WN-G!M&3F.\[0ER7L)Y'U!U,C;P Q:!
M0J7K[/@#1KGS-=[^\'AKC/<]-;O#:XX7HV>HR@: &E$WBZC&^-H31/TD/&S\
MRZZ<L1.IJ"8OQ5F;92P$-0+_\ ALC!,^([ZZ@LM^ZVFSZAI3?WA,-<@7WU+Q
M(O\68O(DW"K:5DUM1=TI;T7]$BXO URG+?;Y\OZL=W75O>[=?*E@SO+6<&F9
M^_25<<DLAMDRT'W:!3W?3JJILS^X\UC)B.4J<D^C4=4\/^JU'SF6J&)@W8&I
MI4@Z56RL"LAIGMOTVE>\4[JDSN)Q+ ,0685M_Z8FVG6JF&@':&NB+S5X=!XK
M&8I2(^=FD=,\KVGOVT1X(7).9*F7 *6Q1^5T\.<Y'_.A4$RWBC*!J7DAG2KF
MA0#^FN=8O8\MD%=#/Y"Z53?$K&:%S;<\ &G6F:BXP/0^Z6)5Q&=3DT<Z5>R^
M _ALGL.U:_\9JUZM*O!*1'O^8%!!;.V8:BXXK*BYP#ROZYD?>Y$()L!H$PDB
M$L,@$SC8DYVC'H4';+I&XA\>B<WSO-X+D&YYWW$K64:R8VH[[,,JML-&_X%Y
M#M<_NI>_]^ZP@/^_OMS]ESW<77:O:DRM,=4<5Y?&U$\W@*C7E]>?V%7WCQI%
M:Q0UQ\6E4?0^[H^=$(N<LLAG_XH#)[1EFU,IL%;6/5LC[Z:1UQP7F$;>KO75
M\Y^P>;0R$50.24UUTQY6U$UK4)_(5EJG%T-9PTPLJQ#2_GKE"*^*EM<:;3>-
MMN:XPC3:GOG>P$'8.+RBIH :23>,I.;XNS22_B8X7JWBR6]J??[#*M;G1^PT
MQWNEL?/+?9?==A_N+F\>6->J8&F+&DDWC:3F.*TTDJ*+*A!AQ.YX)#()@S6V
MUMAJCG=*8^O#R EL"F69LH_"$P/'<GA01>FT1M8-9P^8YZC*FZ=(XP>M*L2_
M(Y]]Y(Z[=TGM)GJ]+DO;G&-U#">**YJ<W3$U2O:PHE&R;?/\6C.(?2>&/*!Z
MZ5UORN[CR<0/(F&S_UR<U0C\*@BLAJA43>JC#=2D/CK>0DWJK>8,+\*0^[/?
M>N=?KGKW6V(8!/Z??SH\^5"*J,]K$YR#_-$AO9AGT4?9!-[79M*7IC#HPZ/F
M24<:;\>@QY%3K+) -0>J!Z"WDZ]\(BQGX,#)=G6&)2!=5)8K#&!C(-PY;1ZV
M*6 FJ?526:C^;@Q03YJG9(7TT+P3.!:*9("UH6.#RNR(%4&\/5"VFJTRZ;'W
MS0$="03.*T&M3U").@N$[42F+ZK3;)<MJDI[TVEVRI:A5-RPH=O1_RTSCAJ@
MXKKHK"%%6*76F[[.HV;KJ&RAMWX8[9VY(#BCYD,Q4\:OY[C9VK%VEY,5!B:8
MOY;V3G_Y6LY%?W6N,--XYN"HW>QL88'MMEQ@*>Y=>H]")4:Q[1PX.,5%RDCO
M__WM\N/EPY9T$0G -721UJR"9YYHT35%LCAL-P_))/;S3Z>M#W<"AGP4-OPX
M* >VX;#]: QL0=DX1C!<^,&8Q!I_/%']7K'K&^@?%H_FNTQ5!,YGQL+YWG<?
MA6=-WP*4SXV!\MOC%#UC8'O0/#[-8G":S:^3^^/Q!(_EJH+ZPAA0=YH'IV\+
MC3\9 UO-(C0:WP9BHIH!W!#Z*EVQJI#^S5A(?_2#P']"'>E._!6#/E%5$!MC
MR$P,\&^'4?S+(-BVVUGT[7T3\GQ["R+;OXT!\]L3V:Z,@>VLR/8O'P$4L.XP
M$-3^KJH@_FP,B/>;QSDN0?&M%BC1W)NB)%%9#G&]9TP@4.= 6D4UC._$(VC/
M9#CVN5=5*%/XPO7>MG*T,;AC(90? NY9(\&Z[$' E034K+JPWE9*\<JP_KC7
M>CO0WE9N[%)HWZ,2@J]4E76T.@#@FVVQY\XR1>_JK.H:WJTI1U]B"LK)%Y@_
MTW,%^8"K#NK_& /J632^< * ,_JFE51'$1_^*N)S%0-D3ZL>(#OC3&]UFJU9
M5)>R^E;.PX>1$[*SN][YY0/K?KKK]3[WKA\:S.88)\4II*@;#V/ N%:[P=K[
MK5.V Y?'?,KZ@G'L8B+L!D/:QU<:+(PG$Y?0$ 8 K/2CD0B>G%"PL6_+N,%!
MX(]9!*O !!#\;X-%.(V??SIIMQ<&Q;_T^;S DS]'7=O8+8)0Z\-N R#O8U0'
M_]V)./ !JPF7V#G0\1,/!(,%3-0:V XVEC4:M-("*P(S((O@2B,P"=MM,8 7
M;.9X6PHS61KSK@[=[74Z(B#NL@GE) +%B\B7H RIDJ;+^MS[*H/>B".P09+I
MY60RO9!C8+6-R(%9S?$)YB*[@4VAI4NFD=!E!1#]2D[?##S_"!M"['T,(UF\
MP:Z;W2;#ZX'EPFDJ'[B].FNHH%)V'SLA\'%2 B]@663JP/N??->&F;%[;HW4
M>U_NNPWVV0^&>#GBGBNF[%YX#NRO>K5!;(LPXC[V'@(\8_#5!AX[EK]G^Q8U
MQY9<#$Y\C/+: 1(,8VO$+#[AEA--)9(9O>OGN85TA]E\A.VB@-I7("$'/B[8
MF3HV!.U*&EVG]N5?MVI#ST;8E51>)*S!QS]_N?BDKEU%=E-O8SB%W;8JOXGW
MF668M(74/$ZX;L@N0!+U]:;01(&W=L/0!R:+OVA#N UBL1-&@>R11!O2@&UR
M00$@-DU7:-0P,4=(KMM<+83P6=E,K>/39OMX7E;6ES,"NH629?#BTO)Q(=S_
MN'RX[MW?]QY^6R.HLOT<B!BO./SQ6^^NU[V7I*LE./EKF$I/4AZ(L@*!/L-S
MMPK.>L3!4HY3BLSTVBP^P],@%*L/PO C'C%+!!$'1B359WA.B1%YW>=?,>!_
MNT.:#_P;A4&E\V K\<]P5(Y8^Y1NG\#,_$<Q[H-DTF[)2Y(Q@JYT)'6G"C"Z
M)&(\/1S,T7NH&NMJ5'?PXU =2- 1X&2(N V;!MO%T,V'N,==%]'8@5/7CR/0
MT:74=M@\/MS_!\CF))!Y?@0SM&/ ]/UV>PT8=U:$<>ZEE8PD+=P_XX".[,+W
M/*5L/3G1B/8!KH7Q>"R% X V7D/72<AE.DQ.A^P+UW_:G=E X&ZP<V0PA4?P
MEE(5<$L!" *9FJ1'F />'RAKX [?+7*)A<B>8&O)/$8OZ!2=<^!NM!*.\A@0
M]Q#EO4G@>-@5R47#0@P@AJ'_I]4 +&D ;.D?MM-//_5QYE.S7UCM ^WL!PA?
M=ZQ==H[<.\BX4S-YO*N->[P_,ZJ]R[HN0,*3)\59' 04Y?P=WSA(OR%K1,.'
MEC*9+':OSYTZS<I0"N+#)/ M(>Q0DX1$%CR) :G[@L6A-*EP"\XAFV+[B:3,
M/!>UB:6SO8)0NK( (-OUS1\-]H#0OKBYZS5R+ ,A_.2XF&6881]2X9(\!.ON
M:-:#](%O7X9A+'-)R;;BA-DQ0.^/47)+TDS50,"%Z&7<0D48R<"**\ ;8VGW
M">/^GP!$*8$1U[0=R1]#04/!WJ,TZ'A-UB6<0 5$*8<HO*%-2(F+)*ZAC#8
M9N$_A6N(XP?/TE#:^_O4&F:&_)++<QI*WI=U6DJ2+?S?B^!+^Z %^'+?.WNX
MO+EFK6UER-$LSGL7E]>7.)'[=7A=%H9'QPO<@2\'Q5:K);.PM^40;,TX!-MM
M57_H7$D4>!*'0#)APE'SAM%&A@Y=AR0,_<P6U[2:-7N+,WSW:SA"\7G$06)
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M+'BXOZ8LN&"&SY8"%XQ92X%5I[,*2H&'2Z7 ,I);00HL?;66 BN,Y-63 KO
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M:#58>[]U*JV?<Y;;F6Q,2M@DA2#;)H7<IX4\&%O#ZCKI2<;V;()#KK;VZ]8
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M25RI?V/1TSK'7V$S?(&S3Z!S!!2'CVTL$OE,DB"0DKR#EY+D.Z4-S7\!=!X
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M'#)IL8M02?H)(119<H<.>6?L6,C: _"150P@/R+8T>_K[$J5@G!4:4X!*H8
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ME@E0&(?&\5%7!1<I.&%4H(6U-RGO5D?58?3@3+9;6#(CNC2?<25-]ZEDM)D
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M.SPP+-%.8GDZNZ1HG&I"IF0^+\/)554),G$S*DC-1J"=1B-46REJ!Z78]'G
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M8,[R/"8R5A=2-)%4CDE69F7XM>YY/['.G?93S_U4)55-YHC%3WAP.\DCH:/
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M:O)CSAZ-"-S(N2R>L0(#5F?6DM[F6!C6A.=QQG-U7N3UV;DSB"B<!Y=>Y&0
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MC85>ESUYN(2$*A7X!C;3!2T+;6.1V.R%/4(.S/B*P4640&&J8*&;=8@]-O&
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M8B"-ZE>EGO_0-81_1W!.I*%A1'O$@/@\KU;&=-UPU3PA\UUP9)-0O;P*(<]
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MV6SR&)_6=/3YA@B<&7IN/)W7S 6S;OW\;<VE5K\5*K;%%&5IAM?&OZ*7!0^
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MU$X>SZ%CHB]0I$<@B@] Z=94X(^,F&/0N>) ?-1%:8G + P@\7LBTZVNT!X
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MG7&VI/1(ZO8RE7V)ON\NLC1I@W[:X-03@G&I@> _'Q\_#>&I]/^2T),B)Q?
M3=,\HB"M,[6;,2-;Q>1%Z?DN?O7$2I=)K#N#T,E46-&GL.+NF"2GH%S_8,MI
M\#HI5U@2.<J0G#'A)2_4VFF^VZA<?<VX8U]_^6]V*7ZP8LB7#[H8\LFA=L06
MK=?S)WNL7O:CQN(M7WP?J]=R8O4ZH*<\SWM<=D>K Y)*J\_ U,5<<'"2@MQG
MG'X]Y2(E\#).]X)DKP7AO_%-KR/R>+$GS7C:=0>6[UVVCH^?#"U;.(1K9&M0
MMF1OBO;"Q6YLU] CCW-J#6GSKT/.[&+8^KMKQ8^]CO'(W@U2\%LXVS<8/O&A
M&L<YS>W"X?$9AR^7A$:G*A_\AJJCOE5>_%5JP@PS+?6Q4>DKKD%B&Y.,,[O?
M!CS>&6#SF -K7.IVFF=Q#0I$RCGNS&7L%R2:LK,WL-@$^?+7]3J)QA<P=N3'
MFNLEJ<24QDKY5/I7:7O8Q.&,=1D5R0JC1R5_88H,39D55>>6[<*[_\$3'"8H
M4[!SJ<R8?L3YH_VG4L6D/!+;W_<;.[#@=]T"+;RJRO>VX5VF:,MW15M:'4 .
M3^J-2\0-F%_IB,/T,P;&?:3TR>L_7BR' ^B[D]*CO;-L.K7ZG%JMQ/]X#JZ>
M9ODXYW44VXPF]<ZWV01T]MU[[T(7ZDPCOE%R'2O)"$L,Z(VH\5K-J?D:?_R6
M$<Y\_)&&P8:-3Y_ ."P2:@3]7*_*)$Y4D>C2+S&@WS>1,S[#/Y(U5F;M=YGX
MM4S*6;$T^)DJRWIC"\A(HZAOR:;>>+@1Y%K2;]J/\9Z2E%17!9-2J,ML/E+5
MLTWK00/&W.4M7CG52#!:N%]110ZO="RM')(7"A$)#<RTZW9@:5NKJ 'TT=GC
M)GUMI@X4JS+D^H8@&JR?]57B.-+E!4D>?GUAG>JMA6K79<G[!%FI<&'JK'!S
M2A6(N/5/\1]O_JB3"T3BK,J;Z@?&$CRUT$E8>4F(@M3ZMYL'__G\Z9&IA\#!
M(8Q?X_(WK][]]OKDQL\UXK3)RXHP=[**,$PWVU3CQ1^T*FLN/3(H@K:FU.JA
MV^XE>U#8)K]1@,X_[CP<2I4BV#!.)"WPQR)'Y)^-"E[1ZL(DGE'G*#7@FC"&
M'!!40!MC? -T/-ZAH"IKE?$:84UL$@N@$DQ.G93G&,Q85VWRB(XUQ.Y4NXX,
MVH6-F[ G,YW7I6DQY?9[$Y3D.KL2P1(D7F):]6606U9IKEJW,3BNP%,(KPRV
MKL5+Z*#XH;MO!:[QE[S"L;@S,-MA)_=9&[6)_J$2Z18E/;M5L"B%VIYC!1%R
M+,ARF$*_UK*U81@-Z,I'V#CXDY^+)!:@#VJX/7V+TXE;!N_AFG1];$E&9/)0
MG;A)% \-[[,NX9@_!.R(YXOELV%KZ&<G\S^_:3PT+'.X,RPSG;2NLK1C)S5Z
MO-F-&^>2;0N2\(T:]( 534>;Y=7<-'7+MB10(Z,[5U32*MI!*FNQ$Z("+<2%
MK;%.8;Z+!]5S\@R<YB'A])EF<)QS-"B0/.H2C-7;S1Y:V^B*@W3?\IG0:N\U
MSM#&4AY7J(&M#$:PIF[!%7;=Y>LU:2W"65:2X=&%@\QX=_HF> 5VU3F8SU\;
M.2"XSWM$9(5K9PU45P&WX#" ^HH&S(78@:KY>V-?X=/GSIUTAUQD2IL:<-@,
MCPZ6%?@W9V@:YMT,*["'XJ3<IFK'VAOK!DO&O#Y:HN[A?QX[=*>:'%W!ILZ+
M%H"-'6L0YUJH:K9;A%Q'X*=$LFY\F;D7/3,T\#]$2U.6>1$([J7@<>)5> VC
M5_/C:?YD_*5[MD$3DIDJ<K"=E;W%VL\ )AD=LHQ'+Y#8=-=MO4K1VO!N2YE'
M<]ZU"<P.PVTWLH<"56=[MC0.'UX&!W#;G1AC34.T783*9^@*30F&"]*4-@Z6
ML(@H4.GQQII_C?X6G?'>).JACG88!Z-VK2E\IQR9L^$>?I6&/AER3@:U)\#.
M:^DR[O)%H"PN)!7:@2XTITXB <0L)J'4L< :,8B5..AEJVQ(3NZ]6S7/*5=.
MY-W(:/?F2'^L,O?E\8,N<^^(BST=4UQLW'9CHK.1F8IX#FWRHCH#"0QQ2W(
MHJBQ7ACV?8P?G^^V>(Q%!I&_1'PT;A.--6TA'U _A,,KJC>K@N'$4T37F*$#
M75,_M\&: #45G8.P>10(# )!.&MBWHFUN;5*(N0 (EZT_S,'AH$!&/D-,1OX
M>/_24_LUR2@DDV'#+:)WJJK,,3370)[+*,(7DY+ .(!*O?&"28?=]1HS,@1O
M:)]O> ;>VM[<]]@LBREX@HEK%&)7AKD(A";+-TEDXQ6ER:HT;(OY!*_; UX7
M#\$L-_8\2;P*?LFS1^TU<>T23:X;#T1?$01%3\/V^';R#5,_<5^ERI[IJ=FF
MP8EC"QF#MF6RHS:-B3"Y6):2\Z2('R$!2X-N8=;$"'#YCL PDUC08@Q%S]&-
MRS-241N$);UI8BXQA"O$)Q-Z+##6V7>8.^0R-KP6R8S (#?6[;>PR)Q]D$5R
M05;AJ>(J1ID5_.4*TRKD25F @[XUJ _<L7Q@V^TWQTDRKNV&5317:@<BZEDA
M!FJLO32B4#.A<;.&$X+-&(M)0U=AM,,:+U[F4>"QN,."@'T]$GA#$258RV+;
M^%=0C [/'C>&_?'8P>RZQL$#\#F6/2@?NZFF/36J/96K46R=EE] U&8;%6O&
MEMMU-<VW#@#OO'HXV;'CQ?&3(:=_?LM=25,/TJWN3 <6/[(]VMQ[7-1W ,:R
MY&\_&T_9OA)__DM>::[Z:MJ;;PGZ[\3$J>]23H?I^'D@$O@1">3U^.2OHW?L
MYUJ!/0C"UP][8&I'N6OQB1"\#1XV0N%):7 FH8B%;Y*U;N<F?*P+6.Z<RN9-
M(JT;(4,*X^;T"O^;%U^#4U!\H<O'W?.A2W>:1+:'R'Y07SC :WL;!P4XN!DU
ML!ESV(9-IG , ;T^/?JK+?*S*"]U1B6"6W :HV2+$>N-7VCOHR_N SJ6AA/X
MMQRA&AW:8I-,S/"R"%<VH2YB<_ **PV\?@_&JJ1,G%V"F5<B03^4@0GJC'ND
M_84,J7-S[E\>NL)@ L+Q6V,<C%Z*&_C @UO@DSV>W<"B[+-</+W7/9FONLFS
M_1?LZPSTC3(W\GE/.X%^ID;K+B64Q8KR51]=>.<A-E:/E&1"?.^'V_9]O%@N
M9_HA]'M_%R+#OJ:8 @E_SJC!R0T^5WGT=5QVC"G8X>6'\< (S55*N@;9U/ZD
MSZ1@/OC=9994$5N3@K+8;%)P=1OW0I3UUI80?3=R\UUB\DP%+'VE&$X5K*<8
M68JU"7FGFAD>A16Q"3=74648]JNY2TI3$,+Y3>+'V.H"35(_^\D94:I.YHQF
MTW['K&<"\\3;0S@:,&[>:)'MS+ON3*+&$7;Z?9>WG*"9(*ON97_$%R!-.GA#
MA3QCVR)(,L#C5#).*3A"VDW%?89&]OW]@/_E* QEZ5U[E$WKW[C@ +L&F$X7
MME6._2^8D,5;7*@4KF)'4F-Y>Z1=E4 [[^3ZSZM#1*^FK0;GIN1TJ7"@R*^Z
M2M\/D*S(O0Q"GL?@6?Q8Q:I/'WJQZD!:JO)%(IA%\[8<&0DB9B,DQ%$7!-_6
M+6\S/'9P&ZUT!O989?ER::?*9PWA_RQ,2I(YF'<0=+GF$E=2:<#J<%CW&R"=
MVL]N<LJ,E4B'@OA=G058)!2ADO6CEE2E0F$,[F3&!GT3W'Q0Y0-/A^T@/3#!
M3:XBP1"X:G%>/5I.RW.WR].8XHX%.K!"W<'F:8%N;X'<#+>IK265>+&_,H0O
MG*J23,@#:9DK:;8D[X"&=-IB_L(F3;]AL-4N:S,["(^+=G:$U'RNC].C'I*J
M+6R"97MU:A_HU3ZP-GV\YX00(TZZ"EZ9J,!K)6D^'ZNC00]G>]W()_)^%R0;
M=#[@FE1:A77,C2'\M%OH\#](2#+94WOV%(/7C:N3?]SIG9ZZ?;E<+%\,"M8Y
M+'7#M:*WA^TQ'@'LBUIY",1MG=<$\87M>700O4U*K/?YGQI\4@R;B*&R!^SF
M!5E=B,E'.$C*WE[F0+EMA,E(2L.T$#,7\MSTNJ2]<QZWA5TWQ7!OL"5C.,N3
MD6U$MDFHM^41\L2"3&'3:<5I-8S1GA5J(Z4[OU%?ZO]]]W]-3.AS3GO(EO^>
M1-(B(N96&:QU3$&A,RS>Y$Y\A+SBA,>&IB2EQE]A:[8X66*D1H%.D[-$ K01
M/ 4#S,&LZ\DPJ.7+9T]#-\XP^+AXOPA>O'ST\CD#(G'RD"W5)\?![XO/BU/4
MY<MGSW\*EH]?/AOIP:<'#?:/=%)*_<>@-D#?FJKO;G)J:=MC4MR3MNVM;;%F
M,=E8$E$$I41U-K**3U*E/&#D8#$'!<4'?BOH4Z.(2XL P.'X<ZW2"C$'W262
M36.7W6;3V-FG5!BW^"*<:&4:L$1+AZR<\0(NH3Y#V*WL!BT:O6E:IJC][4IZ
M,2(/T]D53GX>E5O$=R[ZV!?_>/?NW0TL#"J D(V09.#VD"%1[L"8V="W;$'
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M[?&$:@,S6E&(S/NI+= ;LU"YGC3<[_R8KK?QIYF[F:*\1-X$UY#DFOYP@9U
MPE[=4$EBJ9&?C/X9@^1$54BY=+@E%=ER64JCD/9'F.+P)@JS<U=T7&^+P$/;
M/M>M.G5!<-V2XL(UQE[M3/%/S2.01\Z;UG;_Y(U?@'OO;</W#=YGZN3IPXGA
MZ3 YJ35G\QFJQ&3V/U^JK7_M+1<1[CD++>OOZ;'?@#/!@?G6WMN3P1IG?E#\
MKR>+X\>@!V<7$P;8%7+W[O4D=K<J=L>+XR<D=LFP<M<3'&W*V']OQOY7.-2(
M'\Q2R'D,8V-(VY\+^;O93<@2<8;]CN3;P*Z2_,7;I "'YP0!F&^ 5'Y+^*#C
MD+8'$ Z2SJL.KKJ1A8?\8 *1\!F(&#-T:<"-/,)$!SDE==J$CD/1(D0^<35_
M-Y72J<[Z'F5R2,UW0VEL#7HT8K<'2SJ!+MY(&,=:[2_P6-0#7Q/01EFI#<69
M3%<YQK*X]+Z!D02./$:^*!8K/:QT51A$YR!R?+F)4J7Z@L"P)*C.DMQN(FA0
MH+OF@([H"PW7= +K;\07AT'C6*<) ?PAUA[ROT72#+\.F_&Z5D-#V([\Y <?
M?=?,0-.6ZKVE+"OR@[,YR&.DWJY1&1L]FA,G\;RQ>#X0F6SSN/\I\7N0!=1/
M'G0!];0[^^W.CZH8!U1"HZJSJ\.2*[Y#^O='790YH<5;&'B*/0I7>U*:5&6Z
MXV(%\U?8:(VX9S?A:/%BDLH;2&7PAH#IQB:<:TZ3<J^BY%@IQUCFI8'!(\RR
MQ'3ZRER?GB/,+Q5%P(.+/ W-[0G]+"4@+F6Y:7<8::=,MJ)"!Z[$0=SV/"OK
MS<8U$L-6R8LSE27_DE9-#QK6 8:O') [C34,,HNK*RB-:Y44!H3M0J4U9<;!
MM9$<^G\N%T<!S'**-_;QPEO KAUY9T1"MAL/G!\N88 !^ GKFX^BA?Y#1_5E
M7J<QUK84>HVUX=RW#:.L,YRY/$UB!AU7*5/HG6OM8'5EZN$^G,V .;_G_&L3
M ''*OS;U0I5@ =E$PW3+^;#E<O%L%LUG Z?#QIV&]<0/7("SI*R&:D'[\>4P
M>9B)V8ET\YJM0_@,'_1F!8;!9Z1A'D,.UHL'D#'!_-!E#G9<&17)2O@7L$CK
MP^_@9<#63V\"%W%;6=BGBY?[Y5K\H>=*,_+VY%=T26%5)'F%?,?C\2I&K;?[
MM@Y3&9?ZL5N')\^]QPY[]?.@J*0'NJP^"M/S*YV!9UX9U(L=>.+@R M@O>4U
M0"(SKPX:_%:B<@].*#),_WSW#T=%.)/\&&Q7]%$9I A+=_K"?TX9B?N545VL
M16V=:C!+B.QH*#OD,'I0Y,;6[F$WW>+/3;S),K,=2-K2#]56($&EW^?4-<6<
M<"^'E**5:N.A9Y7U=IO2/0W]CM\:-C3A)3H,;;E_0OV+D^AWBKY$ [F<4)I.
M=XV,%N*4CVTWH'H56D2"46\Q5!IO'+YV/)8!(5;,&Y#K;9I!?U?YJ4 <.H=W
M2YTAOXEY.D)*3.TNO=I=L.N33%A:,5=N0CCK255C!R.W!WIJJRV(TL/H[I.4
M/D%F2X]AH'>LZZ**)-@B\=R@*[-22,XT0\)4#+?G=26-<N8H(9S</.5BT VL
M#FXA"R+]:ZO?3'#$?,I2+&3R</PEP]!."LCQ=)B+SJUJZ+<[PE%'^_&3QV5X
M@1"4%%B ]5]I4!MK\[SS/(V%%\^)D.=W,=T1\2GMB$;/KXORV 9=DL<T4RM1
MH<23^HY@BDF6X0Y6FB<]T4=/).OF]L:Y%K:RH/>!=5#+$YE%MO^10[XK^>^3
M> -/+:N")8I,(MOTV"UUF KL%"NNPD.\4?B]U.$1^NCU,K.XP3L3]P:?A/JZ
M<Y#X$CF0I;]%G(HD/V7='VWREO E'B\7QT^;,2ND>$[6N\E_N9$1]S?2;B.S
MU5[IXFMYCEPO?U.POY$B_%T6+:Q#LJ9D\,EZG:0)H1C08<2=L)3N-I2#W3"_
M<+KD1;7.TR0/##"\$/2&5N7#?7S>F@X@8)0Q[CFG(I&UJ2MIS&Q?!WZ" QYR
M%Z V'5M9(?L5"#!   >[+3L3--1@9H7=Q(W.^4@P./.-Z).)L#X^FGV=^[1W
MQ-&XDR"4BT')O7PV,^8#H5L?H.M]T^!P/J%OYV"^O/B)@&1XW+0QN:J="B5+
MKM3%,XXIU>3G7LF[E+J+!06KB><16HP^[5H#D80XNKGP=YR"9Q;DV6)0\#6V
M+1%"@A?'+#!(1*HNA354E8@J P]0*:R-\!K#\FTT6@!)9*B.PR!2!7B\A?L@
MA66%-XG=)Y=Y\=6["ZT[ L\DA?\IC\:Q(9NF!_E<>A[$]8;[@T53(&48(KV@
M=*]JN !+?<BG(*/>\SG\JB,R@5 F5VS7Q80VLIL+W)!']XW"B2 ;!$^/)5%)
M'N.SR-6G>ST["F*U(Y$E?],1=H<6R W+E,BE ;,*?)9JYTX8?-!*4]L<+)PN
M*]YI9SD\9ZUXD\5[98W\6WC4CU4Y_/S!5P[O%6X.%T[<HV1G\ZF+W"]AQ>PX
MZI'V>:5#:C'VDQOHPA1(L'. :4%42S0/MJF.19.#N82B1+J<W?UN3)\>.YNU
M.ZH3IW#(E@,-P:D8T&#$O*XWVS3?"<A461>645Z42ID3B41IPM^I2\TW5$43
M68KOJG'+<CIHFV*AO^?NTYDZ#YC76-YV6\/K1H0K5,,C<FZLPE*!FO]PLR$3
M&(MN#NT\LCLH$VD5'.,?^9 _U*!EVL$:@P^#51*CQTJESO /XKHH&9.I4%'5
MU)'&EO8 PM9M?8EG1:&QZ!'AN;9;I%=<Y5E,-T<<+S)=#$FLT^PM=#EE5R53
MU#MW Y&0"=-SDG$+[X6#IW0;W3[EY!KYW"OYP]&6\7X0*D<-C]ZL6%Q\1=M]
M:SHJN^[.&\@)AB#GWT3688!AH!.:,*Q#OTCBFD@RD4B(,-'.SC  5QFJ-@?H
MU;)PR7-?KTD,."*.=:SD&VDL$H A<-]?1 6P>.Y1$:PJ\PRV_HXPOTACP(Q0
ME$(%'\0X"$YBQ-32P1MZ@"S'>NZ>O 9OC #=(O#4\XTY_8G;.U!U=6[ *\T)
M3S0P8'P(#ASLZ#:^E"(I\W>8$U'SE+BFFW98K;2:&_0%;2$T'K=&E,[F+8L#
M(YUPS9<Z/A,F49">2P4&#J]KG-.4N> TE@R_N9#QO-9KA0U #\$P?;%8#E;'
M*7$]1I7S=:[;@C<[T;S-QW 8UIG?%GE)O:[D1AG%E?L@<.RR%.B#7.[;8R&!
MSN'/V5;NND'H1_5,E!OE+W$VH^.<!6$I;#0"%2*^2$DCA'."7M7VY](<V9?9
M*-!,\/]XJ3F>PT/G<W>##+V$$6\KW;(=SN<@NEM.?%N%0JH/C5M4\3@<D/8X
M+_PCGHZFN@!OH23X3@[&2#2\'>,' ],\#TQHN*!B:/;@]U-D%TYI1= _(>UJ
M4>>:M$V\@7M'4 8PRYZ!A,^^\%&%(Q8H/C(6.>JD"*C0GDC8CJ1QYA%X,8N*
M7$7GSG66!G)W8A'),1].L!!-8F3>1K=RGH32*?'G#PI*SWR=$V:C9]')4]R\
M@)#DZ_5!W[ MU(3<B1>?XC]</+LWP=WM!.5>>,'J*2;7,R;'7;\CK"3@7'1W
M,K(%C+F;TG>]TG<;S!*#?@#-P4?A67+!F,TYU58H8[::(UQE-MM<E_Z!POS$
M-IJ/ITB6[QMA?CP?#HY:: :E1YN36D6^D=*!=GJQSN0<#[OA40\9(I1L6VFV
M1<&#3-A7PXH#4,](3@AO^HK3Z\HFO(V-3D,0QP%^!TY78Z[,#'E'N;LX-)UQ
M[\'>+M09C!'EP6/R"LZH<U"<OB>+IT<4NUW^?_;>M;EM)$L3_BN(ZNH.,@+%
M$2E+MKMB.T*6[0K/5G5Y;=?.NQ]!,BFA# (L7"2S?_U[;GG!C01ER81DS$Q/
MRR0()#)/GCS7YYF<G/B2.:].@YNRYXAQ4DV\FP?\65#V4]:LY>*2.UN":WZR
MTSP[*TWSS=?-\@-O9;KC/[%/,UQTV-RV7N6(&O"'?QE?CR:O7<:J:7BT:K!G
ME('TX&LJ\1I]X=#NQ^L 5^4=&&-*YSPHVLNVS'9,'@58 4+.P*%@*<B_EGY<
MJ0GX*$M<EAK__D6V)JX-,GE:V?HW;NG4,E%<KK/F ,TF=78U#<>(.JQ#OOT)
M*^)&+Z?CJI_S*^9M<S0*.>SV&G_K=BF7]H )ET@L2N/<EV> KEX$6,##>2*$
M0G9"<KAA.2K D9:8%R?C2,+#CQXGLU2(9DZA2AGADK[DB&3(L5/1GQ'M_]2>
M0!ID;Q4L*+E S[B;KO9)MGM4)O<XU8U=K)X5RC4=ESMJYHP>*TN$NYW:"I!8
M"!M$71S%*ZZ;4O8MVH[R4@[.EELYT$Y<V/>E_BQNB@)W@F?/V>YN=!L#$HSU
MCUMX%254S+4,,^*CAC^9\T#(0\3=WHA.+Y-FP#2H]88A$TR=GZ0198,[T:-2
MQ+4.>""OK%.O$8<\.(9*A ,C<M7SX+.*.5!Z>YU$:JQ%R^5JY6<W3H4\MPS%
MWW;OIP5/='KRU)*,0^G/'<(,'X@-!+=49G= SR(.^,?2[$Y*6!D"#X<8SJ]6
M[-@*&2ZNH3BWU_SNAM#^&T,:#4+[E4)K%JYG0NOVPCAP0EDI@<?!:(S2N*]T
M(79,:I*M$M+!; :VUB314D2<RYG9D'"?^'&C**__GF&62K>OE#MP9X 8$%U_
MIQ^,XPKAO%[\5829@6NB6W5\(U\[-;8RVX2O$'!)19%$ISCI3IOX*@CC+&][
MSA!U[-1<=#%&+BA.N(,T=;.71Q6#N:O C$VA0:GH(755.4C.0P^B(0W.(0EW
MAQJ_- I!X:AEI?C2^M KIY"F= >Q=RV!*?A$:9@M)9OE--_YE9N[G*>XW<$$
MAN&F7'B=T27&0[+PQ)@J%=V=IP7VGT9*=-(__O;L^<_RMS8N>; KE6J]E6S"
MV$Q()2NJK\7=>/CR!-T6!VMH2!.]&C=%FTQ*KO3K3PY*FP2?P,G,\H!STN@Z
MX?@Q(.$JW4448-"<Z!TED-0$-K?[209X3KS$@T:9A:(ZO<LHH=H*BJ T#7)^
M'X.L!?1^/#LY\4_X/\?N/WXY>3%80(=;0*M^VCW-E17<AXI_K9,EM^13H55J
M7X/^4<2:>3!6MUQ*0GHQ<PT+O-EPQ'<ZXH,J:ZR$X0EP8[%(%<H2(40R@:PY
M?,:F!L>$O)U<P%WN)UJ,(U2)R $&A;4,R-\XD4N1 (YXFU@VCF"3<\Q,/UG]
MA72/(&9%3'T/Q&BK7(I;2Y(K[Q1[FZC()/+'M\FH:8*/((QXT1^&X=,&L-O,
MAZ^0:GQ2\QM1=<P7J7YR@=V+N,C#"*1!*(Y(]FPW@YEF3N<:@H2O'>DUQ<)6
MQ 55SD"8(6.(WJ92M%5?O=P5!:[YOX,TV!+KUO1Y.6E.:*WE!#C%2).%)%=H
M)=R4N"U"#N]CQ!(_YEI7Z6^@(Q G1 =2Q1JL97\?8D'O-A[*G' P-:>"LQR#
MI#8RJW/<7%[-Y?0)@Q9@?9XM^C6$(+29;(CFOF2#3#-%!1 "=VWST*@7V!,Q
MW"#WL,#&<:C=_"N7ZB$!=)OJM08VGH,MLH]$\OQH\&".A@5#LT1YW)$AGW:R
MN^,R3HS'P#%=?X,<*$/XI]?8,K*:&[U/:BNJOQE+ EG.DX@J7-O*5RRW=JFC
MRJV?+[>G[P.&^%;0+#U%9OEO7HL!FN7;0+/L.SP>"39+!ZF9'/+6#X_.\B@S
M]Z=/+'-_RC#@ YC-5YJ@?YBJN)X;G[9\[V#SDS.F!QHI]X)?: =M+%,R-P>$
MFSYO#7#[>R;\U$ROV\Y\,L]B&.=UN,'&8P.F[)OLHR;XV6JT)M\V1^<I:$K?
M^S,)Z=V0/,A<)-_!F1SK^^(IG5'+/S^"?X?=(2#8OO>+BT%S(2W)6V,X:FH?
M:D:%F\'%TJG^C?? RT'^N\E_%/1.^G/$CR$NBX+2YO \S@PU8DJ8D-TB82,3
M-'@=/YQ["!CD:3HK(3P=TD?--S.X:OA8\$Y]8\/3@.!Z+B:5H*G+<Z4;0CGF
M9X9T<O[2CG6.F5RL=F:T)NJ3$"&2&3!9^2#CI"];M?IVIZ.SL;F=[WJ6^ Z_
M88!8W\A# 7C07L_IY-FL3J@AGPZ,&MWV:([V1W_VZ9.@TYA.)[/1\DG1:93\
MJO.!-\D.8>?^2K+\)VI3"ZCXZ":)*#DH^:G^D"?U>]OMF679=CT&G=CS K/)
M[-EH<2Q],3V ,6W0%P^K+U(UJ(M!73P9=7%/S'G/7QZ)$N91: Q=+?,[]S_^
M.P'WMD>\C(.N.*ZNF$Y'ZGO2%4<Q+1Z!J\_-UMXO:7C4S'0+VGI.Y7N9(DCH
M_-J;JRBY?5!BBR,*REN,^<';8^MWN24>VR@6&!W\:>I]0LU(EXQ-LOS25.)Z
M;Q5AE2C""^G>$7'X1)V^G+P\IQ_*(NDD= K"]=,"JTDVF?JG_N/G99AMHF#[
MSS"F-Z<?_2SCD,PU[MH;),A;!)$$Z4AT^6O)"[^<3LY?3C$UG,-0\Z5^L&2-
M)Y0U_J]\6?]N]F+RXG3:^O7)I/V[G;<]FYR\;/_ZSK<]@=&^>)#;/NLV"?]%
M$\R3#,N8;8+X?_UP^D-EI4D83L@2PR[0<.G][62*__NS7&#T>.5KD:9_SC9?
MO$JN'>]9DX1D\\..8^).,OQL4D_D\&<]B!-/<27*^$.5*@=9P/:U>:BI+TWB
M]'Q237[]A*'.HUGF%[;%\3>2$2H;>E.DR1*5$8,!9OV<RU.N<RZ+).RNZ@0_
MG[P\GNO3/,$7KS[<;6;-2WYS%5*:^]D4$T[5TH;GM@Y(S_U+!VGA6T]]PTG?
M,-U?J[GO535/J[8X:-CG36KW>8_T+MBC+T[.?D8T0/1)X43M+-4//'DGDUD]
MO:D_[<OTS29@T=YUQCS\[]-G9,!WF[UO;:WC3IR67O%KE%S3Z\^>6P;D/KX]
M%LZ4WW[0.5^O<\Y/7(WC(4R=*"*$@!P4T>%S.@51>^**Z*3TBM^A(CH9%-$#
M*")'X[B*: 93-BBBNRBBLZ=N$9V47O'[4T2SP2)Z"$7D:)RR(CH9+*([*:+9
MT[>(JEOQ.U-$=[*(=/M@0YSM^*JJ85_QASW85B=G5E4=KI/VS_YWKK4:HBWW
M/J>/1:\=%'+:OZ&?G.:;-IE@_T6YYOM"3[X#F&"?FB/?"K3MAJ$O#5"$6PCB
M>]RL;D!#ZPF?"NQ3Y?H*UX[&("+L!T; PF9^H;L@_*T1_M7K2IF+)7: 4^;E
MM9-U.<8:2K',V'2B(2:I3#UQ1"/7:A!A-YM+95!9%4M:$R%@UI*I+!D@#8%(
M\NM4*>]MF,&MO/]3!*DF#<:>+OGX_ZD@]:E'^95N_WP=;!U:%@97BZ7#39J@
MD5<JAR\$/#U5#F)#!:K+Q1_MIUSH[I[SR?1XU;>6H!6!7^])%.Z^SH0\&\>(
MP-=MR?5R9RIGI4+57E0):F\0QD0\9WA6D445^XI#[L&DJQ=X%FE ,T)ZPV>E
MZJ\BU"2O92#0RB#=9SPNV9L?M[',^XC37S\H6/>G"KEP';+K(L[#B.0DAM?S
M-#A*0D11*R&T=1<@OPX1$1.$-@TVUQ/O'<MGHWBE:J52D:Q@GB!>D9"W6*$3
MNE]##[6!]TZ6(($(#8T@>_WO)X15/^:2,\Z/[RQEB:^KL[*H[/(V-<&80=<P
M (10)6X@6Q>*@A40"$=4K.,FFT8$$>%?MR ]E@C.I_YO^"JGR8$Q1<TLX9WP
M.>]UE&_PXD96HHK^+F^4QEL2'?52=0!P=Q^G$7<?CRI\/IF>][/#]E'B.IT_
M>ERGGOA=O?9M-FE(Y!$.4F$/_)O#.H5:^0@N23D3N)Q%9S2/<)4SV1C]7"&#
M(7#<,_^AF:B&S7K@9DW28:/V:G5ZNU'OV!PQ[,A.373K<BWVX]^,%Z\^3+Q[
M$)1!X!Y$X$H$Y/V1.J$91#PU&"*%T@0R&_W.!;S+DBCZR-W\Y>+B/7G0']25
MCD]^_.G_&T"<NX XQTF.DVB8Q>J(V>59]9T5"4PJ(_/6P=; &2.(.).5"L\,
M$B@7P@]GH)<Y4E;- %$@S6'[XM@.+#Q35[#VL4.0,"!?A7$>9$S-.?!&C#=P
MFX)(EK-BLX%SGP-R@1/@I5B&W !9WS88S<#(X^\K^!XA]"H0Z/)3)1S6]#+.
M"W*@.,B2.)A'6YJ"1:XQ\>#J#*E"*+2) Q0X<X6IL(");R2SEN5JDWFQ6J@L
M,XQ\_"R\D%?$_IPYG9-TS_/Y,AVUO%41_'X-LG*-*Q-%0D(9;VO<@=^6IV,Z
M<W+H@Q;?K<4_O>F#YD:=G;'&O@[G3"[I;.1%%&09XJL+D;I@F@ML\1^3CQ/O
MM4+TS+7$2W\-YHA0B:D7+8[VUZAND(QFS>PTK#K0>L+()?SWX& >7R[_#RA>
MUL1O+M];U/X^R*I+ZN=P:?H<5\?N4^\]<4MP/#M!T& AQ&"N.-22/TX-T23K
M;+C37_+.60D\E8788*&"3TH'#(;[4]@> AH;;@++:VF)F[!5,UDB./$;#?Y_
ML6""@P7<=$%DFD',, \;88-*9"3;.SRZ-/(RWNLT&$U?C$<7X]'->/3NW=CB
MT3:-\4'A6>M'QH >?H>M^0[5<,_V).U'9 54*:7RYD'\F;<7\_3!5W."#EX$
MFS 7HIFL2(G[D$DR,%D(LGD',M@['PDU:7PQ"&,G8?R@D#!&J(?Z)8D(6Q]%
M7&<6;7W*[]+Z^J =\TAC< L?9X7L 0D$%3(9^=X:GI4R\9W S5-ZFDIL"'R'
M*3&I&@4> 4IYH2*2X!*O?,A>@L/3=!MC1IN>1(X#NUZ6T8EI GSP;Q0]=R[#
M0@C^!;EF9DADOR%G]Q5?BD>?;W/-]",<'/Z<?#[?PZPN:/U TNPX^LVF ">+
M. 6Q@")B/]#P5.(-PC4ZF*KI1[FW"K\@ZK[0E/Y5A!N\CG]XI7@684+@B F)
M&9J.07V8T=+P9W(<ZHG"C^1;Y'==,@^ I+EQ%H6E@";'3J23N[YG_^?@\D_P
MB$Z'XZVK1K'4X1=DMO5+K< 9QFRD(( IC5495M(@#3,3#0F([I[X6)14X5TE
M6%ZDJV]52G$0C(41G4MZ$^+&JY+!" L 7!+"#FBBMD>3U:W.P$&F*5IR:U/7
MH8U,H1QU+W=*<$K78 $/YV X @%O28$,\Q9FR&+P$OLJG?4;(O_11<9@5?+[
MTS/XYW3LZ]^CB\ET.4:+I@F:ZIFI/G&4P$CKC,+1RL@>-Q:-8DCL2(=I.F*:
M&%T*(^$NGY7XUE,WK*G@3_!^UZ2^C0*B5V(*!2ST06=8HE1DGV-,$QF24R.Y
M;<Q[>]:0KM+FOMS5UQ(H'\-<YKG"8P;&5OU2RZ%5LOH"N+5<$\;P\(*9\JKN
MRA]Q2)Q#E]9^8[:*S"G;DXS!QUPXDW&G_;\D_<QK!V\I#Y*@'7$$VIJ"^H#T
M4COT$EEB&":D!I4DAU:FHRZ_&Z!=@^H^&6S!.VCN3T[TZ(((Q'NFQ9&#OE(C
MS21?U=-'N#USB=IR<9]PHJ.-YS)0%[F)Q=M-%:DKV$>:53KSJ(6*J>"IZAJ]
M>*,<]SZ?,BNQ92ROUNJ5--5U@&H2YNP_K*PV*1I0&S3#.C^/B&5092QR8ADC
M+\X0VRK)/#C+#8)AJ5\HJ*A/ *I-GS?.NSXJ,>:?$),J92]J@QMA]R_XB(ZI
M[CY;U+JFN@%5C0$67&L^1L:^?O*U'1;,R@+/\-!$-.?%EEG8X*2))7Q"IRAJ
M;_= :QIAV9&8AQ$[ YK]<0R3EF45*=*>2E)%3GOLM8,O'WOMX)$4O5B659*H
MMCV+.XL$6.?V28+]RDYA><NHM#@4FTX+\TJQ ;(,,[9F$D-#R%QJ9+R(-UMV
M+9D0BM40CQA-/-C*;'?JI)TM-&8K39L8T=:FO)0N2ZX8P=^:R&WR8G#7.A_Z
M2(&VY5KYGAWR=+*H/(^43DPAD;<QDJLTW"Z%-@@VN!<Y)L:S(B4G#4Z3<*U-
M>:0(5FLY=L6$Q7UFPR82%L(-:JT+8_A?,AWBMV;IG UBW5&LD0V/--)[TTKT
M3M1?OZ3<;^AHL\%#_/M20NT?B8A3'R/BY:/)Z*.^1=N&7?C$Z%_YM]AH;!AN
MV7*5X@YA08RI 1RF"\\<U.L9^\&IL7L"^C+,?/RPV$CC[S6<12H6>P]VK.*.
M&XF0P.;!!A?TIC&?A>,"9]\8N+YMZN,"B50)AR%<F2I]MBU+-AE')9*-VTK#
ME/4ZUC VG80R167OW779?:X_2?A5X6\TYC$3"6*D;> L_**K-&S[TZ]@OF>Y
M]QL>K3BEKQFN?2AZVMELUL^YN08+Y>:X>3B?/;]1.&[8\(Y3: FJJ5YJAXY#
M* @58:$&)ZGM-K$Q.5-?Z@1$:3_2AU0DDO*GQLRD;;7OT48[2(^=1$@#W2)*
M#E.<ITDD:A#;.K$^*P%G4%'$+UPY^DO&^Y7)Z2,=D^B\+A-Z1; =KJX4*R.)
MA=)4D3T2IHMBC>&'A;++3!JO8=K8/19O8M=2.+*#(RC)SZ6Y[67IME29;WG/
MP=J_\\Q/R1 _ULS/S<Q+/%N%%-J@^;<RW7Q:R *53QA]]E8V:$)F8LK%+&QF
M-OA]X%!%Z(BY;ANX7E&"B\R55K6&5?4EQ.0C;@!>'(K!A(UZ0D+AYGPC._BW
M,&:V[7=PQ OV!0E%4WR[*;"]U?5>[EGMS![G2N#')=)OS3]N4YPA/9]/69J.
M_>.TRL&1VYWR/A"&]_*$_:"X-QQ6ZK6:]\C^_NIV)\YZ666IWQ3OA:\JCVN7
MRYI W0\#RB"9!TNF)65Z=/+9S[EU.+.G^S? 741YV"3?=)/ S/5G:QA^.4N3
MB20V11092K4*Z(:N;!3N%=A$Z^"S A,K5['IN)$Z!IO^>X,6&&Z]JJ[W=0D3
MW8"Z>;P@ O]E2=8E1O-'26H&H9;CIHP4WN#U;[]X'X/HO@OG#R]S&JIX[[(G
MO-&%X- $T5$!G)K2Y!=CSIB">!?KM=T+()<Q>S1@0E-9$%XV.YG-O(\J#N'?
M_TYR3BF-7IF4;S#/M#>__ZY^V<> LXP3ZQAZE^F*MHAL%BDN&JH_?46!P*7N
M/*EBY)CP)L4K2&#1][C"C$:L.^IJ=QU*XQ_#IKK ]J)U'W-2W/FDSY!*M$1]
M48M"BH IPPK2B2$@=ROX5$5!H)Q+.!O@?$FI @!N0^?*:#'FWUJ]4G(L&&F/
M0P%+N50^(]<^P-%D%&?@L"]GQ["8B_>I>S-K]OK>[^2I6W9ZRU1&BJ#Z-9.<
MAK$ :=G=J2N.&QJ&^REXVE2=36;/^P7Y,*BF?DB(NV4^*LP=]4TO15'+OL:M
M6_O&W=JL-.#@Q,Z(>11FUS7@1N5E >)C-"EH,G.YR!/,@[^*:ASDHJPNC<$L
MX>NF"]673:JR+-IJ#9;9H.4=7U)GP+2MDRK43MBU'N?<R,HYR, 4]'%)@;H)
MDP)'XDY.71HTD3,63XO2U485S9R%3-Z&*N(&^6"-*EGJ]+(%W+C8Y00\Q@*R
M9[/'7D V-,??B\ZL[L>>:4]$.H7M"AN2O0HOPC[DA:,_; J&-OFJB)>MJH@=
MDL "Z=;UA7._4NM'LT(<\AJ/0\![%CYN%^V:/#,4C.Y\^AHAO$-XZAEQ4I2$
M\OGSH_$S'U?D8 A[1*X@:^4CHL7@9T<5.CMACR1GL6=ZQ1'LK#B/(J*[7F V
M>7X\&'F2AJYJHNM9M5M/G+V8/*M3'^E/^T!]] A.L2LL[.\1$$6_54CWM.<Y
M;,51>'-<5H=[WHX=8DKEC8<X=>%J.QB4!VQ%Q&WZJPAO@@BC(92UZ,_N;"]:
MCR5E%()<47)'@,:H,HV30KB;78?G0P'NT?39LPLGY?I1.ABQ/VJ1VQ*R30HS
MDBMO$P4+CK:[O8/MOU]YTY>GIS[%IW)X+C<M,5HA,N/PL$>2H#(AFRM&S5(8
MW'%>Q%MB@WKZTRI)?^(_38T\QY4P[E-IYS<7<+HMM<MLDL ?WUQ^XZWZ<C+K
ML%.?$;/<L%F;-FNXGL,ZLRA:N.M^[50NQ#:#JT$;4#6GO A]@ZA43I;I\="&
MG$[.CHKIBOM>MV@NT^!6JZ1?5:YIU[B&Y)NC80U9GNY;VI8?O];5Q7T$0&@^
M@$OC?\.8*!2*O+J",P?/SG^KW+O$]OGW&J'%M"H+;%6]R;%2MT2'G)Q;DCBB
MVB>G*YEJLNC)3EB4DS?EY/'CT2ZSR?38!&T,QR"1.M'CPJW%9'_E]0>S,5QT
M+2H;4LK'539];;\F@ *J3N0,J]LM7FERL;R13LU7YO#U?8U\WM=A.)L,+=1W
M$$]>J[[)IW<+;EZN8CQ_$ /&+;YJQI-'Z$=V\@A_O]YPA1);H@;D]FBA!K1)
M_I*8CY8AG*)YM.4N8O.O_#I-BBO!MJ]W5HVE]D  %PDLGLJV"%4X(G"TP&&S
M="JX\/'UHYQ[L'=N6304%MSDR4W609AJ>&5X[*I ;#7JDYX+\:/!6*/?<0&!
MB_.8A;#:X 3;QJV,>^XL%GE37Z&OH44TD"SQ%8!UC B4WQCP?CBT[J85WMO:
M^\=O(^^R_6MHJ@P"94%Y1'IQDZ98:"R53O S=1-0/53SM+TFNM5.>]+5./BN
MT^<_VTWZS0%VAB*8K]PP/2&@O_-V88R,+'<+G!G4CDY/@@1AH<T45OPC3S?:
M@<2G8J&PZC<GA+E*D,IV E-JJ S!Y\U#1K$K-_>D<N^6L])%Z*HVY;2.K>$E
MSYZ=(-FZ!@=I^2D7:R_<:8J;#&8G_^5 <A%XP-<K"4&2%<.B7!+>KJTJJO#H
M6,S#87V [F'\7.33Z%W%<K.ZL=:N1D!RL!F,1%^ .1^%B,%CFOWD/EAAR_9W
MDB)6$=O]\)=:;Z)DJQ#S)[BR\.?+FS!+.#CK@D PJ\&N!S^Q.MVSQUJGNZ,L
M]WPR9*[:] )"FO=+'P@LBU D9)LPBG#7AEE&L+T(;'D-4@#?+15M$/H,_@HB
MX@[X#-+@>YMBO>$_DB*E/Y;Z$^PBW-)?8?PGJ@HT40C=?7&-?Y,U02V_\4V8
M)C%[J4P"D?A<&DDE_>+4H[;2N+J"?0NZ(?_FF("/\4!<K8XF^&3A_$(MHFNF
MHGB5++<E)K6&H\E[I>+%-2S@9[".; %"N"_;^X O^L._]J5,CC3+3DS89L4I
MCJ3A9U=T#I.]GDGKO2[R,!E4%2?2. \_]!G3,UH4;-'@^@PSWSKSJ*]>4VU*
MIKNP@]2P6[Y52Z)7^*"0P0&^1(XGAPG Y\ CNU.Y4FQ%4=7,,.>U.5?Q$@Q(
M!JTD(,W84BO>8=J9+ %)M'2?6I[<<P[O:RKO'W2%>VXT6;7?QV:/IU(T.WU*
MU;)[BM?KQMPI7?6H;+GC[<<TY-8K6P7:G^UH:N\V)N:+>,>FKTK*40GEDU$G
M4T?!8"9/)P K43I\VP6>+3]-W>H:4T@J> R(N-!>T2/MS4LU1]HWW>HE%;!!
M[+0K&X:]19)1+2[/ 69'P81&>&=N:!Z9 2SP&8)H4:(WR:3%>ATLE3XAFQ P
M7*X!NJN0ST68@URH#3Y<!DV$?+CT"PKL4 @6]!Z^A= =$?/=&C$VV;YDAA*X
MF+>FM4J1^$1YJRBA;XL-^'LQO;!.<&J*!5W?S$7!EG$!UMU4] H'%O:!.\$E
M9_'+/"@44.?QRLHX!&"^<3-9;+;Q$KG316KDK7!L(&;4;=JI7.N@T6(X#*],
M8-0Y>=H2>Q?J+!SQ*L(QRD)+*/I-D292(_T!9W>46&Z99:%TFLS!5M08WF,>
M;9AINA7937<0S#*]Q2ZYTPD+K/Z>!R""8S,9+;LN2P3KR^YM)(4T6]M@F>/.
M7OJ>!3+7TQF!=.5"300C%;!5?DVB/K/1AEVX,RYO 6N!DE0CFW?[%"4K?]=;
M?O.Z](&]H_,9*)B\;XTZ?!<3*V'_#D/#]MU(?<5NZB7HCB0*ET%9Q1-AJ\ 0
M53*#5$2R@Y-OC<H!<WTQ%N386C39)HUJ0*<4N *>Z V3U";V::?02SC5JZPC
M,[A-MMK2(8K'M\ZKT2KI%^@K#KZVP<\G1R]TA8GNYQSAW"R.7 2,::L%&5EQ
M: ^T!1)XK- P4&YU5FC5095MP]D,VD3HFMR]DZ8?6OKW*''1-_UIY2^I;:1P
M\4L\$J#>&%4"C;.SD[]K?9<5:^_1TC6$XTK'1!$3EJOE7K2T?_4&A[A$(FG
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M(TK/\" #)A9?!U_"=;%V0*%)F=%OVF.9. >K DN+EFEP&X][>O!MHN*HUKR
M9_.ZJR]$"(1A7GNV\#(S4DU6S!=1@!5<L$=PBVC<3DLOXTM@9:&<!<.=5)<#
M/M.H&(PBJL)TT[(')#+3MMGZN;P@R<=?7UBG8J/7&!-RO$]&7UC%%2Z<UP*3
M$ZC8*$OQQB#0'DX+@CJNS#9"?#\<'M^.O1^?GYWX\/+X'QP<YK1+E[]Y]>[3
MZXN#GZO%J4Q+0B"T"B_^C6%VG<;Z!MZ1N@UT#U[?Z8EEGNME%.03.<<[#!&Q
M N;*)8JEA7Z?)MY;K#;P7M$JPV0BN*6E"*N[)3ZGXMF6A>,/AL]KQ71/^"E,
M"TQ?$6;7& $S^?)4.(:?5FW=L\=>6W<DJ6W8T(@T83:UE':H]084=*R2(@,9
M,U1ZX%<KIO)CA G*#4B5@F;Y\YVB$=\S9(-E":5/KH,EDT88=C$A/(L"T$;+
M8&NL'8;.^*:MA<\H"CL$F1J\+V;J>X=06+J"EXR7?@6:Z,C^<>J?G=B3DRP,
M.E#+G"JND=U$K(+W?,?07_#FC;AW?FE"'!86N.T__O;L^<^,*5\+0E4KM=R8
MA=A\Y"P(*+SLD-8U^-8%E'U*KNT2VFX[ZDB4W1]_?_NA C'+/(GJ+ZQ3%&-4
M>\94.H_W=9A24U''.@*GV(4^WNOVEAZ==@_,MUO_DMQWY^]^--[N&^9(\R0;
MICY5=8Z ?43RQ*<1V#CJ()6UV0[<&3:\97LV_/B;2VVUYO-Y7R2Y[R83E1'W
MS$"BJO"8FR';6R]]BBWZ$GO<$<G6Y?=E.CI9%LE'<@U1%D2*:@&IBD@/3'Y
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MF-(!*W88:,SPBCG.I.OUL#=\8LA)SQ][=4?=EWHV^%)W\Z4^$/ &VOW9\=E
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M3"!L6*A$MDBU(*%JYB&>W'Z=X[=>QSK'53D8^'6*T'W=(R\ES2G;=1;YM_L
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M'9'L4QH(7DX_6IP&C,B"?DFB<$F!J#>OWGUZ?;$'C@[K$1"P:PT';)$RIFZ
M6<P%/#&0.&_]KF-?(&V$^>T#WHP_^ZAB=)4^(E(BH6.5+TD8TLKV^9&'6:IT
M;4R^V6Z^WT@$Q^PC)^EP1.[9!/W9!>#ZG)#K@S)'3:I<<$T<2))1FP?99T3B
MM,C']6C3/I'6]^@LU)\T#.@%P8"*;"&Z&9JMF.,W[GC9]S%!]9'[+P.I; @V
M$>KN"SR?..S1H)7;-'8*;O>=!;!'>LU2].OE)^^-O'H/&(E$6>FR3ZV"C=:L
M0>W)R1UF4LZ12VNQ6\9<+2U!3L=:[5E]'2\6H+TY#N^,RFTMP59P+>F9+>O>
M>2O"U% 4$.($A,]LC0TU=YBL6&]T,+/4(DI4F'R\4/@K1<IDZ:!>WM Y):!\
MHL3=*Y*5P(R"Y@9'!AY(M],M%E@@YSAUG'9W&KYQ*[N+1.^\>P3UIU-%?]CR
MX@X.TGM^Y_(3>0T64:#9>@]]NNW>KS[(&Z$>>13[]JA1W7[."OIJE/'KARKC
MXB*_#+0&9B.1600.Y!H9:+NUAK1LB.UECQA=N^.JE,I9E6M831<FCI1"+-$+
M972*?D[!NQ$&NU!JF>DZXC%E06@';KWK8"E0KWAN\YD[5V!N:8)HJF]-LIP*
M9F$A?N-#GO89A\(]1@$MU?SCD606TB^?W8NDB)8"*\YNFG,(2*.*">J4;L1S
M4K;BF9D>KO#%M$VT4>/O^*[I5+&@I_P,^!2?8,J;S L@M;8T17KNV6M"4H9J
M)</B87IT9I_-IPQ[%^[;E#O-<2ZYJ"RPP!BER:!#Z LNK3:YP$TI(CI;5E&Q
MR N)@ C(W*Z9LC*U+"@>5[U!DZN3I#O-NIK1IJ&R6B#RR.:CB)TC2!AS+-;K
M4FF%1<BS6XC.2+'7S(MFUC;%PY?7@1B1[<(+<X5=_+8II;N6ID7""U7_R?4Y
MM:WSY$H-GCW64H,2RN21@FJ[!;AL"//)8+:!: ;4FT/6NF/6FE,:-2T<KG&4
M:N\^%X4BER_UG9R.>., 4V&Z5^3@8?\'V;4ZGQPK,?'W>**4D6YQ8L'<S[".
M%B:Z$J;";YM/P5) H)H[IZKHNG4!O_XU5#@M4A-BNU_>Q3?P&"%:JMOE\.%:
MI5=*][52IF:+AY_O1<2J8&BC=(<L#1^9OU-ZOQPV3<B<"I8./&@\;7S=JK#1
MWH=UQ7SC-6'SS H>S97?^ND93%.VTOM2OS=M4684HQ!SNYG"M";.*:8"V!?\
M-BU5*SL7'C5"60/4&R4[.;\-/F]7EQ>&H/UXUD'JRX;BHCHB5#VI]]_3WV.6
M.&!!; G-MR7P,EK\>DAKQPV)+N,]&.]OR7A_Q6P9&8R;NEGV+X3#)N*:[VVV
MNFM2VN7K9L%33B/+DD5(/\(]M]>R/R"!>1_XS0WGZG3RLC_)J^Z9HGM($7GW
MFFL(L ';>W-C8D6K@,ZG5/]9 ^3"LT5[<KYH# 0H"YGQY9:\+CGF*#E?B;_5
M;JB+\>3=:3/NB<OZCF'-2C0D'K_$BQ*4]NS0EU)?0DR7B%=X]^!=:0]7@G?-
MQ[2.'[/+(J_[B+I0CIBIQRX4K<%V+#9+:U8Y4CNL<5Z&F]R]VK">E<!*[73N
M>')5<@*R>7:]8$.0 =U-.A5,T 5/)^5NUB[^9'<UULVZ: B\WP-_<=]S=3VL
M4OQWDN.RF:)86&ALRKUR9!4LCW1KL%>K5KL+1"N6!;N,KKU2V@](S.28)V,I
M:.?3BRRF72<7'57+1''.04ZP^OE7RT!+?&MO<I&[$]VDMNMY[<Q^C[V1/>-X
M2M@.[G56X&WX!=[D@L?;AQAXQ?-"#AVNB8ZVCDWUK47.V$I-IA;[\&T2]PB%
MXIWU$<!IZ9=\^$*-0,/-\B196IH&X2[ ^2W)-2["4JA/LNN&%(4].L.,F=J4
M ]!2"F_@1VUK[9@)HD#;9K+U[&R3?L=O>_I'Y70R/>G-6<FML;NVR^N0E<=1
M]\<$HPSE%GWM/U0QSOVVH-XRU%H0;,(H('DWG_'=7JLHN$6?!HF$1Q)'1*48
M,+Z<(@-50.W@QRLB*\Z]/XLTS)9,E6XJ:. >&1Z;_=:&>GG[H/VH,A1F;*S[
MHR@<Z3,QL5]J#$[!L-&A*@G+"GL\LQ-D-IS9Z??.8O)]=(!X3WI3!U=30R.-
M#CT\,$3(!1F2J$LGJJR?064?<_.^,<RG_(9?@DYX<MP5A7:97M)>M7-L27H5
MQ!@\US[_*H0SQ52-$/&\OK5&X[Y.HJ4@<^#WE\$&K,?(^Y@GB\\8K^" ("S^
M/>CIK^M$@?]9K8ZR94"!3_=LEX<<V:$*G+@V)MZGM@X3XW" YDLQ $_9,Z:J
MH*HK1#C*0MDL*PR86U(/XX,35WO8DO_P:5-KG\LB_6,MB#,D^0CVR3K,,OW/
MBHDB6IDCQV#R,@!9%.06O!Y9L+V/O[_]X'TP=/(?J'CB8OEG0>%O<XGO7%VZ
M]2OXV37VP9C"7SP(DIA1!PR6<FZ9FU(B-2'2:B&UK$,OYYK %L.(3>ZF[:^D
MW;Y069:D4N]FNC53">RD"AV <@C<C!M>WOQB[)8E.(ET?B=)2Z C<1U@CP_(
M99:'"U/"S!:^,[2GE8!__L@3\)Q/Z)V>W"V^'<66NLPI&YPP$KOPJ05Z)[O@
MG#ID.YM,SWU3G9*%\-I!2GJ(:F*29;'@P&@6K)6'A$&4L41.VV0=+CREZ3(H
MCT2_XAHK\Q.0S+5B,P*N7:+."\3YO5_M8\.K>!XC8*)H4,FR%K&;MJ.AHD%!
MF5)IY [!J:?I-+9/:=>OA!\UQBH\7 Z&R=EU9.CJHXO5BBB 5683OEH78]\@
M$2;AHJGX*N#^P'*I'D&9:+*]FC<:N$KX0.W82;STG)O<,TN5L!6*?C5 8J6A
M2WU"L$3L9^,1&^BG]KG#'V9470_3086/G!)*BG3!\P@;\8:Z+ 4JT^D@M8"9
M=&!D"^G8*[VB?_^GE=M/4('#593+SNJQ)==,H-T3)XZ%4)DP'9S4F(5V)VS8
MTL7MB1+%-6++8!U<V1:;SR'#VIO"NS EY QD..*_?6Z9#2*L5^!4"/T@1#,S
MB#P)HK%YCK$/>0)R$U'Q6Y1D&2^/^K)1,?X],OBFN!II[DM$F9]L.;YP&DRR
M(2??DD9&:B;?CGU3L@)+D91YQ>P&U94W2B)^>G5-F,=0B4E#.U?:U$3,D;"'
ML.&GSU^622GEC-(?.^?@@N*81XK"?'QS^>G=[__V9O<,TE9.ZL^:YN)L=MA4
M/+3[??';[W_\^Y-W\>_7WJ<W'W[[Z/W^UKO\_;??WGWZ[<V_/WU\\@$YL!9Z
M$X_3K=AD%EPFZW7(IQ%R,9:H&5CI"N&!=&M[6EVCMT7Z&E.3"SR)V,[0"+ 5
MFH=JC98X:OJNI7ZV?D:QM.%W-ID=-U>?4=:,JNJ$6ME UN&*P3$2Q%70.F&$
MZ'VHL"I,\"I]B!I630FI+FR!OK-TH977L9O->X/E>'QFZE8).&N1WIE**YB?
M3XCSI.:=*]TYZ&@H.W<_Q51'*$V20I9[:=^^<O?M=R%<KX8VKH8VKIYOM]HN
MN],6>;5GB[!3=<3(:Q?=>+SA'55\'2'-6C"+YHQ_M63>4<M3_>J#@8UKX@<M
MM3P1RG)H([V-'G8#/&D_][58+9DW.Z[90E/;SRD"V_RH4S/IJ[YQ]>9/4Z_+
M[L-K^JR>CC25%'Q]4'4T3'IMTJL*VE6%-+6X\2=]GKB'#<E((=6<I6WY>*KE
MCQI,D:,,&]7"I9LM2I6>R:/7+3Q\-.N(!V9+-.L]UB0ND80)(]WFK!)E"M>S
M:6]T*R<-KD))N36K50?%1+!-)(&!$6])'^G[>Q^$%F7$W4'R@W61B7@L5'BS
MFY/>)N(,0]K[R6\3GR;N_R7I9^^2\AK$E,;E#L@6NH/,T7+=V'%J[ZD* =/5
M/3Z2.O_IB 4Q_?%[4+;K,3))<^IL=#\7T*:A]:M\MPM:=5+[N6"^KAP"!15M
MO]O%DG('#,^ZFG90M$]OJ0]5M,:3&VL!X+Y(Z:%P NL91]'MI_P005,JRXQ4
M-3#^MNF<YW@FXXM4;':*YU]&099-O#^0=J[*EBJV2*O=L8/-V$T.Y)K9]M\5
M0M>9-E?^G6#)<9.YTA3"U0W M=>O=!57Q\'#Y;0$5R9%N\FQ=4]+P5UZOZ]6
M.!TV?(Q5, Z=A;WI"GZ181%%$)4J/\FT=!@J-1F*,\H=]3D\?N'1IL5=+-QH
M=37N/4^2SYE9S(1'G^Q@\=-\25YP=87M.!;#3S=^,:Q)I\D3@[4DS+LG[$&*
M/GI%;#:;G/;% S+4<Q]<M$JK9-I!)AYC(>W+D\=:2-M#*>X16KRFYWO+4!=+
M)[<^-Z=#<[Y;0JFE;SH3\]4(S%X<#V?,GBSPHNVU->;XRS': 9IX^I(+"Q<%
M:6TXK%*8.T+2SW*XE&M-"0LG;IM [S>\'1[7? 27LJOF_',RI:8'K7*S]Q9'
M>EU$><C(C'*&R/ULM<]<1<FMEVQ(D2A=3VA&?0".__1.U7//SR?GO/]R.KZ,
M@DOA%7]:H(NVR=0_]1\_+\-L$P7;?X8Q+1_]Z&<9AVA%%*H;E8+!%42B1&B_
M\]>B<YX_F\QFYZAV<AAJOM0/%HTT(8WT7_FR_MWYR>3%\V>M7\-$M'ZWZ[:G
MYY.7/*"]M_TO&C(/&R8FVP3Q__KA](?*_/YSMOGB3<LEB#CEM;E)-C^TK\]L
M<ISM^&Q/>[>14.]UH4KPMW(NR"0^X/RPPIHQ=G_+B=6?*7N?8B7T!M0(YQT:
MINM[D*LSV$6OP3DC'K#3J>_-3J8O[RHZ'O[W^3D%P+M-QS%>]\?IB?_R]+E_
M=F):TK^KY?XM2.%0X[6>G0QK_937^K^+6'FG)\-2/_VE_J@VN:CQ8;V_@_6N
MG-I/?KEG4__%\S/_Y#M=[M*I/1W6^BFOM7MJ#TO]I)>Z=FH/Z_VDU[MZ:@_+
M_:27NW1JSX:U?LIK[9[:PU(_Z:6NG=K#>C_I]:Z>VD]]N4]G_HOI[+L-K91.
M[=-AK9_R6KNG]K#43WJI:Z?VL-Y/>KVKI_937^YGI_[SLY/OUD@KG=K/AK5^
MRFOMGMK#4C_9I<:RPKVUH4<J='M.%9[]*'3#;+@_.W]1$Y1*,=M_47WH$X8U
M[",E5RML2:VJVG[;4%<]"HGFJ*686@JIHX#(#K;FUG0H^A[J2]^S!C#67AOS
M:+1(UG"7!56TQUZY/FPL[4Z'UU^;MVFMP#Z9S,[^;AJ!3&?0QI1FMF!FE;%?
MDB(W=&<R#6^)].$"7FK)X'8$MXRUZ-P"Z78*45G_2AJQ&A_S-E@(T'0=2*^\
MH"6]Q.AV83BN5KGO^DWS-*,8I&H=,(F?^\)M<R*M62V2]?0)AV:39[U1!!H1
MXH.Z2:(;0AMW0$Z?_%*,@O$__C8]/_FY_O^/V5I[$+;L5# J&5G2LRNY#Z4R
M-5=*=V5$^],%J>PU1&7]A3O  SSHNK5B,M;QOY:@6$6I-^T]/)C"9*EU;OOY
M$S K##;<TWU=!4S8*CYBG<,MEDO&Q6HZ%FLSZ1R+<L#]>NG];OB:,B9C<I[E
M6]J:1ES)3D]U7I_.IYE(]H6E&? NF9=N>R]RCK.&-!8)V# -#T&VA'YO@7TS
M,VR(NVV(/?-:WQY901!': AWV"W6_.IF77[$CDZ<78.K\/6[;\\KVIF?>*^[
M+4UI@1'LJ\A4ZX\R-+)-MZH/KXX=V?7'_*KWZNUU$BDA:M@$J=!9:" QN@>:
MH@U@HWN.4,8>:#Y,\!=U0Z=K^_7I#_O,HWK3,YM'%;*&&?$=',#$]J";NHO2
M:8.]/AH4;?\;^Q]CB_X.:3V6<#Y:R.&SH^,T]G.*C@\Y3-@T=U!Z8*@T_BP1
MNK_ ZD5#'%K5@^V()+MVW1/RT.>]]- ;X#')@"$;Q+7TJB*"#/"6N+L48)NT
M'U('*MVGL_Q'58N=T%/+"]P*H4K\=/0/ARF[V3#NZ DE0C/GP.S]XV]G+W_N
MJ1K7=&A'/>4,VMPC@;:==8*V9:_SCNBV?A5UL6:)MYCR"/6(+NPJ*=)O\N"V
M"$W].!T;WLV[ 5'6AN9@%XZ&[;5[>QFN0Y%\VAXE7"HSFXXJW&-?Z3P7KMP*
M1 +->D%PRV@9PY3W5#]71Z.QGQ[9RA>65%1W,86+7&#*_;I&DH6:L1[_!KD#
M_Q?G7J_PV'?A.'5$S :CJA91&:73MW&Q]MT)E\@U#1+BTJ&R"N;P%Y[.8>8
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MZS=?<A5G%%J&BR^E+J $;:$3D5^%=N&-<(B]3LBS=^I:S4.4L39)_:E5:,
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MODO]+C2""[@.?&BY/AR)Z9[!<F1:@C-(K>W"9YDDPCY=*T=+1>%CMKK(86E
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M>^9LM3K*PL(;D.KZ^/O;#UX7^J ''.=149%_^%<+@X/Q"59)D>X2@;T24'E
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M$N8(HHQKTPA/3V.9$(_V8T+;G!W1E?SA7Q/O#W0X"*EX8\#8')K%=K]#VJ/
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MM5^UR72=/C1[J:EY-*CB7-OLM<8PY.56V7/C35V2CBCG :&>WYU;^4%T$70
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M)I\/::DXS<C3%/:0=F$]*$:2+*<J2F(OV>,&]ZE0#TV8A%V@2R-_CXZ@:GC
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M&B7QNR]78[/A3!4\-FHO!.6,)SHP8[*^(ELOR1%@9O50E":XWE?@A<01\>@
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MIYGW&;4W::E84J>Y_@U>VA'+NL+$M:Q+FVH*J'U0YF;29^<W*, _GTQ!5Q.
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MPR%8A?.@MP;=P%6B *'$7 X!6>H]X''WI1,^CWEKS+TL_,@_6!:0'MHZ!VY
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MLJ@8)])<?,O"*LQ#WQIZURM9BE&]+CXEE8E(9_..Q?.#!K#3'\-@\7II6QG
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M[6Z<7:-.\5$BG&\WQ2]6Z_4]IO@.'0;LF6$3G %^MXIKH:9\,J1>D?Q>WQY
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M#UZKC.,?A$ME!TEX50;9-DSW)@+:#4F8-,^AMTCA&6O*2!'!ADSEM<MR_@7
M%:1YL-N#W5%B0U2>>5J8Z;^FT@I%-DQ;3(A8XP-1:,]'0:&MX?\><*+/5NN+
M(W/]] $UV>V1>;&ZP$'^O2P #!,%?Y1)5*M>M=^)N+4:.F%?9[[N)/OZT--U
M7-KUV\W6J]4YC,.[R%)S;DDREZS0KA1[I"Y82*A:IN-M?;$@^?1&MV2AQA4M
MAUVBT/WBJ-Q: @7!6_4YI4%OJ\=)I/6(0]G7@2)6O_CM,??T 9\.&-E0N=Y
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M&;M0RFC2@8%M NQ8(:8_R2,@9PSIF"65+)JGI7DPHR.&&%_X-GJ<\DPIN35
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MT"5272?KU=/_D2&,F(T<:,XS5R*SXYK0G+V^^*'R_!U3&IL$P77RR4A>%%E
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M8-!E632'=KS5*?EL(<VMPQM*!=)2 [)4_'R38&F4,A@2D>[X^];?.E:6=1^
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M-7B9G]S"0%*X1,V39 C=P:<MK*>':GZ;OKGL()[7+9'4LV1B8CNOP/?\KI;
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MA9!CA5]@"W#P8IA JUBWB6@ .5&MGB7TT4^&6C>U,5Q$6RG*)3*0?A?+]H]
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M+KYIF1?I;*V)K2R-B5+&N6WECL]*X]+SJL/IX;@_,L+:D7()^\Y(UU5;VBK
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M QQNU3P&F9'F/YH9@=@W3 Q(MCK>ATZ52);32N;=8V6U&W8<!3Y.("W%-/.
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M:?-(4!:W8%3_R[LB#NY=6/4!-^K,2F3'H_YY9:%*,SZFN6QBJ09,Y[K@4T7
M4M)GJ$ ,QA_[E7.GLS)7[8%ZO=3Q*KVF&=BJP2(+5K>$ 2.)&<&OH4O!%:"Z
M4\&CK?H43O:NHGQ 0%1;5+)_,);'*8DTG#\./9)S_^J)QW]J&AD9Q_ NF GA
M^%T:S7+#62T=XHA&HQ(L?$\Q[_A%I@\P 'BZE>#M1VY<ICX9.=Q@Y? U$,_!
M!D_K)4&P=>//^K/QG00!=?7;%VZ@I#98IZ+K))1.P$T\$4UJ1B[PVNOP.! X
M*:L@KDWK"W,6:)<?MEQK?UEJ!6Q'WQ0L[&2\U["P!@FCBPZY!58I,FYB>]6*
M#S.[@+#9L/;G*8H@S!3G:__,\)*1K&&L H6Q"/EH^%GO?1RQ#:=:OK;SC)3,
M+LUDZWA'I=/S$RV%B3&885$_0/+#:I6I7LE7-_2**TJ#:R&!S&V7X,7%B-QG
M;#+C_(V!<U<."H/XYK0,ED$B55YMR.+@ES1# ]\@IQE>GF@[!C-D ,J+4  @
MZ'O6'@@_;'ML?(/.X"D8JMX<"EKQ_E$YF./!;RK..;ARN4X/(>IIAA8SV9+M
MA'0%<J@5<.>U+1^'BCAQCHB1+5LH^F ]9J(J@^754)BS'!KGIUYH_O1=C#W/
M1HTA?^H8X"GV]F?>"CQYTTG*^?AD#&OPYNW5I_>_?1B<M7O.UPUD,F=-3]C1
M"7#UVX>?WN,#W0RN/[Z]>OO3VP^?GN?)'K X^F)TQOC"SSK#0,'M*S;G0J1-
MKBRO.I5VF:[M"HX.B/;>(IHP)[N#2%RK9&T5P4/I'D32UKF#_62+]#[/2^H!
MXJ]AIU,I)>EHPZT(NQCFA:'3(23H!"G%+!:R5IZ(N/X!09SFEW(8:#Z7J,TA
MC2E\,GDF,:4?N'$6,4!T^+):(.HZ74U_^IMF*VP\?Q\@5_ +TFZO,%K;5AJ%
ME 8#W"E\4QJYV  X&I9A#&LNLXRAE^+[9A1V,C8:Z0N.?JC__T&BW /HN)1X
MP&A,[AH+?Q9>,(A[!L;8ML"O3 MI?U9YXQ)V%[Z2LK]@-OJ)V;#B% ;DDX?3
MC*FA,:V1YQ&J0Q3NQ^I.V23>S!"D^8$>7YY89UDE'H6)BP)^K;U%2$R-13LG
M*F,99OB/E;W7E:&EN+/KW_2].".1!X++'U0$;XRW-Y26UX!6)\I6X--+3>_&
M?<R;PIT7_0?1_6:+((G^*ZW:K)W^B&>#F!/SA^3<D7AL,$M7A:TP_IBB*@=\
M\2>ENFMZ9JW!F*Y?KB+@R.3,85@7MI)@S"TTR/7SPC8*56_A$&>P^^R3'/JL
M/E2#H7]1FQ1.!=DQA7C"1 GIKWUZLA;<\@)'Y3*=T4LD!<III!DI34Y1(W[&
M+70EF!IJ1N/.-^F'L=R*L@J0_7PY"1-EW,+B,%QMP)7A,G.Y&HF+S&$!,AEK
MN_ D:4W-+JIZXASP/JP-)X EPUT^PNH45V3,:GM3:*3-^![X;*VVMGUF>KO.
M #3,8!I+3,T/C:KX,RJ O@"I'@>D<E^=72A8.!U82=^Z'3_ 'K;TU30@U)Z
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M0"U<.TNTELF"[-K63(_Y;97"3_:Z%-[D6!X=ON[L**)*!1:'ERLXQ2-:\\N
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M&_B9+N<H*(P1+GH_.0/Z<_';T4TGC1K#G^%MHV\#Z7.^]TB?KAJ#[E3,0\D
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M#1,Q.>R7+%R[S7G?)H]O=QI8[3U^FYN[7,.%IBF;:6Q'?.(S@>5G:2&J ,8
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MS5V^ IQ[%[''7\GI?42YDG*+HMK0.R5NPZ1Z)7 2&$[A2.'\LC5TK$B8<T^
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M)^+ 4\(+P67T3W-@-428U?V%^3 WH0V1= &K3;:Z9TFP>\,AGH]H+=6C64M
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MA8BEU&L1<BH(Q]OS&89 89JQ>C$F%.9@$J*]1[?RXP]>2V!=[KB>E _9H4!
M8:A;G@F?P1A;'8?XEEB.?SY!P/,$$"EZ"UDEL"?X"Z@/4>(/C*#Q8RMZ:2L4
M(IX+);55!'<R0R4B$=G#RQ): QD#H5%J]\-A^C7Y H<10E)9+M1A NCY[($4
M [S-/%<LE[TVPP'$9YAW3W??;7*(JL5];< 7I^UNO"?!6,^*AZ,IZ+UV41/$
M0IS4U[$49C3:@+]NM0:]\;9_=N>4"L,L[^C=IQD>&8!/0PCB2<<)@4= K*--
MSE],I.JZBX&CMWGLJ8WICRY Z5K ,8WAZY,OT'DW-/U,BP10]4ER-YC>.8\+
M3_CBZ/&$75&G%\-AX?:VJIV@\;"N0O38/$TS;6!C7]?,>E/M@V*X9D3O^!P:
M:(^_X%#\B69G2)J=\710'A7/SOUEW=^,2N-B?$+Q?T#LT,IV<F8>ZX^4@<T(
MS5@XU U&T%R<;&.%U,UJ:B/331/V5D0SWG*$IO'9\[L0(M]?-@GCXM&LQQ%J
MKG26#YX4$*Y16M]J_;6%%!C] CE%*!X:2XKH<:[6%FD#*XOKD91O20K'2@_G
M. 6G0@U"_YFL3<PWS\C 2QY?M2S2MT#/'10$DPK:D6LGQVKVB[&;30:.#\+*
MS,,7ERDZ0JHF#UU_D@**(/(1&7G$$MN;M:I9E.(1'XGTY%57"#=AAG\-0[/<
M<&<(%K/F^%!-\A5]#4X^>3B"K+ >B%R>GS7N-)FTKV-/'O-LL]2</DOT^FPE
M(R!' )?KG1\WQ#0INU0$JO:P]@W*@=V(]T>3_KH#"7K2RO!27)T,[Z[Z%5B-
MCB9HIU+H%X!M>7>V10P* D%5YB'V-":V?_F/EV^^JU-S*.*6I]I<;59V<P,P
M4K14225XFRZ+ $!R]!G'>[THBV?]Z7#/OT2&)'<)<P16:<J9*?]>^B]E=9D4
MV;_(G"W*^88WI0GM,A84L-_F]+'Y3&*5SCNXYWW6>MXMF028"I<CO'U2T!^X
M_Y'SY[HCG:U%8XWKXQHE9MM(Y7;VA G>J7P9[($;+NS_N6S !CN9B6)K(@SS
M#X@\8?71@%*I&2;;0W$1+4TMF=!QAIV*+FO0R!-=:_!3S:!=9;.LD9&M-ZM5
M8D]VL\:SJDJO2SJG=6[$94P(* '=B7$G+T*GI:!4H C4=-,8^A;FF5"II^),
M?4)WH]W#ER%\%4*V/#U#@6"H58 1ZH58ESWWTHM[VDLO]6']U$]ZS!LF#C7.
M!2K$/6UR%$-"8@^#RE"C7*C:[+"%V);2"G,QG7)X2U/@H;^QM6ENGJU(]M]>
MCQ+1?CX:]U40[3^8Q6!\G/^7)M5I]!/$LC[,F:+"#CE5F(2(/:=%/[5/@6TS
MDKA,J7')]X%,I)76-5S.?&X.&^3BX*^HIPU2+X>?"Y>H^NE3RGF/E'.H,=*>
MG^ #*$3IQ0+.##/RA.FXN$16(UXZ2;2DH=^:H7\&M1'TGFE!X1%O)?-@!0$$
MEN+]<L>US812(AI742<&Z_LANC2<$C#&%BP8,)YLFBMC8O_EJ*9^3 MTX2&Z
MLOT-R>+WC51^177$>@T*.&37+Z0'JP415E7I$H#ZO/1I9,S?ET3R9D:G2M&P
M0L:"WDS?3AJIC%U-N4P#[T1X@;YW-:<ZGS*)N<IB1<$D/@9F,MV3V##DHPFK
M8+_%=A0_2?0I0X(>%3B%Y>SW%#>:Q&#N+K!.8)O#.1B=O)E$?Q/%PN^3;=U_
M AQE6??U<9=UQW5 OAW= ?G1 6O W/V"9@L0-'2*_%0NLF4VEWZF9?1.JE:P
M$;^W>0S83_Q;^2R.TF9^&GV/8.I\2R#N!?_7 8T@]R;]<#XN2<3QM8+@40!^
M\"6"+C&Y@Y&HRC^K[N]M=&UL4-&@3&'%^6'4>=X*8%YW9Q0D5.NRYG[ZQ\'7
MRF4L>'G]>^_'+<I[/+^@'R^JDSRU9S/4\$NK35UG9AR-9Y5RJ37&GR%:K-NY
M"X?#V?.SL^AS6D#;P<]E Q!._OAE^.-7K8_M]:G(75/E 3J%X?0PC[: :AEI
M?I_83,'O&[R&_&42S0!=T,8H.);_SW2ECW*E3^G2<JO2VU6M7[A=?A]/-J$7
MW11RC>"-^"'JS8Q(6Y&X#OYP3$U^_TT#8+EKQ]#A1X::FZN696653+4.A%L1
MO%O:;^*@$@]3F#[(5.QK)[IO 9H%.WA?V\)(=\&D/@D:/,%2CPR6&N_&I6Z_
M0:0@WH$GI.VLP=OQCHTMR&VP8/]ZPA$^X0A'@R-$9'XDHL,/ 26<P(H_9C#A
MO8 Q7IZ>V0"-L@&0(LJ6V]'$;&/L)%UQ=]L*0O6MYO'P<V/R%8[F;0!DBX5]
MKB%]K4MOVPDKM-R82PT$ZB=FR24+LQ+KU/T5ZT2Y9E_'_G 4?:B=%"'GZ<@<
MEM4?C2(\PW3$:-;C^'I2J<!*U1!8>C&O2Z1LXXRY:D\+9Y/4,<H9ZV66<]S1
M6L-4Q0&D'WZ84IE7J1_P*DU<)KMDRYS10D34R[;#_=_MGFL=[IK'!V*QZ9OO
MW%TFN ]1LH2[0R&;8H;=/<>M-XRC5E7*3T/7L3<6M1MA(AZ"+WMWK"7SSNV_
MW[@%<60K7ZJ<T^DVG?AC<O/DN.SCN AQ2?21(5B WR)R#)S(UL)0,3JA1VJ8
M LC4U1ZB14H^NI3C\&%T=%#S<\].A)4KY2.W!KVGN6=PUE$5O*?/1V-_S]!Y
M^M-??X8 #B;Q8YXN+M-34-L5(X1FP40O%05U6=VT:;_L&L3R=+K[I[Y=E37'
M=AIRB!C8(8X1L2!I8N,^LUX5>!ING*6%@,/M\0#=_2D\"_TD)6]BF5R7MC[^
M67*.O&\X#\;:E[N^R@V99!/!P<>W"DF[6->_C5RE8CPE=31T42E]@X7TP@H,
MLV7,4LP2V4QM'/KZ-OQ]CC?XIE5J3'V2Q_1L=2;9=B_OAWL78^RV_;C]YXLR
MK5G"9RW%TWI>*O99/1RQ- -VP>74O,AY<6_4QGE&<#0VZ!$QSI$!,>LA^ZJ
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M1P^S':1^4U3YXCG406K.Y!5ED\U=DH60Z.;\NEBLL@+XI$A.\>)2*!-:-*K
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M(HO@[PL!5-L%RD@^1UTB6?QN#!:4(B/HZ+6/1H--C^;_R'_(6!-/Q7@YZB^
MP %=K&>;-3"4&FNWX%\LLAH](FZO7UF%+3L%_!K=Q\?',F< C$9MY=#ET8RQ
M!M(N&R\S^084,CD2BHF-S:P*ZNS'\+,I*W=K:>(HE]2WB<-*-\94C^M.J,WZ
M,FYD U^23@54Z<-CV#:J/-!B)D*[R$1UYB#(-4]L@#0$'LO$X\8'-TO(C\@Q
MNK4@"[M'C$-]F4#(_##OL-<.Q"GDCI<6RD0%.LFLO&:% MBRY$!9W\P,2"6H
MY,XVL1,)@C&R$215K-<2+3/C&\"0@%7(ZI59Q!#WXG_,K\R)053YFV)F@IU
M8O U)0;UZ(][^&57F1?=V)R,0"_P/YK&.%&TV5/J>>+M;=S+K/"T0?$^T)##
MK[7W/K*LSK?/JE*9Q>DEWD@;Z3KPPG4"!F^!C\I31R:N2;8TBSR':T:YF\4
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M76L67M7(BV>&A*-_;TK$O]]9H4V=BBRE<MWC@@DUWE"VT@E _*"&8?D[J@W
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MG#A,3'K,7_"RR-)=!T%@GEUF2+6!["'FHH")18)D]Z;VK2M$I%Y6R:KFM@7
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M%]^")+HLH;E07.+(Z:ROG6''>1Q1F(9=2X@B-'_+<D+-LE4>HE'VQ>F;$5G
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M43/]8C/W[5&V(H02K3!0Z+A,JD7.E  W5Q15)U8B#8BA/4FR3+<E'P"@VYM
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M\X[F.FN0VZ9+#5+M2P#RC8=_D2(/(U!N$2ZH<U3-0*+I&K,&EV6Y@ T-!:/
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MRN<Q]G=#*U=-U1%J%>=>M)MRDR_@MN!CSS:N,[7=#)U&OP*A:32=AI'S[TJ
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MR4X*P8!+<$."V3%@E/WI:O4'<3YBFR\1+/\E-L57O$ FW=;#S@R:-83KK>_
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MI*'MENS6A+Q^D*B,_O(?;Z??@;9$A;*=;U]\9__H/#)FS82J1W*9<HXC<WX
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M5'Q4^#R,=42F0S#CLC&"<C)0S]Y4S/S'J"VF'2;+"-YO"_5'EQ'<5,ES/R-
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M N8&N4N+E"&D4$@V_[Y)9\;.I?7$ S8;<SU/%YN*LKW&=N]6]7@JH^Y31O5
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M3@'S1X9"S*UX#?U=C81[:6HC2[_:IQ!@JV\ +,*8^N\I^I6G)$5IZ(JA#E&
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M<G)"RVG #X.S\HD1/^LFSUOJ-6G*Y&D4Z*>+LX?;]W/']DX-F%5SA MUUQD
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M2P$"% ,4    " !KB*A6_:I.6>80  !.I0  $               @ $1_0$
M9'9A+3(P,C,P,S,Q+GAS9%!+ 0(4 Q0    ( &N(J%9X-1)UXQP  $07 0 4
M              "  24. @!D=F$M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( &N(J%;SC?_GXE@  #JQ P 4              "  3HK @!D=F$M,C R
M,S S,S%?9&5F+GAM;%!+ 0(4 Q0    ( &N(J%8-KDCWB68  )!^   3
M          "  4Z$ @!D=F$M,C R,S S,S%?9S$N:G!G4$L! A0#%     @
M:XBH5MFA,,.(W   @.H( !0              ( !".L" &1V82TR,#(S,#,S
M,5]L86(N>&UL4$L! A0#%     @ :XBH5F8CWTOOB0  T_P% !0
M     ( !PL<# &1V82TR,#(S,#,S,5]P<F4N>&UL4$L! A0#%     @ :XBH
M5FJ[]9OR!P  @"0  !8              ( !XU$$ &1V82TS,S$R,V5X,S$Q
M,3!X<2YH=&U02P$"% ,4    " !KB*A6E@2$@L\'  #C(@  %@
M    @ $)6@0 9'9A+3,S,3(S97@S,3(Q,'AQ+FAT;5!+ 0(4 Q0    ( &N(
MJ%::4^T-6@4  #P6   6              "  0QB! !D=F$M,S,Q,C-E>#,R
M,3$P>'$N:'1M4$L! A0#%     @ :XBH5M>:VU)"!0  U!0  !8
M     ( !FF<$ &1V82TS,S$R,V5X,S(R,3!X<2YH=&U02P$"% ,4    " !K
MB*A6LK=F"-<Q  !6/P$ '@              @ $0;00 97@Q,#$M9F]R;7-S
M87)A=V%R9&%G<F5E;64N:'1M4$L! A0#%     @ :XBH5H=\D+@J,@  -2\!
M !X              ( !(Y\$ &5X,3 R+69O<FUP<W5A=V%R9&%G<F5E;65N
M+FAT;5!+ 0(4 Q0    ( &N(J%:&]Z;3@2\  /43 0 >              "
M 8G1! !E>#$P,RUF;W)M<G-U87=A<F1A9W)E96UE;BYH=&U02P$"% ,4
M" !KB*A645[4?+8& P"H,!H '@              @ %& 04 97@Q,#0M<V5C
K;VYD86UE;F1M96YT=&]C<F4N:'1M4$L%!@     /  \ !00  #@("     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
